primaryid,number,drug_seq,role_cod,drugname,drugname2,route,start_dt,end_dt,dose_vbm,dosage_unit,usage,indi,treatment,pt_again,r3
AB-15051636,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20151028,20151225,20,mg,1,胃癌,不适用,"",""
AB-15051636,4,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20141008,201512,"","","",胃癌,不适用,"",""
AB-15051636,4,3,C,シスプラチン,"",静脈内（明記されていない場合）,20141015,201512,"","","",胃癌,不适用,"",""
AB-15051636,4,4,C,メチルプレドニゾロンコハク酸エステルナトリウム,"",静脈内（明記されていない場合）,20141015,"","","","","",未知,"",""
AB-15051636,4,5,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,20141015,"","","","","",未知,"",""
AB-15051636,4,6,C,ラモセトロン塩酸塩,"",経口,20141015,"","","","","",未知,"",""
AB-15056685,14,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20150818,20160223,2,mg/kg,1,悪性黒色腫,不适用,肺臓炎(不明);大腸炎(不明);血小板数減少(不明);急性胆嚢炎(不明),""
AB-15056685,14,2,C,ワルファリンカリウム,"",不明,"","",3,mg,1,"",不适用,"",""
AB-15056685,14,3,C,アスピリン,"",不明,"","",100,mg,1,"",不适用,"",""
AB-15056685,14,4,C,ファモチジン,"",不明,"","",20,mg,1,"",不适用,"",""
AB-15056685,14,5,C,ピタバスタチンカルシウム,"",不明,"","",1,mg,1,"",不适用,"",""
AB-16014127,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20150529,20150710,2,mg/kg,1,悪性黒色腫,剂量停止,"",""
AB-16014127,4,2,C,デノスマブ,"",不明,20150529,20151211,120,mg,1,"",未知,"",""
AB-16016056,9,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20160224,20160527,3,mg/kg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺癌),剂量停止,"",""
AB-16023027,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20160705,20160920,2,mg/kg,1,悪性黒色腫,剂量不变,"",""
AB-16027216,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20151228,20160126,3,mg/kg,1,再発非小細胞肺癌,不适用,"",""
AB-16044167,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20161026,"",3,mg/kg,1,遠隔転移を伴う腎細胞癌,剂量停止,"",""
AB-16055909,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20161222,20161222,3,mg/kg,1,遠隔転移を伴う腎細胞癌,剂量停止,"",""
AB-16059856,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20160602,20160901,140,mg,1,再発非小細胞肺癌,剂量停止,"",""
AB-16059856,2,2,C,ワルファリンカリウム,"",経口,"","","","","","",剂量不变,"",""
AB-16059856,2,3,C,プレガバリン,"",経口,"","","","","","",剂量不变,"",""
AB-16059856,2,4,C,ブロチゾラム,"",経口,"","","","","","",剂量不变,"",""
AB-16059856,2,5,C,ベポタスチンベシル酸塩,"",経口,"","","","","","",剂量不变,"",""
AB-16059856,2,6,C,フロセミド,"",経口,"","","","","","",剂量不变,"",""
AB-16059856,2,7,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","","",剂量不变,"",""
AB-17000515,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20170202,"",3,mg/kg,1,遠隔転移を伴う腎細胞癌,剂量不变,"",""
AB-17004815,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,悪性黒色腫(根治切除不能な悪性黒色腫);胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,血清反応陰性関節炎(再投与なし),""
AB-17011265,6,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20170329,20170329,200,mg,1,肺腺癌第４期,剂量停止,"",""
AB-17011265,6,2,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-17011265,6,3,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-17011265,6,4,C,ミラベグロン,"",不明,"","","","","","",未知,"",""
AB-17011265,6,5,C,トラゾドン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-17011265,6,6,C,ゾルピデム酒石酸塩,"",不明,"","","","","","",未知,"",""
AB-17011265,6,7,C,ルビプロストン,"",不明,"","","","","","",未知,"",""
AB-17011265,6,8,C,テプレノン,"",不明,"","","","","","",未知,"",""
AB-17011265,6,9,C,アルギン酸ナトリウム,"",不明,"","","","","","",未知,"",""
AB-17011265,6,10,C,アピキサバン,"",不明,"","","","","","",未知,"",""
AB-17011265,6,11,C,アムロジピンベシル酸塩,"",経口,"","",2.5,DF,1,高血圧,未知,"",""
AB-17011265,6,12,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,DF,1,胃炎,未知,"",""
AB-17011265,6,13,C,ポラプレジンク,"",経口,"","",75,DF,2,味覚不全,未知,"",""
AB-17011265,6,14,C,テルミサルタン,"",経口,"","",20,DF,1,高血圧,未知,"",""
AB-17011265,6,15,C,酪酸菌製剤,"",経口,"","","","","",胃腸障害,未知,"",""
AB-17011265,6,16,C,メコバラミン,"",経口,"","",500,DF,3,末梢性ニューロパチー,未知,"",""
AB-17011265,6,17,C,ウルソデオキシコール酸,"",経口,"","",100,DF,3,肝障害,未知,"",""
AB-17011265,6,18,C,グルコン酸カリウム,"",経口,"","",10,DF,1,低カリウム血症,未知,"",""
AB-17011265,6,19,C,レチノール・カルシフェロール配合剤,"",経口,"","","","","","",未知,"",""
AB-17011265,6,20,C,デキサメタゾン,"",経口,"","","","","","",未知,"",""
AB-17011265,6,21,C,レベチラセタム,"",不明,"","","","","","",未知,"",""
AB-17011265,6,22,C,スルファメトキサゾール・トリメトプリム,"",経口,"","","","","","",未知,"",""
AB-17011265,6,23,C,アレンドロン酸ナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-17011265,6,24,C,ミコナゾール,"",不明,"","","","","","",未知,"",""
AB-17011265,6,25,C,レボフロキサシン水和物,"",経口,"","","","","","",未知,"",""
AB-17012123,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20170328,20170418,200,mg,1,肺扁平上皮癌第１期,不适用,"",""
AB-17012123,4,2,C,クエン酸カリウム・クエン酸ナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-17012123,4,3,C,酸化マグネシウム,"",経口,"","",330,μg,1,"",未知,"",""
AB-17012123,4,4,C,フェブキソスタット,"",不明,"","",10,mg,1,"",未知,"",""
AB-17012123,4,5,C,プレドニゾロン,"",不明,"","",5,mg,1,"",未知,"",""
AB-17012123,4,6,C,ランソプラゾール,"",不明,"","",15,mg,1,"",未知,"",""
AB-17012123,4,7,C,エチゾラム,"",不明,"","",0.5,mg,1,"",未知,"",""
AB-17012123,4,8,C,デキサメタゾン,"",経口,"",20170524,0.5,mg,1,肺扁平上皮癌第１期,剂量停止,"",""
AB-17012380,9,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20170501,20170530,200,mg,1,肺腺癌(PD-L1陽性の切除不能な進行・再発の非小細胞肺癌（腺がん）),剂量停止,呼吸困難(再投与なし);間質性肺疾患(再投与なし),""
AB-17013001,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20170519,20170519,3,mg/kg,1,再発非小細胞肺癌,剂量停止,"",""
AB-17013001,3,2,C,チオトロピウム臭化物水和物,"",吸入,20151028,"",18,μg,1,慢性閉塞性肺疾患,剂量不变,"",""
AB-17013001,3,3,C,アンブロキソール塩酸塩,"",経口,20151028,"",15,mg,3,慢性閉塞性肺疾患,剂量不变,"",""
AB-17013001,3,4,C,サルメテロールキシナホ酸塩・フルチカゾンプロピオン酸エステル,"",吸入,"","",100,μg,2,慢性閉塞性肺疾患,剂量不变,"",""
AB-17013001,3,5,C,テオフィリン,"",経口,"","",100,mg,2,慢性閉塞性肺疾患,剂量不变,"",""
AB-17013203,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20160209,20160407,3,mg/kg,1,再発非小細胞肺癌,剂量停止,"",""
AB-17013628,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20170111,"",3,mg/kg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺癌),剂量停止,骨壊死(不明);大腸炎(不明),""
AB-17015198,9,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20170427,20180111,200,mg,1,非小細胞肺癌(PD-L1陽性の切除不能な進行・再発の非小細胞肺癌（低分化腺癌、ステージ4）),剂量停止,肺炎(再投与なし);自己免疫性大腸炎(再投与なし),""
AB-17015198,9,2,C,リバーロキサバン,"",経口,不明,"",15,mg,1,"",未知,"",""
AB-17015198,9,3,C,アムロジピンベシル酸塩,"",経口,不明,"",5,mg,1,"",未知,"",""
AB-17015198,9,4,C,ナプロキセン,"",経口,不明,"",300,mg,1,"",未知,"",""
AB-17015198,9,5,C,レバミピド,"",経口,不明,"",300,mg,1,予防(予防的),未知,"",""
AB-17023551,6,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20170602,20170626,200,mg,1,肺腺癌,剂量停止,"",""
AB-17023551,6,2,C,オキシコドン塩酸塩水和物,"",経口,"","",50,mg,2,肺腺癌,剂量不变,"",""
AB-17023828,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20170113,20170523,3,mg/kg,1,遠隔転移を伴う腎細胞癌,剂量停止,"",""
AB-17024126,2,1,PS,メトトレキサート,メソトレキセート,包膜内,20150407,20150407,15,mg,4,リンパ腫,未知,"",""
AB-17024126,2,2,PS,メトトレキサート,"",包膜内,20150422,20150422,15,mg,4,"",未知,"",""
AB-17024126,2,3,PS,メトトレキサート,"",包膜内,20150513,20150513,15,mg,4,"",未知,"",""
AB-17024126,2,4,PS,メトトレキサート,"",包膜内,"",20150715,15,mg,4,"",未知,"",""
AB-17024126,2,5,PS,シタラビン,"",包膜内,20150407,20150407,40,mg,4,リンパ腫,未知,"",""
AB-17024126,2,6,PS,シタラビン,"",包膜内,20150422,20150422,40,mg,4,"",未知,"",""
AB-17024126,2,7,PS,シタラビン,"",包膜内,20150513,20150513,40,mg,4,"",未知,"",""
AB-17024126,2,8,PS,シタラビン,"",包膜内,20150715,20150715,40,mg,4,"",未知,"",""
AB-17024126,2,9,PS,プレドニゾロン酢酸エステル,"",包膜内,20150407,20150407,10,mg,4,リンパ腫,未知,"",""
AB-17024126,2,10,PS,プレドニゾロン酢酸エステル,"",包膜内,20150422,20150422,10,mg,4,"",未知,"",""
AB-17024126,2,11,PS,プレドニゾロン酢酸エステル,"",包膜内,20150513,20150513,10,mg,4,"",未知,"",""
AB-17024126,2,12,PS,プレドニゾロン酢酸エステル,"",包膜内,20150715,20150715,10,mg,4,"",未知,"",""
AB-17024126,2,13,PS,ニボルマブ,"",不明,"","","","","",胃癌,未知,"",""
AB-17024126,2,14,C,スルファメトキサゾール・トリメトプリム,"",不明,20150314,20150730,"","","","",未知,"",""
AB-17024126,2,15,C,フルコナゾール,"",不明,20150314,20150730,"","","","",未知,"",""
AB-17024126,2,16,C,ランソプラゾール,"",不明,20150314,20150730,"","","","",未知,"",""
AB-17024126,2,17,C,リツキシマブ,"",不明,20150324,20150324,"","","","",未知,"",""
AB-17024126,2,18,C,リツキシマブ,"",不明,20150417,20150417,"","","","",未知,"",""
AB-17024126,2,19,C,リツキシマブ,"",不明,20150508,20150508,"","","","",未知,"",""
AB-17024126,2,20,C,リツキシマブ,"",不明,20150529,20150529,"","","","",未知,"",""
AB-17024126,2,21,C,リツキシマブ,"",不明,20150619,20150619,"","","","",未知,"",""
AB-17024126,2,22,C,リツキシマブ,"",不明,20150710,20150710,"","","","",未知,"",""
AB-17024126,2,23,C,ドキソルビシン塩酸塩,"",不明,20150324,20150324,"","","","",未知,"",""
AB-17024126,2,24,C,ドキソルビシン塩酸塩,"",不明,20150417,20150417,"","","","",未知,"",""
AB-17024126,2,25,C,ドキソルビシン塩酸塩,"",不明,20150508,20150508,"","","","",未知,"",""
AB-17024126,2,26,C,ドキソルビシン塩酸塩,"",不明,20150529,20150529,"","","","",未知,"",""
AB-17024126,2,27,C,ドキソルビシン塩酸塩,"",不明,20150619,20150619,"","","","",未知,"",""
AB-17024126,2,28,C,ドキソルビシン塩酸塩,"",不明,20150710,20150710,"","","","",未知,"",""
AB-17024126,2,29,C,ビンクリスチン硫酸塩,"",不明,20150324,20150324,"","","","",未知,"",""
AB-17024126,2,30,C,ビンクリスチン硫酸塩,"",不明,20150417,20150417,"","","","",未知,"",""
AB-17024126,2,31,C,ビンクリスチン硫酸塩,"",不明,20150508,20150508,"","","","",未知,"",""
AB-17024126,2,32,C,ビンクリスチン硫酸塩,"",不明,20150529,20150529,"","","","",未知,"",""
AB-17024126,2,33,C,ビンクリスチン硫酸塩,"",不明,20150619,20150619,"","","","",未知,"",""
AB-17024126,2,34,C,ビンクリスチン硫酸塩,"",不明,20150710,20150710,"","","","",未知,"",""
AB-17024126,2,35,C,シクロホスファミド水和物,"",不明,20150324,20150324,"","","","",未知,"",""
AB-17024126,2,36,C,シクロホスファミド水和物,"",不明,20150417,20150417,"","","","",未知,"",""
AB-17024126,2,37,C,シクロホスファミド水和物,"",不明,20150508,20150508,"","","","",未知,"",""
AB-17024126,2,38,C,シクロホスファミド水和物,"",不明,20150529,20150529,"","","","",未知,"",""
AB-17024126,2,39,C,シクロホスファミド水和物,"",不明,20150619,20150619,"","","","",未知,"",""
AB-17024126,2,40,C,シクロホスファミド水和物,"",不明,20150710,20150710,"","","","",未知,"",""
AB-17024126,2,41,C,プレドニゾロン酢酸エステル,"",不明,20150324,20150324,"","","","",未知,"",""
AB-17024126,2,42,C,プレドニゾロン酢酸エステル,"",不明,20150417,20150417,"","","","",未知,"",""
AB-17024126,2,43,C,プレドニゾロン酢酸エステル,"",不明,20150508,20150508,"","","","",未知,"",""
AB-17024126,2,44,C,プレドニゾロン酢酸エステル,"",不明,20150529,20150529,"","","","",未知,"",""
AB-17024126,2,45,C,プレドニゾロン酢酸エステル,"",不明,20150619,20150619,"","","","",未知,"",""
AB-17024126,2,46,C,プレドニゾロン酢酸エステル,"",不明,20150710,20150710,"","","","",未知,"",""
AB-17027655,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20170206,20170525,2,mg/kg,1,再発非小細胞肺癌,不适用,"",""
AB-17027655,2,2,PS,セリチニブ,"",経口,20170616,20170714,600,mg,1,"",未知,"",""
AB-17027655,2,3,C,アロプリノール,"",経口,201410,"",100,mg,1,"",剂量不变,"",""
AB-17027655,2,4,C,ロキソプロフェンナトリウム水和物,"",経口,201410,"",60,mg,1,"",剂量不变,"",""
AB-17027655,2,5,C,レバミピド,"",経口,201410,"",100,mg,1,"",剂量不变,"",""
AB-17027655,2,6,C,ランソプラゾール,"",経口,201410,"",15,mg,1,"",剂量不变,"",""
AB-17027655,2,7,C,プレガバリン,"",経口,201410,"","","","","",剂量不变,"",""
AB-17027655,2,8,C,沈降炭酸カルシウム・コレカルシフェロール・炭酸マグネシウム,"",経口,201506,"",2,DF,1,"",剂量不变,"",""
AB-17027655,2,9,C,ゾレドロン酸水和物,"",静脈内点滴,201410,"","","","","",剂量不变,"",""
AB-17027655,2,10,C,デノスマブ,"",静脈内点滴,201506,"","","","","",剂量不变,"",""
AB-17030231,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20161110,"",3,mg/kg,1,遠隔転移を伴う腎細胞癌,不适用,"",""
AB-17033950,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20170925,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-17034269,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20170411,20170523,200,mg,1,肺腺癌,剂量停止,"",""
AB-17035174,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20170926,"",3,mg/kg,1,胃癌,不适用,"",""
AB-17035736,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171005,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-17035736,4,2,PS,スルファメトキサゾール・トリメトプリム,"",経口,20170928,20171010,2,DF,2,予防,剂量停止,"",""
AB-17035736,4,3,C,プレドニゾロン,"",経口,20170928,"",20,mg,1,間質性肺疾患,剂量不变,"",""
AB-17035736,4,4,C,ナルデメジントシル酸塩,"",経口,20170720,"",0.2,mg,1,便秘,剂量不变,"",""
AB-17035736,4,5,C,フェンタニルクエン酸塩,"",経皮,20170726,"",1,DF,1,癌疼痛,剂量不变,"",""
AB-17035736,4,6,C,アセトアミノフェン,"",経口,20170413,"",2,DF,1,癌疼痛,剂量不变,"",""
AB-17035736,4,7,C,パクリタキセル,"",不明,20170726,20170926,"","","",胃癌,不适用,"",""
AB-17035736,4,8,C,パクリタキセル,"",不明,"","","","","",胃癌,未知,"",""
AB-17035736,4,9,C,ラムシルマブ,"",不明,"",20170926,"","","",胃癌,不适用,"",""
AB-17035736,4,10,C,ラムシルマブ,"",不明,"","","","","",胃癌,未知,"",""
AB-17038684,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171026,"","","","",胃癌,剂量不变,"",""
AB-17039752,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20160906,20161018,100,mg,1,再発非小細胞肺癌,剂量不变,"",""
AB-17039752,4,2,PS,ドセタキセル,"",不明,20170921,"","","","",再発非小細胞肺癌,不适用,"",""
AB-17039752,4,3,C,シロドシン,"",不明,"","","","","","",未知,"",""
AB-17039752,4,4,C,沈降炭酸カルシウム・コレカルシフェロール・炭酸マグネシウム,"",経口,"","","","","","",未知,"",""
AB-17039752,4,5,C,トラマドール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-17039752,4,6,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-17039752,4,7,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-17040346,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171010,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-17040492,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171012,"",3,mg/kg,1,胃癌,剂量停止,甲状腺炎(不明),""
AB-17040492,6,2,PS,トラマドール塩酸塩,"",経口,"",20180104,"","","","",未知,"",""
AB-17040492,6,3,PS,プレガバリン,"",経口,"",20180104,"","","","",未知,"",""
AB-17040492,6,4,PS,トラマドール塩酸塩・アセトアミノフェン配合剤,"",経口,"",20180104,"","","","",未知,"",""
AB-17040492,6,5,PS,乾燥甲状腺,"",経口,20171201,20171207,25,μg,1,甲状腺炎,剂量增加,"",""
AB-17040492,6,6,PS,乾燥甲状腺,"",経口,20171208,20171214,50,μg,1,甲状腺炎,剂量增加,"",""
AB-17040492,6,7,PS,乾燥甲状腺,"",経口,20171215,20180104,100,μg,1,甲状腺炎,未知,"",""
AB-17040492,6,8,PS,ロキソプロフェンナトリウム水和物,"",経口,"",20180104,"","","","",未知,"",""
AB-17040492,6,9,PS,レバミピド,"",経口,"",20180104,"","","","",未知,"",""
AB-17040757,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171003,"",3,mg/kg,1,胃癌,剂量停止,肝機能異常(不明),""
AB-17041352,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171012,"","","","",胃癌,剂量停止,"",""
AB-17041510,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171106,"",3,mg/kg,1,胃癌,不适用,"",""
AB-17041510,3,2,C,ルビプロストン,"",不明,"","","","","","",不适用,"",""
AB-17041510,3,3,C,プレガバリン,"",不明,"","","","","","",不适用,"",""
AB-17041510,3,4,C,オキシコドン塩酸塩水和物,"",不明,"","","","","","",不适用,"",""
AB-17042920,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,剂量停止,"",""
AB-17043322,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171018,"",160,mg,1,胃癌,未知,"",""
AB-17043540,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171005,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,発熱性好中球減少症(再投与なし),""
AB-17043540,6,2,C,デキサメタゾン,"",経口,201701,"",3,{DF},1,全身健康状態悪化(PS低下),剂量不变,"",""
AB-17043540,6,3,C,スルファメトキサゾール・トリメトプリム,"",経口,201701,"",1,{DF},1,予防(Steroid使用),剂量不变,"",""
AB-17043540,6,4,C,ウルソデオキシコール酸,"",経口,201701,"",6,{DF},1,肝機能異常(肝機能障害),剂量不变,"",""
AB-17043540,6,5,C,ポラプレジンク,"",経口,201702,"",2,{DF},1,胃潰瘍(胃かいよう),剂量不变,"",""
AB-17043984,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171110,20171110,200,mg,1,胃癌,剂量停止,"",""
AB-17043984,2,2,C,モルヒネ塩酸塩水和物,"",経口,"","",10,mg,1,"",未知,"",""
AB-17043984,2,3,C,フェンタニル,"",経皮,"","",1.7,mg,1,"",未知,"",""
AB-17043985,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171110,"",3,mg/kg,1,胃癌,剂量不变,"",""
AB-17045858,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171101,20171101,3,mg/kg,1,胃癌,不适用,"",""
AB-17045858,2,2,C,デノスマブ,"",皮下,20170612,20171108,120,mg,5,骨転移,不适用,"",""
AB-17046180,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20170428,20170519,200,mg,1,肺腺癌,剂量停止,大腸炎(無);倦怠感(無),""
AB-17046180,4,2,PS,ペムブロリズマブ,"",静脈内点滴,20170825,20171208,200,mg,1,"",未知,大腸炎(無);倦怠感(無),""
AB-17046180,4,3,C,デノスマブ,"",非経口,"","",120,mg,1,肺腺癌,剂量不变,"",""
AB-17046429,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171102,20171102,3,mg/kg,1,胃癌,剂量停止,"",""
AB-17046429,3,2,PS,アセトアミノフェン,"",経口,20170608,20171217,500,mg,2,筋肉痛,剂量停止,"",""
AB-17046429,3,3,C,ランソプラゾール,"",経口,201610,20171122,15,mg,1,胃切除,剂量停止,"",""
AB-17046429,3,4,C,レベチラセタム,"",経口,201612,"",500,mg,2,外傷後てんかん,剂量不变,"",""
AB-17046429,3,5,C,アジルサルタン,"",経口,20170615,"",20,mg,1,高血圧,剂量不变,"",""
AB-17046429,3,6,C,アムロジピンベシル酸塩,"",経口,20171102,"",5,mg,1,高血圧,剂量不变,"",""
AB-17046443,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20161207,"",140,mg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺癌),剂量停止,斑状丘疹状皮疹(再投与なし);末梢性ニューロパチー(再投与なし),""
AB-17046443,6,2,C,チアマゾール,"",経口,"","","","","",甲状腺機能亢進症(甲状腺機能亢進症),未知,"",""
AB-17046443,6,3,C,セレコキシブ,"",経口,"","","","","","",剂量不变,"",""
AB-17046443,6,4,C,ランソプラゾール,"",経口,"","","","","","",剂量不变,"",""
AB-17046443,6,5,C,アセトアミノフェン,"",経口,"","","","","","",剂量不变,"",""
AB-17046443,6,6,C,グリメピリド,"",経口,"","","","","","",剂量不变,"",""
AB-17046443,6,7,C,コデインリン酸塩水和物,"",経口,"","","","","","",剂量不变,"",""
AB-17046939,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171128,20171128,3,mg/kg,1,胃癌,不适用,"",""
AB-17047020,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171013,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-17047158,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,剂量不变,"",""
AB-17047574,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171117,20171117,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,サイトカイン放出症候群(再投与なし);胆管炎(再投与なし);肝損傷(再投与なし),""
AB-17047574,4,2,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-17047574,4,3,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-17047574,4,4,C,レバミピド,"",不明,"","","","","","",未知,"",""
AB-17047574,4,5,C,アデニン,"",不明,"","","","","","",未知,"",""
AB-17047574,4,6,C,ナルデメジントシル酸塩,"",不明,"","","","","","",未知,"",""
AB-17047574,4,7,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-17047574,4,8,C,フェンタニル,"",経皮,"","","","","","",未知,"",""
AB-17047574,4,9,C,オキシコドン塩酸塩水和物,"",不明,"","","","","",疼痛(疼痛),未知,"",""
AB-17047792,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171109,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-17048149,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171109,"",130,mg,2,胃癌,剂量不变,"",""
AB-17048298,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171116,20171208,2,mg/kg,1,胃癌,不适用,"",""
AB-17048332,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌,剂量不变,"",""
AB-17048674,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,剂量不变,"",""
AB-17048961,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171117,20171117,3,mg/kg,1,胃癌,不适用,"",""
AB-17049331,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171011,2017,3,mg/kg,1,胃癌,剂量停止,"",""
AB-17049739,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201711,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,死亡(再投与なし);副腎障害(再投与なし),""
AB-17050087,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,不适用,"",""
AB-17050129,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171025,20171204,3,mg/kg,1,胃癌,剂量停止,"",""
AB-17050294,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171017,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,食欲減退(再投与なし);肺炎(再投与なし);敗血症性ショック(再投与なし);倦怠感(再投与なし),""
AB-17050294,5,2,C,オキシコドン塩酸塩水和物,"",経口,"","",10,mg,1,"",未知,"",""
AB-17050294,5,3,C,乾燥硫酸鉄（３）,"",経口,"","",105,mg,1,"",未知,"",""
AB-17050294,5,4,C,プレガバリン,"",経口,"","",125,mg,1,"",未知,"",""
AB-17050294,5,5,C,フロセミド,"",経口,"","",40,mg,1,"",未知,"",""
AB-17050294,5,6,C,アロプリノール,"",経口,"","",100,mg,1,"",未知,"",""
AB-17051138,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171219,20171219,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,静脈塞栓症(再投与なし);医療機器関連感染(再投与なし),""
AB-17051455,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171006,20171117,160,mg,2,胃癌,剂量停止,"",""
AB-17051931,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171010,20171010,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-17051931,4,2,C,モサプリドクエン酸塩水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-17051931,4,3,C,ランソプラゾール,"",経口,"","",15,mg,1,"",未知,"",""
AB-17051931,4,4,C,経腸成分栄養剤（６−２）,"",不明,"","",400,mL,1,"",未知,"",""
AB-17051931,4,5,C,ポラプレジンク,"",経口,"","",75,mg,1,"",未知,"",""
AB-17052043,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171017,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,亜急性甲状腺炎(再投与なし),""
AB-17052043,4,2,C,ベザフィブラート,"",経口,"","",200,mg,1,高トリグリセリド血症(高ＴＧ血症),剂量不变,"",""
AB-17052043,4,3,C,ラベプラゾールナトリウム,"",経口,"","",10,mg,1,胃潰瘍(胃潰瘍),未知,"",""
AB-17052172,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171017,20171031,3,mg/kg,1,胃癌,剂量停止,"",""
AB-17052190,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20160810,20160908,151,mg,1,再発非小細胞肺癌,剂量不变,"",""
AB-17052190,2,2,C,モルヒネ塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-17052190,2,3,C,フェンタニルクエン酸塩,"",経皮,"","","","","","",未知,"",""
AB-17052190,2,4,C,センノシド,"",不明,"","","","","","",未知,"",""
AB-17052190,2,5,C,セレコキシブ,"",不明,"","","","","","",未知,"",""
AB-17052286,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171106,"",3,mg/kg,1,胃癌,未知,"",""
AB-17052481,10,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20171116;20180215,20171214;20180329,3;3,mg/kg;mg/kg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(無),""
AB-17052481,10,2,C,オキシコドン塩酸塩水和物,"",不明,201710,"","","","",癌疼痛(癌性疼痛),未知,"",""
AB-17052481,10,3,C,オキシコドン塩酸塩水和物,"",不明,"","","","","",癌疼痛(癌性疼痛),未知,"",""
AB-17052481,10,4,C,ロキソプロフェンナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-17052481,10,5,C,トラマドール塩酸塩・アセトアミノフェン配合剤,"",経口,"","","","","","",未知,"",""
AB-17052539,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171204,20171219,3,mg/kg,2,胃癌,不适用,"",""
AB-17052552,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201711,"","","","",胃癌,未知,"",""
AB-17052552,1,2,PS,アンベノニウム塩化物,"",不明,"","","","","",重症筋無力症,未知,"",""
AB-17052596,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,剂量停止,"",""
AB-17052625,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171105,"",2,mg/kg,2,胃癌,未知,"",""
AB-17052625,1,2,C,カモスタットメシル酸塩,"",経口,"","","","","","",未知,"",""
AB-17052625,1,3,C,ジアスターゼ配合剤（１）,"",経口,"","","","","","",未知,"",""
AB-17052625,1,4,C,シロドシン,"",経口,"","","","","","",未知,"",""
AB-17052625,1,5,C,クエン酸第一鉄ナトリウム,"",経口,"","","","","","",未知,"",""
AB-17052625,1,6,C,ラクトミン,"",経口,"","","","","","",未知,"",""
AB-17052826,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171017,"","","","",胃癌,未知,"",""
AB-17052854,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171219,20171219,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,ブドウ球菌性胃腸炎(再投与なし);間質性肺疾患(再投与なし),""
AB-17052854,7,2,PS,メロペネム水和物,メロペネム,不明,20180105,20180126,3,g,1,間質性肺疾患(肺臓炎（薬剤性間質性肺炎）),不适用,"",""
AB-17052854,7,3,PS,レボフロキサシン水和物,"",不明,20180105,20180110,500,mg,1,間質性肺疾患(肺臓炎（薬剤性間質性肺炎）),不适用,"",""
AB-17052854,7,4,C,プレガバリン,"",経口,20170731,"",75,mg,1,感覚鈍麻(PTXによるしびれ),剂量不变,"",""
AB-17052854,7,5,C,ランソプラゾール,"",経口,"","",15,mg,1,"",剂量不变,"",""
AB-17052854,7,6,C,酪酸菌配合剤,"",経口,"","",6,{DF},1,"",剂量不变,"",""
AB-17052854,7,7,C,クロピドグレル硫酸塩,"",不明,"","",75,mg,1,"",未知,"",""
AB-17052925,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171207,20171221,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血中クレアチニン増加(再投与なし),""
AB-17052925,4,2,C,ニフェジピン,"",経口,20171207,"",20,mg,1,"",未知,"",""
AB-17052925,4,3,C,ポリスチレンスルホン酸カルシウム,"",経口,20171207,"",25,g,1,"",未知,"",""
AB-17052925,4,4,C,アロプリノール,"",経口,20171207,"",50,mg,1,"",未知,"",""
AB-17052925,4,5,C,炭酸水素ナトリウム,"",経口,20171207,"",1000,mg,1,"",未知,"",""
AB-17052925,4,6,C,エソメプラゾールマグネシウム水和物,"",経口,20171207,"",20,mg,1,"",未知,"",""
AB-17053175,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171017,"",3,mg/kg,1,胃癌,剂量不变,"",""
AB-17053175,4,2,C,レボチロキシンナトリウム水和物,"",経口,"","",50,μg,1,"",剂量不变,"",""
AB-17053175,4,3,C,膵臓性消化酵素配合剤（１）,"",経口,"","",1,g,3,"",未知,"",""
AB-17053175,4,4,C,アムロジピンベシル酸塩,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-17053175,4,5,C,レバミピド,"",経口,"","",100,mg,3,"",未知,"",""
AB-17053281,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171113,"",3,mg/kg,1,胃癌,不适用,"",""
AB-17053281,5,2,PS,ナプロキセン,"",経口,20171228,20180112,100,mg,3,癌疼痛,剂量停止,"",""
AB-17053281,5,3,C,セレコキシブ,"",経口,20171113,20171227,100,mg,2,癌疼痛,未知,"",""
AB-17053660,9,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20170418,20170824,200,mg,1,肺腺癌(PD-L1陽性の切除不能な進行・再発の非小細胞肺癌（腺がん）),剂量停止,間質性肺疾患(再投与なし),""
AB-17053660,9,2,C,アログリプチン安息香酸塩,"",経口,不明,"",12.5,mg,1,"",未知,"",""
AB-17053660,9,3,C,エソメプラゾールマグネシウム水和物,"",経口,不明,"",20,mg,1,"",剂量不变,"",""
AB-17053660,9,4,C,ビソプロロールフマル酸塩,"",経口,不明,"",5,mg,1,"",剂量不变,"",""
AB-17053764,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201710,"",3,mg/kg,1,胃癌,剂量不变,"",""
AB-17053896,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-17053984,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,不适用,"",""
AB-17054397,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171113,20171225,177,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腸壁気腫症(再投与なし),""
AB-17054509,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171118,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-17055042,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌,剂量停止,"",""
AB-17055201,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20170817,20171221,200,mg,1,肺扁平上皮癌,剂量停止,"",""
AB-17055201,3,2,PS,エトドラク,"",経口,20170103,"",200,mg,2,癌疼痛,剂量不变,"",""
AB-17055201,3,3,C,オキシコドン塩酸塩水和物,"",経口,20161227,"",10,mg,2,癌疼痛,剂量不变,"",""
AB-17055201,3,4,C,オキシコドン塩酸塩水和物,"",経口,20161227,"",2.5,mg,1,癌疼痛,剂量不变,"",""
AB-17055201,3,5,C,リバーロキサバン,"",経口,20170428,"",15,mg,1,肺動脈血栓症,剂量不变,"",""
AB-17055201,3,6,C,クエン酸第一鉄ナトリウム,"",経口,20170601,"",50,mg,2,貧血,剂量不变,"",""
AB-17055255,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20171003;20180521,20171225;,3;3,mg/kg;mg/kg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性大腸炎(無),""
AB-17055265,11,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,2017;2020;,;;,3;;,mg/kg;;,1;;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,急性副腎皮質機能不全(再投与なし);間質性肺疾患(再投与なし);電解質失調(再投与なし);倦怠感(再投与なし),""
AB-17055265,11,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,201803,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-17055265,11,3,C,トラスツズマブ,"",不明,201803,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-17055265,11,4,C,イリノテカン塩酸塩水和物,"",不明,201901,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-17055265,11,5,C,トリフルリジン・チピラシル塩酸塩配合剤,"",不明,2019,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-17055265,11,6,C,カペシタビン,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-17055265,11,7,C,トラスツズマブ,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-17055696,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171201,20171201,3,mg/kg,1,胃癌,不适用,"",""
AB-17055997,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171004,"",3,mg/kg,2,胃癌,剂量停止,発熱性好中球減少症(不明);菌血症(不明);敗血症(不明),""
AB-17055997,5,2,PS,ニボルマブ,"",静脈内点滴,"","",3,mg/kg,2,胃癌,剂量停止,発熱性好中球減少症(不明);菌血症(不明);敗血症(不明),""
AB-17055997,5,3,PS,ラムシルマブ,"",不明,2017,20170920,8,mg/kg,1,胃癌,不适用,"",""
AB-17055997,5,4,C,レボチロキシンナトリウム水和物,"",経口,"","",1,DF,1,甲状腺機能低下症,剂量不变,"",""
AB-17055997,5,5,C,ロスバスタチンカルシウム,"",経口,"","",2.5,mg,1,"",剂量不变,"",""
AB-17055997,5,6,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",剂量不变,"",""
AB-17055997,5,7,C,ペリンドプリルエルブミン,"",経口,"","",4,mg,1,"",剂量不变,"",""
AB-17055997,5,8,C,ニフェジピン,"",経口,"","",1,DF,1,"",剂量不变,"",""
AB-17055997,5,9,C,フロセミド,"",経口,20171004,"",1,DF,1,"",剂量不变,"",""
AB-17055997,5,10,C,フェブキソスタット,"",経口,"","",10,mg,1,"",剂量不变,"",""
AB-17055997,5,11,C,プレガバリン,"",経口,"","",75,mg,2,"",剂量不变,"",""
AB-17055997,5,12,C,トラマドール塩酸塩・アセトアミノフェン配合剤,"",経口,"","",1,DF,2,"",剂量不变,"",""
AB-17055997,5,13,C,ロキソプロフェンナトリウム水和物,"",経皮,"","",1,DF,1,"",剂量不变,"",""
AB-17055997,5,14,C,ロキソプロフェンナトリウム水和物,"",経口,"","",3,DF,3,"",剂量不变,"",""
AB-17055997,5,15,C,酸化マグネシウム,"",経口,"","",3,DF,3,"",剂量不变,"",""
AB-17055997,5,16,C,フルニトラゼパム,"",経口,"","",1,DF,1,"",未知,"",""
AB-17055997,5,17,C,ロラゼパム,"",経口,"","",1,DF,2,"",未知,"",""
AB-17056465,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180109,20180109,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍随伴性皮膚筋炎(再投与なし),""
AB-17056465,7,2,C,ボノプラザンフマル酸塩,"",経口,20170412,"",20,mg,1,胃潰瘍(胃潰瘍),剂量不变,"",""
AB-17056465,7,3,C,ビソプロロールフマル酸塩,"",経口,20170613,"",2.5,mg,1,高血圧(高血圧),剂量不变,"",""
AB-17056465,7,4,C,酸化マグネシウム,"",経口,20171024,"",330,mg,1,便秘(便秘症),剂量不变,"",""
AB-17056465,7,5,C,乾燥水酸化アルミニウムゲル・水酸化マグネシウム,"",経口,20171110,"",1.2,g,1,胃潰瘍(胃潰瘍),剂量不变,"",""
AB-17056465,7,6,C,プラバスタチンナトリウム,"",経口,"",20180126,10,mg,1,脂質異常症(脂質異常症),剂量停止,"",""
AB-17056466,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201711,"","","","",胃癌,剂量不变,"",""
AB-17056794,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171207,"",3,mg/kg,1,胃癌,未知,"",""
AB-17056825,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171121,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,白質脳症(再投与なし);意識変容状態(再投与なし);死亡(再投与なし);脱水(再投与なし);播種性血管内凝固(再投与なし),""
AB-17056905,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180125,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-17057679,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171110,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-17057700,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171019,20171228,140,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,汎血球減少症(再投与なし);肝性脳症(再投与なし);胆管炎(再投与なし);薬物性肝障害(再投与なし),""
AB-17057863,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171206,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-17057872,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180104,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-17058514,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20141212,"",2,mg/kg,1,悪性黒色腫(根治切除不能な悪性黒色腫),剂量不变,器質化肺炎(再投与なし),""
AB-17058514,2,2,PS,カモスタットメシル酸塩,フオイパン,経口,"","","","","",適応症不明の製品使用(不明),未知,器質化肺炎(再投与なし),""
AB-17058514,2,3,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-17058514,2,4,C,シロスタゾール,"",不明,"","","","","","",未知,"",""
AB-17058677,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180202,"","","","",胃癌,未知,"",""
AB-17058907,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171108,"",3,mg/kg,1,胃癌,剂量不变,"",""
AB-17059272,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201709,201709,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,筋炎(再投与なし),""
AB-17059347,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171013,"",3,mg/kg,1,胃癌,剂量不变,"",""
AB-17059348,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20171108;201808,201801;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(不明),""
AB-17059634,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180111,20180125,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,硬化性胆管炎(再投与なし);肝機能異常(再投与なし);膵炎(再投与なし),""
AB-17059634,3,2,C,オルメサルタンメドキソミル,"",経口,20161027,"",40,mg,1,"",未知,"",""
AB-17059634,3,3,C,フロセミド,"",経口,20161117,"",40,mg,1,"",未知,"",""
AB-17059634,3,4,C,ウルソデオキシコール酸,"",経口,201407,20180211,100,mg,1,"",未知,"",""
AB-17059727,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20160802,20160802,140,mg,1,再発非小細胞肺癌,剂量不变,"",""
AB-17059727,3,2,PS,カルボプラチン,"",不明,20160822,20170106,"","","",再発非小細胞肺癌,不适用,"",""
AB-17059727,3,3,PS,パクリタキセル,"",不明,20160822,20170106,"","","",再発非小細胞肺癌,不适用,"",""
AB-17059727,3,4,PS,ベバシズマブ,"",不明,20160822,20170106,"","","",再発非小細胞肺癌,不适用,"",""
AB-17059999,6,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20170407;20180801,20180409;,200;200,mg;mg,1;1,肺腺癌(PD-L1陽性の切除不能な進行・再発の非小細胞肺癌（腺がん）);胃癌(4型胃がん),剂量不变,類天疱瘡(再投与なし);肝機能異常(不明),""
AB-17060091,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171219,20180130,160,mg,1,胃癌,剂量停止,"",""
AB-17060091,1,2,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-17060091,1,3,C,ジフェニドール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-17060091,1,4,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-17060091,1,5,C,ラベプラゾールナトリウム,"",不明,"","","","","","",未知,"",""
AB-17060091,1,6,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-17060091,1,7,C,プレガバリン,"",不明,"","","","","","",未知,"",""
AB-17060091,1,8,C,フェキソフェナジン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-17060091,1,9,C,スルピリド,"",不明,"","","","","","",未知,"",""
AB-17060091,1,10,C,プラバスタチンナトリウム,"",不明,"","","","","","",未知,"",""
AB-17060091,1,11,C,トラマドール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-17060091,1,12,C,リナクロチド,"",不明,"","","","","","",未知,"",""
AB-17060099,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,未知,"",""
AB-17060295,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180210,20180210,170,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,血小板減少症(再投与なし);出血性ショック(再投与なし);上部消化管出血(再投与なし),""
AB-17060295,5,2,C,エソメプラゾールマグネシウム水和物,"",経口,20171110,20180219,"","","","",不适用,"",""
AB-17060391,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171211,20171211,3,mg/kg,1,胃癌,不适用,"",""
AB-17060426,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20160426,20160719,146,mg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺癌),不适用,糖尿病性腎症(再投与なし);死亡(再投与なし),""
AB-17060426,6,2,PS,シタグリプチンリン酸塩水和物,グラクティブ,経口,"","","","","",２型糖尿病(2型糖尿病),不适用,糖尿病性腎症(再投与なし);死亡(再投与なし),""
AB-17060426,6,3,C,Ｌ−カルボシステイン,"",経口,"","","","","","",不适用,"",""
AB-17060426,6,4,C,ベンプロペリンリン酸塩,"",経口,"","","","","","",不适用,"",""
AB-17060426,6,5,C,アンブロキソール塩酸塩,"",経口,"","","","","","",不适用,"",""
AB-17060426,6,6,C,酪酸菌配合剤,"",経口,"","","","","","",不适用,"",""
AB-17060426,6,7,C,フルオシノニド,"",経口,"","","","","","",不适用,"",""
AB-17060669,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171020,20171020,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,視力低下(再投与なし);間質性肺疾患(再投与なし),""
AB-17060669,5,2,C,セレコキシブ,"",不明,"","","","","","",未知,"",""
AB-17060669,5,3,C,プレガバリン,"",不明,"","","","","","",未知,"",""
AB-17060669,5,4,C,シロスタゾール,"",不明,"","","","","","",未知,"",""
AB-17060669,5,5,C,シタグリプチンリン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-17060669,5,6,C,エドキサバントシル酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-17060669,5,7,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-17060670,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171201,20171215,3,mg/kg,2,胃癌,剂量停止,"",""
AB-17060948,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180105,20180202,3,mg/kg,1,胃癌,不适用,"",""
AB-17061238,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,未知,"",""
AB-17061241,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171017,"",120,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし);１型糖尿病(再投与なし),""
AB-17061384,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171211,20180129,3,mg/kg,1,胃癌,不适用,"",""
AB-17061821,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180130;20180201,20180130;20180227,190;3,mg;mg/kg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし);誤嚥性肺炎(再投与なし);心筋炎(再投与なし),""
AB-17061821,2,2,C,ランソプラゾール,"",経口,20150311,"","","","","",未知,"",""
AB-17061823,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180202,20180202,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,自己免疫性膵炎(再投与なし);敗血症(再投与なし);胆管炎(再投与なし),""
AB-17061823,4,2,C,クエン酸第一鉄ナトリウム,"",経口,20170609,20180204,50,mg,1,貧血(貧血),不适用,"",""
AB-17061823,4,3,C,酪酸菌製剤,"",経口,20170609,20180204,1,{DF},1,下痢(下痢),不适用,"",""
AB-17061823,4,4,C,ミラベグロン,"",経口,20180119,20180204,50,mg,1,腎盂腎炎(腎盂腎炎),不适用,"",""
AB-17062037,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180104,"","","","",胃癌,剂量停止,"",""
AB-17062206,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180215,20180426,3,mg/kg,1,胃癌,剂量停止,"",""
AB-17062206,3,2,C,ジアスターゼ配合剤（１）,"",経口,20170222,"","","","",消化不良,剂量不变,"",""
AB-17062206,3,3,C,タカヂアスターゼ・生薬配合剤,"",経口,"","",1.3,g,3,胃潰瘍,剂量不变,"",""
AB-17062206,3,4,C,アムロジピンベシル酸塩,"",経口,"","",2.5,mg,1,高血圧,剂量不变,"",""
AB-17062206,3,5,C,リバーロキサバン,"",経口,"","",15,mg,1,心房細動,剂量不变,"",""
AB-17062206,3,6,C,カモスタットメシル酸塩,"",経口,"","",100,mg,3,慢性膵炎,剂量不变,"",""
AB-17062206,3,7,C,カンデサルタンシレキセチル,"",経口,"","",4,mg,1,高血圧,剂量不变,"",""
AB-17062206,3,8,C,牛車腎気丸,"",経口,20170711,"",2.5,g,3,末梢性ニューロパチー,剂量不变,"",""
AB-17062206,3,9,C,エソメプラゾールマグネシウム水和物,"",経口,20170222,"",20,mg,1,胃潰瘍,剂量不变,"",""
AB-17062206,3,10,C,ピルシカイニド塩酸塩水和物,"",経口,"","",50,mg,2,心房細動,剂量不变,"",""
AB-17062206,3,11,C,フロセミド,"",経口,20170613,"",10,mg,1,高血圧,剂量不变,"",""
AB-17062206,3,12,C,メコバラミン,"",経口,20170516,"",500,μg,3,末梢性ニューロパチー,剂量不变,"",""
AB-17062206,3,13,C,一硝酸イソソルビド,"",経口,"","",40,mg,1,プリンツメタル狭心症,剂量不变,"",""
AB-17062206,3,14,C,酸化マグネシウム,"",経口,20170801,"",330,mg,3,便秘,剂量不变,"",""
AB-17062420,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171025,"",260,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(不明);低ナトリウム血症(不明),""
AB-17062795,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180122,20180205,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,免疫性血小板減少症(再投与なし);播種性血管内凝固(再投与なし);血小板数減少(再投与なし);くも膜下出血(再投与なし);髄膜転移(再投与なし),""
AB-17062795,7,2,C,クエン酸第一鉄ナトリウム,"",経口,20170512,20180219,"","","","",不适用,"",""
AB-17062795,7,3,C,ボノプラザンフマル酸塩,"",不明,20180201,20180219,"","","","",不适用,"",""
AB-17062795,7,4,C,ベタメタゾン,"",経口,20180201,20180219,"","","","",不适用,"",""
AB-17062795,7,5,C,アセトアミノフェン,"",経口,"","","","","","",不适用,"",""
AB-17062917,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171122,20171206,3,mg/kg,1,胃癌,剂量停止,"",""
AB-17062922,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180123,20180206,3,mg/kg,1,胃癌,不适用,"",""
AB-17062922,3,2,C,インフルエンザＨＡワクチン,"",不明,2018,"","","","","",不适用,"",""
AB-17063989,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171018,20180207,3,mg/kg,1,胃癌,不适用,"",""
AB-17064384,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180202,20180216,3,mg/kg,2,胃癌,不适用,"",""
AB-17064384,2,2,C,デキサメタゾン,"",経口,"","",0.5,mg,1,"",不适用,"",""
AB-17064384,2,3,C,ウルソデオキシコール酸,"",経口,"","",100,mg,3,"",不适用,"",""
AB-17064384,2,4,C,酪酸菌製剤,"",経口,"","",1,g,3,"",不适用,"",""
AB-17064384,2,5,C,フロセミド,"",経口,"","",60,mg,1,"",不适用,"",""
AB-17064384,2,6,C,ヘパリン類似物質,"",皮膚,"","","","","","",不适用,"",""
AB-17064671,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20160517,20161115,120,mg,1,再発非小細胞肺癌,剂量停止,腸炎(不明),""
AB-17064672,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171025,"","","","",胃癌,未知,"",""
AB-17064672,2,2,C,トルバプタン,"",不明,"","","","","","",未知,"",""
AB-17064706,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180111,20180314,3,mg/kg,1,胃癌,剂量停止,皮膚障害(不明),""
AB-17065218,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171117,"",3,mg/kg,1,胃癌,未知,"",""
AB-17065218,2,2,C,六君子湯,"",経口,"","","","","","",未知,"",""
AB-17065218,2,3,C,経腸成分栄養剤（２−２）,"",不明,"","","","","","",未知,"",""
AB-17065218,2,4,C,ラクトミン,"",不明,"","","","","","",未知,"",""
AB-17065429,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171023,20180129,"","","",胃癌,未知,"",""
AB-17065429,2,2,C,アログリプチン安息香酸塩,"",経口,"","",25,mg,1,"",未知,"",""
AB-17065429,2,3,C,グリメピリド,"",経口,"","",2,mg,1,"",未知,"",""
AB-17065429,2,4,C,エチゾラム,"",経口,"","",0.5,mg,3,"",未知,"",""
AB-17065429,2,5,C,アセトアミノフェン,"",経口,"","",500,mg,3,"",未知,"",""
AB-17065429,2,6,C,ロキソプロフェンナトリウム水和物,"",経口,"","",60,mg,3,"",未知,"",""
AB-17065429,2,7,C,レバミピド,"",経口,"","",100,mg,3,"",未知,"",""
AB-17065429,2,8,C,オルメサルタンメドキソミル・アゼルニジピン配合剤,"",経口,"","","","","","",未知,"",""
AB-17065429,2,9,C,オルメサルタンメドキソミル,"",経口,"","",10,mg,1,"",未知,"",""
AB-17065445,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180116,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-17065932,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,不适用,"",""
AB-17065966,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180208,20180222,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,器質化肺炎(再投与なし),""
AB-17066014,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,不适用,"",""
AB-17066026,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180202;201904,;202002,3;,mg/kg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-17066026,5,2,C,フロセミド,"",経口,"","",20,mg,1,"",未知,"",""
AB-17066026,5,3,C,スピロノラクトン,"",経口,"","",25,mg,1,"",未知,"",""
AB-17066026,5,4,C,プレガバリン,"",経口,"","",150,mg,1,"",未知,"",""
AB-17066026,5,5,C,メコバラミン,"",経口,"","",500,mg,1,"",未知,"",""
AB-17066026,5,6,C,牛車腎気丸,"",経口,"","",2.5,g,1,"",未知,"",""
AB-17066140,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171211,20180219,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);肺臓炎(再投与なし),""
AB-17066415,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171108,"","","","",胃癌,未知,"",""
AB-17066416,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180110,20180307,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺炎(再投与なし);下垂体炎(再投与なし);免疫性腸炎(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-17066416,7,2,C,クエン酸第一鉄ナトリウム,"",経口,"","",50,mg,1,貧血(貧血),剂量停止,"",""
AB-17066416,7,3,C,ピリドキサールリン酸エステル水和物,"",経口,"","",10,mg,1,貧血(貧血),剂量停止,"",""
AB-17066416,7,4,C,ナフトピジル,"",経口,"","",75,mg,1,良性前立腺肥大症(前立腺肥大),剂量不变,"",""
AB-17066416,7,5,C,メコバラミン,"",経口,"","",500,ug,1,神経痛(末梢神経障害性疼痛),剂量停止,"",""
AB-17066416,7,6,C,プレガバリン,"",経口,"","",50,mg,1,神経痛(末梢神経障害性疼痛),剂量不变,"",""
AB-17066416,7,7,C,ロペラミド塩酸塩,"",経口,"","",1,mg,1,下痢(下痢),剂量停止,"",""
AB-17066416,7,8,C,セレコキシブ,"",経口,"","",200,mg,1,頭痛(頭痛),剂量停止,"",""
AB-17066441,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180220,20180507,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,低ナトリウム血症(不明),""
AB-17066441,2,2,PS,デュロキセチン塩酸塩,サインバルタ,経口,20170315,20180623,20,mg,1,末梢性ニューロパチー(末梢神経障害),剂量不变,"",""
AB-17066441,2,3,PS,フロセミド,"",経口,20180213,20180623,20,mg,1,浮腫(浮腫),剂量不变,"",""
AB-17066441,2,4,PS,スピロノラクトン,"",経口,20180213,20180623,25,mg,1,浮腫(浮腫),剂量不变,"",""
AB-17066441,2,5,C,メコバラミン,"",経口,20170315,20180623,500,ug,1,末梢性ニューロパチー(末梢神経障害),未知,"",""
AB-17066441,2,6,C,アムロジピンベシル酸塩,"",経口,"",20180623,5,mg,1,高血圧(高血圧),未知,"",""
AB-17066564,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171102,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-18000019,2,1,PS,イルベサルタン,イルベタン,経口,20180126,20180217,100,mg,1,高血圧,剂量停止,"",""
AB-18000019,2,2,PS,フロセミド,"",経口,20171206,20180217,20,mg,1,末梢性浮腫,剂量停止,"",""
AB-18000019,2,3,PS,ニボルマブ,"",静脈内（明記されていない場合）,20171212,20171212,360,mg,1,再発胃癌,未知,"",""
AB-18000019,2,4,PS,ニボルマブ,"",静脈内（明記されていない場合）,20180125,20180125,360,mg,1,再発胃癌,未知,"",""
AB-18000019,2,5,PS,ニボルマブ,"",静脈内（明記されていない場合）,20180202,20180202,360,mg,1,再発胃癌,未知,"",""
AB-18000019,2,6,PS,ニボルマブ,"",静脈内（明記されていない場合）,20180208,20180208,360,mg,1,再発胃癌,未知,"",""
AB-18000019,2,7,PS,ニボルマブ,"",静脈内（明記されていない場合）,20180215,20180215,360,mg,1,再発胃癌,未知,"",""
AB-18000019,2,8,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20171212,20180202,60,mg,2,胃癌,剂量停止,"",""
AB-18000019,2,9,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20180215,20180217,50,mg,2,胃癌,剂量停止,"",""
AB-18000019,2,10,PS,オキサリプラチン,"",静脈内（明記されていない場合）,20171212,20171212,225.42,mg,1,胃癌,未知,"",""
AB-18000019,2,11,PS,オキサリプラチン,"",静脈内（明記されていない場合）,20180215,20180215,173.4,mg,1,胃癌,未知,"",""
AB-18000019,2,12,PS,アプレピタント,"",経口,20180215,20180217,80,mg,1,悪心・嘔吐の予防,剂量停止,"",""
AB-18000019,2,13,PS,デキサメタゾン,"",経口,20180215,20180217,8,mg,1,悪心・嘔吐の予防,剂量停止,"",""
AB-18000019,2,14,PS,レボチロキシンナトリウム水和物,"",経口,20180215,20180217,50,μg,1,副甲状腺機能低下症,剂量停止,"",""
AB-18000019,2,15,PS,レボチロキシンナトリウム水和物,"",経口,20180220,"",50,μg,1,副甲状腺機能低下症,剂量停止,"",""
AB-18000019,2,16,PS,スピロノラクトン,"",経口,20180130,20180217,25,mg,1,腹水,剂量停止,"",""
AB-18000019,2,17,PS,ボノプラザンフマル酸塩,"",経口,20171206,20180217,20,mg,1,潰瘍,剂量停止,"",""
AB-18000019,2,18,PS,酸化マグネシウム,"",経口,2017,20180217,500,mg,3,便秘予防,剂量停止,"",""
AB-18000019,2,19,PS,アムロジピンベシル酸塩,"",経口,20180208,20180217,5,mg,1,高血圧,剂量停止,"",""
AB-18000019,2,20,PS,センナ・センナ実,"",経口,20180215,20180217,"","","",便秘予防,剂量停止,"",""
AB-18000019,2,21,PS,ルビプロストン,"",経口,20180126,20180217,48,μg,1,便秘予防,剂量停止,"",""
AB-18000019,2,22,C,クロベタゾールプロピオン酸エステル,"",不明,20180215,"","","","","",剂量不变,"",""
AB-18000335,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171111,20171127,3,mg/kg,1,胃癌,不适用,"",""
AB-18000335,3,2,C,プレガバリン,"",経口,20170610,20171208,75,mg,1,神経痛,不适用,"",""
AB-18000335,3,3,C,アムロジピンベシル酸塩,"",経口,"",20171208,5,mg,1,高血圧,不适用,"",""
AB-18000335,3,4,C,ランソプラゾール,"",経口,20170418,20171208,15,mg,1,胃癌,不适用,"",""
AB-18000335,3,5,C,カンデサルタンシレキセチル,"",経口,20170419,20171208,4,mg,1,高血圧,不适用,"",""
AB-18000349,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20161130,"",3,mg/kg,1,悪性黒色腫,剂量不变,"",""
AB-18000349,3,2,PS,イピリムマブ,"",静脈内点滴,"","",3,mg/kg,1,悪性黒色腫,未知,"",""
AB-18000349,3,3,C,トラスツズマブ,"",不明,20170221,20170613,"","","","",不适用,"",""
AB-18000349,3,4,C,シスプラチン,"",不明,20170222,20170613,"","","","",不适用,"",""
AB-18000349,3,5,C,デキサメタゾンリン酸エステルナトリウム,"",不明,20170222,20170613,6.6,mg,1,予防,不适用,"",""
AB-18000698,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171221,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-18000706,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20161129,20161216,170,mg,1,再発非小細胞肺癌,剂量不变,"",""
AB-18000706,2,2,C,シロドシン,"",不明,"","","","","","",未知,"",""
AB-18000706,2,3,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-18000706,2,4,C,レバミピド,"",不明,"","","","","","",未知,"",""
AB-18000742,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180305,20180305,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18000742,1,2,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",剂量不变,"",""
AB-18000742,1,3,C,シタグリプチンリン酸塩水和物,"",経口,"","",25,mg,1,"",剂量不变,"",""
AB-18000742,1,4,C,モサプリドクエン酸塩水和物,"",経口,"","",5,mg,3,"",剂量不变,"",""
AB-18000742,1,5,C,ニザチジン,"",経口,"","",150,mg,2,"",未知,"",""
AB-18000742,1,6,C,ビフィズス菌製剤（４）,"",経口,"","","","","","",未知,"",""
AB-18000923,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180131,20180214,130,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,水疱(再投与なし);皮膚潰瘍(再投与なし),""
AB-18000938,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201801,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-18001214,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180116,20180214,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18001214,2,2,C,カルベジロール,"",経口,"","",10,mg,1,高血圧,未知,"",""
AB-18001237,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180305,20180305,3,mg/kg,1,胃癌,不适用,"",""
AB-18001237,4,2,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",不适用,"",""
AB-18001237,4,3,C,レバミピド,"",不明,"","","","","","",不适用,"",""
AB-18001237,4,4,C,メトホルミン塩酸塩,"",不明,"","","","","","",不适用,"",""
AB-18001237,4,5,C,エナラプリルマレイン酸塩,"",不明,"","","","","","",不适用,"",""
AB-18001448,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171227,20180223,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,消化器カンジダ症(再投与なし);上部消化管出血(再投与なし),""
AB-18001448,4,2,PS,ロキソプロフェンナトリウム水和物,ロキソプロフェン,不明,"","",180,mg,1,"",未知,"",""
AB-18001448,4,3,C,エソメプラゾールマグネシウム水和物,"",経口,201801,201804,20,mg,1,"",未知,"",""
AB-18001448,4,4,C,イリノテカン塩酸塩水和物,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-18001450,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171117,20171215,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18001450,1,2,C,ダビガトランエテキシラートメタンスルホン酸塩,"",経口,"","",110,mg,2,心房細動,剂量不变,"",""
AB-18001500,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201710,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,口内炎(再投与なし);甲状腺炎(再投与なし);副腎機能不全(再投与なし),""
AB-18001639,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171024,"","","","",胃癌,未知,"",""
AB-18001675,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180207,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,関節炎(再投与なし);間質性肺疾患(再投与なし),""
AB-18001719,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180329,20180329,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18001763,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171024,20171219,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(再投与なし),""
AB-18001896,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180315,20180315,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,薬物性肝障害(再投与なし),""
AB-18001896,3,2,C,テルミサルタン,"",経口,"","",40,mg,1,高血圧(高血圧),未知,"",""
AB-18001896,3,3,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,胃炎予防(胃炎予防),未知,"",""
AB-18002146,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴;,20171010;20171101;20171215;,20171010;20171101;20171215;,3;3;3;,mg/kg;mg/kg;mg/kg;,1;1;1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,続発性副腎皮質機能不全(再投与なし);中枢性甲状腺機能低下症(再投与なし),""
AB-18002146,6,2,C,トルバプタン,"",経口,20170221,20171129,7.5,mg,1,腹水(腹水),未知,"",""
AB-18002146,6,3,C,スピロノラクトン,"","",20170705,20171204,25,mg,1,腹水(腹水),未知,"",""
AB-18002368,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180312,20180326,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18003076,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171024,20180402,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18003364,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180124,20180124,110,mg,1,胃癌,剂量停止,"",""
AB-18003858,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,関節リウマチ(再投与なし),""
AB-18003861,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,未知,"",""
AB-18004123,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌,剂量停止,"",""
AB-18004153,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20171106;20180511;,20180330;;,3;;480,mg/kg;;mg,1;;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,続発性副腎皮質機能不全(再投与なし),""
AB-18004153,6,2,C,シロドシン,"",不明,"","","","","","",未知,"",""
AB-18004153,6,3,C,アスピリン,"",不明,"","","","","","",未知,"",""
AB-18004243,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180403,20180417,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,注入に伴う反応(再投与なし),""
AB-18004534,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171213,20180124,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18004630,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171129,20180404,3,mg/kg,1,胃癌,不适用,"",""
AB-18004630,4,2,C,アセトアミノフェン,"",経口,20160831,20180416,1500,mg,3,疼痛,不适用,"",""
AB-18004630,4,3,C,酪酸菌配合剤,"",経口,20160526,20180416,"","","",下痢,不适用,"",""
AB-18004630,4,4,C,六君子湯,"",経口,20160518,20180416,7.5,g,3,腹部膨満,不适用,"",""
AB-18004630,4,5,C,フロセミド,"",経口,20171122,20180416,20,mg,1,浮腫,不适用,"",""
AB-18004630,4,6,C,スピロノラクトン,"",経口,20171122,20180416,50,mg,1,浮腫,不适用,"",""
AB-18004630,4,7,C,レボチロキシンナトリウム水和物,"",経口,20171129,20180416,50,μg,1,甲状腺機能低下症,不适用,"",""
AB-18004860,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201802;20181211,;,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし);下痢(再投与なし);肺炎(再投与なし);血小板数減少(再投与なし);腎盂腎炎(再投与なし),""
AB-18004868,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201803,201804,3,mg/kg,1,胃癌,不适用,"",""
AB-18004883,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180417,20180417,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,肝機能異常(再投与なし);脱水(再投与なし);意識変容状態(再投与なし);低血糖(再投与なし),""
AB-18004885,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171102,20180329,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,類天疱瘡(再投与なし),""
AB-18004968,8,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171018,20171128,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-18004968,8,2,C,イリノテカン塩酸塩水和物,"",不明;不明,201712;,;,120;,mg/m2;,1;,胃癌(胃癌),未知,"",""
AB-18005537,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171213,20180329,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-18005978,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171102,20171130,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18006035,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-18006075,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180427,20180427,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18006545,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171214,20180308,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺障害(再投与なし);スティーヴンス・ジョンソン症候群(再投与なし),""
AB-18006545,3,2,C,プレガバリン,"",その他,20160916,2018,75,mg,1,"",剂量停止,"",""
AB-18006545,3,3,C,鎮咳配合剤（１）,"",経口,201708,"",3,mL,1,"",未知,"",""
AB-18006545,3,4,C,ピコスルファートナトリウム水和物,"",経口,201709,"",10,[drp],1,便秘(便秘),未知,"",""
AB-18006545,3,5,C,フェンタニルクエン酸塩,"",舌下,20171020,"",100,ug,1,疼痛(痛い時),未知,"",""
AB-18006545,3,6,C,フェンタニルクエン酸塩,"",経皮,20171022,"",56,mg,1,"",未知,"",""
AB-18006545,3,7,C,酪酸菌製剤,"",経口,20171109,"",2,{DF},1,"",未知,"",""
AB-18006545,3,8,C,経腸成分栄養剤（２−１）,"",その他,20171109,"",250,mL,1,"",未知,"",""
AB-18006545,3,9,C,ミルタザピン,"",その他,20171117,2018,15,mg,1,"",剂量停止,"",""
AB-18006545,3,10,C,クロミプラミン塩酸塩,"",その他,20171117,"",10,mg,1,"",未知,"",""
AB-18006545,3,11,C,アミノ酸・糖・電解質・ビタミン（２−５）,"",静脈内点滴,20171124,"","","","","",不适用,"",""
AB-18006545,3,12,C,ドンペリドン,"",直腸,20171124,"",60,mg,1,悪心(吐気),未知,"",""
AB-18006545,3,13,C,クエン酸第一鉄ナトリウム,"",その他,20171208,"",100,mg,1,"",未知,"",""
AB-18006545,3,14,C,アスコルビン酸・パントテン酸カルシウム（１）,"",その他,20171208,"",200,mg,1,"",未知,"",""
AB-18006545,3,15,C,アミノ酸・糖・電解質・ビタミン（２−６）,"",静脈内点滴,20180111,"",1000,mL,1,"",未知,"",""
AB-18006545,3,16,C,ナルデメジントシル酸塩,"",その他,20180125,"",.2,mg,1,"",未知,"",""
AB-18006545,3,17,C,レボフロキサシン水和物,"",眼,"","","","","","",未知,"",""
AB-18006545,3,18,C,ヘパリン類似物質,"",皮膚,"","","","","","",未知,"",""
AB-18006545,3,19,C,プロカテロール塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-18006983,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180502,20180502,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18006984,9,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201801,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,自己免疫性脳症(再投与なし),""
AB-18007107,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180115,20180226,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18007107,3,2,C,モサプリドクエン酸塩水和物,"",経口,20160728,"",5,mg,3,便秘,剂量不变,"",""
AB-18007107,3,3,C,ポラプレジンク,"",経口,20160516,"",75,mg,2,胃炎予防,剂量不变,"",""
AB-18007107,3,4,C,酸化マグネシウム,"",経口,20160119,"",330,mg,3,便秘,剂量不变,"",""
AB-18007107,3,5,C,アムロジピンベシル酸塩,"",経口,20160929,"",2.5,mg,1,高血圧,剂量不变,"",""
AB-18007290,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180424,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-18007335,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171010,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-18007335,2,2,C,ヒドロモルフォン塩酸塩,"",経口,20171010,20171104,2,mg,1,癌疼痛,剂量不变,"",""
AB-18007335,2,3,C,アスピリン,"",経口,"",20171104,100,mg,1,心房細動,剂量不变,"",""
AB-18007335,2,4,C,バルサルタン,"",経口,"",20171104,80,mg,1,高血圧,剂量不变,"",""
AB-18007335,2,5,C,テネリグリプチン臭化水素酸塩水和物,"",経口,"",20171104,20,mg,1,糖尿病,剂量不变,"",""
AB-18007510,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180417,20180502,121.5,mg,1,胃癌,剂量停止,"",""
AB-18007510,4,2,PS,デュロキセチン塩酸塩,"",経口,20180401,20180525,20,mg,1,"",未知,"",""
AB-18007510,4,3,PS,フルニトラゼパム,"",経口,"","",1,mg,1,"",未知,"",""
AB-18007510,4,4,C,塩化ナトリウム,"",不明,"","","","","","",未知,"",""
AB-18007521,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180405,20180419,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18007521,5,2,C,グリチルリチン酸一アンモニウム・グリシン・ＤＬ−メチオニン配合剤,"",経口,20171003,"",1,DF,3,"",剂量不变,"",""
AB-18007521,5,3,C,クエン酸第一鉄ナトリウム,"",経口,20161110,"",50,mg,1,"",剂量不变,"",""
AB-18007673,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180105;20181210,201805;,3;,mg/kg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,ぶどう膜炎(再投与なし),""
AB-18007673,5,2,C,ルビプロストン,"",経口,20180202,"",24,ug,1,便秘(便秘),未知,"",""
AB-18007673,5,3,C,ニフェジピン,"",経口,"","",20,mg,1,高血圧(HT),未知,"",""
AB-18007673,5,4,C,カルベジロール,"",経口,"","",2.5,mg,1,狭心症(狭心症),未知,"",""
AB-18007673,5,5,C,ロスバスタチンカルシウム,"",経口,"","",2.5,mg,1,高脂血症(HL),未知,"",""
AB-18007673,5,6,C,アスピリン,"",経口,"","",100,mg,1,狭心症(狭心症),未知,"",""
AB-18007673,5,7,C,フェブキソスタット,"",経口,"","",10,mg,1,"",未知,"",""
AB-18007673,5,8,C,クエン酸第一鉄ナトリウム,"",経口,"","",50,mg,1,"",未知,"",""
AB-18007673,5,9,C,塩化カリウム,"",経口,"","",600,mg,1,"",未知,"",""
AB-18007673,5,10,C,ランソプラゾール,"",経口,"","",15,mg,1,"",未知,"",""
AB-18007673,5,11,C,シタグリプチンリン酸塩水和物,"",経口,"","",25,mg,1,"",未知,"",""
AB-18007878,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180417,"","","","",胃癌,未知,"",""
AB-18007892,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180423,20180423,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18007892,2,2,C,ジアスターゼ配合剤（１）,"",経口,20180320,20180508,0.5,g,3,消化不良,剂量停止,"",""
AB-18007892,2,3,C,ドンペリドン,"",経口,20161012,20180508,10,mg,3,食欲減退,剂量停止,"",""
AB-18007892,2,4,C,アスピリン,"",経口,"",20180616,100,mg,1,狭心症,剂量不变,"",""
AB-18007892,2,5,C,ボノプラザンフマル酸塩,"",経口,20180318,20180510,20,mg,1,胃食道逆流性疾患,剂量不变,"",""
AB-18007892,2,6,C,ベタメタゾン,"",経口,20180328,20180508,1,mg,2,悪液質,未知,"",""
AB-18007947,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180130,20180329,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18007947,3,2,PS,オキサリプラチン,"",不明,"","","","","","",不适用,"",""
AB-18007947,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","","",不适用,"",""
AB-18007947,3,4,PS,パクリタキセル,"",不明,"","","","","","",不适用,"",""
AB-18007947,3,5,PS,ラムシルマブ,"",不明,"","","","","","",不适用,"",""
AB-18008023,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180219,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(不明),""
AB-18008023,4,2,C,ルビプロストン,"",経口,20170621,"",24,ug,1,便秘(便秘症),剂量不变,"",""
AB-18008023,4,3,C,モサプリドクエン酸塩水和物,"",経口,20170809,"",5,mg,1,便秘(便秘症),剂量不变,"",""
AB-18008023,4,4,C,ウルソデオキシコール酸,"",経口,20171108,"",100,mg,1,脂質異常症(脂質異常症),剂量不变,"",""
AB-18008023,4,5,C,フロセミド,"",経口,20180402,"",20,mg,1,高血圧(高血圧),剂量不变,"",""
AB-18008023,4,6,C,ビラスチン,"",経口,"","",20,mg,1,上咽頭炎(感冒),未知,"",""
AB-18008050,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180202,20180511,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし),""
AB-18008050,3,2,PS,ジアスターゼ配合剤（１）,タフマックＥ,経口,"","","","","",適応症不明の製品使用(適応症不明の製品使用),未知,重症筋無力症(再投与なし),""
AB-18008050,3,3,C,プレガバリン,"",不明,2018,"","","","","",未知,"",""
AB-18008050,3,4,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-18008050,3,5,C,芍薬甘草湯,"",不明,"","","","","","",未知,"",""
AB-18008050,3,6,C,エトドラク,"",不明,"","","","","","",未知,"",""
AB-18008162,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171227,20171227,3,mg/kg,1,胃癌,不适用,"",""
AB-18008186,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180425,20180425,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,肝不全(再投与なし);薬物性肝障害(再投与なし),""
AB-18008186,4,2,PS,オキサリプラチン,"",不明,"","","","","","",未知,"",""
AB-18008186,4,3,C,プレガバリン,"",経口,20180131,20180509,150,mg,1,末梢性ニューロパチー(末梢神経障害),不适用,"",""
AB-18008186,4,4,C,パンクレリパーゼ,"",経口,"","",300,mg,1,体重減少(体重減少),不适用,"",""
AB-18008377,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,未知,"",""
AB-18008545,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201802,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,腹水(再投与なし),""
AB-18008630,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201710,201711,"","","",胃癌,不适用,"",""
AB-18008728,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180413,20180413,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18008817,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180131,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,感染性脊椎炎(再投与なし);副腎機能不全(再投与なし);肝障害(再投与なし);敗血症性塞栓(再投与なし);ブドウ球菌性敗血症(再投与なし);カンジダ性敗血症(再投与なし),""
AB-18008835,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180126,20180209,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし);間質性肺疾患(再投与なし),""
AB-18008835,6,2,PS,ドセタキセル,"",静脈内点滴,20180425,20180515,60,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-18008835,6,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20180425,20180528,40,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-18008835,6,4,PS,トラスツズマブ,ハーセプチン,静脈内点滴,20180425,20180515,450,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-18008835,6,5,C,イリノテカン塩酸塩水和物,"",静脈内点滴,20180306,20180403,230,mg,1,"",未知,"",""
AB-18009190,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,剂量不变,"",""
AB-18009255,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180323,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-18009695,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171130,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-18009949,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180508,20180522,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし);原発性副腎機能不全(再投与なし),""
AB-18010686,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180215,20180412,140,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,関節炎(再投与なし),""
AB-18010686,3,2,C,ポラプレジンク,"",経口,"","","","","","",未知,"",""
AB-18010686,3,3,C,ドンペリドン,"",経口,"","","","","","",未知,"",""
AB-18010686,3,4,C,ランソプラゾール,"",経口,"","","","","","",未知,"",""
AB-18010686,3,5,C,アルギン酸ナトリウム,"",不明,"","","","","","",未知,"",""
AB-18010686,3,6,C,水酸化アルミニウムゲル・水酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-18010686,3,7,C,六君子湯,"",不明,"","","","","","",未知,"",""
AB-18011205,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180323;20180510,201805;20180510,3;175,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,クロストリジウム・ディフィシレ大腸炎(再投与なし);血小板減少症(再投与なし),""
AB-18011205,5,2,PS,プレドニゾロン,"",経口,"","",5,mg,1,適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-18011405,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171208,20180105,"","","",胃癌,剂量不变,"",""
AB-18011405,2,2,PS,プレガバリン,"",不明,20171115,20180118,25,mg,1,"",未知,"",""
AB-18011405,2,3,PS,ボノプラザンフマル酸塩,"",不明,20161118,20180205,40,mg,1,"",未知,"",""
AB-18011728,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180320,201806,3,mg/kg,1,胃癌,未知,"",""
AB-18011786,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180112,20180508,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18011786,2,2,C,ボノプラザンフマル酸塩,"",経口,20170509,"",20,mg,1,"",剂量不变,"",""
AB-18011786,2,3,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",剂量不变,"",""
AB-18011786,2,4,C,ポラプレジンク,"",経口,20171215,"",75,mg,2,"",剂量不变,"",""
AB-18011786,2,5,C,牛車腎気丸,"",経口,20160830,"",2.5,g,2,"",剂量不变,"",""
AB-18012289,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180531,20180803,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(無),""
AB-18012289,4,2,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","","",未知,"",""
AB-18012289,4,3,C,クエン酸第一鉄ナトリウム,"",経口,"","","","","","",未知,"",""
AB-18012289,4,4,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-18012289,4,5,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
AB-18012295,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171211,20171211,160,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,筋炎(再投与なし),""
AB-18012295,4,2,C,ボノプラザンフマル酸塩,"",経口,20170501,20180214,20,mg,1,予防(予防),未知,"",""
AB-18012295,4,3,C,酸化マグネシウム,"",経口,20171010,20180214,250,mg,1,予防(予防),未知,"",""
AB-18012295,4,4,C,センノシド,"",経口,20171010,20180219,12,mg,1,予防(予防),未知,"",""
AB-18012295,4,5,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-18012295,4,6,C,ウルソデオキシコール酸,"",不明,"","","","","","",未知,"",""
AB-18012304,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,剂量不变,"",""
AB-18012641,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,未知,"",""
AB-18013036,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌,剂量停止,"",""
AB-18013579,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201803,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,続発性副腎皮質機能不全(再投与なし),""
AB-18014273,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171205,20180122,3,mg/kg,1,胃癌,不适用,"",""
AB-18014516,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180508,20180612,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,血栓性血小板減少性紫斑病(再投与なし);播種性血管内凝固(再投与なし);溶血性貧血(再投与なし),""
AB-18014516,3,2,C,酸化マグネシウム,"",経口,20170303,"",660,mg,1,便秘(便秘),未知,"",""
AB-18014516,3,3,C,ロフラゼプ酸エチル,"",経口,20170509,"",1,mg,1,神経症(神経症),未知,"",""
AB-18014518,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180614,"","","","",胃癌,未知,"",""
AB-18014643,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180424,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,劇症１型糖尿病(再投与なし),""
AB-18014643,3,2,C,Ｌ−カルボシステイン,"",経口,"","","","","","",未知,"",""
AB-18014643,3,3,C,ロキソプロフェンナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-18014643,3,4,C,レバミピド,"",経口,"","","","","","",未知,"",""
AB-18014643,3,5,C,アンブロキソール塩酸塩,"",経口,"","","","","","",未知,"",""
AB-18015402,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180302,20180607,175,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,歩行不能(再投与なし);甲状腺機能低下症(再投与なし);無力症(再投与なし);下痢(再投与なし);眼瞼下垂(再投与なし);慢性炎症性脱髄性多発根ニューロパチー(再投与なし);低カリウム血症(再投与なし);末梢性ニューロパチー(再投与なし),""
AB-18015630,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180506,20180613,3,mg/kg,1,胃癌,不适用,"",""
AB-18015640,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,疲労(再投与なし),""
AB-18015828,3,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口,20180509;20180620,;20180624,50;40,mg;mg,1;1,胃癌(胃癌),剂量停止,"",""
AB-18015828,3,2,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20180509,20180620,200,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18015828,3,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20180509;20180530;20180620,20180509;20180530;,187;179;138,mg/m2;mg/m2;mg/m2,1;1;1,胃癌(胃癌),剂量停止,"",""
AB-18015828,3,4,C,ボノプラザンフマル酸塩,"",経口,20180417,"",20,mg,1,"",剂量不变,"",""
AB-18015828,3,5,C,ポラプレジンク,"",経口,20180509,"",75,mg,1,"",剂量不变,"",""
AB-18015828,3,6,C,ドンペリドン,"",経口,20180606,"",10,mg,1,悪心(悪心),剂量不变,"",""
AB-18015828,3,7,C,オランザピン,"",経口,20180626,"",5,mg,1,悪心(悪心),剂量不变,"",""
AB-18015828,3,8,C,ヘパリン類似物質,"",局所,20180627,"","","","",皮膚乾燥(皮膚乾燥),剂量不变,"",""
AB-18015828,3,9,C,アズレンスルホン酸ナトリウム水和物・炭酸水素ナトリウム,"",口腔咽頭,20180627,"","","","",予防(口内炎予防),剂量不变,"",""
AB-18015828,3,10,C,複方ヨード・グリセリン,"",口腔咽頭,20180627,"","","","",予防(口内炎予防),剂量不变,"",""
AB-18015950,2,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20180613,"",60,mg,2,胃癌,剂量停止,"",""
AB-18015950,2,2,PS,ペムブロリズマブ,"",静脈内点滴,20180613,20180613,200,mg,1,胃癌,剂量停止,"",""
AB-18015950,2,3,PS,オキサリプラチン,"",静脈内点滴,20180613,20180613,245,mg,1,胃癌,剂量停止,"",""
AB-18015950,2,4,C,アロプリノール,"",経口,"","",100,mg,1,"",剂量停止,"",""
AB-18015950,2,5,C,カルベジロール,"",経口,"","",20,mg,1,"",剂量停止,"",""
AB-18015950,2,6,C,ランソプラゾール,"",経口,"","",30,mg,1,"",剂量停止,"",""
AB-18015950,2,7,C,トホグリフロジン水和物,"",経口,"","",20,mg,1,"",剂量停止,"",""
AB-18015950,2,8,C,アトルバスタチンカルシウム水和物,"",経口,"","",10,mg,1,"",剂量停止,"",""
AB-18015950,2,9,C,乾燥硫酸鉄（３）,"",経口,"","",105,mg,1,"",剂量停止,"",""
AB-18015950,2,10,C,プレガバリン,"",経口,"","",75,mg,2,"",剂量停止,"",""
AB-18015950,2,11,C,メトホルミン塩酸塩,"",経口,"","",250,mg,2,"",剂量停止,"",""
AB-18015950,2,12,C,イフェンプロジル酒石酸塩,"",経口,"","",105,mg,2,"",剂量停止,"",""
AB-18015950,2,13,C,デュラグルチド,"",皮下,"","",0.75,mg,1,"",剂量停止,"",""
AB-18015950,2,14,C,インスリングラルギン,"",皮下,"","",10,iu,1,"",剂量停止,"",""
AB-18015950,2,15,C,ラクトミン,"",経口,20180620,"",1,mg,1,下痢,剂量停止,"",""
AB-18015950,2,16,C,ロペラミド塩酸塩,"",経口,20180620,"",1,DF,3,下痢,剂量停止,"",""
AB-18016080,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171116,"",3,mg/kg,1,胃癌,剂量不变,"",""
AB-18016225,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171211,20180416,190,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,自己免疫性溶血性貧血(再投与なし),""
AB-18016226,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌,剂量停止,"",""
AB-18017280,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180612,"",3,mg/kg,1,胃癌,剂量停止,甲状腺機能亢進症(不明),""
AB-18017301,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20171017;20181002,20180626;20181127,3;195.9,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,扁平苔癬(有);扁平苔癬(有);扁平苔癬(有),""
AB-18017310,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180529,20180703,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,低血圧(再投与なし);食欲減退(再投与なし);視床下部−下垂体障害(再投与なし);倦怠感(再投与なし),""
AB-18017357,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180608,"",3,mg/kg,1,胃癌,剂量减少,"",""
AB-18017357,2,2,C,アンブロキソール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-18017357,2,3,C,ブロムヘキシン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-18017363,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180427,"","","","",胃癌,剂量停止,"",""
AB-18017518,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180319,20180709,156,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎皮質刺激ホルモン欠損症(再投与なし);多形紅斑(再投与なし);副腎機能不全(再投与なし),""
AB-18017518,3,2,C,ゾルピデム酒石酸塩,"",経口,"",20180613,5,mg,1,不眠症(不眠症),未知,"",""
AB-18017518,3,3,C,経腸成分栄養剤（１０）,"",不明,"","","","","","",未知,"",""
AB-18017518,3,4,C,ベタヒスチンメシル酸塩,"",経口,"",20180613,6,mg,1,浮動性めまい(めまい症),未知,"",""
AB-18017518,3,5,C,ホウ酸・無機塩類配合剤,"",眼,"","","","","","",未知,"",""
AB-18017518,3,6,C,グリメピリド,"",経口,"",20180613,3,mg,1,糖尿病(糖尿病),未知,"",""
AB-18017518,3,7,C,アロプリノール,"",経口,"","","","","","",未知,"",""
AB-18017518,3,8,C,シタグリプチンリン酸塩水和物,"",経口,"",20180613,50,mg,1,糖尿病(糖尿病),未知,"",""
AB-18017518,3,9,C,メトホルミン塩酸塩,"",経口,"",20180613,250,mg,1,糖尿病(糖尿病),未知,"",""
AB-18017518,3,10,C,生理食塩液,"",不明,"","","","","","",未知,"",""
AB-18017906,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201712,201804,3,mg/kg,1,胃癌,不适用,"",""
AB-18017906,1,2,PS,イリノテカン塩酸塩水和物,"",不明,201805,201805,"","","",胃癌,不适用,"",""
AB-18018017,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180620,20180704,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18018017,4,2,C,カンデサルタンシレキセチル,"",不明,"","","","","","",未知,"",""
AB-18018017,4,3,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-18018017,4,4,C,アセトアミノフェン,"",不明,"","","","","",上気道の炎症,未知,"",""
AB-18018017,4,5,C,ジメモルファンリン酸塩,"",不明,"","","","","",上気道の炎症,未知,"",""
AB-18018252,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,未知,"",""
AB-18018252,1,2,C,カペシタビン,"",不明,"","","","","",胃癌,未知,"",""
AB-18018344,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180705,"",3,mg/kg,1,胃癌,剂量不变,"",""
AB-18018577,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171122,20180328,3,mg/kg,1,胃癌,剂量不变,"",""
AB-18018577,1,2,PS,イリノテカン塩酸塩水和物,"",不明,2018,"","","","",胃癌,不适用,"",""
AB-18018584,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201711,"","","","",胃癌,未知,"",""
AB-18018673,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,剂量不变,"",""
AB-18018727,10,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180413;20190325,20180706;20190325,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,糖尿病性ケトアシドーシス(再投与なし);ネフローゼ症候群(再投与なし);劇症１型糖尿病(再投与なし),""
AB-18018727,10,2,PS,ラムシルマブ,"",不明,"","","","","",胃癌(胃癌),未知,"",""
AB-18018727,10,3,C,ボノプラザンフマル酸塩,"",経口,"","","","","","",未知,"",""
AB-18018727,10,4,C,モサプリドクエン酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-18018727,10,5,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-18018727,10,6,C,エチゾラム,"",経口,"","","","","","",未知,"",""
AB-18018886,8,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20171117;20180525;;,20180420;;;,180;180;240;480,mg;mg;mg;mg,1;1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,胸水(再投与なし);甲状腺機能低下症(再投与なし);甲状腺機能亢進症(再投与なし),""
AB-18018887,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171117,20180907,100,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,脊椎圧迫骨折(再投与なし),""
AB-18019235,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171220,20180329,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18019235,3,2,PS,プレドニゾロン,プレドニン,不明;不明,20180418;20180509,20180508;2018,30;25,mg;mg,1;1,間質性肺疾患(間質性肺炎),未知,"",""
AB-18019435,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171204,20180129,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,脳梗塞(再投与なし);肺塞栓症(再投与なし),""
AB-18019512,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180501,20180622,"","","",胃癌,剂量停止,"",""
AB-18019703,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,未知,"",""
AB-18019773,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180427,20180608,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,潰瘍性大腸炎(再投与なし),""
AB-18019773,3,2,C,メサラジン,"",不明,"","","","","","",未知,"",""
AB-18019773,3,3,C,アメジニウムメチル硫酸塩,"",不明,"","","","","","",未知,"",""
AB-18019773,3,4,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-18019773,3,5,C,オキシコドン塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-18019773,3,6,C,ウルソデオキシコール酸,"",不明,"","","","","","",未知,"",""
AB-18019774,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180601;20180622,20180601;,360;360,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(無);サルコイドーシス(無);腸閉塞(無);ネフローゼ症候群(無);下垂体機能低下症(無),""
AB-18019938,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180524,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,意識レベルの低下(再投与なし);死亡(再投与なし);脳炎(再投与なし);尿管狭窄(再投与なし);全身健康状態悪化(再投与なし);発熱(再投与なし);自己免疫性脳炎(再投与なし),""
AB-18019938,5,2,C,エスゾピクロン,"",経口,20170502,"",1,mg,1,不眠症(不眠),剂量停止,"",""
AB-18019938,5,3,C,アムロジピンベシル酸塩,"",経口,20170516,"",5,mg,1,高血圧(HT),剂量停止,"",""
AB-18019938,5,4,C,ルビプロストン,"",経口,20170613,"",24,ug,1,便秘(便秘),剂量停止,"",""
AB-18019938,5,5,C,フロセミド,"",経口,20180306,"",20,mg,1,浮腫(浮腫),剂量停止,"",""
AB-18019938,5,6,C,ジフェンヒドラミン,"",経皮,"","","","","","",未知,"",""
AB-18020305,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180702,20180702,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-18020538,10,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180117;20180627,20180523;20180627,3;140,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(有);小腸穿孔(有);腹膜炎(有);大腸炎(有),""
AB-18020538,10,2,PS,リマプロストアルファデクス,オパルモン,経口,"",20180727,10,ug,1,末梢動脈閉塞性疾患(閉塞性動脈硬化症),剂量不变,下痢(再投与なし);小腸穿孔(再投与なし);腹膜炎(再投与なし);大腸炎(再投与なし),""
AB-18020538,10,3,C,シタグリプチンリン酸塩水和物,"",経口,20160613,20180727,50,mg,1,２型糖尿病(2型糖尿病),未知,"",""
AB-18020538,10,4,C,グリクラジド,"",経口,20160613,20180727,20,mg,1,２型糖尿病(2型糖尿病),未知,"",""
AB-18020538,10,5,C,シロスタゾール,"",経口,20160803,20180727,100,mg,1,末梢動脈閉塞性疾患(閉塞性動脈硬化症),未知,"",""
AB-18020645,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171207,20180206,3,mg/kg,1,胃癌,剂量停止,肺炎(不明),""
AB-18020679,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180514,20180625,3,mg/kg,1,胃癌,不适用,"",""
AB-18020698,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180314,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,譫妄(再投与なし);頭痛(再投与なし),""
AB-18020718,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180727,"","","","",胃癌,剂量不变,"",""
AB-18021079,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20170929,20180413,"","","",胃癌,剂量停止,"",""
AB-18021082,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201711,201807,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-18021280,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20180525,20180706,200,mg,1,肺腺癌,剂量停止,"",""
AB-18021280,3,2,PS,エソメプラゾールマグネシウム水和物,"",経口,20170721,"",20,mg,1,"",未知,"",""
AB-18021280,3,3,PS,エンテカビル水和物,"",経口,20170802,"",0.5,mg,1,"",未知,"",""
AB-18021280,3,4,PS,ミノサイクリン塩酸塩,"",経口,20170807,"",50,mg,2,"",未知,"",""
AB-18021280,3,5,C,酸化マグネシウム,"",経口,20170721,"",330,mg,3,"",未知,"",""
AB-18021280,3,6,C,クエン酸第一鉄ナトリウム,"",経口,20170727,"",50,mg,1,"",未知,"",""
AB-18021280,3,7,C,アムロジピンベシル酸塩,"",経口,20170830,"",5,mg,1,"",未知,"",""
AB-18021280,3,8,C,ラクツロース,"",経口,20171005,"",20,mL,2,"",未知,"",""
AB-18021280,3,9,C,レチノール・カルシフェロール配合剤,"",経口,20180417,"",1,g,1,"",未知,"",""
AB-18021520,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,不适用,"",""
AB-18021579,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180216,"","","","",胃癌,剂量停止,"",""
AB-18021604,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180403,20180403,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,尿細管間質性腎炎(再投与なし),""
AB-18021604,2,2,C,カンデサルタンシレキセチル,"",不明,"","","","","","",未知,"",""
AB-18021604,2,3,C,フルバスタチンナトリウム,"",不明,"","","","","","",未知,"",""
AB-18021604,2,4,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-18021656,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180125,20180530,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18021656,2,2,PS,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-18021656,2,3,PS,アピキサバン,"",不明,"","","","","",静脈塞栓症,未知,"",""
AB-18021656,2,4,PS,エドキサバントシル酸塩水和物,"",不明,"","","","","",静脈塞栓症,未知,"",""
AB-18021703,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180125;20180809,20180712;,3;3,mg/kg;mg/kg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下垂体機能低下症(不明);副腎機能不全(不明),""
AB-18021703,2,2,C,ワルファリンカリウム,"",不明,"","",2.25,mg,1,"",未知,"",""
AB-18021704,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,剂量停止,尿細管間質性腎炎(無),""
AB-18021704,3,2,C,ミグリトール,"",不明,"","",25,mg,1,ダンピング症候群,未知,"",""
AB-18021734,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171020,20171117,260,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性血小板減少症(再投与なし);イレウス(再投与なし),""
AB-18021916,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201807201453,20180720,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腸閉塞(再投与なし);敗血症(再投与なし);腹膜炎(再投与なし);腫瘍破裂(再投与なし);心嚢液貯留(再投与なし),""
AB-18021916,3,2,PS,オキシコドン塩酸塩水和物,オキシコンチン,経口,20180801,20180807,5,mg,1,癌疼痛(癌性疼痛),剂量停止,"",""
AB-18021916,3,3,C,アセトアミノフェン,"",経口,20170725,20180811,400,mg,1,癌疼痛(癌性疼痛（上腹部痛）),不适用,"",""
AB-18021916,3,4,C,カンデサルタンシレキセチル・アムロジピンベシル酸塩配合剤,"",経口,"",20180807,"","","",高血圧(高血圧),剂量停止,"",""
AB-18021916,3,5,C,ラベプラゾールナトリウム,"",経口,"",20180807,10,mg,1,胃食道逆流性疾患(逆流性食道炎),剂量停止,"",""
AB-18021916,3,6,C,ブロチゾラム,"",経口,"",20180807,.25,mg,1,不眠症(不眠症),剂量停止,"",""
AB-18022026,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180627,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,胃腸出血(再投与なし);頭痛(再投与なし),""
AB-18022027,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180621,20180705,140,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-18022079,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180626,20180718,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18022303,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,剂量停止,"",""
AB-18022333,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171219,20180201,3,mg/kg,1,胃癌,剂量不变,"",""
AB-18022334,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171017,20180808,140,mg,1,頭頚部癌(再発又は遠隔転移を有する頭頸部癌),不适用,死亡(再投与なし);誤嚥性肺炎(再投与なし);機械的イレウス(再投与なし),""
AB-18022334,3,2,C,補中益気湯,"",経口,"","",1,{DF},1,"",未知,"",""
AB-18022334,3,3,C,セレコキシブ,"",経口,"","",2,{DF},1,"",未知,"",""
AB-18022334,3,4,C,タペンタドール塩酸塩,"",経口,"","",1,{DF},1,"",未知,"",""
AB-18022334,3,5,C,ブロチゾラム,"",経口,"","",1,{DF},1,"",未知,"",""
AB-18022334,3,6,C,アンブロキソール塩酸塩,"",経口,"","",1,{DF},1,"",未知,"",""
AB-18022334,3,7,C,Ｌ−カルボシステイン,"",経口,"","","","","","",未知,"",""
AB-18022334,3,8,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-18022334,3,9,C,センノシド,"",経口,"","","","","","",未知,"",""
AB-18022334,3,10,C,メトクロプラミド,"",経口,"","","","","","",未知,"",""
AB-18022334,3,11,C,レボチロキシンナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-18022334,3,12,C,デキサメタゾン,"",経口,"","","","","","",未知,"",""
AB-18022334,3,13,C,ボノプラザンフマル酸塩,"",経口,"","",2,{DF},1,"",未知,"",""
AB-18022682,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌,未知,"",""
AB-18022787,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201801,20180508,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,糖尿病性ケトアシドーシス(再投与なし);炎症性腸疾患(再投与なし);劇症１型糖尿病(再投与なし);自己免疫性肝炎(再投与なし),""
AB-18022788,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180807;20181002,20180829;20181016,3;,mg/kg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発熱(不明);尿路閉塞(不明),""
AB-18022877,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201805,20180710,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-18022885,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180115,20180115,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,悪性心膜炎(再投与なし),""
AB-18023040,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180709,20180806,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,筋炎(再投与なし);重症筋無力症(再投与なし),""
AB-18023075,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌,剂量不变,"",""
AB-18023142,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171228,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発疹(再投与なし),""
AB-18023142,3,2,C,アムロジピンベシル酸塩,"",経口,"","","","","","",未知,"",""
AB-18023206,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180405,20180524,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,中毒性表皮壊死融解症(再投与なし),""
AB-18023206,4,2,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-18023206,4,3,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-18023210,9,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180710,20180724,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし);重症筋無力症(再投与なし);うっ血性心不全(再投与なし),""
AB-18023210,9,2,C,フロセミド,"",経口,20180726,20180820,40,mg,1,"",未知,"",""
AB-18023210,9,3,C,エソメプラゾールマグネシウム水和物,"",経口,20180726,20180820,20,mg,1,"",未知,"",""
AB-18023210,9,4,C,リナグリプチン,"",経口,20180726,20180820,5,mg,1,"",未知,"",""
AB-18023210,9,5,C,カルベジロール,"",経口,20180726,20180820,2,{DF},1,"",未知,"",""
AB-18023210,9,6,C,スピロノラクトン,"",経口,20180726,20180820,1,{DF},1,"",未知,"",""
AB-18023210,9,7,C,アピキサバン,"",経口,20180726,20180820,2,{DF},1,"",未知,"",""
AB-18023210,9,8,C,ルビプロストン,"",経口,20180726,20180820,2,{DF},1,"",未知,"",""
AB-18023210,9,9,C,レボチロキシンナトリウム水和物,"",経口,20180726,20180820,1,{DF},1,"",未知,"",""
AB-18023210,9,10,C,酸化マグネシウム,"",経口;経口,20180726;,20180820;20180730,6;9,{DF};{DF},1;1,"",未知,"",""
AB-18023210,9,11,C,アデニン,"",経口,"",20180730,6,{DF},1,"",未知,"",""
AB-18023499,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,剂量停止,"",""
AB-18023557,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20161208,"",2,mg/kg,1,胃癌(胃癌),剂量不变,甲状腺機能亢進症(再投与なし),""
AB-18023647,1,1,PS,アピキサバン,エリキュース,不明,"","","","","",血栓症予防,未知,発熱(不明);悪性新生物進行(不明),""
AB-18023647,1,2,PS,ニボルマブ,"",静脈内点滴,20180125,20180530,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18023647,1,3,PS,エドキサバントシル酸塩水和物,"",不明,"","","","","",静脈塞栓症,未知,発熱(不明);悪性新生物進行(不明),""
AB-18024034,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180413,20180502,144,mg,1,胃癌,不适用,"",""
AB-18024182,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180228;20180523,20180228;202002,3;3,mg/kg;mg/kg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-18024382,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180808,"",3,mg/kg,1,胃癌,未知,"",""
AB-18024454,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171125,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-18024519,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180425,20180802,120,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,倦怠感(再投与なし),""
AB-18024773,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201804,201807,3,mg/kg,2,胃癌,剂量不变,"",""
AB-18024953,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180727,"","","","",胃癌,未知,"",""
AB-18024954,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180111,20180816,170,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性肝炎(再投与なし);劇症１型糖尿病(再投与なし),""
AB-18025282,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171016,20180305,3,mg/kg,1,胃癌,未知,"",""
AB-18025282,1,2,C,乾燥甲状腺,"",不明,"","","","","",甲状腺機能低下症,未知,"",""
AB-18025353,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,未知,"",""
AB-18025698,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,未知,"",""
AB-18025853,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180608,20180822,250,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18026173,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180803,20181031,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし),""
AB-18026712,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180307;2019,;,150;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,直腸癌(再投与なし);血便排泄(再投与なし);下痢(再投与なし);意識変容状態(再投与なし);重症筋無力症(再投与なし);網膜剥離(再投与なし),""
AB-18026970,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171121,20180206,168,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-18026970,3,2,C,アミノ酸・糖・電解質・ビタミン（２−６）,"",静脈内点滴,20180502,20180517,1500,mL,1,栄養補給(栄養維持),未知,"",""
AB-18026970,3,3,C,モルヒネ塩酸塩水和物,"",静脈内点滴,20180502,20180517,10,mg,1,疼痛(疼痛),未知,"",""
AB-18027044,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180501,"",3,mg/kg,1,胃癌,剂量不变,"",""
AB-18027337,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180301,20180920,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,硬化性胆管炎(再投与なし),""
AB-18027475,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201806;,;,3;,mg/kg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(不明);副腎機能不全(不明),""
AB-18027560,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180912,201809,"","","",胃癌,剂量停止,"",""
AB-18027592,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180306,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-18027799,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180817,20180905,140,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-18028295,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180815,20180829,140,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,スティーヴンス・ジョンソン症候群(再投与なし),""
AB-18028295,3,2,C,アロチノロール塩酸塩,"",経口,20130626,"",10,mg,1,パーキンソン病(パーキンソン病),未知,"",""
AB-18028295,3,3,C,クエン酸第一鉄ナトリウム,"",経口,20171227,"",100,mg,1,貧血(貧血),未知,"",""
AB-18028295,3,4,C,トリヘキシフェニジル塩酸塩,"",経口,20180129,"",1,mg,1,パーキンソン病(パーキンソン病),未知,"",""
AB-18028295,3,5,C,フロセミド,"",経口,20180207,"",20,mg,1,末梢性浮腫(下肢浮腫),未知,"",""
AB-18028295,3,6,C,スピロノラクトン,"",経口,20180207,"",25,mg,1,末梢性浮腫(下肢浮腫),未知,"",""
AB-18028295,3,7,C,膵臓性消化酵素配合剤（１）,"",経口,20180404,"",1,g,1,"",未知,"",""
AB-18028295,3,8,C,ポリカルボフィルカルシウム,"",経口,20180704,"",.6,g,1,過敏性腸症候群(過敏性腸症候群);下痢(下痢),未知,"",""
AB-18028826,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌,剂量不变,"",""
AB-18028953,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20171017;20171212,20171128;20180403,219.6;192.6,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);甲状腺障害(再投与なし);敗血症性ショック(再投与なし);胆嚢炎(再投与なし),""
AB-18028953,4,2,PS,シタグリプチンリン酸塩水和物,グラクティブ,経口,"","","","","",２型糖尿病(2型糖尿病),未知,副腎機能不全(再投与なし);甲状腺障害(再投与なし);敗血症性ショック(再投与なし);胆嚢炎(再投与なし),""
AB-18028953,4,3,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-18028953,4,4,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-18028953,4,5,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-18028953,4,6,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-18028983,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201805,201807,3,mg/kg,1,胃癌,不适用,"",""
AB-18029011,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180702,20180912,3,mg/kg,1,頭頚部癌(再発又は遠隔転移を有する頭頸部癌),剂量停止,呼吸不全(再投与なし);肺胞出血(再投与なし);間質性肺疾患(再投与なし),""
AB-18029011,4,2,PS,セツキシマブ,"",静脈内点滴;静脈内点滴,20180423;2018,20180423;20180618,600;400,mg;mg,1;1,頭頚部癌(再発又は遠隔転移を有する頭頸部癌),不适用,"",""
AB-18029011,4,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20181024,201810,80,mg,1,頭頚部癌(再発又は遠隔転移を有する頭頸部癌),剂量停止,"",""
AB-18029011,4,4,C,セファゾリンナトリウム,"",不明,20180808,20180809,2,g,1,発熱(発熱),未知,"",""
AB-18029011,4,5,C,アンピシリンナトリウム,"",不明,20180810,20180910,2,g,1,"",未知,"",""
AB-18029011,4,6,C,アモキシシリン水和物,"",経口,20180911,"","","","","",未知,"",""
AB-18029015,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201805,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,１型糖尿病(再投与なし),""
AB-18029015,3,2,C,トホグリフロジン水和物,"",不明,2012,"",20,mg,1,２型糖尿病(2型糖尿病),未知,"",""
AB-18029015,3,3,C,アナグリプチン,"",不明,2012,"",200,mg,1,２型糖尿病(2型糖尿病),未知,"",""
AB-18029052,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20180109,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,乾癬(再投与なし),""
AB-18029052,3,2,C,プレドニゾロン,"",不明,"","","","","",乾癬(尋常性乾癬),未知,"",""
AB-18029052,3,3,C,アルファカルシドール,"",経口,"","",1,ug,1,乾癬(尋常性乾癬),未知,"",""
AB-18029052,3,4,C,ミノサイクリン塩酸塩,"",経口,"","",100,mg,1,乾癬(尋常性乾癬),未知,"",""
AB-18029052,3,5,C,エピナスチン塩酸塩,"",経口,"","",20,mg,1,乾癬(尋常性乾癬),未知,"",""
AB-18029052,3,6,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",皮膚,"","","","","",乾癬(尋常性乾癬),未知,"",""
AB-18029052,3,7,C,カルシポトリオール水和物・ベタメタゾンジプロピオン酸エステル,"",皮膚,"","","","","",乾癬(尋常性乾癬),未知,"",""
AB-18029052,3,8,C,クロベタゾールプロピオン酸エステル,"",皮膚,"","","","","",乾癬(尋常性乾癬),未知,"",""
AB-18029054,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180406,20180420,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発熱(再投与なし),""
AB-18029264,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171013,"",3,mg/kg,2,胃癌,剂量停止,"",""
AB-18029354,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171211,20180604,157,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-18029411,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171222,20180202,143,mg,1,胃癌,不适用,"",""
AB-18029411,2,2,C,酸化マグネシウム,"",不明,20170801,"","","","","",未知,"",""
AB-18029411,2,3,C,ブロチゾラム,"",不明,20171201,"","","","","",未知,"",""
AB-18029452,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180918,20181016,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,癌性リンパ管症(再投与なし),""
AB-18029454,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180419,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝炎(無),""
AB-18029455,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180726,20180920,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-18029456,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180510,20180906,3,mg/kg,1,胃癌,未知,"",""
AB-18029553,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180903,20180920,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,関節リウマチ(再投与なし),""
AB-18029553,3,2,C,プレドニゾロン,"",不明,"","","","","",関節リウマチ(リウマチ（RA）),未知,"",""
AB-18029554,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180906,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,注入に伴う反応(再投与なし),""
AB-18029554,2,2,C,アセトアミノフェン,"",不明,"","","","","",癌疼痛(疼痛),未知,"",""
AB-18029562,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180809,20180906,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,乾癬様皮膚炎(再投与なし);間質性肺疾患(再投与なし);胆管炎(再投与なし),""
AB-18029605,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,剂量停止,細菌性肺炎(不明),""
AB-18029748,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180208,20180328,159,mg,1,胃癌,剂量不变,"",""
AB-18029748,1,2,C,酸化マグネシウム,"",不明,20160922,"","","","","",剂量不变,"",""
AB-18029748,1,3,C,ランソプラゾール,"",不明,20160926,"","","","","",剂量不变,"",""
AB-18029750,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180405,20180621,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18029751,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20170928,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-18029775,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌,剂量停止,"",""
AB-18029912,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180208,20180816,140,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし);脊椎圧迫骨折(再投与なし);転倒(再投与なし);譫妄(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-18029912,3,2,C,アセトアミノフェン,"",経口,20180208,20180816,300,mg,1,"",未知,"",""
AB-18029912,3,3,C,メトクロプラミド,"",経口,20180208,20180816,5,mg,1,"",未知,"",""
AB-18029920,3,1,PS,イリノテカン塩酸塩水和物,トポテシン,静脈内点滴,20180927,20180927,150,mg/m2,1,胃癌(Gastric cancer),剂量停止,死亡(再投与なし);下痢(再投与なし);発熱(再投与なし);骨髄抑制(再投与なし),""
AB-18029920,3,2,PS,ニボルマブ,オプジーボ,不明,20180524,20180925,"","","",胃癌(Gastric cancer),未知,"",""
AB-18029920,3,3,C,フィルグラスチム［後続１］,"",皮下,20181005,20181011,75,ug,1,"",未知,"",""
AB-18029925,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180507,20180507,3,mg/kg,1,胃癌,剂量停止,"",""
AB-18029925,1,2,PS,ラムシルマブ,"",不明,20180115,20180429,"","","",胃癌,不适用,"",""
AB-18030157,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201802,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,消化管浮腫(再投与なし);胃拡張(再投与なし),""
AB-18030173,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180926,20180926,240,mg,1,胃癌,剂量停止,"",""
AB-18030173,1,2,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-18030173,1,3,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-18030173,1,4,C,スルファメトキサゾール・トリメトプリム,"",不明,"","","","","","",未知,"",""
AB-18030173,1,5,C,シタグリプチンリン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-18030173,1,6,C,ラメルテオン,"",不明,"","","","","","",未知,"",""
AB-18030173,1,7,C,グリメピリド,"",不明,"","","","","","",未知,"",""
AB-18030173,1,8,C,フマル酸第一鉄,"",不明,"","","","","","",未知,"",""
AB-18030218,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-18030388,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181004;20181130,20181004;20181130,140;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,倦怠感(再投与なし);疲労(再投与なし),""
AB-18030396,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180710,20180724,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18030401,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",190,mg,1,胃癌,不适用,"",""
AB-18030502,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180727,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,硬膜下血腫(再投与なし);血小板数減少(再投与なし),""
AB-18033195,8,1,PS,イピリムマブ,ヤーボイ,静脈内点滴,20180918,20180918,1,mg/kg,1,遠隔転移を伴う腎細胞癌(根治切除不能又は転移性の腎細胞癌),剂量停止,胆管炎(不明);肺炎(不明),""
AB-18033195,8,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20180918,20180918,240,mg,1,遠隔転移を伴う腎細胞癌(遠隔転移を伴う腎細胞癌),剂量停止,胆管炎(不明);肺炎(不明),""
AB-18034954,4,1,PS,イピリムマブ,ヤーボイ,静脈内点滴,20181019,20181019,48,mg,1,腎細胞癌(腎細胞癌),剂量停止,間質性肺疾患(不明),""
AB-18034954,4,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20181019,20181019,240,mg,1,腎細胞癌(腎細胞癌),剂量停止,間質性肺疾患(不明),""
AB-18034954,4,3,C,ロキソプロフェンナトリウム水和物,"",経口,20181005,20181026,180,mg,1,疼痛(疼痛対策),未知,"",""
AB-18034954,4,4,C,エソメプラゾールマグネシウム水和物,"",経口,20181005,20181026,20,mg,1,予防(NSAIDs投与時の予防投与),未知,"",""
AB-18034954,4,5,C,メトクロプラミド,"",経口,20181016,20181026,15,mg,1,悪心(吐気対策),未知,"",""
AB-18034954,4,6,C,スルファメトキサゾール・トリメトプリム,"",経口,20181016,20181026,"","","",抗真菌薬予防投与(抗真菌薬予防投与),未知,"",""
AB-18034954,4,7,C,オキシコドン塩酸塩水和物,"",経口,20181022,20181026,10,mg,1,疼痛(適応症不明の製品使用),未知,"",""
AB-18040302,1,1,PS,セフェピム塩酸塩水和物,マキシピーム,不明,20181014,"","","","",細菌性肺炎,未知,"",""
AB-18040302,1,2,PS,ニボルマブ,"",不明,20180914,20181023,240,mg,1,胃癌,未知,"",""
AB-18040302,1,3,C,レボフロキサシン水和物,"",不明,"","","","","",適応症不明の製品使用,未知,"",""
AB-18040302,1,4,C,ポリスチレンスルホン酸ナトリウム,"",不明,"","","","","",適応症不明の製品使用,未知,"",""
AB-18040302,1,5,C,ケトプロフェン,"",不明,"","","","","",適応症不明の製品使用,未知,"",""
AB-18040302,1,6,C,フェンタニルクエン酸塩,"",不明,"","","","","",適応症不明の製品使用,未知,"",""
AB-18040302,1,7,C,オキシコドン塩酸塩水和物,"",不明,"","","","","",適応症不明の製品使用,未知,"",""
AB-18040302,1,8,C,アセトアミノフェン,"",不明,"","","","","",適応症不明の製品使用,未知,"",""
AB-18040302,1,9,C,ランソプラゾール,"",不明,"","","","","",適応症不明の製品使用,未知,"",""
AB-18040302,1,10,C,スボレキサント,"",不明,"","","","","",適応症不明の製品使用,未知,"",""
AB-18040302,1,11,C,アミノ酸・糖・電解質・ビタミン（２−４）,"",不明,"","","","","",適応症不明の製品使用,未知,"",""
AB-18040302,1,12,C,ピコスルファートナトリウム水和物,"",不明,"","","","","",適応症不明の製品使用,未知,"",""
AB-18040302,1,13,C,メトクロプラミド,"",不明,"","","","","",適応症不明の製品使用,未知,"",""
AB-18503686,9,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,20180613,20180613,1200,mg,1,肺腺癌(切除不能な進行・再発の非小細胞肺癌),不适用,"",""
AB-18503686,9,2,PS,メチルプレドニゾロンコハク酸エステルナトリウム,ソル・メドロール,不明,"","","","","","",未知,"",""
AB-18503686,9,3,PS,プレドニゾロン酢酸エステル,プレドニン,不明,"","","","","","",未知,"",""
AB-18503686,9,4,C,モサプリドクエン酸塩水和物,"",経口,"","",5,mg,1,慢性胃炎(慢性胃炎),未知,"",""
AB-18503686,9,5,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,慢性胃炎(慢性胃炎),未知,"",""
AB-18507578,4,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口;経口,20180613;20180711;20180829,;;20180901,60;50;40,mg;mg;mg,1;1;1,胃癌(胃癌),剂量停止,"",""
AB-18507578,4,2,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20180613,20180829,200,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18507578,4,3,PS,オキサリプラチン,"",静脈内点滴,20180613,20180829,245,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18507578,4,4,C,カルベジロール,"",経口,"","",20,mg,1,"",剂量不变,"",""
AB-18507578,4,5,C,ランソプラゾール,"",経口,"","",30,mg,1,"",剂量不变,"",""
AB-18507578,4,6,C,乾燥硫酸鉄（３）,"",経口,"","",105,mg,1,"",剂量停止,"",""
AB-18507578,4,7,C,プレガバリン,"",経口,"","",75,mg,1,"",剂量停止,"",""
AB-18507578,4,8,C,イフェンプロジル酒石酸塩,"",経口,"","",20,mg,1,"",剂量停止,"",""
AB-18507578,4,9,C,デュラグルチド,"",皮下,"","",0.75,mg,1,"",剂量停止,"",""
AB-18507578,4,10,C,インスリングラルギン,"",皮下,"","",10,[iU],1,"",剂量增加,"",""
AB-18507578,4,11,C,ラクトミン,"",経口,20180711,"",1,mg,1,下痢(下痢),剂量不变,"",""
AB-18507578,4,12,C,ロペラミド塩酸塩,"",経口,20180711,"",1,{DF},1,下痢(下痢),剂量不变,"",""
AB-18508275,3,1,PS,アテゾリズマブ,テセントリク,静脈内点滴;静脈内点滴,20180711;20180808,20180711;20180920,1200;1200,mg;mg,1;1,肺扁平上皮癌(切除不能な進行・再発の非小細胞肺癌),剂量停止,"",""
AB-18509406,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171004,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし);脳梗塞(再投与なし),""
AB-18509502,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180511;20180928,20180810;20181012,160;160,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-18509512,3,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20180530,"",40,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18509512,3,2,PS,オキサリプラチン,"",静脈内点滴,20180530,"",146,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18509512,3,3,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20180530,"",200,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18509512,3,4,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,20180530,"",0.75,mg,1,悪心・嘔吐の予防(悪心・嘔吐の予防),剂量停止,"",""
AB-18509512,3,5,C,デキサメタゾン,"",経口,20180530,"",9.9,mg,1,悪心・嘔吐の予防(悪心・嘔吐の予防),剂量停止,"",""
AB-18509512,3,6,C,ベタメタゾン吉草酸エステル,"",局所,20180530,"",5,g,1,ざ瘡様皮膚炎(ざ瘡様発疹),剂量不变,"",""
AB-18509512,3,7,C,エソメプラゾールマグネシウム水和物,"",経口,201805,"",20,mg,1,胃食道逆流性疾患(胃食道逆流症),剂量不变,"",""
AB-18509512,3,8,C,ナジフロキサシン,"",局所,20180622,"","","","",ざ瘡様皮膚炎(ざ瘡様発疹),剂量不变,"",""
AB-18509512,3,9,C,ヘパリン類似物質,"",局所,20180720,"","","","",ざ瘡様皮膚炎(ざ瘡様発疹),剂量不变,"",""
AB-18509512,3,10,C,ヒドロコルチゾン酪酸エステル,"",局所,20180912,"","","","",ざ瘡様皮膚炎(ざ瘡様発疹),剂量不变,"",""
AB-18509512,3,11,C,エチゾラム,"",経口,20181003,"",0.5,mg,1,不眠症(不眠症),剂量不变,"",""
AB-18509512,3,12,C,クロベタゾールプロピオン酸エステル,"",局所,20181003,"","","","",斑状丘疹状皮疹(斑状丘疹状皮疹),剂量不变,"",""
AB-18509512,3,13,C,デカリニウム塩化物,"",経口,20181012,"",0.25,mg,1,上気道感染(上気道感染症),剂量不变,"",""
AB-18509512,3,14,C,トラネキサム酸,"",経口,20181017,"",250,mg,1,上気道感染(上気道感染症),剂量不变,"",""
AB-18509512,3,15,C,酪酸菌製剤,"",経口,20181017,"",1,g,1,下痢(下痢),剂量不变,"",""
AB-18509784,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180926,20181010,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,遊走性血栓静脈炎(再投与なし);脳梗塞(再投与なし);脳梗塞(再投与なし),""
AB-18509796,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171023,20180507,240,mg,1,胃癌(がん化学療法後に増悪した治療切除不能な進行・再発の胃癌),不适用,１型糖尿病(再投与なし);急性胆管炎(再投与なし);肝機能異常(再投与なし),""
AB-18509796,7,2,C,大建中湯,"",経口,"","","","","","",未知,"",""
AB-18510003,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,3;,mg/kg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(不明),""
AB-18510181,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201801;2018,2018;2018,3;3,mg/kg;mg/kg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,胃穿孔(再投与なし),""
AB-18510181,5,2,C,フルオロウラシル,"",不明,201812,201812,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-18510181,5,3,C,レボホリナートカルシウム,"",不明,201812,201812,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-18510285,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180105,20180206,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,リウマチ性多発筋痛(再投与なし),""
AB-18510307,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20160929,20160929,170,mg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18510307,3,2,C,トロンボモデュリンアルファ,"",静脈内点滴,20160928,20161004,21660,[iU],1,播種性血管内凝固(DIC),剂量停止,"",""
AB-18510307,3,3,C,センナ・センナ実,"",経口,"","",.5,g,1,便秘(便秘症),未知,"",""
AB-18510307,3,4,C,エチゾラム,"",経口,"","",.5,mg,1,不安障害(不安神経症),未知,"",""
AB-18510307,3,5,C,モルヒネ塩酸塩水和物,"",経口,"","",5,mg,1,癌疼痛(癌性疼痛),未知,"",""
AB-18510307,3,6,C,クエン酸第一鉄ナトリウム,"",経口,"","",50,mg,1,鉄欠乏性貧血(鉄欠乏性貧血),未知,"",""
AB-18510307,3,7,C,フロセミド,"",経口,"","",20,mg,1,心疾患による浮腫(心性浮腫),未知,"",""
AB-18510307,3,8,C,ブロチゾラム,"",経口,"","",.25,mg,1,不眠症(不眠症),未知,"",""
AB-18510307,3,9,C,ロキソプロフェンナトリウム水和物,"",経口,"","",60,mg,1,癌疼痛(癌性疼痛),未知,"",""
AB-18510307,3,10,C,酸化マグネシウム,"",経口,"","",660,mg,1,便秘(便秘症),未知,"",""
AB-18510307,3,11,C,モルヒネ硫酸塩水和物,"",経口,"","",10,mg,1,癌疼痛(癌性疼痛),未知,"",""
AB-18510307,3,12,C,オロパタジン塩酸塩,"",経口,"","",5,mg,1,そう痒症(皮膚掻痒症),未知,"",""
AB-18510307,3,13,C,ゾルピデム酒石酸塩,"",経口,"","",5,mg,1,不眠症(不眠症),未知,"",""
AB-18510307,3,14,C,ランソプラゾール,"",経口,"","",15,mg,1,胃食道逆流性疾患(逆流性食道炎),未知,"",""
AB-18510649,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180330;20180928,20180914;,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腎機能障害(再投与なし),""
AB-18510649,4,2,PS,ラムシルマブ,サイラムザ,不明,20171006,20180316,442.4,mg,1,"",不适用,"",""
AB-18510689,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180402,20180615,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,頭蓋内出血(無),""
AB-18510736,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180418,20180502,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-18510820,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180905,20180905,140,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,食欲減退(再投与なし),""
AB-18510878,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201710,"","","","",胃癌(がん化学療法語に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-18510886,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171127,20180727,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,乾癬(再投与なし),""
AB-18510896,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180223,20180521,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,倦怠感(再投与なし),""
AB-18510904,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171004,20181010,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,シェーグレン症候群(再投与なし),""
AB-18511219,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180601;,;20180913,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,貧血(再投与なし),""
AB-18511245,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-18511246,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20180205;20180723;20181112,20180521;20181029;20181210,220;160;190,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,好中球数減少(不明);副腎皮質刺激ホルモン欠損症(不明);甲状腺機能亢進症(不明),""
AB-18511246,3,2,PS,シタグリプチンリン酸塩水和物,グラクティブ,経口,20180605,20180612,"","","",高血糖(高血糖),不适用,好中球数減少(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし);甲状腺機能亢進症(再投与なし),""
AB-18511246,3,3,C,フロセミド,"",経口,20180607,20180618,20,mg,1,心不全(心不全),剂量停止,"",""
AB-18511246,3,4,C,ゾルピデム酒石酸塩,"",経口,"","",5,mg,1,不眠症(不眠),未知,"",""
AB-18511246,3,5,C,メコバラミン,"",経口,"","",500,ug,1,末梢性ニューロパチー(末梢神経障害),未知,"",""
AB-18511246,3,6,C,ルビプロストン,"",経口,"","",24,ug,1,便秘(便秘),未知,"",""
AB-18511246,3,7,C,ラニチジン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-18511246,3,8,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-18511246,3,9,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,胃食道逆流性疾患(逆流性食道炎),未知,"",""
AB-18511246,3,10,C,酸化マグネシウム,"",経口,"","",250,mg,1,便秘(便秘),未知,"",""
AB-18511363,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201810,"","","","",胃癌(胃癌),未知,多発性筋炎(再投与なし),""
AB-18511372,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201710,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肺臓炎(再投与なし),""
AB-18511448,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180222,20180419,"","","",胃癌(がん化学療法後に増悪した治療切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-18511798,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201802,201806,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-18511800,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20180731;20180911;20181002,20180828;20180925;20181023,120;140;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下垂体機能低下症(再投与なし),""
AB-18511810,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180608,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-18511864,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180412;20180906,20180412;,3;3,mg/kg;mg/kg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血中クレアチンホスホキナーゼ増加(不明),""
AB-18511864,3,2,C,ラムシルマブ,"",静脈内点滴,20180510,20180823,360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-18511893,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181112,20181112,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-18511893,3,2,C,プレドニゾロン,"",経口,20171007,20181113,5,mg,1,間質性肺疾患(間質性肺炎),未知,"",""
AB-18511893,3,3,C,ボノプラザンフマル酸塩,"",経口,20171008,20181113,20,mg,1,胃炎予防(胃炎の予防),未知,"",""
AB-18511893,3,4,C,ロスバスタチンカルシウム,"",経口,20171008,20181113,2.5,mg,1,高脂血症(高脂血症),未知,"",""
AB-18511893,3,5,C,スルファメトキサゾール・トリメトプリム,"",経口,20171110,20181113,"","","",間質性肺疾患(間質性肺炎),未知,"",""
AB-18511893,3,6,C,アミノ酸・糖・電解質・ビタミン（２−３）,"",静脈内点滴,20181016,20181113,1000,mL,1,過小食(経口摂取困難のため);栄養補給(栄養維持のため),未知,"",""
AB-18511893,3,7,C,塩化ナトリウム,"",静脈内点滴,20181016,20181113,4,g,1,過小食(経口摂取困難のため);栄養補給(栄養維持のため),未知,"",""
AB-18511893,3,8,C,グリチルリチン酸一アンモニウム・グリシン・Ｌ−システイン配合剤,"",静脈内点滴,20181016,20181113,20,mL,1,過小食(経口摂取困難のため);栄養補給(栄養維持のため),未知,"",""
AB-18511893,3,9,C,肝臓エキス・フラビンアデニンジヌクレオチドナトリウム,"",静脈内点滴,20181016,20181113,1,mL,1,過小食(経口摂取困難のため);栄養補給(栄養維持のため),未知,"",""
AB-18511893,3,10,C,アセトアミノフェン,"",経口,20181029,20181113,400,mg,1,癌疼痛(癌性疼痛),未知,"",""
AB-18511893,3,11,C,デキサメタゾン,"",静脈内点滴,20181112,20181112,6.6,mg,1,前投薬(抗癌剤投与前の前投薬),未知,"",""
AB-18511893,3,12,C,塩酸メトクロプラミド,"",静脈内点滴,20181112,20181112,10,mg,1,前投薬(抗癌剤投与前の前投薬),未知,"",""
AB-18511897,2,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口;経口,20181001;20181105,;20181110,50;50,mg;mg,1;1,胃癌(胃癌),剂量停止,"",""
AB-18511897,2,2,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20181001,20181105,200,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18511897,2,3,PS,シスプラチン,"",静脈内点滴,20181001,20181105,75,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18511897,2,4,C,アスピリン,"",経口,"","",100,mg,1,大動脈解離(大動脈解離),剂量不变,"",""
AB-18511897,2,5,C,エスゾピクロン,"",経口,"","",2,mg,1,不眠症(不眠症),剂量不变,"",""
AB-18511897,2,6,C,ランソプラゾール,"",経口,"","",15,mg,1,胃潰瘍(胃潰瘍),剂量不变,"",""
AB-18511897,2,7,C,経腸成分栄養剤（９−２）,"",経口,"","","","","",食欲減退(食欲不振),剂量不变,"",""
AB-18511897,2,8,C,無機質製剤（一般薬）,"",経口,20181004,"",2,g,1,低ナトリウム血症(低ナトリウム血症),剂量不变,"",""
AB-18511897,2,9,C,塩化ナトリウム,"",静脈内点滴,20181004,"",2,g,1,低ナトリウム血症(低ナトリウム血症),剂量不变,"",""
AB-18511897,2,10,C,アズレンスルホン酸ナトリウム水和物,"",口腔咽頭,20181017,"",2,g,1,口内炎(口腔粘膜炎),剂量不变,"",""
AB-18512082,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180801,201810,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,抗リン脂質抗体症候群(再投与なし),""
AB-18512082,3,2,C,エドキサバントシル酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-18512161,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,2017,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-18512423,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180219;20180507,20180305;20180507,3;3,mg/kg;mg/kg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(無),""
AB-18512441,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180320,20180507,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし),""
AB-18512586,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180207,20181117,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし);多形紅斑(再投与なし),""
AB-18512586,2,2,PS,スルタミシリントシル酸塩水和物,ユナシン,不明,201811,201811,"","","","",剂量停止,"",""
AB-18512711,1,1,PS,ニボルマブ,オプジーボ,"",20170925,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18512888,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20171201;20180306,20180119;20180403,3;,mg/kg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺炎(再投与なし),""
AB-18512892,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201709,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,筋炎(再投与なし),""
AB-18512896,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180417,20181029,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18512963,4,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口,20180830;20181011,;20181115,50;40,mg;mg,1;1,胃癌(胃癌),剂量停止,"",""
AB-18512963,4,2,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20180830,20181101,200,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18512963,4,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20180830;20181011,;20181101,130;100,mg/m2;mg/m2,1;1,胃癌(胃癌),剂量停止,"",""
AB-18512963,4,4,C,エソメプラゾールマグネシウム水和物,"",経口,"",20181123,20,mg,1,"",剂量停止,"",""
AB-18512963,4,5,C,センノシド,"",経口,20180927,20181123,12,mg,1,便秘(便秘),剂量停止,"",""
AB-18512963,4,6,C,酸化マグネシウム,"",経口,20180906,20181123,330,mg,1,便秘(便秘),剂量停止,"",""
AB-18512963,4,7,C,六君子湯,"",経口,20181004,20181123,2.5,g,1,食欲減退(食欲不振),剂量停止,"",""
AB-18512963,4,8,C,オロパタジン塩酸塩,"",経口,20180911,20181123,10,mg,1,斑状丘疹状皮疹(斑状丘疹状皮疹),剂量停止,"",""
AB-18512963,4,9,C,プレドニゾロン,"",経口;経口;経口;経口,20180913;20180927;20181004;20181122,20180926;20181003;20181121;20181123,7.5;5;5;2.5,mg;mg;mg;mg,1;1;1;1,斑状丘疹状皮疹(斑状丘疹状皮疹),剂量停止,"",""
AB-18512963,4,10,C,ナプロキセン,"",経口,"",20181123,"","","",癌疼痛(癌疼痛),剂量停止,"",""
AB-18512963,4,11,C,トラマドール塩酸塩,"",経口,20180906,20181123,"","","",癌疼痛(癌疼痛),剂量停止,"",""
AB-18512963,4,12,C,アジルサルタン,"",経口,20180907,20181123,20,mg,1,高血圧(高血圧),剂量停止,"",""
AB-18512963,4,13,C,ロスバスタチンカルシウム,"",経口,"",20181123,5,mg,1,高脂血症(高脂血症),剂量停止,"",""
AB-18512963,4,14,C,クロピドグレル硫酸塩,"",経口,"",20181123,75,mg,1,脳梗塞(脳梗塞),剂量停止,"",""
AB-18513044,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180508,20180828,150,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,硬化性胆管炎(有),""
AB-18513044,3,2,C,ボノプラザンフマル酸塩,"",経口,"","",20,mg,1,腹部不快感(消化器症状緩和),未知,"",""
AB-18513044,3,3,C,モサプリドクエン酸塩水和物,"",経口,"","",5,mg,1,腹部不快感(消化器症状緩和),未知,"",""
AB-18513044,3,4,C,クエン酸第一鉄ナトリウム,"",経口,"","",50,mg,1,貧血(貧血),未知,"",""
AB-18513044,3,5,C,ウルソデオキシコール酸,"",経口,"","",100,mg,1,肝障害(肝障害),未知,"",""
AB-18513044,3,6,C,酸化マグネシウム,"",経口,"","",330,mg,1,便秘(便秘),未知,"",""
AB-18513049,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180809,20180920,150,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし);敗血症性ショック(再投与なし);小腸炎(再投与なし);食道カンジダ症(再投与なし);播種性血管内凝固(再投与なし),""
AB-18513055,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180214,20180314,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,脳梗塞(再投与なし);肝障害(再投与なし),""
AB-18513056,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-18513060,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180911,20180925,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18513061,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180323,20180817,130,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,類天疱瘡(再投与なし),""
AB-18513061,2,2,C,ベタヒスチンメシル酸塩,"",経口,"","",12,mg,1,"",未知,"",""
AB-18513061,2,3,C,酪酸菌製剤,"",経口,"","",1,g,1,"",未知,"",""
AB-18513061,2,4,C,メコバラミン,"",経口,"","",500,ug,1,"",未知,"",""
AB-18513061,2,5,C,ランソプラゾール,"",経口,"","",30,mg,1,"",未知,"",""
AB-18513061,2,6,C,モサプリドクエン酸塩水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-18513061,2,7,C,ロキソプロフェンナトリウム水和物,"",経口,"","",60,mg,1,"",未知,"",""
AB-18513061,2,8,C,レバミピド,"",経口,"","",100,mg,1,"",未知,"",""
AB-18513061,2,9,C,アセトアミノフェン,"",経口,"","",500,mg,1,"",未知,"",""
AB-18513061,2,10,C,経腸成分栄養剤（１−１）,"",経口,"","",80,g,1,"",未知,"",""
AB-18513188,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180226,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,貧血(再投与なし),""
AB-18513188,2,2,PS,アセトアミノフェン,アセリオ,不明;不明;不明;不明;不明;不明,20180412;20180413;20180502;20180503;20180512;20180813,20180412;20180419;20180502;20180508;20180730;20180817,2000;4000;2000;1000;4000;2000,mg;mg;mg;mg;mg;mg,1;1;1;1;1;1,"",剂量停止,"",""
AB-18513188,2,3,PS,ラムシルマブ,"",不明,"","","","","","",不适用,"",""
AB-18513188,2,4,PS,パクリタキセル,"",不明,"","","","","","",不适用,"",""
AB-18513436,3,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴,20180914,20181022,177.4,mg,1,遠隔転移を伴う胃癌(胃癌（肝、リンパ節転移）),剂量停止,"",""
AB-18513436,3,2,PS,ラムシルマブ,サイラムザ,静脈内点滴,20180914,20181015,580,mg,1,遠隔転移を伴う胃癌(胃癌（肝、リンパ節転移）),剂量停止,"",""
AB-18513436,3,3,PS,オキサリプラチン,エルプラット,静脈内点滴,20180416,20180808,228,mg,1,遠隔転移を伴う胃癌(胃癌（肝、リンパ節転移）),剂量停止,"",""
AB-18513436,3,4,PS,ニボルマブ,オプジーボ,静脈内点滴,20180416,20180808,366,mg,1,遠隔転移を伴う胃癌(胃癌（肝、リンパ節転移）),剂量停止,"",""
AB-18513436,3,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20180416,20180822,60,mg,1,遠隔転移を伴う胃癌(胃癌（肝、リンパ節転移）),剂量停止,"",""
AB-18513511,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171011,20180110,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-18513836,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181105,20181119,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性脳炎(再投与なし);自己免疫性肝炎(再投与なし);自己免疫性脳炎(再投与なし),""
AB-18513836,5,2,C,酪酸菌配合剤,"",経口,20150511,"",2,{DF},1,"",未知,"",""
AB-18513836,5,3,C,アセトアミノフェン,"",経口,20171113,"",600,mg,1,"",未知,"",""
AB-18513836,5,4,C,バルサルタン,"",経口,20180205,20181124,80,mg,1,"",未知,"",""
AB-18513836,5,5,C,フロセミド,"",経口,20181022,"",20,mg,1,"",未知,"",""
AB-18513836,5,6,C,レボフロキサシン水和物,"",不明,"","","","","",発熱(発熱),未知,"",""
AB-18513836,5,7,C,非ピリン系感冒剤（４）,"",不明,"","","","","",発熱(発熱),未知,"",""
AB-18514353,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180324,20181020,150,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,脳炎(再投与なし);低ナトリウム血症(再投与なし);死亡(再投与なし),""
AB-18514545,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180509,201809,3,mg/kg,1,胃癌(がん化学療法後に増悪した切除不能な進行・再発の胃癌),剂量停止,類天疱瘡(再投与なし),""
AB-18514547,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180323,20180406,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし);食欲減退(再投与なし),""
AB-18514738,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,発熱(再投与なし);インフルエンザ様疾患(再投与なし),""
AB-18514745,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180712,20180809,135,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18514919,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180822,20181031,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18515319,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171205,"",170,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍破裂(再投与なし),""
AB-18515321,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(胃癌),未知,国際標準比増加(再投与なし);出血(再投与なし),""
AB-18515321,1,2,PS,ワルファリンカリウム,ワーファリン,経口;経口,;20181023,20181022;,1;1,mg;mg,1;1,"",剂量停止,"",""
AB-18515323,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181002,20181113,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18515323,3,2,C,エソメプラゾールマグネシウム水和物,"",経口,20180109,"",20,mg,1,胃潰瘍(胃潰瘍),未知,"",""
AB-18515323,3,3,C,乾燥硫酸鉄（３）,"",経口,20180109,"",105,mg,1,鉄欠乏性貧血(鉄欠貧血),未知,"",""
AB-18515323,3,4,C,アゾセミド,"",経口,20180725,"",60,mg,1,末梢性浮腫(下腿浮腫),未知,"",""
AB-18515323,3,5,C,スピロノラクトン,"",経口,20180725,"",25,mg,1,末梢性浮腫(下腿浮腫),未知,"",""
AB-18515324,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-18515326,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし);腫瘍出血(再投与なし);急性胆嚢炎(再投与なし),""
AB-18515557,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180405,20180405,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,倦怠感(再投与なし),""
AB-18515562,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181129,20181129,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,塞栓症(再投与なし),""
AB-18515562,2,2,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-18515562,2,3,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-18515562,2,4,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-18515562,2,5,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
AB-18515562,2,6,C,アスピリン,"",不明,"","","","","","",未知,"",""
AB-18515562,2,7,C,ロスバスタチンカルシウム,"",不明,"","","","","","",未知,"",""
AB-18515575,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201810,"",3,mg/kg,1,"胃癌(unresectable, advanced or recurrent gastric cancer aggravated after anticancer chemotherapy)",剂量停止,肝障害(再投与なし),""
AB-18515719,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180511,20180622,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,麻痺性イレウス(無),""
AB-18515720,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180731;20180913,20180814;20180913,150;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-18515720,3,2,C,ヒドロモルフォン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-18515720,3,3,C,ヒドロモルフォン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-18515720,3,4,C,ジクロフェナクナトリウム,"",経口,"","","","","","",未知,"",""
AB-18515720,3,5,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","","",未知,"",""
AB-18515720,3,6,C,ロスバスタチンカルシウム,"",経口,"","","","","","",未知,"",""
AB-18515720,3,7,C,クロピドグレル硫酸塩,"",経口,"","","","","","",未知,"",""
AB-18515720,3,8,C,ロラゼパム,"",経口,"","","","","","",未知,"",""
AB-18515720,3,9,C,メトクロプラミド,"",経口,"","","","","","",未知,"",""
AB-18515720,3,10,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
AB-18515720,3,11,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-18515720,3,12,C,カンレノ酸カリウム,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-18515732,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201804;,;20181129,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-18515732,5,2,C,レボチロキシンナトリウム水和物,"",不明,"","",75,ug,1,自己免疫性甲状腺炎(橋本病),未知,"",""
AB-18515955,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171205,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(不明),""
AB-18516178,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180613,20180718,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪心(再投与なし);胸水(再投与なし);食欲減退(再投与なし),""
AB-18516183,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180112,20180126,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝障害(再投与なし),""
AB-18516186,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181129;20190104,20181129;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝不全(不明),""
AB-18516186,3,2,C,フロセミド,"",経口,20180719,"",10,mg,1,末梢性浮腫(四肢浮腫),未知,"",""
AB-18516186,3,3,C,スピロノラクトン,"",経口,20180719,"",12.5,mg,1,末梢性浮腫(四肢浮腫),未知,"",""
AB-18516186,3,4,C,酪酸菌製剤,"",経口,"","",1,{DF},1,下痢(下痢症),未知,"",""
AB-18516329,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180907,20181005,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,ニューモシスチス・イロベチイ肺炎(再投与なし);スティーヴンス・ジョンソン症候群(再投与なし),""
AB-18516487,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180911;20190123,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,低ナトリウム血症(無);続発性副腎皮質機能不全(無);下垂体機能低下症(無),""
AB-18516487,5,2,C,プレガバリン,"",経口,20180411,"",225,mg,1,末梢性ニューロパチー(末梢神経障害),未知,"",""
AB-18516487,5,3,C,アロプリノール,"",経口,20181205,"",100,mg,1,高尿酸血症(高尿酸血症),未知,"",""
AB-18516487,5,4,C,レボドパ・カルビドパ水和物,"",経口,"","",300,mg,1,パーキンソン病(パーキンソン病),未知,"",""
AB-18516487,5,5,C,ロチゴチン,"",経皮,"","",9,mg,1,パーキンソン病(パーキンソン病),未知,"",""
AB-18516487,5,6,C,カルベジロール,"",経口,"","",10,mg,1,高血圧(高血圧),未知,"",""
AB-18516487,5,7,C,ラベプラゾールナトリウム,"",経口,"","",10,mg,1,胃食道逆流性疾患(逆流性食道炎),未知,"",""
AB-18516487,5,8,C,テプレノン,"",経口,"","",150,mg,1,慢性胃炎(慢性胃炎),未知,"",""
AB-18516487,5,9,C,トラゾドン塩酸塩,"",経口,"","",50,mg,1,不眠症(不眠症),未知,"",""
AB-18516487,5,10,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,高血圧(高血圧),未知,"",""
AB-18516487,5,11,C,イソロイシン・ロイシン・バリン,"",経口,"","",15,g,1,低アルブミン血症(低アルブミン),未知,"",""
AB-18516629,11,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180207;201809,;20181203,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-18516722,1,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20181205,20181209,60,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18516722,1,2,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20181205,20181205,200,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18516722,1,3,PS,シスプラチン,"",静脈内点滴,20181205,20181205,92,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18516722,1,4,C,モサプリドクエン酸塩水和物,"",経口,"","",5,mg,1,"",剂量不变,"",""
AB-18516722,1,5,C,カモスタットメシル酸塩,"",経口,"","",100,mg,1,"",剂量不变,"",""
AB-18516722,1,6,C,膵臓性消化酵素配合剤（１）,"",経口,"","",1,g,1,"",剂量不变,"",""
AB-18516722,1,7,C,アムロジピンベシル酸塩,"",経口,"","",2.5,mg,1,"",剂量不变,"",""
AB-18516722,1,8,C,トラボプロスト・チモロールマレイン酸塩,"",眼,"","","","","","",剂量不变,"",""
AB-18516722,1,9,C,レボフロキサシン水和物,"",眼,"","","","","","",剂量不变,"",""
AB-18516722,1,10,C,フルオロメトロン,"",眼,"","","","","","",剂量不变,"",""
AB-18516777,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171218,20180305,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,脳梗塞(再投与なし);食欲減退(再投与なし),""
AB-18516778,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181114,20181128,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,中毒性表皮壊死融解症(再投与なし),""
AB-18516778,4,2,PS,アンピシリンナトリウム,ビクシリン,静脈内点滴,20181207,20181209,1,g,1,尿路感染(尿路感染症),剂量停止,"",""
AB-18516778,4,3,C,ナプロキセン,"",経口,20180825,20190118,200,mg,1,発熱(発熱),未知,"",""
AB-18516778,4,4,C,メトロニダゾール,"",経口,20181113,20190118,250,mg,1,クロストリジウム・ディフィシレ大腸炎(CD関連腸炎),未知,"",""
AB-18516778,4,5,C,ビソプロロール,"",経皮,20181127,20190118,2,mg,1,上室性頻脈(発作性上室性頻拍),未知,"",""
AB-18516778,4,6,C,ボノプラザンフマル酸塩,"",経口,20181127,20190118,10,mg,1,出血性胃潰瘍(出血性胃潰瘍),未知,"",""
AB-18516778,4,7,C,アセトアミノフェン,"",静脈内点滴,"",20181222,500,mg,1,発熱(発熱),未知,"",""
AB-18516778,4,8,C,フロセミド,"",静脈内（明記されていない場合）,"",20190119,10,mg,1,"",未知,"",""
AB-18516778,4,9,C,アルプラゾラム,"",経口,"",20190118,.4,mg,1,不安(不安),未知,"",""
AB-18516778,4,10,C,レバミピド,"",経口,"",20190118,100,mg,1,胃腸障害予防(胃粘膜保護),未知,"",""
AB-18516780,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171211,20180124,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発疹(再投与なし),""
AB-18516999,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-18517000,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181029,20181210,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18517002,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180705,20180719,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-18517002,2,2,C,プレガバリン,"",経口,"","",150,mg,1,"",未知,"",""
AB-18517002,2,3,C,アセトアミノフェン,"",経口,"","",500,mg,1,"",未知,"",""
AB-18517002,2,4,C,レボフロキサシン水和物,"",経口,"","",500,mg,1,"",未知,"",""
AB-18517002,2,5,C,酪酸菌製剤,"",経口,"","",20,mg,1,"",未知,"",""
AB-18517002,2,6,C,スルファメトキサゾール・トリメトプリム,"",経口,"","",1,{DF},1,"",未知,"",""
AB-18517002,2,7,C,カモスタットメシル酸塩,"",経口,"","",100,mg,1,"",未知,"",""
AB-18517081,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180831;20181228,;,;240,;mg,;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(不明),""
AB-18517136,2,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20180725,"",60,mg,1,胃癌(胃癌),剂量不变,"",""
AB-18517136,2,2,PS,オキサリプラチン,"",静脈内点滴,20180725,"",100,mg/m2,1,胃癌(胃癌),剂量不变,"",""
AB-18517136,2,3,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20180725,"",200,mg,1,胃癌(胃癌),剂量不变,"",""
AB-18517136,2,4,C,経腸成分栄養剤（２−１）,"",経口,20180702,20181220,1,{DF},1,栄養補給(栄養補給),剂量停止,"",""
AB-18517136,2,5,C,酸化マグネシウム,"",経口,20180907,20181220,330,mg,1,便秘(便秘),剂量停止,"",""
AB-18517136,2,6,C,センノシド,"",経口,20180907,20181220,12,mg,1,便秘(便秘),剂量停止,"",""
AB-18517136,2,7,C,クエン酸第一鉄ナトリウム,"",経口,20180906,20181220,50,mg,1,貧血(貧血),剂量停止,"",""
AB-18517204,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181227,"",240,mg,1,胃癌(進行胃癌),未知,胃出血(再投与なし),""
AB-18517204,2,2,C,エドキサバントシル酸塩水和物,"",不明,20180512,"",30,mg,1,肺塞栓症(肺塞栓症),未知,"",""
AB-18518110,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181002,20190312,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし),""
AB-18518110,6,2,C,オキシコドン塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-18518110,6,3,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-18518110,6,4,C,ポラプレジンク,"",不明,"","","","","","",未知,"",""
AB-18518110,6,5,C,センノシド,"",不明,"","","","","","",未知,"",""
AB-18518110,6,6,C,ナプロキセン,"",不明,"","","","","","",未知,"",""
AB-18518110,6,7,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-18518110,6,8,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
AB-18518110,6,9,C,オロパタジン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-18518110,6,10,C,フマル酸第一鉄,"",不明,"","","","","","",未知,"",""
AB-18518306,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20181030;201901;20190514,201812;20190226;,240;240;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,汎血球減少症(不明);副腎機能不全(不明),""
AB-18518309,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180607;20181010,20180926;20181219,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,悪性新生物進行(再投与なし),""
AB-18518491,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201801,20180919,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18518491,5,2,C,ピリドキサールリン酸エステル水和物,"",経口,201605,"",60,mg,1,予防(副作用対策),未知,"",""
AB-18518491,5,3,C,アムロジピンベシル酸塩,"",経口,201708,"",5,mg,1,高血圧(高血圧),未知,"",""
AB-18518491,5,4,C,メコバラミン,"",経口,201711,"",1500,ug,1,予防(副作用対策),未知,"",""
AB-18518491,5,5,C,エトドラク,"",経口,201712,"",400,mg,1,疼痛(疼痛),未知,"",""
AB-18518491,5,6,C,乾燥硫酸鉄（３）,"",経口,201803,"",210,mg,1,貧血(貧血),未知,"",""
AB-18518491,5,7,C,ビフィズス菌製剤（４）,"",経口,201805,"",3,g,1,細菌叢異常(整腸),未知,"",""
AB-18518491,5,8,C,ファモチジン,"",経口,201809,"",20,mg,1,胃潰瘍(胃潰瘍),未知,"",""
AB-18518533,2,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,20180816,"",500,mg,1,非小細胞肺癌(CRT後の非小細胞肺癌),剂量停止,"",""
AB-18518666,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181211,20190205,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,劇症１型糖尿病(再投与なし),""
AB-18518666,3,2,C,ボノプラザンフマル酸塩,"",経口,20160713,"",20,mg,1,胃癌(胃癌),未知,"",""
AB-18518666,3,3,C,クエン酸第一鉄ナトリウム,"",経口,20160713,"",100,mg,1,胃癌(胃癌),未知,"",""
AB-18518666,3,4,C,アルギン酸ナトリウム,"",経口,20160713,"",40,mL,1,胃癌(胃癌),未知,"",""
AB-18518666,3,5,C,フェキソフェナジン塩酸塩,"",経口,20170207,"",60,mg,1,胃癌(胃癌),未知,"",""
AB-18518666,3,6,C,プレガバリン,"",経口,20170411,"",75,mg,1,神経痛(神経障害性疼痛),未知,"",""
AB-18518666,3,7,C,アムロジピンベシル酸塩,"",経口,"","",10,mg,1,高血圧(高血圧),未知,"",""
AB-18518666,3,8,C,バルサルタン,"",経口,"","",160,mg,1,高血圧(高血圧),未知,"",""
AB-18518666,3,9,C,シロドシン,"",経口,"","",4,mg,1,良性前立腺肥大症(前立腺肥大),未知,"",""
AB-18518670,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20180206;20180306;20180807,20180206;20180612;20181002,3;3;3,mg/kg;mg/kg;mg/kg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,憩室穿孔(再投与なし);骨膿瘍(再投与なし),""
AB-18518873,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201804,201812,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18518873,2,2,PS,ミカファンギンナトリウム,"",不明,201901,201901,"","","",誤嚥性肺炎(誤嚥性肺炎),不适用,"",""
AB-18519204,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181213,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし);死亡(再投与なし),""
AB-18519204,3,2,C,アレンドロン酸ナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-18519204,3,3,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
AB-18519204,3,4,C,アコチアミド塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-18519204,3,5,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-18519204,3,6,C,ウルソデオキシコール酸,"",不明,"","","","","","",未知,"",""
AB-18519280,2,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20181120,"",60,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18519280,2,2,PS,ジアゼパム,ジアパックス,経口,20181121,"",2,mg,1,認知障害(認知低下),剂量不变,"",""
AB-18519280,2,3,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20181120,"",200,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18519280,2,4,PS,シスプラチン,"",静脈内点滴,20181120,"",108,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18519280,2,5,C,カンデサルタンシレキセチル・アムロジピンベシル酸塩配合剤,"",経口,"","",1,{DF},1,高血圧(高血圧),剂量不变,"",""
AB-18519280,2,6,C,リスペリドン,"",経口,20181121,"",1,mg,1,認知障害(認知低下),剂量不变,"",""
AB-18519280,2,7,C,トリアゾラム,"",経口,"","",0.25,mg,1,不眠症(不眠症),剂量不变,"",""
AB-18519280,2,8,C,ジフェンヒドラミン,"",局所,20181121,"","","","",そう痒症(皮膚の痒み),剂量不变,"",""
AB-18519280,2,9,C,ファモチジン,"",経口,20190121,"",20,mg,1,胃炎予防(胃炎の予防),剂量不变,"",""
AB-18519280,2,10,C,スルファメトキサゾール・トリメトプリム,"",経口,20190122,"",1,{DF},1,感染予防(肺感染の予防),剂量不变,"",""
AB-18519280,2,11,C,アレンドロン酸ナトリウム水和物,"",経口,20190122,"",35,mg,1,骨粗鬆症予防(骨粗鬆症の予防),剂量不变,"",""
AB-18519280,2,12,C,カンデサルタンシレキセチル,"",経口,20190127,20190130,8,mg,1,高血圧(高血圧),剂量停止,"",""
AB-18519280,2,13,C,アムロジピンベシル酸塩,"",経口,20190127,20190130,5,mg,1,高血圧(高血圧),剂量停止,"",""
AB-18519280,2,14,C,デキストロメトルファン臭化水素酸塩水和物,"",経口,20190128,"",15,mg,1,咳嗽(咳),剂量不变,"",""
AB-18519280,2,15,C,アンブロキソール塩酸塩,"",経口,20190128,"",45,mg,1,咳嗽(咳),剂量不变,"",""
AB-18519283,2,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20181120,"",40,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18519283,2,2,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20181120,"",200,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18519283,2,3,PS,シスプラチン,"",静脈内点滴,20181120,"",50,mg/m2,1,胃癌(胃癌),剂量停止,"",""
AB-18519283,2,4,C,ランソプラゾール,"",経口,20181030,"",15,mg,1,胃腸潰瘍予防(胃潰瘍予防),剂量不变,"",""
AB-18519283,2,5,C,ロキソプロフェンナトリウム水和物,"",経口,20181120,"",60,mg,1,片頭痛(片頭痛),剂量不变,"",""
AB-18519283,2,6,C,メトクロプラミド,"",経口,20181123,"",5,mg,1,悪心(悪心),剂量不变,"",""
AB-18519283,2,7,C,オロパタジン塩酸塩,"",経口,20181213,"",5,mg,1,そう痒症(そう痒症),剂量不变,"",""
AB-18519283,2,8,C,ジフルプレドナート,"",局所,20181213,"","","","",そう痒症(そう痒症),剂量不变,"",""
AB-18519283,2,9,C,ロペラミド塩酸塩,"",経口,20181222,"",1,mg,1,下痢(下痢),剂量不变,"",""
AB-18519283,2,10,C,酪酸菌製剤,"",経口,20181010,"","","","",下痢(下痢),剂量不变,"",""
AB-18519283,2,11,C,ゾピクロン,"",経口,20181124,"",7.5,mg,1,不眠症(不眠症),剂量不变,"",""
AB-18519283,2,12,C,ゾルピデム酒石酸塩,"",経口,201806,"",5,mg,1,片頭痛(片頭痛),剂量不变,"",""
AB-18519283,2,13,C,ロメリジン塩酸塩,"",経口,201806,"",10,mg,1,片頭痛(片頭痛),剂量不变,"",""
AB-18519283,2,14,C,クロナゼパム,"",経口,201806,"",0.25,mg,1,片頭痛(片頭痛),剂量不变,"",""
AB-18519581,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20170330,20170426,200,mg,1,非小細胞肺癌(PD-L1陽性の切除不能な進行・再発の非小細胞肺癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18520104,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181023,20181121,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-18520113,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201811,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肝機能異常(再投与なし),""
AB-18520114,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180402,20180809,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし),""
AB-18520257,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181211;20190409,20190108;20190423,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(有),""
AB-18520257,4,2,C,ラベプラゾールナトリウム,"",不明,"","","","","","",未知,"",""
AB-18520257,4,3,C,レバミピド,"",不明,"","","","","","",未知,"",""
AB-18520257,4,4,C,オルメサルタンメドキソミル,"",不明,"","","","","","",未知,"",""
AB-18520265,8,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180926,20190805,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,意識変容状態(再投与なし);血中クレアチンホスホキナーゼ増加(再投与なし);自己免疫性脳炎(再投与なし),""
AB-18520265,8,2,C,フェンタニルクエン酸塩,"",経皮;経皮;経皮;経皮;経皮;経皮;経皮;経皮,2018;;;;;;;,;;;;;;;20190701,;8;7;6;5;4;3;.5,;mg;mg;mg;mg;mg;mg;mg,;1;1;1;1;1;1;1,腹痛(腹痛),未知,"",""
AB-18520265,8,3,C,ミルタザピン,"",経口;経口,2018;,;,;45,;mg,;1,抑うつ症状(抑うつ),未知,"",""
AB-18520265,8,4,C,リナクロチド,"",経口,"","",.25,mg,1,"",未知,"",""
AB-18520265,8,5,C,デュロキセチン塩酸塩,"",経口;経口,;,;,60;30,mg;mg,1;1,"",未知,"",""
AB-18520265,8,6,C,酪酸菌配合剤,"",経口,"","",1,{DF},1,"",未知,"",""
AB-18520265,8,7,C,メロキシカム,"",経口,"","",.5,{DF},1,"",未知,"",""
AB-18520265,8,8,C,モサプリドクエン酸塩水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-18520265,8,9,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-18520265,8,10,C,ブロチゾラム,"",経口,"","",.5,mg,1,"",未知,"",""
AB-18520265,8,11,C,ラメルテオン,"",経口,"","",8,mg,1,"",未知,"",""
AB-18520265,8,12,C,クロナゼパム,"",経口,"","",.5,mg,1,"",未知,"",""
AB-18520265,8,13,C,ラクツロース,"",経口;経口,;,;,15;15,mL;mL,1;1,"",未知,"",""
AB-18520265,8,14,C,ペロスピロン塩酸塩水和物,"",経口,"","",.5,{DF},1,悪心(吐気),未知,"",""
AB-18520265,8,15,C,エスゾピクロン,"",経口,"","",1,mg,1,不眠症(不眠),未知,"",""
AB-18520265,8,16,C,ベタヒスチンメシル酸塩,"",経口,"","",12,mg,1,"",未知,"",""
AB-18520265,8,17,C,イフェンプロジル酒石酸塩,"",経口,"","",20,mg,1,"",未知,"",""
AB-18520265,8,18,C,フルニトラゼパム,"",経口,"","",2,mg,1,"",未知,"",""
AB-18520265,8,19,C,レボセチリジン塩酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-18520265,8,20,C,ヘパリン類似物質,"",局所,"","","","","","",未知,"",""
AB-18520267,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181018,20190124,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発熱(再投与なし);倦怠感(再投与なし),""
AB-18520267,1,2,C,トラマドール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-18520267,1,3,C,ナルデメジントシル酸塩,"",不明,"","","","","","",未知,"",""
AB-18520267,1,4,C,ピコスルファートナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-18520267,1,5,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-18520489,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180607;20181011,20180927;,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血中クレアチンホスホキナーゼ増加(無),""
AB-18520490,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180724;20181206,20181114;201903,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし);間質性肺疾患(再投与なし),""
AB-18520887,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180213,20180426,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-18520887,3,2,C,アセトアミノフェン,"",経口,"","",1500,mg,1,"",未知,"",""
AB-18520887,3,3,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-18520887,3,4,C,アスピリン,"",経口,"","",100,mg,1,"",未知,"",""
AB-18520887,3,5,C,クロピドグレル硫酸塩,"",経口,"","",75,mg,1,"",未知,"",""
AB-18521046,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171102,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);間質性肺疾患(再投与なし),""
AB-18521046,1,2,C,イリノテカン塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-18521051,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肺臓炎(再投与なし),""
AB-18521432,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201802,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,発熱(再投与なし);発疹(再投与なし);肝障害(再投与なし);血球貪食性リンパ組織球症(再投与なし),""
AB-18521561,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180628,20180906,160,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,高カリウム血症(再投与なし),""
AB-18522000,1,1,PS,レゴラフェニブ水和物,スチバーガ,経口;経口,20180531;20180713,20180704;20190206,120;80,mg;mg,1;1,悪性新生物進行(進行性転移性固形がん),剂量不变,"",""
AB-18522000,1,2,PS,ニボルマブ,"",静脈内（明記されていない場合）,20180531,20190131,172.2,mg,1,悪性新生物進行(進行性転移性固形がん),剂量不变,"",""
AB-18522000,1,3,C,尿素,"","",20180531,201902,"","","",手掌・足底発赤知覚不全症候群(HFS予防及びHFS),未知,"",""
AB-18522000,1,4,C,ジフルプレドナート,"","",20180608,201902,"","","",手掌・足底発赤知覚不全症候群(HFS),未知,"",""
AB-18522000,1,5,C,クロベタゾールプロピオン酸エステル,"","",20180608,201902,"","","",手掌・足底発赤知覚不全症候群(HFS),未知,"",""
AB-18522000,1,6,C,ウルソデオキシコール酸,"",経口,20180927,201902,"","","",肝胆道系障害予防(肝障害予防),未知,"",""
AB-18522000,1,7,C,グリチルリチン酸一アンモニウム,"",経口,20180927,201902,"","","",肝胆道系障害予防(肝障害予防),未知,"",""
AB-18522000,1,8,C,カンデサルタンシレキセチル,"",経口,20181108,201902,4,mg,1,高血圧(高血圧),未知,"",""
AB-18522000,1,9,C,ベタメタゾン・ｄ−クロルフェニラミンマレイン酸塩,"",経口,20181224,201902,"","","",口内炎(口腔粘膜炎及び口腔粘膜予防),未知,"",""
AB-18522000,1,10,C,ヒドロコルチゾン酪酸エステル,"","",20190104,201902,"","","",発疹(皮疹),未知,"",""
AB-18522000,1,11,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"","",20190104,201902,"","","",発疹(皮疹),未知,"",""
AB-18522000,1,12,C,エソメプラゾールマグネシウム水和物,"",経口,201612,201902,20,mg,1,胃炎予防(胃炎予防),未知,"",""
AB-18522000,1,13,C,エチゾラム,"",経口,201612,201902,.5,mg,1,不眠症(不眠症),未知,"",""
AB-18522000,1,14,C,六君子湯,"",経口,201612,201902,"","","",胃炎予防(胃炎予防),未知,"",""
AB-18522000,1,15,C,モサプリドクエン酸塩水和物,"",経口,201612,201902,"","","",胃炎予防(胃炎予防),未知,"",""
AB-18522000,1,16,C,ブロチゾラム,"",経口,201612,201902,.25,mg,1,不眠症(不眠症),未知,"",""
AB-18522089,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180316,20181026,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし);心不全(再投与なし);心房細動(再投与なし),""
AB-18522196,5,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,20190124,20190124,10,mg/kg,1,非小細胞肺癌(CRT後の非小細胞肺癌),不适用,"",""
AB-18522196,5,2,C,ゴセレリン酢酸塩,"",皮下,"","",3.6,mg,1,前立腺癌(前立腺癌),未知,"",""
AB-18522340,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190125,20190125,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,敗血症(再投与なし);細菌性腸炎(再投与なし),""
AB-18522340,3,2,C,経腸成分栄養剤（２−２）,"",不明,20190125,20190223,1,{DF},1,栄養補給(栄養補給),未知,"",""
AB-18522341,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180814,20180814,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,穿孔性虫垂炎(再投与なし),""
AB-18522343,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180426,20180510,255,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,横紋筋融解症(再投与なし);重症筋無力症(再投与なし),""
AB-18522343,2,2,C,メコバラミン,"",不明,"","","","","","",未知,"",""
AB-18522343,2,3,C,デュロキセチン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-18522343,2,4,C,バルサルタン・アムロジピンベシル酸塩配合剤,"",不明,"","","","","","",未知,"",""
AB-18522343,2,5,C,イミダプリル塩酸塩,"",不明,"","","","","","",未知,"",""
AB-18522343,2,6,C,サキサグリプチン水和物,"",不明,"","","","","","",未知,"",""
AB-18522343,2,7,C,シロドシン,"",不明,"","","","","","",未知,"",""
AB-18522477,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181002;201811,20181030;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,鎖骨下静脈血栓症(不明),""
AB-18522478,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20171214;20180705;20181108;20190404,20171228;20181025;20190124;20190516,180;200;240;240,mg;mg;mg;mg,1;1;1;1,悪性黒色腫(根治切除不能な悪性黒色腫),剂量停止,下垂体機能低下症(再投与なし);低ナトリウム血症(再投与なし),""
AB-18522481,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180717;20190411,20190205;20200317,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);房室ブロック(再投与なし),""
AB-18522481,7,2,C,アムロジピンベシル酸塩,"",経口,20180710,"",2.5,mg,1,"",未知,"",""
AB-18522481,7,3,C,水酸化アルミニウムゲル・水酸化マグネシウム,"",経口,20180710,"",10,mL,1,"",未知,"",""
AB-18522481,7,4,C,バルサルタン・アムロジピンベシル酸塩配合剤,"",経口,20180710,"",1,{DF},1,"",未知,"",""
AB-18522481,7,5,C,ランソプラゾール,"",経口,20180710,"",30,mg,1,"",未知,"",""
AB-18522481,7,6,C,クエン酸第一鉄ナトリウム,"",経口,20180710,"",100,mg,1,"",未知,"",""
AB-18522481,7,7,C,バルサルタン,"",経口,20180719,"",40,mg,1,"",未知,"",""
AB-18522481,7,8,C,ロキソプロフェンナトリウム水和物,"",経口,20180719,"",60,mg,1,"",未知,"",""
AB-18522481,7,9,C,六君子湯,"",経口,20180719,"",2.5,g,1,"",未知,"",""
AB-18522482,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181113;20190205,20181224;20190528,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-18522482,4,2,C,セレコキシブ,"",経口,20171031,20181223,100,mg,1,"",未知,"",""
AB-18522482,4,3,C,アセトアミノフェン,"",経口,20171031,20181223,1000,mg,1,"",未知,"",""
AB-18522482,4,4,C,エソメプラゾールマグネシウム水和物,"",経口,20180401,20181223,20,mg,1,予防(予防投与),未知,"",""
AB-18522482,4,5,C,アピキサバン,"",経口,20180401,20181223,5,mg,1,動脈塞栓症(肺動脈血栓塞栓症);深部静脈血栓症(深部静脈血栓症),未知,"",""
AB-18522482,4,6,C,フロセミド,"",経口,20181127,20181223,20,mg,1,"",未知,"",""
AB-18522482,4,7,C,スピロノラクトン,"",経口,20181127,20181223,50,mg,1,"",未知,"",""
AB-18522482,4,8,C,フルオロウラシル,"",不明,20190614,20200416,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-18522482,4,9,C,レボホリナートカルシウム,"",不明,20190614,20200416,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-18522482,4,10,C,オキサリプラチン,"",不明,20190614,20200416,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-18522484,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180719;20190306,;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(不明),""
AB-18522485,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181011;20181101,20181011;20190124,170;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,脳梗塞(再投与なし),""
AB-18522485,2,2,PS,アゾセミド,"",経口,20181101,20190126,15,mg,1,末梢性浮腫(下肢浮腫),未知,"",""
AB-18522485,2,3,PS,スピロノラクトン,"",経口,20181101,20181129,25,mg,1,末梢性浮腫(下肢浮腫),不适用,"",""
AB-18522485,2,4,C,イリノテカン塩酸塩水和物,"",不明,20181129,20181213,200,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-18522485,2,5,C,オキシコドン塩酸塩水和物,"",経口,20190110,"",2.5,mg,1,癌疼痛(癌性疼痛),未知,"",""
AB-18522485,2,6,C,ラベプラゾールナトリウム,"",経口,"","",10,mg,1,"",未知,"",""
AB-18522485,2,7,C,酸化マグネシウム,"",経口,"","",1980,mg,1,"",未知,"",""
AB-18522485,2,8,C,クエン酸第一鉄ナトリウム,"",経口,"","",1,{DF},1,"",未知,"",""
AB-18522485,2,9,C,アセトアミノフェン,"",経口,"","",400,mg,1,"",未知,"",""
AB-18522485,2,10,C,ボグリボース,"",経口,"","",.3,mg,1,"",未知,"",""
AB-18522485,2,11,C,ドンペリドン,"",経口,"","",10,mg,1,"",未知,"",""
AB-18522485,2,12,C,セフカペンピボキシル塩酸塩水和物,"",経口,"","",100,mg,1,"",未知,"",""
AB-18522718,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190104,20190208,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,低カリウム血症(再投与なし),""
AB-18522718,1,2,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-18522718,1,3,C,メコバラミン,"",不明,"","","","","","",未知,"",""
AB-18522719,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20180906;20181025;20181108,20181011;20181025;20190124,115;120;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,肺炎(再投与なし),""
AB-18522934,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-18522941,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201808,20190220,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-18523146,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181226,20190123,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,急性腎障害(再投与なし),""
AB-18523148,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治療切除不能な進行・再発の胃癌),未知,食欲減退(再投与なし);発熱(再投与なし);意識レベルの低下(再投与なし),""
AB-18523149,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190121,20190218,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-18523181,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190111,20190111,200,mg,1,非小細胞肺癌(非小細胞肺癌),不适用,間質性肺疾患(再投与なし);悪心(再投与なし),""
AB-18523332,2,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20181206,20190213,60,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18523332,2,2,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20181206,20190130,200,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18523332,2,3,PS,シスプラチン,"",静脈内点滴,20181206,20190130,95,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18523332,2,4,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,胃炎予防(胃炎予防),剂量不变,"",""
AB-18523332,2,5,C,アムロジピンベシル酸塩,"",経口,20181206,"",2.5,mg,1,高血圧(高血圧),剂量不变,"",""
AB-18523332,2,6,C,ホウ酸・無機塩類配合剤,"",眼,20190108,"","","","",眼脂(眼脂),剂量不变,"",""
AB-18523428,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201810,201901,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,続発性副腎皮質機能不全(無);副腎皮質刺激ホルモン欠損症(無);間質性肺疾患(無),""
AB-18523428,5,2,C,ボノプラザンフマル酸塩,"",不明,"","",20,mg,1,"",未知,"",""
AB-18523437,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20190208,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎尿細管壊死(再投与なし),""
AB-18523620,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201811,"","","","",胃癌(胃癌),未知,ぶどう膜炎(再投与なし),""
AB-18523625,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-18523874,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20170601,20170727,180,mg,1,頭頚部癌(再発又は遠隔転移を有する頭頸部癌),剂量停止,悪性新生物進行(再投与なし),""
AB-18523875,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180823,20181101,153,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,血便排泄(再投与なし),""
AB-18523875,3,2,PS,カペシタビン,ゼローダ,不明,"","","","","","",未知,"",""
AB-18523876,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,2018,2018,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,腎機能障害(再投与なし),""
AB-18523877,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180817,20181030,170,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,免疫介在性胆管炎(再投与なし),""
AB-18524157,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181221;20190313,;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,関節炎(再投与なし),""
AB-18524163,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180817,20181005,195,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,小脳出血(再投与なし),""
AB-18524163,3,2,C,フロセミド,"",経口,"","",1,{DF},1,"",未知,"",""
AB-18524163,3,3,C,スピロノラクトン,"",経口,"","",1,{DF},1,"",未知,"",""
AB-18524163,3,4,C,メコバラミン,"",経口,"","",3,{DF},1,"",未知,"",""
AB-18524163,3,5,C,ボノプラザンフマル酸塩,"",経口,"","",1,{DF},1,"",未知,"",""
AB-18524163,3,6,C,ロキソプロフェンナトリウム水和物,"",経口,"","",3,{DF},1,"",未知,"",""
AB-18524163,3,7,C,レバミピド,"",経口,"","",3,{DF},1,"",未知,"",""
AB-18524166,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180823;20181101,20181018;20190110,129;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18524603,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20181116;20190408;202004,20190125;20191224;,240;240;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし);間質性肺疾患(再投与なし),""
AB-18524603,5,2,C,トルバプタン,"",不明,"","","","","","",未知,"",""
AB-18524603,5,3,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-18524604,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180803,20181005,200,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,続発性副腎皮質機能不全(再投与なし);肝障害(再投与なし);続発性副腎皮質機能不全(再投与なし);下垂体機能低下症(再投与なし);黄疸(再投与なし),""
AB-18524604,4,2,C,スルファメトキサゾール・トリメトプリム,"",経口;経口,;20190302,20190204;,;,;,;,感染予防(ステロイド投与に伴う感染予防),未知,"",""
AB-18524606,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-18524608,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181003,20181031,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし),""
AB-18525068,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180612,20180713,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,悪性新生物進行(再投与なし);悪性新生物進行(再投与なし),""
AB-18525386,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180122,20180219,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,低カリウム血症(再投与なし),""
AB-18525386,2,2,PS,アセトアミノフェン,アセリオ,静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）,20180122;20180128;20180129;20180131;20180207;20180208;20180209;20180211;20180213;20180228;20180303,20180127;20180128;20180130;20180131;20180207;20180208;20180210;20180211;20180213;20180302;20180310,2000;3000;2000;1000;1000;2000;1000;3000;2000;2000;3000,mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg,1;1;1;1;1;1;1;1;1;1;1,疼痛(疼痛緩和),不适用,"",""
AB-18525389,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181211,20190219,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-18525391,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181017,20181219,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,反回神経麻痺(再投与なし),""
AB-18525391,3,2,PS,イリノテカン塩酸塩水和物,トポテシン,不明,20181108,20181108,165,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-18525393,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181127,20190219,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-18525564,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180828,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-18525570,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-18525573,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181120,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-18525576,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190109,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-18525967,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能亢進症(再投与なし),""
AB-18525972,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能亢進症(再投与なし),""
AB-18526530,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-18526536,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190104,20190104,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし);呼吸不全(再投与なし);肺胞出血(再投与なし),""
AB-18526536,6,2,PS,ワルファリンカリウム,ワーファリン,経口,20180601,20190117,1.25,mg,1,腸間膜静脈血栓症(SMV血栓);予防(予防投与),不适用,"",""
AB-18526536,6,3,C,メトクロプラミド,"",経口,20161029,20190109,5,mg,1,悪心(嘔気症),未知,"",""
AB-18526536,6,4,C,セフトリアキソンナトリウム水和物,"",静脈内（明記されていない場合）,20190109,20190110,2,g,1,予防(予防投与),未知,"",""
AB-18526536,6,5,C,レボフロキサシン水和物,"",静脈内（明記されていない場合）,20190109,20190115,.5,g,1,予防(予防投与),未知,"",""
AB-18526536,6,6,C,タゾバクタム・ピペラシリン水和物,"",静脈内（明記されていない場合）,20190110,20190110,4.5,g,1,予防(予防投与),未知,"",""
AB-18526798,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍のハイパープログレッション(再投与なし),""
AB-18526799,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180305,20180611,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,口内炎(再投与なし);食道炎(再投与なし),""
AB-18527213,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-18527215,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-18527217,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-18527471,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180806;20180910,20180827;20181226,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎盂腎炎(有);腎盂腎炎(有);腎盂腎炎(有);腎盂腎炎(有),""
AB-18527471,1,2,C,デノスマブ,"",不明,"",20181105,120,mg,1,"",未知,"",""
AB-18527883,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190220,20190306,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,歯肉出血(再投与なし);骨髄異形成症候群(再投与なし);血小板数減少(再投与なし),""
AB-18527883,3,2,PS,ラムシルマブ,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-18527883,3,3,PS,パクリタキセル（アルブミン懸濁型）,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-18527883,3,4,PS,セフィキシム水和物,セフスパン,不明,"","","","","","",不适用,"",""
AB-18527883,3,5,C,ビソプロロールフマル酸塩,"",経口,20160201,"",2.5,mg,1,肥大型心筋症(肥大型心筋症),未知,"",""
AB-18527883,3,6,C,エナラプリルマレイン酸塩,"",経口,20170123,"",5,mg,1,肥大型心筋症(肥大型心筋症),未知,"",""
AB-18527883,3,7,C,ベタメタゾン・ｄ−クロルフェニラミンマレイン酸塩,"",経口,20190306,"",1,{DF},1,そう痒症(化学療法による掻痒感),未知,"",""
AB-18527883,3,8,C,シクロスポリン,"",不明,"","","","","",骨髄異形成症候群(骨髄異形成症候群),未知,"",""
AB-18527884,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180830;20181108,20181025;20181108,179;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,続発性副腎皮質機能不全(再投与なし),""
AB-18527884,5,2,C,インスリン,"",皮下,"","","","","",２型糖尿病(2型糖尿病),未知,"",""
AB-18528267,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201809;,;201902,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治療切除不能な進行・再発の胃癌),剂量停止,下垂体機能低下症(再投与なし);続発性副腎皮質機能不全(再投与なし);心嚢液貯留(再投与なし);漿膜炎(再投与なし),""
AB-18528267,3,2,PS,メチルプレドニゾロン,"",不明;不明,20190213;2019,;,125;,mg;,1;,下垂体機能低下症(下垂体機能低下症);漿膜炎(漿膜炎),剂量减少,"",""
AB-18528288,8,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20181002;20190115;20190409,20181225;20190226;,240;240;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,劇症１型糖尿病(再投与なし);血中コルチコトロピン減少(再投与なし);副腎機能不全(再投与なし),""
AB-18528288,8,2,C,ラベプラゾールナトリウム,"",経口,"","",10,mg,1,"",未知,"",""
AB-18528288,8,3,C,インスリンデグルデク,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-18528288,8,4,C,インスリンアスパルト,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-18528642,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181107,20181107,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝障害(再投与なし),""
AB-18528642,3,2,C,オルメサルタンメドキソミル,"",経口,20180628,20181214,10,mg,1,"",未知,"",""
AB-18528642,3,3,C,アムロジピンベシル酸塩,"",経口,20180726,20181128,2.5,mg,1,"",未知,"",""
AB-18528642,3,4,C,プレドニゾロン,"",経口,20181114,20181121,5,mg,1,"",未知,"",""
AB-18528642,3,5,C,オメプラゾール,"",経口,20181114,20181127,20,mg,1,"",未知,"",""
AB-18528775,7,1,PS,パクリタキセル,タキソール,不明,"","","","","",再発胃癌(再発胃癌),不适用,"",""
AB-18528775,7,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20180126,20180209,3,mg/kg,1,再発胃癌(再発胃癌),不适用,"",""
AB-18528775,7,3,PS,ドセタキセル水和物,"",不明,20180425,20180515,60,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18528775,7,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20180425,20180528,160,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18528775,7,5,PS,トラスツズマブ,ハーセプチン,静脈内点滴,20180425,20180515,450,mg,1,胃癌(胃癌),剂量停止,"",""
AB-18528775,7,6,C,イリノテカン塩酸塩水和物,"",静脈内点滴,20180306,20180403,230,mg,1,適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-18528969,8,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181120,20190115,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,心不全(再投与なし);１型糖尿病(再投与なし);高血糖(再投与なし),""
AB-18529200,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190318,20190318,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,劇症１型糖尿病(再投与なし);腎障害(再投与なし),""
AB-18529200,5,2,C,大腸菌死菌,"",局所,20180220,"","","","","",未知,"",""
AB-18529200,5,3,C,エソメプラゾールマグネシウム水和物,"",不明,20180501,"","","","","",未知,"",""
AB-18529200,5,4,C,酸化マグネシウム,"",不明,20180523,"","","","","",未知,"",""
AB-18529200,5,5,C,モサプリドクエン酸塩水和物,"",不明,20181121,"","","","","",未知,"",""
AB-18529200,5,6,C,Ｌ−カルボシステイン,"",不明,20190128,"","","","","",未知,"",""
AB-18529200,5,7,C,ナプロキセン,"",不明,20190311,"","","","","",未知,"",""
AB-18529200,5,8,C,フマル酸第一鉄,"",不明,20190316,"","","","","",未知,"",""
AB-18529202,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19100189,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,硬化性胆管炎(再投与なし),""
AB-19100189,2,2,PS,パクリタキセル（アルブミン懸濁型）,"",不明,"","",100,mg/m2,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19100189,2,3,PS,ラムシルマブ,"",不明,"","",8,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19101078,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201807;201810,201809;20190110,160;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,急性胆管炎(再投与なし);敗血症(再投与なし);間質性肺疾患(再投与なし),""
AB-19101081,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20180921;20181102;,20181005;;20191011,160;240;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,１型糖尿病(再投与なし),""
AB-19101082,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180723,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,急性副腎皮質機能不全(再投与なし),""
AB-19101084,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171116,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-19101084,3,2,C,エソメプラゾールマグネシウム水和物,"",経口,201705,"",20,mg,1,"",剂量不变,"",""
AB-19101084,3,3,C,フェンタニルクエン酸塩,"",経皮,20171202,"",3,mg,1,"",剂量不变,"",""
AB-19101084,3,4,C,フロセミド,"",経口,20180104,"",40,mg,1,"",未知,"",""
AB-19101084,3,5,C,アスピリン,"",経口,"","",100,mg,1,"",剂量不变,"",""
AB-19101084,3,6,C,カルベジロール,"",経口,"","",10,mg,1,"",剂量不变,"",""
AB-19101165,2,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口;経口,20190208;20190301;20190322,;20190305;20190324,40;;,mg;;,1;;,胃癌(胃癌),剂量停止,"",""
AB-19101165,2,2,PS,パロノセトロン塩酸塩,アロキシ,静脈内（明記されていない場合）,20190210,"",50,mL,1,予防(予防),剂量不变,"",""
AB-19101165,2,3,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190208,"",200,mg,1,胃癌(胃癌),剂量不变,"",""
AB-19101165,2,4,PS,シスプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20190208;20190301;20190322,20190208;20190301;20190322,66.8;;,mg;;,1;;,胃癌(胃癌),剂量停止,"",""
AB-19101165,2,5,C,ミアンセリン塩酸塩,"",経口,"","",10,mg,1,"",剂量不变,"",""
AB-19101165,2,6,C,酸化マグネシウム,"",経口,"","",330,mg,1,"",剂量不变,"",""
AB-19101165,2,7,C,ルビプロストン,"",経口,"","",48,ug,1,"",剂量不变,"",""
AB-19101165,2,8,C,ピコスルファートナトリウム水和物,"",経口,20190210,"","","","","",剂量不变,"",""
AB-19101165,2,9,C,プロクロルペラジンマレイン酸塩,"",経口,20190210,20190222,5,mg,1,悪心(悪心),剂量不变,"",""
AB-19101165,2,10,C,維持液（４）,"",静脈内（明記されていない場合）,20190208,"",1000,mL,1,予防(予防),剂量不变,"",""
AB-19101165,2,11,C,乳酸リンゲル液,"",静脈内（明記されていない場合）,20190208,"",500,mL,1,予防(予防),剂量不变,"",""
AB-19101165,2,12,C,硫酸マグネシウム水和物,"",静脈内（明記されていない場合）,20190208,"",20,mL,1,予防(予防),剂量不变,"",""
AB-19101165,2,13,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内（明記されていない場合）,20190208,"",3,mL,1,予防(予防),剂量不变,"",""
AB-19101336,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190314,20190425,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,遊走性血栓静脈炎(再投与なし),""
AB-19101368,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20180131;20190213,20180221;20190306,200;200,mg;mg,1;1,非小細胞肺癌(非小細胞肺癌),剂量停止,肺障害(有);間質性肺疾患(再投与なし),""
AB-19101368,4,2,C,アンブロキソール塩酸塩,"",経口,20161109,"",45,mg,1,肺気腫(肺気腫),未知,"",""
AB-19101368,4,3,C,ボノプラザンフマル酸塩,"",経口,20180322,"",10,mg,1,ステロイド療法(ステロイド投与),未知,"",""
AB-19101368,4,4,C,インダパミド,"",経口,20180528,"",1,mg,1,高血圧(高血圧症),未知,"",""
AB-19101368,4,5,C,アムロジピンベシル酸塩,"",経口,不明,"",5,mg,1,高血圧(高血圧症),未知,"",""
AB-19101368,4,6,C,フェブキソスタット,"",経口,不明,"",20,mg,1,高尿酸血症(高尿酸血症),未知,"",""
AB-19101606,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,尿細管間質性腎炎(再投与なし),""
AB-19101608,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190130,20190313,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,皮下出血(再投与なし),""
AB-19101779,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,ＩｇＡ腎症(無),""
AB-19101779,2,2,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-19101779,2,3,C,ロペラミド塩酸塩,"",不明,"","","","","","",未知,"",""
AB-19101779,2,4,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-19101783,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180720;20180914,20180831;20181026,150;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-19102190,1,1,PS,パクリタキセル,タキソール,不明,"","","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19102190,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴;,20180829;20181026,20181012;20181109,3;240,mg/kg;mg,1;1,胃癌(胃癌),剂量不变,倦怠感(再投与なし);末梢性ニューロパチー(再投与なし);塞栓症(再投与なし),""
AB-19102190,1,3,PS,M_BMS-986227_Oxaliplatin,"",不明,"","","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19102474,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181121,20190320,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,急性腎障害(再投与なし),""
AB-19102474,1,2,C,カルベジロール,"",経口,"","","","","","",未知,"",""
AB-19102474,1,3,C,ジルチアゼム塩酸塩,"",経口,"","","","","","",未知,"",""
AB-19102474,1,4,C,ジゴキシン,"",経口,"","","","","","",未知,"",""
AB-19102474,1,5,C,ダビガトランエテキシラートメタンスルホン酸塩,"",経口,"","","","","","",未知,"",""
AB-19102474,1,6,C,フルニトラゼパム,"",経口,"","","","","","",未知,"",""
AB-19102474,1,7,C,フロセミド,"",経口,"","","","","","",未知,"",""
AB-19102474,1,8,C,アロプリノール,"",経口,"","","","","","",未知,"",""
AB-19102474,1,9,C,ゾルピデム酒石酸塩,"",経口,"","","","","","",未知,"",""
AB-19102475,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201803;201809,;,140;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,ミオクローヌス(再投与なし),""
AB-19102482,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180718;20181107,20181017;20181107,120;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19103115,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190109,20190327,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(不明);敗血症性ショック(不明);汎血球減少症(不明);播種性血管内凝固(不明);蜂巣炎(不明);肝機能異常(不明);低カリウム血症(不明),""
AB-19103115,6,2,PS,スルファメトキサゾール・トリメトプリム,バクタ,不明,20190307,20190403,1,g,1,肝機能異常(肝機能異常),不适用,"",""
AB-19103115,6,3,C,レパグリニド,"",経口,"",2019,.5,mg,1,"",未知,"",""
AB-19103115,6,4,C,ミグリトール,"",経口,"",2019,1,{DF},1,"",未知,"",""
AB-19103306,1,1,PS,エドキサバントシル酸塩水和物,リクシアナ,経口,20170824,20190120,30,mg,1,心房細動(Atrial fibrillation),剂量停止,頭蓋内腫瘍出血(再投与なし),""
AB-19103306,1,2,PS,ゲムシタビン塩酸塩,ゲムシタビン,静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）,20170823;20170823;20170925;20171026;20171124;20171124,20170906;20171109;20171002;20171109;20180111;20180111,;;;;;,;;;;;,;;;;;,"",未知,"",""
AB-19103306,1,3,PS,ビノレルビン酒石酸塩,ナベルビン,静脈内（明記されていない場合）,20180201,20180222,"","","","",未知,"",""
AB-19103306,1,4,PS,フィルグラスチム［後続１］,フィルグラスチムＢＳ［後続１］,静脈内（明記されていない場合）,20180215,20180218,"","","","",未知,"",""
AB-19103306,1,5,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）,20180402;20180507;20180604;20180712;20180820;20181010,20180416;20180521;20180618;20180726;20181017;20181017,;;;;;,;;;;;,;;;;;,"",未知,"",""
AB-19103306,1,6,PS,アテゾリズマブ,テセントリク,静脈内（明記されていない場合）,20181106,20181128,"","","","",未知,"",""
AB-19103306,1,7,PS,アムルビシン塩酸塩,カルセド,静脈内（明記されていない場合）,20181219,20181220,"","","","",未知,"",""
AB-19103306,1,8,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）,20170823;20170925;20171124;20180201;20180402;20180507;20181213;20181214;20181219;20181222;20181226,20170906;20171109;20180111;20180222;20180416;20181017;20181213;20181218;20181221;20181225;20190123,;;;;;;;;;;,;;;;;;;;;;,;;;;;;;;;;,"",未知,"",""
AB-19103306,1,9,C,プロプラノロール塩酸塩,"",静脈内（明記されていない場合）,20170824,20170824,"","","",心房細動(Atrial fibrillation),未知,"",""
AB-19103306,1,10,C,モサプリドクエン酸塩水和物,"",経口,20171130,20171210,"","","","",未知,"",""
AB-19103306,1,11,C,タゾバクタム・ピペラシリン水和物,"",静脈内（明記されていない場合）,20180322,20180326,"","","","",未知,"",""
AB-19103306,1,12,C,ラモセトロン塩酸塩,"",静脈内（明記されていない場合）;静脈内（明記されていない場合）,20180402;20180507,20180416;20181017,;,;,;,"",未知,"",""
AB-19103306,1,13,C,プレドニゾロン,"",経口;経口;経口;経口,20180425;20180514;20180604;20180712,20180513;20180521;20180711;20180826,;;;,;;;,;;;,"",未知,"",""
AB-19103306,1,14,C,アンブロキソール塩酸塩,"",経口,20181017,20181228,"","","","",未知,"",""
AB-19103306,1,15,C,濃グリセリン・果糖,"",静脈内（明記されていない場合）,20181210,20190126,"","","","",未知,"",""
AB-19103306,1,16,C,アムロジピンベシル酸塩,"",経口,"",20190105,"","","","",未知,"",""
AB-19103306,1,17,C,タムスロシン塩酸塩,"",経口,"",20190121,"","","","",未知,"",""
AB-19103306,1,18,C,Ｌ−カルボシステイン,"",経口,"",20171114,"","","","",未知,"",""
AB-19103306,1,19,C,ボノプラザンフマル酸塩,"",経口,"",20180528,"","","","",未知,"",""
AB-19103306,1,20,C,ブロチゾラム,"",経口,"",20181229,"","","","",未知,"",""
AB-19103306,1,21,C,フルチカゾンフランカルボン酸エステル,"",鼻,"",20190205,"","","","",未知,"",""
AB-19103306,1,22,C,トラマゾリン塩酸塩,"",鼻,"",20180321,"","","","",未知,"",""
AB-19103306,1,23,C,アンブロキソール塩酸塩,"",経口,"",20180528,"","","","",未知,"",""
AB-19103306,1,24,C,ピレノキシン,"",眼,"",20181204,"","","","",未知,"",""
AB-19103306,1,25,C,精製ヒアルロン酸ナトリウム,"",眼,"",20181206,"","","","",未知,"",""
AB-19103306,1,26,C,ブデソニド・ホルモテロールフマル酸塩水和物,"",その他(吸入に使用),"",20170911,"","","","",未知,"",""
AB-19103306,1,27,C,ジヒドロコデインリン酸塩（１％以下）,"",経口,"",20170911,"","","","",未知,"",""
AB-19103462,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181218,20190118,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,溶血性貧血(再投与なし);網状赤血球数増加(再投与なし);血小板数減少(再投与なし),""
AB-19103462,4,2,PS,カモスタットメシル酸塩,フオイパン,経口,"","","","","",適応症不明の製品使用(適応症不明の製品使用),未知,溶血性貧血(再投与なし);網状赤血球数増加(再投与なし);血小板数減少(再投与なし),""
AB-19103462,4,3,C,ボノプラザンフマル酸塩,"",経口,20181203,"",20,mg,1,"",未知,"",""
AB-19103462,4,4,C,アルギン酸ナトリウム,"",経口,20181203,201901,180,uL,1,"",未知,"",""
AB-19103462,4,5,C,ロキソプロフェンナトリウム水和物,"",経口,201812,"",60,mg,1,"",未知,"",""
AB-19103462,4,6,C,大建中湯,"",経口,201812,"",5,g,1,"",未知,"",""
AB-19103462,4,7,C,ゾレドロン酸水和物,"",不明;不明,20181219;20190116,20181219;20190116,;,;,;,"",未知,"",""
AB-19103462,4,8,C,ワルファリンカリウム,"",不明,20190115,20190204,"","","","",未知,"",""
AB-19103462,4,9,C,パクリタキセル,"",静脈内（明記されていない場合）,20190212,"",100,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19103462,4,10,C,ブロチゾラム,"",経口,"",20181220,.25,mg,1,"",未知,"",""
AB-19103462,4,11,C,レバミピド,"",経口,"","","","","","",未知,"",""
AB-19103462,4,12,C,乳酸カルシウム水和物,"",不明,"","",1,g,1,"",未知,"",""
AB-19103462,4,13,C,アルファカルシドール,"",経口,"","",.25,ug,1,"",未知,"",""
AB-19103462,4,14,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
AB-19103462,4,15,C,アセトアミノフェン,"",経口,"","","","","","",未知,"",""
AB-19103757,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180214,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,死亡(再投与なし);口腔内出血(再投与なし),""
AB-19103764,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190208,20190329,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-19103841,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180207,20180828,177,mg,1,非小細胞肺癌(肺腺癌),未知,心嚢液貯留(不明);薬物性肝障害(不明);心タンポナーデ(不明),""
AB-19103841,2,2,C,アトルバスタチンカルシウム水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-19103841,2,3,C,ブロチゾラム,"",不明,"","",.25,mg,1,"",未知,"",""
AB-19103841,2,4,C,ゾルピデム酒石酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-19103841,2,5,C,メトクロプラミド,"",経口,"","",5,mg,1,"",未知,"",""
AB-19103841,2,6,C,プロクロルペラジンマレイン酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-19104019,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190104,20190329,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19104019,5,2,PS,プレドニゾロン酢酸エステル,プレドニン,静脈内点滴,20190405,20190409,50,mg,1,間質性肺疾患(間質性肺炎),不适用,"",""
AB-19104019,5,3,PS,プレドニゾロン,プレドニン,経口;経口;経口;経口;経口;経口;経口;経口;経口;経口;経口;経口;経口;経口;経口,20190410;20190415;20190420;20190425;20190430;20190521;20190528;20190604;20190611;20190621;20190627;20190703;20190719;20190815;20190822,20190414;20190419;20190424;20190429;20190514;20190527;20190603;20190610;20190617;20190626;20190702;20190718;20190808;20190821;,40;30;20;10;5;10;7.5;5;2.5;1;1.5;;;5;3,mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;;;mg;mg,1;1;1;1;1;1;1;1;1;1;1;;;1;1,間質性肺疾患(間質性肺炎);倦怠感(倦怠感);食欲減退(食欲不振),剂量不变,"",""
AB-19104062,6,1,PS,パクリタキセル,タキソール,不明,20190212,"",100,mg,1,胃癌(適応症不明の製品使用),未知,"",""
AB-19104062,6,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20181220,20190118,240,mg,1,胃癌(胃癌),不适用,"",""
AB-19104062,6,3,C,ボノプラザンフマル酸塩,"",経口,20181203,"",20,mg,1,適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,4,C,アルギン酸ナトリウム,"",経口,20181203,201901,540,uL,1,適応症不明の製品使用(適応症不明の製品使用),剂量停止,"",""
AB-19104062,6,5,C,アセトアミノフェン,"",不明;不明,20181219;20190116,20181219;20190116,;,;,;,適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,6,C,アルギン酸ナトリウム,"",経口,20181220,"",.25,mg,1,適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,7,C,アセトアミノフェン,"",不明,20190115,20190204,"","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,8,C,ロキソプロフェンナトリウム水和物,"",経口,201812,"",180,mg,1,適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,9,C,レバミピド,"",経口,"","","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,10,C,乳酸カルシウム水和物,"",不明,"","",3,g,1,適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,11,C,アルファカルシドール,"",経口,"","",.25,ug,1,適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,12,C,大建中湯,"",経口,201812,"",15,g,1,適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,13,C,ラムシルマブ,"",不明,"","","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,14,C,酪酸菌製剤,"",経口,"","","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,15,C,カモスタットメシル酸塩,"",経口,"","","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,16,C,レバミピド,"",不明,"","","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104062,6,17,C,アセトアミノフェン,"",経口,"","","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19104278,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190118;20190515,20190403;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,低ナトリウム血症(無);抗利尿ホルモン不適合分泌(無),""
AB-19104278,4,2,C,アセトアミノフェン,"",経口,20190320,20190410,1600,mg,1,脊椎転移(胸椎転移),未知,"",""
AB-19104278,4,3,C,ゾレドロン酸水和物,"",不明,"","","","","","",未知,"",""
AB-19104278,4,4,C,シロドシン,"",経口,"","",8,mg,1,良性前立腺肥大症(前立腺肥大),未知,"",""
AB-19104278,4,5,C,ジアスターゼ配合剤（１）,"",経口,"","",3,{DF},1,胃炎予防(胃炎予防),未知,"",""
AB-19104683,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180822,20190206,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,慢性気管支炎(再投与なし),""
AB-19104683,2,2,C,カンデサルタンシレキセチル,"",経口,"","",8,mg,1,"",未知,"",""
AB-19104683,2,3,C,テネリグリプチン臭化水素酸塩水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-19104683,2,4,C,ニフェジピン,"",経口,"","",20,mg,1,"",未知,"",""
AB-19104683,2,5,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-19104683,2,6,C,デュロキセチン塩酸塩,"",経口,"","",20,mg,1,"",未知,"",""
AB-19104683,2,7,C,グリメピリド,"",経口,"","",1,mg,1,"",未知,"",""
AB-19104683,2,8,C,エピナスチン塩酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-19104683,2,9,C,トリクロルメチアジド,"",経口,"","",2,mg,1,"",未知,"",""
AB-19104683,2,10,C,プレドニゾロン,"",不明,"","",10,mg,1,"",未知,"",""
AB-19104687,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180713,20180713,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);ニューモシスチス・イロベチイ肺炎(再投与なし),""
AB-19104972,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201801,201805,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,胆管炎(再投与なし);胆管炎(再投与なし),""
AB-19105266,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201808;201902,201812;,3;3,mg/kg;mg/kg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,シェーグレン症候群(不明);劇症１型糖尿病(不明);甲状腺機能低下症(不明);甲状腺機能亢進症(不明),""
AB-19105712,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180905,20181128,240,mg,1,胃癌(がん化学療法後に増悪した治療切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-19105713,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,;20180110;;20181018;20190124;20190328,;;20180920;20181213;20190307;20201224,120;240;120;240;240;120,mg;mg;mg;mg;mg;mg,1;1;1;1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心拡大(無);血栓性脳梗塞(無);心房細動(無),""
AB-19106099,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181016,20181225,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-19106101,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181106;,;20190402,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-19106101,3,2,C,セレコキシブ,"",経口,"","",100,mg,1,胃癌(胃がん),未知,"",""
AB-19106101,3,3,C,ビフィズス菌製剤（４）,"",経口,"","",1,g,1,下痢(下痢),未知,"",""
AB-19106101,3,4,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,高血圧(高血圧),未知,"",""
AB-19106101,3,5,C,アセトアミノフェン,"",経口,"","",500,mg,1,胃癌(胃がん),未知,"",""
AB-19106101,3,6,C,ロペラミド塩酸塩,"",経口,"","",1,mg,1,下痢(下痢),未知,"",""
AB-19106116,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190411,20190411,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝炎(再投与なし);肝壊死(再投与なし),""
AB-19106116,3,2,C,デキサメタゾン,"",経口,"","",4,mg,1,"",未知,"",""
AB-19106116,3,3,C,レボチロキシンナトリウム水和物,"",経口,"","",50,ug,1,"",未知,"",""
AB-19106116,3,4,C,酸化マグネシウム,"",経口,"","",990,mg,1,"",未知,"",""
AB-19106116,3,5,C,ブロチゾラム,"",経口,"","",.25,mg,1,"",未知,"",""
AB-19106116,3,6,C,フロセミド,"",経口,"","",40,mg,1,"",未知,"",""
AB-19106116,3,7,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-19106365,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190405,20190405,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,くも膜下出血(再投与なし),""
AB-19106975,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180830;,20190125;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(不明);嘔吐(不明),""
AB-19106975,2,2,C,ランソプラゾール,"",経口,20181220,"","","","","",未知,"",""
AB-19106982,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190115,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,機械的イレウス(再投与なし),""
AB-19106982,1,2,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-19106982,1,3,C,エドキサバントシル酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-19106982,1,4,C,デュロキセチン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-19106982,1,5,C,ウルソデオキシコール酸,"",不明,"","","","","","",未知,"",""
AB-19106982,1,6,C,デキサメタゾン,"",非経口,"","","","","","",未知,"",""
AB-19107056,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190118;20190520,2019;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,口渇(無);劇症１型糖尿病(無);倦怠感(無),""
AB-19107056,2,2,C,ドンペリドン,"",経口,20181214,"",10,mg,1,胃癌(胃癌),未知,"",""
AB-19107056,2,3,C,ロキソプロフェンナトリウム水和物,"",経口,20190201,"",60,mg,1,胃癌(胃癌),未知,"",""
AB-19107056,2,4,C,レバミピド,"",経口,20190201,"",100,mg,1,胃癌(胃癌),未知,"",""
AB-19107056,2,5,C,ボノプラザンフマル酸塩,"",経口,20190201,"",10,mg,1,胃癌(胃癌),未知,"",""
AB-19107293,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190116,20190327,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(再投与なし);脱水(再投与なし),""
AB-19107526,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190402,20190416,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,急性膵炎(再投与なし);急性膵炎(再投与なし);急性膵炎(再投与なし);急性膵炎(再投与なし),""
AB-19107526,4,2,C,メトホルミン塩酸塩,"",経口,"",20190502,250,mg,1,糖尿病(糖尿病),未知,"",""
AB-19107526,4,3,C,ニフェジピン,"",経口,"",20190502,10,mg,1,高血圧(高血圧),未知,"",""
AB-19107526,4,4,C,アジルサルタン,"",経口,"",20190502,10,mg,1,高血圧(高血圧),未知,"",""
AB-19107526,4,5,C,アスピリン,"",経口,"",20190502,100,mg,1,脳梗塞(脳梗塞),未知,"",""
AB-19107526,4,6,C,アセトアミノフェン,"",経口,"",20190502,500,mg,1,癌疼痛(癌性疼痛),未知,"",""
AB-19107526,4,7,C,酸化マグネシウム,"",経口,"",20190502,330,mg,1,便秘(便秘),未知,"",""
AB-19107526,4,8,C,ルビプロストン,"",経口,"",20190502,24,ug,1,便秘(便秘),未知,"",""
AB-19107665,2,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口,20190108;20190312,;,60;50,mg;mg,1;1,胃癌(胃癌),剂量不变,"",""
AB-19107665,2,2,PS,パロノセトロン塩酸塩,アロキシ,静脈内点滴,20190108,"",0.75,mg,1,予防(Prophylaxis),剂量不变,"",""
AB-19107665,2,3,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190108,"",200,mg,1,胃癌(胃癌),剂量不变,"",""
AB-19107665,2,4,PS,シスプラチン,"",静脈内点滴;静脈内点滴,20190108;20190312,;,105;87,mg;mg,1;1,胃癌(胃癌),剂量不变,"",""
AB-19107665,2,5,C,エソメプラゾールマグネシウム水和物,"",経口,20181211,"",20,mg,1,胃癌(胃癌),剂量不变,"",""
AB-19107665,2,6,C,アプレピタント,"",経口,20190108,"",80,mg,1,予防(Prophylaxis),剂量不变,"",""
AB-19107665,2,7,C,ビサコジル,"",直腸,20190111,"",10,mg,1,便秘(constipation),剂量不变,"",""
AB-19107665,2,8,C,酸化マグネシウム,"",経口,20190115,"",500,mg,1,便秘(constipation),剂量不变,"",""
AB-19107665,2,9,C,アセトアミノフェン,"",経口,20190114,"",500,mg,1,発熱(Fever),剂量不变,"",""
AB-19107665,2,10,C,硫酸マグネシウム水和物,"",静脈内点滴,20190108,"",20,meq,1,予防(Prophylaxis),剂量不变,"",""
AB-19107665,2,11,C,Ｌ−アスパラギン酸カリウム,"",静脈内点滴,20190108,"",100,meq,1,予防(Prophylaxis),剂量不变,"",""
AB-19107665,2,12,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20190108,"",9.9,mg,1,予防(Prophylaxis),剂量不变,"",""
AB-19107665,2,13,C,Ｄ−マンニトール,"",静脈内点滴,20190108,"",300,mL,1,予防(Prophylaxis),剂量不变,"",""
AB-19107665,2,14,C,生理食塩液,"",静脈内点滴,20190108,"",500,mL,1,予防(Prophylaxis),剂量不变,"",""
AB-19107665,2,15,C,ピコスルファートナトリウム水和物,"",経口,20190201,"","","","",便秘(constipation),剂量不变,"",""
AB-19107665,2,16,C,フロセミド,"",静脈内点滴,20190109,"",20,mg,1,体重管理(Weight control),剂量不变,"",""
AB-19107665,2,17,C,ゾルピデム酒石酸塩,"",経口,20190111,"",5,mg,1,不眠症(Insomnia),剂量不变,"",""
AB-19107665,2,18,C,アズレンスルホン酸ナトリウム水和物,"",口腔咽頭,20190112,"","","","",予防(Stomatitis Prophylaxis),剂量不变,"",""
AB-19107665,2,19,C,炭酸水素ナトリウム,"",口腔咽頭,20190112,"","","","",予防(Stomatitis Prophylaxis),剂量不变,"",""
AB-19107665,2,20,C,グリセリンカリ液,"",口腔咽頭,20190112,"","","","",予防(Stomatitis Prophylaxis),剂量不变,"",""
AB-19107665,2,21,C,センノシド,"",経口,20190131,"",24,mg,1,便秘(constipation),剂量不变,"",""
AB-19107665,2,22,C,クロルプロマジン塩酸塩,"",経口,20190221,"",25,mg,1,しゃっくり(Hiccups),剂量不变,"",""
AB-19107741,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171128,20171226,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍のハイパープログレッション(再投与なし),""
AB-19107743,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190319,20190402,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし);心筋炎(再投与なし),""
AB-19107743,5,2,C,グリメピリド,"",不明,"","","","","",糖尿病(糖尿病),未知,"",""
AB-19107747,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180313,20180329,240,mg,1,胃癌(がん化学療法後に増悪した治療切除不能な進行・再発の胃癌),不适用,硬化性胆管炎(再投与なし),""
AB-19107896,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190326,20190326,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,胃出血(再投与なし),""
AB-19107896,1,2,C,メコバラミン,"",経口,20190306,"",500,ug,1,関節障害(上右肩外転運動不全),未知,"",""
AB-19107896,1,3,C,ロキソプロフェンナトリウム水和物,"",経口,20190310,"",60,mg,1,胃癌(胃癌),未知,"",""
AB-19107896,1,4,C,トラマドール塩酸塩・アセトアミノフェン配合剤,"",経口,20190319,"",1,{DF},1,胃癌(胃癌),未知,"",""
AB-19107896,1,5,C,フロセミド,"",経口,20190319,"",20,mg,1,腹水(腹水の除去),未知,"",""
AB-19108073,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171117,20171205,160,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍のハイパープログレッション(再投与なし),""
AB-19108282,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,3;3,mg/kg;mg/kg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腸炎(不明),""
AB-19108287,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190306,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,硬化性胆管炎(再投与なし),""
AB-19108463,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201802,2018,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,関節リウマチ(再投与なし),""
AB-19108463,2,2,C,プレドニゾロン,"",不明;不明,2016;20180220,20180219;,5;10,mg;mg,1;1,関節リウマチ(関節リウマチ),未知,"",""
AB-19108464,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190117,20190508,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(不明),""
AB-19108465,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190417,20190502,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,口内炎(再投与なし);口腔内出血(再投与なし),""
AB-19108465,2,2,C,オキシコドン塩酸塩水和物,"",経口,20190401,"",10,mg,1,疼痛(疼痛緩和),未知,"",""
AB-19108465,2,3,C,セレコキシブ,"",経口,20190410,"",100,mg,1,疼痛(疼痛緩和),未知,"",""
AB-19108651,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,視床下部−下垂体障害(不明),""
AB-19108905,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃がん),剂量停止,甲状腺機能亢進症(再投与なし);皮膚障害(再投与なし);湿疹(再投与なし);間質性肺疾患(再投与なし),""
AB-19108910,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能亢進症(再投与なし),""
AB-19108913,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181220,20190502,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,１型糖尿病(再投与なし),""
AB-19108913,2,2,C,メコバラミン,"",経口,20130205,"",500,ug,1,"",未知,"",""
AB-19108913,2,3,C,ウルソデオキシコール酸,"",経口,20170808,"",100,mg,1,"",未知,"",""
AB-19108913,2,4,C,アムロジピンベシル酸塩,"",経口,20181206,"",5,mg,1,"",未知,"",""
AB-19108913,2,5,C,ワルファリンカリウム,"",経口,20181206,20190517,.5,mg,1,"",未知,"",""
AB-19108913,2,6,C,ワルファリンカリウム,"",経口;経口,20181206;20190108,20181224;20190517,3;2.5,mg;mg,1;1,"",未知,"",""
AB-19108913,2,7,C,ヘパリンカルシウム,"",不明,20181225,20190107,"","","","",未知,"",""
AB-19108913,2,8,C,メトホルミン塩酸塩,"",経口,20190416,20190502,250,mg,1,"",未知,"",""
AB-19108918,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19108923,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19109169,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181010,20181023,150,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,血中ビリルビン増加(再投与なし);アラニンアミノトランスフェラーゼ増加(再投与なし);γ−グルタミルトランスフェラーゼ増加(再投与なし);血中アルカリホスファターゼ増加(再投与なし);アスパラギン酸アミノトランスフェラーゼ増加(再投与なし);血中乳酸脱水素酵素増加(再投与なし),""
AB-19109170,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181031,20181128,240,mg,1,胃癌(胃癌),剂量停止,呼吸困難(再投与なし),""
AB-19109170,3,2,C,アスピリン,"",経口,"","",100,mg,1,"",未知,"",""
AB-19109170,3,3,C,カルベジロール,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-19109170,3,4,C,酪酸菌配合剤,"",経口,"","",3,{DF},1,"",未知,"",""
AB-19109170,3,5,C,ラベプラゾールナトリウム,"",経口,"","",10,mg,1,"",未知,"",""
AB-19109170,3,6,C,デュロキセチン塩酸塩,"",経口,"","",20,mg,1,"",未知,"",""
AB-19109170,3,7,C,牛車腎気丸,"",経口,"","",5,g,1,"",未知,"",""
AB-19109170,3,8,C,経腸成分栄養剤（２−１）,"",経口,"","",250,mL,1,"",未知,"",""
AB-19109173,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180803,20181109,140,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,中枢性甲状腺機能低下症(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-19109173,4,2,PS,ジアスターゼ配合剤（１）,タフマックＥ,経口,20150903,"",3,{DF},1,消化不良(胃切後障害),剂量不变,中枢性甲状腺機能低下症(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-19109173,4,3,C,酪酸菌製剤,"",経口,20170106,"",6,{DF},1,下痢(下痢),未知,"",""
AB-19109173,4,4,C,メコバラミン,"",経口,20170519,"",3000,ug,1,神経系障害(神経障害),未知,"",""
AB-19109173,4,5,C,プレガバリン,"",経口,20170519,"",150,mg,1,神経系障害(神経障害),未知,"",""
AB-19109173,4,6,C,牛車腎気丸,"",経口,20170714,"",7.5,g,1,神経系障害(神経障害),未知,"",""
AB-19109173,4,7,C,ウルソデオキシコール酸,"",経口,20180413,"",300,mg,1,胆汁うっ滞(胆汁うっ滞),未知,"",""
AB-19109463,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190104;20190329,20190215;20190524,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,アスパラギン酸アミノトランスフェラーゼ増加(不明);死亡(不明);肺炎(不明);血中アルカリホスファターゼ増加(不明);アスパラギン酸アミノトランスフェラーゼ増加(不明);腹膜転移(不明);アラニンアミノトランスフェラーゼ増加(不明);アラニンアミノトランスフェラーゼ増加(不明);呼吸不全(不明),""
AB-19109466,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180608,20181130,180,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下垂体炎(再投与なし),""
AB-19109467,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180821;,;20190226,170;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,１型糖尿病(再投与なし),""
AB-19109635,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181204;20190226,20181218;20190226,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,糸球体腎炎(有),""
AB-19109636,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190320,20190417,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,薬物性肝障害(再投与なし),""
AB-19109636,4,2,C,オキシコドン塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-19109636,4,3,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-19109636,4,4,C,レバミピド,"",不明,"","","","","","",未知,"",""
AB-19109636,4,5,C,アスピリン,"",経口,"","","","","",予防(予防),未知,"",""
AB-19109636,4,6,C,酸化マグネシウム,"",不明,"","","","","",便秘(便秘),未知,"",""
AB-19109636,4,7,C,ルビプロストン,"",不明,"","","","","",便秘(便秘),未知,"",""
AB-19109638,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180626,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(無);脱髄性多発ニューロパチー(無),""
AB-19109638,3,2,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-19109788,3,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴,20190227,"","","","",胃癌(胃癌),剂量停止,"",""
AB-19109788,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口,20180727;20190201,;20190215,120;100,mg;mg,1;1,胃癌(胃癌),剂量停止,"",""
AB-19109788,3,3,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20180727,20190201,200,mg,1,胃癌(胃癌),剂量停止,"",""
AB-19109788,3,4,C,オキサリプラチン,"",静脈内点滴,20180727,"",230,mg,1,胃癌(胃癌),剂量停止,"",""
AB-19109788,3,5,C,ラムシルマブ,"",静脈内点滴,20190227,"","","","",胃癌(胃癌),剂量停止,"",""
AB-19109788,3,6,C,酸化マグネシウム,"",経口,20180620,"",250,mg,1,便秘(便秘),剂量不变,"",""
AB-19109788,3,7,C,大建中湯,"",経口,20180620,"",2.5,g,1,便秘(便秘),剂量不变,"",""
AB-19109788,3,8,C,ボノプラザンフマル酸塩,"",経口,20180621,"",20,mg,1,出血予防(胃出血予防),剂量不变,"",""
AB-19109908,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-19110272,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181012,20190111,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,抗利尿ホルモン不適合分泌(再投与なし),""
AB-19110273,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181001,20190219,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,胆管炎(再投与なし),""
AB-19110273,3,2,PS,ドセタキセル,"",静脈内点滴;静脈内点滴,20190320;20190416,20190320;20190810,;99,;mg,;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量减少,"",""
AB-19110273,3,3,C,ヘパリン類似物質,"",経皮,20180119,"",2,g,1,皮膚炎(皮膚炎),未知,"",""
AB-19110273,3,4,C,ロキソプロフェンナトリウム水和物,"",経口,20180607,"",60,mg,1,癌疼痛(癌性疼痛),未知,"",""
AB-19110273,3,5,C,エソメプラゾールマグネシウム水和物,"",経口,20180614,"",10,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19110273,3,6,C,ニフェジピン,"",経口,20180625,"",500,ug,1,高血圧(高血圧),未知,"",""
AB-19110273,3,7,C,タペンタドール塩酸塩,"",経口,20181030,"",75,mg,1,癌疼痛(癌性疼痛),未知,"",""
AB-19110273,3,8,C,ペグフィルグラスチム,"",皮下,20190322,"","","","","",未知,"",""
AB-19110273,3,9,C,メトクロプラミド,"",経口,"","","","","","",未知,"",""
AB-19110273,3,10,C,アセトアミノフェン,"",経口,"","","","","","",未知,"",""
AB-19110273,3,11,C,牛車腎気丸,"",経口,"","","","","","",未知,"",""
AB-19110273,3,12,C,メコバラミン,"",経口,"","","","","","",未知,"",""
AB-19110273,3,13,C,アズレンスルホン酸ナトリウム水和物・炭酸水素ナトリウム,"",経口,"","","","","","",未知,"",""
AB-19110273,3,14,C,ヒドロモルフォン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-19110273,3,15,C,センノシド,"",経口,"","",12,mg,1,便秘(便秘症),未知,"",""
AB-19110273,3,16,C,酸化マグネシウム,"",経口,"","",250,mg,1,便秘(便秘症),未知,"",""
AB-19110273,3,17,C,1172010,"",経口,"","",5,mg,1,悪心(嘔気症),未知,"",""
AB-19110512,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,潰瘍性大腸炎(再投与なし),""
AB-19110792,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181203,20190218,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし);下垂体機能低下症(再投与なし),""
AB-19110792,4,2,C,膵臓性消化酵素配合剤（１）,"",経口,20130121,"",1,g,1,"",未知,"",""
AB-19110792,4,3,C,チペピジンヒベンズ酸塩,"",経口,20151026,"",10,mg,1,"",未知,"",""
AB-19110792,4,4,C,モサプリドクエン酸塩水和物,"",経口,20170424,"",5,mg,1,"",未知,"",""
AB-19110792,4,5,C,ボノプラザンフマル酸塩,"",経口,20180803,"",20,mg,1,"",未知,"",""
AB-19110792,4,6,C,生理食塩液,"",静脈内点滴,20181203,20190218,100,mL,1,予防(予防投与),未知,"",""
AB-19110792,4,7,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20181203,20190218,6.6,mg,1,予防(予防投与),未知,"",""
AB-19110792,4,8,C,塩酸メトクロプラミド,"",静脈内点滴,20181203,20190218,10,mg,1,予防(予防投与),未知,"",""
AB-19110793,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190108,20190423,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19110793,2,2,C,レバミピド,"",経口,20171129,20190605,100,mg,1,"",剂量不变,"",""
AB-19110793,2,3,C,クエン酸第一鉄ナトリウム,"",経口,20171129,20190605,50,mg,1,"",剂量不变,"",""
AB-19110793,2,4,C,ランソプラゾール,"",経口,20171204,20190605,10,mg,1,"",剂量不变,"",""
AB-19110793,2,5,C,アセトアミノフェン,"",経口,20171207,20190605,400,mg,1,"",剂量不变,"",""
AB-19110793,2,6,C,酸化マグネシウム,"",経口,20171207,20190605,330,mg,1,"",剂量不变,"",""
AB-19110793,2,7,C,バルサルタン,"",経口,20180911,20190605,120,mg,1,"",剂量不变,"",""
AB-19110793,2,8,C,アムロジピンベシル酸塩,"",経口,20181009,20190605,2.5,mg,1,"",剂量不变,"",""
AB-19111120,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181210;,20190212;201905,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-19111123,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190225;,;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,成人潜在性自己免疫性糖尿病(再投与なし);続発性副腎皮質機能不全(再投与なし);副腎機能不全(再投与なし);感染(再投与なし),""
AB-19111123,7,2,C,アムロジピンベシル酸塩,"",経口,20190225,"",2.5,mg,1,高血圧(高血圧),未知,"",""
AB-19111123,7,3,C,カルバマゼピン,"",経口,20190401,"",100,mg,1,中枢神経系転移(転移性脳腫瘍),未知,"",""
AB-19111123,7,4,C,レベチラセタム,"",不明,"","","","","","",未知,"",""
AB-19111123,7,5,C,ジアゼパム,"",不明,"","","","","","",未知,"",""
AB-19111123,7,6,C,レベチラセタム,"",不明,"","","","","","",未知,"",""
AB-19111131,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190122,20190205,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし);ミオパチー(再投与なし),""
AB-19111131,6,2,PS,ジアスターゼ配合剤（１）,タフマックＥ,経口,"","",1,{DF},1,消化不良(不消化),剂量停止,重症筋無力症(再投与なし);ミオパチー(再投与なし),""
AB-19111131,6,3,C,アゾセミド,"",経口,20181211,"","","","",浮腫(浮腫),未知,"",""
AB-19111131,6,4,C,エロビキシバット水和物,"",経口,20181211,"","","","",便秘(便秘),未知,"",""
AB-19111131,6,5,C,ボノプラザンフマル酸塩,"",経口,20181228,"",20,mg,1,予防(NSAIDs潰瘍予防),未知,"",""
AB-19111131,6,6,C,アムロジピンベシル酸塩,"",経口,"","","","","",高血圧(高血圧),未知,"",""
AB-19111131,6,7,C,アトルバスタチンカルシウム水和物,"",経口,"","","","","",高脂血症(高脂血症),未知,"",""
AB-19111131,6,8,C,テルミサルタン,"",経口,"","","","","",高血圧(高血圧),未知,"",""
AB-19111131,6,9,C,ロキソプロフェンナトリウム水和物,"",経口,"","","","","",疼痛(疼痛),未知,"",""
AB-19111131,6,10,C,酪酸菌製剤,"",経口,"","",1,g,1,胃腸障害予防(整腸),未知,"",""
AB-19111134,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201904,201905,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発熱(再投与なし),""
AB-19111137,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190509,20190509,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし),""
AB-19111137,1,2,C,セレコキシブ,"",経口,"","",100,mg,1,"",未知,"",""
AB-19111137,1,3,C,スピロノラクトン,"",経口,"","",100,mg,1,"",未知,"",""
AB-19111137,1,4,C,フロセミド,"",経口,"","",80,mg,1,"",未知,"",""
AB-19111137,1,5,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-19111137,1,6,C,酪酸菌製剤,"",経口,"","",3,{DF},1,"",未知,"",""
AB-19111137,1,7,C,クエン酸第一鉄ナトリウム,"",経口,"","",200,mg,1,"",未知,"",""
AB-19111137,1,8,C,オランザピン,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-19111137,1,9,C,レボフロキサシン水和物,"",経口,"","",1,{DF},1,"",未知,"",""
AB-19111137,1,10,C,エチゾラム,"",経口,"","",.5,mg,1,"",未知,"",""
AB-19111390,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181116;20190215,20190125;20190310,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし);肝機能異常(再投与なし);原発性甲状腺機能低下症(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-19111390,5,2,C,フロセミド,"",経口,20180831,"",20,mg,1,"",未知,"",""
AB-19111405,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190517,20190517,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,高カルシウム血症(再投与なし),""
AB-19111405,3,2,C,維持液（３）,"",不明,"","",500,mL,1,"",未知,"",""
AB-19111405,3,3,C,オルメサルタンメドキソミル,"",経口,"","",20,mg,1,"",未知,"",""
AB-19111405,3,4,C,ボノプラザンフマル酸塩,"",経口,"","",20,mg,1,"",未知,"",""
AB-19111405,3,5,C,アムロジピンベシル酸塩,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-19112068,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180810,20180914,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,薬物性肝障害(再投与なし),""
AB-19112160,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180920,"",240,mg,1,胃癌(がん化学療法後に増悪した治療切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(不明),""
AB-19112165,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190125,20190308,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-19112396,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190416,20190729,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,水腎症(再投与なし),""
AB-19112403,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201905;2019,201905;2019,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(不明),""
AB-19112926,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",204,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,播種性血管内凝固(再投与なし),""
AB-19112933,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180803,20190329,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎皮質刺激ホルモン欠損症(再投与なし);続発性副腎皮質機能不全(再投与なし);多発性関節炎(再投与なし),""
AB-19113258,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190530,20190530,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,痙攣発作(再投与なし);注入に伴う反応(再投与なし),""
AB-19113578,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,多発性単ニューロパチー(再投与なし),""
AB-19113581,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171219,20180403,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-19113581,2,2,PS,イリノテカン塩酸塩水和物,"",不明,20181112,20190326,130,mg,1,"",不适用,"",""
AB-19113922,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190320,20190403,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,筋炎(再投与なし);心筋炎(再投与なし);重症筋無力症(再投与なし);肝炎(再投与なし),""
AB-19113922,3,2,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-19113922,3,3,C,ロペラミド塩酸塩,"",経口,"","",1,mg,1,"",未知,"",""
AB-19113922,3,4,C,プレガバリン,"",経口,"","",25,mg,1,"",未知,"",""
AB-19113922,3,5,C,ケトプロフェン,"",経皮,"","",20,mg,1,"",未知,"",""
AB-19113922,3,6,C,ブロチゾラム,"",経口,"","",.25,mg,1,"",未知,"",""
AB-19113923,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190430,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,発熱(再投与なし);尿路感染(再投与なし),""
AB-19113923,3,2,C,エソメプラゾールマグネシウム水和物,"",経口,"","",10,mg,1,胃炎予防(胃粘液保護),未知,"",""
AB-19113923,3,3,C,カンデサルタンシレキセチル,"",経口,"","",8,mg,1,高血圧(高血圧),未知,"",""
AB-19113923,3,4,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,高血圧(高血圧),未知,"",""
AB-19113930,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181018,20181226,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,心筋炎(再投与なし),""
AB-19114144,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201801,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,視床下部−下垂体障害(再投与なし),""
AB-19114145,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190208,20190308,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19114145,2,2,C,チオトロピウム臭化物水和物・オロダテロール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-19114145,2,3,C,Ｌ−カルボシステイン,"",不明,"","","","","","",未知,"",""
AB-19114145,2,4,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-19114145,2,5,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-19114145,2,6,C,レバミピド,"",不明,"","","","","","",未知,"",""
AB-19114145,2,7,C,テルミサルタン,"",不明,"","","","","","",未知,"",""
AB-19114145,2,8,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-19114145,2,9,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-19114145,2,10,C,アズレンスルホン酸ナトリウム水和物,"",口腔咽頭,"","","","","","",未知,"",""
AB-19114149,9,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190207;20190612,;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,虚血性心筋症(再投与なし);心房細動(再投与なし);心不全(再投与なし);慢性腎臓病(再投与なし);心筋炎(再投与なし),""
AB-19114149,9,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,201803,"","","","",化学療法(術後補助化学療法),不适用,"",""
AB-19114149,9,3,C,ビソプロロールフマル酸塩,"",経口;経口;経口,201709;20190329;20190405,201903;20190404;,1.25;2.5;3.75,mg;mg;mg,1;1;1,心室性頻脈(非持続性心室),未知,"",""
AB-19114149,9,4,C,アピキサバン,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-19114149,9,5,C,ニフェジピン,"",経口,"","",20,mg,1,"",未知,"",""
AB-19114149,9,6,C,アジルサルタン,"",経口,"","",20,mg,1,"",未知,"",""
AB-19114149,9,7,C,ニフェジピン,"",経口,"","",20,mg,1,"",未知,"",""
AB-19114151,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181011;20190110,20181206;20190124,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝胆道系疾患(無);下痢(無),""
AB-19114406,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,肝不全(再投与なし),""
AB-19114712,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171010,20171218,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-19114722,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190426,20190524,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,腹膜炎(再投与なし);胆管炎(再投与なし);肝膿瘍(再投与なし),""
AB-19114722,3,2,C,オルメサルタンメドキソミル,"",経口,"","",10,mg,1,"",未知,"",""
AB-19114722,3,3,C,パンクレリパーゼ,"",経口,"","",300,mg,1,"",未知,"",""
AB-19114722,3,4,C,シルニジピン,"",経口,"","",10,mg,1,"",未知,"",""
AB-19114722,3,5,C,フェキソフェナジン塩酸塩,"",経口,"","",60,mg,1,"",未知,"",""
AB-19114722,3,6,C,クエン酸第一鉄ナトリウム,"",経口,"","",60,mg,1,"",未知,"",""
AB-19114722,3,7,C,ロキソプロフェンナトリウム水和物,"",経皮,"","",50,mg,1,"",未知,"",""
AB-19114722,3,8,C,アセトアミノフェン,"",経口,"","",500,mg,1,"",未知,"",""
AB-19114722,3,9,C,トラマドール塩酸塩・アセトアミノフェン配合剤,"",経口,"","","","","","",未知,"",""
AB-19114722,3,10,C,センノシド,"",経口,"","",12,mg,1,"",未知,"",""
AB-19115030,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181228,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,急性膵炎(再投与なし),""
AB-19115030,1,2,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",局所,20190405,"",5,g,1,発疹(皮疹),未知,"",""
AB-19115030,1,3,C,ビラスチン,"",経口,20190426,"",20,mg,1,発疹(皮疹),未知,"",""
AB-19115032,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181106,20190212,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-19115051,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190425,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,重症筋無力症(再投与なし),""
AB-19115053,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20190327;20190424;20190710,2019;20190424;,150;240;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,ウイルス性髄膜炎(無);帯状疱疹(無);脳炎(無),""
AB-19115057,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181029,20181210,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,１型糖尿病(再投与なし),""
AB-19115057,4,2,C,レボチロキシンナトリウム水和物,"",経口,20181022,"",12.5,mg,1,"",未知,"",""
AB-19115057,4,3,C,ラムシルマブ,"",不明,20190107,20190714,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19115057,4,4,C,モサプリドクエン酸塩水和物,"",経口,"","",5,g,1,"",未知,"",""
AB-19115057,4,5,C,サナクターゼ配合剤,"",経口,"","",1,g,1,"",未知,"",""
AB-19115057,4,6,C,テルミサルタン,"",経口,"","",40,mg,1,"",未知,"",""
AB-19115281,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190222,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,胆汁うっ滞性黄疸(再投与なし),""
AB-19115283,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180501,20180501,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,肝障害(再投与なし),""
AB-19115289,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190426,20190531,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍出血(再投与なし),""
AB-19115291,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,類天疱瘡(再投与なし),""
AB-19115292,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190422,20190527,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-19115297,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-19115541,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190226,20190319,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし);グレーブス病(再投与なし),""
AB-19115560,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,劇症１型糖尿病(再投与なし),""
AB-19115561,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190502,20190530,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,急性腎障害(再投与なし);糖尿病性ケトアシドーシス(再投与なし);１型糖尿病(再投与なし),""
AB-19115561,2,2,C,アムロジピンベシル酸塩,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-19115561,2,3,C,フェブキソスタット,"",経口,"","",10,mg,1,"",未知,"",""
AB-19116151,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20181219,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,フォークト・小柳・原田病(再投与なし),""
AB-19116185,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180305,20181003,144,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19116186,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし),""
AB-19116862,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19116863,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19116864,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19116865,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19116866,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19116867,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19116868,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19116870,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19116871,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,2017,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(不明);腸閉塞(不明),""
AB-19116873,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19116875,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19116879,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19116881,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19116884,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19117193,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190516,20190519,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腹痛(再投与なし),""
AB-19117199,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190509,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,類天疱瘡(再投与なし),""
AB-19117199,3,2,C,プレドニゾロン,"",不明;不明,;,;,15;3,mg;mg,1;1,類天疱瘡(類天疱瘡),未知,"",""
AB-19117479,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190530,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19117483,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし),""
AB-19117488,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190610,20190610,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,頭蓋内腫瘍出血(再投与なし),""
AB-19117794,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190517,20190517,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,横紋筋融解症(再投与なし);網膜出血(再投与なし);脳出血(再投与なし);血便排泄(再投与なし);意識変容状態(再投与なし),""
AB-19117794,5,2,C,プレガバリン,"",経口,"",20190531,75,mg,1,"",未知,"",""
AB-19117794,5,3,C,ベンフォチアミン・Ｂ６・Ｂ１２配合剤（１）,"",経口,"","",1,{DF},1,"",未知,"",""
AB-19117794,5,4,C,葉酸,"",経口,"","",5,mg,1,"",未知,"",""
AB-19117807,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190601,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,大腸炎(再投与なし),""
AB-19118153,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,発熱(再投与なし),""
AB-19118155,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201902,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし),""
AB-19118156,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180510,20181220,240,mg,1,頭頚部癌(再発又は遠隔転移を有する頭頸部癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19118156,2,2,C,フェンタニルクエン酸塩,"",経皮,"","",2,mg,1,"",未知,"",""
AB-19118156,2,3,C,オキシコドン塩酸塩水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-19118156,2,4,C,オランザピン,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-19118156,2,5,C,セレコキシブ,"",経口,"","",100,mg,1,"",未知,"",""
AB-19118156,2,6,C,ランソプラゾール,"",経口,"","",15,mg,1,"",未知,"",""
AB-19118156,2,7,C,ラメルテオン,"",経口,"","",8,mg,1,"",未知,"",""
AB-19118156,2,8,C,スボレキサント,"",経口,"","",15,mg,1,"",未知,"",""
AB-19118156,2,9,C,ポラプレジンク,"",経口,"","",75,mg,1,"",未知,"",""
AB-19118158,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,脳梗塞(再投与なし),""
AB-19118162,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,下痢(再投与なし),""
AB-19119121,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190424,20190605,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,リウマチ性多発筋痛(再投与なし),""
AB-19119125,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181122,20190221,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,下垂体機能低下症(再投与なし);続発性副腎皮質機能不全(再投与なし);低ナトリウム血症(再投与なし),""
AB-19119125,4,2,C,ポラプレジンク,"",不明,"","","","","","",未知,"",""
AB-19119125,4,3,C,メコバラミン,"",不明,"","","","","","",未知,"",""
AB-19119125,4,4,C,リュープロレリン酢酸塩,"",不明,"","","","","","",未知,"",""
AB-19119127,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190412,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,医療機器関連感染(再投与なし),""
AB-19119127,2,2,C,アミノ酸・糖・電解質・ビタミン（２−４）,"",不明,20190411,"",1500,mL,1,栄養補給(栄養維持),未知,"",""
AB-19119127,2,3,C,フェンタニルクエン酸塩,"",不明,20190506,"",720,ug,1,癌疼痛(癌性疼痛の緩和),未知,"",""
AB-19119500,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180516,20180618,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,腎障害(再投与なし),""
AB-19119500,1,2,C,イリノテカン塩酸塩水和物,"",不明,2018,"","","","","",未知,"",""
AB-19119502,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171019,20171207,177.75,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺水腫(再投与なし),""
AB-19119513,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180914;20181016,20180928;20181030,135.6;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,食欲減退(再投与なし),""
AB-19119516,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180919,20190724,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,ＩｇＡ腎症(再投与なし),""
AB-19119516,7,2,PS,プレドニゾロン,プレドニン,不明;不明;不明;不明;不明;不明;不明,20190612;2019;2019;2019;2019;2019;20191016,2019;2019;2019;2019;2019;2019;,30;25;20;15;10;5;2.5,mg;mg;mg;mg;mg;mg;mg,1;1;1;1;1;1;1,ＩｇＡ腎症(ＩｇＡ腎症),剂量减少,"",""
AB-19119516,7,3,C,アムロジピンベシル酸塩,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-19119516,7,4,C,サキサグリプチン水和物,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-19119516,7,5,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-19119516,7,6,C,メコバラミン,"",経口,"","",500,ug,1,"",未知,"",""
AB-19119516,7,7,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
AB-19119516,7,8,C,リナグリプチン,"",不明,"","",5,mg,1,２型糖尿病(２型糖尿病),未知,"",""
AB-19119601,3,1,PS,イピリムマブ,ヤーボイ,静脈内点滴,20190129,"",1,mg/kg,1,遠隔転移を伴う腎細胞癌(腎細胞癌),未知,"",""
AB-19119601,3,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20190129,"",240,mg,1,遠隔転移を伴う腎細胞癌(腎細胞癌),剂量停止,"",""
AB-19120127,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190314;20190613,2019;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(無),""
AB-19120127,2,2,C,エソメプラゾールマグネシウム水和物,"",経口,20180607,"",20,mg,1,胃食道逆流性疾患(逆流性食道炎),未知,"",""
AB-19120127,2,3,C,セレコキシブ,"",経口,20181106,"",100,mg,1,癌疼痛(癌性疼痛),未知,"",""
AB-19120127,2,4,C,塩酸メトクロプラミド,"",経口,20181106,"",5,mg,1,悪心(嘔気),未知,"",""
AB-19120127,2,5,C,ポラプレジンク,"",経口,20181203,"",.5,g,1,味覚障害(味覚障害),未知,"",""
AB-19120127,2,6,C,経腸成分栄養剤（２−１）,"",経口,20181210,"",250,mL,1,摂食障害(経口摂取困難),未知,"",""
AB-19120127,2,7,C,ニトラゼパム,"",経口,20181221,"",5,mg,1,不眠症(不眠症),未知,"",""
AB-19120127,2,8,C,モメタゾンフランカルボン酸エステル水和物,"",鼻,20190219,"",200,ug,1,アレルギー性鼻炎(アレルギー性鼻炎),未知,"",""
AB-19120127,2,9,C,センノシド,"",経口,"","",24,mg,1,便秘(便秘症),未知,"",""
AB-19120483,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180313,20180509,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,発熱(再投与なし),""
AB-19120483,1,2,PS,イリノテカン塩酸塩水和物,"",不明,20180711,20181114,130,mg,1,"",剂量不变,"",""
AB-19120874,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし),""
AB-19120880,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181116,20181130,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし);血小板減少症(再投与なし),""
AB-19120880,1,2,C,シタグリプチンリン酸塩水和物,"",経口,20181116,"",50,mg,1,糖尿病(DM),未知,"",""
AB-19120880,1,3,C,酸化マグネシウム,"",経口,20181116,"",330,mg,1,便秘(便秘),未知,"",""
AB-19120880,1,4,C,フロセミド,"",経口,20181116,"",20,mg,1,腹水(腹水),未知,"",""
AB-19120884,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180425;,;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(不明),""
AB-19120886,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし),""
AB-19120888,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180410;,;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(不明),""
AB-19120897,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190626;20190730,20190626;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,多形紅斑(無),""
AB-19121204,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20180906,20190604,200,mg,1,非小細胞肺癌(非小細胞肺癌),剂量停止,肺炎(再投与なし),""
AB-19121247,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171120,20190129,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-19121248,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190815,20190913,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,腎不全(再投与なし);肝不全(再投与なし);譫妄(再投与なし),""
AB-19121250,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190606,20190620,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,中毒性表皮壊死融解症(再投与なし),""
AB-19121254,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181204,20190125,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,乾癬(再投与なし),""
AB-19121371,3,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20190522,"",50,mg,1,胃腺癌(胃腺癌);食道腺癌(食道腺癌),剂量不变,食欲減退(無),""
AB-19121371,3,2,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190522,"","","","",胃腺癌(胃腺癌);食道腺癌(食道腺癌),剂量不变,"",""
AB-19121371,3,3,PS,オキサリプラチン,"",静脈内点滴,20190522,"",222.3,mg,1,胃腺癌(胃腺癌);食道腺癌(食道腺癌),剂量不变,"",""
AB-19121371,3,4,PS,トラスツズマブ,"",静脈内点滴;静脈内点滴,20190522;20190612,20190522;,512.8;384.6,mg;mg,1;1,胃腺癌(胃腺癌);食道腺癌(食道腺癌),剂量不变,"",""
AB-19121371,3,5,C,エゼチミブ,"",経口,201801,20190526,10,mg,1,"",不适用,"",""
AB-19121371,3,6,C,ゾルピデム酒石酸塩,"",経口,201801,20190611,5,mg,1,不眠症(不眠症悪化),剂量停止,"",""
AB-19121371,3,7,C,センノシド,"",経口,201801,"",12,mg,1,"",剂量不变,"",""
AB-19121371,3,8,C,ナフトピジル,"",経口,201801,20190526,75,mg,1,"",不适用,"",""
AB-19121371,3,9,C,ラタノプロスト,"",眼,201801,"",1,[drp],1,"",剂量不变,"",""
AB-19121371,3,10,C,クエン酸第一鉄ナトリウム,"",経口,201801,20190611,50,mg,1,"",剂量停止,"",""
AB-19121371,3,11,C,グラニセトロン塩酸塩,"",静脈内点滴,20190522,20190522,3,mg,1,"",不适用,"",""
AB-19121371,3,12,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20190522,20190522,9.9,mg,1,"",不适用,"",""
AB-19121371,3,13,C,プロクロルペラジンマレイン酸塩,"",経口,20190522,20190613,5,mg,1,悪心(悪心),剂量停止,"",""
AB-19121371,3,14,C,デキサメタゾン,"",経口,20190523,20190523,4,mg,1,"",不适用,"",""
AB-19121371,3,15,C,メトクロプラミド,"",経口,20190525,20190526,5,mg,1,"",不适用,"",""
AB-19121371,3,16,C,ナフトピジル,"",経口,20190527,"",50,mg,1,"",剂量不变,"",""
AB-19121371,3,17,C,ゾルピデム酒石酸塩,"",経口,20190527,20190611,5,mg,1,不眠症(不眠症悪化),剂量停止,"",""
AB-19121371,3,18,C,ナテグリニド,"",経口,20190527,20190619,30,mg,1,"",剂量停止,"",""
AB-19121371,3,19,C,ナテグリニド,"",経口,201801,20190527,30,mg,1,"",不适用,"",""
AB-19121371,3,20,C,シタグリプチンリン酸塩水和物,"",経口,201801,20190527,50,mg,1,"",不适用,"",""
AB-19121371,3,21,C,アスピリン,"",経口,201801,"",100,mg,1,"",剂量不变,"",""
AB-19121371,3,22,C,オメプラゾール,"",経口,201801,20190527,20,mg,1,"",不适用,"",""
AB-19121371,3,23,C,カンデサルタンシレキセチル,"",経口,201801,20190527,4,mg,1,"",不适用,"",""
AB-19121371,3,24,C,ロスバスタチンカルシウム,"",経口,201801,20190526,5,mg,1,"",不适用,"",""
AB-19121525,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190108,20190612,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19121526,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(unresectable recurrent gastric cancer),不适用,死亡(再投与なし),""
AB-19121528,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190520,20190520,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,胸水(再投与なし);心筋症(再投与なし),""
AB-19121529,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,血小板数減少(再投与なし);血球貪食性リンパ組織球症(再投与なし),""
AB-19122123,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-19122862,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,細菌性肺炎(再投与なし),""
AB-19122865,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190510,20190920,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-19122865,2,2,PS,リマプロストアルファデクス,オパルモン,経口,20170719,"",5,ug,1,腰部脊柱管狭窄症(腰部脊柱管狭窄症),剂量不变,副腎機能不全(再投与なし),""
AB-19122865,2,3,C,セレコキシブ,"",経口,20170719,"",100,mg,1,"",未知,"",""
AB-19122865,2,4,C,ファモチジン,"",経口,20171204,"",20,mg,1,予防(予防),未知,"",""
AB-19122865,2,5,C,酸化マグネシウム,"",経口,20171204,"",330,mg,1,"",未知,"",""
AB-19122865,2,6,C,レボチロキシンナトリウム水和物,"",経口,20190412,"",25,ug,1,甲状腺機能低下症(甲状腺機能低下症),未知,"",""
AB-19122865,2,7,C,インドメタシン,"",経皮,"","",1,{DF},1,"",未知,"",""
AB-19123169,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20190111;20190524;,20190405;;,240;240;,mg;mg;,1;1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-19123169,5,2,C,ロキソプロフェンナトリウム水和物,"",経口,"","",1,{DF},1,"",未知,"",""
AB-19123169,5,3,C,レバミピド,"",経口,"","",1,{DF},1,"",未知,"",""
AB-19123169,5,4,C,アミノ酸・糖・電解質・ビタミン（２−６）,"",静脈内（明記されていない場合）,"","",1500,mL,1,"",未知,"",""
AB-19123175,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肺炎(再投与なし),""
AB-19123383,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190207,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,シェーグレン症候群(再投与なし),""
AB-19123384,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,難聴(再投与なし);間質性肺疾患(再投与なし),""
AB-19123387,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201803,201901,120,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,誤嚥性肺炎(再投与なし);１型糖尿病(再投与なし),""
AB-19123391,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181217,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-19123740,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181116,20190517,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,視床下部−下垂体障害(再投与なし),""
AB-19123740,1,2,PS,ジアスターゼ配合剤（１）,タフマックＥ,経口,"","",10,mg,1,"",剂量不变,視床下部−下垂体障害(再投与なし),""
AB-19123740,1,3,C,フェブキソスタット,"",経口,20190510,"",5,mg,1,"",未知,"",""
AB-19123740,1,4,C,モサプリドクエン酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-19123740,1,5,C,酸化マグネシウム,"",経口,"","",330,mg,1,"",未知,"",""
AB-19123749,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190405,201907,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,低ナトリウム血症(再投与なし),""
AB-19123753,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190516,20190529,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,脳梗塞(再投与なし),""
AB-19123753,4,2,PS,ラムシルマブ,サイラムザ,静脈内点滴,20181114,20190414,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-19123753,4,3,C,オルメサルタンメドキソミル,"",不明,"","",20,mg,1,高血圧(高血圧),未知,"",""
AB-19124073,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190705,20190705,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,横紋筋融解症(再投与なし);心筋炎(再投与なし),""
AB-19124073,3,2,C,プレガバリン,"",経口,"",20190717,75,mg,1,"",未知,"",""
AB-19124073,3,3,C,クエン酸第一鉄ナトリウム,"",経口,"",20190717,50,mg,1,"",未知,"",""
AB-19124073,3,4,C,ロキソプロフェンナトリウム水和物,"",経口,"",20190717,60,mg,1,"",未知,"",""
AB-19124073,3,5,C,モサプリドクエン酸塩水和物,"",経口,"",20190717,5,mg,1,"",未知,"",""
AB-19124073,3,6,C,酸化マグネシウム,"",経口,"",20190717,330,mg,1,"",未知,"",""
AB-19124073,3,7,C,フロセミド,"",経口,"",20190717,20,mg,1,"",未知,"",""
AB-19124073,3,8,C,スピロノラクトン,"",経口,"",20190717,12.5,mg,1,"",未知,"",""
AB-19124073,3,9,C,エソメプラゾールマグネシウム水和物,"",経口,"",20190717,20,mg,1,"",未知,"",""
AB-19124073,3,10,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",局所,"","","","","","",未知,"",""
AB-19124073,3,11,C,トリベノシド・リドカイン,"",局所,"","","","","","",未知,"",""
AB-19124168,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20180914,20190527,200,mg,1,非小細胞肺癌(非小細胞肺癌),未知,遊走性血栓静脈炎(再投与なし);副腎機能不全(再投与なし);関節炎(再投与なし),""
AB-19124356,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181119,20190218,240,mg,1,胃癌(がん化学療法後に増悪した治療切除不能な進行・再発の胃癌),剂量停止,腎機能障害(再投与なし),""
AB-19124357,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190702,20190702,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,下痢(再投与なし),""
AB-19124357,1,2,C,牛車腎気丸,"",経口,"","","","","","",未知,"",""
AB-19124357,1,3,C,メコバラミン,"",経口,"","","","","","",未知,"",""
AB-19124357,1,4,C,アムロジピンベシル酸塩,"",経口,"","","","","","",未知,"",""
AB-19124357,1,5,C,バルサルタン,"",経口,"","","","","","",未知,"",""
AB-19124357,1,6,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","","",未知,"",""
AB-19124357,1,7,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
AB-19124357,1,8,C,クエン酸第一鉄ナトリウム,"",経口,"","","","","","",未知,"",""
AB-19124357,1,9,C,アルギン酸ナトリウム,"",経口,"","","","","","",未知,"",""
AB-19124357,1,10,C,ウルソデオキシコール酸,"",経口,"","","","","","",未知,"",""
AB-19124357,1,11,C,フロセミド,"",経口,"","","","","","",未知,"",""
AB-19124357,1,12,C,デキサメタゾン,"",口腔咽頭,"","","","","","",未知,"",""
AB-19124736,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,120;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,血中クレアチンホスホキナーゼ増加(再投与なし),""
AB-19124745,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180904,20181016,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,薬物性肝障害(再投与なし),""
AB-19124746,3,1,PS,ニボルマブ,オプジーボ,その他(CVポート),20190718,20190718,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,悪寒(再投与なし);発熱(再投与なし);くも膜下出血(再投与なし),""
AB-19124746,3,2,C,ニフェジピン,"",経口,"","",20,mg,1,"",未知,"",""
AB-19124746,3,3,C,アジルサルタン,"",経口,"","",20,mg,1,"",未知,"",""
AB-19124746,3,4,C,トラマドール塩酸塩,"",経口,"","",50,mg,1,"",未知,"",""
AB-19124746,3,5,C,アセトアミノフェン,"",経口,"","",500,mg,1,"",未知,"",""
AB-19124746,3,6,C,酸化マグネシウム,"",経口,"","",330,mg,1,"",未知,"",""
AB-19124746,3,7,C,大建中湯,"",経口,"","",2.5,g,1,"",未知,"",""
AB-19124746,3,8,C,酪酸菌製剤,"",経口,"","",2,{DF},1,"",未知,"",""
AB-19124746,3,9,C,酪酸菌配合剤,"",経口,"","",2,{DF},1,"",未知,"",""
AB-19124746,3,10,C,ウルソデオキシコール酸,"",経口,"","",100,mg,1,"",未知,"",""
AB-19124746,3,11,C,タムスロシン塩酸塩,"",経口,"","",.2,mg,1,"",未知,"",""
AB-19125013,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190514,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-19125013,3,2,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","","",未知,"",""
AB-19125013,3,3,C,クエン酸第一鉄ナトリウム,"",経口,"","","","","","",未知,"",""
AB-19125013,3,4,C,スピロノラクトン,"",経口,"","","","","","",未知,"",""
AB-19125013,3,5,C,スボレキサント,"",経口,"","","","","","",未知,"",""
AB-19125013,3,6,C,モサプリドクエン酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-19125013,3,7,C,ベザフィブラート,"",経口,"","","","","","",未知,"",""
AB-19125013,3,8,C,ビルダグリプチン,"",経口,"","","","","","",未知,"",""
AB-19125014,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180508,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,膀胱出血(再投与なし),""
AB-19125016,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19125017,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201809,201811,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍のハイパープログレッション(再投与なし),""
AB-19125024,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19125199,10,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20190717,20190721,60,mg,1,胃腺癌(HER2陽性進行性胃腺癌),剂量停止,疲労(無);食欲減退(無);脱水(無);出血性胃潰瘍(無),""
AB-19125199,10,2,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190717,"","","","",胃腺癌(HER2陽性進行性胃腺癌),剂量停止,"",""
AB-19125199,10,3,PS,オキサリプラチン,"",静脈内点滴,20190717,"",210.9,mg,1,胃腺癌(HER2陽性進行性胃腺癌),剂量停止,"",""
AB-19125199,10,4,PS,トラスツズマブ,"",静脈内点滴;静脈内点滴,20190717;,20190717;,500.8;6,mg;mg/kg,1;1,胃腺癌(HER2陽性進行性胃腺癌),剂量停止,"",""
AB-19125199,10,5,C,ミグリトール,"",経口,20100908,20190719,25,mg,1,糖尿病(糖尿病),剂量停止,"",""
AB-19125199,10,6,C,メトホルミン塩酸塩,"",経口,20100908,20190719,250,mg,1,糖尿病(糖尿病),剂量停止,"",""
AB-19125199,10,7,C,ロスバスタチンカルシウム,"",経口,20140331,20190719,2.5,mg,1,"",剂量停止,"",""
AB-19125199,10,8,C,イコサペント酸エチル,"",経口,20110323,20190719,600,mg,1,高脂血症(高脂血症),剂量停止,"",""
AB-19125199,10,9,C,ラタノプロスト・チモロールマレイン酸塩,"",眼,20110902,"",1,[drp],1,緑内障(緑内障),剂量不变,"",""
AB-19125199,10,10,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20190717,20190717,6.6,mg,1,悪心・嘔吐の予防(制吐),不适用,"",""
AB-19125199,10,11,C,グラニセトロン塩酸塩,"",静脈内点滴,20190717,20190717,3,mg,1,悪心・嘔吐の予防(制吐),不适用,"",""
AB-19125199,10,12,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",局所,20190718,20190720,1,{DF},1,"",剂量停止,"",""
AB-19125283,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180221,20180422,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-19125283,1,2,C,イリノテカン塩酸塩水和物,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19125384,3,1,PS,パクリタキセル,タキソール,不明,20181023,20190604,"","","",胃癌(胃癌),不适用,くも膜下出血(再投与なし),""
AB-19125384,3,2,PS,ニボルマブ,オプジーボ,静脈内点滴,201907181450,201907181530,240,mg,1,胃癌(胃癌),不适用,くも膜下出血(再投与なし),""
AB-19125384,3,3,PS,ラムシルマブ,"",不明,20181023,20190604,"","","",胃癌(胃癌),不适用,"",""
AB-19125384,3,4,C,ニフェジピン,"",経口,"","",20,mg,1,適応症不明の製品使用(適応症不明の製品使用),剂量停止,"",""
AB-19125384,3,5,C,アジルサルタン,"",経口,"","",20,mg,1,適応症不明の製品使用(適応症不明の製品使用),剂量停止,"",""
AB-19125384,3,6,C,トラマドール塩酸塩,"",経口,"","",150,mg,1,適応症不明の製品使用(適応症不明の製品使用),剂量停止,"",""
AB-19125384,3,7,C,アセトアミノフェン,"",経口,"","",1500,mg,1,適応症不明の製品使用(適応症不明の製品使用),剂量停止,"",""
AB-19125384,3,8,C,酸化マグネシウム,"",経口,"","",990,mg,1,適応症不明の製品使用(適応症不明の製品使用),剂量停止,"",""
AB-19125384,3,9,C,大建中湯,"",経口,"","",7.5,g,1,適応症不明の製品使用(適応症不明の製品使用),剂量停止,"",""
AB-19125384,3,10,C,酪酸菌製剤,"",経口,"","","","","",適応症不明の製品使用(適応症不明の製品使用),剂量停止,"",""
AB-19125384,3,11,C,酪酸菌配合剤,"",経口,"","","","","",適応症不明の製品使用(適応症不明の製品使用),剂量停止,"",""
AB-19125384,3,12,C,ウルソデオキシコール酸,"",経口,"","",300,mg,1,適応症不明の製品使用(適応症不明の製品使用),剂量停止,"",""
AB-19125384,3,13,C,タムスロシン塩酸塩,"","","","",.2,mg,1,適応症不明の製品使用(適応症不明の製品使用),剂量停止,"",""
AB-19125939,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171212,20180214,140,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19125945,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,心不全(再投与なし);小腸炎(再投与なし),""
AB-19125954,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19126279,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190703,20190708,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,直腸炎(再投与なし),""
AB-19126563,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190621,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,尿細管間質性腎炎(再投与なし),""
AB-19126563,2,2,PS,ラベプラゾールナトリウム,ラベプラゾールＮａ,経口,"","","","","","",剂量停止,"",""
AB-19126952,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190220;20190820,20190611;20190820,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,リウマチ性多発筋痛(再投与なし);リウマチ性多発筋痛(再投与なし),""
AB-19126952,3,2,C,ラベプラゾールナトリウム,"",経口,20170830,"",10,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19126952,3,3,C,大建中湯,"",経口,20170906,"",2.5,g,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19126952,3,4,C,酸化マグネシウム,"",経口,20170915,"",330,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19126952,3,5,C,ナプロキセン,"",経口,20181219,"",100,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19126952,3,6,C,クエン酸第一鉄ナトリウム,"",経口,20190209,"",50,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19127155,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,自殺既遂(再投与なし),""
AB-19127915,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181128,20190717,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19127918,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19127921,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19127922,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19127923,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19127924,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190704,20190718,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,膜性糸球体腎炎(再投与なし),""
AB-19127925,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19127936,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19127937,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19127939,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19127940,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19127941,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19127942,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19127943,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19127944,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19128007,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190723,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,食欲減退(再投与なし),""
AB-19128156,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,腹部膿瘍(再投与なし),""
AB-19128163,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,メレナ(再投与なし),""
AB-19128164,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190619,20190702,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝障害(再投与なし),""
AB-19128164,2,2,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-19128164,2,3,C,ロキソプロフェンナトリウム水和物,"",経皮,"","","","","","",未知,"",""
AB-19128164,2,4,C,経腸成分栄養剤（２−１）,"",経口,"","","","","","",未知,"",""
AB-19128164,2,5,C,ピコスルファートナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-19128164,2,6,C,ベポタスチンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-19128164,2,7,C,プレガバリン,"",不明,"","","","","","",未知,"",""
AB-19128370,2,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,"","",10,mg/kg,1,非小細胞肺癌(CRT後の非小細胞肺癌),剂量停止,"",""
AB-19128390,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181120,20190122,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,気胸(再投与なし);気胸(再投与なし),""
AB-19128392,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181102,20190705,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,ラクナ梗塞(再投与なし);末梢性ニューロパチー(再投与なし);末梢性ニューロパチー(再投与なし),""
AB-19128392,4,2,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-19128392,4,3,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-19128392,4,4,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-19128392,4,5,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-19128392,4,6,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-19128392,4,7,C,プレガバリン,"",不明,"","","","","","",未知,"",""
AB-19128392,4,8,C,メコバラミン,"",不明,"","","","","","",未知,"",""
AB-19129136,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180323,"",120,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,ぶどう膜炎(再投与なし),""
AB-19129136,2,2,C,ヒドロコルチゾン,"",不明,"","","","","","",未知,"",""
AB-19129136,2,3,C,ラベプラゾールナトリウム,"",不明,"","","","","","",未知,"",""
AB-19129140,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,2017,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19129346,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181214,20190125,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,水疱(再投与なし);皮膚潰瘍(再投与なし);粘膜障害(再投与なし),""
AB-19129346,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,2019,201903,"","","",胃癌(胃癌),剂量停止,"",""
AB-19129346,2,3,PS,ドセタキセル,"",不明,2019,201903,"","","",胃癌(胃癌),剂量停止,"",""
AB-19129347,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190509;2020,20190801;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,尿細管間質性腎炎(不明),""
AB-19129347,4,2,C,ロキソプロフェンナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-19129547,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190624,20190708,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,多発性筋炎(再投与なし);重症筋無力症(再投与なし),""
AB-19129547,4,2,C,アジルサルタン,"",経口,"","","","","","",未知,"",""
AB-19129547,4,3,C,ニフェジピン,"",経口,"","","","","","",未知,"",""
AB-19129548,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201808,201905,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19129751,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190620,20190813,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,食欲減退(再投与なし),""
AB-19129751,2,2,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-19129751,2,3,C,メコバラミン,"",不明,"","","","","","",未知,"",""
AB-19129751,2,4,C,ドンペリドン,"",不明,"","","","","","",未知,"",""
AB-19129751,2,5,C,レバミピド,"",不明,"","","","","","",未知,"",""
AB-19129751,2,6,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-19129751,2,7,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-19129751,2,8,C,トラマドール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-19129751,2,9,C,リセドロン酸ナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-19129751,2,10,C,エルデカルシトール,"",不明,"","","","","","",未知,"",""
AB-19129751,2,11,C,酪酸菌配合剤,"",不明,"","","","","","",未知,"",""
AB-19129751,2,12,C,半夏瀉心湯,"",不明,"","","","","","",未知,"",""
AB-19129751,2,13,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-19129751,2,14,C,トラマドール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-19129751,2,15,C,アレンドロン酸ナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-19129751,2,16,C,アルファカルシドール,"",不明,"","","","","","",未知,"",""
AB-19129751,2,17,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
AB-19129751,2,18,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-19129752,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190731;20190918,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19129754,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190731,20190814,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,気胸(再投与なし),""
AB-19129965,3,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口,20180607;20190104,;20190621,50;40,mg;mg,1;1,胃癌(胃癌),剂量停止,"",""
AB-19129965,3,2,PS,ラフチジン,プロテカジン,経口,20180530,20190822,10,mg,1,悪心(悪心),剂量停止,"",""
AB-19129965,3,3,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20180607,20190607,200,mg,1,胃癌(胃癌),剂量停止,"",""
AB-19129965,3,4,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20180607;20180720;20181012,;;20190104,170;130;100,mg;mg;mg,1;1;1,胃癌(胃癌),剂量停止,"",""
AB-19129965,3,5,C,デキサメタゾン,"",局所,20180530,20190822,"","","",口内炎(口腔粘膜炎),剂量停止,"",""
AB-19129965,3,6,C,グラニセトロン塩酸塩,"",経口,20180608,20190822,"","","",悪心(悪心),剂量停止,"",""
AB-19129965,3,7,C,アセトアミノフェン,"",経口,20180613,20190822,"","","",発熱(発熱),剂量停止,"",""
AB-19129965,3,8,C,ロペラミド塩酸塩,"",経口,20180613,20190822,"","","",下痢(下痢),剂量停止,"",""
AB-19129965,3,9,C,半夏瀉心湯,"",経口,20180706,20190822,"","","",口内炎(口腔粘膜炎),剂量停止,"",""
AB-19129965,3,10,C,酢酸亜鉛水和物,"",経口,20180720,20190822,"","","",味覚障害(味覚障害),剂量停止,"",""
AB-19129965,3,11,C,クエン酸第一鉄ナトリウム,"",経口,20190309,20190822,10,mg,1,貧血(貧血),剂量停止,"",""
AB-19129965,3,12,C,ラメルテオン,"",経口,20190419,20190822,100,mg,1,不眠症(不眠症),剂量停止,"",""
AB-19130255,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",.3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19130255,1,2,C,シクロホスファミド水和物,"",不明,"","","","","","",未知,"",""
AB-19130604,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190507,20190814,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下垂体機能低下症(再投与なし);続発性副腎皮質機能不全(再投与なし);血小板減少症(再投与なし),""
AB-19130611,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190724,20190724,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,硬化性胆管炎(再投与なし),""
AB-19130611,2,2,C,フマル酸第一鉄,"",経口,20180921,"",100,mg,1,"",未知,"",""
AB-19130611,2,3,C,スピロノラクトン,"",経口,20190403,"",25,mg,1,"",未知,"",""
AB-19130611,2,4,C,ランソプラゾール,"",経口,"","",15,mg,1,"",未知,"",""
AB-19130611,2,5,C,酸化マグネシウム,"",経口,"","",330,mg,1,"",未知,"",""
AB-19130838,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190305,20190806,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,意識変容状態(再投与なし);自己免疫性脳炎(再投与なし),""
AB-19130841,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190621;20190731,20190621;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,血小板数減少(有),""
AB-19130841,2,2,C,酸化マグネシウム,"",経口,"","",330,mg,1,"",未知,"",""
AB-19130845,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190626,20190724,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,スティーヴンス・ジョンソン症候群(再投与なし),""
AB-19131099,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190306,20190306,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,下部消化管穿孔(再投与なし),""
AB-19131108,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190731,20190814,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,食欲減退(再投与なし),""
AB-19131108,2,2,C,ボノプラザンフマル酸塩,"",経口,20190605,20190825,10,mg,1,食欲減退(症状緩和),未知,"",""
AB-19131108,2,3,C,メトクロプラミド,"",経口,20190626,20190825,15,mg,1,食欲減退(症状緩和),未知,"",""
AB-19131108,2,4,C,ジメチコン,"",経口,20190807,20190825,2,mL,1,食欲減退(症状緩和),未知,"",""
AB-19131110,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190423,20190730,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下垂体機能低下症(再投与なし),""
AB-19131110,5,2,C,ファモチジン,"",経口,"","",20,mg,1,"",未知,"",""
AB-19131110,5,3,C,ウラピジル,"",経口,"","",30,mg,1,"",未知,"",""
AB-19131110,5,4,C,ミラベグロン,"",経口,"","",50,mg,1,"",未知,"",""
AB-19131110,5,5,C,ロキソプロフェンナトリウム水和物,"",経口,"","",60,mg,1,"",未知,"",""
AB-19131110,5,6,C,抑肝散,"",経口,"","",2.5,g,1,"",未知,"",""
AB-19131110,5,7,C,スボレキサント,"",経口,"","",15,mg,1,"",未知,"",""
AB-19131625,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,潰瘍性大腸炎(再投与なし),""
AB-19131625,2,2,C,イリノテカン塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-19131638,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治療切除不能な進行・再発の胃癌),剂量停止,自己免疫性膵炎(再投与なし),""
AB-19131640,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201905,20190801,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,類天疱瘡(再投与なし),""
AB-19131975,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-19131986,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180913;,;20190327,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-19131993,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190618,20190704,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19131993,2,2,C,フロセミド,"",静脈内点滴,20190707,20190716,10,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19131993,2,3,C,オクトレオチド酢酸塩,"",皮下,20190710,20190716,300,ug,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19131993,2,4,C,フルルビプロフェンアキセチル,"",静脈内点滴,20190712,20190715,50,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19131993,2,5,C,ハロペリドール,"",静脈内点滴,20190715,20190715,5,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19131993,2,6,C,リドカイン,"",静脈内点滴,20190715,20190715,100,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19131993,2,7,C,モルヒネ塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-19132112,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201901,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腎盂腎炎(再投与なし);腎結石症(再投与なし),""
AB-19132498,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190726,20190726,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,小腸炎(再投与なし),""
AB-19132498,2,2,C,ベタメタゾン,"",経口,20140707,"",2,mg,1,"",未知,"",""
AB-19132498,2,3,C,エソメプラゾールマグネシウム水和物,"",経口,20180328,"",20,mg,1,"",未知,"",""
AB-19132498,2,4,C,クエン酸第一鉄ナトリウム,"",経口,20180402,"",50,mg,1,"",未知,"",""
AB-19132498,2,5,C,ゾピクロン,"",経口,20180414,"",7.5,mg,1,"",未知,"",""
AB-19132498,2,6,C,レバミピド,"",経口,20181212,"",300,mg,1,"",未知,"",""
AB-19132498,2,7,C,オキシコドン塩酸塩水和物,"",経口,20190605,"",120,mg,1,"",未知,"",""
AB-19132498,2,8,C,酸化マグネシウム,"",経口,20190605,"",990,mg,1,"",未知,"",""
AB-19132498,2,9,C,オキシコドン塩酸塩水和物,"",経口,20190702,"",10,mg,1,"",未知,"",""
AB-19132499,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-19132730,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20180601;20181109;20190604,20181026;20190125;20190802,185;240;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,出血性胃潰瘍(再投与なし);血小板数減少(再投与なし),""
AB-19132730,4,2,PS,リバーロキサバン,イグザレルト,経口,20171010,20190108,15,mg,1,"",剂量不变,"",""
AB-19132730,4,3,C,酪酸菌製剤,"",経口,20141117,"","","","","",未知,"",""
AB-19132730,4,4,C,アセトアミノフェン,"",経口,20170719,"",500,mg,1,"",未知,"",""
AB-19132730,4,5,C,クエン酸第一鉄ナトリウム,"",経口,20171016,"",50,mg,1,"",未知,"",""
AB-19132730,4,6,C,フェキソフェナジン塩酸塩,"",経口,20190125,"",60,mg,1,"",未知,"",""
AB-19132730,4,7,C,ミダゾラム,"",不明;不明;不明,20190816;20190824;20190912,20190816;20190824;20190912,3.5;2;3,mg;mg;mg,1;1;1,"",未知,"",""
AB-19133252,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190910,20190910,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,胃穿孔(再投与なし);肝機能異常(再投与なし);下痢(再投与なし),""
AB-19133252,3,2,C,センノシド,"",経口,20190503,"",12,mg,1,"",未知,"",""
AB-19133252,3,3,C,リナクロチド,"",経口,20190508,"",.25,mg,1,"",未知,"",""
AB-19133252,3,4,C,ボノプラザンフマル酸塩,"",経口,20190510,"",10,mg,1,"",未知,"",""
AB-19133252,3,5,C,アミノ酸・糖・電解質・ビタミン（２−４）,"",静脈内点滴,20190910,20190911,1000,mL,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19133252,3,6,C,ベタメタゾンリン酸エステルナトリウム,"",静脈内点滴,20190910,20190911,2,mg,1,"",未知,"",""
AB-19133252,3,7,C,生理食塩液,"",静脈内点滴,20190910,"",140,mL,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19133733,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,類天疱瘡(再投与なし),""
AB-19134087,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180315,20180502,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-19134096,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-19134099,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19134103,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,胆嚢炎(再投与なし),""
AB-19134111,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺障害(再投与なし),""
AB-19134205,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190612,20190723,200,mg,1,移行上皮癌(尿路上皮癌),剂量停止,尿細管間質性腎炎(再投与なし),""
AB-19134205,2,2,PS,ランソプラゾール,タケプロン,経口,20190424,20190823,15,mg,1,胃炎(胃炎),剂量停止,"",""
AB-19134205,2,3,C,メコバラミン,"",経口,20190220,"",3,{DF},1,末梢性ニューロパチー(末梢神経障害),未知,"",""
AB-19134205,2,4,C,ウルソデオキシコール酸,"",経口,20190222,"",300,mg,1,肝機能異常(肝機能障害),未知,"",""
AB-19134205,2,5,C,ベンフォチアミン・Ｂ６・Ｂ１２配合剤（１）,"",経口,20190226,"",3,{DF},1,末梢性ニューロパチー(末梢神経障害),未知,"",""
AB-19134205,2,6,C,ベンフォチアミン・Ｂ６・Ｂ１２配合剤（１）,"",経口,20190226,"",3,{DF},1,末梢性ニューロパチー(末梢神経障害),未知,"",""
AB-19134205,2,7,C,カルバゾクロムスルホン酸ナトリウム水和物,"",経口,20190429,"",90,mg,1,血尿(血尿),未知,"",""
AB-19134205,2,8,C,葉酸,"",経口,20190517,"",15,mg,1,葉酸欠乏(葉酸欠乏),未知,"",""
AB-19134205,2,9,C,クエン酸第一鉄ナトリウム,"",経口,不明,"",50,mg,1,貧血(貧血),未知,"",""
AB-19134205,2,10,C,ラクトミン,"",経口,不明,"",3,{DF},1,下痢(下痢),未知,"",""
AB-19135115,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-19135118,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180221,"",180,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,リウマチ性多発筋痛(再投与なし),""
AB-19135118,1,2,C,メトクロプラミド,"",不明,"","","","","","",未知,"",""
AB-19135118,1,3,C,タゾバクタム・ピペラシリン水和物,"",不明,"","","","","","",未知,"",""
AB-19135118,1,4,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-19135338,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,死亡(再投与なし),""
AB-19135339,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19135343,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腸炎(再投与なし),""
AB-19135344,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19135346,1,1,PS,ニボルマブ,オプジーボ,"","","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19135347,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,死亡(再投与なし),""
AB-19135622,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腸炎(再投与なし),""
AB-19135626,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190125,20190607,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝毒性(再投与なし),""
AB-19136125,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201909,201909,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,筋炎(再投与なし),""
AB-19136127,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190905,20190905,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎不全(再投与なし),""
AB-19136362,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190823,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,注入に伴う反応(再投与なし);注入に伴う反応(再投与なし),""
AB-19136922,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180905,20181024,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎皮質刺激ホルモン欠損症(不明);甲状腺機能低下症(不明),""
AB-19136925,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190521;2019,20190924;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,口腔内潰瘍形成(不明),""
AB-19136935,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190612,20190829,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19136935,2,2,C,ボノプラザンフマル酸塩,"",経口,20180524,"","","","","",未知,"",""
AB-19136935,2,3,C,タムスロシン塩酸塩,"",経口,20180526,"","","","","",未知,"",""
AB-19136946,18,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口,20190911;20200205,20190920;20200219,50;40,mg;mg,1;1,胃腺癌(HER2陽性進行性胃腺癌),剂量停止,"",""
AB-19136946,18,2,PS,パロノセトロン塩酸塩,アロキシ,静脈内点滴,20190911,20190911,0.75,mg,1,悪心・嘔吐の予防(悪心予防),不适用,"",""
AB-19136946,18,3,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190911,"","","","",胃腺癌(HER2陽性進行性胃腺癌),剂量停止,"",""
AB-19136946,18,4,PS,スルファメトキサゾール・トリメトプリム,ダイフェン,経口,20190925,20200122,80,mg,1,感染予防(感染症予防),剂量停止,"",""
AB-19136946,18,5,C,トラスツズマブ,"",静脈内点滴;静脈内点滴,20190911;20200205,20190911;20200205,348;6,mg;mg/kg,1;1,胃腺癌(HER2陽性進行性胃腺癌),剂量停止,"",""
AB-19136946,18,6,C,オキサリプラチン,"",静脈内点滴,20190911,"",184.6,mg,1,胃腺癌(HER2陽性進行性胃腺癌),剂量停止,"",""
AB-19136946,18,7,C,酪酸菌製剤,"",経口,20190502,"",1,g,1,"",剂量不变,"",""
AB-19136946,18,8,C,ジメチルイソプロピルアズレン,"",局所,20190911,"","","","","",剂量不变,"",""
AB-19136946,18,9,C,ヘパリン類似物質,"",局所,20190911,"","","","","",剂量不变,"",""
AB-19136946,18,10,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20190911,20190911,9.9,mg,1,悪心・嘔吐の予防(悪心予防),不适用,"",""
AB-19136946,18,11,C,デキサメタゾン,"",経口,20190912,20190913,4,mg,1,"",不适用,"",""
AB-19136946,18,12,C,ヒドロキソコバラミン酢酸塩,"",非経口,20190913,20190919,1000,ug,1,"",剂量停止,"",""
AB-19136946,18,13,C,クロベタゾールプロピオン酸エステル,"",局所,"","","","","",ざ瘡様皮膚炎(座瘡様発疹),未知,"",""
AB-19136946,18,14,C,デキサメタゾン,"",口腔咽頭,"","","","","",口角口唇炎(口角炎),未知,"",""
AB-19137240,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190912,20190912,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,器質化肺炎(再投与なし),""
AB-19137584,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190402,20190430,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,劇症１型糖尿病(再投与なし);膵萎縮(再投与なし),""
AB-19137591,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190627,20190711,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし);劇症肝炎(再投与なし),""
AB-19137591,4,2,C,ヘパリン類似物質,"",経皮,"","","","","","",未知,"",""
AB-19137591,4,3,C,ヘパリン類似物質,"",経皮,"","","","","","",未知,"",""
AB-19137591,4,4,C,アムホテリシンＢ,"",経口,"","",1,mL,1,"",未知,"",""
AB-19137591,4,5,C,アズレンスルホン酸ナトリウム水和物・炭酸水素ナトリウム,"",経口,"","",2,g,1,"",未知,"",""
AB-19137591,4,6,C,オキシコドン塩酸塩水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-19137591,4,7,C,酸化マグネシウム,"",経口,"","",660,mg,1,"",未知,"",""
AB-19137591,4,8,C,センノシド,"",経口,"","",12,mg,1,"",未知,"",""
AB-19137591,4,9,C,ジメチルイソプロピルアズレン,"",経皮,"","","","","","",未知,"",""
AB-19137591,4,10,C,オキシコドン塩酸塩水和物,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-19137591,4,11,C,ホスアプレピタントメグルミン,"",静脈内点滴,"","",150,mg,1,"",未知,"",""
AB-19137591,4,12,C,パロノセトロン塩酸塩,"",静脈内点滴,"","",.75,mg,1,"",未知,"",""
AB-19137591,4,13,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,"","",3.8,mg,1,"",未知,"",""
AB-19137591,4,14,C,レボホリナートカルシウム,"",静脈内点滴,"","",330,mg,1,"",未知,"",""
AB-19137591,4,15,C,オキサリプラチン,"",静脈内点滴,"","",80,mg,1,"",未知,"",""
AB-19137591,4,16,C,フルオロウラシル,"",静脈内点滴,"","",330,mg,1,"",未知,"",""
AB-19137591,4,17,C,フルオロウラシル,"",静脈内（明記されていない場合）,"","",2400,mg,1,"",未知,"",""
AB-19137766,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20181101;20190411;20190808,20190307;20190606;,240;240;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(無),""
AB-19138049,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190909,20190909,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血小板数減少(再投与なし),""
AB-19138050,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181109,20181214,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,尿細管間質性腎炎(再投与なし);敗血症(再投与なし),""
AB-19138050,4,2,C,クエン酸第一鉄ナトリウム,"",経口,20180518,"",50,mg,1,"",未知,"",""
AB-19138050,4,3,C,ナプロキセン,"",経口,20181102,20181214,100,mg,1,予防(予防),未知,"",""
AB-19138050,4,4,C,酸化マグネシウム,"",経口,"","",660,mg,1,"",未知,"",""
AB-19138051,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(IV期の進行胃癌),未知,ニューモシスチス・イロベチイ肺炎(再投与なし);細胞性免疫不全症(再投与なし),""
AB-19138051,1,2,C,メトトレキサート,"",脊髄内,"","","","","","",未知,"",""
AB-19138051,1,3,C,デキサメタゾン,"",不明,"","","","","","",未知,"",""
AB-19138184,6,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190326,20190716,200,mg,1,胃癌第４期(MSI-Highを有する結腸・直腸癌以外の固形癌（胃癌）),不适用,抗利尿ホルモン不適合分泌(再投与なし);多形紅斑(再投与なし),""
AB-19138459,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,尿細管間質性腎炎(再投与なし),""
AB-19138462,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190828,20190925,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,眼瞼下垂(再投与なし),""
AB-19138462,2,2,PS,オキサリプラチン,"",静脈内点滴,20191002,"",145,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-19138462,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20191002,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19138470,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180427,20180427,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,尿細管間質性腎炎(再投与なし),""
AB-19138470,2,2,PS,ロキソプロフェンナトリウム水和物,ロキソプロフェン,経口,20171110,"",60,mg,1,腹痛(腹痛),剂量停止,"",""
AB-19138472,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180516;20181107,20181024;20181219,180;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19139252,1,1,PS,パクリタキセル,タキソール,静脈内点滴,20180530,"",130,mg,1,胃癌(胃癌),剂量不变,胆管炎(再投与なし);発熱性好中球減少症(再投与なし),""
AB-19139252,1,2,PS,NIVOLUMAB;PLACEBO,"",静脈内点滴,20180116,20180424,360,mg,1,胃癌(胃癌),不适用,胆管炎(再投与なし);発熱性好中球減少症(再投与なし),""
AB-19139252,1,3,C,ゾルピデム酒石酸塩,"",不明,20171211,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,4,C,オキサリプラチン,"",静脈内点滴,20180116,"",210,mg,1,胃癌(胃癌),未知,胆管炎(再投与なし),""
AB-19139252,1,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20180116,"","","","",胃癌(胃癌),未知,胆管炎(再投与なし),""
AB-19139252,1,6,C,アプレピタント,"",不明,20180116,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,7,C,デキサメタゾン,"",不明,20180116,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,8,C,ラフチジン,"",不明,20180116,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,9,C,酸化マグネシウム,"",不明,20180116,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,10,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,20180116,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,11,C,デキサメタゾンリン酸エステルナトリウム,"",不明,20180116,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,12,C,CROMOGLICATESODIUM,"",不明,20180116,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,13,C,クロルフェニラミンマレイン酸塩,"",不明,20180116,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,14,C,バクロフェン,"",不明,20180117,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,15,C,ピコスルファートナトリウム水和物,"",経口,20180206,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,16,C,アズレンスルホン酸ナトリウム水和物,"",不明,20180213,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,17,C,イオヘキソール,"",不明,20180227,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,18,C,イオヘキソール,"",静脈内点滴,20180227,"","","","",コンピュータ断層撮影(コンピュータ断層撮影),未知,"",""
AB-19139252,1,19,C,麻子仁丸,"",経口,20180227,"",2.5,g,1,便秘予防(便秘予防),未知,"",""
AB-19139252,1,20,C,パンテチン,"",不明,20180326,"","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139252,1,21,C,グラニセトロン塩酸塩,"",静脈内点滴,20180530,"",3,mg,1,予防(予防),未知,"",""
AB-19139252,1,22,C,フィルグラスチム［後続１］,"",皮下,20180606,"",75,ug,1,好中球数減少(好中球数減少),未知,"",""
AB-19139252,1,23,C,デキサメタゾン,"",経口,"","","","","",適応症不明の製品使用(適応症不明の製品使用),未知,"",""
AB-19139387,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20181106;202004;20201022,20190212;;,;;480,;;mg,;;1,遠隔転移を伴う腎細胞癌(根治切除不能又は転移性の腎細胞癌に対する併用療法),剂量停止,異常感(再投与なし);倦怠感(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-19139387,6,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,20181106,20190108,"","","",遠隔転移を伴う腎細胞癌(根治切除不能又は転移性の腎細胞癌に対する併用療法),不适用,"",""
AB-19139388,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190827,20190827,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,スティーヴンス・ジョンソン症候群(再投与なし),""
AB-19139388,4,2,PS,バンコマイシン塩酸塩,バンコマイシン,静脈内点滴,20190903,20190903,1,g,1,ブドウ球菌感染(コアグラーゼ陰性ブドウ球菌検出),不适用,"",""
AB-19139388,4,3,C,ダプトマイシン,"",不明,20190904,"","","","",ブドウ球菌感染(コアグラーゼ陰性ブドウ球菌検出),未知,"",""
AB-19139388,4,4,C,乳酸リンゲル液,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-19139393,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201902,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-19139396,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20191011,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,リウマチ性多発筋痛(再投与なし),""
AB-19139401,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,アラニンアミノトランスフェラーゼ増加(再投与なし);アスパラギン酸アミノトランスフェラーゼ増加(再投与なし),""
AB-19139467,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190725,20190808,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし),""
AB-19139467,3,2,C,フロセミド,"",経口,201907,"",20,mg,1,"",未知,"",""
AB-19139467,3,3,C,スピロノラクトン,"",経口,201907,"",25,mg,1,"",未知,"",""
AB-19139467,3,4,C,酸化マグネシウム,"",不明,201907,"",330,mg,1,"",未知,"",""
AB-19139467,3,5,C,ドネペジル塩酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-19139470,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171113,20191007,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,胆管結石(再投与なし),""
AB-19139472,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171111,20171125,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19139480,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,20190731;,;240,;mg,;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(無),""
AB-19139848,1,1,PS,ロキソプロフェンナトリウム水和物,"",経口,"","","","","","",剂量停止,"",""
AB-19139848,1,2,PS,ニボルマブ,"",静脈内点滴,"","","","","",胃癌(進行胃癌),未知,"",""
AB-19140126,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190802,20191001,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし),""
AB-19140406,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190514,20190903,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,ＫＬ−６増加(再投与なし),""
AB-19140406,2,2,C,ベンフォチアミン・Ｂ６・Ｂ１２配合剤（１）,"",不明,"","","","","","",未知,"",""
AB-19140406,2,3,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-19140999,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181018,20181129,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺障害(再投与なし),""
AB-19141947,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190508;20191011,20190920;20200131,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,浮動性めまい(再投与なし);悪心(再投与なし);食欲減退(再投与なし);原発性副腎機能不全(再投与なし);頭痛(再投与なし);副腎機能不全(再投与なし),""
AB-19141953,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201805,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,大腸穿孔(再投与なし);免疫性腸炎(再投与なし),""
AB-19141954,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190212,20190619,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19142112,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190925,20190925,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,スティーヴンス・ジョンソン症候群(再投与なし),""
AB-19142113,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,大静脈血栓症(再投与なし),""
AB-19142114,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,胆管炎(再投与なし);胆管狭窄(再投与なし),""
AB-19142119,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,胆管炎(再投与なし),""
AB-19142508,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180913,20190214,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,排便障害(再投与なし),""
AB-19143395,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180314;20181219,20181024;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,食道炎(再投与なし),""
AB-19143401,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190702,20190702,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし),""
AB-19143416,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,慢性炎症性脱髄性多発根ニューロパチー(再投与なし);サイトメガロウイルス感染(再投与なし);ギラン・バレー症候群(再投与なし),""
AB-19143435,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,免疫性腸炎(再投与なし);多発ニューロパチー(再投与なし),""
AB-19143465,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肺炎(再投与なし),""
AB-19143466,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肺炎(再投与なし),""
AB-19143477,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎皮質刺激ホルモン欠損症(再投与なし);甲状腺炎(再投与なし),""
AB-19143843,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190723,20191008,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19144186,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181031,20181031,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下垂体機能低下症(再投与なし),""
AB-19144187,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,１型糖尿病(再投与なし),""
AB-19144187,1,2,C,トリフルリジン・チピラシル塩酸塩配合剤,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19144192,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190527,20191007,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺結核(再投与なし),""
AB-19144192,5,2,C,ミラベグロン,"",経口,"","",50,mg,1,"",未知,"",""
AB-19144192,5,3,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-19144192,5,4,C,アロプリノール,"",経口,"","",100,mg,1,"",未知,"",""
AB-19144192,5,5,C,クエン酸第一鉄ナトリウム,"",経口,"","",50,mg,1,"",未知,"",""
AB-19144192,5,6,C,フェキソフェナジン塩酸塩,"",経口,"","",60,mg,1,"",未知,"",""
AB-19144192,5,7,C,ヘパリン類似物質,"",不明,"","","","","","",未知,"",""
AB-19144192,5,8,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",不明,"","","","","","",未知,"",""
AB-19144765,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍出血(再投与なし);間質性肺疾患(再投与なし),""
AB-19145092,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190815,20191219,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし),""
AB-19145092,3,2,C,ボノプラザンフマル酸塩,"",経口,20180828,"",10,mg,1,"",未知,"",""
AB-19145092,3,3,C,スルファメトキサゾール・トリメトプリム,"",経口,"","",1,{DF},1,"",未知,"",""
AB-19145092,3,4,C,アセトアミノフェン,"",経口,"","",500,mg,1,"",未知,"",""
AB-19145311,6,1,PS,イピリムマブ,ヤーボイ,静脈内点滴,20181106,20190108,"","","",遠隔転移を伴う腎細胞癌(遠隔転移を伴う腎細胞癌),不适用,副腎皮質刺激ホルモン欠損症(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-19145311,6,2,PS,ニボルマブ,オプジーボ,静脈内点滴;不明;静脈内点滴;静脈内点滴;静脈内点滴,20181106;20200326;202004;20201022;20210321,20190212;;;;,;;;480;480,;;;mg;mg,;;;1;1,遠隔転移を伴う腎細胞癌(遠隔転移を伴う腎細胞癌),剂量停止,副腎皮質刺激ホルモン欠損症(不明);続発性副腎皮質機能不全(不明),""
AB-19145376,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-19145381,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190823,20190823,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,急性腎障害(再投与なし),""
AB-19145381,5,2,PS,プレドニゾロン,プレドニン,不明,20190830,"","","","",急性腎障害(クレアチニン増加（急性腎障害）),未知,"",""
AB-19145381,5,3,PS,プレドニゾロン,"",経口;経口;経口;経口,20190907;201909;20191007;20191021,201909;20191006;20191020;,40;30;25;20,mg;mg;mg;mg,1;1;1;1,急性腎障害(クレアチニン増加（急性腎障害）),剂量减少,"",""
AB-19145395,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190508;,201909;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(不明),""
AB-19145396,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190708,20190723,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,紅斑(再投与なし);そう痒症(再投与なし),""
AB-19145396,1,2,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-19145396,1,3,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-19145396,1,4,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-19145396,1,5,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-19145396,1,6,C,シロドシン,"",経口,"","","","","","",未知,"",""
AB-19145396,1,7,C,エピナスチン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-19146103,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201805,201805,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,１型糖尿病(再投与なし),""
AB-19146103,2,2,C,ラムシルマブ,"",不明;不明,;20181003,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19146103,2,3,C,パクリタキセル,"",不明;不明,;20181003,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19146438,2,1,PS,パクリタキセル,タキソール,不明;不明,;20181003,;,;,;,;,胃癌(胃癌),剂量停止,"",""
AB-19146438,2,2,PS,ニボルマブ,オプジーボ,静脈内点滴,201805,201805,3,mg/kg,1,胃癌(胃癌),不适用,"",""
AB-19146438,2,3,PS,ラムシルマブ,"",不明;不明,;20181003,;,;,;,;,胃癌(胃癌),剂量停止,"",""
AB-19147279,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190117,20190131,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,自己免疫性肝炎(再投与なし);間質性肺疾患(再投与なし);副腎機能不全(再投与なし),""
AB-19147281,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腸炎(再投与なし),""
AB-19147282,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20190805,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,糖尿病(再投与なし),""
AB-19147283,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,虫垂癌(再投与なし);下部消化管穿孔(再投与なし),""
AB-19147592,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-19147977,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191009,20191118,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,２型糖尿病(再投与なし),""
AB-19147988,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181219,20191025,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし);自己免疫性大腸炎(再投与なし),""
AB-19148288,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20191114,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,視床下部−下垂体障害(再投与なし),""
AB-19148653,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-19148656,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190521,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎障害(再投与なし),""
AB-19148663,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180808,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし);血中コルチコトロピン減少(再投与なし);劇症１型糖尿病(再投与なし);甲状腺機能亢進症(再投与なし),""
AB-19148749,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,高カルシウム血症(再投与なし),""
AB-19148749,3,2,PS,エルデカルシトール,"",経口,"","","","","","",剂量停止,"",""
AB-19149301,5,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口;経口,20191111;20191112;20191120,20191111;20191119;20191120,60;60;60,mg;mg;mg,1;1;1,胃腺癌(HER2陽性進行性胃腺癌),剂量停止,"",""
AB-19149301,5,2,PS,パロノセトロン塩酸塩,アロキシ,静脈内点滴,20191111,20191111,0.75,mg,1,悪心・嘔吐の予防(悪心・嘔吐の予防),不适用,"",""
AB-19149301,5,3,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20191111,20191111,"","","",胃腺癌(HER2陽性進行性胃腺癌),剂量停止,"",""
AB-19149301,5,4,C,オキサリプラチン,"",静脈内点滴,20191111,20191111,216,mg,1,胃腺癌(HER2陽性進行性胃腺癌),剂量停止,"",""
AB-19149301,5,5,C,トラスツズマブ,"",静脈内点滴,20191111,20191111,454,mg,1,胃腺癌(HER2陽性進行性胃腺癌),剂量停止,"",""
AB-19149301,5,6,C,ビソプロロールフマル酸塩,"",経口,200901,20191120,5,mg,1,"",剂量停止,"",""
AB-19149301,5,7,C,フルニトラゼパム,"",経口,201601,20191120,2,mg,1,不眠症(不眠症),剂量停止,"",""
AB-19149301,5,8,C,酪酸菌配合剤,"",経口,200801,20191120,1,{DF},1,"",剂量停止,"",""
AB-19149301,5,9,C,ロサルタンカリウム・ヒドロクロロチアジド配合剤,"",経口,201901,20191120,1,{DF},1,"",剂量停止,"",""
AB-19149301,5,10,C,安中散,"",経口,20191023,20191120,2.5,g,1,"",剂量停止,"",""
AB-19149301,5,11,C,ベタメタゾン・ｄ−クロルフェニラミンマレイン酸塩,"",経口,20191023,20191106,1,{DF},1,"",不适用,"",""
AB-19149301,5,12,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20191111,20191111,9.9,mg,1,"",不适用,"",""
AB-19149301,5,13,C,ジクロフェナクナトリウム,"",経口,20191111,20191111,25,mg,1,"",不适用,"",""
AB-19149301,5,14,C,アプレピタント,"",経口;経口,20191111;20191112,20191111;20191113,125;80,mg;mg,1;1,"",不适用,"",""
AB-19149301,5,15,C,メトクロプラミド,"",経口,20191118,20191120,5,mg,1,"",剂量停止,"",""
AB-19149301,5,16,C,ヒドロキシジンパモ酸塩,"",不明,"","","","","",不眠症(不眠症),未知,"",""
AB-19149301,5,17,C,エスゾピクロン,"",経口,"","","","","",不眠症(不眠症),未知,"",""
AB-19149301,5,18,C,ｄ−クロルフェニラミンマレイン酸塩,"",不明,"","","","","",湿疹(湿疹),未知,"",""
AB-19149301,5,19,C,ベポタスチンベシル酸塩,"",経口,"","","","","",湿疹(湿疹),未知,"",""
AB-19149301,5,20,C,クロベタゾン酪酸エステル,"",局所,"","","","","",湿疹(湿疹),未知,"",""
AB-19149301,5,21,C,ジフルプレドナート,"",局所,"","","","","",湿疹(湿疹),未知,"",""
AB-19149301,5,22,C,ヘパリン類似物質,"",局所,"","","","","",そう痒症(そう痒症),未知,"",""
AB-19149301,5,23,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",局所,"","","","","",そう痒症(そう痒症),未知,"",""
AB-19149301,5,24,C,ジフェンヒドラミン,"",不明,"","","","","",そう痒症(そう痒症),未知,"",""
AB-19149373,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190510;20191025,20190927;20200326,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸穿孔(再投与なし);副腎機能不全(再投与なし),""
AB-19149373,6,2,C,クエン酸第一鉄ナトリウム,"",経口,"","",50,mg,1,"",未知,"",""
AB-19149373,6,3,C,フロセミド,"",経口,"","",20,mg,1,"",未知,"",""
AB-19149373,6,4,C,ボノプラザンフマル酸塩,"",経口,"","",10,mg,1,予防(予防),未知,"",""
AB-19149373,6,5,C,ロキソプロフェンナトリウム水和物,"",経口,"","",60,mg,1,"",未知,"",""
AB-19149373,6,6,C,エドキサバントシル酸塩水和物,"",経口,"","",30,mg,1,予防(予防),未知,"",""
AB-19149386,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190806,20191008,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,小腸炎(再投与なし),""
AB-19149386,2,2,C,カンデサルタンシレキセチル,"",経口,"","",8,mg,1,"",未知,"",""
AB-19149386,2,3,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-19149386,2,4,C,酪酸菌製剤,"",経口,"","",1,g,1,"",未知,"",""
AB-19149960,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血小板減少症(再投与なし),""
AB-19149963,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190806,20190820,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし),""
AB-19149963,1,2,C,ポラプレジンク,"",経口,"","","","","","",未知,"",""
AB-19149963,1,3,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-19149963,1,4,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-19149963,1,5,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-19149963,1,6,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-19149963,1,7,C,ロペラミド塩酸塩,"",経口,"","","","","","",未知,"",""
AB-19149963,1,8,C,ドンペリドン,"",不明,"","","","","","",未知,"",""
AB-19149963,1,9,C,バクロフェン,"",不明,"","","","","","",未知,"",""
AB-19149963,1,10,C,センノシド,"",経口,"","","","","","",未知,"",""
AB-19149963,1,11,C,オキシコドン塩酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-19150337,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201904,201904,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,意識変容状態(再投与なし);腎盂腎炎(再投与なし);低ナトリウム血症(再投与なし);死亡(再投与なし),""
AB-19150341,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181126;20191003,201909;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(有);間質性肺疾患(有),""
AB-19150341,2,2,PS,インフルエンザＨＡワクチン,"",静脈内（明記されていない場合）,20191105,20191105,"","","","",不适用,"",""
AB-19150341,2,3,C,ヘパリン類似物質,"",局所,"","","","","",手掌・足底発赤知覚不全症候群(手足症候群),未知,"",""
AB-19150341,2,4,C,ヒドロコルチゾン酪酸エステル,"",局所,"","","","","",手掌・足底発赤知覚不全症候群(手足症候群),未知,"",""
AB-19150343,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191031,20191114,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(再投与なし);多形紅斑(再投与なし),""
AB-19150343,3,2,C,アムロジピンベシル酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-19150343,3,3,C,ブロチゾラム,"",経口,"","",.25,mg,1,"",未知,"",""
AB-19150343,3,4,C,タムスロシン塩酸塩,"",経口,"","",.2,mg,1,"",未知,"",""
AB-19150343,3,5,C,テネリグリプチン臭化水素酸塩水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-19150343,3,6,C,オルメサルタンメドキソミル,"",経口,"","",40,mg,1,"",未知,"",""
AB-19150343,3,7,C,メトクロプラミド,"",経口,"","",5,mg,1,"",未知,"",""
AB-19150343,3,8,C,トリクロルメチアジド,"",経口,"","",2,mg,1,"",未知,"",""
AB-19150343,3,9,C,ロキソプロフェンナトリウム水和物,"",経口,"","",60,mg,1,"",未知,"",""
AB-19150343,3,10,C,ボノプラザンフマル酸塩,"",経口,"","",20,mg,1,"",未知,"",""
AB-19150343,3,11,C,アミノ酸・糖・電解質・ビタミン（２−４）,"",不明,"","",1000,mL,1,"",未知,"",""
AB-19150696,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201801,201804,145,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,２型糖尿病(再投与なし),""
AB-19151149,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190925;20191203,20191029;20220628,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,脳浮腫(再投与なし);間質性肺疾患(再投与なし),""
AB-19151149,3,2,C,生理食塩液,"",静脈内（明記されていない場合）,20190925,20220628,250,mL,1,胃癌(胃癌),未知,"",""
AB-19151160,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,膵炎(再投与なし);腸炎(再投与なし);胆管炎(再投与なし);肝機能異常(再投与なし);シェーグレン症候群(再投与なし),""
AB-19151504,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,胆管炎(再投与なし),""
AB-19151509,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201710,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,原発性副腎機能不全(再投与なし),""
AB-19151513,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-19152168,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190221,20190418,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし),""
AB-19152168,1,2,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-19152168,1,3,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-19152168,1,4,C,フルバスタチンナトリウム,"",不明,"","","","","","",未知,"",""
AB-19152168,1,5,C,アジルサルタン,"",不明,"","","","","","",未知,"",""
AB-19152168,1,6,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-19152168,1,7,C,ピリドスチグミン臭化物,"",不明,"","","","","","",未知,"",""
AB-19152168,1,8,C,プレドニゾロン,"",不明,"","","","","","",未知,"",""
AB-19152168,1,9,C,ヒドロモルフォン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-19152168,1,10,C,ヒドロモルフォン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-19152429,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190719,20190816,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下部消化管出血(再投与なし),""
AB-19152811,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190814,20191009,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19152811,3,2,C,ビソプロロール,"",経皮,"","","","","","",未知,"",""
AB-19152811,3,3,C,シロスタゾール,"",不明,"","","","","","",未知,"",""
AB-19152811,3,4,C,乾燥硫酸鉄（３）,"",経口,"","",105,mg,1,"",未知,"",""
AB-19152811,3,5,C,アセトアミノフェン,"",経口,"","",400,mg,1,"",未知,"",""
AB-19152811,3,6,C,ボノプラザンフマル酸塩,"",経口,"","",20,mg,1,"",未知,"",""
AB-19152811,3,7,C,レバミピド,"",経口,"","",100,mg,1,"",未知,"",""
AB-19152811,3,8,C,大腸菌死菌・ヒドロコルチゾン,"",局所,"","",2,g,1,"",未知,"",""
AB-19152811,3,9,C,ケトプロフェン,"",経皮,"","",120,mg,1,"",未知,"",""
AB-19152815,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,腸炎(再投与なし),""
AB-19153293,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190222,20191120,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,急性腎障害(再投与なし),""
AB-19153293,4,2,PS,イオメプロール,イオメロン３００,静脈内（明記されていない場合）,20191204,20191204,100,mL,1,静脈造影(診断のため),不适用,"",""
AB-19153293,4,3,C,ヘパリン類似物質,"",経皮,20191204,"","","","","",未知,"",""
AB-19153293,4,4,C,フェブキソスタット,"",経口,"","",10,mg,1,"",未知,"",""
AB-19153293,4,5,C,モサプリドクエン酸塩水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-19153293,4,6,C,酪酸菌配合剤,"",経口,"","",1,{DF},1,"",未知,"",""
AB-19153293,4,7,C,酸化マグネシウム,"",経口,"","",660,mg,1,"",未知,"",""
AB-19153293,4,8,C,経腸成分栄養剤（９−２）,"",不明,"","","","","","",未知,"",""
AB-19153293,4,9,C,センノシド,"",経口,"","",24,mg,1,"",未知,"",""
AB-19153293,4,10,C,ガチフロキサシン水和物,"",眼,"","","","","","",未知,"",""
AB-19153293,4,11,C,ベタメタゾンリン酸エステルナトリウム,"",眼,"","","","","","",未知,"",""
AB-19153293,4,12,C,ブロムフェナクナトリウム水和物,"",眼,"","","","","","",未知,"",""
AB-19153293,4,13,C,レボフロキサシン水和物,"",眼,"","","","","","",未知,"",""
AB-19153293,4,14,C,トロピカミド・フェニレフリン塩酸塩,"",眼,"","","","","","",未知,"",""
AB-19153293,4,15,C,精製ヒアルロン酸ナトリウム,"",眼,"","","","","","",未知,"",""
AB-19153293,4,16,C,フラビンアデニンジヌクレオチドナトリウム,"",眼,"","","","","","",未知,"",""
AB-19153293,4,17,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",経皮,"","","","","","",未知,"",""
AB-19153293,4,18,C,アセトアミノフェン,"",経口,"","",2,g,1,"",未知,"",""
AB-19153901,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20191120;20200108,20191204;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-19153901,2,2,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-19153904,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191021,20191119,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19153906,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180208,20180522,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-19154130,1,1,PS,ロキソプロフェンナトリウム水和物,ロキソプロフェンＮａ,経口,不明,不明,"","","",腹痛,剂量停止,"",""
AB-19154130,1,2,PS,ニボルマブ,"",静脈内点滴,不明,不明,"","","",胃癌,未知,"",""
AB-19154300,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190515,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肝機能異常(再投与なし),""
AB-19154303,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190816,20191120,240,mg,1,胃癌(胃癌),剂量停止,腎前性腎不全(再投与なし);下痢(再投与なし);腎後性腎不全(再投与なし);血中クレアチニン増加(再投与なし),""
AB-19154304,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191203,20200218,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,胆嚢炎(再投与なし),""
AB-19154304,2,2,C,ボノプラザンフマル酸塩,"",経口,20171130,"",20,mg,1,"",未知,"",""
AB-19154304,2,3,C,ウルソデオキシコール酸,"",経口,20180130,"",200,mg,1,"",未知,"",""
AB-19154304,2,4,C,アズレンスルホン酸ナトリウム水和物,"",経口,20191106,"","","","","",未知,"",""
AB-19154304,2,5,C,ロキソプロフェンナトリウム水和物,"",経口,20191106,"",60,mg,1,"",未知,"",""
AB-19154304,2,6,C,レバミピド,"",経口,20191106,"",100,mg,1,"",未知,"",""
AB-19154304,2,7,C,レボフロキサシン水和物,"",経口,20191118,"",500,mg,1,"",未知,"",""
AB-19154304,2,8,C,セファレキシン,"",経口,20191119,20191120,250,mg,1,"",未知,"",""
AB-19154304,2,9,C,生理食塩液,"",静脈内（明記されていない場合）,"","",100,mL,1,"",未知,"",""
AB-19154304,2,10,C,イリノテカン塩酸塩水和物,"",静脈内点滴;静脈内点滴,20200303;,;20200428,;,;,;,"",未知,"",""
AB-19154304,2,11,C,ブチルスコポラミン臭化物,"",不明,"","","","","","",未知,"",""
AB-19154304,2,12,C,ルビプロストン,"",経口,"","",24,ug,1,"",未知,"",""
AB-19154304,2,13,C,大建中湯,"",経口,"","",2.5,g,1,"",未知,"",""
AB-19154304,2,14,C,センノシド,"",経口,"","",12,mg,1,便秘(便秘),未知,"",""
AB-19154304,2,15,C,酸化マグネシウム,"",経口,"","",660,mg,1,"",未知,"",""
AB-19154305,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190530,20190530,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,硬化性胆管炎(再投与なし);甲状腺機能低下症(再投与なし);肺炎(再投与なし);皮下出血(再投与なし);薬物性肝障害(再投与なし),""
AB-19154305,2,2,C,スクラルファート水和物,"",経口,"","","","","","",未知,"",""
AB-19154305,2,3,C,葉酸,"",経口,"","","","","","",未知,"",""
AB-19154305,2,4,C,ゾルピデム酒石酸塩,"",経口,"","","","","","",未知,"",""
AB-19154305,2,5,C,フルスルチアミン・Ｂ２・Ｂ６・Ｂ１２配合剤（１）,"",経口,"","","","","","",未知,"",""
AB-19154305,2,6,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
AB-19154305,2,7,C,フロセミド,"",経口,"","","","","","",未知,"",""
AB-19154305,2,8,C,ゾルピデム酒石酸塩,"",経口,"","","","","","",未知,"",""
AB-19154305,2,9,C,スルファメトキサゾール・トリメトプリム,"",経口,"","","","","","",未知,"",""
AB-19154305,2,10,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-19154305,2,11,C,レボチロキシンナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-19154305,2,12,C,ミコフェノール酸モフェチル,"",経口,"","","","","","",未知,"",""
AB-19154305,2,13,C,スピロノラクトン,"",経口,"","","","","","",未知,"",""
AB-19154305,2,14,C,ウルソデオキシコール酸,"",経口,"","","","","","",未知,"",""
AB-19154305,2,15,C,メコバラミン,"",経口,"","","","","","",未知,"",""
AB-19154305,2,16,C,ベザフィブラート,"",経口,"","","","","","",未知,"",""
AB-19154305,2,17,C,プレドニゾロン,"",経口,"","","","","","",未知,"",""
AB-19154305,2,18,C,パンクレリパーゼ,"",経口,"","","","","","",未知,"",""
AB-19154305,2,19,C,アセトアミノフェン,"",経口,"","","","","","",未知,"",""
AB-19154305,2,20,C,ピコスルファートナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-19154305,2,21,C,炭酸水素ナトリウム・無水リン酸二水素ナトリウム,"",直腸,"","","","","","",未知,"",""
AB-19154309,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190220,20191002,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,スティーヴンス・ジョンソン症候群(再投与なし),""
AB-19154532,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,201908,201912,200,mg,1,胃癌(MSI-High癌、胃がん),剂量停止,間質性肺疾患(再投与なし),""
AB-19154643,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190115,20191008,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし);末梢性ニューロパチー(再投与なし);間質性肺疾患(再投与なし),""
AB-19154646,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190117,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(再投与なし),""
AB-19155104,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191107,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-19155104,3,2,PS,カモスタットメシル酸塩,フオイパン,経口,20190829,"",100,mg,1,胃食道逆流性疾患(術後逆流性食道炎),剂量不变,甲状腺機能低下症(再投与なし),""
AB-19155104,3,3,C,アスコルビン酸・パントテン酸カルシウム（１）,"",経口,20190418,"",200,mg,1,色素沈着障害(色素沈着),未知,"",""
AB-19155104,3,4,C,オランザピン,"",経口,20190829,"",2.5,mg,1,悪心(悪心),未知,"",""
AB-19155104,3,5,C,Ｌ−アスパラギン酸カリウム,"",経口,20191128,"",300,mg,1,低カリウム血症(低カリウム血症),未知,"",""
AB-19155115,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-19155386,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20170905;20171025,20170929;20171025,200;200,mg;mg,1;1,非小細胞肺癌(非小細胞肺癌),剂量停止,間質性肺疾患(再投与なし);甲状腺機能低下症(再投与なし),""
AB-19155386,3,2,C,デノスマブ,"",皮下,不明,"","","","","",未知,"",""
AB-19155386,3,3,C,エソメプラゾールマグネシウム水和物,"",経口,不明,"",20,mg,1,"",未知,"",""
AB-19155386,3,4,C,トラマドール塩酸塩,"",経口,不明,"",25,mg,1,"",未知,"",""
AB-19155386,3,5,C,ロキソプロフェンナトリウム水和物,"",経口,不明,"",180,mg,1,"",未知,"",""
AB-19155386,3,6,C,沈降炭酸カルシウム・コレカルシフェロール・炭酸マグネシウム,"",経口,不明,"",2,{DF},1,"",未知,"",""
AB-19155386,3,7,C,アセトアミノフェン,"",経口,不明,"",600,mg,1,"",未知,"",""
AB-19155386,3,8,C,レバミピド,"",経口,不明,"",200,mg,1,"",未知,"",""
AB-19155386,3,9,C,ファモチジン,"",経口,不明,"",20,mg,1,"",未知,"",""
AB-19155395,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190617,20190729,200,mg,1,胃癌(MSI-Highを有する結腸・直腸癌以外の固形癌（胃癌）),剂量停止,末梢性ニューロパチー(再投与なし),""
AB-19155712,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190603;20200129,20191218;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,咽頭の炎症(不明),""
AB-19155712,4,2,C,フェキソフェナジン塩酸塩,"",経口,20191106,"",60,mg,1,"",未知,"",""
AB-19155712,4,3,C,芍薬甘草湯,"",経口,"","",1,{DF},1,"",未知,"",""
AB-19156245,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-19156248,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181108,20190109,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,薬疹(再投与なし),""
AB-19156248,3,2,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","",予防(予防),未知,"",""
AB-19156248,3,3,C,アスコルビン酸・パントテン酸カルシウム（１）,"",経口,"","","","","",予防(予防),未知,"",""
AB-19156248,3,4,C,センナエキス,"",経口,"","","","","",予防(予防),未知,"",""
AB-19156248,3,5,C,オロパタジン塩酸塩,"",経口,"","","","","",予防(予防),未知,"",""
AB-19156248,3,6,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",皮膚,"","","","","",予防(予防),未知,"",""
AB-19156248,3,7,C,ヒドロコルチゾン酪酸エステル,"",皮膚,"","","","","",予防(予防),未知,"",""
AB-19156248,3,8,C,ヘパリン類似物質,"",皮膚,"","","","","",予防(予防),未知,"",""
AB-19156248,3,9,C,アセトアミノフェン,"",経口,"","","","","",予防(予防),未知,"",""
AB-19156248,3,10,C,モキシフロキサシン塩酸塩,"",経口,"","","","","",予防(予防),未知,"",""
AB-19156249,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190909,20191021,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,肝機能異常(再投与なし),""
AB-19156253,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-19156539,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191008,20191217,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸穿孔(再投与なし);敗血症性ショック(再投与なし);大腸炎(再投与なし),""
AB-19156539,5,2,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,非経口,20190709,20190930,"","","",胃癌(胃癌),不适用,"",""
AB-19156539,5,3,PS,ラムシルマブ,サイラムザ,非経口,20190709,20190930,"","","",胃癌(胃癌),不适用,"",""
AB-19156539,5,4,C,クエン酸第一鉄ナトリウム,"",経口,20190709,"",50,mg,1,"",未知,"",""
AB-19156539,5,5,C,酪酸菌製剤,"",経口,20190903,"",2,{DF},1,"",未知,"",""
AB-19156539,5,6,C,ウルソデオキシコール酸,"",経口,20191203,"",200,mg,1,"",未知,"",""
AB-19156539,5,7,C,ブチルスコポラミン臭化物,"",経口,"","","","","","",未知,"",""
AB-19156539,5,8,C,ロペラミド塩酸塩,"",経口,"","","","","","",未知,"",""
AB-19156622,5,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20181114,20190314,200,mg,1,肺扁平上皮癌第４期(非小細胞肺癌（右下葉扁平上皮癌）),剂量停止,免疫性汎血球減少症(再投与なし),""
AB-19156622,5,2,C,オルメサルタンメドキソミル,"",経口,不明,"",20,mg,1,高血圧(高血圧),未知,"",""
AB-19156622,5,3,C,アトルバスタチンカルシウム水和物,"",経口,不明,"",5,mg,1,脂質異常症(脂質異常症),未知,"",""
AB-19157689,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-19157704,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19157706,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(胃癌),剂量停止,間質性肺疾患(有);間質性肺疾患(有),""
AB-19157770,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190507,"",200,mg,1,胃癌第４期(MSI-Highを有する結腸・直腸癌以外の固形癌（標準的治療困難）（癌腫：胃癌3rd）),剂量不变,免疫性甲状腺機能低下症(再投与なし),""
AB-19157949,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201908,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-19157949,2,2,C,デュタステリド,"",不明,"","","","","","",未知,"",""
AB-19157949,2,3,C,シロドシン,"",不明,"","","","","","",未知,"",""
AB-19158216,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;240,;mg,;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,スティーヴンス・ジョンソン症候群(再投与なし),""
AB-19158222,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181203,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,心筋梗塞(再投与なし),""
AB-19158474,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,脳梗塞(再投与なし),""
AB-19158477,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190620,20191024,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,劇症１型糖尿病(再投与なし);糖尿病性ケトアシドーシス(再投与なし),""
AB-19158478,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,腹水(再投与なし),""
AB-19158748,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,関節リウマチ(再投与なし),""
AB-19158762,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20180622;20180807;20180918;20181016;20190416;20210708,20180724;20180904;20181002;20181127;20190416;20210819,180;190;200;240;240;240,mg;mg;mg;mg;mg;mg,1;1;1;1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,免疫性腸炎(再投与なし);１型糖尿病(再投与なし),""
AB-19158762,7,2,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-19159041,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171031,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,免疫性腸炎(再投与なし),""
AB-19159042,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171003,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,免疫性腸炎(再投与なし),""
AB-19159256,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171214,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,心筋症(再投与なし);心筋症(再投与なし);肝不全(再投与なし);胃腸出血(再投与なし);肺炎(再投与なし);腎硬化症(再投与なし);右室拡張(再投与なし);急性膵炎(再投与なし);甲状腺機能低下症(再投与なし);大動脈硬化症(再投与なし),""
AB-19159256,4,2,PS,カペシタビン,"",不明,202004,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-19159256,4,3,PS,オキサリプラチン,"",不明,202004,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-19159556,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181017,20191225,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血小板数減少(再投与なし),""
AB-19159556,1,2,C,アスピリン,"",経口,"","",100,mg,1,"",未知,"",""
AB-19159556,1,3,C,モサプリドクエン酸塩水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-19159556,1,4,C,酸化マグネシウム,"",経口,"","",500,mg,1,"",未知,"",""
AB-19159556,1,5,C,ミグリトール,"",経口,"","",50,mg,1,"",未知,"",""
AB-19159848,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190611,20191001,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-19160718,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20191024;20200217,20200106;20200511,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-19161037,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,発熱(再投与なし);尿閉(再投与なし);腎機能障害(再投与なし),""
AB-19161303,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190911;20191126,20191023;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,尿閉(不明);劇症１型糖尿病(不明),""
AB-19161303,2,2,C,アセトアミノフェン,"",経口;経口,20190716;20191126,20191031;,1000;1000,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19161303,2,3,C,酸化マグネシウム,"",経口;経口,20190827;20191224,20191031;,660;660,mg;mg,1;1,"",未知,"",""
AB-19161305,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190909,20191021,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,アスペルギルス感染(再投与なし),""
AB-19161305,2,2,C,セレコキシブ,"",不明,"","","","","","",未知,"",""
AB-19161305,2,3,C,オキシコドン塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-19161305,2,4,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-19161305,2,5,C,メコバラミン,"",不明,"","","","","","",未知,"",""
AB-19161306,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,譫妄(再投与なし),""
AB-19161510,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20191202,20191223,200,mg,1,非小細胞肺癌(非小細胞肺癌),不适用,喀血(再投与なし);出血性ショック(再投与なし),""
AB-19161510,2,2,PS,パクリタキセル,"",非経口,20191202,20191223,"","","",非小細胞肺癌(非小細胞肺癌),不适用,"",""
AB-19161510,2,3,PS,カルボプラチン,"",静脈内点滴,20191202,20191223,330,mg,1,非小細胞肺癌(非小細胞肺癌),不适用,"",""
AB-19161605,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201801;202002,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-19161680,4,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,20190918,20191031,10,mg/kg,1,非小細胞肺癌(CRT後の非小細胞肺癌),剂量停止,"",""
AB-19161680,4,2,C,ボノプラザンフマル酸塩,"",経口,20190628,"",20,mg,1,胃癌(早期胃癌),未知,"",""
AB-19161680,4,3,C,デキストロメトルファン臭化水素酸塩水和物,"",経口,20190813,"",15,mg,1,食道炎(食道炎の予防),未知,"",""
AB-19161680,4,4,C,アルギン酸ナトリウム,"",経口,20190822,"",20,mL,1,食道炎(食道炎の予防),未知,"",""
AB-19161680,4,5,C,メトクロプラミド,"",経口,20190927,"",5,mg,1,悪心(吐き気),未知,"",""
AB-19161929,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,肝炎(再投与なし);上部消化管穿孔(再投与なし);胆管炎(再投与なし),""
AB-19161932,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,2020,2020,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,穿孔(再投与なし),""
AB-19161937,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190625,20191224,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-19161937,1,2,C,六君子湯,"",経口,"","",3,{DF},1,"",未知,"",""
AB-19161937,1,3,C,モサプリドクエン酸塩水和物,"",経口,"","",3,{DF},1,"",未知,"",""
AB-19161937,1,4,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-19161937,1,5,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-19161937,1,6,C,センノシド,"",不明,"","","","","","",未知,"",""
AB-19162323,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190702,20190813,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍のハイパープログレッション(再投与なし),""
AB-19162323,2,2,C,ロフラゼプ酸エチル,"",経口,"","",2,{DF},1,"",未知,"",""
AB-19162323,2,3,C,ラモトリギン,"",経口,"","",4,{DF},1,"",未知,"",""
AB-19162323,2,4,C,クエチアピンフマル酸塩,"",経口,"","",2,{DF},1,"",未知,"",""
AB-19162323,2,5,C,オランザピン,"",経口,"","",2,{DF},1,"",未知,"",""
AB-19162323,2,6,C,アルプラゾラム,"",経口,"","",1,{DF},1,"",未知,"",""
AB-19162323,2,7,C,クエン酸第一鉄ナトリウム,"",経口,"","","","","","",未知,"",""
AB-19162323,2,8,C,メコバラミン,"",不明,"","","","","","",未知,"",""
AB-19162323,2,9,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-19162581,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191216,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし),""
AB-19162628,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191223,20200106,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,肝不全(再投与なし);腎機能障害(再投与なし);紅斑(再投与なし);硬化性胆管炎(再投与なし),""
AB-19162628,4,2,PS,オキシコドン塩酸塩水和物,オキファスト,皮下,20200128,"",30,mg,1,胃穿孔(胃穿孔),未知,"",""
AB-19162628,4,3,C,タペンタドール塩酸塩,"",経口,"","","","","","",未知,"",""
AB-19162628,4,4,C,エドキサバントシル酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-19162628,4,5,C,ウルソデオキシコール酸,"",経口,"","","","","","",未知,"",""
AB-19162628,4,6,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-19162628,4,7,C,イソロイシン・ロイシン・バリン,"",経口,"","","","","","",未知,"",""
AB-19162628,4,8,C,オランザピン,"",経口,"","","","","","",未知,"",""
AB-19162628,4,9,C,ロスバスタチンカルシウム,"",経口,"","","","","","",未知,"",""
AB-19162628,4,10,C,ナルデメジントシル酸塩,"",経口,"","","","","","",未知,"",""
AB-19162628,4,11,C,フェブキソスタット,"",経口,"","","","","","",未知,"",""
AB-19162628,4,12,C,スピロノラクトン,"",経口,"","","","","","",未知,"",""
AB-19162628,4,13,C,センノシド,"",経口,"","","","","","",未知,"",""
AB-19162628,4,14,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","","",未知,"",""
AB-19162628,4,15,C,モサプリドクエン酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-19162628,4,16,C,補中益気湯,"",経口,"","","","","","",未知,"",""
AB-19162893,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,不明,"","","","",胃癌(MSI-Highを有する胃神経内分泌癌),未知,免疫性腸炎(再投与なし),""
AB-19162920,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190521,20190716,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,続発性副腎皮質機能不全(再投与なし),""
AB-19162920,2,2,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-19162920,2,3,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-19162920,2,4,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-19163290,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190118,20200124,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,胃癌(再投与なし),""
AB-19163290,1,2,C,アムロジピンベシル酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-19163290,1,3,C,ブロチゾラム,"",経口,"","",.25,mg,1,"",未知,"",""
AB-19163290,1,4,C,スボレキサント,"",経口,"","",15,mg,1,不眠症(不眠),未知,"",""
AB-19163301,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191211,20200122,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝炎(再投与なし),""
AB-19163301,5,2,C,アムロジピンベシル酸塩,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-19163301,5,3,C,タムスロシン塩酸塩,"",経口,"","",.2,mg,1,"",未知,"",""
AB-19163301,5,4,C,フロセミド,"",経口,"","",20,mg,1,"",未知,"",""
AB-19163301,5,5,C,レボチロキシンナトリウム水和物,"",経口,"","",12.5,ug,1,"",未知,"",""
AB-19163301,5,6,C,ビカルタミド,"",経口,"","",80,mg,1,"",未知,"",""
AB-19163301,5,7,C,フェブキソスタット,"",経口,"","",10,mg,1,"",未知,"",""
AB-19163305,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-19163383,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20190702;20190822,20190724;,200;200,mg;mg,1;1,胃癌(胃癌),剂量停止,注入に伴う反応(不明);注入に伴う反応(再投与なし),""
AB-19163552,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201811;20190806,20190521;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-19163562,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181217,20190204,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,髄膜転移(再投与なし);悪性新生物進行(再投与なし),""
AB-19164099,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171105,20180208,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,大腸炎(再投与なし),""
AB-19164316,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180516;,20190705;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(不明);死亡(不明),""
AB-19164316,3,2,C,カンデサルタンシレキセチル,"",不明,"","","","","","",未知,"",""
AB-19164316,3,3,C,シルニジピン,"",不明,"","","","","","",未知,"",""
AB-19164316,3,4,C,アンブロキソール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-19164316,3,5,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-19164316,3,6,C,デュロキセチン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-19164316,3,7,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-19164544,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171220,20180103,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,空腸穿孔(再投与なし);感染性胸水(再投与なし),""
AB-19164549,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20191226;20200227,20200123;20200326,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,悪性腹水(再投与なし);間質性肺疾患(再投与なし);膵炎(再投与なし);薬物性肝障害(再投与なし);胆管炎(再投与なし),""
AB-19164549,7,2,PS,ジアスターゼ配合剤（１）,タフマックＥ,経口,20190319,20200709,1,g,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,悪性腹水(再投与なし);間質性肺疾患(再投与なし);膵炎(再投与なし);薬物性肝障害(再投与なし);胆管炎(再投与なし),""
AB-19164549,7,3,C,酪酸菌製剤,"",経口,20190319,20200709,1,g,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19164549,7,4,C,ポラプレジンク,"",経口,20190320,20200623,75,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19164549,7,5,C,酸化マグネシウム,"",経口,20190326,20200709,330,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19164549,7,6,C,アセトアミノフェン,"",経口,20191212,20200716,500,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19164549,7,7,C,大建中湯,"",経口,20191219,20200709,2.5,g,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19164549,7,8,C,プレドニゾロン,"",経口,20191226,20200213,1,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19164996,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181220;20200225,20200123;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(有);下垂体機能低下症(有);副腎機能不全(有),""
AB-19164996,5,2,C,クエン酸第一鉄ナトリウム,"",経口,"","",50,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19164996,5,3,C,エカベトナトリウム水和物,"",経口,"","",1.5,g,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19164996,5,4,C,レバミピド,"",経口,"","",100,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19164996,5,5,C,オキセサゼイン,"",経口,"","",5,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19164996,5,6,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19164996,5,7,C,メコバラミン,"",経口,"","",.5,mg,1,予防(予防),未知,"",""
AB-19164996,5,8,C,ケトプロフェン,"",経皮,"","",20,mg,1,予防(予防),未知,"",""
AB-19165872,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,尿細管間質性腎炎(不明),""
AB-19166184,2,1,PS,イピリムマブ,ヤーボイ,静脈内点滴,20191029,20200107,"","","",悪性黒色腫(根治切除不能な悪性黒色腫),未知,"",""
AB-19166184,2,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20191029,20200107,"","","",悪性黒色腫(根治切除不能な悪性黒色腫),未知,"",""
AB-19166352,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201802;201808,201807;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(不明),""
AB-19166352,1,2,PS,レボチロキシンナトリウム水和物,チラーヂンＳ錠,経口,201806,201807,"","","",甲状腺機能低下症(甲状腺機能低下症),剂量停止,"",""
AB-19166358,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190705,20191025,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,カンジダ感染(再投与なし);脳症(再投与なし);遊走性血栓静脈炎(再投与なし);嚥下障害(再投与なし);誤嚥性肺炎(再投与なし);気胸(再投与なし),""
AB-19166540,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200107,20200206,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-19166543,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190718,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発熱性好中球減少症(再投与なし),""
AB-19166543,3,2,PS,メサラジン,"",経口;経口;経口,20070428;20190816;2020,20180706;20200220;,500;500;,mg;mg;,1;1;,潰瘍性大腸炎(潰瘍性大腸炎),剂量停止,"",""
AB-19166543,3,3,C,アムロジピンベシル酸塩,"",経口,20190329,"",5,mg,1,"",未知,"",""
AB-19166543,3,4,C,プレガバリン,"",経口,20190510,"",25,mg,1,"",未知,"",""
AB-19166543,3,5,C,カンデサルタンシレキセチル,"",経口,20190719,"",8,mg,1,"",未知,"",""
AB-19166543,3,6,C,酪酸菌製剤,"",経口,20190809,"","","","","",未知,"",""
AB-19166543,3,7,C,フェキソフェナジン塩酸塩,"",経口,20200123,"",60,mg,1,"",未知,"",""
AB-19166744,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191107,20191218,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-19166744,1,2,C,アセトアミノフェン,"",経口,20191016,"",4,{DF},1,"",未知,"",""
AB-19166744,1,3,C,ランソプラゾール,"",経口,20191016,"",30,mg,1,"",未知,"",""
AB-19166744,1,4,C,プレガバリン,"",経口,20191016,"",75,mg,1,"",未知,"",""
AB-19166744,1,5,C,スルファメトキサゾール・トリメトプリム,"",経口,20191016,"",1,{DF},1,"",未知,"",""
AB-19166744,1,6,C,プレドニゾロン,"",経口,20191016,"",20,mg,1,"",未知,"",""
AB-19166744,1,7,C,エドキサバントシル酸塩水和物,"",経口,20191016,"",30,mg,1,"",未知,"",""
AB-19166744,1,8,C,酸化マグネシウム,"",経口,20191016,"",660,mg,1,"",未知,"",""
AB-19167503,2,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,20191018,"",10,mg/kg,1,非小細胞肺癌(CRT後の非小細胞肺癌),剂量停止,"",""
AB-19167540,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,不明,"",200,mg,1,胃癌(MSI-High胃癌),未知,腸炎(再投与なし),""
AB-19168395,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-19168399,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191107,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,軟部組織感染(再投与なし),""
AB-19168399,3,2,C,ボノプラザンフマル酸塩,"",経口,20180323,"",10,mg,1,胃食道逆流性疾患(逆流性食道炎),未知,"",""
AB-19168399,3,3,C,酪酸菌配合剤,"",経口,20180705,"","","","",胃腸障害治療(整腸),未知,"",""
AB-19168399,3,4,C,オキシコドン塩酸塩水和物,"",経口,20181115,"",2.5,mg,1,癌疼痛(癌性疼痛),未知,"",""
AB-19168399,3,5,C,ヒドロモルフォン塩酸塩,"",経口,20181213,"",4,mg,1,癌疼痛(癌性疼痛),未知,"",""
AB-19168399,3,6,C,カンデサルタンシレキセチル,"",経口,20190502,"",8,mg,1,高血圧(高血圧症),未知,"",""
AB-19168667,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190729,20191007,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-19168667,1,2,C,フロセミド,"",経口,"","",20,mg,1,"",未知,"",""
AB-19168667,1,3,C,経腸成分栄養剤（９−１）,"",不明,"","","","","","",未知,"",""
AB-19168667,1,4,C,酪酸菌製剤,"",経口,"","",1,{DF},1,"",未知,"",""
AB-19168888,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201902,201909,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);食道炎(再投与なし),""
AB-19169362,3,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20180613,20200306,40,mg,1,胃癌(胃癌),剂量停止,"",""
AB-19169362,3,2,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20180613,"",200,mg,1,胃癌(胃癌),剂量不变,"",""
AB-19169362,3,3,C,オキサリプラチン,"",静脈内点滴,20180613,"",130,mg,1,胃癌(胃癌),剂量不变,"",""
AB-19169362,3,4,C,カルベジロール,"",経口,"","",20,mg,1,"",剂量不变,"",""
AB-19169362,3,5,C,ランソプラゾール,"",経口,"","",30,mg,1,"",剂量不变,"",""
AB-19169362,3,6,C,デュラグルチド,"",皮下,"","",0.75,mg,1,"",剂量不变,"",""
AB-19169362,3,7,C,インスリングラルギン,"",皮下,"","",10,[iU],1,"",剂量不变,"",""
AB-19169362,3,8,C,ラクトミン,"",経口,20180711,"",1,mg,1,下痢(下痢),剂量不变,"",""
AB-19169362,3,9,C,ロペラミド塩酸塩,"",経口,20180711,"",1,{DF},1,下痢(下痢),剂量不变,"",""
AB-19169362,3,10,C,コハク酸ソリフェナシン,"",経口,20181212,"",5,mg,1,緊張性膀胱(過活動膀胱),剂量不变,"",""
AB-19169520,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190208,20200228,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,敗血症(再投与なし);甲状腺機能低下症(再投与なし);尿閉(再投与なし),""
AB-19169520,5,2,C,セレコキシブ,"",不明,"","","","","","",未知,"",""
AB-19169520,5,3,C,プレガバリン,"",不明,"","","","","","",未知,"",""
AB-19169719,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200228,20200313,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝障害(再投与なし),""
AB-19169918,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181105,20190603,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,胃狭窄(再投与なし);嘔吐(再投与なし),""
AB-19169918,1,2,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-19169918,1,3,C,ピコスルファートナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-19169918,1,4,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-19169918,1,5,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-19169918,1,6,C,セレコキシブ,"",不明,"","","","","","",未知,"",""
AB-19169918,1,7,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-19169918,1,8,C,カンデサルタンシレキセチル,"",不明,"","","","","","",未知,"",""
AB-19169918,1,9,C,アピキサバン,"",不明,"","","","","","",未知,"",""
AB-19169919,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,咽頭炎(再投与なし),""
AB-19169919,1,2,C,イリノテカン塩酸塩水和物,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-19170170,2,1,PS,イピリムマブ,ヤーボイ,静脈内点滴,20190116,20190116,1,mg/kg,1,遠隔転移を伴う腎細胞癌(遠隔転移を伴う腎細胞癌),未知,意識変容状態(再投与なし);副腎機能不全(再投与なし),""
AB-19170170,2,2,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190116;201904,;,240;,mg;,1;,遠隔転移を伴う腎細胞癌(原疾患治療のため);腎転移(腎転移),未知,意識変容状態(再投与なし);副腎機能不全(再投与なし),""
AB-19170170,2,3,C,ヒドロコルチゾン,"",不明;不明;不明;不明;不明;不明;不明;不明;不明;不明,20181101;20181108;20181112;20181115;20181226;20190204;20190225;20190318;20190327;20190403,20181107;20181111;20181114;20181225;20190203;20190224;20190317;20190326;20190402;,20;15;35;20;15;10;5;10;20;10,mg;mg;mg;mg;mg;mg;mg;mg;mg;mg,1;1;1;1;1;1;1;1;1;1,副腎機能不全(副腎不全),未知,"",""
AB-20000248,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191111,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,胃腸出血(再投与なし);甲状腺機能低下症(再投与なし),""
AB-20001255,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190816,20190830,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍出血(再投与なし);腫瘍のハイパープログレッション(再投与なし),""
AB-20001257,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,不整脈(再投与なし);筋炎(再投与なし),""
AB-20001454,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201810;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,続発性副腎皮質機能不全(再投与なし);死亡(再投与なし),""
AB-20001455,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201804,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-20001594,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし);糖尿病(再投与なし);糖尿病性ケトアシドーシス(再投与なし),""
AB-20001596,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200407,20200407,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,急性膵炎(再投与なし),""
AB-20002105,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180216,20180412,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-20002114,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191204,20200414,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,貧血(再投与なし);腫瘍出血(再投与なし),""
AB-20002383,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200127,20200330,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし);甲状腺機能亢進症(再投与なし),""
AB-20002486,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,重症筋無力症(再投与なし),""
AB-20002490,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200213,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし);自己免疫性甲状腺炎(再投与なし),""
AB-20002497,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200401,20200401,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,劇症肝炎(再投与なし),""
AB-20002617,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181106,20190109,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-20002974,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190311,20191021,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,ショック症状(再投与なし);誤嚥性肺炎(再投与なし);血圧低下(再投与なし),""
AB-20004051,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202001;202007,202005;202009,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍穿孔(無),""
AB-20004051,7,2,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-20004051,7,3,C,エナラプリルマレイン酸塩,"",不明,"","","","","","",未知,"",""
AB-20004051,7,4,C,芍薬甘草湯,"",不明,"","","","","","",未知,"",""
AB-20004351,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200403,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腹水(再投与なし),""
AB-20004354,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200212,20200507,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,心停止(再投与なし);甲状腺機能低下症(再投与なし);多臓器機能不全症候群(再投与なし),""
AB-20004354,3,2,C,モサプリドクエン酸塩水和物,"",経口,20170520,20200507,5,mg,1,"",未知,"",""
AB-20004354,3,3,C,ボノプラザンフマル酸塩,"",経口,20190520,20200507,20,mg,1,"",未知,"",""
AB-20004354,3,4,C,スボレキサント,"",経口,20200212,20200507,15,mg,1,"",未知,"",""
AB-20004354,3,5,C,フロセミド,"",経口,20200423,20200507,10,mg,1,"",未知,"",""
AB-20004354,3,6,C,モルヒネ塩酸塩水和物,"",静脈内（明記されていない場合）;静脈内（明記されていない場合）,20200509;20200510,20200509;20200510,;,;,;,"",未知,"",""
AB-20004354,3,7,C,ロキソプロフェンナトリウム水和物,"",経口,"","",60,mg,1,"",未知,"",""
AB-20004354,3,8,C,フルルビプロフェンアキセチル,"",静脈内（明記されていない場合）,"","",50,mg,1,"",未知,"",""
AB-20004663,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200226,20200226,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,アラニンアミノトランスフェラーゼ増加(再投与なし);アスパラギン酸アミノトランスフェラーゼ増加(再投与なし),""
AB-20004777,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200212;202007,20200408;202008,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎皮質刺激ホルモン欠損症(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-20004780,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191003,20200430,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし),""
AB-20004780,2,2,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-20004780,2,3,C,アジルサルタン,"",経口,"","",20,mg,1,"",未知,"",""
AB-20004780,2,4,C,ニフェジピン,"",経口,"","",20,mg,1,"",未知,"",""
AB-20004780,2,5,C,フロセミド,"",経口,"","",20,mg,1,"",未知,"",""
AB-20004780,2,6,C,モサプリドクエン酸塩水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-20004780,2,7,C,アピキサバン,"",経口,"","",5,mg,1,"",未知,"",""
AB-20004780,2,8,C,フェブキソスタット,"",経口,"","",20,mg,1,"",未知,"",""
AB-20004780,2,9,C,エンテカビル水和物,"",経口,"","",.5,mg,1,"",未知,"",""
AB-20004780,2,10,C,Ｌ−カルボシステイン,"",経口,"","",500,mg,1,"",未知,"",""
AB-20004780,2,11,C,アンブロキソール塩酸塩,"",経口,"","",15,mg,1,"",未知,"",""
AB-20004957,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191204,20191204,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-20005114,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",140,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,硬化性胆管炎(再投与なし),""
AB-20005253,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;20200617,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,視床下部−下垂体障害(再投与なし);副腎機能不全(再投与なし),""
AB-20005842,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200428,202005,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腹膜炎(再投与なし),""
AB-20006016,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20181211,"",200,mg,1,胃癌(マイクロサテライト不安定性癌（病型：胃がん）),未知,免疫性肝炎(再投与なし),""
AB-20006155,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201905,201911,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-20006506,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200319,20200430,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-20006700,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191113,20200501,240,mg,1,頭頚部癌(再発又は遠隔転移を有する頭頸部癌),剂量停止,小脳性運動失調(再投与なし),""
AB-20006700,1,2,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-20006700,1,3,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-20006700,1,4,C,タムスロシン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-20006700,1,5,C,塩化ナトリウム,"",不明,"","","","","","",未知,"",""
AB-20006700,1,6,C,アンブロキソール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-20006700,1,7,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-20006700,1,8,C,ビフィズス菌製剤（４）,"",不明,"","","","","","",未知,"",""
AB-20006700,1,9,C,経腸成分栄養剤（９−１）,"",不明,"","","","","","",未知,"",""
AB-20006700,1,10,C,経腸成分栄養剤（１０）,"",不明,"","","","","","",未知,"",""
AB-20006700,1,11,C,トラネキサム酸,"",不明,"","","","","","",未知,"",""
AB-20006700,1,12,C,カルバゾクロムスルホン酸ナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-20006701,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201911,202004,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし);意識レベルの低下(再投与なし),""
AB-20007622,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180202,20180313,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍のハイパープログレッション(再投与なし),""
AB-20007622,2,2,PS,グリチルリチン酸一アンモニウム・グリシン・ＤＬ−メチオニン配合剤,グリチロン,不明,20180220,20180305,"","","",血中乳酸脱水素酵素増加(LDH上昇),不适用,"",""
AB-20007623,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200303,20200331,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-20007992,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191101,20191114,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,発熱(再投与なし);血小板数減少(再投与なし);白血球数減少(再投与なし);発疹(再投与なし);播種性血管内凝固(再投与なし);発熱(再投与なし);肝障害(再投与なし);白血球数減少(再投与なし),""
AB-20007992,3,2,PS,シタグリプチンリン酸塩水和物,グラクティブ,経口,20190718,"","","","",糖尿病(糖尿病),剂量不变,発熱(再投与なし);血小板数減少(再投与なし);白血球数減少(再投与なし);発疹(再投与なし);播種性血管内凝固(再投与なし);発熱(再投与なし);肝障害(再投与なし);白血球数減少(再投与なし),""
AB-20007992,3,3,C,イソロイシン・ロイシン・バリン,"",経口,20190301,"","","","","",未知,"",""
AB-20007992,3,4,C,ボノプラザンフマル酸塩,"",経口,20190719,"","","","","",未知,"",""
AB-20007992,3,5,C,アセトアミノフェン,"",経口,20191101,"","","","","",未知,"",""
AB-20007992,3,6,C,バゼドキシフェン酢酸塩,"",経口,"","","","","","",未知,"",""
AB-20007995,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,ＩｇＡ腎症(無);尿細管間質性腎炎(無),""
AB-20007995,1,2,PS,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",剂量停止,"",""
AB-20008279,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20191121;20200203;20200226;20200511,20200106;20200203;20200408;,200;200;200;200,mg;mg;mg;mg,1;1;1;1,胃癌第４期(MSI-Highを有する結腸・直腸癌以外の固形癌（標準的治療困難）（胃癌）),剂量停止,多形紅斑(無),""
AB-20008332,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190501;20200715,20200527;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(無);甲状腺機能低下症(無),""
AB-20008617,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200305,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,劇症１型糖尿病(再投与なし),""
AB-20008617,3,2,C,アセトアミノフェン,"",経口,"","","","","","",未知,"",""
AB-20008617,3,3,C,ルビプロストン,"",経口,"","","","","","",未知,"",""
AB-20008617,3,4,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-20009129,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180601,20180713,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,麻痺性イレウス(再投与なし);腹水(再投与なし);肝機能異常(再投与なし),""
AB-20009130,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180608;,;20190328,170;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,水疱性皮膚炎(再投与なし),""
AB-20009604,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171006,20180202,165,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,乾癬性関節症(再投与なし);甲状腺機能低下症(再投与なし),""
AB-20009607,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171020,20180330,165,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-20009623,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌);胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,脳幹脳炎(再投与なし),""
AB-20009623,1,2,PS,イピリムマブ,ヤーボイ,不明,"","","","","",食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌);胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20010065,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201904,"","","","",悪性黒色腫(根治切除不能な悪性黒色腫に対する併用療法),未知,肉芽腫性肝疾患(再投与なし),""
AB-20010065,1,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,201904,"","","","",悪性黒色腫(根治切除不能な悪性黒色腫に対する併用療法),未知,"",""
AB-20010229,2,1,PS,イピリムマブ,ヤーボイ,静脈内点滴,201904,"","","","",悪性黒色腫(悪性黒色腫),未知,"",""
AB-20010229,2,2,PS,ニボルマブ,オプジーボ,静脈内点滴,201904,"","","","",悪性黒色腫(悪性黒色腫),未知,"",""
AB-20010455,2,1,PS,イピリムマブ,ヤーボイ,静脈内点滴,"","","","","",食道癌(進行食道癌),未知,脳幹脳炎(不明);咽頭障害(不明);反射減弱(不明);反射消失(不明),""
AB-20010455,2,2,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",食道癌(進行食道癌),未知,脳幹脳炎(不明);咽頭障害(不明);反射減弱(不明);反射消失(不明),""
AB-20010504,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200214,20200313,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,胃穿孔(再投与なし),""
AB-20010900,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,硝子体混濁(再投与なし),""
AB-20010961,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190329,20190517,200,mg,1,再発胃癌(MSI-Highを有する結腸・直腸癌以外の固形癌（胃癌）),剂量停止,胆管炎(再投与なし);肝機能異常(再投与なし),""
AB-20011071,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190319,"",200,mg,1,胃癌第４期(MSI-Highを有する結腸・直腸癌以外の固形癌（胃癌）),剂量不变,視床下部−下垂体障害(再投与なし);甲状腺機能低下症(再投与なし),""
AB-20011302,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし);甲状腺機能低下症(再投与なし),""
AB-20011302,1,2,C,トリフルリジン・チピラシル塩酸塩配合剤,"",経口;経口;経口,;;,;;,110;100;90,mg;mg;mg,1;1;1,"",未知,"",""
AB-20011515,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191218,20200318,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-20011515,4,2,C,ミロガバリンベシル酸塩,"",経口,20200205,"",15,mg,1,"",未知,"",""
AB-20011515,4,3,C,リバーロキサバン,"",経口,"","",10,mg,1,"",未知,"",""
AB-20011515,4,4,C,フェブキソスタット,"",経口,"","",10,mg,1,"",未知,"",""
AB-20011515,4,5,C,ベプリジル塩酸塩水和物,"",経口,"","",50,mg,1,"",未知,"",""
AB-20011515,4,6,C,アプリンジン塩酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-20011515,4,7,C,ビソプロロールフマル酸塩,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-20011515,4,8,C,シルニジピン,"",経口,"","",10,mg,1,"",未知,"",""
AB-20011515,4,9,C,シロドシン,"",経口,"","",4,mg,1,"",未知,"",""
AB-20011516,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,スティーヴンス・ジョンソン症候群(再投与なし),""
AB-20011516,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20011516,3,3,C,ドセタキセル,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20012039,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200130,20200227,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,腹膜炎(再投与なし);免疫性腸炎(再投与なし),""
AB-20012039,5,2,C,セレコキシブ,"",経口,"","",200,mg,1,"",未知,"",""
AB-20012039,5,3,C,ランソプラゾール,"",経口,"","",30,mg,1,"",未知,"",""
AB-20012039,5,4,C,モサプリドクエン酸塩水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-20012039,5,5,C,メトホルミン塩酸塩,"",経口,"","",250,mg,1,"",未知,"",""
AB-20012049,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-20012237,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190215,20200221,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし);リウマチ性多発筋痛(再投与なし);下垂体機能低下症(再投与なし);間質性肺疾患(再投与なし),""
AB-20012237,3,2,C,レボチロキシンナトリウム水和物,"",経口,"","",50,ug,1,予防(予防),未知,"",""
AB-20012237,3,3,C,ヒドロコルチゾン,"",経口,"","",10,mg,1,予防(予防),未知,"",""
AB-20012894,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201811,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,びまん性大細胞型Ｂ細胞性リンパ腫(再投与なし),""
AB-20013136,3,1,PS,ニボルマブ,オプジーボ,その他(中心静脈ポート),20200313,20200522,240,mg,1,食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),剂量停止,免疫性血小板減少症(再投与なし),""
AB-20013136,3,2,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,予防(予防投与),未知,"",""
AB-20013136,3,3,C,ブロチゾラム,"",経口,"","",.5,mg,1,"",未知,"",""
AB-20013136,3,4,C,タムスロシン塩酸塩,"",経口,"","",.2,mg,1,"",未知,"",""
AB-20013136,3,5,C,アピキサバン,"",経口,"","",10,mg,1,"",未知,"",""
AB-20013136,3,6,C,ウラピジル,"",経口,"","",15,mg,1,"",未知,"",""
AB-20013136,3,7,C,ビラスチン,"",経口,"","",20,mg,1,"",未知,"",""
AB-20013136,3,8,C,スボレキサント,"",経口,"","",15,mg,1,"",未知,"",""
AB-20013136,3,9,C,モルヒネ硫酸塩水和物,"",経口,"","",30,mg,1,"",未知,"",""
AB-20013136,3,10,C,タペンタドール塩酸塩,"",経口,"","",100,mg,1,"",未知,"",""
AB-20013136,3,11,C,ルビプロストン,"",経口,"","",24,ug,1,"",未知,"",""
AB-20013136,3,12,C,センノシド,"",経口,"","",24,mg,1,"",未知,"",""
AB-20013136,3,13,C,モルヒネ塩酸塩水和物,"",経口,"","",10,mg,1,"",未知,"",""
AB-20013363,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190914,20191111,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし);食欲減退(再投与なし),""
AB-20013363,1,2,C,レボチロキシンナトリウム水和物,"",経口,20190906,"","","","","",未知,"",""
AB-20013363,1,3,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
AB-20013363,1,4,C,半夏瀉心湯,"",経口,"","","","","","",未知,"",""
AB-20013752,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20190110;20200228;,;;,240;240;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,糖尿病性ケトアシドーシス(不明),""
AB-20013752,2,2,C,ボノプラザンフマル酸塩,"",経口,20180315,"",10,mg,1,胃癌(胃癌),未知,"",""
AB-20013752,2,3,C,モサプリドクエン酸塩水和物,"",経口,20180315,"",5,mg,1,胃癌(胃癌),未知,"",""
AB-20013752,2,4,C,アムロジピンベシル酸塩,"",経口,20180315,"",5,mg,1,"",未知,"",""
AB-20013752,2,5,C,アジルサルタン,"",経口,20180315,"",20,mg,1,"",未知,"",""
AB-20013752,2,6,C,コデインリン酸塩水和物,"",経口,"","",20,mg,1,予防(予防),未知,"",""
AB-20013755,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190110,20190125,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍のハイパープログレッション(再投与なし),""
AB-20013757,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,硬化性胆管炎(再投与なし),""
AB-20013759,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200330,20200529,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,溶血性貧血(再投与なし);皮膚障害(再投与なし),""
AB-20013759,2,2,C,スピロノラクトン,"",不明,"","",50,mg,1,"",未知,"",""
AB-20013759,2,3,C,アセトアミノフェン,"",不明,"","",2000,mg,1,"",未知,"",""
AB-20013759,2,4,C,酪酸菌製剤,"",不明,"","",3,g,1,"",未知,"",""
AB-20013759,2,5,C,ボノプラザンフマル酸塩,"",不明,"","",10,mg,1,"",未知,"",""
AB-20013759,2,6,C,フロセミド,"",不明,"","",20,mg,1,"",未知,"",""
AB-20014002,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191125,20200302,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,末梢性感覚ニューロパチー(再投与なし),""
AB-20014002,3,2,C,ボノプラザンフマル酸塩,"",経口,20181115,"",10,mg,1,"",未知,"",""
AB-20014002,3,3,C,酪酸菌製剤,"",経口,20190624,"",1,{DF},1,"",未知,"",""
AB-20014002,3,4,C,ウルソデオキシコール酸,"",経口,20200113,20200416,100,mg,1,"",未知,"",""
AB-20014002,3,5,C,レボチロキシンナトリウム水和物,"",経口,2020,20200311,"","","","",未知,"",""
AB-20014225,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191211,20200205,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,類天疱瘡(再投与なし),""
AB-20014225,3,2,C,クエン酸第一鉄ナトリウム,"",不明,20200120,"",50,mg,1,"",未知,"",""
AB-20014225,3,3,C,シロドシン,"",経口,"","",4,mg,1,"",未知,"",""
AB-20014225,3,4,C,デュタステリド,"",経口,"","",.5,mg,1,"",未知,"",""
AB-20014225,3,5,C,ロスバスタチンカルシウム,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-20014225,3,6,C,リナグリプチン,"",経口,"","",5,mg,1,"",未知,"",""
AB-20014234,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,下垂体機能低下症(再投与なし);自己免疫性脳炎(再投与なし),""
AB-20014618,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,不整脈(再投与なし),""
AB-20014618,1,2,C,カルベジロール,"",経口,"","","","","","",未知,"",""
AB-20015259,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",202007,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,認知症(再投与なし);譫妄(再投与なし),""
AB-20015260,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200714,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし),""
AB-20015447,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190623,20200709,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性溶血性貧血(再投与なし),""
AB-20015447,3,2,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-20015447,3,3,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-20015447,3,4,C,アズレンスルホン酸ナトリウム水和物・Ｌ−グルタミン,"",経口,"","",.67,g,1,"",未知,"",""
AB-20015689,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200515,202006,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);自己免疫性溶血性貧血(再投与なし),""
AB-20015706,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191030,20200318,240,mg,1,ホジキン病(再発又は難治性の古典的ホジキンリンパ腫);胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,末梢性ニューロパチー(再投与なし),""
AB-20015706,2,2,C,プレガバリン,"",経口,20190813,"","","","","",未知,"",""
AB-20015713,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-20015717,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200409,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,低カリウム血症(再投与なし);脱水(再投与なし);下痢(再投与なし),""
AB-20015717,2,2,C,経腸成分栄養剤（２−１）,"",不明,"","","","","","",未知,"",""
AB-20015976,8,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200421,20200421,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,重症筋無力症(再投与なし);心筋炎(再投与なし);１型糖尿病(再投与なし),""
AB-20015976,8,2,C,クロルフェニラミンマレイン酸塩,"",静脈内（明記されていない場合）,20200421,20200421,5,mg,1,予防(予防投与),未知,"",""
AB-20015976,8,3,C,生理食塩液,"",静脈内点滴,20200421,20200421,250,mL,1,"",未知,"",""
AB-20015979,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,椎間板炎(再投与なし),""
AB-20015984,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190115,20200428,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,低カリウム血症(再投与なし),""
AB-20016185,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,腹部膿瘍(再投与なし),""
AB-20016493,3,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,20200313,20210226,10,mg/kg,1,非小細胞肺癌(CRT後の非小細胞肺癌),剂量不变,"",""
AB-20016650,1,1,PS,エソメプラゾールマグネシウム水和物,ネキシウム,経口,"","","","","",胃癌第４期(胃癌),剂量停止,"",""
AB-20016650,1,2,PS,ニボルマブ,"",静脈内点滴,"","",240,mg/kg,1,胃癌第４期(胃癌),剂量停止,尿細管間質性腎炎(無);リンパ球刺激試験陽性(無),""
AB-20016650,1,3,PS,ニボルマブ,"",静脈内点滴,"","","","","",胃癌第４期(胃癌),未知,尿細管間質性腎炎(無);リンパ球刺激試験陽性(無),""
AB-20016650,1,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌第４期(胃癌),未知,"",""
AB-20016650,1,5,C,オキサリプラチン,"",不明,"","","","","",胃癌第４期(胃癌),未知,"",""
AB-20016650,1,6,C,ラムシルマブ,"",不明,"","","","","",胃癌第４期(胃癌),未知,"",""
AB-20016650,1,7,C,パクリタキセル（アルブミン懸濁型）,"",不明,"","","","","",胃癌第４期(胃癌),未知,"",""
AB-20016878,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201905,201905,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);血中コルチコトロピン減少(再投与なし),""
AB-20016878,2,2,C,アピキサバン,"",経口,"","","","","","",未知,"",""
AB-20016878,2,3,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-20016878,2,4,C,ランソプラゾール,"",経口,"","","","","","",未知,"",""
AB-20016878,2,5,C,メコバラミン,"",経口,"","","","","","",未知,"",""
AB-20016878,2,6,C,ポリスチレンスルホン酸カルシウム,"",経口,"","","","","","",未知,"",""
AB-20016878,2,7,C,ロキソプロフェンナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-20016878,2,8,C,レボフロキサシン水和物,"",経口,"","","","","","",未知,"",""
AB-20016878,2,9,C,プレガバリン,"",経口,"","","","","","",未知,"",""
AB-20016878,2,10,C,アセトアミノフェン,"",経口,"","","","","","",未知,"",""
AB-20016996,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腸炎(再投与なし),""
AB-20016999,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200708,20200721,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);急性肝炎(再投与なし),""
AB-20016999,2,2,C,ランソプラゾール,"",経口,20200219,"",15,mg,1,"",未知,"",""
AB-20016999,2,3,C,モサプリドクエン酸塩水和物,"",経口,20200219,"",5,mg,1,"",未知,"",""
AB-20016999,2,4,C,アセトアミノフェン,"",経口,20200220,"",.3,g,1,"",未知,"",""
AB-20016999,2,5,C,ルビプロストン,"",経口,20200227,"",24,ug,1,"",未知,"",""
AB-20016999,2,6,C,ナルデメジントシル酸塩,"",経口,20200305,"",.2,mg,1,"",未知,"",""
AB-20016999,2,7,C,フェンタニルクエン酸塩,"",経皮,20200516,"",3,mg,1,"",未知,"",""
AB-20016999,2,8,C,補中益気湯,"",経口,20200617,"",2.5,g,1,"",未知,"",""
AB-20017461,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180913;,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,尿崩症(再投与なし);下垂体炎(再投与なし),""
AB-20017461,1,2,C,ジフルプレドナート,"",経皮,201808,"",2,g,1,痒疹(急性痒疹),未知,"",""
AB-20017461,1,3,C,デキサメタゾン,"",不明,201808,"",1,g,1,口内炎(口内炎),未知,"",""
AB-20017466,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治療切除不能な進行・再発の胃癌),未知,塞栓性脳梗塞(再投与なし),""
AB-20017473,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治療切除不能な進行・再発の胃癌),未知,腸間膜静脈血栓症(再投与なし),""
AB-20017475,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200625,20200709,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,重症筋無力症(再投与なし),""
AB-20017475,6,2,PS,ジスチグミン臭化物,ウブレチド,経口;経口,20200728;20200801,;20200803,5;10,mg;mg,1;1,重症筋無力症(重症筋無力症),剂量停止,"",""
AB-20017475,6,3,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-20017475,6,4,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-20017475,6,5,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-20017475,6,6,C,ナフトピジル,"",不明,"","","","","","",未知,"",""
AB-20017475,6,7,C,ニフェジピン,"",不明,"","","","","","",未知,"",""
AB-20017729,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,心筋炎(再投与なし),""
AB-20018320,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-20018573,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20191209;20200317,20200204;20200317,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腸壁気腫症(無),""
AB-20018573,1,2,C,ボノプラザンフマル酸塩,"",経口,"","","","","","",未知,"",""
AB-20018573,1,3,C,フェブキソスタット,"",経口,"","","","","","",未知,"",""
AB-20018573,1,4,C,プレガバリン,"",経口,"","","","","","",未知,"",""
AB-20018573,1,5,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-20018573,1,6,C,クエン酸第一鉄ナトリウム,"",経口,"","","","","","",未知,"",""
AB-20018798,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200228,20200612,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,ＩｇＡ腎症(再投与なし),""
AB-20018807,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201805,"",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫介在性肝障害(再投与なし),""
AB-20018807,4,2,C,デュロキセチン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-20019543,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,シェーグレン症候群(再投与なし),""
AB-20019544,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200814,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝不全(再投与なし),""
AB-20019544,2,2,C,オキシコドン塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-20019544,2,3,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-20019544,2,4,C,プレガバリン,"",不明,"","","","","","",未知,"",""
AB-20019544,2,5,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-20019544,2,6,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-20019544,2,7,C,サナクターゼ配合剤,"",不明,"","","","","","",未知,"",""
AB-20019544,2,8,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-20019972,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);急性腎障害(再投与なし),""
AB-20020271,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝障害(再投与なし);貧血(再投与なし),""
AB-20020457,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200819,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,変色便(再投与なし);血圧低下(再投与なし);腫瘍出血(再投与なし),""
AB-20020457,2,2,C,ランソプラゾール,"",経口,20191205,20200902,1,{DF},1,"",未知,"",""
AB-20020457,2,3,C,フェンタニル,"",不明,"","",2,mg,1,"",未知,"",""
AB-20020941,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200605,20200703,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,尿路感染(再投与なし);１型糖尿病(再投与なし),""
AB-20020941,3,2,C,ブロチゾラム,"",経口,20190212,20200924,.25,mg,1,"",未知,"",""
AB-20020941,3,3,C,酸化マグネシウム,"",経口,20190212,"",330,mg,1,予防(予防投与),未知,"",""
AB-20020941,3,4,C,アズレンスルホン酸ナトリウム水和物,"",口腔咽頭,20200717,"","","","","",未知,"",""
AB-20020941,3,5,C,アルギン酸ナトリウム,"",口腔咽頭,20200717,"","","","","",未知,"",""
AB-20020941,3,6,C,フェンタニルクエン酸塩,"",経皮,20200808,20200927,.5,mg,1,"",未知,"",""
AB-20020941,3,7,C,オキシコドン塩酸塩水和物,"",経口,20200808,"",2.5,mg,1,"",未知,"",""
AB-20020941,3,8,C,アセトアミノフェン,"",経口,20200809,"",600,mg,1,"",未知,"",""
AB-20020941,3,9,C,ナルデメジントシル酸塩,"",経口,20200809,"",.2,mg,1,予防(予防投与),未知,"",""
AB-20020941,3,10,C,ベタメタゾンリン酸エステルナトリウム,"",静脈内（明記されていない場合）,20200811,20200811,4,mg,1,"",未知,"",""
AB-20020944,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202008,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,多形紅斑(再投与なし),""
AB-20021487,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,感染性胆汁性嚢胞(再投与なし),""
AB-20021512,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200601,20200727,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血小板減少症(再投与なし);劇症１型糖尿病(再投与なし),""
AB-20021512,5,2,C,ファモチジン,"",経口,20170713,"",20,mg,1,"",未知,"",""
AB-20021512,5,3,C,エンテカビル水和物,"",経口,20180119,"",.5,mg,1,"",未知,"",""
AB-20021512,5,4,C,アムロジピンベシル酸塩,"",経口,20181005,"",2.5,mg,1,"",未知,"",""
AB-20021512,5,5,C,プレガバリン,"",経口,20190222,"",300,mg,1,"",未知,"",""
AB-20021512,5,6,C,オキシコドン塩酸塩水和物,"",経口,20191203,"",20,mg,1,"",未知,"",""
AB-20021513,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200327,20210115,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,多発性筋炎(再投与なし),""
AB-20021514,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200729,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-20022132,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181003,20190725,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,気胸(再投与なし);間質性肺疾患(再投与なし),""
AB-20022132,5,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","",100,mg,1,胃癌(切除不能胃癌),未知,"",""
AB-20022132,5,3,C,トラスツズマブ,"",不明,"","",480,mg,1,胃癌(切除不能胃癌),未知,"",""
AB-20022544,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190219;20200106,20190805;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);糖尿病性ケトアシドーシス(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし);１型糖尿病(再投与なし),""
AB-20022544,4,2,C,シロスタゾール,"",経口,"","",100,mg,1,"",未知,"",""
AB-20022544,4,3,C,ピタバスタチンカルシウム,"",経口,"","",2,mg,1,"",未知,"",""
AB-20022544,4,4,C,クエン酸第一鉄ナトリウム,"",経口,"","",50,mg,1,"",未知,"",""
AB-20022544,4,5,C,メトクロプラミド,"",経口,"","",5,mg,1,"",未知,"",""
AB-20022612,5,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20191220;20200929,20200630;20201201,200;200,mg;mg,1;1,胆管細胞癌(MSI-Highを有する結腸・直腸癌以外の固形癌（胆道癌（肝内胆管がん））);胃癌第４期(MSI-Highを有する結腸・直腸癌以外の固形癌（胃癌）),剂量停止,尿細管間質性腎炎(無),""
AB-20022861,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202006,202007,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,横紋筋融解症(再投与なし),""
AB-20023426,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20180522;20180918;;20201027,20180821;20181101;202009;,3;240;;,mg/kg;mg;;,1;1;;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,水疱性皮膚炎(再投与なし),""
AB-20023787,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200905,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎障害(再投与なし),""
AB-20023788,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190530,20190801,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-20023789,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190426,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,類天疱瘡(不明);甲状腺機能低下症(不明),""
AB-20023789,2,2,C,カンデサルタンシレキセチル・ヒドロクロロチアジド配合剤,"",不明,"","","","","","",未知,"",""
AB-20023789,2,3,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-20023789,2,4,C,タダラフィル,"",不明,"","","","","","",未知,"",""
AB-20023789,2,5,C,シロドシン,"",不明,"","","","","","",未知,"",""
AB-20023789,2,6,C,六君子湯,"",不明,"","","","","","",未知,"",""
AB-20023789,2,7,C,セファランチン,"",不明,"","","","","","",未知,"",""
AB-20023955,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎障害(再投与なし),""
AB-20023956,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201903,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎障害(再投与なし),""
AB-20023963,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);甲状腺機能低下症(再投与なし),""
AB-20024146,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201812,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-20024147,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181029,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし);発熱(再投与なし),""
AB-20024147,3,2,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-20024147,3,3,C,ボグリボース,"",経口,"","",.2,mg,1,"",未知,"",""
AB-20024147,3,4,C,メコバラミン,"",経口,"","",500,ug,1,"",未知,"",""
AB-20024147,3,5,C,ボノプラザンフマル酸塩,"",経口,"","",20,mg,1,"",未知,"",""
AB-20024147,3,6,C,炭酸ランタン水和物,"",経口,"","",250,mg,1,"",未知,"",""
AB-20024383,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180418,20180418,166.9,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-20024387,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200110,20200814,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,１型糖尿病(再投与なし),""
AB-20024387,1,2,C,イリノテカン塩酸塩水和物,"",不明,20200814,"","","","",胃癌(胃癌),未知,"",""
AB-20024660,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181122,20190222,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,蜂巣炎(再投与なし);細菌性咽頭炎(再投与なし),""
AB-20024880,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200709,20200709,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,掌蹠膿疱症(再投与なし);口腔カンジダ症(再投与なし),""
AB-20024880,5,2,C,ボノプラザンフマル酸塩,"",経口,"","","","","","",未知,"",""
AB-20024880,5,3,C,プレガバリン,"",経口,"","","","","","",未知,"",""
AB-20024880,5,4,C,フロセミド,"",経口,"","","","","","",未知,"",""
AB-20024880,5,5,C,レベチラセタム,"",経口,"","","","","","",未知,"",""
AB-20024880,5,6,C,Ｌ−カルボシステイン,"",経口,"","","","","","",未知,"",""
AB-20024880,5,7,C,チペピジンヒベンズ酸塩,"",経口,"","","","","","",未知,"",""
AB-20024880,5,8,C,アズレンスルホン酸ナトリウム水和物,"",頬側,"","","","","","",未知,"",""
AB-20025148,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200911,20200911,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,皮膚びらん(再投与なし);水疱性皮膚炎(再投与なし),""
AB-20025151,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200804,20200917,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,播種性血管内凝固(再投与なし),""
AB-20025459,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181107;20181212,;20200715,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);肺炎(再投与なし),""
AB-20025459,3,2,C,ボノプラザンフマル酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-20025459,3,3,C,ポラプレジンク,"",経口,"","",75,mg,1,"",未知,"",""
AB-20025459,3,4,C,アセトアミノフェン,"",経口,"","",400,mg,1,"",未知,"",""
AB-20025470,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180314,2018,200,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,胆管炎(再投与なし);胆嚢炎(再投与なし),""
AB-20025470,1,2,C,レボチロキシンナトリウム水和物,"",不明,"","","","","",自己免疫性甲状腺炎(橋本病),未知,"",""
AB-20025802,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-20025802,1,2,C,イリノテカン塩酸塩水和物,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20025805,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201801,201810,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし),""
AB-20026605,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200512;,;20201110,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腎機能障害(再投与なし);下痢(再投与なし),""
AB-20026620,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20200513,20200715,200,mg,1,胃腺癌(高頻度マイクロサテライト不安定性(MSI-High)癌：胃がん),剂量停止,悪性新生物進行(再投与なし),""
AB-20027578,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180720;,;20181207,160;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-20027584,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190301,20190905,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-20028017,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20171031;20180605,20180403;,3;,mg/kg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(不明);副腎機能不全(不明),""
AB-20028017,2,2,PS,ジアスターゼ配合剤（１）,タフマックＥ,経口,20170317,20180918,1,{DF},1,消化不良(消化異常),剂量不变,甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし),""
AB-20028017,2,3,C,モサプリドクエン酸塩水和物,"",経口,20170317,20180918,1,{DF},1,消化不良(消化異常),未知,"",""
AB-20028235,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200605;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし);甲状腺機能亢進症(再投与なし),""
AB-20028240,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202007,20201005,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-20028536,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200313,20200624,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,抗利尿ホルモン不適合分泌(再投与なし);甲状腺機能低下症(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-20028536,2,2,C,芍薬甘草湯,"",経口,20200610,20200722,2.5,mg,1,"",未知,"",""
AB-20028536,2,3,C,ロキソプロフェンナトリウム水和物,"",経口,20200610,20200722,60,mg,1,"",未知,"",""
AB-20028791,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190722,20190912,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-20028791,6,2,C,ラムシルマブ,"",不明;不明,20190925;20191120,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20028791,6,3,C,パクリタキセル,"",不明;不明,20190925;20191120,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20028791,6,4,C,デキサメタゾン,"",不明;不明,20190925;20191120,;,19.8;6.6,mg;mg,1;1,"",未知,"",""
AB-20028793,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-20029373,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-20029380,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200904,20200928,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,ぶどう膜炎(再投与なし);副腎機能不全(再投与なし),""
AB-20029380,3,2,C,エンテカビル水和物,"",経口,20191115,"",.5,mg,1,予防(予防投与),未知,"",""
AB-20029380,3,3,C,レボチロキシンナトリウム水和物,"",経口,20200918,"",50,ug,1,甲状腺機能低下症(甲状腺機能低下症),未知,"",""
AB-20029758,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-20030336,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,免疫性血小板減少症(再投与なし);血小板数減少(再投与なし),""
AB-20030340,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201013,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-20030638,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190819,20200316,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,食欲減退(再投与なし);低ナトリウム血症(再投与なし);副腎機能不全(再投与なし);悪心(再投与なし);発熱性好中球減少症(再投与なし),""
AB-20030640,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200930,20200930,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,低血糖(再投与なし);筋炎(再投与なし);心肺停止(再投与なし);血中クレアチンホスホキナーゼ増加(再投与なし),""
AB-20030640,2,2,C,酪酸菌製剤,"",経口,20190801,"",1,g,1,"",未知,"",""
AB-20030640,2,3,C,経腸成分栄養剤（１−１）,"",経口,20190816,"",80,g,1,"",未知,"",""
AB-20030640,2,4,C,センナ・センナ実,"",経口,20190830,"",1,g,1,"",未知,"",""
AB-20030640,2,5,C,酸化マグネシウム,"",経口,20200617,"",660,mg,1,"",未知,"",""
AB-20030640,2,6,C,パンテチン,"",経口,20200617,"",.66,{DF},1,"",未知,"",""
AB-20030650,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,スティーヴンス・ジョンソン症候群(再投与なし),""
AB-20031300,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,ケトアシドーシス(再投与なし),""
AB-20031300,2,2,PS,カナグリフロジン水和物,"",不明,"","","","","",２型糖尿病(2型糖尿病),未知,"",""
AB-20031301,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200509;20201202,20201024;20210109,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(再投与なし);糖尿病性ケトアシドーシス(再投与なし);１型糖尿病(再投与なし),""
AB-20031301,4,2,C,酪酸菌製剤,"",経口,20181215,"",2,{DF},1,予防(予防投与),未知,"",""
AB-20031301,4,3,C,アスコルビン酸・パントテン酸カルシウム（１）,"",経口,20190307,"",1,{DF},1,予防(予防投与),未知,"",""
AB-20031301,4,4,C,サナクターゼ配合剤,"",経口,20190307,"",1,{DF},1,予防(予防投与),未知,"",""
AB-20031301,4,5,C,補中益気湯,"",経口,20191026,"",2.5,g,1,予防(予防投与),未知,"",""
AB-20031301,4,6,C,アムロジピンベシル酸塩,"",経口,20200310,"",2.5,mg,1,予防(予防投与),未知,"",""
AB-20031301,4,7,C,アゼラスチン塩酸塩,"",経口,20200718,"",1,{DF},1,予防(予防投与),未知,"",""
AB-20031301,4,8,C,天然ケイ酸アルミニウム,"",経口,20200912,"",2,g,1,予防(予防投与),未知,"",""
AB-20031568,1,1,PS,ラベプラゾールナトリウム,ラベプラゾールＮａ,"","","","","","","",剂量停止,"",""
AB-20031568,1,2,PS,ニボルマブ,"","","","","","","","",剂量停止,"",""
AB-20031590,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190718;20200410,20191220;20200619,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(無),""
AB-20031590,2,2,C,ボノプラザンフマル酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-20031590,2,3,C,酪酸菌配合剤,"",経口,"","",1,{DF},1,"",未知,"",""
AB-20031590,2,4,C,エルデカルシトール,"",経口,"","",.75,ug,1,"",未知,"",""
AB-20031590,2,5,C,酸化マグネシウム,"",経口,"","",660,mg,1,"",未知,"",""
AB-20031590,2,6,C,アムロジピンベシル酸塩,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-20031590,2,7,C,大建中湯,"",経口,"","",1,{DF},1,"",未知,"",""
AB-20031590,2,8,C,ベタメタゾン吉草酸エステル・ゲンタマイシン硫酸塩,"",皮膚,"","","","","","",未知,"",""
AB-20031795,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,胸水(再投与なし);死亡(再投与なし),""
AB-20031806,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202006,"","","","",食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),剂量不变,上部消化管出血(再投与なし);胃前庭部毛細血管拡張症(再投与なし),""
AB-20032122,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,口腔カンジダ症(再投与なし),""
AB-20032158,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20200318;20201021,20200729;202012,200;200,mg;mg,1;1,胃癌第４期(高頻度マイクロサテライト不安定性(MSI-High)癌（癌種：胃癌）),剂量停止,間質性肺疾患(無),""
AB-20032765,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,転倒(再投与なし);間質性肺疾患(再投与なし),""
AB-20032769,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180823,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-20033091,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,240;120,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(無),""
AB-20033098,3,1,PS,アプレピタント,イメンド,経口;経口,20200501;20200502,20201112;20200912,125;80,mg;mg,1;1,悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),剂量停止,糖尿病(再投与なし),""
AB-20033098,3,2,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200501;20201112,;20201224,360;360,mg;mg,1;1,胃癌(胃癌),剂量不变,糖尿病(再投与なし),""
AB-20033098,3,3,PS,デキサメタゾンリン酸エステルナトリウム,デキサート,静脈内点滴;静脈内点滴,20200501;20201001,20200910;20201112,6.6;3.3,mg;mg,1;1,悪心・嘔吐の予防(嘔気予防),剂量不变,"",""
AB-20033098,3,4,PS,デキサメタゾン,デカドロン,経口,20200502,20200801,4,mg,1,悪心・嘔吐の予防(嘔気予防),不适用,"",""
AB-20033098,3,5,C,モサプリドクエン酸塩水和物,"",経口,202003,"",5,mg,1,胃炎(胃炎),未知,"",""
AB-20033098,3,6,C,ラベプラゾールナトリウム,"",経口,202003,"",10,mg,1,胃炎(胃炎),未知,"",""
AB-20033098,3,7,C,トラスツズマブ,"",静脈内点滴;静脈内点滴;静脈内点滴,20200501;;20201112,;;20201224,8;6;6,mg/kg;mg/kg;mg/kg,1;1;1,胃癌(胃癌),未知,"",""
AB-20033098,3,8,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20200501;20201112,;20201112,130;130,mg/m2;mg/m2,1;1,胃癌(胃癌),未知,"",""
AB-20033098,3,9,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,20200501;20201112,;20210107,60;60,mg;mg,1;1,胃癌(胃癌),未知,"",""
AB-20033098,3,10,C,酸化マグネシウム,"",経口,20200501,"",500,mg,1,便秘予防(便秘予防),未知,"",""
AB-20033098,3,11,C,酪酸菌配合剤,"",経口,20200501,"",1,{DF},1,便秘予防(便秘予防),未知,"",""
AB-20033098,3,12,C,センノシド,"",経口,20200501,"",24,mg,1,便秘(便秘),未知,"",""
AB-20033806,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201804,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-20033813,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肝機能異常(再投与なし),""
AB-20033823,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,膜性糸球体腎炎(再投与なし),""
AB-20033825,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201105,20201105,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,唾液腺炎(再投与なし);耳下腺炎(再投与なし),""
AB-20033825,2,2,C,グリチルリチン酸一アンモニウム・グリシン・ＤＬ−メチオニン配合剤,"",経口,"","","","","","",未知,"",""
AB-20033825,2,3,C,トリメタジジン塩酸塩,"",経口,"","",3,mg,1,"",未知,"",""
AB-20033825,2,4,C,シルニジピン,"",経口,"","",10,mg,1,"",未知,"",""
AB-20033825,2,5,C,バルサルタン・ヒドロクロロチアジド配合剤,"",経口,"","",92.5,mg,1,"",未知,"",""
AB-20033825,2,6,C,テネリグリプチン臭化水素酸塩水和物・カナグリフロジン水和物配合剤,"",経口,"","","","","","",未知,"",""
AB-20033825,2,7,C,ラベプラゾールナトリウム,"",経口,"","",10,mg,1,"",未知,"",""
AB-20033825,2,8,C,フルバスタチンナトリウム,"",不明,"","",20,mg,1,"",未知,"",""
AB-20033825,2,9,C,ベポタスチンベシル酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-20033827,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200911,20200925,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし),""
AB-20034081,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190307,20190530,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,筋炎(再投与なし);譫妄(再投与なし),""
AB-20034871,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171026,20180125,219,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-20035538,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190709,20191029,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,小腸炎(再投与なし),""
AB-20035548,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20171002;201802,;20181225,170;170,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(不明);副腎機能不全(不明),""
AB-20035548,5,2,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-20035548,5,3,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-20035548,5,4,C,プレガバリン,"",不明,"","","","","","",未知,"",""
AB-20035548,5,5,C,エナラプリルマレイン酸塩,"",不明,"","","","","","",未知,"",""
AB-20035549,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201008,20201022,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-20035554,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180109,20180311,165,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし),""
AB-20035554,2,2,C,プレガバリン,"",不明,"","","","","","",未知,"",""
AB-20035554,2,3,C,アジルサルタン・アムロジピンベシル酸塩配合剤,"",不明,"","","","","","",未知,"",""
AB-20035554,2,4,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-20035554,2,5,C,牛車腎気丸,"",不明,"","","","","","",未知,"",""
AB-20035555,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180413,20180719,200,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-20035555,2,2,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-20035555,2,3,C,六君子湯,"",不明,"","","","","","",未知,"",""
AB-20035555,2,4,C,大建中湯,"",不明,"","","","","","",未知,"",""
AB-20035555,2,5,C,ジフルコルトロン吉草酸エステル・リドカイン,"",局所,"","","","","","",未知,"",""
AB-20035555,2,6,C,アジルサルタン・アムロジピンベシル酸塩配合剤,"",不明,"","","","","","",未知,"",""
AB-20035555,2,7,C,プレガバリン,"",不明,"","","","","","",未知,"",""
AB-20035555,2,8,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-20035571,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-20035576,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-20035670,4,1,PS,トラスツズマブデルクステカン,エンハーツ,静脈内点滴,20201120,20201120,6.4,mg/kg,1,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),剂量停止,間質性肺疾患(再投与なし);敗血症性ショック(再投与なし),""
AB-20035670,4,2,PS,ニボルマブ,"",その他,20200904,20201030,240,mg,1,胃癌(Advanced gastric carcinoma),未知,"",""
AB-20036050,4,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,20200915,20200915,10,mg/kg,1,非小細胞肺癌(CRT後の非小細胞肺癌),剂量停止,"",""
AB-20036050,4,2,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,胃癌(胃癌),未知,"",""
AB-20036050,4,3,C,アンブロキソール塩酸塩,"",経口,"","",15,mg,1,肺気腫(肺気腫),未知,"",""
AB-20036050,4,4,C,カモスタットメシル酸塩,"",経口,"","",200,mg,1,慢性膵炎(アルコール性慢性膵炎),未知,"",""
AB-20036050,4,5,C,フロセミド,"",経口,"","",20,mg,1,高血圧(高血圧症),未知,"",""
AB-20036050,4,6,C,テルミサルタン,"",経口,"","",40,mg,1,高血圧(高血圧症),未知,"",""
AB-20036050,4,7,C,ミラベグロン,"",経口,"","",50,mg,1,緊張性膀胱(過活動膀胱),未知,"",""
AB-20036050,4,8,C,スボレキサント,"",経口,"","",15,mg,1,不眠症(不眠症),未知,"",""
AB-20036050,4,9,C,エスゾピクロン,"",経口,"","",1,mg,1,不眠症(不眠症),未知,"",""
AB-20036050,4,10,C,パンクレリパーゼ,"",経口,"","",300,mg,1,慢性膵炎(アルコール性慢性膵炎),未知,"",""
AB-20036050,4,11,C,酸化マグネシウム,"",経口,"","",660,mg,1,便秘(便秘症),未知,"",""
AB-20036050,4,12,C,ビフィズス菌製剤（４）,"",経口,"","",1,g,1,便秘(便秘症),未知,"",""
AB-20036050,4,13,C,大建中湯,"",経口,"","",2.5,g,1,便秘(便秘症),未知,"",""
AB-20036156,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(胃癌及び食道胃接合部腺癌);食道腺癌(胃癌及び食道胃接合部腺癌),未知,間質性肺疾患(再投与なし),""
AB-20036158,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-20036406,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20171204;,;20181210,;240,;mg,;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし);肝機能異常(再投与なし),""
AB-20036406,2,2,C,ナルデメジントシル酸塩,"",不明,"","","","","","",未知,"",""
AB-20036406,2,3,C,ファモチジン,"",不明,"","","","","","",未知,"",""
AB-20036406,2,4,C,エトドラク,"",不明,"","","","","","",未知,"",""
AB-20036406,2,5,C,オキシコドン塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-20036406,2,6,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-20036440,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181129;20210210,20201029;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,第６脳神経麻痺(無),""
AB-20036441,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,膜性糸球体腎炎(再投与なし);尿細管間質性腎炎(再投与なし),""
AB-20036651,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190619,20190821,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-20037019,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-20037323,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201030,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし),""
AB-20037323,3,2,C,ボノプラザンフマル酸塩,"",経口,20201109,"",20,mg,1,"",未知,"",""
AB-20037323,3,3,C,クエン酸第一鉄ナトリウム,"",経口,20201113,"",50,mg,1,"",未知,"",""
AB-20037323,3,4,C,アセトアミノフェン,"",経口,20201113,"",500,mg,1,"",未知,"",""
AB-20037323,3,5,C,エドキサバントシル酸塩水和物,"",経口,"","",30,mg,1,心房細動(心房細動),未知,"",""
AB-20037323,3,6,C,ビソプロロールフマル酸塩,"",経口,"","",2.5,mg,1,心房細動(心房細動),未知,"",""
AB-20037720,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,関節リウマチ(再投与なし),""
AB-20037723,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし),""
AB-20037723,2,2,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20037723,2,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20037723,2,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20037724,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);続発性副腎皮質機能不全(再投与なし);原発性甲状腺機能低下症(再投与なし),""
AB-20037726,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-20037879,4,1,PS,トラスツズマブデルクステカン,エンハーツ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20201112;20210107;20210128;20210218;20210311;20210408;20210430;20210521,20201112;20210107;20210128;20210218;20210311;20210408;20210430;20210521,6.4;5.4;4.4;4.4;4.4;4.4;4.4;4.4,mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg,1;1;1;1;1;1;1;1,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),剂量停止,血小板減少症(不明),""
AB-20037879,4,2,PS,ニボルマブ,"",静脈内（明記されていない場合）,20200108,20201015,240,mg,1,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),未知,"",""
AB-20037879,4,3,C,ボノプラザンフマル酸塩,"",不明,20201119,"",10,mg,1,"",未知,"",""
AB-20037879,4,4,C,アムロジピンベシル酸塩,"",経口,"","",2.5,mg,1,高血圧(Hypertension),未知,"",""
AB-20038210,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200410;202008,20200612;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝障害(不明),""
AB-20038212,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし),""
AB-20038666,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,大腸炎(再投与なし),""
AB-20038680,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-20038902,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200925,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,倦怠感(再投与なし);食欲減退(再投与なし),""
AB-20038925,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201014,202011,480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,黄疸(再投与なし),""
AB-20039169,1,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,201901,201912,10,mg/kg,1,非小細胞肺癌(CRT後の非小細胞肺癌),不适用,"",""
AB-20039169,1,2,C,ラベプラゾールナトリウム,"",経口,"","","","","","",未知,"",""
AB-20039169,1,3,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-20039169,1,4,C,ゾルピデム酒石酸塩,"",不明,"","","","","","",未知,"",""
AB-20039483,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200108,20200304,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,頭痛(再投与なし),""
AB-20039486,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200716;202011,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血小板減少症(不明),""
AB-20039733,5,1,PS,トラスツズマブデルクステカン,エンハーツ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20201130;20210104;20210201;20210222,20201130;20210104;20210201;20210222,5.4;4.4;4.4;4.4,mg/kg;mg/kg;mg/kg;mg/kg,1;1;1;1,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),剂量停止,好中球減少症(不明),""
AB-20039733,5,2,PS,ニボルマブ,"",不明;不明,;20210405,;20210927,;,;,;,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),未知,"",""
AB-20039733,5,3,C,リバーロキサバン,"",経口,20190924,"",10,mg,1,血栓症(Thrombosis),未知,"",""
AB-20039733,5,4,C,ボノプラザンフマル酸塩,"",経口,20190924,"",10,mg,1,胃食道逆流性疾患(Gastrooesophageal reflux disease),未知,"",""
AB-20039733,5,5,C,レボフロキサシン水和物,"",経口,20210125,20210131,"","","","",未知,"",""
AB-20039838,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-20039999,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20200114;20200420,2020;,200;200,mg;mg,1;1,頭頚部癌第４期(頭頚部癌),剂量停止,免疫介在性肝障害(無),""
AB-20040225,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191018,20191115,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,下痢(再投与なし);顕微鏡的大腸炎(再投与なし);大腸炎(再投与なし),""
AB-20040232,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,視床下部−下垂体障害(再投与なし),""
AB-20040449,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200709,20200924,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,血中クレアチンホスホキナーゼ増加(再投与なし);甲状腺機能低下症(再投与なし),""
AB-20040449,2,2,PS,ホスアプレピタントメグルミン,プロイメンド,静脈内点滴,20201008,20210114,150,mg,1,悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),剂量不变,血中クレアチンホスホキナーゼ増加(再投与なし);甲状腺機能低下症(再投与なし),""
AB-20040449,2,3,C,クロルフェニラミンマレイン酸塩,"",静脈内（明記されていない場合）,20200709,20200924,5,mg,1,予防(予防投与),未知,"",""
AB-20040449,2,4,C,アムロジピンベシル酸塩,"",経口,20200709,"",5,mg,1,"",未知,"",""
AB-20040449,2,5,C,エソメプラゾールマグネシウム水和物,"",経口,20200709,"",20,mg,1,"",未知,"",""
AB-20040449,2,6,C,フェキソフェナジン塩酸塩,"",経口,20200813,"",60,mg,1,"",未知,"",""
AB-20040449,2,7,C,芍薬甘草湯,"",経口,20200813,"",2.5,mg,1,"",未知,"",""
AB-20040449,2,8,C,アセトアミノフェン,"",経口,20200924,"",500,mg,1,疼痛(疼痛時),未知,"",""
AB-20040449,2,9,C,カペシタビン,"",経口;経口;経口;経口;経口,20201008;20201029;20201119;20201224;20210114,20201021;20201111;20201202;20210106;20210127,1500;1500;1500;1500;1500,mg;mg;mg;mg;mg,1;1;1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20040449,2,10,C,シスプラチン,"",静脈内（明記されていない場合）,20201008,20210114,120,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20040449,2,11,C,硫酸マグネシウム水和物,"",静脈内（明記されていない場合）,20201008,20210114,20,mL,1,予防(予防投与),未知,"",""
AB-20040449,2,12,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内（明記されていない場合）,20201008,20210114,9.9,mg,1,予防(予防投与),未知,"",""
AB-20040449,2,13,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,20201008,20210114,.75,mg,1,予防(予防投与),未知,"",""
AB-20040449,2,14,C,フロセミド,"",静脈内（明記されていない場合）,20201008,20210114,20,mg,1,予防(予防投与),未知,"",""
AB-20040449,2,15,C,酸化マグネシウム,"",経口,20201030,"",330,mg,1,便秘(便秘時),未知,"",""
AB-20040460,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20180126;;,;;,240;240;480,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-20040793,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200515,20201202,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,炎症性腸疾患(再投与なし),""
AB-20041120,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200528,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-20041133,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,感覚鈍麻(再投与なし),""
AB-20041133,1,2,C,プレガバリン,"",経口,"","","","","","",未知,"",""
AB-20041608,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20180820;;,;;,240;;,mg;;,1;;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,薬疹(無),""
AB-20041608,3,2,PS,アスピリン,バイアスピリン,不明,"","","","","","",未知,"",""
AB-20041608,3,3,PS,アムロジピンベシル酸塩,アムロジピン,不明,"","","","","","",剂量停止,"",""
AB-20041608,3,4,PS,アンブロキソール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-20041608,3,5,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-20041608,3,6,C,ウルソデオキシコール酸,"",不明,"","","","","","",未知,"",""
AB-20041623,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-20041690,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20201020;20210119,20201020;,200;200,mg;mg,1;1,胃癌第４期(高頻度マイクロサテライト不安定性（MSI-High）癌 胃がん),剂量停止,腫瘍壊死(不明);腫瘍出血(不明);悪性新生物進行(不明);肝性昏睡(不明);肺炎(不明);肝機能異常(不明);発熱(無);背部痛(無);貧血(無),""
AB-20041690,4,2,C,メロペネム水和物,"",不明,20201010,"","","","",発熱(発熱),未知,"",""
AB-20041690,4,3,C,オキシコドン塩酸塩水和物,"",不明,20201010,20201109,"","","",疼痛管理(疼痛管理),剂量停止,"",""
AB-20041690,4,4,C,ミノサイクリン塩酸塩,"",不明,20201014,"","","","","",剂量不变,"",""
AB-20041690,4,5,C,フェキソフェナジン塩酸塩,"",経口,20201019,"",120,mg,1,発疹(皮疹),未知,"",""
AB-20041690,4,6,C,ジフェンヒドラミン,"",不明,20201019,"","","","",発疹(皮疹),未知,"",""
AB-20041690,4,7,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",不明,20201019,"","","","",発疹(皮疹),未知,"",""
AB-20041690,4,8,C,ウルソデオキシコール酸,"",不明,不明,"","","","","",剂量不变,"",""
AB-20041690,4,9,C,セレコキシブ,"",不明,不明,"",200,mg,1,"",未知,"",""
AB-20041690,4,10,C,酪酸菌配合剤,"",経口,不明,"",3,{DF},1,"",未知,"",""
AB-20041905,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-20041911,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-20041915,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-20041916,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-20041917,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-20041918,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-20042191,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202002,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,発熱(再投与なし);Ｃ−反応性蛋白増加(再投与なし),""
AB-20042196,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190802,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-20042196,1,2,C,カリジノゲナーゼ,"",経口,"","",1,{DF},1,"",未知,"",""
AB-20042196,1,3,C,ニコランジル,"",経口,"","",5,mg,1,"",未知,"",""
AB-20042196,1,4,C,メコバラミン,"",経口,"","",.5,mg,1,"",未知,"",""
AB-20042684,3,1,PS,ビニメチニブ,メクトビ,経口;経口;経口;経口;経口;経口,20191025;20191213;20200327;20200605;20200703;20200911,20191206;20200306;20200522;20200619;20200828;20201025,90;60;30;30;30;30,mg;mg;mg;mg;mg;mg,1;1;1;1;1;1,悪性黒色腫(BRAF遺伝子変異を有する根治切除不能な悪性黒色腫),剂量停止,横紋筋融解症(有);横紋筋融解症(有);間質性肺疾患(有);横紋筋融解症(有);横紋筋融解症(有);横紋筋融解症(有),""
AB-20042684,3,2,PS,エンコラフェニブ,ビラフトビ,経口;経口;経口;経口;経口;経口,20191025;20191213;20200327;20200605;20200703;20200911,20191206;20200306;20200522;20200619;20200828;20201025,450;300;200;200;200;200,mg;mg;mg;mg;mg;mg,1;1;1;1;1;1,悪性黒色腫(BRAF遺伝子変異を有する根治切除不能な悪性黒色腫),剂量停止,横紋筋融解症(有);横紋筋融解症(有);間質性肺疾患(有);横紋筋融解症(有);横紋筋融解症(有);横紋筋融解症(有),""
AB-20042684,3,3,PS,ニボルマブ,オプジーボ,静脈内点滴,20180918,20181129,240,mg,1,悪性黒色腫(悪性黒色腫の術後補助療法),不适用,横紋筋融解症(再投与なし);横紋筋融解症(再投与なし);間質性肺疾患(再投与なし);横紋筋融解症(再投与なし);横紋筋融解症(再投与なし);横紋筋融解症(再投与なし),""
AB-20042684,3,4,C,ビソプロロールフマル酸塩,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-20042684,3,5,C,フェノフィブラート,"",経口,"","",80,mg,1,"",未知,"",""
AB-20042684,3,6,C,グリメピリド,"",経口,"","",.5,mg,1,"",未知,"",""
AB-20042684,3,7,C,テルミサルタン,"",経口,"","",40,mg,1,"",未知,"",""
AB-20042684,3,8,C,トリアゾラム,"",経口,"","",.25,mg,1,"",未知,"",""
AB-20042684,3,9,C,ランソプラゾール,"",経口,"","",15,mg,1,"",未知,"",""
AB-20042684,3,10,C,ビルダグリプチン・メトホルミン塩酸塩配合剤,"",経口,"","",1,{DF},1,"",未知,"",""
AB-20042684,3,11,C,シロドシン,"",経口,"","",4,mg,1,"",未知,"",""
AB-20042903,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,皮膚障害(再投与なし);副腎障害(再投与なし),""
AB-20043470,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201111,20201209,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-20043470,2,2,C,Ｌ−カルボシステイン,"",不明,"","","","","","",未知,"",""
AB-20043470,2,3,C,スボレキサント,"",不明,"","","","","","",未知,"",""
AB-20043470,2,4,C,五苓散,"",不明,"","","","","","",未知,"",""
AB-20043470,2,5,C,シロスタゾール,"",不明,"","","","","","",未知,"",""
AB-20043470,2,6,C,アスピリン,"",不明,"","","","","","",未知,"",""
AB-20043772,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180501,20190807,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,類天疱瘡(再投与なし),""
AB-20043778,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-20043893,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201022,202012,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-20044136,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,多形紅斑(再投与なし),""
AB-20044139,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181128,20181128,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫介在性肝障害(再投与なし),""
AB-20044152,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180426,"",175.8,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫介在性肝障害(再投与なし),""
AB-20044159,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180626,"",140,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,免疫介在性肝障害(再投与なし),""
AB-20044190,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201023,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-20044434,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201906,201908,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,感覚鈍麻(再投与なし),""
AB-20044435,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201116,20201216,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心室細動(再投与なし);免疫性心筋炎(再投与なし),""
AB-20044435,5,2,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","","",未知,"",""
AB-20044435,5,3,C,クエン酸第一鉄ナトリウム,"",経口,"","","","","","",未知,"",""
AB-20044638,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181215;20190813,20190702;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-20044710,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20200622,20201208,200,mg,1,頭頚部癌(頭頸部癌),剂量停止,副腎機能不全(再投与なし),""
AB-20044854,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200602,20201127,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎皮質刺激ホルモン欠損症(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-20044854,1,2,C,アロプリノール,"",不明,"","","","","","",未知,"",""
AB-20044854,1,3,C,一硝酸イソソルビド,"",不明,"","","","","","",未知,"",""
AB-20044854,1,4,C,ニコランジル,"",不明,"","","","","","",未知,"",""
AB-20044854,1,5,C,ビソプロロールフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-20044854,1,6,C,リバーロキサバン,"",不明,"","","","","","",未知,"",""
AB-20044854,1,7,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","","",未知,"",""
AB-20044857,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,硬化性胆管炎(再投与なし),""
AB-20045335,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-20045567,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190424,20190515,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし);心筋炎(再投与なし);筋炎(再投与なし);重症筋無力症(再投与なし),""
AB-20045567,2,2,C,エスゾピクロン,"",経口,"","",2,mg,1,"",未知,"",""
AB-20045602,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,食欲減退(再投与なし);腎機能障害(再投与なし);下垂体機能低下症(再投与なし);血圧低下(再投与なし),""
AB-20045768,3,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,20200828,20201218,600,mg,1,非小細胞肺癌(CRT後の非小細胞肺癌),剂量停止,"",""
AB-20045768,3,2,C,タゾバクタム・ピペラシリン水和物,"",不明,20200829,20200904,4.5,g,1,"",未知,"",""
AB-20046070,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201904,202003,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,アミラーゼ増加(再投与なし);ぶどう膜炎(再投与なし);帯状疱疹(再投与なし),""
AB-20046070,1,2,C,トリフルリジン・チピラシル塩酸塩配合剤,"",経口,202009,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20046070,1,3,C,血圧降下剤,"",経口,"","","","","","",未知,"",""
AB-20046311,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201810;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,糖尿病(再投与なし),""
AB-20046500,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200216;202010,202010;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,サイトカインストーム(再投与なし);Ｃ−反応性蛋白増加(再投与なし);食欲減退(再投与なし);劇症１型糖尿病(再投与なし);高血糖(再投与なし);白血球数減少(再投与なし);脱水(再投与なし),""
AB-20046501,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,201912;202006;202009,;;,;;,;;,;;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-20046971,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201113,20201228,240,mg,1,食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),剂量停止,間質性肺疾患(再投与なし);間質性肺疾患(再投与なし),""
AB-20046971,3,2,C,Ｌ−カルボシステイン,"",不明,"","","","","","",未知,"",""
AB-20046971,3,3,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-20046971,3,4,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-20046971,3,5,C,トラマドール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-20047476,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180808;20181003,20180919;20190320,235;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-20047476,2,2,PS,ポラプレジンク,ポラプレジンクＯＤ,経口,"","",75,mg,1,"",未知,"",""
AB-20047476,2,3,C,酪酸菌製剤,"",経口,"","",1,{DF},1,"",未知,"",""
AB-20047476,2,4,C,カルバゾクロムスルホン酸ナトリウム水和物,"",経口,"","",10,mg,1,"",未知,"",""
AB-20047476,2,5,C,トラネキサム酸,"",経口,"","",250,mg,1,"",未知,"",""
AB-20047476,2,6,C,アンブロキソール塩酸塩,"",経口,"","",15,mg,1,"",未知,"",""
AB-20047476,2,7,C,Ｌ−カルボシステイン,"",経口,"","",500,mg,1,"",未知,"",""
AB-20047476,2,8,C,テオフィリン,"",経口,"","",200,mg,1,"",未知,"",""
AB-20047476,2,9,C,ロキソプロフェンナトリウム水和物,"",経口,"","",60,mg,1,"",未知,"",""
AB-20047481,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200717,20200717,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,薬疹(再投与なし),""
AB-20047481,1,2,PS,アンピシリンナトリウム・スルバクタムナトリウム,ユナシンＳ,静脈内点滴,20200721,20200727,3,g,1,"",不适用,"",""
AB-20047481,1,3,C,酸化マグネシウム,"",経口,20200305,"",250,mg,1,予防(予防投与),未知,"",""
AB-20047481,1,4,C,エソメプラゾールマグネシウム水和物,"",経口;経口,20200511;20200722,20200721;,10;20,mg;mg,1;1,予防(予防投与),未知,"",""
AB-20047481,1,5,C,デキサメタゾン,"",経口,20200601,20200721,4,mg,1,"",未知,"",""
AB-20048016,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201013,20201203,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発熱性好中球減少症(再投与なし),""
AB-20048016,1,2,PS,サラゾスルファピリジン,"",経口,20201023,20201223,500,mg,1,関節リウマチ(関節リウマチ),剂量停止,"",""
AB-20048016,1,3,PS,プレドニゾロン,プレドニン,経口,20201102,20201222,10,mg,1,関節リウマチ(関節リウマチ),剂量停止,"",""
AB-20048016,1,4,C,ランソプラゾール,"",経口,"","",15,mg,1,"",未知,"",""
AB-20048016,1,5,C,モサプリドクエン酸塩水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-20048016,1,6,C,アルファカルシドール,"",経口,"","",.5,ug,1,"",未知,"",""
AB-20048016,1,7,C,フロセミド,"",経口,"","",40,mg,1,"",未知,"",""
AB-20048016,1,8,C,乾燥硫酸鉄（３）,"",経口,"","",105,mg,1,"",未知,"",""
AB-20048016,1,9,C,パンテチン,"",経口,"","",100,mg,1,"",未知,"",""
AB-20048029,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-20048309,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,多形紅斑(再投与なし),""
AB-20048564,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-20048572,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-20048676,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,201904,20191016,"","","",尿管癌(右尿管癌),不适用,劇症１型糖尿病(再投与なし);高カリウム血症(再投与なし);糖尿病性ケトアシドーシス(再投与なし);膵酵素増加(再投与なし);腎機能障害(再投与なし),""
AB-20048676,4,2,C,パクリタキセル,"",不明,20191210,"","","","",尿管癌(右尿管癌),剂量停止,"",""
AB-20048676,4,3,C,ボグリボース,"",経口,不明,"",.9,mg,1,"",未知,"",""
AB-20048676,4,4,C,Ｌ−カルボシステイン,"",経口,不明,"",1500,mg,1,"",未知,"",""
AB-20048676,4,5,C,クエン酸カリウム・クエン酸ナトリウム水和物,"",経口,不明,"",3,g,1,"",未知,"",""
AB-20048676,4,6,C,ベンズブロマロン,"",経口,不明,"",50,mg,1,"",未知,"",""
AB-20048676,4,7,C,ニフェジピン,"",経口,不明,"",40,mg,1,"",未知,"",""
AB-20048676,4,8,C,ジメチコン,"",経口,不明,"",240,mg,1,"",未知,"",""
AB-20048676,4,9,C,トリアゾラム,"",経口,不明,"",.25,mg,1,"",未知,"",""
AB-20048676,4,10,C,タムスロシン塩酸塩,"",経口,不明,"",.2,mg,1,"",未知,"",""
AB-20048676,4,11,C,アセトアミノフェン,"",経口,不明,"",3000,mg,1,"",未知,"",""
AB-20048676,4,12,C,ロキソプロフェンナトリウム水和物,"",非経口,不明,"","","","","",未知,"",""
AB-20048676,4,13,C,ブデソニド・ホルモテロールフマル酸塩水和物,"",非経口,不明,"","","","","",未知,"",""
AB-20048876,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20201223;20210224,20210120;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発熱性好中球減少症(無),""
AB-20048876,4,2,C,クロピドグレル硫酸塩,"",経口,"","",75,mg,1,"",未知,"",""
AB-20048876,4,3,C,レボチロキシンナトリウム水和物,"",経口,"","",62.5,ug,1,グレーブス病(Basedow病),未知,"",""
AB-20048876,4,4,C,アムロジピンベシル酸塩,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-20048876,4,5,C,フロセミド,"",経口,"","",10,mg,1,"",未知,"",""
AB-20049224,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202006,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,筋力低下(再投与なし),""
AB-20049225,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,２型糖尿病(再投与なし),""
AB-20049553,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171013,20171028,320,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,血小板数減少(再投与なし),""
AB-20049560,4,1,PS,ドセタキセル水和物,タキソテール,不明,不明,不明,"","","",胃癌(胃癌),剂量停止,ブドウ球菌感染(再投与なし);スティーヴンス・ジョンソン症候群(再投与なし);腎機能障害(再投与なし),""
AB-20049560,4,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,不明,不明,"","","",胃癌(胃癌),剂量停止,"",""
AB-20049560,4,3,PS,ニボルマブ,"",不明,不明,不明,"","","",胃癌(胃癌),不适用,"",""
AB-20049580,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,腎機能障害(再投与なし),""
AB-20050001,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201019,20201203,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,肺炎球菌性肺炎(再投与なし);間質性肺疾患(再投与なし);ニューモシスチス・イロベチイ肺炎(再投与なし),""
AB-20050001,1,2,PS,ベタメタゾン,"",経口,20201022,20201205,4,mg,1,悪液質(癌性悪液質),未知,"",""
AB-20050001,1,3,C,デキサメタゾン,"",経口,20201019,"","","","",悪液質(癌性悪液質),未知,"",""
AB-20050001,1,4,C,ヘパリンカルシウム,"",不明,"","","","","","",未知,"",""
AB-20050001,1,5,C,芍薬甘草湯,"",不明,"","","","","","",未知,"",""
AB-20050001,1,6,C,アセトアミノフェン,"",経口,"","","","","","",未知,"",""
AB-20050001,1,7,C,フロセミド,"",経口,"","","","","","",未知,"",""
AB-20050001,1,8,C,スピロノラクトン,"",経口,"","","","","","",未知,"",""
AB-20050001,1,9,C,ラクツロース,"",経口,"","","","","","",未知,"",""
AB-20050001,1,10,C,ポリスチレンスルホン酸ナトリウム,"",経口,"","","","","","",未知,"",""
AB-20050001,1,11,C,球形吸着炭,"",経口,"","","","","","",未知,"",""
AB-20050001,1,12,C,ポラプレジンク,"",経口,"","","","","","",未知,"",""
AB-20050001,1,13,C,ニフェジピン,"",経口,"","","","","","",未知,"",""
AB-20050001,1,14,C,ロラタジン,"",経口,"","","","","","",未知,"",""
AB-20050001,1,15,C,カンデサルタンシレキセチル,"",経口,"","","","","","",未知,"",""
AB-20050001,1,16,C,フェブキソスタット,"",経口,"","","","","","",未知,"",""
AB-20050001,1,17,C,リナグリプチン,"",経口,"","","","","","",未知,"",""
AB-20050001,1,18,C,レボフロキサシン水和物,"",経口,"","","","","","",未知,"",""
AB-20050004,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202008;20201117,;20210309,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,急性腎障害(再投与なし);劇症１型糖尿病(再投与なし),""
AB-20050630,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202002,202007,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,血管デバイス感染(再投与なし);失禁(再投与なし);腎機能障害(再投与なし);転倒(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-20050630,2,2,C,フロセミド,"",経口;経口,201911;202005,;,20;20,mg;mg,1;1,腹水(腹水),未知,"",""
AB-20050630,2,3,C,ゾルピデム酒石酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-20051068,1,1,PS,ドセタキセル,"",静脈内点滴,"","","","","",胃癌(切除不能進行胃癌),剂量停止,"",""
AB-20051068,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,"","","","","",胃癌(切除不能進行胃癌),剂量停止,"",""
AB-20051068,1,3,PS,ニボルマブ,"",不明,"","","","","",胃癌(切除不能進行胃癌),不适用,"",""
AB-20051286,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190318;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性膵炎(再投与なし),""
AB-20051286,3,2,C,ベラパミル塩酸塩,"",経口,"","",80,mg,1,"",未知,"",""
AB-20051286,3,3,C,ニフェジピン,"",経口,"","",20,mg,1,"",未知,"",""
AB-20051286,3,4,C,タムスロシン塩酸塩,"",経口,"","",.2,mg,1,"",未知,"",""
AB-20051286,3,5,C,ランソプラゾール,"",経口,"","",15,mg,1,"",未知,"",""
AB-20051286,3,6,C,オランザピン,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-20051554,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20201124;20210104;20210118,20201214;20210104;,240;240;,mg;mg;,1;1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血中クレアチンホスホキナーゼ増加(不明),""
AB-20051567,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200318;20200731,2020;20210321,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-20051596,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",1,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,中毒性表皮壊死融解症(再投与なし),""
AB-20051888,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201801,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-20052156,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺中毒クリーゼ(再投与なし),""
AB-20052508,7,1,PS,イピリムマブ,ヤーボイ,"",20201214,20210125,3,mg/kg,1,結腸癌(Large intestine carcinoma),剂量停止,免疫性腸炎(再投与なし);糖尿病性ケトアシドーシス(再投与なし),""
AB-20052508,7,2,PS,ニボルマブ,オプジーボ,"",20201214,20210125,240,mg,1,結腸癌(LARGE INTESTINE CARCINOMA),剂量停止,免疫性腸炎(再投与なし);糖尿病性ケトアシドーシス(再投与なし),""
AB-20052969,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200512,20210105,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,憩室炎(再投与なし);ショック(再投与なし);心筋炎(再投与なし);徐脈(再投与なし);心不全(再投与なし);アナフィラキシーショック(再投与なし),""
AB-20052969,2,2,C,フロセミド,"",経口;経口,20200423;20210121,;20210130,;,;,;,"",未知,"",""
AB-20052969,2,3,C,プレガバリン,"",経口,"",20210130,"","","","",未知,"",""
AB-20052969,2,4,C,ピコスルファートナトリウム水和物,"",経口,"",20210130,"","","","",未知,"",""
AB-20052969,2,5,C,アスピリン,"",経口,"","","","","","",未知,"",""
AB-20052969,2,6,C,ラベプラゾールナトリウム,"",経口,"","","","","","",未知,"",""
AB-20052969,2,7,C,セレコキシブ,"",経口,"",20210130,"","","","",未知,"",""
AB-20052969,2,8,C,レバミピド,"",経口,"",20210130,"","","","",未知,"",""
AB-20052969,2,9,C,ニフェジピン,"",経口,"",20210130,"","","","",未知,"",""
AB-20052969,2,10,C,牛車腎気丸,"",経口,"",20210130,"","","","",未知,"",""
AB-20052969,2,11,C,トルバプタン,"",経口,"","","","","","",未知,"",""
AB-20052969,2,12,C,アコチアミド塩酸塩水和物,"",経口,"",20210130,"","","","",未知,"",""
AB-20052969,2,13,C,ポリスチレンスルホン酸カルシウム,"",経口,"",20210130,"","","","",未知,"",""
AB-20052969,2,14,C,エロビキシバット水和物,"",経口,"",20210130,"","","","",未知,"",""
AB-20052969,2,15,C,センノシド,"",経口,"","","","","","",未知,"",""
AB-20052969,2,16,C,カルペリチド,"",不明,"","","","","","",未知,"",""
AB-20052969,2,17,C,開始液（１）,"",不明,"","","","","","",未知,"",""
AB-20053141,1,1,PS,ラベプラゾールナトリウム,ラベプラゾールＮａ,経口,"","","","","",適応症不明の製品使用(不明),剂量停止,"",""
AB-20053141,1,2,PS,ラベプラゾールナトリウム,ラベプラゾールＮａ,経口,"","","","","",適応症不明の製品使用(不明),剂量停止,"",""
AB-20053141,1,3,PS,ラベプラゾールナトリウム,ラベプラゾールＮａ,経口,"","","","","",適応症不明の製品使用(不明),剂量停止,"",""
AB-20053141,1,4,PS,ニボルマブ,"",静脈内点滴,"","","","","",胃癌(胃癌),剂量停止,"",""
AB-20053321,1,1,PS,ゾルピデム酒石酸塩,マイスリー,経口(経口),不明,不明,"","","",適応症不明の製品使用(適応症不明の薬剤使用),未知,"",""
AB-20053321,1,2,PS,ペムブロリズマブ,"","","","","","","",肺扁平上皮癌(肺扁平上皮癌再発),未知,"",""
AB-20053321,1,3,C,プレドニゾロン,"",経口(経口);経口(経口),;,;,;,;,;,関節リウマチ(関節リウマチ),未知,"",""
AB-20053321,1,4,C,モサプリドクエン酸塩水和物,"",経口(経口),"","","","","",適応症不明の製品使用(適応症不明の薬剤使用),未知,"",""
AB-20053321,1,5,C,ボノプラザンフマル酸塩,"",経口(経口),"","","","","",適応症不明の製品使用(適応症不明の薬剤使用),未知,"",""
AB-20053321,1,6,C,アスピリン・ダイアルミネート,"",経口(経口),"","","","","",適応症不明の製品使用(適応症不明の薬剤使用),未知,"",""
AB-20053321,1,7,C,プレガバリン,"",経口(経口),"","","","","",適応症不明の製品使用(適応症不明の薬剤使用),未知,"",""
AB-20053321,1,8,C,ブロチゾラム,"",経口(経口),"","","","","",適応症不明の製品使用(適応症不明の薬剤使用),未知,"",""
AB-20053321,1,9,C,スボレキサント,"",経口(経口),"","","","","",適応症不明の製品使用(適応症不明の薬剤使用),未知,"",""
AB-20053321,1,10,C,シスプラチン,"","","","","","","",肺扁平上皮癌(肺扁平上皮癌),未知,"",""
AB-20053321,1,11,C,ビノレルビン酒石酸塩,"","","","","","","",肺扁平上皮癌(肺扁平上皮癌),未知,"",""
AB-20054666,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,多発ニューロパチー(再投与なし);甲状腺機能亢進症(再投与なし);腎機能障害(再投与なし),""
AB-20054880,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210112;20210209,20210126;20210209,240;480,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腸炎(再投与なし);細気管支炎(再投与なし);倦怠感(再投与なし),""
AB-20054880,3,2,C,トリフルリジン・チピラシル塩酸塩配合剤,"",不明,"","","","","","",未知,"",""
AB-20054880,3,3,C,イリノテカン塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-20055145,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180710,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-20055146,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201118,20201118,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,播種性血管内凝固(再投与なし);急性腎障害(再投与なし),""
AB-20055146,2,2,C,フマル酸第一鉄,"",不明,"","","","","","",未知,"",""
AB-20055146,2,3,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-20055146,2,4,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-20055158,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200312,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,末梢動脈血栓症(再投与なし),""
AB-20055158,2,2,PS,ラムシルマブ,サイラムザ,静脈内点滴,201911,20200220,300,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-20055159,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202003;,202006;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-20055398,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,低カリウム血症(再投与なし),""
AB-20055400,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-20055403,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200204,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-20055738,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200218,20200721,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,扁平苔癬(再投与なし);圧迫骨折(再投与なし),""
AB-20055738,1,2,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-20055738,1,3,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-20055738,1,4,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-20055738,1,5,C,オルメサルタンメドキソミル,"",不明,"","","","","","",未知,"",""
AB-20055774,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能亢進症(再投与なし),""
AB-20056042,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201112,20201210,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,腰筋膿瘍(再投与なし),""
AB-20056042,3,2,PS,トラスツズマブデルクステカン,"",不明,20210112,20210408,"","","","",不适用,"",""
AB-20056333,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-20056411,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210127,20210224,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-20056412,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210210,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし);免疫性腸炎(再投与なし),""
AB-20056412,3,2,C,ボノプラザンフマル酸塩,"",経口,20191203,"",10,mg,1,胃食道逆流性疾患(逆流性食道炎),未知,"",""
AB-20056412,3,3,C,クエン酸第一鉄ナトリウム,"",経口,20191226,"",50,mg,1,鉄欠乏性貧血(鉄欠乏性貧血),未知,"",""
AB-20056412,3,4,C,ベニジピン塩酸塩,"",経口,20200128,"",4,mg,1,高血圧(高血圧),未知,"",""
AB-20056412,3,5,C,パンクレリパーゼ,"",経口,20200218,"",300,mg,1,膵不全(膵外分泌機能不全),未知,"",""
AB-20056412,3,6,C,ドンペリドン,"",経口,20200406,"",10,mg,1,慢性胃炎(慢性胃炎),未知,"",""
AB-20056412,3,7,C,ピリドキサールリン酸エステル水和物,"",経口,20200715,"",10,mg,1,ビタミンＢ６欠乏(ビタミンB6欠乏症),未知,"",""
AB-20056412,3,8,C,酢酸亜鉛水和物,"",経口,20200819,"",25,mg,1,亜鉛欠乏(亜鉛欠乏),未知,"",""
AB-20056601,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20200902;20201021;20210301,20200916;20201118;20210317,240;240;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,カテーテル留置部位熱感(有);ブドウ球菌性敗血症(有);硬膜炎(有);血管デバイス感染(有),""
AB-20056601,4,2,C,アセトアミノフェン,"",不明,20200904,20200930,"","","","",未知,"",""
AB-20056601,4,3,C,レボチロキシンナトリウム水和物,"",経口,"","","","","",甲状腺機能低下症(甲状腺機能低下症),未知,"",""
AB-20056614,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200422,20200708,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-20056625,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,汎血球減少症(再投与なし);心筋炎(再投与なし);肺胞出血(再投与なし);器質化肺炎(再投与なし);敗血症(再投与なし),""
AB-20056914,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180313,20180620,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-20056917,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201802;2020,202002;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-20056917,2,2,C,ウルソデオキシコール酸,"",不明,"","","","","","",未知,"",""
AB-20056942,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,血栓性微小血管症(再投与なし),""
AB-20056943,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腎機能障害(再投与なし),""
AB-20056953,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200120,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,原発性副腎機能不全(再投与なし),""
AB-20057254,1,1,PS,ラベプラゾールナトリウム,"",経口,不明,不明,"","","","",剂量停止,"",""
AB-20057254,1,2,PS,ニボルマブ,"",静脈内点滴,不明,不明,"","","",胃癌,剂量停止,"",""
AB-20057437,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20210108;20210222,20210108;20210222,200;200,mg;mg,1;1,胃癌第４期(MSI-High癌),剂量停止,肝機能異常(有);肝機能異常(再投与なし);多形紅斑(再投与なし),""
AB-20057584,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;480,;mg,;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発熱性好中球減少症(再投与なし),""
AB-20058249,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201202,20210224,480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,劇症１型糖尿病(再投与なし),""
AB-20058249,4,2,C,シタグリプチンリン酸塩水和物,"",経口,"","",50,mg,1,２型糖尿病(2型糖尿病),未知,"",""
AB-20058249,4,3,C,トラマドール塩酸塩,"",経口,"","",50,mg,1,"",未知,"",""
AB-20058249,4,4,C,アセトアミノフェン,"",経口,"","",400,mg,1,"",未知,"",""
AB-20058249,4,5,C,酪酸菌製剤,"",経口,"","",2,{DF},1,"",未知,"",""
AB-20058251,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180105,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,原発性副腎機能不全(再投与なし);低ナトリウム血症(再投与なし);嘔吐(再投与なし);変色便(再投与なし),""
AB-20058330,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210301,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,間質性肺疾患(再投与なし),""
AB-20058346,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,強皮症様反応(再投与なし),""
AB-20058396,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200213,20210218,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-20058396,3,2,C,エスゾピクロン,"",経口,20191029,"",2,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20058396,3,3,C,ラフチジン,"",経口,20200604,"",10,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20058396,3,4,C,ニフェジピン,"",経口,"","",20,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20058396,3,5,C,カンデサルタンシレキセチル,"",経口,"","",8,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-20058396,3,6,C,クロピドグレル硫酸塩,"",経口,"","",75,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21000104,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190405,20190419,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,胆管炎(再投与なし),""
AB-21000106,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191127,20200108,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし),""
AB-21000111,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20191220;,20200131;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,筋炎(再投与なし),""
AB-21000832,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191217,20200405,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎尿細管障害(再投与なし),""
AB-21001228,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190830,20190913,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,薬疹(再投与なし);口内炎(再投与なし),""
AB-21001230,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181018;,;20200702,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(不明),""
AB-21001230,1,2,C,デュラグルチド,"",皮下,"","","","","","",未知,"",""
AB-21001230,1,3,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-21001230,1,4,C,ラベプラゾールナトリウム,"",不明,"","","","","","",未知,"",""
AB-21001230,1,5,C,プレガバリン,"",不明,"","","","","","",未知,"",""
AB-21001230,1,6,C,アズレンスルホン酸ナトリウム水和物・Ｌ−グルタミン,"",経口,"","","","","","",未知,"",""
AB-21001230,1,7,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-21001230,1,8,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-21001230,1,9,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
AB-21001244,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201910,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,骨転移(再投与なし);播種性血管内凝固(再投与なし),""
AB-21001265,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202005,202009,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21001368,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20200110;20210416,202103;,200;200,mg;mg,1;1,胃癌(胃がん（MSI-H）),剂量停止,関節リウマチ(不明);免疫性甲状腺機能低下症(再投与なし),""
AB-21001368,2,2,C,ビソプロロールフマル酸塩,"",経口,不明,"","","","",心房細動(心房細動),剂量不变,"",""
AB-21001502,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191212,20191212,240,mg,1,遠隔転移を伴う腎細胞癌(根治切除不能又は転移性の腎細胞癌に対する併用療法),剂量停止,薬物性肝障害(再投与なし),""
AB-21001502,2,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,20191212,20191212,40,mg,1,遠隔転移を伴う腎細胞癌(根治切除不能又は転移性の腎細胞癌に対する併用療法),剂量停止,"",""
AB-21001506,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200325;20200527,20200513;,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎皮質刺激ホルモン欠損症(無),""
AB-21001506,6,2,C,テノホビルアラフェナミドフマル酸塩,"",経口,"","",25,mg,1,Ｂ型肝炎ウイルス検査陽性(HBV既感染),未知,"",""
AB-21001506,6,3,C,酪酸菌配合剤,"",経口,"","","","","","",未知,"",""
AB-21001506,6,4,C,膵臓性消化酵素配合剤（１）,"",経口,"","",3,g,1,"",未知,"",""
AB-21001506,6,5,C,メコバラミン,"",経口,"","",500,ug,1,"",未知,"",""
AB-21001506,6,6,C,酢酸亜鉛水和物,"",経口,"","",25,mg,1,"",未知,"",""
AB-21001829,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210318,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発疹(再投与なし),""
AB-21002054,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201105,20201203,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,類天疱瘡(再投与なし);腎機能障害(再投与なし),""
AB-21002054,2,2,C,トリフルリジン・チピラシル塩酸塩配合剤,"",不明,20201218,"","","","",胃癌(胃癌),未知,"",""
AB-21002054,2,3,C,アムロジピンベシル酸塩,"",不明,"","",10,mg,1,高血圧(高血圧),未知,"",""
AB-21002054,2,4,C,シタグリプチンリン酸塩水和物・イプラグリフロジンＬ−プロリン配合剤,"",経口,"","",1,{DF},1,糖尿病(糖尿病),未知,"",""
AB-21002054,2,5,C,ビソプロロールフマル酸塩,"",不明,"","",2.5,mg,1,高血圧(高血圧),未知,"",""
AB-21002097,4,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,20210203,20210203,1200,mg,1,肝細胞癌(肝細胞癌),不适用,間質性肺疾患(再投与なし);肝炎(再投与なし),""
AB-21002097,4,2,PS,ベバシズマブ,アバスチン,静脈内点滴,20210203,20210203,800,mg,1,肝細胞癌(肝細胞癌),不适用,間質性肺疾患(再投与なし);肝炎(再投与なし),""
AB-21002097,4,3,PS,レンバチニブメシル酸塩,レンビマ,経口,20210303,20210317,4,mg,1,肝細胞癌(肝細胞癌),不适用,"",""
AB-21002097,4,4,C,ニコランジル,"",不明,"","","","","","",不适用,"",""
AB-21002097,4,5,C,リバーロキサバン,"",不明,"","","","","","",不适用,"",""
AB-21002097,4,6,C,硝酸イソソルビド,"",不明,"",20210323,"","","","",不适用,"",""
AB-21002097,4,7,C,ビソプロロールフマル酸塩,"",不明,"",20210323,"","","","",不适用,"",""
AB-21002097,4,8,C,アムロジピンベシル酸塩,"",不明,"","","","","","",不适用,"",""
AB-21002097,4,9,C,フェブキソスタット,"",不明,"",20210323,"","","","",不适用,"",""
AB-21002097,4,10,C,ビラスチン,"",不明,"",20210323,"","","","",不适用,"",""
AB-21002097,4,11,C,アトルバスタチンカルシウム水和物,"",不明,"",20210323,"","","","",不适用,"",""
AB-21002137,4,1,PS,イピリムマブ,ヤーボイ,静脈内点滴,20191212,20191212,40,mg,1,遠隔転移を伴う腎細胞癌(遠隔転移を伴う腎細胞癌);肺転移(肺転移),剂量停止,薬物性肝障害(再投与なし),""
AB-21002137,4,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20191212,20191212,240,mg,1,遠隔転移を伴う腎細胞癌(遠隔転移を伴う腎細胞癌);肺転移(肺転移),剂量停止,薬物性肝障害(再投与なし),""
AB-21002376,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200805,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,下垂体機能低下症(再投与なし);ラトケ嚢胞(再投与なし),""
AB-21002376,1,2,C,ミロガバリンベシル酸塩,"",経口,20200318,"",2.5,mg,1,末梢性感覚ニューロパチー(末梢性感覚ニューロパチー),未知,"",""
AB-21002376,1,3,C,デュロキセチン塩酸塩,"",経口,20200318,"",20,mg,1,末梢性感覚ニューロパチー(末梢性感覚ニューロパチー),未知,"",""
AB-21002376,1,4,C,ロサルタンカリウム,"",経口,"","",50,mg,1,高血圧(高血圧),未知,"",""
AB-21002376,1,5,C,カンデサルタンシレキセチル・アムロジピンベシル酸塩配合剤,"",経口,"","","","","",高血圧(高血圧),未知,"",""
AB-21002386,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-21002389,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能亢進症(再投与なし),""
AB-21002787,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);甲状腺機能低下症(再投与なし),""
AB-21004042,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200604;20201119,20200910;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,続発性副腎皮質機能不全(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-21004270,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201802,20200512,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心不全(再投与なし),""
AB-21004270,1,2,C,フロセミド,"",経口,"","","","","","",未知,"",""
AB-21004270,1,3,C,フェキソフェナジン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-21004270,1,4,C,ポリスチレンスルホン酸ナトリウム,"",不明,"","","","","","",未知,"",""
AB-21004270,1,5,C,ウルソデオキシコール酸,"",経口,"","","","","","",未知,"",""
AB-21004270,1,6,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
AB-21004270,1,7,C,レボチロキシンナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-21004446,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20191120,20191211,200,mg,1,胃腺癌(MSI-High癌を有する結腸・ 直腸癌以外の固形癌（胃がん）),剂量停止,悪性新生物進行(再投与なし),""
AB-21006082,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190614;2020,2020;20210108,240;480,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,消化管浮腫(再投与なし);直腸炎(再投与なし);急性膵炎(再投与なし),""
AB-21006082,2,2,C,トラスツズマブデルクステカン,"",静脈内点滴,20210122,20210312,6.4,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21006082,2,3,C,イリノテカン塩酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-21006121,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200515,20200612,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし);悪性新生物進行(再投与なし),""
AB-21006122,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200201,20200329,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21006123,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200626,20200725,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,悪性新生物進行(再投与なし);死亡(再投与なし),""
AB-21006123,1,2,C,カンデサルタンシレキセチル,"",経口,"","",8,mg,1,"",未知,"",""
AB-21006123,1,3,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-21006123,1,4,C,オメガ−３脂肪酸エチル,"",経口,"","",2,g,1,"",未知,"",""
AB-21006123,1,5,C,ピタバスタチンカルシウム,"",経口,"","",1,mg,1,"",未知,"",""
AB-21006124,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200304,20200612,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし);悪性新生物進行(再投与なし),""
AB-21006124,1,2,C,イリノテカン塩酸塩水和物,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21006125,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191002,20200113,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21006126,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190711,20190822,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21006127,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200712,20200726,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21006127,1,2,C,チオトロピウム臭化物水和物,"",不明,"","","","","","",未知,"",""
AB-21006127,1,3,C,ドキサゾシンメシル酸塩,"",不明,"","","","","","",未知,"",""
AB-21006127,1,4,C,オルメサルタンメドキソミル,"",不明,"","","","","","",未知,"",""
AB-21006127,1,5,C,ニフェジピン,"",不明,"","","","","","",未知,"",""
AB-21006128,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200510,20200816,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21006129,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200201,20200315,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21006560,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200815,20201010,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21006617,1,1,PS,ラベプラゾールナトリウム,ラベプラゾールＮａ,経口,"","","","","","",剂量停止,"",""
AB-21006617,1,2,PS,ニボルマブ,"",不明,"","","","","",胃癌(胃癌),剂量停止,"",""
AB-21007651,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21007652,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21007653,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21007654,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21007656,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21008082,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210331;20210721,20210331;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,てんかん(再投与なし),""
AB-21008082,3,2,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-21008082,3,3,C,クロピドグレル硫酸塩,"",経口,"","",75,mg,1,"",未知,"",""
AB-21008082,3,4,C,ランソプラゾール,"",経口,"","",15,mg,1,"",未知,"",""
AB-21008082,3,5,C,アセトアミノフェン,"",経口,"","",500,mg,1,"",未知,"",""
AB-21008090,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし),""
AB-21008452,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210217;20210521,20210413;20210910,240;240,mg;mg,1;1,"",剂量停止,副腎機能不全(無);うつ病(無);肺炎(無),""
AB-21008452,5,2,PS,ヒドロコルチゾンコハク酸エステルナトリウム,サクシゾン,静脈内（明記されていない場合）,"","",200,mg,1,副腎機能不全(副腎不全),未知,"",""
AB-21008452,5,3,C,フェキソフェナジン塩酸塩,"",経口,20200406,"",60,mg,1,"",未知,"",""
AB-21008452,5,4,C,プレドニゾロン吉草酸エステル酢酸エステル,"",局所,20200406,"","","","","",未知,"",""
AB-21008452,5,5,C,ボノプラザンフマル酸塩,"",経口,20200728,"",10,mg,1,"",未知,"",""
AB-21008452,5,6,C,経腸成分栄養剤（２−２）,"",経口,20200728,"",250,mL,1,"",未知,"",""
AB-21008452,5,7,C,レンボレキサント,"",経口,20210126,"",10,mg,1,"",未知,"",""
AB-21008549,2,1,PS,パクリタキセル,タキソール,不明,20190917,20200116,"","","",腎癌(腎癌);胃癌(胃癌),剂量停止,糖尿病(再投与なし);好中球減少症(再投与なし),""
AB-21008549,2,2,PS,ニボルマブ,オプジーボ,静脈内点滴,202002131050,202102181439,240,mg,1,胃癌(胃癌),剂量停止,糖尿病(再投与なし);好中球減少症(再投与なし),""
AB-21008549,2,3,C,エスゾピクロン,"",経口,20191029,"",2,mg,1,腎癌(腎癌),剂量不变,"",""
AB-21008549,2,4,C,ラフチジン,"",経口,20200604,"",20,mg,1,腎癌(腎癌),剂量不变,"",""
AB-21008549,2,5,C,ニフェジピン,"",経口,"","",20,mg,1,腎癌(腎癌),剂量不变,"",""
AB-21008549,2,6,C,カンデサルタンシレキセチル,"",経口,"","",8,mg,1,腎癌(腎癌),剂量不变,"",""
AB-21008549,2,7,C,クロピドグレル硫酸塩,"",経口,"","",75,mg,1,腎癌(腎癌),剂量不变,"",""
AB-21010002,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,201711;;;;,;;;;20200407,200;200;240;240;240,mg;mg;mg;mg;mg,1;1;1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-21010004,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200312,20200731,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,誤嚥性肺炎(再投与なし);間質性肺疾患(再投与なし),""
AB-21010004,2,2,C,シロドシン,"",不明,"","","","","","",未知,"",""
AB-21010004,2,3,C,タダラフィル,"",不明,"","","","","","",未知,"",""
AB-21010004,2,4,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-21010004,2,5,C,フェキソフェナジン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-21010004,2,6,C,大建中湯,"",不明,"","","","","","",未知,"",""
AB-21010005,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-21010259,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171025,20180319,160,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21010259,1,2,C,アゾセミド,"",経口,20170617,20180627,30,mg,1,"",未知,"",""
AB-21010259,1,3,C,カルバゾクロムスルホン酸ナトリウム水和物,"",経口,20171121,20180627,30,mg,1,予防(予防投与),未知,"",""
AB-21010259,1,4,C,クエン酸第一鉄ナトリウム,"",経口,20171211,20180627,50,mg,1,"",未知,"",""
AB-21010259,1,5,C,ジフェンヒドラミン,"",経皮,20180208,20180724,"","","",予防(予防投与),未知,"",""
AB-21010259,1,6,C,フェキソフェナジン塩酸塩,"",経口,20180319,20180627,60,mg,1,予防(予防投与),未知,"",""
AB-21010259,1,7,C,ポリカルボフィルカルシウム,"",経口,"",20180627,.6,g,1,予防(予防投与),未知,"",""
AB-21010259,1,8,C,酪酸菌製剤,"",経口,"",20180627,1,g,1,予防(予防投与),未知,"",""
AB-21010259,1,9,C,エソメプラゾールマグネシウム水和物,"",経口,"",20180627,20,mg,1,"",未知,"",""
AB-21010263,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-21010266,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,リンパ節症(再投与なし),""
AB-21010267,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-21010269,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腫瘍のハイパープログレッション(再投与なし),""
AB-21010389,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,皮膚炎(再投与なし),""
AB-21010602,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200331;20200611,20200414;20200722,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍のハイパープログレッション(再投与なし),""
AB-21010602,1,2,C,エソメプラゾールマグネシウム水和物,"",経口,20190607,"",20,mg,1,予防(予防投与),未知,"",""
AB-21010602,1,3,C,アセトアミノフェン,"",経口,20200312,"",600,mg,1,"",未知,"",""
AB-21010636,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191016,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-21010636,1,2,C,シルニジピン,"",不明,"","","","","","",未知,"",""
AB-21011780,1,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,"","",10,mg/kg,1,非小細胞肺癌(CRT後の非小細胞肺癌),剂量不变,"",""
AB-21011918,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210209,20210324,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-21012597,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210319;,;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能亢進症(不明),""
AB-21012868,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202008,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし),""
AB-21012868,4,2,PS,パクリタキセル,"",不明;不明,20200327;,20200710;,;,;,;,胃癌(進行胃癌),不适用,"",""
AB-21012868,4,3,C,膵臓性消化酵素配合剤（１）,"",経口,20200222,"",1,g,1,"",未知,"",""
AB-21012868,4,4,C,酪酸菌配合剤,"",経口,20200222,"","","","","",未知,"",""
AB-21012868,4,5,C,ビルダグリプチン,"",経口,"","",50,mg,1,"",未知,"",""
AB-21012868,4,6,C,メトホルミン塩酸塩,"",経口,"","",250,mg,1,"",未知,"",""
AB-21012868,4,7,C,メトクロプラミド,"",経口,"","",5,mg,1,"",未知,"",""
AB-21012868,4,8,C,テルミサルタン・アムロジピンベシル酸塩配合剤,"",経口,"","","","","","",未知,"",""
AB-21012868,4,9,C,ベニジピン塩酸塩,"",経口,"","",2,mg,1,"",未知,"",""
AB-21012868,4,10,C,テルミサルタン,"",経口,"","",20,mg,1,"",未知,"",""
AB-21012872,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20210210,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-21012872,1,2,PS,ワルファリンカリウム,ワーファリン,経口,"","","","","",脳梗塞(脳梗塞再発予防),剂量停止,"",""
AB-21012872,1,3,PS,アスピリン,"",経口,"","",100,mg,1,"",未知,"",""
AB-21012931,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴;静脈内点滴,20190521;20191212;不明,20191114;20200220;,200;200;,mg;mg;,1;1;,胃癌第４期(MSI-Highを有する結腸・直腸癌以外の固形癌（標準的治療困難）胃癌),剂量停止,副腎機能不全(不明);免疫性血小板減少症(不明),""
AB-21013442,3,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,20201017,20201116,650,mg,1,非小細胞肺癌(CRT後の非小細胞肺癌),剂量停止,"",""
AB-21013442,3,2,PS,デュルバルマブ,イミフィンジ,静脈内点滴,20201228,20201228,650,mg,1,非小細胞肺癌(CRT後の非小細胞肺癌),剂量停止,"",""
AB-21013442,3,3,PS,デュルバルマブ,イミフィンジ,静脈内点滴,20210426,"",10,mg/kg,1,非小細胞肺癌(CRT後の非小細胞肺癌),未知,"",""
AB-21013653,5,1,PS,トラスツズマブデルクステカン,エンハーツ,静脈内点滴;静脈内点滴,20210415;20210506,20210415;20210506,6.4;6.4,mg/kg;mg/kg,1;1,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),剂量停止,間質性肺疾患(再投与なし);発熱(再投与なし),""
AB-21013653,5,2,PS,ニボルマブ,"",不明,20210205,20210401,"","","",ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),未知,"",""
AB-21013653,5,3,C,グラニセトロン塩酸塩,"",不明,20210415,"",1,mg,1,"",未知,"",""
AB-21013653,5,4,C,デキサメタゾンリン酸エステルナトリウム,"",不明,20210415,"",3.3,mg,1,"",未知,"",""
AB-21013653,5,5,C,メトクロプラミド,"",不明,"","",5,mg,1,"",未知,"",""
AB-21013653,5,6,C,ゾルピデム酒石酸塩,"",不明,"","",5,mg,1,"",未知,"",""
AB-21013653,5,7,C,フロセミド,"",不明,"","",20,mg,1,"",未知,"",""
AB-21013653,5,8,C,ボノプラザンフマル酸塩,"",不明,"","",20,mg,1,"",未知,"",""
AB-21013653,5,9,C,フェンタニルクエン酸塩,"",不明,"","","","","","",未知,"",""
AB-21013689,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191031,20191114,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし);甲状腺機能低下症(再投与なし);甲状腺機能低下症(再投与なし),""
AB-21013700,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,2019,202001,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21013701,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21013702,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201710,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血中クレアチンホスホキナーゼ増加(再投与なし),""
AB-21013702,1,2,C,ロキソプロフェンナトリウム水和物,"",経口,"","","","","",背部痛(腰背部痛);背部痛(腰背部痛),未知,"",""
AB-21013703,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21013704,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202005,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,イレウス(再投与なし),""
AB-21013724,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21013725,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21013726,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21013727,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21013728,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21013729,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21013730,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21013731,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21014010,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21014097,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201810;202010,201912;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,免疫性甲状腺機能低下症(再投与なし),""
AB-21014379,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180313;20181226,20180620;20190220,160;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-21014379,2,2,C,ビルダグリプチン,"",経口,"","",50,mg,1,"",未知,"",""
AB-21014379,2,3,C,ラベプラゾールナトリウム,"",経口,"","",10,mg,1,予防(予防投与),未知,"",""
AB-21014379,2,4,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-21014379,2,5,C,インダパミド,"",経口,"","",.5,mg,1,"",未知,"",""
AB-21014379,2,6,C,アジルサルタン・アムロジピンベシル酸塩配合剤,"",経口,"","",1,{DF},1,"",未知,"",""
AB-21014381,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21014382,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21014384,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21014387,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191003,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21014389,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21014439,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20201026;202103;,20210215;20211129;,240;240;,mg;mg;,1;1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(不明),""
AB-21014731,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下垂体機能低下症(再投与なし),""
AB-21015153,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,２型糖尿病(再投与なし);２型糖尿病(再投与なし),""
AB-21015306,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,不明,"","","","",胃癌(胃癌多発リンパ節転移);リンパ節転移(胃癌多発リンパ節転移),剂量不变,糖尿病(再投与なし);インスリン分泌障害(再投与なし),""
AB-21015941,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20210519,20210519,200,mg,1,胃癌第４期(高頻度マイクロサテライト不安定性（MSI-High）癌、胃癌),剂量停止,腫瘍崩壊症候群(再投与なし),""
AB-21016063,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-21016065,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200422,202006,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,免疫性甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-21016065,3,2,PS,デキサメタゾン,"",不明;不明,;,;,.5;1,mg;mg,1;1,副腎機能不全(相対的副腎不全),剂量不变,"",""
AB-21016065,3,3,C,ラムシルマブ,"",不明,202006,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21016065,3,4,C,パクリタキセル,"",不明,202007,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21016065,3,5,C,イリノテカン塩酸塩水和物,"",不明,202203,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21016065,3,6,C,オキサリプラチン,"",不明,202205,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21016065,3,7,C,レボホリナートカルシウム,"",不明,202205,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21016065,3,8,C,フルオロウラシル,"",不明,202205,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21016065,3,9,C,トリフルリジン・チピラシル塩酸塩配合剤,"",不明,202210,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21016065,3,10,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202212,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21016065,3,11,C,インスリンデグルデク・インスリン　アスパルト（遺伝子組換え）配合剤,"",不明,202301,"","","","",糖尿病(糖尿病),未知,"",""
AB-21016065,3,12,C,インスリンデグルデク・リラグルチド（遺伝子組換え）配合剤,"",不明,"","","","","",糖尿病(糖尿病),未知,"",""
AB-21016065,3,13,C,イプラグリフロジンＬ−プロリン,"",不明;不明,;,202302;,50;50,mg;mg,1;1,"",未知,"",""
AB-21016065,3,14,C,エルトロンボパグオラミン,"",経口,"","","","","","",未知,"",""
AB-21016487,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190205,20200916,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,関節リウマチ(再投与なし),""
AB-21017857,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20200817;20201208;,20201109;20201208;,240;240;480,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,続発性副腎皮質機能不全(再投与なし),""
AB-21017857,2,2,C,インフルエンザワクチン,"",不明,20201024,"","","","",インフルエンザ免疫(インフル予防接種),未知,"",""
AB-21017857,2,3,C,酪酸菌製剤,"",経口,"","",1,g,1,"",未知,"",""
AB-21017857,2,4,C,アトルバスタチンカルシウム水和物,"",経口,"","",10,mg,1,"",未知,"",""
AB-21017857,2,5,C,酸化マグネシウム,"",経口,"","",330,mg,1,"",未知,"",""
AB-21017857,2,6,C,ニルバジピン,"",経口,"","",4,mg,1,"",未知,"",""
AB-21017857,2,7,C,オロパタジン塩酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-21017857,2,8,C,ベタメタゾン吉草酸エステル・ゲンタマイシン硫酸塩,"",局所,"","","","","","",未知,"",""
AB-21017864,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-21017868,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,消化管穿孔(再投与なし),""
AB-21018363,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171115,"",3,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21018762,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181001,20181001,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし);肺腫瘍血栓性微小血管症(再投与なし),""
AB-21019097,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191204,20200108,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,心不全(再投与なし),""
AB-21019098,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200314,20200328,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21019259,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200122,20200318,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-21019640,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202011;,;202105,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(不明),""
AB-21019652,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,筋炎(再投与なし),""
AB-21019744,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171030,20180402,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-21019746,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190128,20190225,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,イレウス(再投与なし),""
AB-21019748,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181127,20190108,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肺炎(再投与なし);肺転移(再投与なし),""
AB-21019749,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190415,20190820,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-21020164,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20170519;;20180323,;20171012;20180514,;;,;;,;;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血小板減少症(再投与なし);間質性肺疾患(再投与なし);間質性肺疾患(再投与なし),""
AB-21020164,1,2,C,カペシタビン,"",不明,20180111,20180315,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21020169,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171116,20180814,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21020170,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200117,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-21020531,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180911,20180911,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腹水(再投与なし),""
AB-21020532,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180626,20180710,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腸炎(再投与なし);腸炎(再投与なし),""
AB-21020534,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,2019,201911,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-21020535,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171031,20180424,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-21020536,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201902,2019,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-21020984,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210427,20210525,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,低ナトリウム血症(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-21020984,2,2,C,コロナウイルス（ＳＡＲＳ−ＣｏＶ−２）ＲＮＡワクチン,"",筋肉内,20210519,20210519,.3,mL,1,ＣＯＶＩＤ−１９予防(コロナウイルス予防),未知,"",""
AB-21020984,2,3,C,酸化マグネシウム,"",経口,20210525,2021,250,mg,1,"",未知,"",""
AB-21020984,2,4,C,塩酸メトクロプラミド,"",経口,20210525,2021,5,mg,1,"",未知,"",""
AB-21020984,2,5,C,生理食塩液,"",静脈内点滴,20210525,20210525,150,mL,1,"",未知,"",""
AB-21020984,2,6,C,ケトプロフェン,"",経皮,"","","","","","",未知,"",""
AB-21021391,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200528;202010,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(有);副腎機能不全(有);帯状疱疹(有),""
AB-21021391,4,2,C,アルギン酸ナトリウム,"",経口,201811,"",20,mL,1,胃癌(胃癌),未知,"",""
AB-21021391,4,3,C,ランソプラゾール,"",経口,201811,"",15,mg,1,胃癌(胃癌),未知,"",""
AB-21021391,4,4,C,六君子湯,"",経口,201811,"",25,g,1,胃癌(胃癌),未知,"",""
AB-21021391,4,5,C,スルタミシリントシル酸塩水和物,"",経口,20200930,20201002,375,mg,1,予防(予防),未知,"",""
AB-21021921,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201906,202101,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,乾癬様皮膚炎(再投与なし),""
AB-21021930,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,膵炎(再投与なし);硬化性胆管炎(再投与なし),""
AB-21021932,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210304,20210304,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,筋炎(再投与なし),""
AB-21021932,1,2,C,オメプラゾール,"",経口,"","","","","","",未知,"",""
AB-21021932,1,3,C,ポリスチレンスルホン酸ナトリウム,"",不明,"","","","","","",未知,"",""
AB-21021932,1,4,C,グリメピリド,"",経口,"","","","","","",未知,"",""
AB-21021932,1,5,C,クロピドグレル硫酸塩,"",経口,"","","","","","",未知,"",""
AB-21021932,1,6,C,メトホルミン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-21021932,1,7,C,ビルダグリプチン,"",経口,"","","","","","",未知,"",""
AB-21021932,1,8,C,インスリングラルギン［後続１］,"",不明,"","","","","","",未知,"",""
AB-21021932,1,9,C,メコバラミン,"",経口,"","","","","","",未知,"",""
AB-21021990,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190607;20200512,20200228;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-21022401,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,１型糖尿病(再投与なし),""
AB-21022404,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20190129;202105;,;;20210622,240;480;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,貧血(不明),""
AB-21022404,2,2,C,シタグリプチンリン酸塩水和物,"",経口,201803,"",50,mg,1,"",未知,"",""
AB-21022404,2,3,C,ボノプラザンフマル酸塩,"",経口,"","",20,mg,1,胃癌(胃癌),未知,"",""
AB-21022404,2,4,C,スボレキサント,"",経口,"","",15,mg,1,"",未知,"",""
AB-21022404,2,5,C,ラメルテオン,"",経口,"","",8,mg,1,"",未知,"",""
AB-21022404,2,6,C,ミチグリニドカルシウム水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-21022728,2,1,PS,イピリムマブ,ヤーボイ,"","","","","","",遠隔転移を伴う腎細胞癌(Metastatic renal cell carcinoma),不适用,死亡(再投与なし),""
AB-21022728,2,2,PS,ニボルマブ,オプジーボ,"","","","","","",遠隔転移を伴う腎細胞癌(Metastatic renal cell carcinoma),不适用,死亡(再投与なし),""
AB-21022790,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210317,20210511,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺結核(再投与なし),""
AB-21023185,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210413;20210601,20210511;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,高血圧性脳症(再投与なし);甲状腺機能亢進症(再投与なし),""
AB-21023189,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180515;20180725,;20181226,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし);甲状腺機能低下症(再投与なし),""
AB-21023275,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190724;20191106,20190918;20191218,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,続発性副腎皮質機能不全(再投与なし),""
AB-21023712,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21024654,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍出血(再投与なし),""
AB-21024724,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,心タンポナーデ(再投与なし),""
AB-21024740,8,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210414;20211001,;,240;,mg;,1;,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),剂量停止,肝障害(再投与なし);間質性肺疾患(再投与なし),""
AB-21024740,8,2,PS,イピリムマブ,ヤーボイ,静脈内点滴;静脈内点滴,20210414;20211001,;,1;,mg/kg;,1;,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),剂量停止,"",""
AB-21024740,8,3,C,カルベジロール,"",経口,"","",1.25,mg,1,"",未知,"",""
AB-21024740,8,4,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",経皮,"","","","","",斑状丘疹状皮疹(斑状丘状性皮疹),未知,"",""
AB-21025232,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20201221;20210426;,20210118;;20211122,240;240;,mg;mg;,1;1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,感染性胸水(再投与なし);食道穿孔(再投与なし);甲状腺機能低下症(再投与なし);気胸(再投与なし);甲状腺機能亢進症(再投与なし),""
AB-21025232,2,2,PS,バンコマイシン塩酸塩,バンコマイシン,不明,"","","","","",気胸(気胸);感染性胸水(膿胸),未知,"",""
AB-21025232,2,3,C,トリフルリジン・チピラシル塩酸塩配合剤,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21025232,2,4,C,ラムシルマブ,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21025622,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190305,20201001,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,細菌性肺炎(再投与なし),""
AB-21025753,13,1,PS,イピリムマブ,ヤーボイ,;,20210414;20211001,;,1;,mg/kg;,1;,再発非小細胞肺癌(Non-small cell lung cancer recurrent),剂量停止,斑状丘疹状皮疹(再投与なし);胸水(再投与なし);リンパ節症(再投与なし),""
AB-21025753,13,2,PS,ニボルマブ,オプジーボ,;,20210414;20211001,;,240;,mg;,1;,再発非小細胞肺癌(NON-SMALL CELL LUNG CANCER RECURRENT),剂量停止,斑状丘疹状皮疹(再投与なし);胸水(再投与なし);リンパ節症(再投与なし),""
AB-21025753,13,3,C,カルベジロール,"",;,;,;,1.25;1.25,mg;mg,1;1,適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-21025753,13,4,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",;,;,;,;,;,;,斑状丘疹状皮疹(Rash maculo-papular),未知,"",""
AB-21025906,4,1,PS,トラスツズマブデルクステカン,エンハーツ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20210112;20210202;20210224;20210317;20210407;20210428,20210112;20210202;20210224;20210317;20210407;20210428,6.4;6.4;6.4;6.4;6.4;6.4,mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg,1;1;1;1;1;1,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),剂量停止,間質性肺疾患(再投与なし),""
AB-21025906,4,2,PS,ニボルマブ,"",不明,20201001,20201214,"","","",ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),未知,"",""
AB-21025984,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,急性リンパ性白血病(再投与なし),""
AB-21026430,11,1,PS,アナモレリン塩酸塩,エドルミズ,経口,20210622,20210630,50,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,血中ブドウ糖増加(再投与なし);急性腎障害(再投与なし);間質性肺疾患(再投与なし),""
AB-21026430,11,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20210427,20210622,240,mg,1,胃癌(胃癌（残胃癌）),剂量停止,血中ブドウ糖増加(再投与なし);急性腎障害(再投与なし);間質性肺疾患(再投与なし),""
AB-21026430,11,3,C,Ｌ−カルボシステイン,"",経口,20200107,20210630,500,mg,1,"",未知,"",""
AB-21026430,11,4,C,ビラスチン,"",経口,20210126,20210630,20,mg,1,"",未知,"",""
AB-21026430,11,5,C,コハク酸ソリフェナシン,"",経口,20210309,20210630,2.5,mg,1,"",未知,"",""
AB-21026430,11,6,C,酪酸菌配合剤,"",経口,"",20210630,1,{DF},1,"",未知,"",""
AB-21026430,11,7,C,メコバラミン,"",経口,"",20210630,.5,mg,1,"",未知,"",""
AB-21026430,11,8,C,アセトアミノフェン,"",経口,"",20210630,500,mg,1,"",未知,"",""
AB-21026430,11,9,C,ケトプロフェン,"",経皮,"","",40,mg,1,"",未知,"",""
AB-21026434,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180406,20181130,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21026434,3,2,C,トラマドール塩酸塩,"",経口,20180223,20191220,50,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21026434,3,3,C,エソメプラゾールマグネシウム水和物,"",経口,20180316,20191220,20,mg,1,予防(予防投与),未知,"",""
AB-21026434,3,4,C,酸化マグネシウム,"",経口,20180330,20191220,660,mg,1,予防(予防投与),未知,"",""
AB-21026434,3,5,C,センノシド,"",経口,20180330,"",24,mg,1,予防(予防投与),未知,"",""
AB-21026434,3,6,C,レボチロキシンナトリウム水和物,"",経口,20180406,20191231,62.5,mg,1,予防(予防投与),未知,"",""
AB-21026434,3,7,C,ヘパリン類似物質,"",経皮,20180622,20191231,"","","",予防(予防投与),未知,"",""
AB-21026434,3,8,C,トリアゾラム,"",経口,"",20191231,.25,mg,1,予防(予防投与),未知,"",""
AB-21026529,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202106,202106,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-21027339,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201222,20210216,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能亢進症(再投与なし);甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし),""
AB-21027339,2,2,C,フロセミド,"",経口,"","",20,mg,1,"",未知,"",""
AB-21027339,2,3,C,リバーロキサバン,"",経口,"","",10,mg,1,"",未知,"",""
AB-21027339,2,4,C,アスピリン・ボノプラザンフマル酸塩配合剤,"",経口,"","","","","","",未知,"",""
AB-21027339,2,5,C,ピタバスタチンカルシウム,"",経口,"","",2,mg,1,"",未知,"",""
AB-21027339,2,6,C,ビソプロロールフマル酸塩,"",経口,"","",.625,mg,1,"",未知,"",""
AB-21027822,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210507,20210521,240,mg,1,食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),剂量停止,甲状腺機能低下症(再投与なし);甲状腺炎(再投与なし),""
AB-21028897,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,胆管結石(再投与なし);胆管狭窄(再投与なし);発熱(再投与なし);胆管炎(再投与なし),""
AB-21029572,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20200630;20201117,20200630;20201117,200;200,mg;mg,1;1,胃癌第４期(MSI-High癌（結腸・直腸以外）、胃癌),剂量停止,免疫介在性肝障害(無);腎不全(無);免疫性腸炎(無);下痢(再投与なし),""
AB-21029704,1,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,"","","","","",小細胞肺癌(小細胞肺癌),剂量停止,"",""
AB-21029704,1,2,PS,デュルバルマブ,イミフィンジ,静脈内点滴,"","","","","",小細胞肺癌(小細胞肺癌),剂量不变,"",""
AB-21029704,1,3,C,エトポシド,"",不明,"","","","","",小細胞肺癌(小細胞肺癌),未知,"",""
AB-21029704,1,4,C,カルボプラチン,"",不明,"","","","","",小細胞肺癌(小細胞肺癌),未知,"",""
AB-21030662,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210520;,20210617;,240;,mg;,1;,食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),剂量停止,食道穿孔(再投与なし);器質化肺炎(再投与なし),""
AB-21030696,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202101,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-21031488,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20191219;20200601;20210621,20200220;20210524;20210621,240;240;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21031488,3,2,C,イオパミドール,"",不明,20210621,20210621,86,mL,1,造影スキャン(造影スキャン),未知,"",""
AB-21031488,3,3,C,コロナウイルス（ＳＡＲＳ−ＣｏＶ−２）ＲＮＡワクチン,"",不明,"","","","","","",未知,"",""
AB-21031489,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210610,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(再投与なし),""
AB-21032243,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-21032247,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210611,20210611,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性肝炎(再投与なし),""
AB-21032247,3,2,C,アセトアミノフェン,"",経口,20210326,20210622,1000,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21032247,3,3,C,オキシコドン塩酸塩水和物,"",経口,20210416,20210626,5,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21032247,3,4,C,オキシコドン塩酸塩水和物,"",経口,20210416,20210626,2.5,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21032247,3,5,C,ナルデメジントシル酸塩,"",経口,20210422,20210626,.2,mg,1,予防(予防投与),未知,"",""
AB-21032247,3,6,C,酸化マグネシウム,"",経口,20210422,20210622,1000,mg,1,予防(予防投与),未知,"",""
AB-21032247,3,7,C,オランザピン,"",経口,20210506,20210622,5,mg,1,予防(予防投与),未知,"",""
AB-21032247,3,8,C,クエチアピンフマル酸塩,"",経口,"","",25,mg,1,"",未知,"",""
AB-21032735,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180821,20180904,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発疹(再投与なし),""
AB-21032735,2,2,PS,イオヘキソール,イオパーク３５０,静脈内点滴,20180830,20180830,100,mL,1,"",不适用,"",""
AB-21032735,2,3,PS,カルバゾクロムスルホン酸ナトリウム水和物,アドナ,不明,"","","","","","",未知,"",""
AB-21032735,2,4,PS,ランソプラゾール,タケプロン,不明,"","","","","","",未知,"",""
AB-21032735,2,5,PS,アミノ酸・糖・電解質・ビタミン（４）,ビーフリード,不明,"","","","","","",未知,"",""
AB-21032749,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21032750,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200729,20200813,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,自己免疫性肝炎(再投与なし),""
AB-21032750,1,2,PS,ウルソデオキシコール酸,"",不明,20200902,20200924,600,mg,1,"",剂量停止,"",""
AB-21032750,1,3,C,フェンタニルクエン酸塩,"",経皮;経皮;経皮;経皮;経皮;経皮,;20200827;20201003;20201015;20201105;20210107,;;;;;,1.5;2;3;4;5;6,mg;mg;mg;mg;mg;mg,1;1;1;1;1;1,"",未知,"",""
AB-21033110,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201805,201908,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,類天疱瘡(再投与なし),""
AB-21033254,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210518,20210701,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-21033254,2,2,C,アスピリン,"",不明,"","","","","","",未知,"",""
AB-21033254,2,3,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-21033254,2,4,C,ラベプラゾールナトリウム,"",不明,"","","","","","",未知,"",""
AB-21033254,2,5,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-21033254,2,6,C,センノシド,"",不明,"","","","","","",未知,"",""
AB-21033254,2,7,C,ルビプロストン,"",不明,"","","","","","",未知,"",""
AB-21033254,2,8,C,ゾルピデム酒石酸塩,"",不明,"","","","","","",未知,"",""
AB-21033765,1,1,PS,イリノテカン塩酸塩水和物,"",不明,"","","","","",胃腺癌,不适用,"",""
AB-21033765,1,2,PS,オキサリプラチン,"",不明,"","","","","",胃腺癌,不适用,"",""
AB-21033765,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃腺癌(METASTATIC GASTRIC ADENOCARCINOMA),不适用,"",""
AB-21033765,1,4,PS,パクリタキセル,"",不明,"","","","","",胃腺癌(METASTATIC GASTRIC ADENOCARCINOMA),不适用,"",""
AB-21033765,1,5,PS,ラムシルマブ,"",不明,"","","","","",胃腺癌(METASTATIC GASTRIC ADENOCARCINOMA),不适用,"",""
AB-21033765,1,6,PS,ニボルマブ,"",不明,"","","","","",胃腺癌(METASTATIC GASTRIC ADENOCARCINOMA),剂量停止,"",""
AB-21033972,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,脳炎(再投与なし),""
AB-21034573,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20210518,"",200,mg,1,胃癌第４期(MSI-High癌),剂量不变,胃腸管狭窄(不明),""
AB-21034742,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-21035327,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-21035332,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201901;20190526,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下垂体機能低下症(再投与なし);副腎機能不全(再投与なし),""
AB-21035447,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし),""
AB-21035448,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし),""
AB-21035818,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201712,201802,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍のハイパープログレッション(再投与なし),""
AB-21037785,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190403,20190523,200,mg,1,胃癌第４期(MSI-Highを有する結腸・直腸癌以外の固形癌（標準的治療困難）胃癌),剂量停止,下痢(無);肝機能異常(再投与なし),""
AB-21037785,2,2,C,フェンタニルクエン酸塩,"",経皮,不明,"",4,mg,1,"",未知,"",""
AB-21037785,2,3,C,ロスバスタチンカルシウム,"",経口,不明,"",5,mg,1,"",未知,"",""
AB-21037785,2,4,C,ペリンドプリルエルブミン,"",経口,不明,"",2,mg,1,"",未知,"",""
AB-21037785,2,5,C,ビソプロロールフマル酸塩,"",経口,不明,"",2.5,mg,1,"",未知,"",""
AB-21037785,2,6,C,アスピリン,"",経口,不明,"","","","","",未知,"",""
AB-21037785,2,7,C,ロキソプロフェンナトリウム水和物,"",経口,不明,"","","","","",未知,"",""
AB-21037785,2,8,C,レバミピド,"",経口,不明,"","","","","",未知,"",""
AB-21037785,2,9,C,アミノ酸・糖・電解質・ビタミン（２−６）,"",不明,不明,"","","","","",未知,"",""
AB-21037827,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20190418;20190620,20190516;20190620,200;200,mg;mg,1;1,胃癌第４期(MSI-Highを有する結腸・直腸癌以外の固形癌（標準的治療困難）胃癌),剂量停止,肝機能異常(不明),""
AB-21038256,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210524,20220331,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21038256,4,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20210510,20220425,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-21038256,4,3,PS,ラムシルマブ,サイラムザ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-21038256,4,4,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴,"","",100,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-21038256,4,5,C,オルメサルタンメドキソミル,"",経口,"",20211122,20,mg,1,"",未知,"",""
AB-21038256,4,6,C,アムロジピンベシル酸塩,"",経口,"",20211205,5,mg,1,"",未知,"",""
AB-21038256,4,7,C,カモスタットメシル酸塩,"",経口;経口,;20211122,20210620;20220425,300;300,mg;mg,1;1,胃食道逆流性疾患(逆流性食道炎),未知,"",""
AB-21038256,4,8,C,モサプリドクエン酸塩水和物,"",経口,"",20210620,15,mg,1,"",未知,"",""
AB-21038272,1,1,PS,パクリタキセル,"",静脈内点滴,2017,"",1200,mg,1,胃癌(切除不能胃癌),未知,"",""
AB-21038272,1,2,PS,ラムシルマブ,"",静脈内点滴,2017,"",240,mg/m2,1,胃癌(切除不能胃癌),未知,"",""
AB-21038272,1,3,PS,ニボルマブ,"",静脈内点滴,2018,"",4940,mg,1,胃癌(切除不能胃癌),未知,"",""
AB-21038531,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180316,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21038880,1,1,PS,イピリムマブ,ヤーボイ,不明,"","","","","",非小細胞肺癌(非小細胞肺癌),未知,末梢性ニューロパチー(不明),""
AB-21038880,1,2,PS,ニボルマブ,オプジーボ,不明,"","","","","",非小細胞肺癌(非小細胞肺癌),未知,末梢性ニューロパチー(不明),""
AB-21038880,1,3,PS,カルボプラチン,"",不明,"","","","","",非小細胞肺癌(非小細胞肺癌),未知,"",""
AB-21038880,1,4,PS,ペメトレキセドナトリウム水和物,"",不明,"","","","","",非小細胞肺癌(非小細胞肺癌),未知,"",""
AB-21040378,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210107,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-21040378,2,2,C,カンデサルタンシレキセチル,"",経口,20200123,"",1,{DF},1,"",未知,"",""
AB-21040378,2,3,C,アムロジピンベシル酸塩,"",経口,20200206,"",1,{DF},1,"",未知,"",""
AB-21040379,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200205,20201021,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-21040381,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20180730;20180910;20181004,20180812;20180910;20181018,;160;,;mg;,;1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-21040381,2,2,C,ボノプラザンフマル酸塩,"",経口,20170428,"",20,mg,1,"",未知,"",""
AB-21040381,2,3,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-21040381,2,4,C,メコバラミン,"",経口,"","",500,ug,1,"",未知,"",""
AB-21040381,2,5,C,ワクシニアウイルス接種家兎炎症皮膚抽出液,"",経口,"","",4,{DF},1,"",未知,"",""
AB-21040381,2,6,C,レバミピド,"",経口,"","",100,mg,1,予防(予防投与),未知,"",""
AB-21040790,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,皮下出血(再投与なし),""
AB-21040847,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,好中球減少症(再投与なし),""
AB-21041060,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,2018,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,うっ血性心不全(再投与なし),""
AB-21041062,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210813,20210813,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21041062,2,2,PS,トラスツズマブデルクステカン,エンハーツ,不明,20210331,20210721,"","","",胃癌(胃癌),不适用,"",""
AB-21041062,2,3,C,エドキサバントシル酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-21041062,2,4,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-21041062,2,5,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-21041062,2,6,C,プレガバリン,"",不明,"","","","","","",未知,"",""
AB-21041062,2,7,C,スボレキサント,"",不明,"","","","","","",未知,"",""
AB-21041062,2,8,C,セレコキシブ,"",不明,"","","","","","",未知,"",""
AB-21041062,2,9,C,シルニジピン,"",不明,"","","","","","",未知,"",""
AB-21041062,2,10,C,イミダプリル塩酸塩,"",不明,"","","","","","",未知,"",""
AB-21041652,3,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴,"",20210510,100,mg,1,胃癌(胃癌),剂量停止,"",""
AB-21041652,3,2,PS,ラムシルマブ,サイラムザ,静脈内点滴,"",20210510,30,mL,1,胃癌(胃癌),剂量停止,"",""
AB-21041652,3,3,PS,ニボルマブ,オプジーボ,静脈内点滴,20210524,20220331,48,mL,1,胃癌(胃癌),剂量停止,"",""
AB-21041652,3,4,C,他に分類されない代謝性医薬品,"",経口,20210510,20220425,100,mg,1,悪液質(癌性悪液質),剂量停止,"",""
AB-21041652,3,5,C,ドンペリドン,"",経口,20210518,20210620,30,mg,1,悪心(QUEASY),剂量停止,"",""
AB-21041652,3,6,C,アムロジピンベシル酸塩,"",経口,"",20210620,300,mg,1,"",剂量停止,"",""
AB-21041652,3,7,C,モサプリドクエン酸塩水和物,"",経口,"",20210620,15,mg,1,"",剂量停止,"",""
AB-21041652,3,8,C,カモスタットメシル酸塩,"",経口;経口,;20211122,20210620;20220425,300;300,mg;mg,1;1,胃食道逆流性疾患(逆流性食道炎),剂量停止,"",""
AB-21041652,3,9,C,オルメサルタンメドキソミル,"",経口,"",20211122,20,mg,1,"",剂量停止,"",""
AB-21041652,3,10,C,アムロジピンベシル酸塩,"",経口,"",20211205,5,mg,1,"",剂量停止,"",""
AB-21042429,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201711,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,心房細動(再投与なし),""
AB-21042878,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-21043869,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,結核(再投与なし),""
AB-21043876,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし);意識レベルの低下(再投与なし);小脳梗塞(再投与なし);重症筋無力症(再投与なし),""
AB-21043876,1,2,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-21044653,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210303,20210609,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,虹彩毛様体炎(再投与なし);劇症１型糖尿病(再投与なし);フォークト・小柳・原田病(再投与なし);難聴(再投与なし);白内障(再投与なし);ぶどう膜炎(再投与なし),""
AB-21044933,3,1,PS,イピリムマブ,ヤーボイ,"","","","","","",遠隔転移を伴う腎細胞癌(METASTATIC RENAL CELL CARCINOMA),不适用,免疫介在性副腎機能不全(再投与なし);倦怠感(再投与なし),""
AB-21044933,3,2,PS,ニボルマブ,オプジーボ,"","","","","","",遠隔転移を伴う腎細胞癌(METASTATIC RENAL CELL CARCINOMA),剂量停止,免疫介在性副腎機能不全(再投与なし);倦怠感(再投与なし),""
AB-21044933,3,3,C,プラバスタチンナトリウム,"","","","","","","",適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-21044933,3,4,C,アキシチニブ,"",;,;,;,10;6,mg;mg,1;1,適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),剂量减少,"",""
AB-21044933,3,5,C,アスピリン,"","","","","","","",適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-21044933,3,6,C,カンデサルタンシレキセチル・アムロジピンベシル酸塩配合剤,"","","","","","","",適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-21045077,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能亢進症(再投与なし),""
AB-21045078,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190131,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-21045087,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210713,20210713,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし);免疫性筋炎(再投与なし);免疫性心筋炎(再投与なし),""
AB-21045171,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201711;201810,;201903,3;240,mg/kg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-21045215,1,1,PS,レボフロキサシン水和物,"",不明,"","","","","",自己炎症疾患,未知,"",""
AB-21045215,1,2,PS,ニボルマブ,"",不明,"","","","","",胃癌(GASTRIC CANCER),剂量停止,"",""
AB-21045215,1,3,C,ピルシカイニド塩酸塩水和物,"",不明,"","","","","",心房粗動(ATRIAL FLUTTER),未知,"",""
AB-21045216,1,1,PS,レボフロキサシン水和物,"",不明,"","","","","",自己炎症疾患,未知,"",""
AB-21045216,1,2,PS,ニボルマブ,"",不明,"","","","","",胃癌(GASTRIC CANCER),剂量停止,"",""
AB-21045216,1,3,C,ピルシカイニド塩酸塩水和物,"",不明,"","","","","",心房粗動(ATRIAL FLUTTER),未知,"",""
AB-21045452,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180614;20181003,20180919;,160;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能亢進症(再投与なし);甲状腺機能低下症(再投与なし),""
AB-21045453,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180307,20180523,3,mg/kg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-21045454,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181221,20190131,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21045473,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180824,20181116,130,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-21045473,3,2,PS,カモスタットメシル酸塩,フオイパン,経口,20180322,20190119,100,mg,1,胃食道逆流性疾患(術後逆流性食道炎),剂量不变,甲状腺機能低下症(再投与なし),""
AB-21045473,3,3,C,アズレンスルホン酸ナトリウム水和物・炭酸水素ナトリウム,"",口腔咽頭,20170417,20190119,"","","",予防(予防),未知,"",""
AB-21045473,3,4,C,ウルソデオキシコール酸,"",経口,20171017,20190119,50,mg,1,予防(予防),未知,"",""
AB-21045473,3,5,C,ラクトミン,"",経口,20180810,20190119,1,{DF},1,予防(予防),未知,"",""
AB-21045473,3,6,C,チキジウム臭化物,"",経口,20180817,20190119,10,mg,1,予防(予防),未知,"",""
AB-21045473,3,7,C,膵臓性消化酵素配合剤（１）,"",経口,20180907,20190119,1,g,1,予防(予防),未知,"",""
AB-21045473,3,8,C,ロペラミド塩酸塩,"",不明,"","","","","","",未知,"",""
AB-21045823,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",遠隔転移を伴う腎細胞癌(根治切除不能又は転移性の腎細胞癌に対する併用療法),剂量停止,副腎機能不全(再投与なし),""
AB-21045823,2,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,"","","","","",遠隔転移を伴う腎細胞癌(根治切除不能又は転移性の腎細胞癌に対する併用療法),不适用,"",""
AB-21045823,2,3,C,アスピリン,"",経口,"","","","","","",未知,"",""
AB-21045823,2,4,C,カンデサルタンシレキセチル・アムロジピンベシル酸塩配合剤,"",経口,"","","","","","",未知,"",""
AB-21045823,2,5,C,プラバスタチンナトリウム,"",経口,"","","","","","",未知,"",""
AB-21045826,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし),""
AB-21046052,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20201224,"",200,mg,1,胃癌(MSI-High癌（結腸・直腸以外）、胃癌),未知,脳梗塞(再投与なし),""
AB-21046331,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200622;20200923,20200622;20201021,240;120,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血中アルカリホスファターゼ増加(不明);アラニンアミノトランスフェラーゼ増加(不明);アスパラギン酸アミノトランスフェラーゼ増加(不明),""
AB-21046332,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210218,20210318,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,脊椎炎(再投与なし),""
AB-21046343,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,202108,202108,200,mg,1,胃癌第４期(MSI-High癌（結腸・直腸以外）、胃癌),剂量停止,免疫介在性肝障害(再投与なし),""
AB-21046402,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腎不全(再投与なし),""
AB-21046402,1,2,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-21046402,1,3,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-21046402,1,4,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-21046943,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,胃狭窄(再投与なし),""
AB-21047456,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200820,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-21047458,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210729,20210810,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(再投与なし),""
AB-21047889,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201201,20210609,"","","",食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),剂量停止,悪性新生物進行(再投与なし),""
AB-21047923,10,1,PS,アテゾリズマブ,テセントリク,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20210318;2021;20210706;20210824;;;,20210318;2021;20210727;;20211130;;20220512,1200;1200;1200;1200;1200;1200;1200,mg;mg;mg;mg;mg;mg;mg,1;1;1;1;1;1;1,肺腺癌(切除不能な進行・再発の非小細胞肺癌),不适用,甲状腺機能低下症(不明);心筋梗塞(再投与なし),""
AB-21047923,10,2,PS,ベバシズマブ,アバスチン,静脈内点滴;静脈内点滴;静脈内点滴,20210318;2021;,20210318;20210615;20220421,945;945;950,mg;mg;mg,1;1;1,肺腺癌(切除不能な進行・再発の非小細胞肺癌),不适用,甲状腺機能低下症(不明);心筋梗塞(再投与なし),""
AB-21047923,10,3,PS,カルボプラチン,"",静脈内点滴;静脈内点滴,20210318;2021,20210318;20210615,550;550,mg;mg,1;1,肺腺癌(切除不能な進行・再発の非小細胞肺癌),未知,"",""
AB-21047923,10,4,C,パクリタキセル,"",静脈内点滴;静脈内点滴,20210318;2021,20210318;20210615,309;309,mg;mg,1;1,肺腺癌(切除不能な進行・再発の非小細胞肺癌),未知,"",""
AB-21049717,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201210,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,眼筋麻痺(再投与なし);眼瞼機能障害(再投与なし);心筋炎(再投与なし),""
AB-21049717,2,2,PS,シタグリプチンリン酸塩水和物,グラクティブ,経口,"","",50,mg,1,２型糖尿病(2型糖尿病),剂量不变,眼筋麻痺(再投与なし);眼瞼機能障害(再投与なし);心筋炎(再投与なし),""
AB-21049717,2,3,C,ランソプラゾール,"",経口,"","",15,mg,1,予防(予防),未知,"",""
AB-21049717,2,4,C,酸化マグネシウム,"",経口,"","",250,mg,1,"",未知,"",""
AB-21049717,2,5,C,エンパグリフロジン,"",経口,"","",10,mg,1,"",未知,"",""
AB-21049717,2,6,C,リナクロチド,"",経口,"","",.5,mg,1,"",未知,"",""
AB-21050403,1,1,PS,オキサリプラチン,"",不明,"","","","","",胃癌第４期,不适用,"",""
AB-21050403,1,2,PS,カペシタビン,"",不明,"","","","","",胃癌第４期(GASTRIC CANCER STAGE IV WITH METASTASES),不适用,"",""
AB-21050403,1,3,PS,トラスツズマブ,"",不明,"","","","","",胃癌第４期(GASTRIC CANCER STAGE IV WITH METASTASES),不适用,"",""
AB-21050403,1,4,PS,パクリタキセル,"",不明,"","","","","",胃癌第４期(GASTRIC CANCER STAGE IV WITH METASTASES),剂量停止,"",""
AB-21050403,1,5,PS,ニボルマブ,"",不明,"","","","","",胃癌第４期(GASTRIC CANCER STAGE IV WITH METASTASES),不适用,"",""
AB-21050403,1,6,C,ラムシルマブ,"",不明,"","","","","",胃癌第４期(GASTRIC CANCER STAGE IV WITH METASTASES),剂量停止,"",""
AB-21050403,1,7,C,アセトアミノフェン,"",不明,"","","","","",適応症不明の製品使用(DRUG USE FOR UNKNOWN INDICATION),剂量停止,"",""
AB-21050403,1,8,C,ランソプラゾール,"",不明,"","","","","",適応症不明の製品使用(DRUG USE FOR UNKNOWN INDICATION),未知,"",""
AB-21050403,1,9,C,酸化マグネシウム,"",不明,"","","","","",適応症不明の製品使用(DRUG USE FOR UNKNOWN INDICATION),未知,"",""
AB-21050403,1,10,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","",適応症不明の製品使用(DRUG USE FOR UNKNOWN INDICATION),未知,"",""
AB-21050457,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191002,20201028,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性溶血性貧血(再投与なし),""
AB-21051238,3,1,PS,トラスツズマブデルクステカン,エンハーツ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20210331;20210421;20210519;20210609;20210630;20210721,20210331;20210421;20210519;20210609;20210630;20210721,6.4;6.4;6.4;6.4;6.4;6.4,mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg,1;1;1;1;1;1,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),剂量停止,間質性肺疾患(再投与なし);貧血(再投与なし),""
AB-21051238,3,2,PS,エドキサバントシル酸塩水和物,リクシアナ,経口,20200111,"","","","",心房細動(Atrial fibrillation),未知,間質性肺疾患(再投与なし);貧血(再投与なし),""
AB-21051238,3,3,PS,ニボルマブ,"",不明,20210813,20210813,"","","",胃癌(Gastric cancer),未知,"",""
AB-21051492,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180126;,;20210419,240;480,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-21051492,5,2,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-21051492,5,3,C,デュロキセチン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-21051492,5,4,C,牛車腎気丸,"",不明,"","","","","","",未知,"",""
AB-21051545,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201023,"",240,mg,1,食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),剂量停止,多発性筋炎(再投与なし);１型糖尿病(再投与なし),""
AB-21051560,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200817;20210104,202010;20210118,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,急性副腎皮質機能不全(再投与なし);下垂体機能低下症(再投与なし),""
AB-21051560,3,2,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,高血圧(高血圧),未知,"",""
AB-21051560,3,3,C,プレガバリン,"",経口,"","",75,mg,1,疼痛管理(疼痛コントロール),未知,"",""
AB-21051560,3,4,C,ロキソプロフェンナトリウム水和物,"",経口,"","",60,mg,1,疼痛管理(疼痛コントロール),未知,"",""
AB-21051779,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20210302,20210803,200,mg,1,非小細胞肺癌(非小細胞肺癌),剂量停止,腹水(再投与なし);心嚢液貯留(再投与なし);低酸素症(再投与なし);呼吸不全(再投与なし);免疫介在性肝障害(再投与なし);胸水(再投与なし),""
AB-21051779,4,2,C,インダカテロールマレイン酸塩・グリコピロニウム臭化物,"",不明,不明,"","","","","",未知,"",""
AB-21051779,4,3,C,アムロジピンベシル酸塩,"",不明,不明,"","","","","",未知,"",""
AB-21051779,4,4,C,オルメサルタンメドキソミル,"",不明,不明,"","","","","",未知,"",""
AB-21051779,4,5,C,アンブロキソール塩酸塩,"",不明,不明,"","","","","",未知,"",""
AB-21051865,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210303,20210527,"","","",再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),不适用,甲状腺機能亢進症(再投与なし);大腸炎(再投与なし),""
AB-21051865,6,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,20210303,20210527,"","","",再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),不适用,"",""
AB-21051865,6,3,PS,カルボプラチン,"",不明,20210303,20210324,"","","",再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),不适用,"",""
AB-21051865,6,4,PS,パクリタキセル,"",不明,20210303,20210324,"","","",再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),不适用,"",""
AB-21051869,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,類天疱瘡(再投与なし),""
AB-21052009,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20210617,2021,200,mg,1,胃癌(MSI-H　胃がん),剂量停止,腎機能障害(再投与なし),""
AB-21052018,8,1,PS,イピリムマブ,ヤーボイ,静脈内点滴(041);静脈内点滴(041);静脈内点滴(041);静脈内点滴(041),20210303;202103;;,20210527;;;,;;;,;;;,;;;,再発非小細胞肺癌(Non-small cell lung cancer recurrent),剂量停止,大腸炎(再投与なし);甲状腺機能亢進症(再投与なし);下垂体機能低下症(再投与なし);下垂体炎(再投与なし);肺臓炎(再投与なし);好中球数減少(再投与なし);発疹(再投与なし),""
AB-21052018,8,2,PS,OPDIVO,"",静脈内点滴(041);静脈内点滴(041);静脈内点滴(041);静脈内点滴(041);静脈内点滴(041);静脈内点滴(041),20210303;202103;;;;,20210527;;;;;,;;;;;,;;;;;,;;;;;,再発非小細胞肺癌(Non-small cell lung cancer recurrent),剂量停止,大腸炎(再投与なし);甲状腺機能亢進症(再投与なし);下垂体機能低下症(再投与なし);下垂体炎(再投与なし);肺臓炎(再投与なし);好中球数減少(再投与なし);発疹(再投与なし),""
AB-21052018,8,3,PS,CARBOPLATIN,"",その他(不明);不明(065),20210303;202103,20210324;,;,;,;,再発非小細胞肺癌(Non-small cell lung cancer recurrent),不适用,大腸炎(再投与なし);甲状腺機能亢進症(再投与なし);下垂体機能低下症(再投与なし);下垂体炎(再投与なし);肺臓炎(再投与なし);好中球数減少(再投与なし);発疹(不明),""
AB-21052018,8,4,PS,PACLITAXEL,"",不明(065);不明(065),20210303;,20210324;,;,;,;,再発非小細胞肺癌(Non-small cell lung cancer recurrent),不适用,大腸炎(再投与なし);甲状腺機能亢進症(再投与なし);下垂体機能低下症(再投与なし);下垂体炎(再投与なし);肺臓炎(再投与なし);好中球数減少(再投与なし);発疹(再投与なし),""
AB-21052202,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,;;202109,;;,;;,;;,;;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,急性副腎皮質機能不全(不明),""
AB-21052219,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210603,20210617,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし),""
AB-21052680,9,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210708,20220120,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-21052680,9,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20210707,20220131,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-21052680,9,3,PS,コロナウイルスワクチン,"",筋肉内;筋肉内,;20220128,;20220128,;,;,;,ＣＯＶＩＤ−１９予防(ＣＯＶＩＤ−１９予防),不适用,"",""
AB-21052680,9,4,C,ボノプラザンフマル酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-21052680,9,5,C,酸化マグネシウム,"",経口,"","",6,{DF},1,"",未知,"",""
AB-21052680,9,6,C,センノシド,"",経口,"","",2,{DF},1,"",未知,"",""
AB-21052680,9,7,C,ゾルピデム酒石酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-21052680,9,8,C,クロチアゼパム,"",経口,"","",15,mg,1,"",未知,"",""
AB-21052680,9,9,C,エスシタロプラムシュウ酸塩,"",経口,"",20220526,10,mg,1,"",未知,"",""
AB-21052680,9,10,C,レボチロキシンナトリウム水和物,"",経口,"",20220203,75,ug,1,"",未知,"",""
AB-21053228,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201006,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,尿細管間質性腎炎(再投与なし),""
AB-21053228,2,2,PS,ラムシルマブ,サイラムザ,静脈内点滴,202004,202009,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-21053228,2,3,PS,パクリタキセル（アルブミン懸濁型）,"",静脈内点滴,202004,202009,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-21053231,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,劇症１型糖尿病(再投与なし);甲状腺機能低下症(再投与なし);糖尿病性ケトアシドーシス(再投与なし),""
AB-21053527,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,注入に伴う反応(再投与なし),""
AB-21053532,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腸炎(再投与なし),""
AB-21053543,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20211029,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,アカシジア(再投与なし),""
AB-21053543,2,2,C,エチゾラム,"",不明,"","","","","","",未知,"",""
AB-21053543,2,3,C,ブロチゾラム,"",不明,"","","","","","",未知,"",""
AB-21053544,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200629;,20200910;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,リウマチ性多発筋痛(再投与なし),""
AB-21053552,3,1,PS,アナモレリン塩酸塩,エドルミズ,経口;経口,20210612;20210615,20210612;,100;100,mg;mg,1;1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,脱水(再投与なし),""
AB-21053552,3,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20211216,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,脱水(再投与なし),""
AB-21053552,3,3,C,フロセミド,"",不明;不明;不明,20210625;20210820;20220507,20210819;20220506;,10;20;10,mg;mg;mg,1;1;1,"",未知,"",""
AB-21053552,3,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20210703,20210710,80,mg,1,胃癌(胃癌),未知,"",""
AB-21053552,3,5,C,パクリタキセル,"",不明,20210716,20211203,90,mg,1,胃癌(胃癌),未知,"",""
AB-21053552,3,6,C,ラムシルマブ,"",不明,20210716,20210716,360,mg,1,胃癌(胃癌),未知,"",""
AB-21053552,3,7,C,スピロノラクトン,"",不明,20210813,20210903,25,mg,1,"",未知,"",""
AB-21053745,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202104,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,意識レベルの低下(再投与なし);副腎機能不全(再投与なし),""
AB-21053753,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肝不全(再投与なし),""
AB-21053753,1,2,C,プレドニゾロン,"",不明,"","",12.5,mg,1,"",未知,"",""
AB-21053753,1,3,C,アピキサバン,"",不明,"","",10,mg,1,"",未知,"",""
AB-21053753,1,4,C,デュロキセチン塩酸塩,"",不明,"","",20,mg,1,"",未知,"",""
AB-21053753,1,5,C,プレガバリン,"",不明,"","",150,mg,1,"",未知,"",""
AB-21053753,1,6,C,ヒドロモルフォン塩酸塩,"",不明,"","",32,mg,1,"",未知,"",""
AB-21053770,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,類天疱瘡(再投与なし),""
AB-21054238,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190718;,20191205;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,薬疹(再投与なし);肺炎(再投与なし),""
AB-21054238,1,2,C,パクリタキセル（アルブミン懸濁型）,"",不明,20200127,20200210,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21054238,1,3,C,ラムシルマブ,"",不明,20200127,20200210,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21054238,1,4,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-21054249,5,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,20210406,20210406,1200,mg,1,進展型小細胞肺癌(進展型小細胞肺癌),剂量停止,好中球数減少(再投与なし),""
AB-21054249,5,2,C,カルボプラチン,"",静脈内点滴,20210406,20210406,400,mg,1,進展型小細胞肺癌(進展型小細胞肺癌),未知,"",""
AB-21054249,5,3,C,エトポシド,"",不明,20210406,20210408,140,mg,1,進展型小細胞肺癌(進展型小細胞肺癌),未知,"",""
AB-21054270,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,免疫性腸炎(再投与なし),""
AB-21054272,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21054274,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,多形紅斑(再投与なし),""
AB-21054278,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210803,20210803,480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,胆管炎(再投与なし),""
AB-21054280,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210830,20210927,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性筋炎(再投与なし);免疫性心筋炎(再投与なし),""
AB-21054289,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,急性副腎皮質機能不全(再投与なし),""
AB-21055796,4,1,PS,トラスツズマブデルクステカン,エンハーツ,静脈内点滴,202107191100,20210722,6.4,mg/kg,1,胃癌(Gastric cancer);再発胃癌(Gastric cancer recurrent),剂量不变,発熱性好中球減少症(再投与なし),""
AB-21055796,4,2,PS,ニボルマブ,"",不明,"",20210607,"","","",再発胃癌(Gastric cancer recurrent),未知,"",""
AB-21055796,4,3,C,ランソプラゾール,"",経口,20190601,20210724,15,mg,1,吻合部潰瘍(Anastomotic ulcer);予防(Prophylaxis),未知,"",""
AB-21055796,4,4,C,ピリドキサールリン酸エステル水和物,"",経口,20190701,20210724,10,mg,1,ビタミン補給(Vitamin supplementation),未知,"",""
AB-21055796,4,5,C,リマプロストアルファデクス,"",経口,20210412,20210724,10,mg,1,末梢性ニューロパチー(Neuropathy peripheral),未知,"",""
AB-21055796,4,6,C,アプレピタント,"",経口;経口,20210719;20210720,20210719;20210721,125;80,mg;mg,1;1,制吐薬による補助療法(Antiemetic supportive care);予防(Prophylaxis),未知,"",""
AB-21055796,4,7,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20210719,"",9.9,mg,1,制吐薬による補助療法(Antiemetic supportive care);予防(Prophylaxis),未知,"",""
AB-21055796,4,8,C,パロノセトロン塩酸塩,"",静脈内点滴,20210719,20210719,.75,mg,1,制吐薬による補助療法(Antiemetic supportive care);予防(Prophylaxis),未知,"",""
AB-21055796,4,9,C,デキサメタゾン,"",経口,20210720,20210721,8,mg,1,制吐薬による補助療法(Antiemetic supportive care);予防(Prophylaxis),未知,"",""
AB-21055796,4,10,C,酢酸リンゲル液（ブドウ糖加）,"",静脈内点滴,20210720,"","","","",補液(Fluid replacement),未知,"",""
AB-21055796,4,11,C,チアミンジスルフィド・Ｂ６・Ｂ１２配合剤,"",静脈内点滴,20210720,"",10,mL,1,ビタミン補給(Vitamin supplementation),未知,"",""
AB-21055796,4,12,C,アセトアミノフェン,"",静脈内点滴,20210720,"",600,mg,1,解熱処置(Antipyresis);鎮痛療法(Analgesic therapy),未知,"",""
AB-21055796,4,13,C,アミノ酸・糖・電解質・ビタミン（４）,"",静脈内点滴,20210724,"",500,mL,1,補液(Fluid replacement),未知,"",""
AB-21055796,4,14,C,オメプラゾールナトリウム,"",静脈内（明記されていない場合）,20210725,"",20,mg,1,吻合部潰瘍(Anastomotic ulcer);予防(Prophylaxis),未知,"",""
AB-21055796,4,15,C,セフジトレンピボキシル,"",不明,"","","","","","",未知,"",""
AB-21056377,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210219,20210415,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(不明),""
AB-21056377,2,2,C,ラベプラゾールナトリウム,"",不明,"","","","","","",未知,"",""
AB-21056377,2,3,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-21056377,2,4,C,ミロガバリンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-21056377,2,5,C,アジルサルタン,"",不明,"","","","","","",未知,"",""
AB-21058432,1,1,PS,プレドニゾロン,"",不明,"","","","","",重症筋無力症,不适用,"",""
AB-21058432,1,2,PS,ニボルマブ,"",不明,201904,"","","","",胃癌第４期(GASTRIC CANCER STAGE IV),剂量停止,"",""
AB-21058432,1,3,PS,メチルプレドニゾロン,"",不明,"","",1000,mg,1,重症筋無力症(MYASTHENIA GRAVIS),不适用,"",""
AB-21058651,2,1,PS,イピリムマブ,ヤーボイ,静脈内点滴,"","","","","",再発非小細胞肺癌(再発非小細胞肺癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21058651,2,2,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",再発非小細胞肺癌(再発非小細胞肺癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21059071,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-21059071,5,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20210728,20210803,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,間質性肺疾患(再投与なし),""
AB-21059071,5,3,C,アピキサバン,"",経口,20210728,20210825,10,mg,1,"",未知,"",""
AB-21059071,5,4,C,ビフィズス菌配合剤,"",経口,"","",9,g,1,"",未知,"",""
AB-21059071,5,5,C,レバミピド,"",経口,"","",300,mg,1,予防(予防),未知,"",""
AB-21059071,5,6,C,トラマドール塩酸塩,"",経口,"","",100,mg,1,"",未知,"",""
AB-21059071,5,7,C,ミロガバリンベシル酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-21059071,5,8,C,エピナスチン塩酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-21059071,5,9,C,フロセミド,"",経口,"","",20,mg,1,"",未知,"",""
AB-21059071,5,10,C,スピロノラクトン,"",経口,"","",50,mg,1,"",未知,"",""
AB-21059071,5,11,C,フェキソフェナジン塩酸塩,"",経口,"","",120,mg,1,"",未知,"",""
AB-21059079,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210901,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,リウマチ性多発筋痛(再投与なし),""
AB-21059506,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200519,20200812,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,類天疱瘡(再投与なし),""
AB-21059514,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),剂量停止,間質性肺疾患(再投与なし),""
AB-21059514,1,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,"","","","","",再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),剂量停止,"",""
AB-21059519,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210723,20210806,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,免疫性腸炎(再投与なし),""
AB-21059519,4,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20210723,20220611,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,免疫性腸炎(再投与なし),""
AB-21059519,4,3,PS,プレドニゾロン,"",経口;経口;経口;経口,20210929;20211027;20211110;20211124,20211026;20211109;20211123;20211221,10;5;2;1,mg;mg;mg;mg,1;1;1;1,下痢(下痢);免疫性腸炎(irAEの大腸炎),剂量不变,"",""
AB-21059519,4,4,C,ロペラミド塩酸塩,"",不明,20210806,20210928,1,mg,1,"",未知,"",""
AB-21059519,4,5,C,酪酸菌製剤,"",経口,"",20211222,6,{DF},1,"",未知,"",""
AB-21059519,4,6,C,テノホビルアラフェナミドフマル酸塩,"",不明,"",20220630,25,mg,1,"",未知,"",""
AB-21059519,4,7,C,アジルサルタン・アムロジピンベシル酸塩配合剤,"",経口,"",20211016,1,{DF},1,"",未知,"",""
AB-21059546,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,肺毒性(再投与なし),""
AB-21059546,1,2,PS,トラスツズマブデルクステカン,エンハーツ,不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-21059867,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210129,20210611,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(再投与なし),""
AB-21059890,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20210514;;20211117,;20210825;,240;;,mg;;,1;;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,続発性副腎皮質機能不全(無),""
AB-21059890,2,2,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-21059890,2,3,C,セレコキシブ,"",不明,"","","","","","",未知,"",""
AB-21059890,2,4,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-21059890,2,5,C,酪酸菌配合剤,"",不明,"","","","","","",未知,"",""
AB-21059890,2,6,C,アズレンスルホン酸ナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-21059890,2,7,C,モンテルカストナトリウム,"",不明,"","","","","","",未知,"",""
AB-21059890,2,8,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-21059890,2,9,C,ケトプロフェン,"",経皮,"","","","","","",未知,"",""
AB-21060739,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20210507;20210730;20210910,20210618;20210730;,240;240;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(無),""
AB-21060739,1,2,C,経腸成分栄養剤（１−１）,"",経口,20201113,"",1,{DF},1,"",未知,"",""
AB-21060740,2,1,PS,アナモレリン塩酸塩,エドルミズ,経口,20210630,20210827,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,糖尿病(再投与なし);副腎機能不全(再投与なし),""
AB-21060740,2,2,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,糖尿病(再投与なし);副腎機能不全(再投与なし),""
AB-21060740,2,3,PS,シタグリプチンリン酸塩水和物,グラクティブ,経口;経口,;20210714,20210713;,50;100,mg;mg,1;1,２型糖尿病(2型糖尿病),剂量增加,糖尿病(再投与なし);副腎機能不全(再投与なし),""
AB-21060740,2,4,C,グラニセトロン塩酸塩,"",不明;不明;不明;不明;不明,20210630;20210714;20210728;20210811;20210825,20210630;20210714;20210728;20210811;20210825,1;1;1;1;1,mg;mg;mg;mg;mg,1;1;1;1;1,予防(予防),未知,"",""
AB-21060740,2,5,C,デキサメタゾンリン酸エステルナトリウム,"",不明;不明;不明;不明;不明,20210630;20210714;20210728;20210811;20210825,20210630;20210714;20210728;20210811;20210825,6.6;6.6;6.6;6.6;6.6,mg;mg;mg;mg;mg,1;1;1;1;1,予防(予防),未知,"",""
AB-21060740,2,6,C,イリノテカン塩酸塩水和物,"",不明,"","",200,mg,1,胃癌(胃癌),未知,"",""
AB-21060740,2,7,C,アスピリン,"",不明,"","",100,mg,1,予防(予防),未知,"",""
AB-21060740,2,8,C,ランソプラゾール,"",不明,"","",15,mg,1,予防(予防),未知,"",""
AB-21060740,2,9,C,アムロジピンベシル酸塩,"",不明,"",20210907,5,mg,1,"",未知,"",""
AB-21060740,2,10,C,グリメピリド,"",不明,"","",2,mg,1,"",未知,"",""
AB-21060740,2,11,C,ダパグリフロジンプロピレングリコール水和物,"",不明,"","",5,mg,1,"",未知,"",""
AB-21060740,2,12,C,酸化マグネシウム,"",不明,"","",660,mg,1,予防(予防),未知,"",""
AB-21060740,2,13,C,アセトアミノフェン,"",不明,"","",1500,mg,1,"",未知,"",""
AB-21060740,2,14,C,炭酸水素ナトリウム,"",不明,"","",1.5,g,1,予防(予防),未知,"",""
AB-21060740,2,15,C,ウルソデオキシコール酸,"",不明,"","",300,mg,1,予防(予防),未知,"",""
AB-21061059,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21061395,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210908,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし);小腸炎(再投与なし);消化管穿孔(再投与なし),""
AB-21061400,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190702;20210309,;20211019,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);免疫性腸炎(再投与なし),""
AB-21062201,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202102;20211115,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心嚢液貯留(再投与なし),""
AB-21062523,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210723;20210922,;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腸壁気腫症(不明),""
AB-21062523,1,2,C,ファモチジン,"",静脈内点滴,"","","","","","",未知,"",""
AB-21062523,1,3,C,ベタメタゾンリン酸エステルナトリウム,"",静脈内点滴,"","","","","","",未知,"",""
AB-21062527,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202103,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,１型糖尿病(再投与なし),""
AB-21062532,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210512,20210512,480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-21062532,2,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20210625,20210701,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-21062532,2,3,C,酪酸菌製剤,"",経口,"",20210702,6,{DF},1,"",未知,"",""
AB-21062532,2,4,C,アセトアミノフェン,"",経口,"",20210702,1800,mg,1,"",未知,"",""
AB-21062532,2,5,C,カルバゾクロムスルホン酸ナトリウム水和物,"",経口,"",20210701,90,mg,1,"",未知,"",""
AB-21062532,2,6,C,ヒドロモルフォン塩酸塩,"",経口,"",20210702,4,mg,1,"",未知,"",""
AB-21062532,2,7,C,ヒドロモルフォン塩酸塩,"",経口,"",20210702,1,mg,1,"",未知,"",""
AB-21062532,2,8,C,デキサメタゾン,"",経口,"",20210702,1,mg,1,"",未知,"",""
AB-21062532,2,9,C,フロセミド,"",経口,"",20210702,20,mg,1,"",未知,"",""
AB-21062568,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210325,20210422,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21062872,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210225,20210617,160,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-21062872,4,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20210715,20210730,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21062872,4,3,C,カモスタットメシル酸塩,"",不明,"","",300,mg,1,"",未知,"",""
AB-21062872,4,4,C,六君子湯,"",不明,"","",7.5,g,1,"",未知,"",""
AB-21062875,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20201223;202106;20211201,20210303;;,240;;240,mg;;mg,1;;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし);アシドーシス(再投与なし),""
AB-21062875,2,2,C,トリフルリジン・チピラシル塩酸塩配合剤,"",不明,20210429,20210524,"","","","",未知,"",""
AB-21063309,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-21063309,1,2,C,イリノテカン塩酸塩水和物,"",不明,"","","","","",胃癌(胃癌),未知,"",""
AB-21063309,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(胃癌),未知,"",""
AB-21063695,4,1,PS,アナモレリン塩酸塩,エドルミズ,経口,20210915,20211018,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,天疱瘡(再投与なし),""
AB-21063695,4,2,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;20220105,;,480;480,mg;mg,1;1,適応症不明の製品使用(適応症不明の製品使用),剂量停止,天疱瘡(再投与なし),""
AB-21063695,4,3,C,ボノプラザンフマル酸塩,"",不明,"","",20,mg,1,"",未知,"",""
AB-21063695,4,4,C,酸化マグネシウム,"",不明,"","",660,mg,1,"",未知,"",""
AB-21064443,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210218,20210218,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21064459,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211019,20211102,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,ギラン・バレー症候群(再投与なし);甲状腺機能低下症(再投与なし);感染(再投与なし);播種性血管内凝固(再投与なし);多臓器機能不全症候群(再投与なし),""
AB-21064459,4,2,C,エソメプラゾールマグネシウム水和物,"",経口,"",20211109,"","","","",未知,"",""
AB-21064459,4,3,C,ポラプレジンク,"",経口,"",20211109,"","","","",未知,"",""
AB-21064459,4,4,C,ロスバスタチンカルシウム,"",経口,"",20211109,"","","","",未知,"",""
AB-21064459,4,5,C,ミロガバリンベシル酸塩,"",経口,"",20211109,"","","","",未知,"",""
AB-21064459,4,6,C,酸化マグネシウム,"",経口,"",20211109,"","","","",未知,"",""
AB-21064459,4,7,C,デュロキセチン塩酸塩,"",経口,"",20211109,"","","","",未知,"",""
AB-21064459,4,8,C,ケトプロフェン,"",経皮,"",20211109,"","","","",未知,"",""
AB-21064459,4,9,C,ヘパリン類似物質,"",経皮,"",20211109,"","","","",未知,"",""
AB-21064467,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202108,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21064796,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210830,20211101,480,mg,1,食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),剂量停止,肺炎(再投与なし);間質性肺疾患(再投与なし),""
AB-21064797,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,黄疸(再投与なし);血中ビリルビン増加(再投与なし),""
AB-21064799,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211007,20211007,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-21064799,3,2,C,フロセミド,"",経口,20210422,"",20,mg,1,"",未知,"",""
AB-21064799,3,3,C,トルバプタン,"",経口,20210930,"",7.5,mg,1,腹水(腹水),未知,"",""
AB-21065181,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210806,20210819,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,多発ニューロパチー(再投与なし);軸索型ニューロパチー(再投与なし),""
AB-21065181,4,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20210729,20210908,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,多発ニューロパチー(再投与なし);軸索型ニューロパチー(再投与なし),""
AB-21065181,4,3,C,パクリタキセル（アルブミン懸濁型）,"",不明,20210609,20210729,160,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21065181,4,4,C,ラムシルマブ,"",不明,20210609,20210729,510,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21065181,4,5,C,ミロガバリンベシル酸塩,"",不明,20210805,20210922,5,mg,1,"",未知,"",""
AB-21065181,4,6,C,アセトアミノフェン,"",不明,20210823,20210922,2000,mg,1,"",未知,"",""
AB-21065181,4,7,C,ラベプラゾールナトリウム,"",不明,"",20210922,10,mg,1,"",未知,"",""
AB-21065181,4,8,C,オキシコドン塩酸塩水和物,"",不明,"",20210922,20,mg,1,"",未知,"",""
AB-21065181,4,9,C,酸化マグネシウム,"",不明,"",20210922,1.5,g,1,"",未知,"",""
AB-21065181,4,10,C,アルプラゾラム,"",不明,"",20210922,.8,mg,1,"",未知,"",""
AB-21065181,4,11,C,オキシコドン塩酸塩水和物,"",不明,"",20210922,2.5,mg,1,"",未知,"",""
AB-21065184,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202110,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎障害(再投与なし),""
AB-21066526,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202004,202110,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,味覚障害(再投与なし);鼻の炎症(再投与なし);口内炎(再投与なし);類天疱瘡(再投与なし),""
AB-21066526,2,2,PS,コロナウイルスワクチン,"",不明,"","","","","","",不适用,"",""
AB-21066897,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200415,20210803,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-21066911,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201809,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);間質性肺疾患(再投与なし),""
AB-21067252,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201810,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,マイコバクテリウム・アビウムコンプレックス感染(再投与なし),""
AB-21067272,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211014,20211028,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし);重症筋無力症(再投与なし),""
AB-21067272,3,2,C,オキシコドン塩酸塩水和物,"",経口,20200811,"",2.5,mg,1,"",未知,"",""
AB-21067272,3,3,C,フェンタニルクエン酸塩,"",経皮,20210226,"",1,mg,1,"",未知,"",""
AB-21067272,3,4,C,ルビプロストン,"",経口,20210527,"",24,ug,1,"",未知,"",""
AB-21067272,3,5,C,ナルデメジントシル酸塩,"",経口,20210729,"",.2,mg,1,"",未知,"",""
AB-21067630,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211005,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,下垂体機能低下症(再投与なし),""
AB-21067631,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,視床下部−下垂体障害(再投与なし),""
AB-21067639,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,視床下部−下垂体障害(再投与なし),""
AB-21067640,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,視床下部−下垂体障害(再投与なし),""
AB-21067857,2,1,PS,パクリタキセル,タキソール,"","","","","","",胃癌(GASTRIC CANCER),未知,血尿(再投与なし);末梢性ニューロパチー(不明),""
AB-21067857,2,2,PS,ニボルマブ,オプジーボ,"",20200825,20201110,240,mg,1,胃癌(GASTRIC CANCER),剂量不变,血尿(再投与なし);末梢性ニューロパチー(再投与なし),""
AB-21067857,2,3,C,プラバスタチンナトリウム,"",;,;,;,;,;,;,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-21067857,2,4,C,アムロジピンベシル酸塩,"","","","","","","","",未知,"",""
AB-21067857,2,5,C,テネリグリプチン臭化水素酸塩水和物,"",;,;,;,;,;,;,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-21067857,2,6,C,アムロジピンベシル酸塩,"","","","","","","",適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-21067857,2,7,C,メトホルミン塩酸塩,"","","","","","","",適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-21067857,2,8,C,エソメプラゾールマグネシウム水和物,"","","","","","","",適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-21067951,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210609,20210806,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-21068983,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし),""
AB-21069689,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-21069704,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202101,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21069705,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202108,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,糖尿病(再投与なし),""
AB-21069708,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20181129;20210406,20210105;20220614,480;480,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍出血(再投与なし),""
AB-21069708,3,2,C,ジフェンヒドラミン塩酸塩,"",経口,20210105,"",50,mg,1,予防(予防),未知,"",""
AB-21069708,3,3,C,アセトアミノフェン,"",経口,20210105,"",400,mg,1,予防(予防),未知,"",""
AB-21071284,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211029,20211029,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,口内炎(再投与なし),""
AB-21071284,2,2,PS,カモスタットメシル酸塩,フオイパン,経口,"","","","","",適応症不明の製品使用(適応症不明の製品使用),未知,口内炎(再投与なし),""
AB-21071284,2,3,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-21071284,2,4,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-21071284,2,5,C,アズレンスルホン酸ナトリウム水和物・Ｌ−グルタミン,"",経口,"","","","","","",未知,"",""
AB-21071284,2,6,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-21071284,2,7,C,パンクレリパーゼ,"",経口,"","","","","","",未知,"",""
AB-21071284,2,8,C,スボレキサント,"",不明,"","","","","","",未知,"",""
AB-21071286,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210603,20210916,360,mg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),剂量停止,筋炎(再投与なし),""
AB-21071286,1,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,20210603,20210826,47,mg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),剂量停止,"",""
AB-21071286,1,3,C,カルボプラチン,"",静脈内点滴,20210603,20210624,325,mg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),未知,"",""
AB-21071286,1,4,C,ペメトレキセドナトリウム水和物,"",静脈内点滴,20210603,20210624,750,mg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),未知,"",""
AB-21071286,1,5,C,チオトロピウム臭化物水和物・オロダテロール塩酸塩,"",吸入,"","",1,{DF},1,"",未知,"",""
AB-21071303,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,胆管狭窄(再投与なし);胆管炎(再投与なし),""
AB-21071344,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,皮膚障害(再投与なし),""
AB-21071597,4,1,PS,ダパグリフロジンプロピレングリコール水和物,フォシーガ,経口,"","",5,mg,1,２型糖尿病(2型糖尿病),剂量停止,"",""
AB-21071597,4,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20201215,20210601,360,mg,1,肺腺癌(肺腺癌),剂量停止,"",""
AB-21071597,4,3,PS,イピリムマブ,ヤーボイ,静脈内点滴,20201215,20201215,1,mg/kg,1,肺腺癌(肺腺癌),剂量停止,"",""
AB-21071597,4,4,PS,カルボプラチン,"",不明,20201215,202101,300,mg/m2,1,肺腺癌(肺腺癌),剂量停止,"",""
AB-21071597,4,5,PS,ペメトレキセドナトリウムヘミペンタ水和物,ペメトレキセド,不明,20201215,202101,500,mg/m2,1,肺腺癌(肺腺癌),剂量停止,"",""
AB-21071597,4,6,PS,ニボルマブ,オプジーボ,静脈内点滴,20210126,20210216,360,mg,1,肺腺癌(肺腺癌),剂量停止,"",""
AB-21071597,4,7,PS,ニボルマブ,オプジーボ,静脈内点滴,20210309,20210330,360,mg,1,肺腺癌(肺腺癌),剂量停止,"",""
AB-21071597,4,8,PS,ニボルマブ,オプジーボ,静脈内点滴,20210420,20210511,360,mg,1,肺腺癌(肺腺癌),剂量停止,"",""
AB-21071597,4,9,PS,ニボルマブ,オプジーボ,静脈内点滴,20210601,20211005,360,mg,1,肺腺癌(肺腺癌),剂量停止,"",""
AB-21071597,4,10,PS,ニボルマブ,オプジーボ,静脈内点滴,20221220,"",360,mg,1,肺腺癌(肺腺癌),剂量停止,"",""
AB-21071597,4,11,PS,イピリムマブ,ヤーボイ,静脈内点滴,20231128,20231128,1,mg/kg,1,肺腺癌(肺腺癌),剂量停止,"",""
AB-21071597,4,12,PS,ニボルマブ,オプジーボ,静脈内点滴,20231219,20231219,360,mg,1,肺腺癌(肺腺癌),剂量停止,"",""
AB-21071597,4,13,C,メトホルミン塩酸塩,"",不明,20210622,"",250,mg,1,"",剂量停止,"",""
AB-21071597,4,14,C,アトルバスタチンカルシウム水和物,"",経口,"","",5,mg,1,"",未知,"",""
AB-21071597,4,15,C,グリメピリド,"",経口,"","",3,mg,1,"",剂量停止,"",""
AB-21071597,4,16,C,インスリン,"",不明,"","","","","",２型糖尿病(2型糖尿病);１型糖尿病(1型糖尿病),未知,"",""
AB-21071597,4,17,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-21071615,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20211129;20211230,20211129;20211230,480;480,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21071615,3,2,PS,アナモレリン塩酸塩,エドルミズ,経口;経口,20210911;20211119,20211116;20220124,100;100,mg;mg,1;1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-21071615,3,3,C,フロセミド,"",経口;経口,20210913;20211125,20211023;20211202,20;20,mg;mg,1;1,"",未知,"",""
AB-21071615,3,4,C,スピロノラクトン,"",経口;経口,20210913;20211125,20211023;20211202,25;25,mg;mg,1;1,"",未知,"",""
AB-21071615,3,5,C,フルニトラゼパム,"",経口,20210915,20211007,1,mg,1,"",未知,"",""
AB-21071615,3,6,C,ｄ−クロルフェニラミンマレイン酸塩,"",経口,20210927,20211007,6,mg,1,"",未知,"",""
AB-21071615,3,7,C,アピキサバン,"",経口;経口;経口,20210929;20211006;20211029,20211005;20211028;20220124,20;10;5,mg;mg;mg,1;1;1,"",未知,"",""
AB-21071615,3,8,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20211004,20211018,80,mg,1,胃癌(胃癌),未知,"",""
AB-21071615,3,9,C,沈降炭酸カルシウム・コレカルシフェロール・炭酸マグネシウム,"",経口,20211007,20220124,2,{DF},1,"",未知,"",""
AB-21071615,3,10,C,リスペリドン,"",経口,20211013,20211019,1,mL,1,"",未知,"",""
AB-21071615,3,11,C,シタグリプチンリン酸塩水和物,"",経口,20211026,20220124,50,mg,1,"",未知,"",""
AB-21071615,3,12,C,トルバプタン,"",経口;経口,20211105;20211125,20211109;20211128,7.5;3.75,mg;mg,1;1,"",未知,"",""
AB-21071615,3,13,C,ラムシルマブ,"",静脈内点滴,20211108,20211108,30,mL,1,胃癌(胃癌),未知,"",""
AB-21071615,3,14,C,パクリタキセル,"",不明,20211108,20211108,16.7,mL,1,胃癌(胃癌),未知,"",""
AB-21071615,3,15,C,イプラグリフロジンＬ−プロリン,"",経口,20211116,20220124,50,mg,1,"",未知,"",""
AB-21071615,3,16,C,レボカルニチン,"",経口,20211124,20211207,1500,mg,1,"",未知,"",""
AB-21071615,3,17,C,レボチロキシンナトリウム水和物,"",経口,20211202,20220119,50,ug,1,"",未知,"",""
AB-21071615,3,18,C,デキサメタゾン,"",経口,20211230,20220112,2,mg,1,"",未知,"",""
AB-21071615,3,19,C,スボレキサント,"",経口,"",20220124,15,mg,1,"",未知,"",""
AB-21071615,3,20,C,ラメルテオン,"",経口,"",20220124,8,mg,1,"",未知,"",""
AB-21071615,3,21,C,アメジニウムメチル硫酸塩,"",経口,"",20211116,20,mg,1,"",未知,"",""
AB-21071615,3,22,C,ドンペリドン,"",経口,"",20211014,30,mg,1,"",未知,"",""
AB-21071615,3,23,C,エリスロマイシンエチルコハク酸エステル,"",経口,"",20211014,3,g,1,"",未知,"",""
AB-21071615,3,24,C,モサプリドクエン酸塩水和物,"",経口,"",20211014,15,mg,1,"",未知,"",""
AB-21071971,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210804,20210915,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-21071971,2,2,C,プレガバリン,"",経口,"","","","","","",未知,"",""
AB-21071971,2,3,C,アスピリン,"",不明,"","","","","","",未知,"",""
AB-21071971,2,4,C,セレコキシブ,"",不明,"","","","","","",未知,"",""
AB-21071971,2,5,C,大腸菌死菌・ヒドロコルチゾン,"",局所,"","","","","","",未知,"",""
AB-21071971,2,6,C,ケトプロフェン,"",経皮,"","","","","","",未知,"",""
AB-21071971,2,7,C,タムスロシン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-21071994,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-21072003,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20171207;,;20190725,3;3,mg/kg;mg/kg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-21072281,1,1,PS,イピリムマブ,ヤーボイ,静脈内点滴,20210603,20210826,47,mg,1,再発非小細胞肺癌(再発非小細胞肺癌),剂量停止,筋炎(再投与なし),""
AB-21072281,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20210603,20210916,360,mg,1,再発非小細胞肺癌(再発非小細胞肺癌),剂量停止,筋炎(再投与なし),""
AB-21072281,1,3,C,カルボプラチン,"",静脈内点滴,20210603,20210624,325,mg,1,再発非小細胞肺癌(再発非小細胞肺癌),剂量不变,"",""
AB-21072281,1,4,C,ペメトレキセドナトリウム水和物,"",静脈内点滴,20210603,20210624,750,mg,1,再発非小細胞肺癌(再発非小細胞肺癌),剂量不变,"",""
AB-21072281,1,5,C,チオトロピウム臭化物水和物・オロダテロール塩酸塩,"",その他(吸入に使用),"","","","","",適応症不明の製品使用(適応症不明の製品使用),剂量不变,"",""
AB-21072330,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,202104;202112,202108;202202,200;200,mg;mg,1;1,胃癌第４期(MSI-High癌（結腸・直腸以外）、MSI-High胃癌),剂量停止,悪性新生物進行(再投与なし);ぶどう膜炎(不明),""
AB-21072388,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190603,20190716,200,mg,1,胃癌第４期(MSI-Highを有する結腸・直腸癌以外の固形癌（標準的治療困難）胃癌),不适用,体調不良(再投与なし),""
AB-21072998,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210413,20210510,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性肝炎(再投与なし),""
AB-21072998,2,2,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-21072998,2,3,C,酸化マグネシウム,"",経口,"","",330,mg,1,"",未知,"",""
AB-21072998,2,4,C,ポラプレジンク,"",経口,"","",150,mg,1,"",未知,"",""
AB-21072998,2,5,C,リナグリプチン,"",経口,"","",5,mg,1,"",未知,"",""
AB-21072998,2,6,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-21072998,2,7,C,アジルサルタン,"",経口,"","",20,mg,1,"",未知,"",""
AB-21072998,2,8,C,アセトアミノフェン,"",経口,"","",400,mg,1,"",未知,"",""
AB-21073206,2,1,PS,イピリムマブ,ヤーボイ,静脈内点滴,"","","","","",胃癌(胃癌);食道癌(食道癌),剂量停止,下痢(再投与なし);免疫性腸炎(再投与なし),""
AB-21073206,2,2,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(胃癌);食道癌(食道癌),剂量停止,下痢(再投与なし);免疫性腸炎(再投与なし),""
AB-21073273,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210616,20210716,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-21073273,1,2,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-21073273,1,3,C,ウルソデオキシコール酸,"",不明,"","","","","","",未知,"",""
AB-21073273,1,4,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-21073273,1,5,C,ミロガバリンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-21073292,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-21073883,4,1,PS,ニボルマブ,オプジーボ,その他(CVポート),20210405,20210927,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-21073883,4,2,PS,トラスツズマブデルクステカン,エンハーツ,不明,20201130,20210222,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-21073883,4,3,C,リバーロキサバン,"",経口,20190924,"",10,mg,1,"",未知,"",""
AB-21073883,4,4,C,ボノプラザンフマル酸塩,"",経口,20190924,"",10,mg,1,予防(予防),未知,"",""
AB-21074349,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190111,20200911,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-21074349,2,2,C,アトルバスタチンカルシウム水和物,"",不明,"","","","","","",未知,"",""
AB-21074349,2,3,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-21074545,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201008,20201008,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(再投与なし),""
AB-21074545,2,2,C,フェンタニル,"",皮膚,"","","","","","",未知,"",""
AB-21074545,2,3,C,オランザピン,"",不明,"","","","","","",未知,"",""
AB-21074545,2,4,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-21074545,2,5,C,ヒドロモルフォン塩酸塩,"",経口,"","",2,mg,1,疼痛(疼痛),未知,"",""
AB-21074545,2,6,C,エトドラク,"",不明,"","","","","","",未知,"",""
AB-21074545,2,7,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-21074555,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,202112;202201;,;;,240;240;,mg;mg;,1;1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(無);甲状腺機能低下症(無),""
AB-21075042,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211214,20211214,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,発熱性好中球減少症(再投与なし),""
AB-21075042,6,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20211214;20220126,20211214;,190;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21075042,6,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20211214;20220126,20211228;,50;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21075042,6,4,PS,クロルフェニラミンマレイン酸塩,ポララミン,静脈内点滴,20211214,20211214,5,mg,1,予防(予防),不适用,"",""
AB-21075042,6,5,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20211214,20211214,6.6,mg,1,予防(予防),未知,"",""
AB-21075042,6,6,C,パロノセトロン塩酸塩,"",静脈内点滴,20211214,20211214,.75,mg,1,予防(予防),未知,"",""
AB-21075042,6,7,C,プレドニゾロン,"",不明,"","",10,mg,1,家族性地中海熱(家族性地中海熱),未知,"",""
AB-21075640,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21076214,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210616,20210630,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,重症筋無力症(再投与なし);心筋炎(再投与なし),""
AB-21076214,2,2,C,硝酸イソソルビド,"",経口,"","","","","","",未知,"",""
AB-21076214,2,3,C,アスピリン,"",経口,"","","","","","",未知,"",""
AB-21076214,2,4,C,レボチロキシンナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-21076214,2,5,C,タムスロシン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-21076214,2,6,C,ミグリトール,"",経口,"","","","","","",未知,"",""
AB-21076428,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211103,20211117,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし),""
AB-21076486,3,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,"","",1200,mg,1,肝細胞癌(HCC),剂量停止,ネフローゼ症候群(不明);腎前性腎不全(不明),""
AB-21076486,3,2,PS,ベバシズマブ,アバスチン,静脈内点滴,"","",15,mg,1,肝細胞癌(HCC),剂量停止,ネフローゼ症候群(不明);腎前性腎不全(不明),""
AB-21076486,3,3,C,消化性潰瘍用剤,"",経口,"","","","","","",未知,"",""
AB-21076486,3,4,C,酪酸菌配合剤,"",経口,"","","","","","",未知,"",""
AB-21076486,3,5,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-21076486,3,6,C,フェブキソスタット,"",経口,"","","","","","",未知,"",""
AB-21076486,3,7,C,レボチロキシンナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-21076486,3,8,C,シタグリプチンリン酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-21076486,3,9,C,イソロイシン・ロイシン・バリン,"",経口,"","",4.15,g,1,"",未知,"",""
AB-21076486,3,10,C,ロスバスタチンカルシウム,"",経口,"","","","","","",未知,"",""
AB-21076486,3,11,C,ロキソプロフェンナトリウム水和物,"",局所,"","","","","","",未知,"",""
AB-21076486,3,12,C,アムロジピンベシル酸塩,"",経口,"","","","","","",未知,"",""
AB-21077072,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210212;20210702,20210423;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,血中乳酸脱水素酵素減少(再投与なし);γ−グルタミルトランスフェラーゼ増加(再投与なし);血中アルカリホスファターゼ増加(再投与なし);肝機能異常(再投与なし),""
AB-21077368,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211221,20211221,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,てんかん(再投与なし);痙攣発作(再投与なし);間質性肺疾患(再投与なし);死亡(再投与なし),""
AB-21077368,3,2,PS,アナモレリン塩酸塩,エドルミズ,経口,"","","","","",悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),未知,てんかん(再投与なし);痙攣発作(再投与なし);間質性肺疾患(再投与なし);死亡(再投与なし),""
AB-21077368,3,3,C,オキサリプラチン,"",静脈内（明記されていない場合）,"",20220111,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21077368,3,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"",20220111,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21077368,3,5,C,セフォペラゾンナトリウム・スルバクタムナトリウム,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-21077368,3,6,C,酢酸リンゲル液（ブドウ糖加）,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-21077368,3,7,C,塩化ナトリウム,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-21077368,3,8,C,ガベキサートメシル酸塩,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-21077368,3,9,C,ドチヌラド,"",経口,"","","","","","",未知,"",""
AB-21077368,3,10,C,ボノプラザンフマル酸塩,"",経口,"","","","","","",未知,"",""
AB-21077368,3,11,C,レバミピド,"",経口,"","","","","","",未知,"",""
AB-21077411,1,1,PS,アテゾリズマブ,テセントリク,静脈内点滴;静脈内点滴,20211015;20211119,20211015;20211119,;,;,;,非小細胞肺癌(非小細胞肺癌),未知,肝機能異常(不明),""
AB-21077411,1,2,PS,ベバシズマブ,アバスチン,静脈内点滴;静脈内点滴,20211015;20211119,20211015;20211119,;,;,;,非小細胞肺癌(非小細胞肺癌),未知,肝機能異常(不明),""
AB-21077411,1,3,C,カルボプラチン,"",静脈内点滴;静脈内点滴,20211015;20211119,20211015;20211119,;,;,;,非小細胞肺癌(非小細胞肺癌),未知,"",""
AB-21077411,1,4,C,パクリタキセル,"",静脈内点滴;静脈内点滴,20211015;20211119,20211015;20211119,;,;,;,非小細胞肺癌(非小細胞肺癌),未知,"",""
AB-21077699,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,末梢性ニューロパチー(再投与なし),""
AB-21077699,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,100;80,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21077699,1,3,C,オキサリプラチン,"",不明;不明;不明,;;,;;,130;100;85,mg/m2;mg/m2;mg/m2,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21077704,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210608,20210831,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,胆汁うっ滞(再投与なし);多形紅斑(再投与なし);粘膜潰瘍(再投与なし),""
AB-21077704,1,2,PS,アモキシシリン水和物,"",不明,20211209,20211216,"","","",発熱(発熱);頭痛(頭痛),剂量停止,"",""
AB-21077704,1,3,PS,アモキシシリン水和物・クラブラン酸カリウム,オーグメンチン,不明,20211209,20211216,"","","",発熱(発熱);頭痛(頭痛),剂量停止,"",""
AB-21078233,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20211109,20211221,200,mg,1,頭頚部癌(頭頸部癌),剂量停止,免疫性甲状腺機能亢進症(再投与なし),""
AB-21078660,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210825,20211223,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-21078660,2,2,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-21078660,2,3,C,セレコキシブ,"",不明,"","","","","","",未知,"",""
AB-21078660,2,4,C,ピロカルピン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-21078907,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210811,20210830,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,水腎症(再投与なし),""
AB-21079262,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21079264,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202112;20220120,202112;,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,下痢(不明),""
AB-21079264,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202112,202112,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21079264,1,3,C,オキサリプラチン,"",不明,202112,202112,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21079313,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20171115;20181004;20200130,;;20200330,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫介在性膀胱炎(再投与なし);免疫性ニューロパチー(再投与なし);免疫性腸炎(再投与なし),""
AB-21079313,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明;不明;不明;不明;不明,20171115;20180125;20180315;20180705;20200130;20200917,;;20180517;;20200330;20210708,;;;;;,;;;;;,;;;;;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-21079313,2,3,C,オキサリプラチン,"",不明;不明;不明,20171115;20180125;20180405,;2018;2018,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-21079509,1,1,PS,ニボルマブ,オプジーボ,"",20211223,20211223,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21079509,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21079509,1,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21079742,3,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,202103,"","","","",肝細胞癌(多発肝細胞癌),剂量不变,脾臓梗塞(再投与なし),""
AB-21079742,3,2,PS,ベバシズマブ,アバスチン,静脈内点滴,202103,"","","","",肝細胞癌(多発肝細胞癌),剂量停止,脾臓梗塞(再投与なし),""
AB-21079820,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-21079841,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220105,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,食欲減退(再投与なし),""
AB-21079841,2,2,C,オキサリプラチン,"",不明,20220105,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21079841,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220105,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21079886,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,2019,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,悪性新生物進行(再投与なし),""
AB-21080160,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200623,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,関節炎(再投与なし),""
AB-21080244,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-21080244,1,2,C,オキサリプラチン,"",不明,"","",100,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21080507,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201712,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21080526,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210305,20210924,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,消化管浮腫(再投与なし);食欲減退(再投与なし);倦怠感(再投与なし);免疫性腸炎(再投与なし),""
AB-21080526,1,2,C,ジスチグミン臭化物,"",経口,20190629,"","","","","",未知,"",""
AB-21080526,1,3,C,六君子湯,"",経口,20190715,"","","","","",未知,"",""
AB-21080526,1,4,C,酪酸菌製剤,"",経口,20210315,"","","","","",未知,"",""
AB-21080526,1,5,C,レバミピド,"",経口,20210315,"","","","","",未知,"",""
AB-21080526,1,6,C,ランソプラゾール,"",経口,20210620,"","","","","",未知,"",""
AB-21080614,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,心筋梗塞(再投与なし),""
AB-21080614,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21080614,1,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21080615,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220105,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肝炎(再投与なし),""
AB-21080615,1,2,C,オキサリプラチン,"",静脈内点滴,202201,"",130,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21080615,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,202201,"",80,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21080885,1,1,PS,アナモレリン塩酸塩,エドルミズ,経口,20210908,20211005,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,肝機能異常(再投与なし),""
AB-21080885,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(不明),""
AB-21081321,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし);甲状腺機能亢進症(再投与なし);甲状腺機能低下症(再投与なし),""
AB-21081843,1,1,PS,オキサリプラチン,エルプラット：点滴静注液,静脈内点滴;静脈内点滴,20211209;20220127,20220106;,130;100,mg/m2;mg/m2,1;1,胃癌(胃癌),剂量减少,倦怠感(不明),""
AB-21081843,1,2,PS,ニボルマブ,"",静脈内点滴,"","","","","",胃癌(胃癌),未知,"",""
AB-21081843,1,3,C,テガフール・ギメラシル・オテラシルカリウム,"",経口,"","","","","",胃癌(胃癌),未知,"",""
AB-21082023,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-21082361,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,サイトカイン放出症候群(再投与なし);血球貪食性リンパ組織球症(再投与なし);血球貪食性リンパ組織球症(再投与なし),""
AB-21082955,4,1,PS,トラスツズマブデルクステカン,エンハーツ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20210226;20210319;20210409;20210430;20210521;20210611;20210709;20210813;20210903;20210924;20211015;20211105;20211126;20211217,20210226;20210319;20210409;20210430;20210521;20210611;20210709;20210813;20210903;20210924;20211015;20211105;20211126;20211217,6.4;6.4;6.4;6.4;6.4;6.4;5.4;5.4;5.4;5.4;5.4;5.4;5.4;4.4,mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg,1;1;1;1;1;1;1;1;1;1;1;1;1;1,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),剂量停止,間質性肺疾患(再投与なし),""
AB-21082955,4,2,PS,ニボルマブ,"",不明,20200207,20200814,"","","",ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),未知,"",""
AB-21083074,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210414,20210721,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,腎機能障害(再投与なし);眼窩筋炎(再投与なし);痙攣発作(再投与なし),""
AB-21083074,4,2,PS,バルプロ酸ナトリウム,"",不明,"","","","","",片頭痛(片頭痛),不适用,"",""
AB-21083074,4,3,PS,アミトリプチリン塩酸塩,トリプタノール,不明,"","","","","",片頭痛(片頭痛),不适用,"",""
AB-21083074,4,4,PS,ロメリジン塩酸塩,ミグシス,不明,"","","","","",片頭痛(片頭痛),不适用,"",""
AB-21083079,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20220721,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,免疫性甲状腺機能低下症(再投与なし),""
AB-21083079,3,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20211105,20220821,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,免疫性甲状腺機能低下症(再投与なし),""
AB-21083079,3,3,C,フロセミド,"",不明,"",20211126,40,mg,1,"",未知,"",""
AB-21084186,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202112,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,好中球減少症(再投与なし),""
AB-21084872,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200220,202107,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,類天疱瘡(再投与なし),""
AB-21085321,2,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,"","","","","",胃癌(胃癌),剂量停止,"",""
AB-21085321,2,2,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(胃癌),剂量停止,"",""
AB-21085321,2,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(胃癌),剂量停止,"",""
AB-21086012,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210218,20220217,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,脳梗塞(再投与なし),""
AB-21086386,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220120,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,眼傍結合織炎(再投与なし);緑内障(再投与なし),""
AB-21086386,3,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21086386,3,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21086386,3,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21086391,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,腎機能障害(再投与なし),""
AB-21086771,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,血便排泄(再投与なし),""
AB-21086773,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能亢進症(再投与なし),""
AB-21086785,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20220302,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし),""
AB-21087028,6,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20210701,20211202,200,mg,1,非小細胞肺癌第４期(非小細胞肺癌),剂量停止,再生不良性貧血(再投与なし),""
AB-21087028,6,2,C,カルボプラチン,"",静脈内（明記されていない場合）,20210701,20210909,390,mg,1,非小細胞肺癌第４期(非小細胞肺癌),未知,"",""
AB-21087028,6,3,C,ペメトレキセドナトリウム水和物,"",静脈内（明記されていない場合）,20210701,20211021,790,mg,1,非小細胞肺癌第４期(非小細胞肺癌),未知,"",""
AB-21087028,6,4,C,葉酸,"",経口,不明,"","","","","",未知,"",""
AB-21087028,6,5,C,バルサルタン,"",経口,不明,"","","","","",未知,"",""
AB-21087028,6,6,C,アムロジピンベシル酸塩,"",経口,不明,"","","","","",未知,"",""
AB-21087278,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,腸炎(再投与なし),""
AB-21087278,1,2,C,トラスツズマブデルクステカン,"",不明;不明,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21087525,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210524,20210524,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,スティーヴンス・ジョンソン症候群(再投与なし),""
AB-21087525,1,2,PS,セフメタゾールナトリウム,"",静脈内点滴,20210505,20210529,1,g,1,肝膿瘍(肝膿瘍),剂量停止,"",""
AB-21087525,1,3,PS,テイコプラニン,"",静脈内点滴,20210505,20210529,400,mg,1,肝膿瘍(肝膿瘍),剂量停止,"",""
AB-21087525,1,4,PS,ミカファンギンナトリウム,"",静脈内点滴,20210505,20210528,100,mg,1,肝膿瘍(肝膿瘍),剂量停止,"",""
AB-21087525,1,5,PS,フルコナゾール,"",経口,20210528,20210529,400,mg,1,肝膿瘍(肝膿瘍),剂量停止,"",""
AB-21087526,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210804;20220413,20220216;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,大腸炎(再投与なし),""
AB-21088317,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能亢進症(再投与なし),""
AB-21088317,1,2,C,オキサリプラチン,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21088317,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21088324,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211208,20220105,240,mg,1,食道癌(食道癌における術後補助療法),不适用,心肺停止(再投与なし),""
AB-21088324,3,2,C,酪酸菌製剤,"",経口,"","",3,{DF},1,"",未知,"",""
AB-21088324,3,3,C,アセトアミノフェン,"",不明,"","",1200,mg,1,"",未知,"",""
AB-21088324,3,4,C,経腸成分栄養剤（１−１）,"",不明,"","",1,{DF},1,"",未知,"",""
AB-21088324,3,5,C,エソメプラゾールマグネシウム水和物,"",不明,"","",20,mg,1,"",未知,"",""
AB-21088324,3,6,C,モサプリドクエン酸塩水和物,"",不明,"","",15,mg,1,"",未知,"",""
AB-21088324,3,7,C,コデインリン酸塩水和物,"",不明,"","",40,mg,1,"",未知,"",""
AB-21088634,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220112,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,腸炎(再投与なし),""
AB-21088634,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20211222,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21088634,3,3,C,オキサリプラチン,"",静脈内点滴,20211222,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21088641,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし);免疫性筋炎(再投与なし),""
AB-21088740,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-21089080,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,ショック(再投与なし),""
AB-21089080,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21089080,1,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21089080,1,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21089093,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",202112,480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);副腎機能不全(再投与なし),""
AB-21089429,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし),""
AB-21089432,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-21089432,2,2,C,オキサリプラチン,"",不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21089432,2,3,C,フルオロウラシル,"",不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21089432,2,4,C,レボホリナートカルシウム,"",不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21089441,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201912;20200616,20200417;20200929,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-21089785,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220111,20220125,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺毒性(再投与なし),""
AB-21089785,1,2,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-21089785,1,3,C,タムスロシン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-21089785,1,4,C,ビベグロン,"",不明,"","","","","","",未知,"",""
AB-21089785,1,5,C,デュタステリド,"",不明,"","","","","","",未知,"",""
AB-21089785,1,6,C,バルサルタン,"",不明,"","","","","","",未知,"",""
AB-21089785,1,7,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-21090320,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21090321,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし);重症筋無力症(再投与なし),""
AB-21090322,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,非定型マイコバクテリア感染(再投与なし),""
AB-21090324,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-21090329,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,急性副腎皮質機能不全(再投与なし);好中球数減少(再投与なし),""
AB-21090329,2,2,C,トリフルリジン・チピラシル塩酸塩配合剤,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21090329,2,3,C,イリノテカン塩酸塩水和物,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21090329,2,4,C,ラムシルマブ,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21090695,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202201,202201,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-21091011,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20211206;;,20211206;;,360;;,mg;;,1;;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(不明);糖尿病性ケトアシドーシス(不明),""
AB-21091011,5,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,20211206;,20211206;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21091011,5,3,C,オキサリプラチン,"",不明;不明;不明,20211206;;,20211206;;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21091020,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210525,20220125,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,中毒性表皮壊死融解症(再投与なし),""
AB-21091050,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-21091057,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,イレウス(再投与なし),""
AB-21091621,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220202,20220202,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍のハイパープログレッション(再投与なし);多臓器機能不全症候群(再投与なし),""
AB-21091621,4,2,C,ゾレドロン酸水和物,"",不明,20220201,"","","","","",未知,"",""
AB-21091621,4,3,C,オキサリプラチン,"",不明,20220202,"",130,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21091621,4,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220202,"",120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21091623,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220225,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,肺炎(再投与なし),""
AB-21091908,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211214,20220125,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,播種性血管内凝固(再投与なし);血小板数減少(再投与なし),""
AB-21091908,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20211214,20220125,120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21091908,2,3,C,オキサリプラチン,"",静脈内点滴,20211214,20220125,80,mg/kg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21091908,2,4,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-21091908,2,5,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-21091908,2,6,C,センノシド,"",不明,"","","","","","",未知,"",""
AB-21091915,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,水疱性皮膚炎(再投与なし),""
AB-21091915,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","","",未知,"",""
AB-21091915,2,3,C,オキサリプラチン,"",静脈内点滴,"","",80,mg,1,"",未知,"",""
AB-21092053,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,不明,"",200,mg,1,胃癌(胃がん),未知,痙攣発作(再投与なし);悪性新生物進行(再投与なし),""
AB-21092195,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20210518;20210817;20211116,;;20220222,240;480;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,アフタ性潰瘍(再投与なし);紅斑(再投与なし),""
AB-21092199,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,腸炎(再投与なし),""
AB-21092199,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21092199,1,3,C,オキサリプラチン,"",不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21092204,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202112,不明,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-21092204,3,2,C,オキサリプラチン,"",不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21092204,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-21092204,3,4,C,アトルバスタチンカルシウム水和物,"",経口,"","","","","","",未知,"",""
AB-21092204,3,5,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-21092204,3,6,C,アレンドロン酸ナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-21092553,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-21092553,2,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20210807,20210813,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),不适用,甲状腺機能低下症(再投与なし),""
AB-21092553,2,3,C,セレコキシブ,"",不明,"","",200,mg,1,"",未知,"",""
AB-21092553,2,4,C,プロクロルペラジンマレイン酸塩,"",不明,"","",15,mg,1,予防(予防),未知,"",""
AB-21092553,2,5,C,モサプリドクエン酸塩水和物,"",不明,"","",15,mg,1,予防(予防),未知,"",""
AB-21092553,2,6,C,ボノプラザンフマル酸塩,"",不明,"","",20,mg,1,予防(予防),未知,"",""
AB-21092553,2,7,C,オランザピン,"",不明,"","",5,mg,1,予防(予防),未知,"",""
AB-21092553,2,8,C,ナルデメジントシル酸塩,"",不明,"","",.2,mg,1,予防(予防),未知,"",""
AB-21092553,2,9,C,ポラプレジンク,"",不明,"",20210924,150,mg,1,"",未知,"",""
AB-21092553,2,10,C,オキシコドン塩酸塩水和物,"",不明,"","",40,mg,1,"",未知,"",""
AB-22000471,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,;20180515;20210623,;20210414;20210803,240;240;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし);間質性肺疾患(再投与なし),""
AB-22000471,3,2,C,インスリン,"",不明,20170912,"","","","",１型糖尿病(1型糖尿病),未知,"",""
AB-22000475,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-22000477,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,続発性副腎皮質機能不全(再投与なし),""
AB-22000752,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200430;20201224,20201105;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,続発性副腎皮質機能不全(不明),""
AB-22000752,3,2,C,アスピリン,"",不明,"","","","","","",未知,"",""
AB-22000752,3,3,C,アトルバスタチンカルシウム水和物,"",不明,"","","","","","",未知,"",""
AB-22000752,3,4,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-22000752,3,5,C,アズレンスルホン酸ナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-22000752,3,6,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-22000752,3,7,C,ウルソデオキシコール酸,"",不明,"","",400,mg,1,"",未知,"",""
AB-22001678,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220322,20220322,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,紅斑(再投与なし),""
AB-22002002,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220316,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,好中球数減少(再投与なし),""
AB-22002002,1,2,PS,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22002002,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22002008,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,大腸炎(再投与なし),""
AB-22002014,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202105,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,赤芽球癆(再投与なし),""
AB-22002014,1,2,C,ヒドロコルチゾン,"",不明,"","","","","",副腎皮質刺激ホルモン欠損症(ＡＣＴＨ単独欠損症),未知,"",""
AB-22002473,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,202109;202203,202201;2022,200;,mg;,1;,胃癌第４期(MSI-High癌（結腸・直腸以外）、胃癌),剂量停止,多形紅斑(有);多形紅斑(再投与なし),""
AB-22002473,4,2,C,アムロジピンベシル酸塩,"",不明,不明,"","","","","",未知,"",""
AB-22002473,4,3,C,ビソプロロールフマル酸塩,"",不明,不明,"","","","","",未知,"",""
AB-22002473,4,4,C,ロサルタンカリウム,"",経口,不明,"","","","","",未知,"",""
AB-22002697,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211213,20211227,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22002697,1,2,PS,オキサリプラチン,"",不明,20211213,20211227,70,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22002697,1,3,PS,フルオロウラシル,"",静脈内急速;静脈内点滴,20211213;20211213,20211227;20211227,320;1900,mg/m2;mg/m2,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22002697,1,4,PS,レボホリナートカルシウム,レボホリナート,不明,20211213,20211227,200,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22002697,1,5,C,乳酸カルシウム水和物,"",不明,202107,"","","","","",未知,"",""
AB-22002697,1,6,C,ランソプラゾール,"",不明,202107,"","","","","",未知,"",""
AB-22002697,1,7,C,ナルデメジントシル酸塩,"",不明,202109,"","","","","",未知,"",""
AB-22002697,1,8,C,フェンタニルクエン酸塩,"",経皮,202109,"","","","","",未知,"",""
AB-22003237,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20220413,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,胆管炎(再投与なし),""
AB-22003364,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20220121;2022,2022;202210,200;200,mg;mg,1;1,胃癌第４期(MSI-High 癌（結腸・直腸以外）),剂量停止,限局性腹膜炎(無);悪性新生物進行(再投与なし),""
AB-22003364,4,2,C,アムロジピンベシル酸塩,"",経口,不明,"",5,mg,1,高血圧(高血圧),未知,"",""
AB-22003364,4,3,C,ボノプラザンフマル酸塩,"",経口,不明,"",20,mg,1,胃食道逆流性疾患(逆流性食道炎),未知,"",""
AB-22003513,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210830;20220804,20220707;,240;480,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-22003513,5,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20210830,"",100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-22003513,5,3,C,ウルソデオキシコール酸,"",経口,20210913,"",300,mg,1,"",未知,"",""
AB-22003513,5,4,C,ランソプラゾール,"",経口,"","",15,mg,1,"",未知,"",""
AB-22003513,5,5,C,クエン酸第一鉄ナトリウム,"",経口;経口,;20220804,;,100;100,mg;mg,1;1,"",未知,"",""
AB-22003513,5,6,C,酪酸菌製剤,"",経口,"","",3,{DF},1,"",未知,"",""
AB-22003513,5,7,C,酸化マグネシウム,"",経口,"","",660,mg,1,"",未知,"",""
AB-22003513,5,8,C,フロセミド,"",経口,"","",40,mg,1,"",未知,"",""
AB-22003513,5,9,C,スピロノラクトン,"",経口,"","",25,mg,1,"",未知,"",""
AB-22003513,5,10,C,レボチロキシンナトリウム水和物,"",経口;経口;経口;経口;経口;経口;経口,;20210913;20211021;20220106;20220120;20220203;20220414,;20211020;20220105;20220119;20220202;20220413;,50;75;100;125;150;175;200,ug;ug;ug;ug;ug;ug;ug,1;1;1;1;1;1;1,"",未知,"",""
AB-22003603,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-22003603,1,2,PS,コロナウイルス（ＳＡＲＳ−ＣｏＶ−２）ＲＮＡワクチン,コミナティ（１価：起源株）,不明,"","","","","","",未知,"",""
AB-22003865,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211109,"",360,mg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),不适用,脳炎(再投与なし);発疹(再投与なし);甲状腺機能低下症(再投与なし);紅斑(再投与なし),""
AB-22003865,3,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,20211109,"",73,mg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),不适用,"",""
AB-22003865,3,3,C,ルビプロストン,"",経口,20220101,20220101,24,ug,1,"",未知,"",""
AB-22003878,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220119,20220307,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腎障害(再投与なし),""
AB-22003878,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20220119,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22003878,2,3,PS,オキサリプラチン,"",静脈内点滴,20220119,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22003879,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210517,20210727,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-22003879,1,2,C,アスピリン,"",経口,20191220,"","","","","",未知,"",""
AB-22003879,1,3,C,ロスバスタチンカルシウム,"",経口,20191220,"","","","","",未知,"",""
AB-22003879,1,4,C,一硝酸イソソルビド,"",経口,20191220,"","","","","",未知,"",""
AB-22003879,1,5,C,ペマフィブラート,"",経口,20191220,"","","","","",未知,"",""
AB-22003879,1,6,C,ブロチゾラム,"",経口,20191220,"","","","","",未知,"",""
AB-22003879,1,7,C,モサプリドクエン酸塩水和物,"",経口,20191220,"","","","","",未知,"",""
AB-22004281,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211207,20220112,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-22004281,1,2,C,フルオロウラシル,"",静脈内点滴;静脈内点滴,20211207;20211207,;,400;2400,mg/m2;mg/m2,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22004281,1,3,C,レボホリナートカルシウム,"",静脈内点滴,20211207,"",200,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22004281,1,4,C,オキサリプラチン,"",静脈内点滴,20211207,"",85,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22004347,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20191015,20200128,200,mg,1,胃癌第４期(高頻度マイクロサテライト不安定性（MSI-High）癌（胃癌）),不适用,免疫性肺疾患(再投与なし);免疫性甲状腺機能低下症(再投与なし),""
AB-22004347,1,2,C,エソメプラゾールマグネシウム水和物,"",経口,20160510,20200207,20,mg,1,胃潰瘍(胃潰瘍),未知,"",""
AB-22004347,1,3,C,ビフィズス菌製剤（４）,"",経口,20160713,20200207,3,g,1,下痢(下痢),未知,"",""
AB-22004347,1,4,C,アムロジピンベシル酸塩,"",経口,20190924,20200207,5,mg,1,高血圧(高血圧),未知,"",""
AB-22004543,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220105,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,血小板減少症(再投与なし),""
AB-22004543,3,2,C,カペシタビン,"",不明,20220105,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22004543,3,3,C,オキサリプラチン,"",不明;不明,20220105;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22005197,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22005277,6,1,PS,イピリムマブ,ヤーボイ,"",20211109,"",73,mg,1,再発非小細胞肺癌(Non-small cell lung cancer recurrent),不适用,免疫性脳炎(再投与なし);甲状腺機能低下症(再投与なし);免疫性皮膚炎(再投与なし);ＣＳＦ細胞数増加(再投与なし);尿閉(再投与なし);自律神経失調(再投与なし),""
AB-22005277,6,2,PS,ニボルマブ,オプジーボ,"",20211109,"",360,mg,1,再発非小細胞肺癌(Non-small cell lung cancer recurrent),不适用,免疫性脳炎(再投与なし);甲状腺機能低下症(再投与なし);免疫性皮膚炎(再投与なし);ＣＳＦ細胞数増加(再投与なし);尿閉(再投与なし);自律神経失調(再投与なし),""
AB-22005277,6,3,C,ルビプロストン,"","",20220101,20220101,24,ug,1,適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-22005636,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20201110;20210810,20210713;20210824,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし);潰瘍性大腸炎(再投与なし),""
AB-22005636,2,2,C,プレドニゾロン,"",不明,"","","","","","",未知,"",""
AB-22005636,2,3,C,メサラジン,"",経口,"","",1500,mg,1,潰瘍性大腸炎(潰瘍性大腸炎（左側結腸炎型）),未知,"",""
AB-22005636,2,4,C,大腸菌死菌,"",局所,"","","","","","",未知,"",""
AB-22005636,2,5,C,タルク,"",不明,"","","","","","",未知,"",""
AB-22005650,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし);副腎機能不全(再投与なし);糖尿病性ケトアシドーシス(再投与なし),""
AB-22005650,4,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22005650,4,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22005651,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,イレウス(再投与なし),""
AB-22005651,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22005651,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22005826,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22006461,5,1,PS,トラスツズマブデルクステカン,エンハーツ,静脈内点滴;静脈内点滴;静脈内点滴,20211203;20211228;20220118,20211203;20211228;20220118,6.4;6.4;6.4,mg/kg;mg/kg;mg/kg,1;1;1,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer),剂量停止,間質性肺疾患(再投与なし),""
AB-22006461,5,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20220202,20220202,"","","",胃癌(Gastric cancer);再発胃癌(Gastric cancer recurrent),未知,"",""
AB-22006629,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220107,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能亢進症(再投与なし),""
AB-22006629,2,2,C,オキサリプラチン,"",不明,20220107,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22006629,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220107,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22007519,1,1,PS,オキサリプラチン,"",静脈内点滴,20210820,20220225,189,mg,1,胃癌(Cancer of body of stomach),剂量停止,"",""
AB-22007519,1,2,PS,ニボルマブ,オプジーボ,"",20220128,20220225,360,mg,1,胃癌(Cancer of body of stomach),未知,"",""
AB-22007519,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220128,20220210,100,mg,1,"",未知,"",""
AB-22007519,1,4,C,パロノセトロン塩酸塩,"","","","","","","","",未知,"",""
AB-22007596,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220202,"",320,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-22007598,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,ストレス心筋症(再投与なし),""
AB-22008448,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22008450,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220218,"",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,間質性肺疾患(再投与なし),""
AB-22008632,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220328,20220328,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,免疫性肺疾患(再投与なし),""
AB-22008632,4,2,PS,アナモレリン塩酸塩,エドルミズ,経口;経口,20220312;,;20220502,100;,mg;,1;,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,免疫性肺疾患(再投与なし),""
AB-22008633,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220222,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-22008633,2,2,C,フルオロウラシル,"",不明,20220222,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22008633,2,3,C,オキサリプラチン,"",不明,20220222,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22008633,2,4,C,レボホリナートカルシウム,"",不明,20220222,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22009322,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210702,20210917,240,mg,1,食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),不适用,甲状腺機能低下症(再投与なし);自己免疫性肝炎(再投与なし);肝不全(再投与なし),""
AB-22009322,6,2,PS,プレドニゾロン,"",不明;不明;不明;不明;不明;不明;不明;不明;不明;不明,20220217;20220224;20220303;20220318;20220402;20220414;20220420;20220427;20220504;20220511,20220223;20220302;20220317;20220401;;20220419;20220426;20220503;20220510;,60;50;40;30;20;45;35;25;15;10,mg;mg;mg;mg;mg;mg;mg;mg;mg;mg,1;1;1;1;1;1;1;1;1;1,肝不全(肝炎（自己免疫性肝炎、肝不全）);自己免疫性肝炎(肝炎（自己免疫性肝炎、肝不全）),未知,"",""
AB-22009322,6,3,PS,ミコフェノール酸モフェチル,"",不明;不明;不明;不明;不明,20220221;20220318;;20220411;20220423,20220317;20220326;;20220422;20220425,2;3;;2;1,g;g;;g;g,1;1;;1;1,肝不全(肝炎（自己免疫性肝炎、肝不全）);自己免疫性肝炎(肝炎（自己免疫性肝炎、肝不全）),未知,"",""
AB-22009322,6,4,C,ドセタキセル,"",静脈内（明記されていない場合）,20211005,20220113,113,mg,1,食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),未知,"",""
AB-22009322,6,5,C,エンパグリフロジン,"",経口,202201,"",10,mg,1,"",未知,"",""
AB-22009322,6,6,C,シタグリプチンリン酸塩水和物,"",経口,"","",50,mg,1,"",未知,"",""
AB-22009322,6,7,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-22009322,6,8,C,フェブキソスタット,"",経口,"","",20,mg,1,"",未知,"",""
AB-22009616,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210803;20211221,20211109;202207,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-22009616,3,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20210721,20210913,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),不适用,副腎機能不全(再投与なし),""
AB-22009616,3,3,C,アムロジピンベシル酸塩,"",不明,"","",5,mg,1,"",未知,"",""
AB-22009616,3,4,C,ボノプラザンフマル酸塩,"",不明,"","",10,mg,1,"",未知,"",""
AB-22009677,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20210518,20211102,200,mg,1,腎盂および尿管移行上皮癌(尿路上皮癌、左腎盂癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22009677,4,2,C,リナグリプチン,"",経口,不明,"",5,mg,1,"",未知,"",""
AB-22009677,4,3,C,シルニジピン,"",経口,不明,"",5,mg,1,"",未知,"",""
AB-22009677,4,4,C,シロスタゾール,"",経口,不明,"",200,mg,1,"",未知,"",""
AB-22009677,4,5,C,レボチロキシンナトリウム水和物,"",経口,不明,"",50,ug,1,"",未知,"",""
AB-22009743,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202203,202204,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-22009743,1,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20210716,20210825,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),不适用,大腸炎(再投与なし),""
AB-22009743,1,3,PS,オキサリプラチン,"",不明,"","","","","","",未知,"",""
AB-22009743,1,4,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,不明,"",20210820,100,mg/m2,1,胃癌(胃癌),不适用,"",""
AB-22009743,1,5,C,ラムシルマブ,"",不明,"",20210813,8,mg/kg,1,胃癌(胃癌),未知,"",""
AB-22009743,1,6,C,バルサルタン・アムロジピンベシル酸塩配合剤,"",経口,"",20210825,1,{DF},1,"",未知,"",""
AB-22009743,1,7,C,アムロジピンベシル酸塩,"",不明,"",20210825,5,mg,1,"",未知,"",""
AB-22009743,1,8,C,ラベプラゾールナトリウム,"",不明,"",20210825,10,mg,1,"",未知,"",""
AB-22009743,1,9,C,トラスツズマブデルクステカン,"",不明,"","","","","","",未知,"",""
AB-22009759,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,視床下部−下垂体障害(再投与なし);甲状腺機能亢進症(再投与なし);続発性副腎皮質機能不全(再投与なし);血中コルチコトロピン減少(再投与なし),""
AB-22009759,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202107,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22009759,2,3,C,オキサリプラチン,"",不明,202107,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22009791,2,1,PS,イピリムマブ,ヤーボイ,"","",20220420,"","","",非小細胞肺癌(Non-small cell lung cancer),剂量停止,急性腎障害(再投与なし);尿細管間質性腎炎(再投与なし);血小板数減少(再投与なし);喀血(再投与なし),""
AB-22009791,2,2,PS,ニボルマブ,オプジーボ,"","",20220420,"","","",非小細胞肺癌(Non-small cell lung cancer),剂量停止,急性腎障害(再投与なし);尿細管間質性腎炎(再投与なし);血小板数減少(再投与なし);喀血(再投与なし),""
AB-22009791,2,3,PS,アナモレリン塩酸塩,エドルミズ,"",20220311,"",100,mg,1,適応症不明の製品使用(Product used for unknown indication),剂量不变,急性腎障害(再投与なし);尿細管間質性腎炎(再投与なし);血小板数減少(再投与なし);喀血(再投与なし),""
AB-22009807,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,サルコイドーシス(再投与なし),""
AB-22009808,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220425,20220425,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,発疹(再投与なし),""
AB-22009886,1,1,PS,パクリタキセル,タキソール,"","","","","","",胃癌(Gastric cancer),未知,脱毛症(再投与なし);間質性肺疾患(不明),""
AB-22009886,1,2,PS,ニボルマブ,オプジーボ,"","","","","","",胃癌(Gastric cancer),剂量停止,脱毛症(不明);間質性肺疾患(不明),""
AB-22010143,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211130,20220517,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-22010143,4,2,PS,オキサリプラチン,"",不明,20211109,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22010143,4,3,C,タペンタドール塩酸塩,"",不明,20211029,20211108,25,mg,1,疼痛(疼痛),未知,"",""
AB-22010143,4,4,C,カペシタビン,"",不明,20211109,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22010762,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211203,20211217,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,肝性脳症(再投与なし);肺毒性(再投与なし);薬物性肝障害(再投与なし),""
AB-22010762,2,2,C,ランソプラゾール,"",経口,"","","","","","",未知,"",""
AB-22010762,2,3,C,テルミサルタン・アムロジピンベシル酸塩配合剤,"",経口,"","","","","","",未知,"",""
AB-22010765,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22010765,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22010765,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22010773,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211208,20220309,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肝機能検査値上昇(再投与なし),""
AB-22010773,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,20211208;20220420,20220309;,50;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22010773,1,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20211208;20220420,20220309;,100;,mg/m2;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22011124,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220119,20220413,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-22011124,3,2,C,オキサリプラチン,"",静脈内点滴,"","",130,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22011124,3,3,C,ホリナートカルシウム,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22011124,3,4,C,フルオロウラシル,"",静脈内（明記されていない場合）,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22011124,3,5,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-22011124,3,6,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-22011127,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220310;20220516,20220331;,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,下痢(再投与なし);大腸炎(再投与なし);免疫性肝炎(再投与なし);腸炎(再投与なし),""
AB-22011127,3,2,PS,オキサリプラチン,"",不明;不明,20220310;20220516,20220331;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22011127,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,20220310;20220516,20220331;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22011127,3,4,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22011127,3,5,C,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22011406,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211206,20211220,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,ギラン・バレー症候群(再投与なし),""
AB-22011406,1,2,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
AB-22011406,1,3,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-22011406,1,4,C,アデニン,"",不明,"","","","","","",未知,"",""
AB-22011406,1,5,C,イルベサルタン,"",不明,"","","","","","",未知,"",""
AB-22011406,1,6,C,アムロジピンベシル酸塩,"",経口,"","","","","","",未知,"",""
AB-22011406,1,7,C,ビソプロロールフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-22011476,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,好中球減少症(再投与なし),""
AB-22011476,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202111,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22011476,1,3,C,オキサリプラチン,"",不明,202111,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22011754,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-22011754,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",静脈内点滴,"","","","","","",未知,"",""
AB-22011754,1,3,C,オキサリプラチン,"",静脈内点滴,"","","","","","",未知,"",""
AB-22011759,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22011760,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220408,20220506,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,低血糖(再投与なし);下垂体機能低下症(再投与なし),""
AB-22012145,1,1,PS,カルボプラチン,パラプラチン,"","","","","","",適応症不明の製品使用(Product used for unknown indication),未知,肺臓炎(再投与なし),""
AB-22012145,1,2,PS,パクリタキセル,タキソール,"","","",40,mg,1,適応症不明の製品使用(Product used for unknown indication),未知,肺臓炎(再投与なし),""
AB-22012145,1,3,PS,デュルバルマブ,イミフィンジ,"","","",10,mg/kg,1,非小細胞肺癌(Non-small cell lung cancer),未知,肺臓炎(再投与なし),""
AB-22012359,2,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"","",20210820,100,mg/m2,1,胃癌(Gastric cancer),剂量停止,末梢性ニューロパチー(再投与なし);免疫性腸炎(再投与なし);腹部膨満(再投与なし),""
AB-22012359,2,2,PS,オキサリプラチン,"","","","","","","",胃癌(Gastric cancer),未知,末梢性ニューロパチー(再投与なし);免疫性腸炎(再投与なし);腹部膨満(再投与なし),""
AB-22012359,2,3,PS,399,"","",20210716,20210825,100,mg,1,悪液質(Cancer cachexia),剂量停止,末梢性ニューロパチー(再投与なし);免疫性腸炎(再投与なし);腹部膨満(再投与なし),""
AB-22012359,2,4,PS,ニボルマブ,オプジーボ,"",202203,202204,240,mg,1,胃癌(Gastric cancer),剂量停止,末梢性ニューロパチー(再投与なし);免疫性腸炎(再投与なし);腹部膨満(再投与なし),""
AB-22012359,2,5,C,ラムシルマブ,"","","",20210813,8,mg/kg,1,胃癌(Gastric cancer),未知,"",""
AB-22012359,2,6,C,バルサルタン・アムロジピンベシル酸塩配合剤,"","","",20210825,"","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-22012359,2,7,C,アムロジピンベシル酸塩,"","","",20210825,5,mg,1,適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-22012359,2,8,C,ラベプラゾールナトリウム,"","","",20210825,10,mg,1,適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-22012359,2,9,C,トラスツズマブデルクステカン,"","","","","","","",胃癌(Gastric cancer),未知,"",""
AB-22012408,2,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,"","",10,mg/kg,1,非小細胞肺癌(CRT後の非小細胞肺癌),未知,"",""
AB-22012491,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,扁平苔癬(再投与なし);類天疱瘡(再投与なし),""
AB-22012491,1,2,C,ボノプラザンフマル酸塩,"",経口,"","","","","","",未知,"",""
AB-22012558,3,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220325,20220508,50,mg,1,遠隔転移を伴う胃癌(胃癌（腹膜播種）),剂量停止,"",""
AB-22012558,3,2,PS,アセトアミノフェン,カロナール,経口,20220307,20220508,500,mg,1,"",剂量停止,"",""
AB-22012558,3,3,PS,ニボルマブ,オプジーボ,静脈内点滴,20220325,20220418,360,mg,1,遠隔転移を伴う胃癌(胃癌（腹膜播種）),剂量停止,"",""
AB-22012558,3,4,PS,オキサリプラチン,"",静脈内点滴,20220325,20220418,170,mg,1,遠隔転移を伴う胃癌(胃癌（腹膜播種）),剂量停止,"",""
AB-22012558,3,5,C,ヒドロモルフォン塩酸塩,"",経口,20220318,20220508,2,mg,1,"",剂量停止,"",""
AB-22012558,3,6,C,酸化マグネシウム,"",経口,20220318,20220508,330,mg,1,"",剂量停止,"",""
AB-22012717,1,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,"","",10,mg/kg,1,非小細胞肺癌(CRT後の非小細胞肺癌),剂量停止,"",""
AB-22012717,1,2,C,気管支拡張剤,"",不明,"","","","","",慢性閉塞性肺疾患(COPD),未知,"",""
AB-22012822,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211228,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-22012822,1,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20220307,"",100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,副腎機能不全(再投与なし),""
AB-22012822,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,20210727;20211228,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22012822,1,4,C,オキサリプラチン,"",不明;不明,20210727;20211228,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22012822,1,5,C,パクリタキセル,"",不明,20220308,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22012822,1,6,C,ラムシルマブ,"",不明,20220308,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22012822,1,7,C,ウルソデオキシコール酸,"",経口,"","","","","","",未知,"",""
AB-22013942,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220314,20220413,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,筋炎(再投与なし),""
AB-22013954,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,サイトメガロウイルス感染再燃(再投与なし);免疫性肝炎(再投与なし),""
AB-22013954,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22013954,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22013962,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202203,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-22013962,2,2,PS,オキサリプラチン,"",静脈内点滴,202203,"",85,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22013962,2,3,PS,フルオロウラシル,"",静脈内点滴,202203,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22013962,2,4,PS,レボホリナートカルシウム,レボホリナート,不明,202203,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22013964,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200916,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,血中甲状腺刺激ホルモン減少(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22014415,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202201,202204,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-22014415,3,2,C,オキサリプラチン,"",不明,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22014415,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22014590,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220125,20220404,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22014590,2,2,C,オキサリプラチン,"",不明,20220125,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22014590,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220125,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22014596,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎皮質刺激ホルモン欠損症(再投与なし);副腎機能不全(再投与なし),""
AB-22014602,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,サイトメガロウイルス感染(再投与なし),""
AB-22014604,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202010,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,低ナトリウム血症(再投与なし);肺毒性(再投与なし),""
AB-22014604,3,2,C,トラスツズマブデルクステカン,"",不明,20210409,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22014604,3,3,C,ウルソデオキシコール酸,"",経口,"","","","","","",未知,"",""
AB-22014604,3,4,C,ランソプラゾール,"",経口,"","","","","","",未知,"",""
AB-22014604,3,5,C,デュロキセチン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-22014604,3,6,C,レボチロキシンナトリウム水和物,"",経口,"","","","","","",未知,"",""
AB-22014943,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220420,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,誤嚥性肺炎(再投与なし);免疫介在性肝障害(再投与なし),""
AB-22014943,4,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220420,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22014943,4,3,C,オキサリプラチン,"",不明,20220420,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22014974,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220105,20220308,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,視床下部−下垂体障害(再投与なし),""
AB-22015228,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220222,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,肺炎(再投与なし),""
AB-22015228,5,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,20220222,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22015228,5,3,C,オキサリプラチン,"",不明,20220222,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22015230,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211220,20220221,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-22015230,5,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20211123,20220523,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22015230,5,3,PS,ホスアプレピタントメグルミン,プロイメンド,静脈内点滴,"",20220221,150,mg,1,悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),不适用,間質性肺疾患(再投与なし),""
AB-22015230,5,4,PS,オランザピン,ジプレキサザイディス,不明,20211116,20220306,5,mg,1,"",不适用,"",""
AB-22015230,5,5,PS,経腸成分栄養剤（６−１）,ツインライン,不明;不明;不明,20211206;20220207;20220221,20220206;20220220;20220306,1200;800;400,mL;mL;mL,1;1;1,"",不适用,"",""
AB-22015230,5,6,PS,ラムシルマブ,サイラムザ,不明;不明,20220307;20220328,20220307;20220328,430;400,mg;mg,1;1,"",不适用,"",""
AB-22015230,5,7,PS,パクリタキセル,"",不明;不明,20220307;20220314,20220307;20220328,118;100,mg;mg,1;1,"",不适用,"",""
AB-22015230,5,8,PS,プレドニゾロンコハク酸エステルナトリウム,プレドニン〔水溶性〕,不明;不明,20220425;20220512,20220511;20220517,60;50,mg;mg,1;1,間質性肺疾患(薬剤性間質性肺炎),剂量停止,"",""
AB-22015230,5,9,PS,プレドニゾロン,プレドニン,経口,20220518,20220531,40,mg,1,間質性肺疾患(薬剤性間質性肺炎),不适用,"",""
AB-22015230,5,10,PS,デキサメタゾン,デカドロン,不明,"",20220223,4,mg,1,予防(予防),不适用,"",""
AB-22015230,5,11,PS,経腸成分栄養剤（９−１）,ラコール,不明,"",20211205,1200,mL,1,"",不适用,"",""
AB-22015230,5,12,PS,オキサリプラチン,"",不明;不明;不明,;20211122;20211220,;;20220221,;130;,;mg;,;1;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22015230,5,13,C,ジフェンヒドラミン,"",局所,20220124,20220905,2,g,1,予防(予防),未知,"",""
AB-22015230,5,14,C,ヘパリン類似物質,"",局所,20220124,20220905,1,g,1,予防(予防),未知,"",""
AB-22015230,5,15,C,ファモチジン,"",不明,20220307,20220411,20,mg,1,予防(予防),未知,"",""
AB-22015230,5,16,C,クロルフェニラミンマレイン酸塩,"",不明,20220307,20220411,5,mg,1,予防(予防),未知,"",""
AB-22015230,5,17,C,Ｌ−アスパラギン酸カリウム,"",不明,20220328,20220530,300,mg,1,"",未知,"",""
AB-22015230,5,18,C,レボフロキサシン水和物,"",不明,20220425,20220502,500,mg,1,予防(予防),未知,"",""
AB-22015230,5,19,C,スルファメトキサゾール・トリメトプリム,"",経口,20220503,20220724,1,{DF},1,予防(予防),未知,"",""
AB-22015230,5,20,C,イソニアジド,"",不明,20220513,20220807,250,mg,1,予防(予防),未知,"",""
AB-22015230,5,21,C,ベンフォチアミン・Ｂ６・Ｂ１２配合剤（１）,"",経口,20220513,20220807,1,{DF},1,予防(予防),未知,"",""
AB-22015230,5,22,C,レボホリナートカルシウム,"",不明;不明;不明,;20211122;20211220,;;20220221,;300;,;mg;,;1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22015230,5,23,C,フルオロウラシル,"",不明;不明;不明;不明;不明;不明,;;20211122;20211122;20211220;20211220,;;;;20220221;20220222,;;600;3500;;,;;mg;mg;;,;;1;1;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22015230,5,24,C,フロセミド,"",不明,"",20220905,20,mg,1,"",未知,"",""
AB-22015230,5,25,C,スピロノラクトン,"",不明,"",20220621,50,mg,1,"",未知,"",""
AB-22015230,5,26,C,半夏瀉心湯,"",不明,"",20220327,7.5,g,1,"",未知,"",""
AB-22015230,5,27,C,パンクレリパーゼ,"",不明,"",20220816,900,mg,1,"",未知,"",""
AB-22015230,5,28,C,塩化ナトリウム,"",不明,"",20220905,6,g,1,"",未知,"",""
AB-22015230,5,29,C,ドンペリドン,"",不明,"",20220614,30,mg,1,"",未知,"",""
AB-22015230,5,30,C,塩化カリウム,"",不明,"",20220327,.5,g,1,"",未知,"",""
AB-22015230,5,31,C,酪酸菌製剤,"",不明,"",20220830,3,g,1,"",未知,"",""
AB-22015230,5,32,C,クエン酸第一鉄ナトリウム,"",経口,"",20220823,100,mg,1,"",未知,"",""
AB-22015230,5,33,C,ランソプラゾール,"",不明,"",20220808,30,mg,1,"",未知,"",""
AB-22015230,5,34,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"",20220328,6.6,mg,1,予防(予防),未知,"",""
AB-22015230,5,35,C,グラニセトロン塩酸塩,"",静脈内（明記されていない場合）,"",20220411,1,mg,1,予防(予防),未知,"",""
AB-22015230,5,36,C,グラニセトロン塩酸塩,"",不明,"",20220221,2,mg,1,予防(予防),未知,"",""
AB-22015230,5,37,C,アズレンスルホン酸ナトリウム水和物,"",頬側,"",20220905,"","","",予防(予防),未知,"",""
AB-22015230,5,38,C,経腸成分栄養剤（１−１）,"",その他(腸瘻),"","","","","",栄養補給(術後栄養管理),未知,"",""
AB-22015232,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,食欲減退(再投与なし);薬物不耐性(再投与なし),""
AB-22015232,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22015232,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22015232,1,4,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22015232,1,5,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22015245,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能亢進症(再投与なし),""
AB-22015401,7,1,PS,パクリタキセル,タキソール,;,20220307;20220314,20220307;20220328,118;100,mg;mg,1;1,適応症不明の製品使用(product used for unknown indication),未知,間質性肺疾患(再投与なし),""
AB-22015401,7,2,PS,ニボルマブ,オプジーボ,"",20211220,20220221,240,mg,1,胃癌(Gastric cancer),未知,間質性肺疾患(再投与なし),""
AB-22015401,7,3,PS,アナモレリン塩酸塩,エドルミズ,"",20211123,20220523,100,mg,1,悪液質(Cancer cachexia),剂量停止,間質性肺疾患(再投与なし);食欲亢進(再投与なし),""
AB-22015401,7,4,PS,ラムシルマブ,サイラムザ,;,20230307;20230323,20230307;20230323,430;400,mg;mg,1;1,適応症不明の製品使用(product used for unknown indication),不适用,間質性肺疾患(再投与なし);食欲亢進(再投与なし),""
AB-22015401,7,5,PS,オキサリプラチン,"",;;,;20211122;20211220,;;20220221,;130;,;mg;,;1;,胃癌(Gastric Cancer),不适用,間質性肺疾患(再投与なし);食欲亢進(再投与なし),""
AB-22015401,7,6,C,プレドニゾロン,"",;;,20220425;20220512;20220518,20220511;20220517;20220531,60;50;40,mg;mg;mg,1;1;1,間質性肺疾患(Interstitial pneumonia),未知,"",""
AB-22015401,7,7,C,ラムシルマブ,"","",20220307,"","","","",適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,8,C,経腸成分栄養剤（９−１）,"","","",20211205,1200,mL,1,経腸栄養(eneteral nutrition),未知,"",""
AB-22015401,7,9,C,デキサメタゾン,"","","",20220223,4,mg,1,予防(Prophylaxis),剂量不变,"",""
AB-22015401,7,10,C,オランザピン,"","",20211116,20220306,5,mg,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,11,C,ホスアプレピタントメグルミン,"","","",20220221,150,mg,1,悪心・嘔吐の予防(Prophylaxis against chemotherapy induced vomiting),剂量不变,"",""
AB-22015401,7,12,C,フロセミド,"","",20220905,"",20,mg,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,13,C,スピロノラクトン,"","","",20220621,50,mg,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,14,C,パンクレリパーゼ,"","","",20220816,900,mg,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,15,C,塩化ナトリウム,"","","",20220905,6,g,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,16,C,ドンペリドン,"","",20220614,"",30,mg,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,17,C,塩化カリウム,"","","",20220327,0.5,g,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,18,C,酪酸菌製剤,"","","",20220830,3,g,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,19,C,クエン酸第一鉄ナトリウム,"","","",20220823,100,mg,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,20,C,ランソプラゾール,"","","",20220808,30,mg,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,21,C,デキサメタゾンリン酸エステルナトリウム,"","","",20220328,6.6,mg,1,予防(Prophylaxis),未知,"",""
AB-22015401,7,22,C,グラニセトロン塩酸塩,"","","",20220411,1,mg,1,予防(Prophylaxis),未知,"",""
AB-22015401,7,23,C,グラニセトロン塩酸塩,"","","",20220221,2,mg,1,予防(Prophylaxis),未知,"",""
AB-22015401,7,24,C,経腸成分栄養剤（６−１）,"",;;,20211206;20220207;20220221,20220206;20220220;20220306,1200;800;400,mL;mL;mL,1;1;1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,25,C,アズレンスルホン酸ナトリウム水和物,"","","",20220905,"","","",予防(Prophylaxis),未知,"",""
AB-22015401,7,26,C,経腸成分栄養剤（１−１）,"","","","","","","",栄養補給(Nutritional supplementation),未知,"",""
AB-22015401,7,27,C,レボホリナートカルシウム,"",;;,;20211122;20211220,;;20220221,;300;,;mg;,;1;,胃癌(Gastric cancer),未知,"",""
AB-22015401,7,28,C,フルオロウラシル,"",;;;,20211122;20211122;20211220;20211220,;;20220221;20220222,600;3500;;,mg;mg;;,1;1;;,胃癌(Gastric cancer),未知,"",""
AB-22015401,7,29,C,半夏瀉心湯,"","","",20220327,7.5,g,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22015401,7,30,C,ジフェンヒドラミン,"","",20220124,20220905,2,g,1,予防(Prophylaxis),未知,"",""
AB-22015401,7,31,C,ヘパリン類似物質,"","",20220124,20220905,1,g,1,予防(Prophylaxis),未知,"",""
AB-22015401,7,32,C,ファモチジン,"","",20220307,20220411,20,mg,1,予防(Prophylaxis),未知,"",""
AB-22015401,7,33,C,ｄ−クロルフェニラミンマレイン酸塩,"","",20220307,20220411,5,mg,1,予防(Prophylaxis),未知,"",""
AB-22015401,7,34,C,レボフロキサシン水和物,"","",20220425,20220502,500,mg,1,予防(Prophylaxis),未知,"",""
AB-22015401,7,35,C,スルファメトキサゾール・トリメトプリム,"","",20220503,20220724,1,{DF},1,予防(Prophylaxis),未知,"",""
AB-22015401,7,36,C,イソニアジド,"","",20220513,20220807,250,mg,1,予防(Prophylaxis),未知,"",""
AB-22015401,7,37,C,シアノコバラミン,"","",20220513,20220807,1,{DF},1,予防(Prophylaxis),未知,"",""
AB-22015401,7,38,C,Ｌ−アスパラギン酸カリウム,"","",20220328,20220530,300,mg,1,"",未知,"",""
AB-22015568,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220427,20220427,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,脳出血(再投与なし),""
AB-22015580,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210806,20211015,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,脳梗塞(再投与なし),""
AB-22016076,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220512,202206,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22016076,2,2,C,オキサリプラチン,"",静脈内（明記されていない場合）,20220512,"",130,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22016076,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220512,"",40,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22016642,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220201,20220531,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22016976,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,類天疱瘡(再投与なし),""
AB-22016981,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220603,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,多形紅斑(再投与なし),""
AB-22016981,1,2,PS,オキサリプラチン,"",不明,20220603,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-22016981,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220603,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-22017320,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(胃癌の術後補助療法),剂量停止,急性副腎皮質機能不全(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22017328,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202202;202206,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能亢進症(不明),""
AB-22017328,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22017328,2,3,C,オキサリプラチン,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22017434,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,脳症(再投与なし),""
AB-22017689,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,類天疱瘡(再投与なし),""
AB-22018376,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20220415,"",200,mg,1,胃癌(MSI-High癌（結腸・直腸以外）),剂量不变,関節リウマチ(再投与なし),""
AB-22018376,3,2,C,ラクツロース,"",経口,不明,"","","","","",未知,"",""
AB-22018376,3,3,C,ブロチゾラム,"",不明,不明,"","","","","",未知,"",""
AB-22018595,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝障害(再投与なし),""
AB-22018597,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220121,20220311,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,劇症１型糖尿病(再投与なし),""
AB-22018598,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220318,20220527,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし),""
AB-22018598,2,2,PS,オキサリプラチン,"",不明,20220318,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22018598,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220318,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22018980,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202201,202204,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22019270,1,1,PS,ベバシズマブ,アバスチン,静脈内点滴,20220128,20220218,915,mg,1,肝細胞癌(肝細胞癌),剂量停止,胃穿孔(再投与なし),""
AB-22019270,1,2,PS,アテゾリズマブ,テセントリク,静脈内点滴,20220128,20220218,1200,mg,1,肝細胞癌(肝細胞癌),剂量停止,胃穿孔(再投与なし),""
AB-22019270,1,3,C,アセトアミノフェン,"",不明,20210128,"","","","","",未知,"",""
AB-22019270,1,4,C,ファモチジン,"",不明,20211206,20220314,"","","","",未知,"",""
AB-22019270,1,5,C,ウルソデオキシコール酸,"",不明,20211214,20220407,"","","","",未知,"",""
AB-22019270,1,6,C,テノホビルアラフェナミドフマル酸塩,"",経口,20211214,"","","","","",未知,"",""
AB-22019270,1,7,C,ロキソプロフェンナトリウム水和物,"",不明,20211228,20220406,"","","","",未知,"",""
AB-22019270,1,8,C,メトクロプラミド,"",経口,20220111,"","","","","",未知,"",""
AB-22019490,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220118,20220510,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,低カリウム血症(再投与なし);下痢(再投与なし);大腸炎(再投与なし);腹痛(再投与なし),""
AB-22019490,1,2,C,腸癰湯,"",経口,"","","","","","",未知,"",""
AB-22019490,1,3,C,桂枝加芍薬湯,"",経口,"","","","","","",未知,"",""
AB-22019490,1,4,C,モサプリドクエン酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-22019490,1,5,C,サナクターゼ配合剤,"",経口,"","","","","","",未知,"",""
AB-22019490,1,6,C,ランソプラゾール,"",経口,"","","","","","",未知,"",""
AB-22019490,1,7,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
AB-22019490,1,8,C,センノシド,"",経口,"","","","","","",未知,"",""
AB-22019723,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210212;20210823,20210622;,;,;,;,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),剂量停止,続発性副腎皮質機能不全(再投与なし);下垂体機能低下症(再投与なし),""
AB-22019723,1,2,PS,イピリムマブ,ヤーボイ,静脈内点滴;静脈内点滴,20210212;20210823,20210622;,;,;,;,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),剂量停止,"",""
AB-22020154,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220421,20220602,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,意識消失(再投与なし),""
AB-22020154,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22020154,3,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22020332,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220524,20220524,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-22020332,4,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口;経口,20201020;20220524;20220705,20211004;20220605;,;50;40,;mg;mg,;1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22020332,4,3,PS,オキサリプラチン,"",静脈内（明記されていない場合）;静脈内（明記されていない場合）,20220524;20220705,20220524;,160;120,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22020332,4,4,C,ランソプラゾール,"",経口,20220524,"",15,mg,1,"",未知,"",""
AB-22020332,4,5,C,ウルソデオキシコール酸,"",経口,20220524,"",100,mg,1,"",未知,"",""
AB-22020336,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220119,20220601,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22020336,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20211222,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22020336,2,3,C,オキサリプラチン,"",静脈内点滴,20211222,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22020722,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,静脈閉塞性肝疾患(再投与なし),""
AB-22020722,2,2,PS,オキサリプラチン,エルプラット,不明;不明,;,;,130;,mg/m2;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22020722,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22021202,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171003,20180108,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,肝障害(再投与なし),""
AB-22021209,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211012,20220323,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-22021544,6,1,PS,アナモレリン塩酸塩,エドルミズ,経口,20210823,20220117,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),不适用,白内障(再投与なし);白内障(再投与なし);脱水(再投与なし);緑内障(再投与なし),""
AB-22021544,6,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20220117,20220214,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,白内障(再投与なし);白内障(再投与なし);脱水(再投与なし);緑内障(再投与なし),""
AB-22021544,6,3,PS,アプレピタント,イメンド,経口;経口;経口;経口,20210823;20210824;20210913;20210914,20210823;20210826;20210913;20210916,125;80;125;80,mg;mg;mg;mg,1;1;1;1,悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),不适用,白内障(再投与なし);白内障(再投与なし);脱水(再投与なし);緑内障(再投与なし),""
AB-22021544,6,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20210713,20210927,100,mg,1,胃癌(胃癌),不适用,"",""
AB-22021544,6,5,PS,オキサリプラチン,"",不明;不明,20210713;20220228,20210914;20220328,150;130,mg;mg,1;1,胃癌(胃癌),不适用,"",""
AB-22021544,6,6,PS,デキサメタゾンリン酸エステルナトリウム,オルガドロン,不明;不明;不明;不明;不明;不明;不明,20210823;20210913;20211025;20211101;20211122;20211213;20211227,20210823;20210913;20211025;20211101;20211122;20211213;20211227,3.8;3.8;7.6;7.6;7.6;7.6;7.6,mg;mg;mg;mg;mg;mg;mg,1;1;1;1;1;1;1,予防(予防),不适用,"",""
AB-22021544,6,7,PS,デキサメタゾン,デカドロン,不明;不明,20210824;20210914,20210826;20210916,2;2,mg;mg,1;1,予防(予防),不适用,"",""
AB-22021544,6,8,PS,ラムシルマブ,サイラムザ,不明,20211025,20211227,370,mg,1,胃癌(胃癌),不适用,"",""
AB-22021544,6,9,PS,パクリタキセル,"",不明,20211025,20211227,110,mg,1,胃癌(胃癌),不适用,"",""
AB-22021544,6,10,C,オランザピン,"",不明;不明,20210823;20210913,20210827;20210917,5;5,mg;mg,1;1,予防(予防),未知,"",""
AB-22021544,6,11,C,パロノセトロン塩酸塩,"",静脈内点滴;静脈内点滴,20210823;20210913,20210823;20210913,.75;.75,mg;mg,1;1,予防(予防),未知,"",""
AB-22021544,6,12,C,ファモチジン,"",不明;不明;不明;不明;不明,20211025;20211101;20211122;20211213;20211227,20211025;20211101;20211122;20211213;20211227,20;20;20;20;20,mg;mg;mg;mg;mg,1;1;1;1;1,予防(予防),未知,"",""
AB-22021544,6,13,C,ｄ−クロルフェニラミンマレイン酸塩,"",不明;不明;不明;不明;不明;不明;不明;不明,20211025;20211101;20211122;20211213;20211227;20220117;20220131;20220214,20211025;20211101;20211122;20211213;20211227;20220117;20220131;20220214,5;5;5;5;5;5;5;5,mg;mg;mg;mg;mg;mg;mg;mg,1;1;1;1;1;1;1;1,予防(予防),未知,"",""
AB-22021544,6,14,C,酪酸菌製剤,"",経口,20211125,20211206,3,{DF},1,予防(予防),未知,"",""
AB-22021544,6,15,C,カペシタビン,"",不明,20220228,20220403,1800,mg,1,胃癌(胃癌),未知,"",""
AB-22021544,6,16,C,ピリドキサールリン酸エステル水和物,"",不明,"",20211025,30,mg,1,予防(予防),未知,"",""
AB-22021544,6,17,C,デキストロメトルファン臭化水素酸塩水和物,"",不明,"",20220522,15,mg,1,"",未知,"",""
AB-22021544,6,18,C,エソメプラゾールマグネシウム水和物,"",不明,"",20220425,20,mg,1,予防(予防),未知,"",""
AB-22021853,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし);肝炎(再投与なし),""
AB-22021855,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220106,20220421,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22021855,4,2,PS,アプレピタント,イメンド,経口,20220421,20220423,"","","",悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),不适用,間質性肺疾患(再投与なし),""
AB-22021855,4,3,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20211209;20220106;20220310;20220421,;;;20220421,175;137;122;85,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22021855,4,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20211209;20220106,;20220425,60;40,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22021855,4,5,C,オランザピン,"",経口,20220421,20220425,"","","","",未知,"",""
AB-22021855,4,6,C,生理食塩液,"",静脈内（明記されていない場合）,20220421,20220421,"","","","",未知,"",""
AB-22021855,4,7,C,ブドウ糖,"",静脈内（明記されていない場合）,20220421,20220421,"","","","",未知,"",""
AB-22021855,4,8,C,ｄ−クロルフェニラミンマレイン酸塩,"",静脈内（明記されていない場合）,20220421,20220421,"","","","",未知,"",""
AB-22021855,4,9,C,パロノセトロン塩酸塩,"",静脈内点滴,20220421,20220421,"","","","",未知,"",""
AB-22021855,4,10,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内（明記されていない場合）,20220421,20220421,"","","","",未知,"",""
AB-22021855,4,11,C,デキサメタゾン,"",経口,20220422,20220423,"","","","",未知,"",""
AB-22022617,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肝障害(再投与なし),""
AB-22022618,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし),""
AB-22022624,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-22022699,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腸炎(再投与なし),""
AB-22022699,2,2,C,オキサリプラチン,"",不明;不明,;,;,100;,mg/m2;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22022699,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,120;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22022984,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220228,20220613,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-22022984,2,2,C,オキサリプラチン,"",静脈内（明記されていない場合）;静脈内（明記されていない場合）,;,;,130;80,mg/m2;mg/m2,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22022984,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22022986,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220517,20220517,480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,エヴァンズ症候群(再投与なし),""
AB-22022986,3,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20220329,"",100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,エヴァンズ症候群(再投与なし),""
AB-22022986,3,3,C,ロスバスタチンカルシウム,"",経口,20171226,"",5,mg,1,"",未知,"",""
AB-22022986,3,4,C,アスピリン・ランソプラゾール配合剤,"",経口,20171226,"",1,{DF},1,"",未知,"",""
AB-22022986,3,5,C,ビソプロロールフマル酸塩,"",経口,20171226,"",1.25,mg,1,"",未知,"",""
AB-22022986,3,6,C,エゼチミブ・ロスバスタチンカルシウム配合剤,"",経口,20210707,"",1,{DF},1,"",未知,"",""
AB-22022986,3,7,C,ラムシルマブ,"",不明,20220308,20220509,"","","","",未知,"",""
AB-22022986,3,8,C,パクリタキセル,"",不明,20220308,20220509,"","","","",未知,"",""
AB-22023299,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220204,20220506,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし);免疫性腸炎(再投与なし),""
AB-22023299,1,2,C,牛車腎気丸,"",経口,20220107,"","","","","",未知,"",""
AB-22023299,1,3,C,オキサリプラチン,"",静脈内（明記されていない場合）,20220204,20220506,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22023299,1,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220204,20220520,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22023299,1,5,C,メコバラミン,"",経口,"","","","","","",未知,"",""
AB-22023697,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220315,20220426,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,急性副腎皮質機能不全(再投与なし),""
AB-22023697,1,2,C,リバーロキサバン,"",経口,"","","","","","",未知,"",""
AB-22023701,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,免疫性内分泌障害(再投与なし),""
AB-22023701,1,2,PS,アプレピタント,イメンド,経口,"","","","","",悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),未知,免疫性内分泌障害(再投与なし),""
AB-22023701,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22023701,1,4,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22023701,1,5,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22023711,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220203,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-22023711,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22023711,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22023717,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺うっ血(再投与なし),""
AB-22023717,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22023717,3,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024052,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220208,20220531,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22024054,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220209,20220225,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-22024054,3,2,C,オキサリプラチン,"",不明,20220209,20220225,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024054,3,3,C,フルオロウラシル,"",不明,20220209,20220225,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024054,3,4,C,レボホリナートカルシウム,"",不明,20220209,20220225,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024054,3,5,C,パクリタキセル（アルブミン懸濁型）,"",不明,20220322,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024054,3,6,C,ラムシルマブ,"",不明,20220322,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024186,1,1,PS,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(胃がん),未知,"",""
AB-22024186,1,2,PS,フルオロウラシル,"",静脈内点滴,"","","","","",胃癌(胃がん),未知,"",""
AB-22024186,1,3,PS,レボホリナートカルシウム,レボホリナート,静脈内点滴,"","","","","",胃癌(胃がん),未知,"",""
AB-22024186,1,4,PS,ニボルマブ,"",静脈内点滴,"","","","","",胃癌(胃がん),未知,"",""
AB-22024456,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,多形紅斑(再投与なし),""
AB-22024456,2,2,PS,コロナウイルスワクチン,"",不明,"","","","","","",不适用,"",""
AB-22024456,2,3,C,モサプリドクエン酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-22024456,2,4,C,ドンペリドン,"",経口,"","","","","","",未知,"",""
AB-22024456,2,5,C,補中益気湯,"",経口,"","","","","","",未知,"",""
AB-22024456,2,6,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","","",未知,"",""
AB-22024456,2,7,C,セファランチン,"",経口,"","","","","","",未知,"",""
AB-22024458,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220412,20220412,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,骨髄異形成症候群(再投与なし),""
AB-22024458,2,2,C,フルオロウラシル,"",不明,20220328,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024458,2,3,C,レボホリナートカルシウム,"",不明,20220328,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024458,2,4,C,オキサリプラチン,"",不明,20220328,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024458,2,5,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-22024458,2,6,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-22024458,2,7,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-22024458,2,8,C,フェンタニルクエン酸塩,"",経皮,"","","","","","",未知,"",""
AB-22024458,2,9,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-22024458,2,10,C,ハロペリドール,"",不明,"","","","","",感情的苦悩(苦痛),未知,"",""
AB-22024458,2,11,C,ミダゾラム,"",不明,"","","","","",感情的苦悩(苦痛),未知,"",""
AB-22024462,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220328,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,免疫性腸炎(再投与なし),""
AB-22024462,2,2,C,オキサリプラチン,"",不明,20220328,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024462,2,3,C,カペシタビン,"",不明,20220328,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024463,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,心嚢液貯留(再投与なし),""
AB-22024463,1,2,C,パクリタキセル,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024463,1,3,C,ラムシルマブ,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024620,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210727,20211221,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-22024620,2,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20210625,20220504,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22024620,2,3,PS,パクリタキセル,"",不明,20220118,20220412,120,mg,1,胃癌(胃癌);食道癌(食道癌),不适用,"",""
AB-22024620,2,4,C,オキシコドン塩酸塩水和物,"",不明,"",20220509,10,mg,1,"",未知,"",""
AB-22024620,2,5,C,オキシコドン塩酸塩水和物,"",不明,"",20220509,15,mg,1,"",未知,"",""
AB-22024620,2,6,C,フロセミド,"",不明,"",20220509,20,mg,1,"",未知,"",""
AB-22024620,2,7,C,アンブロキソール塩酸塩,"",不明,"",20220509,45,mg,1,"",未知,"",""
AB-22024620,2,8,C,酸化マグネシウム,"",不明,"",20220509,2,g,1,予防(予防),未知,"",""
AB-22024620,2,9,C,スボレキサント,"",不明,"",20220509,15,mg,1,"",未知,"",""
AB-22024620,2,10,C,セレコキシブ,"",不明,"",20220509,200,mg,1,"",未知,"",""
AB-22024620,2,11,C,ピコスルファートナトリウム水和物,"",不明,"",20220504,"","","",予防(予防),未知,"",""
AB-22024620,2,12,C,モサプリドクエン酸塩水和物,"",不明,"",20220504,15,mg,1,"",未知,"",""
AB-22024620,2,13,C,アセトアミノフェン,"",不明,"",20220509,1800,mg,1,"",未知,"",""
AB-22024623,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,特発性間質性肺炎(再投与なし),""
AB-22024632,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202205,"",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,中枢性甲状腺機能低下症(再投与なし),""
AB-22024860,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220210,20220506,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,食欲減退(再投与なし);肺臓炎(再投与なし),""
AB-22024860,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口;経口,20220210;20220303;,;;20220825,80;80;,mg;mg;,1;1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024860,2,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20220210;20220805;20220825,20220506;20220805;20220825,143;140;100,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22024878,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20171214;20180626,20171214;20180919,170;150,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(無),""
AB-22024878,3,2,C,ニフェジピン,"",経口,"","",40,mg,1,"",未知,"",""
AB-22024878,3,3,C,エンテカビル水和物,"",経口,"","",.5,mg,1,"",未知,"",""
AB-22024878,3,4,C,オルメサルタンメドキソミル,"",経口,"","",20,mg,1,"",未知,"",""
AB-22024889,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,器質化肺炎(再投与なし),""
AB-22025348,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,過敏性肺臓炎(再投与なし),""
AB-22025428,3,1,PS,パクリタキセル,タキソール,"",20220118,20220412,120,mg,1,胃癌(Gastric cancer);食道癌(Oesophageal carcinoma),不适用,高血糖(再投与なし);間質性肺疾患(再投与なし),""
AB-22025428,3,2,PS,ニボルマブ,オプジーボ,"",20210727,20211221,240,mg,1,胃癌(GASTRIC CANCER),不适用,高血糖(再投与なし);間質性肺疾患(再投与なし),""
AB-22025428,3,3,PS,アナモレリン塩酸塩,エドルミズ,"",20210625,20220504,100,mg,1,悪液質(CANCER CACHEXIA),剂量停止,高血糖(再投与なし);間質性肺疾患(再投与なし),""
AB-22025428,3,4,C,オキシコドン塩酸塩水和物,"","","",20220509,10,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22025428,3,5,C,フロセミド,"","","",20220509,20,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22025428,3,6,C,AMBROXOLHYDROCHLORIDE,"","","",20220509,45,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22025428,3,7,C,酸化マグネシウム,"","","",20220509,2,g,1,予防(Prophylaxis),未知,"",""
AB-22025428,3,8,C,スボレキサント,"","","",20220509,15,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22025428,3,9,C,セレコキシブ,"","","",20220509,200,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22025428,3,10,C,PARACETAMOL,"","","",20220509,1800,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22025428,3,11,C,オキシコドン塩酸塩水和物,"","","",20220509,15,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22025428,3,12,C,ピコスルファートナトリウム水和物,"","","",20220504,"","","",予防(Prophylaxis),未知,"",""
AB-22025428,3,13,C,モサプリドクエン酸塩水和物,"","","",20220504,15,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22025717,1,1,PS,イピリムマブ,ヤーボイ,"","","","","","",非小細胞肺癌(Non-small cell lung cancer),剂量停止,肺障害(再投与なし);肝障害(再投与なし),""
AB-22025717,1,2,PS,ニボルマブ,オプジーボ,"","","","","","",非小細胞肺癌(Non-small cell lung cancer),剂量停止,肺障害(再投与なし);肝障害(再投与なし),""
AB-22025983,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220609,20220720,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-22025983,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22025983,2,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22025983,2,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22026405,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220118;20220208,20220118;20220607,240;480,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22026405,7,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20220329,"",100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),未知,間質性肺疾患(再投与なし),""
AB-22026405,7,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,20220118,"",120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22026405,7,4,PS,オキサリプラチン,エルプラット,不明,20220118,"",130,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22026405,7,5,C,ピオグリタゾン塩酸塩,"",不明,"","","","","",高血圧(高血圧),未知,"",""
AB-22026744,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22026744,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22026744,2,3,C,オキサリプラチン,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22026758,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-22026758,2,2,C,オキサリプラチン,"",不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22026758,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22026760,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-22026760,2,2,C,オキサリプラチン,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22026760,2,3,C,フルオロウラシル,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22026760,2,4,C,レボホリナートカルシウム,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22026774,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,202112;不明,;,200;200,mg;mg,1;1,胃癌(MSI-High癌（結腸・直腸以外）、胃癌),剂量停止,心不全(不明),""
AB-22027042,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202104;202110,202109;,;,;,;,結腸癌(がん化学療法後に増悪した治癒切除不能な進行・再発の高頻度マイクロサテライト不安定性（MSI-High）を有する結腸・直腸癌),剂量停止,免疫介在性腎障害(再投与なし),""
AB-22027045,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202004,"","","","",食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),未知,リンパ球性下垂体炎(再投与なし),""
AB-22027754,1,1,PS,アムロジピンベシル酸塩,アムロジピンＯＤ,経口,"","","","","",高血圧(高血圧),剂量停止,"",""
AB-22027754,1,2,PS,ニボルマブ,"",静脈内点滴,"","","","","",胃癌(胃癌);食道癌(食道癌),剂量不变,"",""
AB-22027754,1,3,C,アスピリン,"",経口,"","","","","","",未知,"",""
AB-22027754,1,4,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
AB-22027754,1,5,C,アンブロキソール塩酸塩,"",経口,"","","","","","",未知,"",""
AB-22027754,1,6,C,ウルソデオキシコール酸,"",経口,"","","","","","",未知,"",""
AB-22027918,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220620,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,劇症１型糖尿病(再投与なし),""
AB-22027918,2,2,PS,オキサリプラチン,"",静脈内点滴,20220620,"",200,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-22027918,2,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20220621,"",60,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-22027918,2,4,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20220620,"",6.6,mg,1,予防(予防),未知,"",""
AB-22027918,2,5,C,パロノセトロン塩酸塩,"",静脈内点滴,20220620,"",.75,mg,1,予防(予防),未知,"",""
AB-22027944,3,1,PS,オキサリプラチン,エルプラット：点滴静注液,"",20220516,20220704,150,mg,1,胃癌(HER2陰性進行胃癌),剂量停止,"",""
AB-22027944,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220516,20220627,80,mg,1,胃癌(HER2陰性進行胃癌),未知,"",""
AB-22027944,3,3,PS,ニボルマブ,"","",20220516,20220704,360,mg,1,胃癌(HER2陰性進行胃癌),未知,"",""
AB-22027944,3,4,C,パロノセトロン塩酸塩,"","",20220516,20220704,.75,mg,1,"",未知,"",""
AB-22027944,3,5,C,デキサメタゾンリン酸エステルナトリウム,"","",20220516,20220704,9.9,mg,1,"",未知,"",""
AB-22027944,3,6,C,カルベジロール,"",経口,"",20220704,20,mg,1,高血圧(高血圧症),未知,"",""
AB-22027944,3,7,C,アムロジピンベシル酸塩,"",経口,"",20220704,2.5,mg,1,高血圧(高血圧症),未知,"",""
AB-22027944,3,8,C,ラフチジン,"",経口,"",20220704,10,mg,1,"",未知,"",""
AB-22027944,3,9,C,エルデカルシトール,"",経口,"",20220704,.75,ug,1,"",未知,"",""
AB-22027944,3,10,C,メナテトレノン,"",経口,"",20220704,15,mg,1,"",未知,"",""
AB-22028003,1,1,PS,アムロジピンベシル酸塩,アムロジピン,経口,"","","","","",高血圧(高血圧),剂量停止,"",""
AB-22028003,1,2,PS,ニボルマブ,"",静脈内点滴,"","","","","",胃癌(胃癌);食道癌(食道癌),剂量减少,"",""
AB-22028003,1,3,C,アンブロキソール塩酸塩,"",経口,"","","","","","",未知,"",""
AB-22028003,1,4,C,アスピリン,"",経口,"","","","","","",未知,"",""
AB-22028003,1,5,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
AB-22028003,1,6,C,ウルソデオキシコール酸,"",経口,"","","","","","",未知,"",""
AB-22028074,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220510,"",120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-22028074,1,2,C,オキサリプラチン,"",不明,20220510,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22028074,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220510,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22028075,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220325,20220418,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,劇症肝炎(再投与なし),""
AB-22028075,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20220325,20220501,50,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22028075,3,3,C,アセトアミノフェン,"",経口,20220307,20220508,500,mg,1,胃癌(胃癌),未知,"",""
AB-22028075,3,4,C,ヒドロモルフォン塩酸塩,"",経口,20220307,20220508,1,mg,1,胃癌(胃癌),未知,"",""
AB-22028075,3,5,C,ランソプラゾール,"",経口,20220311,20220603,15,mg,1,予防(予防),未知,"",""
AB-22028075,3,6,C,ヒドロモルフォン塩酸塩,"",経口,20220318,20220508,2,mg,1,胃癌(胃癌),未知,"",""
AB-22028075,3,7,C,酸化マグネシウム,"",経口,20220318,"",330,mg,1,予防(予防),未知,"",""
AB-22028075,3,8,C,オキサリプラチン,"",静脈内点滴,20220325,20220418,170,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22028075,3,9,C,ナルデメジントシル酸塩,"",経口,20220408,20220521,.2,mg,1,予防(予防),未知,"",""
AB-22028075,3,10,C,レボチロキシンナトリウム水和物,"",経口,"","",50,ug,1,甲状腺機能低下症(甲状腺機能低下症),未知,"",""
AB-22028075,3,11,C,グラニセトロン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-22028075,3,12,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
AB-22028077,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220527,20220610,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-22028419,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220217,20220217,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,小腸炎(再投与なし);大腸炎(再投与なし);脱水(再投与なし),""
AB-22028419,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,20220217,"",120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22028419,3,3,C,オキサリプラチン,"",不明;不明,20220217;,;,130;,mg/m2;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22028763,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220405,20220705,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腸炎(再投与なし),""
AB-22028763,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20220405,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22028763,1,3,PS,オキサリプラチン,"",静脈内点滴,20220405,20220705,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22028764,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171016,20191030,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-22028770,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210701,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-22028853,3,1,PS,アナモレリン塩酸塩,エドルミズ,経口,20220325,20220408,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,腎盂腎炎(再投与なし),""
AB-22028853,3,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20220324,20220413,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腎盂腎炎(再投与なし),""
AB-22028853,3,3,C,オキサリプラチン,"",不明,20220324,20220413,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22028853,3,4,C,カペシタビン,"",不明,20220324,20220413,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22028853,3,5,C,トラマドール塩酸塩,"",経口,20220405,20220408,50,mg,1,胃癌(胃癌),未知,"",""
AB-22028853,3,6,C,アムロジピンベシル酸塩,"",経口,"",20220408,5,mg,1,"",未知,"",""
AB-22028853,3,7,C,ロスバスタチンカルシウム,"",経口,"",20220408,5,mg,1,"",未知,"",""
AB-22028853,3,8,C,ナルデメジントシル酸塩,"",経口,"",20220408,.2,mg,1,"",未知,"",""
AB-22028853,3,9,C,エソメプラゾールマグネシウム水和物,"",経口,"",20220408,20,mg,1,予防(予防),未知,"",""
AB-22029090,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,自己免疫性脳炎(再投与なし),""
AB-22029095,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220225;20220606,;20220606,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,シェーグレン症候群(再投与なし),""
AB-22029095,3,2,C,フェブキソスタット,"",経口,20220222,20220712,10,mg,1,"",未知,"",""
AB-22029095,3,3,C,オキサリプラチン,"",不明;不明,20220225;20220606,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22029095,3,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,20220225;20220606,;,40;40,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22029095,3,5,C,アミノ酸・糖・電解質・ビタミン（２−６）,"",静脈内（明記されていない場合）,20220306,"",1000,mL,1,"",未知,"",""
AB-22029095,3,6,C,オルメサルタンメドキソミル,"",経口,20220320,"",20,mg,1,"",未知,"",""
AB-22029095,3,7,C,アゼルニジピン,"",経口,20220320,"",16,mg,1,"",未知,"",""
AB-22029095,3,8,C,ピタバスタチンカルシウム,"",経口,20220320,"",1,mg,1,"",未知,"",""
AB-22029095,3,9,C,トリクロルメチアジド,"",経口,20220320,"",1,mg,1,"",未知,"",""
AB-22029095,3,10,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-22029095,3,11,C,エルデカルシトール,"",経口,"","",.75,ug,1,"",未知,"",""
AB-22029514,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220401,20220701,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22029514,2,2,C,オキサリプラチン,"",不明,20220401,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22029514,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220401,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22029516,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-22029516,1,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20211228,202204,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,１型糖尿病(再投与なし),""
AB-22029522,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-22029522,1,2,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22029522,1,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22029522,1,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22029906,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220530,20220530,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,歩行障害(再投与なし),""
AB-22029906,3,2,PS,ホスアプレピタントメグルミン,プロイメンド,静脈内点滴,20220502,20220530,150,mg,1,悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),不适用,歩行障害(再投与なし),""
AB-22029906,3,3,PS,アナモレリン塩酸塩,エドルミズ,経口,20220523,"",100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,歩行障害(再投与なし),""
AB-22029906,3,4,PS,オキサリプラチン,"",静脈内点滴,20220411,20220530,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22029906,3,5,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220411,20220614,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22029906,3,6,PS,パロノセトロン塩酸塩,パロノセトロン,静脈内点滴,20220411,20220530,.75,mg,1,予防(予防),不适用,"",""
AB-22029906,3,7,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20220411,"",9.9,mg,1,予防(予防),未知,"",""
AB-22029906,3,8,C,デキサメタゾン,"",経口,20220411,20220602,4,{DF},1,予防(予防),未知,"",""
AB-22029906,3,9,C,オランザピン,"",経口,20220411,20220602,5,mg,1,予防(予防),未知,"",""
AB-22029922,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220106;20220422,;20220624,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,倦怠感(再投与なし);免疫性腸炎(再投与なし);免疫性下垂体炎(再投与なし);下痢(再投与なし);発熱(再投与なし);食欲減退(再投与なし),""
AB-22029922,5,2,C,オキサリプラチン,"",不明;不明,20220106;20220422,;20220624,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22029922,5,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220106,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22029922,5,4,C,パクリタキセル,"",不明,20220218,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22029922,5,5,C,レボホリナートカルシウム,"",不明,20220422,20220624,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22029922,5,6,C,フルオロウラシル,"",不明,20220422,20220624,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22030168,5,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,20220622,20220712,1200,mg,1,肝細胞癌(肝細胞癌),剂量停止,皮膚障害(再投与なし);乾癬(不明),""
AB-22030168,5,2,PS,ベバシズマブ,アバスチン,静脈内点滴,20220622,20220712,848,mg,1,肝細胞癌(肝細胞癌),剂量停止,皮膚障害(再投与なし);乾癬(再投与なし),""
AB-22030168,5,3,C,カルシポトリオール水和物・ベタメタゾンジプロピオン酸エステル,"",局所,20220531,20220731,"","","",乾癬(尋常性乾癬),未知,"",""
AB-22030168,5,4,C,レバミピド,"",経口,20220613,20220731,100,mg,1,"",未知,"",""
AB-22030168,5,5,C,ロキソプロフェンナトリウム水和物,"",経口,20220613,20220731,60,mg,1,"",未知,"",""
AB-22030168,5,6,C,イソロイシン・ロイシン・バリン,"",経口,20220624,"",4.74,mg,1,"",未知,"",""
AB-22030168,5,7,C,エピナスチン塩酸塩,"",経口,20220711,"",20,mg,1,"",未知,"",""
AB-22030168,5,8,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",局所,20220711,20220731,"","","","",未知,"",""
AB-22030168,5,9,C,酪酸菌配合剤,"",経口,20220719,20220731,"","","","",未知,"",""
AB-22030168,5,10,C,アムロジピンベシル酸塩,"",経口,"",20220814,2.5,mg,1,"",未知,"",""
AB-22030168,5,11,C,カンデサルタンシレキセチル,"",経口,"",20220814,2,mg,1,"",未知,"",""
AB-22030168,5,12,C,シタグリプチンリン酸塩水和物,"",経口,"","",25,mg,1,"",未知,"",""
AB-22030168,5,13,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-22030285,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-22030291,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-22030667,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能亢進症(再投与なし);間質性肺疾患(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22030672,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220526,20220722,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22030727,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211227,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-22030727,1,2,PS,カペシタビン,"",経口,20211227,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22030727,1,3,PS,オキサリプラチン,"",静脈内点滴,20211227,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22030955,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-22030956,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,蛋白漏出性胃腸症(再投与なし);免疫性腸炎(再投与なし),""
AB-22030956,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,202201;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22030956,2,3,C,オキサリプラチン,"",不明;不明,202201;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22030973,2,1,PS,ペムブロリズマブ,キイトルーダ,不明,不明,"",200,mg,1,胆管細胞癌(肝内胆管癌);マイクロサテライト不安定性癌(MSI-H);腫瘍遺伝子変異量高値癌(TMB-H),未知,腹膜炎(再投与なし);腫瘍穿孔(再投与なし),""
AB-22031215,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220428,20220630,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-22031215,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20220428,"",80,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22031215,1,3,PS,オキサリプラチン,"",静脈内点滴,20220428,"",100,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22031524,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220518,20220629,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-22031524,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220518,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22031524,1,3,C,オキサリプラチン,"",静脈内点滴,20220518,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22031677,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,１型糖尿病(再投与なし),""
AB-22031679,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220108,20220528,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-22031679,4,2,C,オキサリプラチン,"",不明;不明,20210114;20220108,20210924;20220528,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22031679,4,3,C,レボホリナートカルシウム,"",不明;不明,20210114;20220108,20210924;20220528,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22031679,4,4,C,フルオロウラシル,"",不明;不明,20210114;20220108,20210924;20220528,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22032099,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,腎機能障害(再投与なし);過敏症(再投与なし);悪寒(再投与なし);血圧低下(再投与なし);無尿(再投与なし),""
AB-22032099,1,2,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22032099,1,3,C,コロナウイルスワクチン,"",不明,202207,202207,"","","","",未知,"",""
AB-22032099,1,4,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22032099,1,5,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22032805,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220316,20220713,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,水疱性皮膚炎(再投与なし),""
AB-22032805,4,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20220316,20220727,50,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22032805,4,3,C,オキサリプラチン,"",静脈内点滴,20220316,20220712,100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22032805,4,4,C,アセトアミノフェン,"",経口,20220316,"",500,mg,1,"",未知,"",""
AB-22032805,4,5,C,酸化マグネシウム,"",経口,20220316,"",330,mg,1,予防(予防),未知,"",""
AB-22032805,4,6,C,エルデカルシトール,"",経口,"","",.75,ug,1,"",未知,"",""
AB-22032805,4,7,C,ロキソプロフェンナトリウム水和物,"",経口,"","",60,mg,1,"",未知,"",""
AB-22032805,4,8,C,ボノプラザンフマル酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-22032805,4,9,C,メコバラミン,"",経口,"","",500,ug,1,"",未知,"",""
AB-22032805,4,10,C,プレガバリン,"",経口,"","",25,mg,1,"",未知,"",""
AB-22033072,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220413,20220817,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-22033074,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220612,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,脱水(再投与なし);腸壁気腫症(再投与なし),""
AB-22033074,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22033074,2,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22033074,2,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22033418,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220207,20220328,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22033418,2,2,C,カペシタビン,"",不明,20220207,"",3000,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22033418,2,3,C,オキサリプラチン,"",不明,20220207,"",100,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22033442,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22033523,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20201126,20211118,200,mg,1,胃癌(MSI-High 癌（結腸・直腸以外）),不适用,肺毒性(再投与なし),""
AB-22033523,1,2,C,イリノテカン塩酸塩水和物,"",不明,不明,"","","","","",未知,"",""
AB-22033770,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220127,20220608,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22033770,3,2,C,デキサメタゾン,"",不明,"","","","","","",未知,"",""
AB-22033770,3,3,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-22033770,3,4,C,メトクロプラミド,"",不明,"","","","","","",未知,"",""
AB-22033817,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,202106,20220622,200,mg,1,胃癌(MSI-High癌（結腸・直腸以外）、胃癌),剂量停止,免疫性肝炎(再投与なし),""
AB-22034238,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220418,20220627,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-22034238,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20220418,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034238,2,3,PS,オキサリプラチン,"",静脈内点滴,20220418,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034241,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22034244,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-22034390,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,不明;不明,;,200;400,mg;mg,1;1,胆管細胞癌((MSI-H) Intrahepatic cholangiocarcinoma),剂量停止,類天疱瘡(不明),""
AB-22034544,5,1,PS,アナモレリン塩酸塩,エドルミズ,経口,"","","","","",悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),不适用,慢性腎臓病(再投与なし);１型糖尿病(再投与なし),""
AB-22034544,5,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20220124,20230110,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,慢性腎臓病(再投与なし);１型糖尿病(再投与なし),""
AB-22034544,5,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220107;20220606,20220523;20220606,130;105,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034544,5,4,C,フルオロウラシル,"",不明,20220107,20230110,4370,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034544,5,5,C,レボホリナートカルシウム,"",不明,20220107,20230110,310,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034560,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);腎障害(再投与なし);肝障害(再投与なし),""
AB-22034560,1,2,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034560,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034567,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220326,20220727,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22034567,2,2,C,オキサリプラチン,"",不明,20220326,202205,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034567,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220326,202207,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034897,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220218;,20220512;,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-22034897,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220218,20220512,120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034897,2,3,C,オキサリプラチン,"",静脈内点滴,20220218,20220512,165,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034897,2,4,C,ランソプラゾール,"",経口,20220219,20220601,15,mg,1,"",未知,"",""
AB-22034912,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202206,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,胃穿孔(再投与なし);免疫性腸炎(再投与なし),""
AB-22034912,4,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202206,202206,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034912,4,3,C,オキサリプラチン,"",不明,202206,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034913,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220614,20220721,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,多発性筋炎(再投与なし);重症筋無力症クリーゼ(再投与なし),""
AB-22034913,3,2,C,オキサリプラチン,"",不明;不明,20220614;,;20220721,120;100,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034913,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220614,20220721,100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034913,3,4,C,ビルダグリプチン・メトホルミン塩酸塩配合剤,"",不明,"","","","","","",未知,"",""
AB-22034913,3,5,C,ボグリボース,"",不明,"","","","","","",未知,"",""
AB-22034913,3,6,C,アスピリン,"",不明,"","","","","","",未知,"",""
AB-22034913,3,7,C,ロスバスタチンカルシウム,"",不明,"","","","","","",未知,"",""
AB-22034913,3,8,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-22034917,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20211221;20220215,20211221;20220607,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-22034917,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034917,3,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22034919,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202206,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,１型糖尿病(再投与なし),""
AB-22034922,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220824,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,播種性血管内凝固(再投与なし),""
AB-22035340,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-22035930,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220602,"",480,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,腹痛(再投与なし);脱水(再投与なし);下痢(再投与なし);発熱(再投与なし);続発性副腎皮質機能不全(再投与なし);腎機能障害(再投与なし),""
AB-22035930,2,2,C,オキサリプラチン,"",静脈内点滴,"","",130,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22035930,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22036252,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210614,20210814,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,糖尿病(再投与なし),""
AB-22036254,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,胆管炎(再投与なし),""
AB-22036254,4,2,PS,オキサリプラチン,エルプラット,不明,"","",100,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22036254,4,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明;不明,;,;,120;100,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22036467,1,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,20220222,2022,1500,mg,1,小細胞肺癌(小細胞肺癌),剂量停止,"",""
AB-22036467,1,2,PS,デュルバルマブ,イミフィンジ,静脈内点滴,2022,2022,"","","",小細胞肺癌(小細胞肺癌),剂量减少,"",""
AB-22036467,1,3,PS,デュルバルマブ,イミフィンジ,静脈内点滴,2022,"","","","",小細胞肺癌(小細胞肺癌),未知,"",""
AB-22036467,1,4,C,カルボプラチン,"",不明,20220222,2022,"","","",小細胞肺癌(小細胞肺癌),未知,"",""
AB-22036467,1,5,C,エトポシド,"",不明,20220222,2022,"","","",小細胞肺癌(小細胞肺癌),未知,"",""
AB-22036570,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,皮膚潰瘍(再投与なし);苔癬様角化症(再投与なし),""
AB-22036574,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220607,20220719,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,サイトカイン放出症候群(再投与なし);急性腎障害(再投与なし);小脳梗塞(再投与なし);代謝性アシドーシス(再投与なし);重症筋無力症(再投与なし);心筋炎(再投与なし);多発性筋炎(再投与なし),""
AB-22036574,6,2,C,オキサリプラチン,"",不明,20220607,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22036574,6,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220607,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22036865,2,1,PS,アムロジピンベシル酸塩,アムロジピン,不明,不明,不明,"","","",高血圧(高血圧);狭心症(狭心症),剂量停止,"",""
AB-22036865,2,2,PS,ニボルマブ,"",不明;不明;不明,不明;不明;不明,不明;不明;不明,;;,;;,;;,化学療法(胃癌・食道癌術後の化学療法),未知,"",""
AB-22036865,2,3,C,ウルソデオキシコール酸,"",不明,"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-22036865,2,4,C,アスピリン,"",不明,"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-22036865,2,5,C,アンブロキソール塩酸塩,"",不明,"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-22036887,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20211210;20220328;20220425,20220304;;20220425,360;360;360,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,サイトメガロウイルス肝炎(再投与なし);免疫性肝炎(再投与なし);免疫性甲状腺機能低下症(再投与なし),""
AB-22036887,5,2,C,オキサリプラチン,"",不明;不明,20211210;20220328,20220304;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22036887,5,3,C,レボホリナートカルシウム,"",不明,20211210,20220304,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22036887,5,4,C,フルオロウラシル,"",不明,20211210,20220304,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22036887,5,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220328,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22037053,3,1,PS,パクリタキセル,タキソール,"",20211013,20211013,90,mg,1,胃癌(Gastric cancer),不适用,ジスキネジア(再投与なし);排尿困難(再投与なし);感覚鈍麻(再投与なし);湿疹(再投与なし);状態悪化(再投与なし),""
AB-22037053,3,2,PS,ニボルマブ,オプジーボ,"",20220427,"",240,mg,1,"胃癌(Unresectable, advanced or recurrent gastric cancer aggravated)",剂量不变,ジスキネジア(再投与なし);排尿困難(再投与なし);感覚鈍麻(再投与なし);湿疹(再投与なし);状態悪化(再投与なし),""
AB-22037053,3,3,PS,シスプラチン,"","","","","","","",胃癌(Gastric cancer),未知,ジスキネジア(再投与なし);排尿困難(再投与なし);感覚鈍麻(再投与なし);湿疹(再投与なし);状態悪化(再投与なし),""
AB-22037053,3,4,PS,アナモレリン塩酸塩,エドルミズ,"",20210906,"",100,mg,1,悪液質(Cancer cachexia),剂量不变,ジスキネジア(再投与なし);排尿困難(再投与なし);感覚鈍麻(再投与なし);湿疹(再投与なし);状態悪化(再投与なし),""
AB-22037053,3,5,PS,ラムシルマブ,サイラムザ,"",20211013,20220415,300,mg,1,胃癌(Gastric cancer),不适用,ジスキネジア(再投与なし);排尿困難(再投与なし);感覚鈍麻(再投与なし);湿疹(再投与なし);状態悪化(再投与なし),""
AB-22037053,3,6,C,カペシタビン,"","","",20211006,2400,mg,1,胃癌(Gastric cancer),未知,"",""
AB-22037053,3,7,C,牛車腎気丸,"","",20210906,"",7.5,g,1,感覚鈍麻(Numbness);予防(Prophylaxis),未知,"",""
AB-22037053,3,8,C,アセトアミノフェン,"","","",20211005,1800,mg,1,適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-22037053,3,9,C,酸化マグネシウム,"","","","",990,mg,1,適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-22037053,3,10,C,ボノプラザンフマル酸塩,"","","",20211005,20,mg,1,予防(Prophylaxis),未知,"",""
AB-22037053,3,11,C,メコバラミン,"","","",20211005,1500,ug,1,感覚鈍麻(Numbness);予防(Prophylaxis),未知,"",""
AB-22037053,3,12,C,補中益気湯,"","","",20211005,7.5,g,1,適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-22037053,3,13,C,ブロチゾラム,"","","","",0.25,mg,1,適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-22037053,3,14,C,ペンタゾシン,"","","",20211019,25,mg,1,適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-22037053,3,15,C,大建中湯,"","","",20211005,7.5,g,1,適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-22037053,3,16,C,オキシコドン塩酸塩水和物,"","",20211020,"",20,mg,1,適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-22037053,3,17,C,センノシド,"","",20211027,"",12,mg,1,適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-22037321,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220803,20230407,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,唾液腺炎(再投与なし);不整脈(再投与なし),""
AB-22037321,3,2,PS,アプレピタント,イメンド,経口;経口,20220803;20220804,20220803;20220805,125;80,mg;mg,1;1,悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),不适用,唾液腺炎(再投与なし);不整脈(再投与なし),""
AB-22037321,3,3,C,オキサリプラチン,"",静脈内（明記されていない場合）,20220803,"",170,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22037321,3,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220803,"",50,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22037321,3,5,C,グラニセトロン塩酸塩,"",静脈内（明記されていない場合）,20220803,"",1,mg,1,予防(予防),未知,"",""
AB-22037321,3,6,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内（明記されていない場合）,20220803,"",4.95,mg,1,予防(予防),未知,"",""
AB-22037321,3,7,C,ファモチジン,"",静脈内（明記されていない場合）,20220803,"",20,mg,1,予防(予防),未知,"",""
AB-22037321,3,8,C,クロルフェニラミンマレイン酸塩,"",静脈内（明記されていない場合）,20220803,"",5,mg,1,予防(予防),未知,"",""
AB-22037321,3,9,C,エドキサバントシル酸塩水和物,"",経口,20220803,"",30,mg,1,"",未知,"",""
AB-22037321,3,10,C,アジルサルタン,"",経口,20220803,"",20,mg,1,"",未知,"",""
AB-22037321,3,11,C,ベプリジル塩酸塩水和物,"",経口,20220803,"",5,mg,1,"",未知,"",""
AB-22037321,3,12,C,ピタバスタチンカルシウム,"",経口,20220803,"",2,mg,1,"",未知,"",""
AB-22037321,3,13,C,エソメプラゾールマグネシウム水和物,"",経口,20220803,"",20,mg,1,"",未知,"",""
AB-22037321,3,14,C,カンデサルタンシレキセチル,"",経口,20220817,"",4,mg,1,"",未知,"",""
AB-22037324,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202208,202209,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,唾液腺炎(再投与なし);肝機能異常(再投与なし),""
AB-22037324,1,2,C,オキサリプラチン,"",不明,202208,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22037324,1,3,C,フルオロウラシル,"",不明,202208,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22037324,1,4,C,レボホリナートカルシウム,"",不明,202208,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22037534,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,血栓症(再投与なし),""
AB-22037534,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22037534,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22037552,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220113,20220609,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,下垂体炎(再投与なし);感覚鈍麻(再投与なし);副腎機能不全(再投与なし),""
AB-22037552,4,2,PS,オキサリプラチン,"",不明,20220113,20220407,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22037552,4,3,C,アセトアミノフェン,"",経口,20211209,"",500,mg,1,"",未知,"",""
AB-22037552,4,4,C,オキシコドン塩酸塩水和物,"",経口,20211228,"",2.5,mg,1,"",未知,"",""
AB-22037552,4,5,C,オランザピン,"",経口,20211228,"",2.5,mg,1,"",未知,"",""
AB-22037552,4,6,C,フェンタニルクエン酸塩,"",経皮,20220104,"",.5,mg,1,"",未知,"",""
AB-22037552,4,7,C,フルオロウラシル,"",静脈内点滴;静脈内点滴,20220113;20220113,20220804;20220804,460;2800,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22037552,4,8,C,レボホリナートカルシウム,"",静脈内点滴,20220113,20220804,230,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22037552,4,9,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20220113,20220804,6.6,mg,1,"",未知,"",""
AB-22037552,4,10,C,ヘパリンナトリウム,"",静脈内点滴,20220113,20220804,5000,[iU],1,"",未知,"",""
AB-22037552,4,11,C,パロノセトロン塩酸塩,"",不明,"",20220407,"","","","",未知,"",""
AB-22037552,4,12,C,クロルフェニラミンマレイン酸塩,"",不明,"",20220407,"","","","",未知,"",""
AB-22037552,4,13,C,メコバラミン,"",経口,"","",500,ug,1,"",未知,"",""
AB-22037553,8,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220208,20220405,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,腸閉塞(再投与なし);免疫性腸炎(再投与なし);甲状腺機能低下症(再投与なし);免疫性腸炎(再投与なし),""
AB-22037553,8,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明;不明;不明;不明,20220208;20220405;20220524;20221122,;;;,;;;,;;;,;;;,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-22037553,8,3,C,オキサリプラチン,"",不明;不明;不明,20220208;20220524;20221122,;;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22037635,5,1,PS,ホスネツピタント塩化物塩酸塩,アロカリス,静脈内点滴(041),"",20220725,"","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),剂量停止,過敏症(不明);腎機能障害(不明);肝機能異常(不明),""
AB-22037635,5,2,PS,オキサリプラチン,エルプラット,静脈内点滴(041),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),剂量停止,過敏症(不明);腎機能障害(不明);肝機能異常(不明),""
AB-22037635,5,3,PS,フルオロウラシル,"",静脈内点滴(041),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),剂量停止,過敏症(不明);腎機能障害(不明);肝機能異常(不明),""
AB-22037635,5,4,PS,レボホリナートカルシウム,"",静脈内点滴(041),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),剂量停止,過敏症(不明);腎機能障害(不明);肝機能異常(不明),""
AB-22037635,5,5,PS,ニボルマブ,オプジーボ,静脈内点滴(041),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),剂量停止,過敏症(不明);腎機能障害(不明);肝機能異常(不明),""
AB-22037635,5,6,C,コロナウイルス（ＳＡＲＳ−ＣｏＶ−２）ＲＮＡワクチン,"",筋肉内(030),"","","","","","",未知,過敏症(再投与なし);腎機能障害(再投与なし);肝機能異常(再投与なし),""
AB-22037715,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190930,20220203,200,mg,1,胃癌第４期(MSI-High癌（結腸・直腸以外）),剂量停止,下垂体機能低下症(再投与なし),""
AB-22037888,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20220720,360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-22038413,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220704,20220829,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,悪性新生物進行(再投与なし);視力障害(再投与なし);緑内障(再投与なし),""
AB-22038413,2,2,C,アゾセミド,"",不明,"","","","","","",未知,"",""
AB-22038413,2,3,C,フルニトラゼパム,"",不明,"","","","","","",未知,"",""
AB-22038413,2,4,C,テネリグリプチン臭化水素酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-22038413,2,5,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-22038663,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220517,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22038663,1,2,C,オキサリプラチン,"",不明,20220517,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22038663,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220517,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22038804,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍のハイパープログレッション(再投与なし),""
AB-22038804,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22038804,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22039118,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202202,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肝萎縮(再投与なし),""
AB-22039118,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,202202,"",40,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22039118,2,3,C,オキサリプラチン,"",静脈内点滴,202202,"",100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22039125,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220310,20220907,480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-22039560,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220628,20220829,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,糖尿病(再投与なし),""
AB-22039560,2,2,C,オキサリプラチン,"",不明,20220628,"",130,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22039560,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220628,"",80,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22039565,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし);間質性肺疾患(再投与なし),""
AB-22039565,1,2,C,ラムシルマブ,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22039565,1,3,C,パクリタキセル,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22039565,1,4,C,コロナウイルスワクチン,"",不明,"","","","","","",未知,"",""
AB-22039827,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,聴覚障害(再投与なし);ぶどう膜炎(再投与なし),""
AB-22039829,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,器質化肺炎(再投与なし),""
AB-22039829,2,2,C,オキサリプラチン,"",静脈内点滴,"","",100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22039829,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22039830,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし);メレナ(再投与なし),""
AB-22039830,1,2,C,デキサメタゾン,"",経口;経口;経口,;202209;202209,;;,5;20;,mg;mg;,1;1;,"",未知,"",""
AB-22040382,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200131,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,硬化性胆管炎(再投与なし),""
AB-22040382,1,2,C,アトルバスタチンカルシウム水和物,"",不明,"","","","","","",未知,"",""
AB-22040382,1,3,C,ロサルタンカリウム,"",不明,"","","","","","",未知,"",""
AB-22040382,1,4,C,ビルダグリプチン,"",不明,"","","","","","",未知,"",""
AB-22040382,1,5,C,メシル酸ガレノキサシン水和物,"",不明,"","","","","","",未知,"",""
AB-22040382,1,6,C,アンブロキソール塩酸塩,"",不明,"","","","","","",未知,"",""
AB-22040382,1,7,C,アスピリン・ダイアルミネート,"",不明,"","","","","","",未知,"",""
AB-22040382,1,8,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-22040382,1,9,C,シロドシン,"",不明,"","","","","","",未知,"",""
AB-22040382,1,10,C,デュタステリド,"",不明,"","","","","","",未知,"",""
AB-22040382,1,11,C,タダラフィル,"",不明,"","","","","","",未知,"",""
AB-22040382,1,12,C,テオフィリン,"",不明,"","","","","","",未知,"",""
AB-22040396,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-22040899,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220604,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肝炎(再投与なし),""
AB-22040899,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22040899,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22040968,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202202,202208,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-22040968,1,2,C,レボホリナートカルシウム,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22040968,1,3,C,オキサリプラチン,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22040968,1,4,C,フルオロウラシル,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22041294,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220117,20220324,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,腎機能障害(再投与なし);甲状腺機能亢進症(再投与なし);間質性肺疾患(再投与なし);腸炎(再投与なし);肝機能異常(再投与なし),""
AB-22041294,2,2,PS,オキサリプラチン,"",不明;不明,20220117;,20220324;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22041294,2,3,PS,カペシタビン,"",不明;不明,20220117;,20220324;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22041296,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220114,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし),""
AB-22041296,4,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220114,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22041296,4,3,PS,オキサリプラチン,"",不明,20220114,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22041353,1,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,20220906,"",1200,mg,1,肝細胞癌(肝細胞癌),未知,間質性肺疾患(不明),""
AB-22041353,1,2,PS,ベバシズマブ,アバスチン,静脈内点滴,20220906,"",15,mg,1,肝細胞癌(肝細胞癌),未知,間質性肺疾患(不明),""
AB-22041391,1,1,PS,タゾバクタム・ピペラシリン水和物,ゾシン,静脈内点滴(041),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),剂量停止,サイトカイン放出症候群(不明);薬疹(不明),""
AB-22041391,1,2,PS,ニボルマブ,オプジーボ,"","","","","","",再発胃癌(胃癌（再発・転移）),剂量停止,サイトカイン放出症候群(不明);薬疹(不明),""
AB-22041534,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220805,20220805,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,血液量減少性ショック(再投与なし);腸壁気腫症(再投与なし);悪性新生物進行(再投与なし);免疫性腸炎(再投与なし);下痢(再投与なし);脳梗塞(再投与なし);壊死(再投与なし);気腹(再投与なし);門脈ガス血症(再投与なし),""
AB-22041534,2,2,PS,オキサリプラチン,"",静脈内点滴,20220805,20220819,140,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22041534,2,3,PS,フルオロウラシル,"",静脈内点滴;静脈内点滴,20220805;20220819,20220806;20220820,4000;4000,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22041534,2,4,PS,レボホリナートカルシウム,"",静脈内点滴,20220805,20220819,330,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22041534,2,5,PS,フルオロウラシル,５−ＦＵ,静脈内点滴,20220805,20220819,670,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22041961,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220726,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,血小板減少症(再投与なし),""
AB-22041961,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220726,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22041961,2,3,C,オキサリプラチン,"",不明,20220726,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22042303,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肝炎(再投与なし),""
AB-22042303,2,2,C,オキサリプラチン,"",静脈内点滴,"","",130,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22042303,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22042771,2,1,PS,オキサリプラチン,エルプラット：点滴静注液,"",20220809,"","","","",胃癌(胃癌),未知,"",""
AB-22042771,2,2,PS,ニボルマブ,"","",20220809,"","","","",胃癌(胃癌),未知,"",""
AB-22042771,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"","",20220809,"","","","",胃癌(胃癌),未知,"",""
AB-22042810,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし);ニューモシスチス・イロベチイ肺炎(再投与なし),""
AB-22042810,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22042810,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22042814,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220809,20220809,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫性腸炎(再投与なし);免疫性腸炎(再投与なし);腫瘍出血(再投与なし);肝炎(再投与なし);腹膜炎(再投与なし);サイトメガロウイルス性胃炎(再投与なし);播種性血管内凝固(再投与なし);免疫性腸炎(再投与なし);免疫性腸炎(再投与なし);免疫性腸炎(再投与なし);敗血症性ショック(再投与なし);直腸穿孔(再投与なし),""
AB-22042814,5,2,PS,オキサリプラチン,エルプラット,静脈内（明記されていない場合）,20220809,20220809,215,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22042814,5,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20220809,20220814,120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22042817,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220225,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-22042817,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22042817,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22042820,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-22042820,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22042820,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22042820,1,4,C,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22042820,1,5,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22042858,7,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20220606;20220704;不明;20230420,20220606;202208;20230309;20230420,200;200;200;400,mg;mg;mg;mg,1;1;1;1,胃癌第４期(MSI-High癌（結腸・直腸以外）、胃癌),剂量停止,視床下部−下垂体障害(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし);皮膚障害(再投与なし);好中球数減少(無);免疫性皮膚炎(無);免疫性甲状腺機能低下症(無),""
AB-22042858,7,2,C,エソメプラゾールマグネシウム水和物,"",経口,20211227,"",20,mg,1,"",未知,"",""
AB-22042858,7,3,C,エスゾピクロン,"",経口,20211227,"",2,mg,1,"",未知,"",""
AB-22042858,7,4,C,フロセミド,"",経口,20220124,"",10,mg,1,"",未知,"",""
AB-22043790,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220126;20220824,20220713;20230208,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);副腎機能不全(再投与なし),""
AB-22043790,4,2,PS,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220126;,20220630;20230208,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22043790,4,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,20220126;20220824,20220713;20230208,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22043888,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210304,20210617,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺炎(再投与なし);胃前庭部毛細血管拡張症(再投与なし),""
AB-22043888,3,2,C,フロセミド,"",経口,20210225,"","","","","",未知,"",""
AB-22043888,3,3,C,ウルソデオキシコール酸,"",経口,20210318,"","","","","",未知,"",""
AB-22043888,3,4,C,ボノプラザンフマル酸塩,"",経口,"","","","","",予防(予防),未知,"",""
AB-22043888,3,5,C,ポラプレジンク,"",経口,"","","","","",予防(予防),未知,"",""
AB-22043888,3,6,C,酪酸菌製剤,"",経口,"","","","","",予防(予防),未知,"",""
AB-22043888,3,7,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-22043888,3,8,C,タムスロシン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-22043888,3,9,C,フラボキサート塩酸塩,"",経口,"","","","","","",未知,"",""
AB-22043889,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20171017,20200916,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,リウマチ性多発筋痛(再投与なし),""
AB-22043889,1,2,C,ベザフィブラート,"",不明,"","","","","","",未知,"",""
AB-22043889,1,3,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-22043896,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220526;,202206;,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-22043896,3,2,C,プロピルチオウラシル,"",経口,"",202208,"","","",甲状腺機能亢進症(甲状腺機能亢進症),未知,"",""
AB-22044511,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし),""
AB-22044515,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-22044596,1,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口(048),20220809,20220814,120,mg,1,遠隔転移を伴う胃癌(Gastric cancer (with peritoneal dissemination)),剂量停止,腸炎(再投与なし);腹膜炎(再投与なし);播種性血管内凝固(再投与なし);消化管穿孔(再投与なし),""
AB-22044596,1,2,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）(042),20220809,20220809,360,mg,1,遠隔転移を伴う胃癌(Gastric cancer (with peritoneal dissemination)),剂量停止,腸炎(再投与なし);腹膜炎(再投与なし);播種性血管内凝固(再投与なし);消化管穿孔(再投与なし),""
AB-22044596,1,3,PS,オキサリプラチン,エルプラット,静脈内（明記されていない場合）(042),20220809,20220809,215,mg,1,遠隔転移を伴う胃癌(Gastric cancer (with peritoneal dissemination)),剂量停止,腸炎(再投与なし);腹膜炎(再投与なし);播種性血管内凝固(再投与なし);消化管穿孔(再投与なし),""
AB-22044753,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202206,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,骨髄抑制(再投与なし),""
AB-22044753,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202206,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22044753,2,3,C,オキサリプラチン,"",不明,202206,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22044822,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,重症筋無力症(再投与なし),""
AB-22044823,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210818,20220407,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,赤芽球癆(再投与なし),""
AB-22044823,1,2,C,オキサリプラチン,"",不明,20210818,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22044823,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20210818,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22045090,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,脳炎(再投与なし);痙攣発作(再投与なし);意識変容状態(再投与なし),""
AB-22045091,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし);大腸炎(再投与なし),""
AB-22045091,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22045091,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22045709,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-22045709,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22045709,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22046056,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,食欲減退(再投与なし);疼痛(再投与なし),""
AB-22046060,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性胃炎(再投与なし),""
AB-22046688,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,免疫性腸炎(再投与なし);免疫性肝炎(再投与なし),""
AB-22046690,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220701;202211,202209;,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-22046690,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22046690,2,3,C,オキサリプラチン,"",静脈内（明記されていない場合）,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22046982,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220405,20220812,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腹水(再投与なし),""
AB-22046982,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220405,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22046982,2,3,C,オキサリプラチン,"",静脈内点滴,20220405,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22047344,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-22047344,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22047344,1,3,C,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22047347,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,腸炎(再投与なし),""
AB-22047347,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22047347,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22047351,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-22047351,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22047351,1,3,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22047986,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-22048019,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220802,20220824,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22048019,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,20220802;,20220824;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22048019,2,3,C,オキサリプラチン,"",不明,20220802,20220824,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22048411,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,2022;20220808,20220719;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,続発性副腎皮質機能不全(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし);劇症１型糖尿病(再投与なし),""
AB-22048411,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口;経口;経口;経口;経口,2014;202001;202005;2022;20220808;,2015;;202205;20220726;202208;,;;;;;,;;;;;,;;;;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22048411,3,3,PS,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,202001;2022;20220808,;20220719;20220808,;100;,;mg;,;1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22048507,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210916,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-22049157,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし);シェーグレン症候群(再投与なし),""
AB-22049157,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22049157,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22049158,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(不明),""
AB-22049158,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22049158,2,3,C,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22049159,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220706,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,１型糖尿病(再投与なし),""
AB-22049159,2,2,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22049159,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22049555,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220526,20220829,360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22049555,1,2,C,ファモチジン,"",不明,"","","","","","",未知,"",""
AB-22049555,1,3,C,レバミピド,"",不明,"","","","","","",未知,"",""
AB-22049561,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220616,20220818,360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし);免疫性腸炎(再投与なし),""
AB-22049561,1,2,C,レボドパ・カルビドパ水和物,"",経口,"","","","","","",未知,"",""
AB-22049561,1,3,C,トリヘキシフェニジル塩酸塩,"",不明,"","","","","","",未知,"",""
AB-22049561,1,4,C,テルミサルタン・アムロジピンベシル酸塩配合剤,"",経口,"","","","","","",未知,"",""
AB-22049561,1,5,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-22049561,1,6,C,経腸成分栄養剤（１−１）,"",不明,"","","","","","",未知,"",""
AB-22049576,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220906,20220913,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-22049576,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20220906,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22049576,1,3,PS,オキサリプラチン,"",静脈内点滴,20220906,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22049594,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22049594,1,2,C,オキサリプラチン,"",静脈内点滴,"","",130,mg,1,"",未知,"",""
AB-22049594,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","","",未知,"",""
AB-22050639,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20171215;20180404,20180119;20180718,150;150,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-22050639,1,2,C,アスピリン,"",経口,"","",100,mg,1,"",未知,"",""
AB-22050639,1,3,C,フロセミド,"",経口,"","",40,mg,1,"",未知,"",""
AB-22050639,1,4,C,シロスタゾール,"",経口,"","",10,mg,1,"",未知,"",""
AB-22050639,1,5,C,スピロノラクトン,"",経口,"","",25,mg,1,"",未知,"",""
AB-22050639,1,6,C,ビソプロロールフマル酸塩,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-22050639,1,7,C,ラベプラゾールナトリウム,"",経口,"","",10,mg,1,予防(予防投与),未知,"",""
AB-22050639,1,8,C,テプレノン,"",経口,"","",50,mg,1,予防(予防投与),未知,"",""
AB-22050639,1,9,C,酪酸菌製剤,"",経口,"","",1,g,1,予防(予防投与),未知,"",""
AB-22050684,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220222,20220315,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,薬疹(再投与なし);免疫介在性膀胱炎(再投与なし),""
AB-22050684,1,2,PS,オキサリプラチン,"",静脈内点滴,20220126,20220315,220,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22050684,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220126,20220328,60,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22050684,1,4,C,ランソプラゾール,"",経口,"","","","","","",未知,"",""
AB-22050684,1,5,C,モサプリドクエン酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-22050684,1,6,C,フェキソフェナジン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-22050684,1,7,C,メコバラミン,"",経口,"","","","","","",未知,"",""
AB-22050685,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220802,20220802,240,mg,1,食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22050685,1,2,C,酸化マグネシウム,"",経口,20220623,20220802,.5,g,1,"",未知,"",""
AB-22050685,1,3,C,アンブロキソール塩酸塩,"",経口,20220704,20220802,45,mg,1,"",未知,"",""
AB-22050685,1,4,C,ナプロキセン,"",経口,20220721,20220802,100,mg,1,食道癌(がん化学療法後に増悪した根治切除不能な進行・再発の食道癌),未知,"",""
AB-22050685,1,5,C,酪酸菌製剤,"",経口,20220725,20220802,1,g,1,"",未知,"",""
AB-22050685,1,6,C,Ｌ−アスパラギン酸カリウム,"",経口,20220802,20220802,300,mg,1,"",未知,"",""
AB-22050685,1,7,C,ビソプロロールフマル酸塩,"",経口,"",20220802,1.25,mg,1,"",未知,"",""
AB-22050685,1,8,C,フロセミド,"",経口,"",20220802,10,mg,1,"",未知,"",""
AB-22050685,1,9,C,アピキサバン,"",経口,"",20220822,2.5,mg,1,"",未知,"",""
AB-22050685,1,10,C,クエン酸第一鉄ナトリウム,"",経口,"",20220802,50,mg,1,"",未知,"",""
AB-22050685,1,11,C,ランソプラゾール,"",経口,"",20220802,30,mg,1,"",未知,"",""
AB-22050685,1,12,C,アスピリン,"",経口,"",20220822,100,mg,1,"",未知,"",""
AB-22050691,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-22050691,1,2,C,レゴラフェニブ水和物,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22050692,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20220519;;20221006,;;20221006,360;360;360,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし);副腎機能不全(再投与なし);免疫性重症筋無力症(再投与なし),""
AB-22050692,2,2,C,カペシタビン,"",経口;経口;経口,20220519;;20221006,;;20230425,1200;1200;1200,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22050692,2,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20220519;;20221006,;;20230425,120;120;120,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22050711,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202011,202110,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性血小板減少症(再投与なし),""
AB-22051076,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220912,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,下痢(再投与なし);発熱(再投与なし);潰瘍性大腸炎(再投与なし);白血球百分率数異常(再投与なし);腸炎(再投与なし);血便排泄(再投与なし);Ｃ−反応性蛋白増加(再投与なし);シュードモナス感染(再投与なし),""
AB-22051076,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220912,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22051076,1,3,C,オキサリプラチン,"",不明,20220912,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22052394,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220810,20220810,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫性腸炎(再投与なし);免疫性肝炎(再投与なし),""
AB-22052394,2,2,C,レボホリナートカルシウム,"",不明,20220810,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22052394,2,3,C,オキサリプラチン,"",不明,20220810,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22052394,2,4,C,フルオロウラシル,"",不明,20220810,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22052394,2,5,C,アミノ酸・糖・電解質・ビタミン（２−６）,"",不明,"","","","","","",未知,"",""
AB-22052394,2,6,C,グラニセトロン塩酸塩,"",静脈内点滴,"","","","","","",未知,"",""
AB-22052394,2,7,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
AB-22052394,2,8,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-22052394,2,9,C,塩酸メトクロプラミド,"",不明,"","","","","","",未知,"",""
AB-22052394,2,10,C,ヒドロモルフォン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-22052394,2,11,C,ダイズ油,"",不明,"","","","","","",未知,"",""
AB-22052394,2,12,C,クロルプロマジンヒベンズ酸塩,"",不明,"","","","","","",未知,"",""
AB-22052394,2,13,C,グラニセトロン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-22052394,2,14,C,ナルデメジントシル酸塩,"",不明,"","","","","","",未知,"",""
AB-22052394,2,15,C,ラクツロース,"",経口,"","","","","","",未知,"",""
AB-22052394,2,16,C,ジクロフェナクナトリウム,"",経皮,"","","","","","",未知,"",""
AB-22052394,2,17,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-22052394,2,18,C,メサラジン,"",経口,"","","","","","",未知,"",""
AB-22052394,2,19,C,レンボレキサント,"",不明,"","","","","","",未知,"",""
AB-22052394,2,20,C,ヒドロモルフォン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-22052394,2,21,C,トラゾドン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-22052394,2,22,C,プレドニゾロン,"",不明,"","","","","","",未知,"",""
AB-22052394,2,23,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-22052394,2,24,C,ヒドロモルフォン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-22052394,2,25,C,スルファメトキサゾール・トリメトプリム,"",不明,"",202209,"","","","",未知,"",""
AB-22052407,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202009,202011,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし),""
AB-22052407,2,2,C,リュープロレリン酢酸塩,"",不明,"","","","","",前立腺癌(前立腺癌),未知,"",""
AB-22052408,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202201,202210,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,出血性腸炎(再投与なし);ニューモシスチス・イロベチイ肺炎(再投与なし),""
AB-22052408,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202201,202210,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22052408,2,3,C,オキサリプラチン,"",不明,202201,202210,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22052408,2,4,C,パクリタキセル（アルブミン懸濁型）,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22052408,2,5,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22052411,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎障害(再投与なし),""
AB-22052415,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-22052425,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,視床下部−下垂体障害(再投与なし);口内炎(再投与なし),""
AB-22052425,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22052425,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22052644,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202205,202205,360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,劇症１型糖尿病(再投与なし),""
AB-22052644,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","","",未知,"",""
AB-22052644,1,3,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
AB-22052722,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20220622,20220914,200,mg,1,胃癌第４期(MSI-High 癌（結腸・直腸以外）、進行胃癌),剂量停止,免疫性重症筋無力症(再投与なし);筋炎(再投与なし),""
AB-22052722,4,2,C,ミラベグロン,"",経口,不明,"","","","","",未知,"",""
AB-22052722,4,3,C,フェソテロジンフマル酸塩,"",不明,不明,"","","","","",未知,"",""
AB-22052722,4,4,C,ボノプラザンフマル酸塩,"",不明,不明,"","","","","",未知,"",""
AB-22052722,4,5,C,酪酸菌製剤,"",不明,不明,"","","","","",未知,"",""
AB-22053072,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220629,20220812,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性肝炎(再投与なし),""
AB-22053072,4,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,20220629;20221108,20220812;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22053072,4,3,C,オキサリプラチン,"",不明;不明,20220629;20221108,20220812;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22053076,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,筋炎(再投与なし),""
AB-22053076,1,2,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22053076,1,3,C,カペシタビン,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22053460,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200916;20211027,20211013;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,関節リウマチ(無),""
AB-22053526,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(治療切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-22053526,1,2,C,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治療切除不能な進行・再発の胃癌),未知,"",""
AB-22053526,1,3,C,レボホリナートカルシウム,"",不明;不明,;,;,;,;,;,胃癌(治療切除不能な進行・再発の胃癌),未知,"",""
AB-22053526,1,4,C,フルオロウラシル,"",不明;不明,;,;,;,;,;,胃癌(治療切除不能な進行・再発の胃癌),未知,"",""
AB-22053529,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,発疹(再投与なし);突然死(再投与なし),""
AB-22053529,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22053531,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22053531,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22053531,2,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22053788,3,1,PS,トラスツズマブデルクステカン,エンハーツ,静脈内点滴,20221101,20221101,4.4,mg/kg,1,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer);胃腺癌(Adenocarcinoma gastric),剂量停止,好中球減少症(再投与なし);白血球減少症(再投与なし);貧血(再投与なし);血小板減少症(再投与なし),""
AB-22053788,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明;不明,20220420;20220721;20220812,20220720;20220810;20221102,;;,;;,;;,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer);胃腺癌(Adenocarcinoma gastric),未知,"",""
AB-22053788,3,3,PS,オキサリプラチン,"",不明;不明;不明,20220420;20220721;20220812,20220720;20220810;20221102,;;,;;,;;,ＨＥＲ２陽性胃癌(HER2 positive gastric cancer);胃腺癌(Adenocarcinoma gastric),未知,"",""
AB-22053788,3,4,PS,ニボルマブ,"",不明,20220420,20220720,"","","",ＨＥＲ２陽性胃癌(HER2 positive gastric cancer);胃腺癌(Adenocarcinoma gastric),未知,"",""
AB-22053788,3,5,PS,トラスツズマブ,ハーセプチン,不明,20220721,20220810,"","","",ＨＥＲ２陽性胃癌(HER2 positive gastric cancer);胃腺癌(Adenocarcinoma gastric),未知,"",""
AB-22053788,3,6,C,クロピドグレル硫酸塩,"",経口,20221101,"",75,mg,1,脳梗塞(Cerebral infarction),未知,"",""
AB-22053788,3,7,C,スピロノラクトン,"",経口,20221101,"",25,mg,1,高血圧(Hypertension),未知,"",""
AB-22053788,3,8,C,オキシコドン塩酸塩水和物,"",経口,20221101,"",10,mg,1,癌疼痛(Cancer pain),未知,"",""
AB-22053788,3,9,C,酸化マグネシウム,"",経口,20221101,"",330,mg,1,便秘予防(Constipation prophylaxis),未知,"",""
AB-22053788,3,10,C,ナルデメジントシル酸塩,"",経口,20221101,"",.2,mg,1,便秘予防(Constipation prophylaxis),未知,"",""
AB-22053788,3,11,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20221101,20221101,6.6,mg,1,悪心・嘔吐の予防(Prophylaxis of nausea and vomiting),未知,"",""
AB-22053788,3,12,C,パロノセトロン塩酸塩,"",静脈内点滴,20221101,20221101,.75,mg,1,悪心・嘔吐の予防(Prophylaxis of nausea and vomiting),未知,"",""
AB-22054010,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能亢進症(再投与なし),""
AB-22054010,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22054010,1,3,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22054015,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220412,20220502,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,好中球数減少(再投与なし);白血球数減少(再投与なし),""
AB-22054015,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口,20220412;20220502,;20220502,80;80,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22054015,3,3,PS,オキサリプラチン,エルプラット,静脈内点滴,20220412,20220502,100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22054393,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200116;20200612,;20210407,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,原発性副腎機能不全(不明),""
AB-22054825,1,1,PS,パクリタキセル,タキソール,"","","","","","",胃癌(Gastric cancer),未知,"",""
AB-22054825,1,2,PS,ニボルマブ,オプジーボ,"",20220310,20220331,360,mg,1,胃癌(Gastric cancer),不适用,免疫性腸炎(再投与なし),""
AB-22054825,1,3,PS,オキサリプラチン,エルプラット,;,20220310;20220516,20220331;,;,;,;,胃癌(Gastric cancer),不适用,免疫性腸炎(再投与なし),""
AB-22054825,1,4,PS,ラムシルマブ,"","","","","","","",胃癌(Gastric cancer),未知,"",""
AB-22054825,1,5,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",;,20220310;20220516,20220331;,;,;,;,胃癌(Gastric cancer),未知,"",""
AB-22055228,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,酸素飽和度低下(再投与なし),""
AB-22055228,1,2,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055228,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055238,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし);糖尿病性ケトアシドーシス(再投与なし),""
AB-22055245,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220715;202212,;,240;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし),""
AB-22055245,3,2,PS,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20220509;20220526;20220715,20220509;20220624;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055245,3,3,C,レボホリナートカルシウム,"",静脈内点滴;静脈内点滴;静脈内点滴,20220509;20220526;20220715,20220509;20220624;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055245,3,4,C,フルオロウラシル,"",不明;不明;不明,20220509;20220526;20220715,20220509;20220624;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055245,3,5,C,グラニセトロン塩酸塩,"",静脈内点滴,"","","","","","",未知,"",""
AB-22055245,3,6,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
AB-22055245,3,7,C,生理食塩液,"",不明,"","","","","","",未知,"",""
AB-22055245,3,8,C,ブドウ糖,"",不明,"","","","","","",未知,"",""
AB-22055245,3,9,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-22055245,3,10,C,溶性ピロリン酸第二鉄,"",経口,"","","","","","",未知,"",""
AB-22055245,3,11,C,ボノプラザンフマル酸塩,"",経口,"","","","","","",未知,"",""
AB-22055245,3,12,C,アトルバスタチンカルシウム水和物,"",経口,"","","","","","",未知,"",""
AB-22055245,3,13,C,エナラプリルマレイン酸塩,"",経口,"","","","","","",未知,"",""
AB-22055245,3,14,C,カルベジロール,"",経口,"","","","","","",未知,"",""
AB-22055251,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,１型糖尿病(再投与なし);免疫性甲状腺機能低下症(再投与なし),""
AB-22055782,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-22055782,3,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055782,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055852,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220902,20220923,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-22055852,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055852,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055857,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220722,20221116,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-22055860,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能亢進症(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22055862,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220719,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,一過性黒内障(再投与なし),""
AB-22055865,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,アナフィラキシーショック(再投与なし),""
AB-22055865,1,2,PS,オキサリプラチン,エルプラット,不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055869,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,240;480,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎皮質刺激ホルモン欠損症(再投与なし);１型糖尿病(再投与なし),""
AB-22055870,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220315,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,免疫介在性副腎機能不全(再投与なし),""
AB-22055870,3,2,PS,オキサリプラチン,"",静脈内点滴,20220315,"",215,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22055870,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口,20220315;,;,50;40,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-22055886,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-22055887,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-22055887,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055887,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055888,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,続発性副腎皮質機能不全(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-22055888,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055888,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055890,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-22055892,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220420,20220914,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-22055892,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055892,2,3,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055892,2,4,C,ルビプロストン,"",不明,"","","","","","",未知,"",""
AB-22055892,2,5,C,タムスロシン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-22055892,2,6,C,デュタステリド,"",経口,"","","","","","",未知,"",""
AB-22055894,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-22055894,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22055894,1,3,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22056420,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20180309;20180511;20180525;20180727;20180810;20180914,20180420;20180511;20180706;20180727;20180824;,3;3;3;3;3;240,mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg,1;1;1;1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-22056483,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肝細胞損傷(再投与なし),""
AB-22056483,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22056483,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22056625,1,1,PS,トリフルリジン・チピラシル塩酸塩配合剤,ロンサーフ,"","","","","","",胃癌(STOMACH CANCER),剂量停止,間質性肺疾患(再投与なし),""
AB-22056625,1,2,PS,ニボルマブ,"","","","","","","",胃癌(STOMACH CANCER),剂量停止,間質性肺疾患(再投与なし),""
AB-22056831,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220713,20221005,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-22056831,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22056831,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22056838,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202211,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-22056838,2,2,PS,オキサリプラチン,"",不明,202211,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22056838,2,3,C,フルオロウラシル,"",不明,202211,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22056838,2,4,C,レボホリナートカルシウム,"",不明,202211,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22056843,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし);重症筋無力症(再投与なし),""
AB-22056843,3,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22056843,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057194,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220607,20220922,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肝性脳症(再投与なし),""
AB-22057194,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220607,20221102,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057194,1,3,C,オキサリプラチン,"",不明,20220607,20221102,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057286,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,肺臓炎(再投与なし),""
AB-22057286,2,2,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057286,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057287,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20230105,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-22057289,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,憩室炎(再投与なし);副腎機能不全(再投与なし),""
AB-22057289,1,2,C,オキサリプラチン,"",不明,"","",100,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057289,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057290,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220330;20220921,;,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-22057290,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220330,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057290,2,3,C,オキサリプラチン,"",不明,20220330,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057627,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-22057627,1,2,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057627,1,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057627,1,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057630,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺臓炎(再投与なし),""
AB-22057630,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057632,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210730,20210730,480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-22057633,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220406,202211,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腹水(再投与なし),""
AB-22057633,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057633,1,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057635,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202206;20221011,;202212,240;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,ＣＯＶＩＤ−１９(再投与なし);癌性リンパ管症(再投与なし),""
AB-22057635,4,2,PS,オキサリプラチン,"",不明,202206,20221011,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22057635,4,3,PS,フルオロウラシル,"",不明,202206,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22057635,4,4,PS,レボホリナートカルシウム,レボホリナート,不明,202206,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22057635,4,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202212,"","","","",胃癌(胃癌),未知,"",""
AB-22057636,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202202,20221027,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,器質化肺炎(再投与なし),""
AB-22057636,4,2,PS,オキサリプラチン,"",静脈内点滴,202202,202208,130,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22057636,4,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,202202;,202210;,40;,mg/m2;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057637,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220204,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,多臓器機能不全症候群(再投与なし);死亡(再投与なし);敗血症性ショック(再投与なし);急性胆管炎(再投与なし),""
AB-22057637,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,20220114;20220204,;20220212,;80,;mg/m2,;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22057637,1,3,C,オキサリプラチン,"",静脈内点滴,20220204,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058011,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202111;202208,202201;2022,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-22058218,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,スティーヴンス・ジョンソン症候群(再投与なし),""
AB-22058218,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058218,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058220,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性甲状腺機能低下症(再投与なし);免疫性関節炎(再投与なし),""
AB-22058220,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058220,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058577,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-22058577,2,2,C,ラムシルマブ,"",不明,202210,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058577,2,3,C,パクリタキセル,"",不明,202210,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058577,2,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058577,2,5,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058580,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220715;20221111,20220909;20221125,240;240,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-22058580,2,2,C,オキサリプラチン,"",不明;不明,20220715;20221111,;,85;85,mg/m2;mg/m2,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058580,2,3,C,レボホリナートカルシウム,"",不明;不明,20220715;20221111,;,200;200,mg/m2;mg/m2,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058580,2,4,C,フルオロウラシル,"",静脈内急速;静脈内（明記されていない場合）;静脈内急速;静脈内（明記されていない場合）,20220715;20220715;20221111;20221111,;;;,400;2400;400;2400,mg/m2;mg/m2;mg/m2;mg/m2,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058890,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220214,20221121,480,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22058890,2,2,C,オキサリプラチン,"",不明,2022,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058890,2,3,C,フルオロウラシル,"",不明,2022,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058890,2,4,C,レボホリナートカルシウム,"",不明,2022,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058891,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220517,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22058891,2,2,C,オキサリプラチン,"",不明,20220517,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058891,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220517,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058891,2,4,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058892,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220516,"",480,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22058892,2,2,C,オキサリプラチン,"",不明,20220516,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058892,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220516,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058893,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,深部静脈血栓症(再投与なし),""
AB-22058893,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058893,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058893,1,4,C,トリフルリジン・チピラシル塩酸塩配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058896,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,免疫性腸炎(再投与なし);免疫性肺疾患(再投与なし),""
AB-22058897,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,免疫性腸炎(再投与なし);口内炎(再投与なし),""
AB-22058897,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22058897,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059256,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220722,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-22059256,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059256,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059261,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202201;20220715,;,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,自己免疫性甲状腺炎(再投与なし);舞踏病(再投与なし);１型糖尿病(再投与なし),""
AB-22059261,4,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,20211011;202201,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059261,4,3,C,オキサリプラチン,"",不明;不明,20211011;202201,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059261,4,4,C,パクリタキセル,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059261,4,5,C,ラムシルマブ,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059276,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし),""
AB-22059276,1,2,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","","",未知,"",""
AB-22059276,1,3,C,プレガバリン,"",経口,"","","","","","",未知,"",""
AB-22059276,1,4,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-22059276,1,5,C,メコバラミン,"",経口,"","","","","","",未知,"",""
AB-22059276,1,6,C,レパグリニド,"",経口,"","","","","","",未知,"",""
AB-22059276,1,7,C,リナグリプチン,"",経口,"","","","","","",未知,"",""
AB-22059474,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201911,202004,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,続発性副腎皮質機能不全(再投与なし),""
AB-22059477,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220318,20220527,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-22059477,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220318,20220527,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059477,1,3,C,オキサリプラチン,"",静脈内点滴,20220318,20220527,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059618,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220712,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肝障害(再投与なし),""
AB-22059618,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220712,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059618,2,3,C,オキサリプラチン,"",不明,20220712,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059839,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"","","","","","",遠隔転移を伴う胃癌(Metastatic gastric cancer),未知,悪性新生物進行(再投与なし);発熱性好中球減少症(再投与なし);菌血症(再投与なし);心内膜炎(再投与なし),""
AB-22059839,1,2,PS,ニボルマブ,オプジーボ,"",20220610,"","","","",遠隔転移を伴う胃癌(Metastatic gastric cancer),剂量停止,悪性新生物進行(不明);発熱性好中球減少症(不明);菌血症(不明);心内膜炎(不明),""
AB-22059839,1,3,PS,ラムシルマブ,サイラムザ,"","","","","","",遠隔転移を伴う胃癌(Metastatic gastric cancer),未知,悪性新生物進行(再投与なし);発熱性好中球減少症(再投与なし);菌血症(再投与なし);心内膜炎(再投与なし),""
AB-22059839,1,4,C,酸化マグネシウム,"","",20220610,"",330,mg,1,予防(PROPHYLAXIS FOR CHEMOTHERAPY SIDE EFFECT),未知,"",""
AB-22059839,1,5,C,プロクロルペラジンマレイン酸塩,"","",20220610,"",5,mg,1,予防(PROPHYLAXIS FOR CHEMOTHERAPY SIDE EFFECT),不适用,"",""
AB-22059839,1,6,C,ロペラミド塩酸塩,"","",20220610,"",1,mg,1,予防(PROPHYLAXIS FOR CHEMOTHERAPY SIDE EFFECT),未知,"",""
AB-22059839,1,7,C,マキサカルシトール,"","",20211207,"","","","",乾癬(PSORIASIS),不适用,"",""
AB-22059839,1,8,C,デキサメタゾン,"","",20220610,20220612,4,mg,1,予防(PROPHYLAXIS FOR CHEMOTHERAPY SIDE EFFECT),剂量停止,"",""
AB-22059839,1,9,C,アズレンスルホン酸ナトリウム水和物,"","",20220610,"","","","",予防(PROPHYLAXIS FOR CHEMOTHERAPY SIDE EFFECT),不适用,"",""
AB-22059839,1,10,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"","",20211207,"","","","",乾癬(PSORIASIS),不适用,"",""
AB-22059839,1,11,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"","",20220610,"","","","",遠隔転移を伴う胃癌(Metastatic gastric cancer),剂量停止,"",""
AB-22059839,1,12,C,オキサリプラチン,"","",20220610,"","","","",遠隔転移を伴う胃癌(Metastatic gastric cancer),剂量停止,"",""
AB-22059839,1,13,C,その他の抗生物質製剤（複合抗生物質製剤を含む。）,"","","","","","","",発熱性好中球減少症(FEBRILE NEUTROPENIA);菌血症(BACTEREMIA);心内膜炎(INFECTIOUS ENDOCARDITIS),未知,"",""
AB-22059992,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-22059998,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-22059998,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059998,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22059999,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,急性副腎皮質機能不全(再投与なし),""
AB-22060015,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220822,20221017,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,筋炎(再投与なし);重症筋無力症(再投与なし),""
AB-22060015,2,2,C,オキサリプラチン,"",不明,20220822,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22060015,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220822,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22060225,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221114,20221214,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫性腸炎(再投与なし),""
AB-22060225,5,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明;不明,202210;202301,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22060225,5,3,C,オキサリプラチン,"",不明;不明,;202301,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22060232,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220117,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,血球減少症(再投与なし),""
AB-22060649,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220510,20220531,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性筋炎(再投与なし),""
AB-22060649,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220510,20220531,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22060649,3,3,C,オキサリプラチン,"",不明,20220510,20220531,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22060656,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221122,20221206,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし);肺炎(再投与なし),""
AB-22060661,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220207,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22060661,4,2,C,オキサリプラチン,"",不明,202111,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22060661,4,3,C,フルオロウラシル,"",不明,202111,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22060661,4,4,C,レボホリナートカルシウム,"",不明,202111,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22060937,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"",20180510,"",100,mg/m2,1,胃癌(GASTRIC CANCER),未知,発熱性好中球減少症(再投与なし),""
AB-22060937,1,2,PS,ニボルマブ,オプジーボ,"",20171214,20180329,360,mg,1,胃癌(GASTRIC CANCER),不适用,発熱性好中球減少症(再投与なし),""
AB-22060937,1,3,PS,ラムシルマブ,サイラムザ,"",20180510,"",8,mg/kg,1,胃癌(GASTRIC CANCER),未知,発熱性好中球減少症(再投与なし),""
AB-22060937,1,4,C,イソロイシン・ロイシン・バリン,"","",20180510,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22060937,1,5,C,スピロノラクトン,"","",20180510,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22060937,1,6,C,フロセミド,"","",20180510,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22060937,1,7,C,補中益気湯,"","",20180510,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22060937,1,8,C,ピレノキシン,"","",20180219,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22060937,1,9,C,オキシブプロカイン塩酸塩,"","",20180219,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22060943,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220909,"","","","",胃癌(胃癌),剂量停止,間質性肺疾患(再投与なし);誤嚥性肺炎(再投与なし),""
AB-22060947,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211019,20221108,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,放射線肺臓炎(再投与なし);肺炎(再投与なし),""
AB-22060947,2,2,C,生理食塩液,"",静脈内（明記されていない場合）,20211019,20221108,250,mL,1,"",未知,"",""
AB-22060947,2,3,C,ルパタジンフマル酸塩,"",経口,20221122,"",10,mg,1,"",未知,"",""
AB-22060947,2,4,C,エルデカルシトール,"",経口,"","",.75,ug,1,"",未知,"",""
AB-22060947,2,5,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-22061088,1,1,PS,パクリタキセル,タキソール,"",20200327,20200710,"","","",胃癌(Advanced gastric carcinoma),不适用,免疫性心筋炎(再投与なし);好中球数減少(再投与なし);悪性新生物進行(再投与なし),""
AB-22061088,1,2,PS,ニボルマブ,オプジーボ,"",202008,"",240,mg,1,胃癌(GASTRIC CANCER),不适用,免疫性心筋炎(再投与なし);好中球数減少(再投与なし);悪性新生物進行(再投与なし),""
AB-22061088,1,3,C,膵臓性消化酵素配合剤（１）,"","",20200222,"",1,g,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22061088,1,4,C,ビルダグリプチン,"","","","",50,mg,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22061088,1,5,C,メトホルミン塩酸塩,"","","","",250,mg,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22061088,1,6,C,メトクロプラミド,"","","","",5,mg,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22061088,1,7,C,テルミサルタン・アムロジピンベシル酸塩配合剤,"","","","","","","",適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22061088,1,8,C,ベニジピン塩酸塩,"","","","",2,mg,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22061088,1,9,C,テルミサルタン,"","","","",20,mg,1,適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22061088,1,10,C,酪酸菌配合剤,"","",20200222,"","","","",適応症不明の製品使用(product used for unknown indication),未知,"",""
AB-22061271,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202002,202003,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-22061278,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし);間質性肺疾患(再投与なし),""
AB-22061278,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22061278,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22061417,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-22061522,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"",20180914,"",130,mg,1,再発胃癌(Gastric cancer recurrent),剂量不变,急性呼吸窮迫症候群(再投与なし);脱水(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061522,1,2,PS,タゾバクタム・ピペラシリン水和物,ゾシン,"",20180920,20180929,"","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),剂量停止,急性呼吸窮迫症候群(再投与なし);脱水(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061522,1,3,PS,ニボルマブ,オプジーボ,"",20180314,20180824,360,mg,1,再発胃癌(Gastric cancer recurrent),剂量停止,急性呼吸窮迫症候群(再投与なし);脱水(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061522,1,4,PS,ラムシルマブ,サイラムザ,"",20180914,"",320,mg,1,再発胃癌(Gastric cancer recurrent),剂量不变,急性呼吸窮迫症候群(再投与なし);脱水(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061522,1,5,PS,オキサリプラチン,"","",20180314,20180824,177,mg,1,再発胃癌(Gastric cancer recurrent),剂量停止,急性呼吸窮迫症候群(再投与なし);脱水(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061522,1,6,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,;,20180314;,20180404;20180824,50;50,mg;mg,1;1,再発胃癌(Gastric cancer recurrent),剂量停止,急性呼吸窮迫症候群(再投与なし);脱水(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061522,1,7,C,デキサメタゾンリン酸エステルナトリウム,"",;,20180314;20180914,;,;6.6,;mg,;1,適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061522,1,8,C,アプレピタント,"","",20180314,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061522,1,9,C,デキサメタゾン,"","",20180314,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061522,1,10,C,ランソプラゾール,"","",20180314,"",15,mg,1,再発胃癌(Gastric cancer recurrent),剂量不变,"",""
AB-22061522,1,11,C,スクラルファート水和物,"","",20180306,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061522,1,12,C,経腸成分栄養剤（２−１）,"","",20180306,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061522,1,13,C,クロルフェニラミンマレイン酸塩,"","",20180914,"",5,mg,1,適応症不明の製品使用(DRUG USED FOR UNKNOWN INDICATION),剂量不变,"",""
AB-22061522,1,14,C,経腸成分栄養剤（９−２）,"","",20180423,"",1,g,1,経腸栄養(ENTERAL NUTRITION),剂量不变,"",""
AB-22061522,1,15,C,パロノセトロン塩酸塩,"","",20180314,"","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),剂量不变,"",""
AB-22061522,1,16,C,酪酸菌製剤,"","",20180706,"",1,g,1,細菌叢異常(DYSBACTERIOSIS),未知,"",""
AB-22061523,1,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,;,20180314;,20180404;20180824,50;50,mg;mg,1;1,再発胃癌(Recurrent gastric cancer),剂量停止,急性呼吸窮迫症候群(再投与なし);脱水(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061523,1,2,PS,ニボルマブ,オプジーボ,"",20180314,20180824,360,mg,1,再発胃癌(Recurrent gastric cancer),剂量停止,急性呼吸窮迫症候群(再投与なし);脱水(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061523,1,3,PS,ラムシルマブ,サイラムザ,"",20180914,"",320,mg,1,再発胃癌(Recurrent gastric cancer),剂量不变,急性呼吸窮迫症候群(再投与なし);脱水(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061523,1,4,PS,オキサリプラチン,"","",20180314,20180824,177,mg,1,再発胃癌(Recurrent gastric cancer),剂量停止,急性呼吸窮迫症候群(再投与なし);脱水(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061523,1,5,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"",20180914,"",130,mg,1,再発胃癌(Recurrent gastric cancer),剂量不变,急性呼吸窮迫症候群(再投与なし);脱水(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061523,1,6,C,デキサメタゾンリン酸エステルナトリウム,"",;,20180314;20180914,;,;6.6,;mg,;1,適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061523,1,7,C,アプレピタント,"","",20180314,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061523,1,8,C,デキサメタゾン,"","",20180314,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061523,1,9,C,ランソプラゾール,"","",20180314,"",15,mg,1,再発胃癌(Recurrent gastric cancer),剂量不变,"",""
AB-22061523,1,10,C,スクラルファート水和物,"","",20180306,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061523,1,11,C,経腸成分栄養剤（２−１）,"","",20180306,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061523,1,12,C,クロルフェニラミンマレイン酸塩,"","",20180914,"",5,mg,1,適応症不明の製品使用(DRUG USED FOR UNKNOWN INDICATION),剂量不变,"",""
AB-22061523,1,13,C,経腸成分栄養剤（９−２）,"","",20180423,"",1,g,1,経腸栄養(ENTERAL NUTRITION),剂量不变,"",""
AB-22061523,1,14,C,パロノセトロン塩酸塩,"","",20180314,"","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),剂量不变,"",""
AB-22061523,1,15,C,酪酸菌製剤,"","",20180706,"",1,g,1,細菌叢異常(DYSBACTERIOSIS),未知,"",""
AB-22061523,1,16,C,タゾバクタム・ピペラシリン水和物,"","",20180920,20180929,"","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),剂量停止,"",""
AB-22061724,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"",20180906,"",160,mg,1,胃癌(GASTRIC CANCER),剂量不变,発熱性好中球減少症(再投与なし);皮膚感染(再投与なし),""
AB-22061724,1,2,PS,ニボルマブ,オプジーボ,"",20171108,20180809,360,mg,1,胃癌(Gastric cancer),剂量停止,発熱性好中球減少症(不明);皮膚感染(不明),""
AB-22061724,1,3,PS,ラムシルマブ,サイラムザ,"",20180906,"",460,mg,1,胃癌(GASTRIC CANCER),剂量不变,発熱性好中球減少症(再投与なし);皮膚感染(再投与なし),""
AB-22061724,1,4,PS,オキサリプラチン,"",;,20171108;20171128,20171108;20180809,130;100,mg/m2;mg/m2,1;1,胃癌(GASTRIC CANCER),剂量停止,発熱性好中球減少症(不明);皮膚感染(不明),""
AB-22061724,1,5,C,ラベプラゾールナトリウム,"","",20171025,"","","","",予防(PROPHYLAXIS),剂量不变,"",""
AB-22061724,1,6,C,タムスロシン塩酸塩,"","",20171120,"","","","",予防(PROPHYLAXIS),剂量不变,"",""
AB-22061724,1,7,C,酸化マグネシウム,"","",20171027,"",0.5,g,1,予防(PROPHYLAXIS),剂量不变,"",""
AB-22061724,1,8,C,レバミピド,"","",20171025,"","","","",予防(PROPHYLAXIS),剂量不变,"",""
AB-22061724,1,9,C,セルニチンポーレンエキス,"","",20171024,"","","","",予防(PROPHYLAXIS),剂量不变,"",""
AB-22061724,1,10,C,オキシコドン塩酸塩水和物,"","",20171027,"","","","",癌疼痛(CANCER PAIN),剂量不变,"",""
AB-22061724,1,11,C,ジフェンヒドラミン塩酸塩,"","",20180906,"","","","",前投薬(PREMEDICATION),剂量不变,"",""
AB-22061724,1,12,C,デキサメタゾンリン酸エステルナトリウム,"","",20180906,"",2,mL,1,前投薬(PREMEDICATION),剂量不变,"",""
AB-22061725,1,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,"",20171221,20200304,60,mg,1,胃癌(GASTRIC CANCER),剂量停止,血小板数減少(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061725,1,2,PS,ニボルマブ,オプジーボ,"",20171221,20200225,360,mg,1,胃癌(GASTRIC CANCER),剂量停止,血小板数減少(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061725,1,3,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"",20200428,"","","","",胃癌(GASTRIC CANCER),未知,血小板数減少(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061725,1,4,PS,ラムシルマブ,サイラムザ,"",20200428,"","","","",胃癌(GASTRIC CANCER),未知,血小板数減少(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061725,1,5,PS,オキサリプラチン,"",;,20200303;20171221,20200303;,117;240,mg;mg,1;1,胃癌(GASTRIC CANCER),剂量停止,血小板数減少(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061725,1,6,C,クエン酸第一鉄ナトリウム,"","",20171216,"",50,mg,1,貧血(ANEMIA),未知,"",""
AB-22061725,1,7,C,ボノプラザンフマル酸塩,"","",20190703,"",10,mg,1,胃腸障害(GASTROINTESTINAL DISORDER),未知,"",""
AB-22061725,1,8,C,ウルソデオキシコール酸,"","",20200128,"",100,mg,1,肝胆道系障害予防(HEPATOBILIARY DISORDER PROPHYLAXIS),未知,"",""
AB-22061725,1,9,C,酸化マグネシウム,"","",20180216,"",330,mg,1,便秘(CONSTIPATION),未知,"",""
AB-22061725,1,10,C,酪酸菌製剤,"","",20200228,"","","","",胃腸障害予防(GASTROINTESTINAL DISORDER PROPHYLAXIS),未知,"",""
AB-22061725,1,11,C,ヘパリン類似物質,"","",20181204,"","","","",発疹(Skin eruption);皮膚乾燥(DRY SKIN),未知,"",""
AB-22061725,1,12,C,ジフルコルトロン吉草酸エステル,"","",20190124,"","","","",発疹(SKIN ERUPTION),未知,"",""
AB-22061726,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"",20200428,"","","","",胃癌(GASTRIC CANCER),未知,血小板数減少(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061726,1,2,PS,ニボルマブ,オプジーボ,"",20171221,20200225,360,mg,1,胃癌(GASTRIC CANCER),剂量停止,血小板数減少(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061726,1,3,PS,ラムシルマブ,サイラムザ,"",20200428,"","","","",胃癌(GASTRIC CANCER),未知,血小板数減少(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061726,1,4,PS,オキサリプラチン,"",;,20200303;20171221,20200303;,117;240,mg;mg,1;1,胃癌(GASTRIC CANCER),剂量停止,血小板数減少(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061726,1,5,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,"",20171221,20200304,60,mg,1,胃癌(Gastric cancer),剂量停止,血小板数減少(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22061726,1,6,C,クエン酸第一鉄ナトリウム,"","",20171216,"",50,mg,1,貧血(ANAEMIA),未知,"",""
AB-22061726,1,7,C,ボノプラザンフマル酸塩,"","",20190703,"",10,mg,1,胃腸障害(GASTROINTESTINAL DISORDER),未知,"",""
AB-22061726,1,8,C,ウルソデオキシコール酸,"","",20200128,"",100,mg,1,肝胆道系障害予防(HEPATOBILLIARY DISORDER PROPHYLAXIS),未知,"",""
AB-22061726,1,9,C,酸化マグネシウム,"","",20180216,"",330,mg,1,便秘(CONSTIPATION),未知,"",""
AB-22061726,1,10,C,酪酸菌製剤,"","",20200228,"","","","",胃腸障害予防(GASTROINTESTINAL DISORDER PROPHYLAXIS),未知,"",""
AB-22061726,1,11,C,ヘパリン類似物質,"","",20181204,"","","","",発疹(SKIN ERRUPTION);皮膚乾燥(DRY SKIN),未知,"",""
AB-22061726,1,12,C,ジフルコルトロン吉草酸エステル,"","",20190124,"","","","",発疹(SKIN ERUPTION),未知,"",""
AB-22061729,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"",20180711,"",160,mg,1,遠隔転移を伴う胃癌(Metastatic gastric cancer),未知,発熱性好中球減少症(再投与なし);肺臓炎(再投与なし);播種性血管内凝固(再投与なし),""
AB-22061729,1,2,PS,ニボルマブ,オプジーボ,"",20171208,"",360,mg,1,遠隔転移を伴う胃癌(Metastatic gastric cancer),剂量停止,発熱性好中球減少症(再投与なし);肺臓炎(再投与なし);播種性血管内凝固(再投与なし),""
AB-22061729,1,3,PS,ラムシルマブ,サイラムザ,"",20180711,"",450,mg,1,遠隔転移を伴う胃癌(Metastatic gastric cancer),未知,発熱性好中球減少症(再投与なし);肺臓炎(再投与なし);播種性血管内凝固(再投与なし),""
AB-22061729,1,4,PS,カペシタビン,"","",20171208,"","","","",遠隔転移を伴う胃癌(Metastatic gastric cancer),剂量停止,発熱性好中球減少症(再投与なし);肺臓炎(再投与なし);播種性血管内凝固(再投与なし),""
AB-22061729,1,5,PS,オキサリプラチン,"","",20171208,"","","","",遠隔転移を伴う胃癌(Metastatic gastric cancer),剂量停止,発熱性好中球減少症(再投与なし);肺臓炎(再投与なし);播種性血管内凝固(再投与なし),""
AB-22061729,1,6,C,ランソプラゾール,"",;,;,;,15;15,mg;mg,1;1,適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061729,1,7,C,NIFEDIPINE,"",;,;,;,40;20,mg;mg,1;1,適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061729,1,8,C,テルミサルタン,"","","","",40,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22061729,1,9,C,トリクロルメチアジド,"","","","",1,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),剂量不变,"",""
AB-22061729,1,10,C,酸化マグネシウム,"","",20180524,"",1320,mg,1,便秘(CONSTIPATION),剂量不变,"",""
AB-22061729,1,11,C,酢酸亜鉛水和物,"","",20180702,20181030,100,mg,1,味覚不全(DYSGEUSIA),剂量停止,"",""
AB-22061729,1,12,C,パロノセトロン塩酸塩,"","",20180711,"",0.75,mg,1,予防(PROPHYLAXIS),剂量不变,"",""
AB-22061729,1,13,C,DEXAMETHASONESODIUM PHOSPHATE,"","",20180711,"",6.6,mg,1,予防(PROPHYLAXIS),剂量不变,"",""
AB-22061729,1,14,C,RANITIDINEHYDROCHLORIDE,"","",20180711,"",50,mg,1,予防(PROPHYLAXIS),剂量不变,"",""
AB-22061729,1,15,C,DEXCHLORPHENIRAMINEMALEATE,"","",20180711,"",5,mg,1,予防(PROPHYLAXIS),剂量不变,"",""
AB-22061729,1,16,C,ラメルテオン,"","",20171215,"",8,mg,1,不眠症(INSOMNIA),剂量不变,"",""
AB-22061729,1,17,C,ZOLPIDEMTARTRATE,"","",20171215,"",10,mg,1,不眠症(INSOMNIA),剂量不变,"",""
AB-22061729,1,18,C,CLOSTRIDIUMBUTYRICUM,"","",20180208,"",3,g,1,下痢(DIARRHOEA);便秘(CONSTIPATION),剂量不变,"",""
AB-22061729,1,19,C,ロペラミド塩酸塩,"","",20180501,"",2,mg,1,下痢(DIARRHOEA),剂量不变,"",""
AB-22061729,1,20,C,ZOLPIDEMTARTRATE,"","",20171215,"",10,mg,1,不眠症(INSOMNIA),剂量不变,"",""
AB-22061729,1,21,C,スピロノラクトン,"","",20180808,"",40,mg,1,適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-22061729,1,22,C,LEVOFLOXACIN,"","",20180831,20180904,500,mg,1,発熱(PYREXIA),剂量停止,"",""
AB-22061729,1,23,C,PARACETAMOL,"","",20180831,20180904,300,mg,1,発熱(PYREXIA),剂量停止,"",""
AB-22061729,1,24,C,パクリタキセル（アルブミン懸濁型）,"","",20180711,"",130,mg,1,遠隔転移を伴う胃癌(Metastatic gastric cancer),剂量停止,"",""
AB-22061815,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220411;20220516,20220425;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,慢性好酸球性副鼻腔炎(再投与なし),""
AB-22061816,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202004,202005,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-22061818,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220531,20220715,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,唾液管の炎症(再投与なし),""
AB-22061818,3,2,C,フルオロウラシル,"",不明,20220531,20230327,4400,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22061818,3,3,C,オキサリプラチン,"",不明,20220531,20221031,130,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22061818,3,4,C,レボホリナートカルシウム,"",不明,20220531,20230327,300,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22061821,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-22061821,1,2,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22061821,1,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22061821,1,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22062144,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,;,20180606;20180704,;,100;80,mg/m2;mg/m2,1;1,再発胃癌(Gastric cancer recurrent),剂量不变,間質性肺疾患(再投与なし);脱水(再投与なし),""
AB-22062144,1,2,PS,ニボルマブ,オプジーボ,"",20171129,"",360,mg,1,再発胃癌(Gastric cancer recurrent),剂量停止,間質性肺疾患(再投与なし);脱水(再投与なし),""
AB-22062144,1,3,PS,ラムシルマブ,サイラムザ,"",20180704,"",8,mg/kg,1,再発胃癌(Gastric cancer recurrent),剂量不变,間質性肺疾患(再投与なし);脱水(再投与なし),""
AB-22062144,1,4,PS,カペシタビン,"",;,20171129;20180208,;20180418,3600;1200,mg;mg,1;1,再発胃癌(Gastric cancer recurrent),剂量停止,間質性肺疾患(再投与なし);脱水(再投与なし),""
AB-22062144,1,5,PS,オキサリプラチン,"","",20171129,20180418,130,mg/m2,1,再発胃癌(Gastric cancer recurrent),剂量停止,間質性肺疾患(再投与なし);脱水(再投与なし),""
AB-22062144,1,6,C,ヘパリン類似物質,"","",20171129,"","","","",皮膚乾燥予防(DRY SKIN PROPHYLAXIS),未知,"",""
AB-22062144,1,7,C,アズレンスルホン酸ナトリウム水和物,"","",20171206,"","","","",口内炎(MUCOSITIS ORAL),未知,"",""
AB-22062144,1,8,C,シタグリプチンリン酸塩水和物,"","",20180206,"","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-22062144,1,9,C,ミコナゾール,"","",20180206,"","","","",粘膜感染(MUCOSAL INFECTION),未知,"",""
AB-22062144,1,10,C,ポラプレジンク,"","",20180206,"",75,mg,1,味覚不全(DYSGEUSIA),未知,"",""
AB-22062144,1,11,C,グリメピリド,"",;,;20180227,;,0.5;1.5,mg;mg,1;1,糖尿病(DIABETES MELLITUS),未知,"",""
AB-22062144,1,12,C,レボチロキシンナトリウム水和物,"","",20180509,"",100,ug,1,甲状腺機能低下症(HYPOTHYROIDISM),未知,"",""
AB-22062144,1,13,C,ビラスチン,"","",20180320,"",20,mg,1,アレルギー性鼻炎(RHINITIS ALLERGIC),未知,"",""
AB-22062144,1,14,C,プレガバリン,"","",20180411,"",150,mg,1,末梢性ニューロパチー(NEUROPATHY PERIPHERAL),未知,"",""
AB-22062144,1,15,C,ボノプラザンフマル酸塩,"","",201611,"",20,mg,1,胃腸潰瘍予防(GASTRIC ULCER PROPHYLAXIS),未知,"",""
AB-22062144,1,16,C,タムスロシン塩酸塩,"","",20151210,"",0.2,mg,1,良性前立腺肥大症(PROSTATIC HYPERTROPHY),未知,"",""
AB-22062144,1,17,C,イコサペント酸エチル,"","",20170901,"","","","",末梢動脈閉塞性疾患(ARTERIOSCLEROSIS OBLITERANS),未知,"",""
AB-22062144,1,18,C,ジクロフェナクナトリウム,"","",20171220,"","","","",口内炎(MUCOSITIS ORAL),未知,"",""
AB-22062144,1,19,C,トラネキサム酸,"","",20171220,"","","","",口内炎(MUCOSITIS ORAL),未知,"",""
AB-22062144,1,20,C,炭酸水素ナトリウム,"","",20171220,"","","","",口内炎(MUCOSITIS ORAL),未知,"",""
AB-22062144,1,21,C,シタグリプチンリン酸塩水和物,"","",20180206,"",50,mg,1,糖尿病(DIABETES MELLITUS),未知,"",""
AB-22062144,1,22,C,酸化マグネシウム,"","",20180416,"",330,mg,1,便秘(CONSTIPATION),未知,"",""
AB-22062144,1,23,C,ルリコナゾール,"","",20180711,"","","","",足部白癬(TINEA PEDIS),未知,"",""
AB-22062144,1,24,C,ヒドロコルチゾン酢酸エステル,"","",20180711,"",10,mg,1,コルチゾール減少(CORTISOL DECREASED),未知,"",""
AB-22062144,1,25,C,ロキソプロフェンナトリウム水和物,"","",20180711,"",60,mg,1,関節痛(SHOULDER PAIN),未知,"",""
AB-22062144,1,26,C,イトラコナゾール,"","",20180131,"",10,mL,1,粘膜感染(MUCOSAL INFECTION),未知,"",""
AB-22062144,1,27,C,メトホルミン塩酸塩,"","",20180206,"",500,mg,1,糖尿病(DIABETES MELLITUS),未知,"",""
AB-22062144,1,28,C,半夏瀉心湯,"","",20180704,"","","","",口内炎(MUCOSITIS ORAL),未知,"",""
AB-22062541,1,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,;,201907;202002,201908;202007,;,;,;,"胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062541,1,2,PS,オキサリプラチン,"",;,201907;201909,201908;202001,;,;,;,"胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062541,1,3,PS,レボホリナートカルシウム,"","",201909,202001,"","","","胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062541,1,4,PS,フルオロウラシル,"","",201909,202001,"","","","胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062541,1,5,PS,シスプラチン,"","",202002,202007,"","","","胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062541,1,6,PS,ラムシルマブ,サイラムザ,"","","","","","","胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062541,1,7,PS,ニボルマブ,オプジーボ,"",202009,202011,"","","","胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062541,1,8,PS,リュープロレリン酢酸塩,"","","","","","","",前立腺癌(Prostate cancer),剂量不变,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062541,1,9,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"","","","","","","胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062541,1,10,C,リュープロレリン酢酸塩,"","","","","","","",前立腺癌(Prostate cancer),未知,"",""
AB-22062542,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"","","","","","","胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062542,1,2,PS,オキサリプラチン,"",;,201907;201909,201908;202001,;,;,;,"胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062542,1,3,PS,レボホリナートカルシウム,"","",201909,202001,"","","","胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062542,1,4,PS,フルオロウラシル,"","",201909,202001,"","","","胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062542,1,5,PS,シスプラチン,"","",202002,202007,"","","","胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062542,1,6,PS,ラムシルマブ,サイラムザ,"","","","","","","胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062542,1,7,PS,ニボルマブ,オプジーボ,"",202009,202011,"","","","胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062542,1,8,PS,リュープロレリン酢酸塩,"","","","","","","",前立腺癌(Prostate cancer),剂量不变,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062542,1,9,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,;,201907;202002,201908;202007,;,;,;,"胃腺癌(Advanced gastric cancer (poorly-differentiated adenocarcinoma, with lymph node metastases))",剂量停止,骨髄抑制(再投与なし);末梢性ニューロパチー(再投与なし);ヘモグロビン減少(再投与なし),""
AB-22062542,1,10,C,リュープロレリン酢酸塩,"","","","","","","",前立腺癌(Prostate cancer),未知,"",""
AB-22062739,1,1,PS,オキサリプラチン,エルプラット：点滴静注液,"","","","","","",胃癌(進行胃癌),剂量不变,劇症１型糖尿病(再投与なし),""
AB-22062739,1,2,PS,レボホリナートカルシウム,レボホリナート,"","","","","","",胃癌(進行胃癌),剂量不变,劇症１型糖尿病(再投与なし),""
AB-22062739,1,3,PS,ニボルマブ,"","","","","","","",胃癌(進行胃癌),未知,"",""
AB-22062739,1,4,C,フルオロウラシル,"","","","","","","",胃癌(進行胃癌),未知,"",""
AB-22062810,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202207,20221021,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22062810,1,2,C,カペシタビン,"",不明,202207,20221021,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22062810,1,3,C,オキサリプラチン,"",不明,202207,20221021,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22063113,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221018,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,１型糖尿病(再投与なし),""
AB-22063113,1,2,PS,オキサリプラチン,"",不明,20221018,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22063113,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20221018,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22063192,3,1,PS,オキサリプラチン,"",静脈内（明記されていない場合）,"","",300,mg/m2,1,"胃癌第４期(Stage IVA (T4b,N2,M0) gastric cancer)",剂量减少,"",""
AB-22063192,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","","胃癌第４期(stage IVA (T4b,N2,M0) gastric cancer)",剂量减少,"",""
AB-22063192,3,3,PS,ニボルマブ,"",静脈内（明記されていない場合）,"","","","","","胃癌第４期(stage IVA (T4b,N2,M0) gastric cancer)",未知,"",""
AB-22063271,1,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,20220610,20220930,"","","",肝細胞癌(肝細胞癌),不适用,血小板数減少(再投与なし),""
AB-22063271,1,2,PS,ベバシズマブ,アバスチン,静脈内点滴,20220610,20220930,"","","",肝細胞癌(肝細胞癌),不适用,血小板数減少(再投与なし),""
AB-22063300,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-22063300,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22063300,1,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22063300,1,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22063364,2,1,PS,パクリタキセル,タキソール,"",20210916,20211021,120,mg,1,胃癌(GASTRIC CANCER),不适用,腎機能障害(再投与なし);感覚鈍麻(再投与なし);末梢性浮腫(再投与なし);上腹部痛(再投与なし),""
AB-22063364,2,2,PS,ニボルマブ,オプジーボ,"",20211125,20211209,240,mg,1,胃癌(GASTRIC CANCER),不适用,腎機能障害(再投与なし);感覚鈍麻(再投与なし);末梢性浮腫(再投与なし);上腹部痛(再投与なし),""
AB-22063364,2,3,PS,アナモレリン塩酸塩,エドルミズ,"",20210824,"",100,mg,1,悪液質(CANCER CACHEXIA),不适用,腎機能障害(再投与なし);感覚鈍麻(再投与なし);末梢性浮腫(再投与なし);上腹部痛(再投与なし),""
AB-22063364,2,4,PS,ラムシルマブ,"","",20210916,20211021,400,mg/kg,1,胃癌(GASTRIC CANCER),不适用,腎機能障害(再投与なし);感覚鈍麻(再投与なし);末梢性浮腫(再投与なし);上腹部痛(再投与なし),""
AB-22063364,2,5,C,オキサリプラチン,"",;;,20210125;20210422;,;20210422;20210826,200;150;200,mg;mg;mg,1;1;1,胃癌(GASTRIC CANCER),未知,"",""
AB-22063364,2,6,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"","",20210125,20210826,100,mg,1,胃癌(GASTRIC CANCER),未知,"",""
AB-22063364,2,7,C,ボノプラザンフマル酸塩,"","","","",20,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,8,C,レバミピド,"","","","",100,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,9,C,酸化マグネシウム,"",;;,;20210823;20210906,;;,990;330;,mg;mg;,1;1;,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,10,C,プレガバリン,"","","","",25,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,11,C,トラマドール塩酸塩,"","","",20211103,25,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,12,C,ベタメタゾン,"","",20210906,"",0.5,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,13,C,フェンタニルクエン酸塩,"","",20211104,"",0.5,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,14,C,モルヒネ塩酸塩水和物,"",;,20211104;20211110,;,5;10,mg;mg,1;1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,15,C,フロセミド,"","",20211103,"",20,mg,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,16,C,アセトアミノフェン,"",;,20211103;20211109,;,400;400,mg;mg,1;1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,17,C,尿素,"","",20211109,20211123,"","","",予防(Prophylaxis),未知,"",""
AB-22063364,2,18,C,白色ワセリン,"","",20211109,20211123,"","","",予防(Prophylaxis),未知,"",""
AB-22063364,2,19,C,トコフェロール・ビタミンＡ油,"","",20211109,20211123,"","","",予防(Prophylaxis),未知,"",""
AB-22063364,2,20,C,アミノ酸・糖・電解質・ビタミン（４）,"",;;;,20210823;20210906;20211111;20211211,;;;,;;;,;;;,;;;,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,21,C,ピコスルファートナトリウム水和物,"","",20210823,"","","","",適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,22,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"","",20210826,"",40,mg,1,胃癌(GASTRIC CANCER),未知,"",""
AB-22063364,2,23,C,炭酸水素ナトリウム・無水リン酸二水素ナトリウム,"","",20211021,20211026,"","","",適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22063364,2,24,C,フェンタニルクエン酸塩,"","",20211211,"",100,ug,1,適応症不明の製品使用(UNKNOWN INDICATION),未知,"",""
AB-22064022,2,1,PS,トラスツズマブデルクステカン,エンハーツ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20220922;20221201;20221229;20230119;20230209;20230302,20220922;20221201;20221229;20230119;20230209;20230302,6.4;6.4;6.4;6.4;6.4;6.4,mg/kg;mg/kg;mg/kg;mg/kg;mg/kg;mg/kg,1;1;1;1;1;1,胃腺癌(Adenocarcinoma gastric),剂量停止,ニューモシスチス・イロベチイ肺炎(不明),""
AB-22064022,2,2,PS,ニボルマブ,オプジーボ,不明,20220623,20220831,"","","","",未知,"",""
AB-22064022,2,3,C,オロパタジン塩酸塩,"",経口,20220407,"",5,mg,1,"",未知,"",""
AB-22064022,2,4,C,ランソプラゾール,"",経口,20221014,"",15,mg,1,"",未知,"",""
AB-22064022,2,5,C,ピオグリタゾン塩酸塩,"",経口,"","",15,mg,1,糖尿病(Diabetes mellitus),未知,"",""
AB-22064022,2,6,C,アログリプチン安息香酸塩,"",経口,"","",25,mg,1,糖尿病(Diabetes mellitus),未知,"",""
AB-22064022,2,7,C,ミチグリニドカルシウム水和物,"",経口,"","",5,mg,1,糖尿病(Diabetes mellitus),未知,"",""
AB-22064022,2,8,C,ウルソデオキシコール酸,"",経口,"","",100,mg,1,"",未知,"",""
AB-22064022,2,9,C,プレドニゾロン,"",経口;経口;経口;経口,20220825;20221020;20221025;2022,202210;20221024;20221029;20221104,20;40;40;20,mg;mg;mg;mg,1;1;1;1,眼瞼下垂(Eyelid ptosis),未知,"",""
AB-22064058,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220721;20230201,20221130;20230607,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし);発疹(再投与なし),""
AB-22064058,7,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220721,20230906,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22064058,7,3,C,オキサリプラチン,"",不明,20220721,20220907,140,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22064191,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20220609;20220723;20220818;20220913,20220630;20220723;20220818;20220913,200;200;200;200,mg;mg;mg;mg,1;1;1;1,下咽頭癌第４期(下咽頭癌),剂量停止,免疫性腸炎(再投与なし),""
AB-22064191,3,2,C,フルオロウラシル,"",不明,20220609,20220913,"","","",頭頚部癌(併用療法),未知,"",""
AB-22064191,3,3,C,シスプラチン,"",不明,20220609,20220913,"","","",頭頚部癌(併用療法),未知,"",""
AB-22064450,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220705,20221004,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);血小板数減少(再投与なし),""
AB-22064450,3,2,PS,オキサリプラチン,"",不明,20220705,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22064450,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,20220705,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22064450,3,4,C,メトホルミン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-22064450,3,5,C,ロスバスタチンカルシウム,"",不明,"","","","","","",未知,"",""
AB-22064450,3,6,C,オメガ−３脂肪酸エチル,"",経口,"","","","","","",未知,"",""
AB-22064759,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,免疫性心筋炎(再投与なし);免疫性筋炎(再投与なし);重症筋無力症(再投与なし),""
AB-22064918,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221116,20221116,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,抗利尿ホルモン不適合分泌(再投与なし);抗利尿ホルモン不適合分泌(再投与なし),""
AB-22064918,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20221116,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22064918,1,3,C,オキサリプラチン,"",不明,20221116,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22065211,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,多発性関節炎(再投与なし);関節リウマチ(再投与なし),""
AB-22065211,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22065211,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22065212,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,筋力低下(再投与なし);呼吸困難(再投与なし);重症筋無力症(再投与なし),""
AB-22065369,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症肝炎(再投与なし),""
AB-22065425,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221011,20221108,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし);間質性肺疾患(再投与なし);下痢(再投与なし);抗利尿ホルモン不適合分泌(再投与なし),""
AB-22065425,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20221011,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22065425,2,3,C,オキサリプラチン,"",不明,20221011,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22065425,2,4,C,ボノプラザンフマル酸塩,"",不明,20221011,"","","","","",未知,"",""
AB-22065632,1,1,PS,ペムブロリズマブ,キイトルーダ,"","","","","","",非小細胞肺癌(NSCLC),未知,免疫介在性副腎機能不全(再投与なし),""
AB-22065632,1,2,C,CARBOPLATIN,"","","","","","","",胃癌(gastric cancer),未知,"",""
AB-22065632,1,3,C,PACLITAXELNANOPARTICLE ALBUMIN-BOUND,"","","","","","","",胃癌(gastric cancer),未知,"",""
AB-22065661,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20180418,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,出血性胃潰瘍(再投与なし),""
AB-22065748,1,1,PS,ペムブロリズマブ,キイトルーダ,"","","","","","",非小細胞肺癌(非小細胞肺癌);胃癌(胃癌),未知,免疫性ぶどう膜炎(再投与なし),""
AB-22065990,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221110,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,間質性肺疾患(再投与なし),""
AB-22065990,2,2,C,オキサリプラチン,"",不明,20221110,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22065990,2,3,C,フルオロウラシル,"",不明,20221110,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22065990,2,4,C,レボホリナートカルシウム,"",不明,20221110,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22065991,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",202212,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-22065991,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22065991,1,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22066167,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20210416,2022,200,mg,1,非小細胞肺癌第４期(非小細胞肺癌),不适用,腹膜炎(再投与なし),""
AB-22066167,2,2,C,ペメトレキセドナトリウム水和物,"",静脈内点滴,20210416,20211021,500,mg/m2,1,非小細胞肺癌第４期(非小細胞肺癌),未知,"",""
AB-22066167,2,3,C,カルボプラチン,"",静脈内点滴,20210416,20210708,"","","",非小細胞肺癌第４期(非小細胞肺癌),未知,"",""
AB-22066307,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210929,20220217,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腹膜炎(再投与なし);アルドラーゼ増加(再投与なし);腫瘍穿孔(再投与なし);筋力低下(再投与なし);筋萎縮(再投与なし);皮膚筋炎(再投与なし);抗核抗体増加(再投与なし),""
AB-22066307,2,2,C,Ｌ−アスパラギン酸カリウム,"",経口,20210204,20210218,300,mg,1,予防(予防),未知,"",""
AB-22066307,2,3,C,ボノプラザンフマル酸塩,"",経口,20210330,"",20,mg,1,"",未知,"",""
AB-22066307,2,4,C,スクラルファート水和物,"",経口,20210702,"",1,g,1,"",未知,"",""
AB-22066307,2,5,C,経腸成分栄養剤（２−２）,"",経口,20211029,"",100,mL,1,予防(予防),未知,"",""
AB-22066314,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,血中甲状腺刺激ホルモン減少(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-22066623,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-22066623,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22066623,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22066623,1,4,C,ラムシルマブ,"",不明,"","","","","",胃癌(胃癌),未知,"",""
AB-22066623,1,5,C,パクリタキセル（アルブミン懸濁型）,"",不明,"","","","","",胃癌(胃癌),未知,"",""
AB-22066624,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,筋炎(再投与なし),""
AB-22066686,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220216,20220311,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,蜂巣炎(再投与なし),""
AB-22066686,7,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口;経口,20220216;,;20220325,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22066686,7,3,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20220216;20220311,20220216;20220311,220;160,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22066686,7,4,PS,ラムシルマブ,"",不明,20220405,20220808,"","","",胃癌(胃癌),未知,"",""
AB-22066686,7,5,PS,パクリタキセル,"",不明,20220405,20220808,"","","",胃癌(胃癌),未知,"",""
AB-22066689,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220203,20220722,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,好中球数減少(再投与なし),""
AB-22066689,4,2,PS,オキサリプラチン,エルプラット,不明;不明;不明,20220203;20220328;20220520,20220303;20220428;20220617,150;140;110,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22066689,4,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明;不明,;,;,;,;,;,"",不适用,"",""
AB-22066689,4,4,C,フルオロウラシル,"",不明;不明;不明,20220203;20220328;20220520,20220303;20220428;20220722,5070;4750;3900,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22066689,4,5,C,レボホリナートカルシウム,"",不明;不明,20220203;20220328,20220303;20220722,375;350,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22066689,4,6,C,トリフルリジン・チピラシル塩酸塩配合剤,"",不明,20220819,20220927,"","","",胃癌(胃癌),未知,"",""
AB-22066694,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220106,20220519,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,心不全(再投与なし);心嚢液貯留(再投与なし),""
AB-22066694,3,2,C,オキサリプラチン,"",不明,20220106,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22066694,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220106,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22066696,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221202,20221202,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,関節痛(再投与なし);筋肉痛(再投与なし);食欲減退(再投与なし);免疫性心筋炎(再投与なし);肝機能異常(再投与なし);ミオパチー(再投与なし);免疫性重症筋無力症(再投与なし);不整脈(再投与なし);免疫性筋炎(再投与なし),""
AB-22066696,3,2,PS,オキサリプラチン,エルプラット,静脈内点滴,20221202,20221202,150,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22067310,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-22067310,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22067310,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22067318,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220822,20221219,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性血小板減少症(再投与なし);間質性肺疾患(再投与なし),""
AB-22067318,3,2,PS,シタグリプチンリン酸塩水和物,グラクティブ,経口,"","",50,mg,1,２型糖尿病(2型糖尿病),剂量不变,免疫性血小板減少症(再投与なし);間質性肺疾患(再投与なし),""
AB-22067318,3,3,C,ウルソデオキシコール酸,"",経口,20220926,20230113,100,mg,1,"",未知,"",""
AB-22067318,3,4,C,グリメピリド,"",経口,20221219,20230113,.5,mg,1,"",未知,"",""
AB-22067318,3,5,C,アセトアミノフェン,"",経口,20230105,20230109,500,mg,1,"",未知,"",""
AB-22067318,3,6,C,セフジトレンピボキシル,"",経口,20230105,20230109,100,mg,1,"",未知,"",""
AB-22067318,3,7,C,アムロジピンベシル酸塩,"",経口,"",20230113,2.5,mg,1,"",未知,"",""
AB-22067321,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,血液障害(再投与なし),""
AB-22067321,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22067321,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22067583,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,2022;20220621,2022;2022,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22067583,2,2,C,オキサリプラチン,"",不明,2022,2022,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22067583,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,2022;20220621,2022;2022,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22067588,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-22067588,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22067588,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22067590,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,糖尿病性ケトアシドーシス(再投与なし);劇症１型糖尿病(再投与なし),""
AB-22067590,1,2,C,オキサリプラチン,"",静脈内点滴,"","",100,mg/m2,1,"",未知,"",""
AB-22067590,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","",40,mg/m2,1,"",未知,"",""
AB-22067851,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220427,20221221,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,末梢性ニューロパチー(再投与なし),""
AB-22067851,1,2,PS,オキサリプラチン,"",不明,20220427,20221221,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22067851,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,20220427,20221221,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22068581,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-22068581,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068581,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068587,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-22068587,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068587,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068589,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22068589,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068589,1,3,C,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068593,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺毒性(再投与なし);意識レベルの低下(再投与なし),""
AB-22068593,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068593,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068617,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221228,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし),""
AB-22068617,1,2,C,オキサリプラチン,"",不明,20221228,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068617,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20221228,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068974,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202208,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,大腸炎(再投与なし);免疫性皮膚炎(再投与なし);出血性膀胱炎(再投与なし),""
AB-22068974,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明;不明,202208;202211;,;;,;;80,;;mg,;;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068974,3,3,C,オキサリプラチン,"",不明;不明;不明,202208;202211;,;;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068975,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺障害(再投与なし),""
AB-22068975,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068975,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068975,1,4,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068984,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,血小板数減少(再投与なし),""
AB-22068984,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068984,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068986,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202211,20221223,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,悪性新生物進行(再投与なし);間質性肺疾患(再投与なし),""
AB-22068986,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202211,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22068986,1,3,C,オキサリプラチン,"",不明,202211,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22069273,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,脳梗塞(再投与なし),""
AB-22069273,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22069273,1,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22069273,1,4,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22069277,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,徐脈(再投与なし),""
AB-22069277,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","",40,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22069277,3,3,C,オキサリプラチン,"",静脈内点滴,"","",130,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22069374,1,1,PS,オキサリプラチン,エルプラット：点滴静注液,"","","","","","",胃癌(進行胃癌),未知,"",""
AB-22069374,1,2,PS,ニボルマブ,"","","","","","","",胃癌(進行胃癌),未知,"",""
AB-22069374,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"","","","","","","",胃癌(進行胃癌),未知,"",""
AB-22069589,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220330,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,脳炎(再投与なし),""
AB-22069590,3,1,PS,アナモレリン塩酸塩,エドルミズ,経口,20210716,20220112,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-22069590,3,2,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20220112,480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-22069614,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22069617,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-22069617,1,2,C,フルオロウラシル,"",静脈内点滴,"","","","","",胃癌(治療切除不能な進行・再発の胃癌),未知,"",""
AB-22069617,1,3,C,レボホリナートカルシウム,"",静脈内点滴,"","","","","",胃癌(治療切除不能な進行・再発の胃癌),未知,"",""
AB-22069617,1,4,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治療切除不能な進行・再発の胃癌),未知,"",""
AB-22069620,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,１型糖尿病(再投与なし),""
AB-22070029,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221228,20221228,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,丘疹性皮疹(再投与なし),""
AB-22070029,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20221228,"",80,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22070029,1,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20221228;,;,130;,mg/m2;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22070050,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,類天疱瘡(再投与なし),""
AB-22070079,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,苔癬様角化症(再投与なし);類天疱瘡(再投与なし),""
AB-22070312,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,大腸炎(再投与なし),""
AB-22070788,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-22070790,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202205,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-22070790,2,2,C,オキサリプラチン,"",不明,202205,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22070790,2,3,C,カペシタビン,"",不明,202205,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22071036,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220225,20221007,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性脳炎(再投与なし),""
AB-22071036,1,2,C,オキサリプラチン,"",静脈内点滴,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22071036,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22071043,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202204,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,転倒(再投与なし);血中コルチコトロピン減少(再投与なし);大腿骨頚部骨折(再投与なし);コルチゾール減少(再投与なし),""
AB-22071043,3,2,C,オキサリプラチン,"",不明,202204,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22071043,3,3,C,カペシタビン,"",不明,202204,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22071044,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,てんかん(再投与なし);意識レベルの低下(再投与なし),""
AB-22071050,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-22071054,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20220804;20230113;不明,不明;不明;20230330,360;360;360,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,溺死(再投与なし);劇症１型糖尿病(再投与なし);血中コルチコトロピン減少(再投与なし);副腎機能不全(再投与なし);骨髄抑制(再投与なし),""
AB-22071054,5,2,PS,オキサリプラチン,"",不明;不明;不明,20220804;20230113;,;;20230330,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22071054,5,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明;不明,20220804;20230113;,;;20230330,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22071064,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220107;,;202210,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫介在性副腎機能不全(不明),""
AB-22071064,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220107,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22071064,2,3,C,オキサリプラチン,"",不明,20220107,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22071311,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220428,20220526,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性脳炎(再投与なし),""
AB-22071311,3,2,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22071311,3,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22071311,3,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22071690,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202211,202212,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-22071691,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220329,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,胃閉塞(再投与なし);胃閉塞(再投与なし),""
AB-22071691,4,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20220329;,;,40;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22071691,4,3,PS,オキサリプラチン,エルプラット,静脈内点滴,20220329,"",180,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-22071691,4,4,C,ラベプラゾールナトリウム,"",経口,"","",10,mg,1,"",未知,"",""
AB-22071693,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220728,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎皮質刺激ホルモン欠損症(再投与なし);副腎機能不全(再投与なし),""
AB-22071693,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220728,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22071693,2,3,PS,オキサリプラチン,"",不明,20220728,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22071947,1,1,PS,カルボプラチン,パラプラチン,"","","","","","",非小細胞肺癌(Non-small cell lung cancer),不适用,間質性肺疾患(再投与なし);呼吸不全(再投与なし);活動状態低下(再投与なし),""
AB-22071947,1,2,PS,ニボルマブ,オプジーボ,"","","",3,mg/kg,1,非小細胞肺癌(Non-small cell lung cancer),剂量停止,間質性肺疾患(再投与なし);呼吸不全(再投与なし);活動状態低下(再投与なし),""
AB-22071947,1,3,PS,パクリタキセル（アルブミン懸濁型）,"","","","","","","",非小細胞肺癌(Non-small cell lung cancer),不适用,間質性肺疾患(再投与なし);呼吸不全(再投与なし);活動状態低下(再投与なし),""
AB-22071980,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-22071980,1,2,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
AB-22072627,1,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,202204,"","","","",肝細胞癌(ＨＣＣ),未知,穿孔性虫垂炎(不明),""
AB-22072627,1,2,PS,ベバシズマブ,アバスチン,静脈内点滴,202204,"","","","",肝細胞癌(肝細胞癌),未知,穿孔性虫垂炎(不明),""
AB-22072630,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-22072630,1,2,C,オキサリプラチン,"",静脈内点滴,"","","","","","",未知,"",""
AB-22072630,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","","",未知,"",""
AB-22072837,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202202;202209,;,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(無),""
AB-22072837,1,2,C,オキサリプラチン,"",不明;不明,202202;202209,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22072837,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,202202;202209,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22072839,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202203,202208,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,劇症１型糖尿病(再投与なし),""
AB-22072839,1,2,C,オキサリプラチン,"",不明,202203,202208,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22072839,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202203,202208,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22072839,1,4,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22072839,1,5,C,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22072858,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221208,"",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22072858,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","","",未知,"",""
AB-22072858,1,3,C,オキサリプラチン,"",静脈内点滴,"","","","","","",未知,"",""
AB-22073223,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220726,20220913,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22073223,2,2,C,オキサリプラチン,"",不明,20220726,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22073223,2,3,C,カペシタビン,"",不明,20220726,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22073262,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220815,20221107,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,倦怠感(再投与なし);劇症１型糖尿病(再投与なし),""
AB-22073262,4,2,C,カペシタビン,"",経口,20220815,202211,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22073262,4,3,C,オキサリプラチン,"",静脈内点滴,20220815,20221107,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22073262,4,4,C,ラムシルマブ,"",静脈内点滴,20221128,20230131,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22073262,4,5,C,パクリタキセル,"",静脈内点滴,20221128,20230131,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22073599,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,末梢性ニューロパチー(再投与なし),""
AB-22073599,3,2,C,オキサリプラチン,"",不明;不明,;,;,150;100,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22073599,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明;不明;不明,;;;,;;;,100;80;60;60,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22073601,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220308,20220329,360,mg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),剂量停止,器質化肺炎(再投与なし),""
AB-22073601,2,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,20220308,20220308,67.8,mg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),剂量停止,"",""
AB-22073984,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,関節リウマチ(再投与なし);末梢性ニューロパチー(再投与なし),""
AB-22073984,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22073984,3,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22073984,3,4,C,プレドニゾロン,"",経口,"","","","","","",未知,"",""
AB-22073984,3,5,C,メトトレキサート,"",経口,"","","","","","",未知,"",""
AB-22073984,3,6,C,イグラチモド,"",経口,"","","","","","",未知,"",""
AB-22073984,3,7,C,葉酸,"",経口,"","","","","","",未知,"",""
AB-22073984,3,8,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","","",未知,"",""
AB-22073984,3,9,C,ベニジピン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-22073984,3,10,C,プラバスタチンナトリウム,"",経口,"","","","","","",未知,"",""
AB-22073984,3,11,C,アスピリン,"",経口,"","","","","","",未知,"",""
AB-22074241,2,1,PS,イピリムマブ,ヤーボイ,"",20220308,20220308,67.8,mg,1,非小細胞肺癌(Non-small cell lung cancer),剂量停止,ＣＯＶＩＤ−１９(再投与なし);器質化肺炎(再投与なし),""
AB-22074241,2,2,PS,ニボルマブ,オプジーボ,;,20220308;20220329,20220308;20220329,360;360,mg;mg,1;1,非小細胞肺癌(Non-small cell lung cancer),剂量停止,ＣＯＶＩＤ−１９(再投与なし);器質化肺炎(再投与なし),""
AB-22074291,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,胃腸出血(再投与なし);免疫性腸炎(再投与なし),""
AB-22074292,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220209,20230124,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺毒性(再投与なし),""
AB-22074292,4,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明;不明,20220111;20220209,;,100;100,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22074292,4,3,PS,オキサリプラチン,"",不明,20220209,"",180,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22074293,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,201801;,201811;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,続発性副腎皮質機能不全(再投与なし),""
AB-22074293,1,2,PS,コルチゾン酢酸エステル,コートン,不明,"","",25,mg,1,続発性副腎皮質機能不全(下垂体性副腎機能低下),剂量停止,"",""
AB-22074461,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20200307,20200519,200,mg,1,胃癌第４期(MSI-High癌（結腸・直腸以外）切除不能進行胃癌),剂量停止,免疫介在性胆管炎(再投与なし),""
AB-22074631,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,不明;不明,不明;不明,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,結腸癌(再投与なし);１型糖尿病(再投与なし),""
AB-22074660,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,視床下部−下垂体障害(再投与なし),""
AB-22074660,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22074660,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22074726,2,1,PS,ペムブロリズマブ,キイトルーダ,不明,不明,"","","","",肺の悪性新生物(高度進行の原発性肺癌),未知,肺毒性(再投与なし);皮膚筋炎(再投与なし);吻合部狭窄(再投与なし);免疫性胃炎(再投与なし),""
AB-22074726,2,2,C,カルボプラチン,"",不明,不明,"","","","",肺の悪性新生物(高度進行の原発性肺癌),未知,"",""
AB-22074726,2,3,C,ペメトレキセドナトリウムヘミペンタ水和物,"",不明,不明,"","","","",肺の悪性新生物(高度進行の原発性肺癌),未知,"",""
AB-22074799,3,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,20221109,20221228,840,mg,1,トリプルネガティブ乳癌(TNBC),剂量停止,肺毒性(再投与なし),""
AB-22074799,3,2,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴,"","","","","",トリプルネガティブ乳癌(TNBC),未知,"",""
AB-22075228,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220912,20221128,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,硬膜下膿瘍(再投与なし);急性腎盂腎炎(再投与なし),""
AB-22075228,2,2,PS,アプレピタント,イメンド,経口,20220606,20221130,80,mg,1,悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),不适用,硬膜下膿瘍(再投与なし);急性腎盂腎炎(再投与なし),""
AB-22075228,2,3,C,オキサリプラチン,"",静脈内点滴,20220606,20221128,120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22075228,2,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220606,"",50,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22075228,2,5,C,パロノセトロン塩酸塩,"",静脈内点滴,20220606,20221128,.75,mg,1,予防(予防投与),未知,"",""
AB-22075228,2,6,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20220606,20221128,3.3,mg,1,予防(予防投与),未知,"",""
AB-22075228,2,7,C,デキサメタゾン,"",経口,20220606,20221130,4,mg,1,"",未知,"",""
AB-22075228,2,8,C,エソメプラゾールマグネシウム水和物,"",経口,20220606,"",20,mg,1,"",未知,"",""
AB-22075228,2,9,C,ルビプロストン,"",経口,20220606,"",24,ug,1,"",未知,"",""
AB-22075228,2,10,C,酪酸菌製剤,"",経口,20220606,"",2,{DF},1,"",未知,"",""
AB-22075228,2,11,C,セレコキシブ,"",経口,20220606,"",200,mg,1,"",未知,"",""
AB-22075231,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,細気管支炎(再投与なし),""
AB-22075411,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-22075411,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220505,20220818,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22075411,1,3,C,オキサリプラチン,"",不明,20220505,20220818,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22075416,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,心筋炎(再投与なし),""
AB-22075416,1,2,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22075416,1,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22075416,1,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22075660,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220522,20220801,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺線維症(再投与なし);間質性肺疾患(再投与なし),""
AB-22075660,1,2,PS,オキサリプラチン,"",不明,20220522,"",130,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22075661,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220228,20220513,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺線維症(再投与なし),""
AB-22075661,1,2,C,オキサリプラチン,"",不明,"","",130,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22075662,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220131;,;20220331,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,腸炎(再投与なし);甲状腺機能低下症(再投与なし),""
AB-22075662,2,2,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220131;,;20220331,125;125,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22075662,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,20220131;,;20220331,50;50,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22075741,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220824;202302,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,続発性副腎皮質機能不全(再投与なし),""
AB-22075741,1,2,C,オキサリプラチン,"",不明;不明,20220824;202302,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22075741,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,20220824;202212,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22076232,1,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,"","","","","",肝細胞癌(Hepatocellular carcinoma),不适用,下垂体機能低下症(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-22076232,1,2,PS,ベバシズマブ,アバスチン,静脈内点滴,"","","","","",肝細胞癌(Hepatocellular carcinoma),不适用,下垂体機能低下症(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-22076317,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし),""
AB-22076317,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22076317,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22076327,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);１型糖尿病(再投与なし),""
AB-22076327,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22076327,1,3,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22076327,1,4,C,アテゾリズマブ,"",不明,"","","","","","",未知,"",""
AB-22076616,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220324,20220407,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-22076620,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220616;20221013,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,胃閉塞(再投与なし),""
AB-22076708,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,免疫性腸炎(再投与なし),""
AB-22076710,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221118,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,心筋炎(再投与なし),""
AB-22076710,2,2,C,オキサリプラチン,"",不明,20221118,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22076710,2,3,C,フルオロウラシル,"",不明,20221118,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22076710,2,4,C,レボホリナートカルシウム,"",不明,20221118,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22076711,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220603,"",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎障害(再投与なし),""
AB-22076711,2,2,C,トラマドール塩酸塩・アセトアミノフェン配合剤,"",不明,"","","","","","",未知,"",""
AB-22076711,2,3,C,エペリゾン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-22076711,2,4,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-22076711,2,5,C,酪酸菌配合剤,"",不明,"","","","","","",未知,"",""
AB-22076711,2,6,C,ナルデメジントシル酸塩,"",不明,"","","","","","",未知,"",""
AB-22076711,2,7,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-22076711,2,8,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-22076711,2,9,C,アジルサルタン,"",不明,"","","","","","",未知,"",""
AB-22076711,2,10,C,リバーロキサバン,"",不明,"","","","","","",未知,"",""
AB-22076898,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221028,20221028,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性血小板減少症(再投与なし),""
AB-22076898,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20221028,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22076898,2,3,C,オキサリプラチン,"",経口,20221028,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22076899,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,膵炎(再投与なし);免疫介在性肝障害(再投与なし),""
AB-22076899,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22076899,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22077378,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,202207,"",200,mg,1,胃癌(胃癌),剂量不变,胃閉塞(再投与なし),""
AB-22077528,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202201,202203,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性甲状腺機能亢進症(再投与なし),""
AB-22077528,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22077528,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22077533,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,硬化性胆管炎(再投与なし);糖尿病(再投与なし),""
AB-22077533,1,2,PS,プレドニゾロン,"",不明;経口,;,;,100;30,mg;mg,1;1,"",未知,"",""
AB-22077535,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-22077538,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210730,202109,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,硬化性胆管炎(再投与なし);発熱(再投与なし);黄疸(再投与なし);肝酵素上昇(再投与なし);炎症(再投与なし);肝酵素上昇(再投与なし);胆管狭窄(再投与なし);体調不良(再投与なし),""
AB-22077538,2,2,C,イリノテカン塩酸塩水和物,"",不明,20211027,"","","","",胃癌(胃癌),未知,"",""
AB-22077841,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202204,202212,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし);肺臓炎(再投与なし),""
AB-22077841,2,2,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22077841,2,3,PS,レボホリナートカルシウム,レボホリナート,不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22077841,2,4,PS,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22077845,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-22077845,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22077845,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22077849,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肝障害(再投与なし),""
AB-22077967,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202204,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,悪性新生物進行(再投与なし),""
AB-22077967,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202204,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22077967,1,3,C,オキサリプラチン,"",不明,202204,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22077968,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-22078200,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202112;20220824,202207;202302,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-22078202,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230105,20230220,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腹膜炎(再投与なし),""
AB-22078202,3,2,C,オキサリプラチン,"",不明;不明,20230105;,20230220;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22078202,3,3,C,フルオロウラシル,"",不明;不明,20230105;,20230220;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22078202,3,4,C,レボホリナートカルシウム,"",不明;不明,20230105;,20230220;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22078204,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221109,20221130,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫性甲状腺機能低下症(再投与なし);間質性肺疾患(再投与なし);発熱性好中球減少症(再投与なし),""
AB-22078204,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;経口,202002;20221109,;20221130,;80,;mg/kg,;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22078204,3,3,C,オキサリプラチン,"",静脈内点滴,20221109,20221130,130,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22078211,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,;;,;;,240;480;240,mg;mg;mg,1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量减少,好中球数減少(再投与なし),""
AB-22079025,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,免疫性膵炎(再投与なし);免疫介在性腎障害(再投与なし),""
AB-22079025,2,2,PS,フルオロウラシル,５−ＦＵ,不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22079025,2,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22079025,2,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22079764,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202112,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-22079764,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22079764,2,3,C,オキサリプラチン,"",不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22080200,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202303,"",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-22080200,2,2,C,オキサリプラチン,"",静脈内点滴,202303,"",100,mg,1,"",未知,"",""
AB-22080200,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,202303,"","","","","",未知,"",""
AB-22080730,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221109,20230301,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-22080730,3,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22080730,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22080732,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230120,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,１型糖尿病(再投与なし),""
AB-22080732,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230120,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22080732,1,3,C,オキサリプラチン,"",不明,20230120,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22080949,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,2021,"",200,mg,1,肺扁平上皮癌(非小細胞肺癌（併用療法）),未知,悪性新生物進行(再投与なし),""
AB-22080949,1,2,C,カルボプラチン,"",不明,2021,"","","","",肺扁平上皮癌(非小細胞肺癌),未知,"",""
AB-22080949,1,3,C,パクリタキセル（アルブミン懸濁型）,"",不明,2021,"","","","",肺扁平上皮癌(非小細胞肺癌),未知,"",""
AB-22081128,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫性腸炎(再投与なし),""
AB-22081128,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明;不明,;;,;;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22081128,1,3,C,オキサリプラチン,"",不明;不明;不明,;;,;;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22081496,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,続発性副腎皮質機能不全(再投与なし),""
AB-22081499,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20220114;20220622;20221019,20220601;20220622;20230315,360;192;,mg;mg;,1;1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-22081499,5,2,PS,オキサリプラチン,エルプラット,不明;不明,20220114;20220324,20220209;20220324,220;170,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22081499,5,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口;経口,20220114;;20221019,;20220622;20230315,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22081499,5,4,C,グラニセトロン塩酸塩,"",静脈内（明記されていない場合）;静脈内（明記されていない場合）,20220117;20221019,20220119;20230315,3;,mg;,1;,化学療法(術後補助療法);食欲減退(食欲不振),未知,"",""
AB-22081499,5,5,C,デキサメタゾンリン酸エステルナトリウム,"",不明,20221019,20230315,"","","",化学療法(術後補助療法),未知,"",""
AB-22081499,5,6,C,ブドウ糖,"",不明,20221019,20230315,"","","",化学療法(術後補助療法),未知,"",""
AB-22081499,5,7,C,ヘパリンナトリウム,"",不明,20221019,20230315,"","","",化学療法(術後補助療法),未知,"",""
AB-22081499,5,8,C,生理食塩液,"",不明,20221019,20230315,"","","",化学療法(術後補助療法),未知,"",""
AB-22081501,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220105,20230111,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし),""
AB-22081501,4,2,PS,オキサリプラチン,エルプラット,不明,20220105,20220309,230,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22081501,4,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220105,20220629,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-22082073,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221215,20230105,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,薬物性肝障害(再投与なし),""
AB-22082073,1,2,PS,オキサリプラチン,"",静脈内点滴,20221215,20230105,192.7,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22082073,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20221215,20230105,60,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-22082073,1,4,C,ダパグリフロジンプロピレングリコール水和物,"",経口,"","","","","","",未知,"",""
AB-22082073,1,5,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
AB-22082073,1,6,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-22082073,1,7,C,アスピリン,"",経口,"","","","","","",未知,"",""
AB-22082073,1,8,C,エソメプラゾールマグネシウム水和物,"",経口,"","","","","","",未知,"",""
AB-22082073,1,9,C,ロスバスタチンカルシウム,"",経口,"","","","","","",未知,"",""
AB-22082073,1,10,C,アジルサルタン,"",経口,"","","","","","",未知,"",""
AB-22082073,1,11,C,メトホルミン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-22082076,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221128,20230227,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-22082076,4,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20221128,20230313,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-22082076,4,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20221128;20221219,20221128;20230227,198;150,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23000147,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-23000568,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221007,20221125,360,mg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),剂量停止,免疫性脳炎(再投与なし),""
AB-23000568,2,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,20221017,20221125,1,mg/kg,1,再発非小細胞肺癌(切除不能な進行・再発の非小細胞肺がんに対する併用療法),剂量停止,"",""
AB-23000823,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,好中球数減少(再投与なし),""
AB-23000823,1,2,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23000823,1,3,PS,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23000823,1,4,PS,レボホリナートカルシウム,レボホリナート,不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001063,2,1,PS,イピリムマブ,ヤーボイ,"",20221017,20221125,1,mg/kg,1,再発非小細胞肺癌(Unresectable advanced/recurrent non-small cell lung cancer);下咽頭癌(Hypopharyngeal cancer),剂量停止,免疫性脳炎(再投与なし),""
AB-23001063,2,2,PS,ニボルマブ,オプジーボ,"",20221007,20221125,360,mg,1,再発非小細胞肺癌(Unresectable advanced/recurrent non-small cell lung cancer);下咽頭癌(Hypopharyngeal cancer),剂量停止,免疫性脳炎(再投与なし),""
AB-23001097,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,コントロール不良の糖尿病(再投与なし);糖尿病(再投与なし);ケトアシドーシス(再投与なし),""
AB-23001097,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001097,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001344,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220929,20220929,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腸炎(再投与なし),""
AB-23001344,3,2,PS,オキサリプラチン,"",静脈内点滴,20220804,20220929,170,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23001344,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エヌケーエスワンＯＤ,経口,20220804,20221013,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23001345,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220621,20221025,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,低ナトリウム血症(再投与なし),""
AB-23001345,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220531,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001345,3,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20220531;20220712;20220823;20221004,20220621;20220802;20220913;20221025,150;140;150;120,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001346,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230119,20230214,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,好中球数減少(再投与なし),""
AB-23001346,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230119,20230214,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23001346,3,3,PS,オキサリプラチン,"",不明,20230119,20230214,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23001347,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220512;20220607,20220512;20220607,240;240,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,アラニンアミノトランスフェラーゼ増加(再投与なし);塞栓症(再投与なし),""
AB-23001347,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,"","","","","","",剂量减少,"",""
AB-23001347,3,3,C,フルオロウラシル,"",不明;不明,20220512;20220607,20220512;20220607,4190;4190,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001347,3,4,C,オキサリプラチン,"",不明;不明,20220512;20220607,20220512;20220607,127;127,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001347,3,5,C,レボホリナートカルシウム,"",不明;不明,20220512;20220607,20220512;20220607,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001604,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220920,20230202,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,疲労(再投与なし);下痢(再投与なし),""
AB-23001604,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220920,20230615,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001604,3,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220920;20230202,20221129;20230202,170;140,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001919,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220726,20220913,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-23001919,2,2,C,オキサリプラチン,"",静脈内点滴,20220726,20220913,200,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001919,2,3,C,カペシタビン,"",経口,20220726,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001921,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220420,20220622,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫性腸炎(再投与なし);サイトメガロウイルス性腸炎(再投与なし),""
AB-23001921,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220420,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23001921,3,3,PS,サラゾスルファピリジン,サラゾピリン,不明,20220714,20220808,"","","",免疫性腸炎(irAE腸炎（薬剤起因性大腸炎（irAE））),剂量停止,"",""
AB-23001921,3,4,C,オキサリプラチン,"",不明;不明,20220420;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001921,3,5,C,カペシタビン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001925,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20220927;20221118;20230228,20221018;20230124;20231010,360;360;360,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,大腸炎(再投与なし),""
AB-23001925,3,2,PS,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220927;20230228,20230124;20230228,160;160,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23001925,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エヌケーエスワンＯＤ,経口;経口,20220927;20230228,;20231010,120;120,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23001927,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220422,20221107,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺臓炎(再投与なし),""
AB-23001927,4,2,PS,オキサリプラチン,"",静脈内点滴,20220422,20221017,130,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23001927,4,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220422,20230417,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001927,4,4,C,パクリタキセル,"",不明,20230526,20230601,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001930,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220613;20220704,20220613;20221226,360;240,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,肺臓炎(再投与なし),""
AB-23001930,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220613,20230124,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001930,3,3,C,オキサリプラチン,"",静脈内点滴,20220613,20220613,80,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001932,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220311,20220725,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺臓炎(再投与なし);甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし),""
AB-23001932,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220311,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23001932,2,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220311;20220704,20220606;20230313,170;130,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002119,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,不明,202303,200,mg,1,胃癌第４期(MSI-High癌（結腸・直腸以外）、胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-23002271,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220510,20220531,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,筋炎(再投与なし);第６脳神経麻痺(再投与なし),""
AB-23002271,4,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エヌケーエスワンＯＤ,経口,20220419,20220531,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23002271,4,3,PS,オキサリプラチン,"",静脈内点滴,20220419,20220531,170,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23002274,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220222,20220708,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,好中球数減少(再投与なし),""
AB-23002274,4,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口;経口;経口;経口;経口,20220222;;;;;,;;;;;20220708,;;;;;,;;;;;,;;;;;,胃癌(治癒切除不能な進行・再発の胃癌),剂量减少,"",""
AB-23002274,4,3,C,オキサリプラチン,"",不明,20220222,20220708,130,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002275,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220810,20221109,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,動脈塞栓症(再投与なし),""
AB-23002275,2,2,PS,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20220810;20220831;20220921,20220810;20220831;20221109,170;130;135,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23002275,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220810,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002277,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220427;20220913,20220802;20221004,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,心房細動(再投与なし);好中球数減少(再投与なし);白血球数減少(再投与なし);低カリウム血症(再投与なし),""
AB-23002277,5,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口;経口,20220427;20220530;20220621,20220529;20220620;20221018,120;100;80,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23002277,5,3,PS,パクリタキセル,"",不明,20221109,20221116,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23002277,5,4,PS,ラムシルマブ,"",不明,20221109,20221116,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23002277,5,5,C,オキサリプラチン,"",不明;不明;不明,20220427;20220530;20220621,20220427;20220530;20220802,205;165;135,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002282,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,糖尿病性ケトアシドーシス(再投与なし);原発性甲状腺機能低下症(再投与なし);劇症１型糖尿病(再投与なし);間質性肺疾患(再投与なし),""
AB-23002282,1,2,PS,シタグリプチンリン酸塩水和物,グラクティブ,経口,"","","","","",２型糖尿病(2型糖尿病),未知,糖尿病性ケトアシドーシス(再投与なし);原発性甲状腺機能低下症(再投与なし);劇症１型糖尿病(再投与なし);間質性肺疾患(再投与なし),""
AB-23002285,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220612,20220815,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-23002285,4,2,C,フルオロウラシル,"",不明,20220602,20220815,3602,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002285,4,3,C,オキサリプラチン,"",静脈内点滴,20220612,20220815,127,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002285,4,4,C,レボホリナートカルシウム,"",静脈内点滴,20220612,20220815,300,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002286,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221117,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,劇症１型糖尿病(再投与なし);敗血症性ショック(再投与なし),""
AB-23002286,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20221117,20230404,40,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002286,2,3,C,オキサリプラチン,"",不明,20221117,20230330,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002286,2,4,C,トラスツズマブ,"",静脈内（明記されていない場合）,20230105,20230330,360,mg,1,胃癌(胃癌),未知,"",""
AB-23002286,2,5,C,酸化マグネシウム,"",経口,"",20230404,330,mg,1,"",未知,"",""
AB-23002286,2,6,C,クエン酸第一鉄ナトリウム,"",経口,"",202304,100,mg,1,"",未知,"",""
AB-23002286,2,7,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-23002286,2,8,C,ロスバスタチンカルシウム,"",経口,"","",2.5,mg,1,"",未知,"",""
AB-23002286,2,9,C,ゾルピデム酒石酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-23002286,2,10,C,エソメプラゾールマグネシウム水和物,"",経口,"","",10,mg,1,"",未知,"",""
AB-23002286,2,11,C,シロスタゾール,"",経口,"","",50,mg,1,予防(予防),未知,"",""
AB-23002286,2,12,C,マクロゴール４０００・塩化ナトリウム・炭酸水素ナトリウム・塩化カリウム,"",経口,"","",6.852,g,1,予防(予防),未知,"",""
AB-23002515,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220215,20220418,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-23002515,5,2,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220215;20220331,20220307;20220418,135;90,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002515,5,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220217,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002594,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220322,20220322,720,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,食欲減退(再投与なし),""
AB-23002594,5,2,PS,オキサリプラチン,エルプラット,静脈内点滴,20220325,20220325,140,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23002594,5,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20220325,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23002596,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220531,20220531,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,斑状丘疹状皮疹(再投与なし),""
AB-23002596,5,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口,20220531,20220613,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23002596,5,3,C,オキサリプラチン,"",静脈内点滴,20220531,20220613,220,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002617,8,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20220216;20220302;20220921,20220216;20220831;20221021,240;360;360,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(不明),""
AB-23002617,8,2,PS,オキサリプラチン,"",静脈内（明記されていない場合）;静脈内（明記されていない場合）,20220216;20220302,20220216;20220518,200;200,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23002617,8,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20220302;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002617,8,4,C,レボホリナートカルシウム,"",静脈内点滴,20220216,20220216,350,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002617,8,5,C,フルオロウラシル,"",不明;不明,20220216;20220217,20220216;20220217,5000;4000,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002820,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220727;20230320,20221212;20230417,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,下垂体機能低下症(再投与なし),""
AB-23002820,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口;経口;経口;経口;経口,20220727;;;;,;;;;,;;;;,;;;;,;;;;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23002820,3,3,PS,パクリタキセル（アルブミン懸濁型）,"",不明,20230524,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002820,3,4,PS,ラムシルマブ,"",不明,20230524,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002820,3,5,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20220727;20220822;20221212,20220727;20220912;20230417,220;170;130,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002822,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220708,20220721,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,慢性腎臓病(再投与なし);血中クレアチニン増加(再投与なし);小腸閉塞(再投与なし),""
AB-23002822,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220630,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23002822,3,3,C,オキサリプラチン,"",静脈内点滴,20220708,"",243,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003039,1,1,PS,パクリタキセル,タキソール,"","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23003039,1,2,PS,ニボルマブ,オプジーボ,"",20220309,20220629,360,mg,1,胃癌(Gastric cancer),不适用,しゃっくり(再投与なし);末梢性感覚ニューロパチー(再投与なし);悪心(再投与なし);湿疹(再投与なし);そう痒症(再投与なし);疲労(再投与なし),""
AB-23003039,1,3,PS,オキサリプラチン,"","","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23003039,1,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,"","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23003045,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20220131;20220225;20220411;20220530,20220131;20220325;20220411;20220530,720;360;720;360,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-23003045,5,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20220131;20220225;20220530;20220616,20220131;20220411;20220530;20220818,400;200;300;150,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003045,5,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口;経口,20220207;,;20221023,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003046,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220427,20220921,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,血小板数減少(再投与なし),""
AB-23003046,1,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20220427;20220831,20220810;20220921,200;156.42,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003046,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220518,20220921,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003047,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220530,20221026,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-23003047,4,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220530,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003047,4,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220530;20221026,20221005;20221026,231.92;185.54,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003048,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220404,20220419,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,嘔吐(再投与なし);下痢(再投与なし),""
AB-23003048,4,2,PS,オキサリプラチン,エルプラット,不明;不明,20220407;20220428,20220407;20220428,158;316,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23003048,4,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口,20220407,20220428,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23003050,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220222,20220325,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,ＳＬＥ関節炎(再投与なし),""
AB-23003050,5,2,C,オキサリプラチン,"",静脈内点滴,20220301,20220325,110,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003050,5,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220307,20220327,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003051,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220117,20220725,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺臓炎(再投与なし),""
AB-23003051,5,2,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20211213;20220117,20211213;20220725,190;150,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003051,5,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20211213,20220725,80,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003198,3,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,その他(不明),20220221,20220406,"","","",胃癌(Gastric cancer),不适用,好中球数減少(再投与なし);白血球数減少(再投与なし);発熱(再投与なし);貧血(再投与なし);関節炎(再投与なし),""
AB-23003198,3,2,PS,オキサリプラチン,"",その他(不明),20211126,20220110,180,mg,1,胃癌(Gastric cancer),不适用,好中球数減少(再投与なし);白血球数減少(再投与なし);発熱(再投与なし);貧血(再投与なし);関節炎(再投与なし),""
AB-23003198,3,3,PS,ニボルマブ,オプジーボ,静脈内点滴(041),20211126,20220110,360,mg,1,胃癌(Gastric cancer),不适用,好中球数減少(再投与なし);白血球数減少(再投与なし);発熱(再投与なし);貧血(再投与なし);関節炎(再投与なし),""
AB-23003198,3,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口(048),20211126,20220110,"","","",胃癌(Gastric cancer),不适用,好中球数減少(再投与なし);白血球数減少(再投与なし);発熱(再投与なし);貧血(再投与なし);関節炎(再投与なし),""
AB-23003198,3,5,C,デキサメタゾンリン酸エステルナトリウム,"",その他(不明),20220221,"","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23003198,3,6,C,生理食塩液,"",その他(不明),20220221,"","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23003262,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20220519;20220728;20221020;20230119,20220630;20220922;不明;20230330,240;240;240;240,mg;mg;mg;mg,1;1;1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性下垂体炎(不明);間質性肺疾患(不明);下垂体炎(不明),""
AB-23003264,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220729,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-23003264,7,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220729,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23003264,7,3,PS,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220729;20220818,20220729;20230322,140;100,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23003803,1,1,PS,オキサリプラチン,"",静脈内点滴,20221215,20230105,192.7,mg,1,胃癌(Advanced gastric carcinoma),剂量停止,"",""
AB-23003803,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20221215,20230105,360,mg,1,胃癌(Advanced gastric carcinoma),剂量停止,"",""
AB-23003803,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20221215,20230105,120,mg,1,胃癌(Advanced gastric carcinoma),剂量停止,"",""
AB-23003803,1,4,C,デキサメタゾンリン酸エステルナトリウム,"","","","","","","","",未知,"",""
AB-23003803,1,5,C,パロノセトロン塩酸塩,"","","","","","","","",未知,"",""
AB-23003803,1,6,C,アスピリン,"","","","","","","","",未知,"",""
AB-23003803,1,7,C,エソメプラゾールマグネシウム水和物,"","","","","","","","",未知,"",""
AB-23003803,1,8,C,ロスバスタチンカルシウム,"","","","","","","","",未知,"",""
AB-23003803,1,9,C,アジルサルタン,"","","","","","","","",未知,"",""
AB-23003803,1,10,C,メトホルミン塩酸塩,"","","","","","","","",未知,"",""
AB-23003803,1,11,C,ダパグリフロジンプロピレングリコール水和物,"","","","","","","","",未知,"",""
AB-23003845,4,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,その他(不明),20220221,20220406,"","","",胃癌(Gastric cancer),剂量停止,悪性新生物進行(再投与なし);血中アルカリホスファターゼ増加(再投与なし),""
AB-23003845,4,2,PS,オキサリプラチン,"",その他(不明),20211126,20220110,180,mg,1,胃癌(Gastric cancer),不适用,悪性新生物進行(再投与なし);血中アルカリホスファターゼ増加(再投与なし),""
AB-23003845,4,3,PS,ニボルマブ,オプジーボ,静脈内点滴(041),20211126,20220110,360,mg,1,胃癌(Gastric cancer),不适用,悪性新生物進行(再投与なし);血中アルカリホスファターゼ増加(再投与なし),""
AB-23003845,4,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口(048),20211126,20220124,"","","",胃癌(Gastric cancer),不适用,悪性新生物進行(再投与なし);血中アルカリホスファターゼ増加(再投与なし),""
AB-23003845,4,5,C,デキサメタゾンリン酸エステルナトリウム,"",その他(不明),20220221,"","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23003845,4,6,C,SODIUMCHLORIDE,"",その他(不明),20220221,"","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23003937,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220405;20220414,20220405;20221031,240;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,γ−グルタミルトランスフェラーゼ増加(再投与なし),""
AB-23003937,4,2,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20220405;20220414;20220815,20220405;20220714;20220926,135;200;155,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003937,4,3,C,フルオロウラシル,"",不明,20220405,"",4400,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23003937,4,4,C,レボホリナートカルシウム,"",静脈内点滴,20220405,"",315,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004522,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230130,不明,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,腎機能障害(再投与なし),""
AB-23004523,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220329,20220419,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし);甲状腺機能亢進症(再投与なし),""
AB-23004523,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20220329;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23004523,3,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220329;20220419,20220329;20220510,200;160,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004524,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220721,20230214,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,低カリウム血症(再投与なし),""
AB-23004524,4,2,PS,オキサリプラチン,エルプラット：点滴静注液,静脈内点滴,20220721,20221220,150,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23004524,4,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220721,"",100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23004524,4,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20230214,20230227,80,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23004525,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220905,20220926,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-23004525,4,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20220812;,;20221018,100;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量减少,"",""
AB-23004525,4,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220812;20220905,;20220926,149;192,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004531,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220922,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,低カリウム血症(再投与なし);大腸炎(再投与なし);低ナトリウム血症(再投与なし);下垂体機能低下症(再投与なし),""
AB-23004531,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220922,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004531,3,3,PS,オキサリプラチン,エルプラット,静脈内点滴,20220922,20230207,175,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23004534,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220725,20220912,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,続発性副腎皮質機能不全(再投与なし),""
AB-23004534,4,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220711,20220927,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23004534,4,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220725;20220815,;20220912,188;191,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004535,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220125,20230328,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,下垂体機能低下症(再投与なし),""
AB-23004535,4,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20220125;20220215,20220125;20220419,185;140,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23004535,4,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,20220125;20220802,20220621;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23004536,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220902,20220916,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,好中球数減少(再投与なし),""
AB-23004536,4,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220715,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004536,4,3,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20220715;20220902,20220805;20220916,135;110,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004537,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20220104;20220426;20221108;20230822,20220329;20221011;20230718;,360;480;360;480,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-23004537,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220104,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23004537,3,3,PS,オキサリプラチン,エルプラット,静脈内点滴,20220104,20220329,170,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23004538,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220330,20230208,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,薬疹(再投与なし);間質性肺疾患(再投与なし),""
AB-23004538,4,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20210224;20220330,20210624;20230208,;100,;mg,;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23004538,4,3,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20210224;20220330,20210624;20220531,;170,;mg,;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23004543,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-23004543,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004543,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004544,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202208,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,腸炎(再投与なし);血球減少症(再投与なし),""
AB-23004544,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202208,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23004544,2,3,PS,オキサリプラチン,"",不明,202208,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23004545,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202201,不明,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);食欲減退(再投与なし),""
AB-23004545,2,2,PS,カペシタビン,"",不明,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23004545,2,3,PS,オキサリプラチン,"",不明,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23004546,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230331,不明,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,発疹(再投与なし),""
AB-23004546,1,2,C,オキサリプラチン,"",静脈内点滴,20230331,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004546,1,3,C,フルオロウラシル,"",静脈内点滴,20230331,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004546,1,4,C,レボホリナートカルシウム,"",静脈内点滴,20230331,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004547,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,肺炎(再投与なし),""
AB-23004547,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004547,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004548,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202210,不明,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,好中球数減少(再投与なし);腸炎(再投与なし),""
AB-23004548,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202210,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23004548,2,3,PS,オキサリプラチン,"",不明,202210,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23004549,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,腸炎(再投与なし),""
AB-23004549,2,2,C,カペシタビン,"",不明,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004549,2,3,C,オキサリプラチン,"",不明,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004550,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202211,不明,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);遊走性血栓静脈炎(再投与なし),""
AB-23004550,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202211,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23004550,2,3,PS,オキサリプラチン,"",不明,202211,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23004551,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-23004551,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004551,1,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004551,1,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004553,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220524;20220621,20220524;20220712,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腸炎(再投与なし),""
AB-23004553,3,2,PS,オキサリプラチン,"",静脈内点滴,20220502,20220712,140,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23004553,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口;経口;経口,20220502;20220524;20220621;20220712,;;;,50;50;50;50,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23004555,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220909;20230206,;20230307,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-23004555,2,2,C,オキサリプラチン,"",静脈内点滴,20220909,"",100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004555,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口;経口,20220909;;20230206,20220909;;20230307,120;80;80,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004556,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221213,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,免疫性肺疾患(再投与なし);口内炎(再投与なし);悪心(再投与なし),""
AB-23004556,4,2,PS,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20221213;20221220;20230207;20230328;20230523;20230711,20221213;20230117;20230314;20230328;20230530;,208;160.16;156.156;158.158;157.157;112.632,mg;mg;mg;mg;mg;mg,1;1;1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004556,4,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20221213,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004561,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-23004561,2,2,PS,フルオロウラシル,"",不明,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23004561,2,3,PS,オキサリプラチン,"",不明,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23004561,2,4,PS,レボホリナートカルシウム,レボホリナート,不明,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23004567,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,血球減少症(再投与なし),""
AB-23004567,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004567,2,3,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004570,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202201,不明,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23004570,2,2,C,カペシタビン,"",不明,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004570,2,3,C,オキサリプラチン,"",不明,202201,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004731,1,1,PS,アナモレリン塩酸塩,エドルミズ,経口,20221107,20221212,"","","",悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,低カリウム血症(再投与なし),""
AB-23004731,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,低カリウム血症(再投与なし),""
AB-23004738,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202209,不明,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23004742,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,硬化性胆管炎(再投与なし),""
AB-23004743,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23004743,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23004743,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23005087,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220620,20221003,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし);食欲減退(再投与なし),""
AB-23005087,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20220519;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23005087,3,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220620;20220912,20220822;20221003,185;111,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23005091,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,びまん性大細胞型Ｂ細胞性リンパ腫(再投与なし),""
AB-23005097,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202206;,202207;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,再生不良性貧血(再投与なし),""
AB-23005098,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,腫瘍偽性進行(再投与なし),""
AB-23005102,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23005184,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23005185,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230201,20230201,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,サイトカイン放出症候群(再投与なし),""
AB-23005185,2,2,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20230201;20230329,20230201;,150;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23005185,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,20230201;20230329,20230215;,40;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23005185,2,4,C,パロノセトロン塩酸塩,"",静脈内点滴,20230201,20230201,.75,mg,1,予防(予防),未知,"",""
AB-23005185,2,5,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20230201,20230201,9.9,mg,1,予防(予防),未知,"",""
AB-23005354,1,1,PS,ベバシズマブ［後続１］,ベバシズマブＢＳ［後続１］,"","","","","","",肝細胞癌(hepatocellular carcinoma),剂量不变,"",""
AB-23005354,1,2,PS,アテゾリズマブ,"","","","","","","",肝細胞癌(hepatocellular carcinoma),剂量不变,"",""
AB-23005392,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210401,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,肺炎(再投与なし),""
AB-23005917,4,1,PS,イピリムマブ,ヤーボイ,;;;,20220616;20220727;20220907;20221028,;20220727;20220907;20221209,52.2;50;46;49.1,mg;mg;mg;mg,1;1;1;1,食道癌(Oesophageal carcinoma),剂量停止,脾腫(再投与なし);発熱(再投与なし);免疫性肝炎(再投与なし);細菌性尿路感染(再投与なし);食欲減退(再投与なし);口腔咽頭痛(再投与なし);全身性カンジダ(再投与なし);肝腫大(再投与なし);免疫性甲状腺機能低下症(再投与なし);アスパラギン酸アミノトランスフェラーゼ増加(再投与なし);アラニンアミノトランスフェラーゼ増加(再投与なし);倦怠感(再投与なし);胆管炎(再投与なし),""
AB-23005917,4,2,PS,ニボルマブ,オプジーボ,;,20220616;20230203,20221209;20230310,240;240,mg;mg,1;1,食道癌(Oesophageal carcinoma),剂量停止,脾腫(再投与なし);発熱(再投与なし);免疫性肝炎(再投与なし);細菌性尿路感染(再投与なし);食欲減退(再投与なし);口腔咽頭痛(再投与なし);全身性カンジダ(再投与なし);肝腫大(再投与なし);免疫性甲状腺機能低下症(再投与なし);アスパラギン酸アミノトランスフェラーゼ増加(再投与なし);アラニンアミノトランスフェラーゼ増加(再投与なし);倦怠感(再投与なし);胆管炎(再投与なし),""
AB-23005917,4,3,C,レボチロキシンナトリウム水和物,"","","","",0.5,g,1,適応症不明の製品使用(Product used for unknown indication),剂量不变,"",""
AB-23005917,4,4,C,ブロチゾラム,"","","","",0.25,mg,1,適応症不明の製品使用(Product used for unknown indication),剂量不变,"",""
AB-23005917,4,5,C,トラゾドン塩酸塩,"","","","",25,mg,1,適応症不明の製品使用(Product used for unknown indication),剂量不变,"",""
AB-23005917,4,6,C,アメジニウムメチル硫酸塩,"","","","",20,mg,1,適応症不明の製品使用(Product used for unknown indication),剂量不变,"",""
AB-23005917,4,7,C,ボノプラザンフマル酸塩,"","","","",20,mg,1,予防(Prophylaxis),剂量不变,"",""
AB-23005917,4,8,C,タゾバクタム・ピペラシリン水和物,"","",20221220,20221228,13.5,g,1,適応症不明の製品使用(Product used for unknown indication),剂量不变,"",""
AB-23005917,4,9,C,ミカファンギンナトリウム,"","",20221223,20230111,200,mg,1,適応症不明の製品使用(Product used for unknown indication),剂量不变,"",""
AB-23006146,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,腸炎(再投与なし),""
AB-23006146,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23006146,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23006147,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,不明,不明,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-23006147,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23006147,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23006153,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220616;20230203,20221209;20230310,240;240,mg;mg,1;1,食道癌(根治切除不能な進行・再発の食道癌),剂量停止,肝炎(再投与なし);肝炎(再投与なし);甲状腺機能低下症(再投与なし);胆管炎(再投与なし),""
AB-23006153,3,2,PS,イピリムマブ,ヤーボイ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20220616;20220727;20220907;20221028,20220616;20220727;20220907;20221209,52.2;50;46;49.1,mg;mg;mg;mg,1;1;1;1,食道癌(根治切除不能な進行・再発の食道癌),不适用,"",""
AB-23006153,3,3,C,レボチロキシンナトリウム水和物,"",経口,"","",.5,g,1,"",未知,"",""
AB-23006153,3,4,C,ブロチゾラム,"",経口,"","",.25,mg,1,"",未知,"",""
AB-23006153,3,5,C,トラゾドン塩酸塩,"",経口,"","",25,mg,1,"",未知,"",""
AB-23006153,3,6,C,アメジニウムメチル硫酸塩,"",経口,"","",20,mg,1,"",未知,"",""
AB-23006153,3,7,C,ボノプラザンフマル酸塩,"",経口,"","",20,mg,1,予防(予防),未知,"",""
AB-23006183,3,1,PS,アナモレリン塩酸塩,エドルミズ,経口,20230313,20230411,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,免疫性肝炎(再投与なし),""
AB-23006183,3,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20230313,20230313,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性肝炎(再投与なし),""
AB-23006183,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,20230221;20230313,;20230326,120;60,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23006183,3,4,PS,オキサリプラチン,"",静脈内点滴,20230221,"",185,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23006183,3,5,C,ボノプラザンフマル酸塩,"",経口,"","","","","","",未知,"",""
AB-23006183,3,6,C,クエン酸第一鉄ナトリウム,"",経口,"","","","","","",未知,"",""
AB-23006183,3,7,C,アセトアミノフェン,"",経口,"","","","","","",未知,"",""
AB-23006183,3,8,C,フロセミド,"",経口,"","","","","","",未知,"",""
AB-23006183,3,9,C,パロノセトロン塩酸塩,"",静脈内点滴,"","","","","","",未知,"",""
AB-23006183,3,10,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
AB-23006194,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202203,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23006195,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221212,20230131,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,麻痺性イレウス(再投与なし);間質性肺疾患(再投与なし);急性呼吸窮迫症候群(再投与なし);誤嚥(再投与なし),""
AB-23006195,2,2,C,オキサリプラチン,"",不明,20221212,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23006195,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20221212,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23007523,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,脳梗塞(再投与なし),""
AB-23007535,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202212,202302,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍出血(再投与なし);下痢(再投与なし);発熱(再投与なし),""
AB-23007535,1,2,C,オキサリプラチン,"",静脈内点滴,202212,202302,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23007535,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,202212,202302,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23007540,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220614,20230328,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,下垂体機能亢進症(再投与なし);血球減少症(再投与なし),""
AB-23007540,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23007540,1,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23007541,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220814,20230120,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,急性副腎皮質機能不全(再投与なし);副腎機能不全(再投与なし),""
AB-23007541,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23007541,2,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23007794,1,1,PS,パクリタキセル,タキソール,"",20211025,20211227,110,mg,1,胃癌(Gastric cancer),不适用,死亡(再投与なし),""
AB-23007794,1,2,PS,ニボルマブ,オプジーボ,"",20220117,20220214,240,mg,1,胃癌(Gastric cancer),不适用,死亡(再投与なし),""
AB-23007794,1,3,PS,デキサメタゾン,デカドロン,;,20210824;20210914,20210826;20210916,2;2,mg;mg,1;1,予防(Prophylaxis),不适用,死亡(再投与なし),""
AB-23007794,1,4,PS,アナモレリン塩酸塩,エドルミズ,"",20210823,20220117,100,mg,1,悪液質(Cancer cachexia),不适用,死亡(再投与なし),""
AB-23007794,1,5,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,"",20210713,20210927,100,mg,1,胃癌(Gastric cancer),不适用,死亡(再投与なし),""
AB-23007794,1,6,PS,オキサリプラチン,"",;,20210713;20220228,20210914;20220328,150;130,mg;mg,1;1,胃癌(Gastric cancer),不适用,死亡(再投与なし),""
AB-23007794,1,7,PS,ラムシルマブ,サイラムザ,"",20211025,20211227,370,mg,1,胃癌(Gastric cancer),不适用,死亡(再投与なし),""
AB-23007794,1,8,PS,デキサメタゾンリン酸エステルナトリウム,オルガドロン,;;;;;;,20210823;20210913;20211025;20211101;20211122;20211213;20211227,20210823;20210913;20211025;20211101;20211122;20211213;20211227,3.8;3.8;7.6;7.6;7.6;7.6;7.6,mg;mg;mg;mg;mg;mg;mg,1;1;1;1;1;1;1,予防(Prophylaxis),不适用,死亡(再投与なし),""
AB-23007794,1,9,PS,アプレピタント,イメンド,;;;,20210823;20210824;20210913;20210914,20210823;20210826;20210913;20210916,125;80;125;80,mg;mg;mg;mg,1;1;1;1,悪心・嘔吐の予防(Prophylaxis against chemotherapy induced vomiting),不适用,死亡(再投与なし),""
AB-23007794,1,10,C,オランザピン,"",;,20210823;20210913,20210827;20210917,5;5,mg;mg,1;1,予防(Prophylaxis),不适用,"",""
AB-23007794,1,11,C,ピリドキサールリン酸エステル水和物,"","","",20211025,30,mg,1,予防(Prophylaxis),不适用,"",""
AB-23007794,1,12,C,デキストロメトルファン臭化水素酸塩水和物,"","","",20220522,15,mg,1,適応症不明の製品使用(product used for unknown indication),不适用,"",""
AB-23007794,1,13,C,パロノセトロン塩酸塩,"",;,20210823;20210913,20210823;20210913,0.75;0.75,mg;mg,1;1,予防(Prophylaxis),不适用,"",""
AB-23007794,1,14,C,ファモチジン,"",;;;;,20211025;20211101;20211122;20211213;20211227,20211025;20211101;20211122;20211213;20211227,20;20;20;20;20,mg;mg;mg;mg;mg,1;1;1;1;1,予防(Prophylaxis),不适用,"",""
AB-23007794,1,15,C,クロルフェニラミンマレイン酸塩,"",;;;;;;;,20211025;20211101;20211122;20211213;20211227;20220117;20220131;20220214,20211025;20211101;20211122;20211213;20211227;20220117;20220131;20220214,5;5;5;5;5;5;5;5,mg;mg;mg;mg;mg;mg;mg;mg,1;1;1;1;1;1;1;1,予防(Prophylaxis),不适用,"",""
AB-23007794,1,16,C,カペシタビン,"","",20220228,20220403,1800,mg,1,胃癌(Gastric cancer),不适用,"",""
AB-23007796,1,1,PS,パクリタキセル,タキソール,"",20211025,20211227,110,mg,1,胃癌(Gastric cancer),不适用,間質性肺疾患(再投与なし);細菌性肺炎(再投与なし);脱水(再投与なし);白内障(再投与なし);緑内障(再投与なし);低マグネシウム血症(再投与なし);好中球数減少(再投与なし),""
AB-23007796,1,2,PS,ニボルマブ,オプジーボ,"",20220117,20220214,240,mg,1,胃癌(Gastric cancer),不适用,間質性肺疾患(再投与なし);細菌性肺炎(再投与なし);脱水(再投与なし);白内障(再投与なし);緑内障(再投与なし);低マグネシウム血症(再投与なし);好中球数減少(再投与なし),""
AB-23007796,1,3,PS,デキサメタゾン,デカドロン,;,20210824;20210914,20210826;20210916,2;2,mg;mg,1;1,予防(Prophylaxis),不适用,間質性肺疾患(再投与なし);細菌性肺炎(再投与なし);脱水(再投与なし);白内障(再投与なし);緑内障(再投与なし);低マグネシウム血症(再投与なし);好中球数減少(再投与なし),""
AB-23007796,1,4,PS,アナモレリン塩酸塩,エドルミズ,"",20210823,20220117,100,mg,1,悪液質(Cancer cachexia),不适用,間質性肺疾患(再投与なし);細菌性肺炎(再投与なし);脱水(再投与なし);白内障(再投与なし);緑内障(再投与なし);低マグネシウム血症(再投与なし);好中球数減少(再投与なし),""
AB-23007796,1,5,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,"",20210713,20210927,100,mg,1,胃癌(Gastric cancer),不适用,間質性肺疾患(再投与なし);細菌性肺炎(再投与なし);脱水(再投与なし);白内障(再投与なし);緑内障(再投与なし);低マグネシウム血症(再投与なし);好中球数減少(再投与なし),""
AB-23007796,1,6,PS,オキサリプラチン,"",;,20210713;20220228,20210914;20220328,150;130,mg;mg,1;1,胃癌(Gastric cancer),不适用,間質性肺疾患(再投与なし);細菌性肺炎(再投与なし);脱水(再投与なし);白内障(再投与なし);緑内障(再投与なし);低マグネシウム血症(再投与なし);好中球数減少(再投与なし),""
AB-23007796,1,7,PS,ラムシルマブ,サイラムザ,"",20211025,20211227,370,mg,1,胃癌(Gastric cancer),不适用,間質性肺疾患(再投与なし);細菌性肺炎(再投与なし);脱水(再投与なし);白内障(再投与なし);緑内障(再投与なし);低マグネシウム血症(再投与なし);好中球数減少(再投与なし),""
AB-23007796,1,8,PS,ORGADRONE[DEXAMETHASONE SODIUM PHOSPHATE],"",;;;;;;,20210823;20210913;20211025;20211101;20211122;20211213;20211227,20210823;20210913;20211025;20211101;20211122;20211213;20211227,3.8;3.8;7.6;7.6;7.6;7.6;7.6,mg;mg;mg;mg;mg;mg;mg,1;1;1;1;1;1;1,予防(Prophylaxis),不适用,間質性肺疾患(再投与なし);細菌性肺炎(再投与なし);脱水(再投与なし);白内障(再投与なし);緑内障(再投与なし);低マグネシウム血症(再投与なし);好中球数減少(再投与なし),""
AB-23007796,1,9,PS,アプレピタント,イメンド,;;;,20210823;20210824;20210913;20210914,20210823;20210826;20210913;20210916,125;80;125;80,mg;mg;mg;mg,1;1;1;1,悪心・嘔吐の予防(Prophylaxis against chemotherapy induced vomiting),不适用,間質性肺疾患(再投与なし);細菌性肺炎(再投与なし);脱水(再投与なし);白内障(再投与なし);緑内障(再投与なし);低マグネシウム血症(再投与なし);好中球数減少(再投与なし),""
AB-23007796,1,10,C,OLANZAPINE,"",;,20210823;20210913,20210827;20210917,5;5,mg;mg,1;1,予防(Prophylaxis),不适用,"",""
AB-23007796,1,11,C,ピリドキサールリン酸エステル水和物,"","","",20211025,30,mg,1,予防(Prophylaxis),不适用,"",""
AB-23007796,1,12,C,デキストロメトルファン臭化水素酸塩水和物,"","","",20220522,15,mg,1,適応症不明の製品使用(product used for unknown indication),不适用,"",""
AB-23007796,1,13,C,パロノセトロン塩酸塩,"",;,20210823;20210913,20210823;20210913,0.75;0.75,mg;mg,1;1,予防(Prophylaxis),不适用,"",""
AB-23007796,1,14,C,ファモチジン,"",;;;;,20211025;20211101;20211122;20211213;20211227,20211025;20211101;20211122;20211213;20211227,20;20;20;20;20,mg;mg;mg;mg;mg,1;1;1;1;1,予防(Prophylaxis),不适用,"",""
AB-23007796,1,15,C,クロルフェニラミンマレイン酸塩,"",;;;;;;;,20211025;20211101;20211122;20211213;20211227;20220117;20220131;20220214,20211025;20211101;20211122;20211213;20211227;20220117;20220131;20220214,5;5;5;5;5;5;5;5,mg;mg;mg;mg;mg;mg;mg;mg,1;1;1;1;1;1;1;1,予防(Prophylaxis),不适用,"",""
AB-23007796,1,16,C,カペシタビン,"","",20220228,20220403,1800,mg,1,胃癌(Gastric cancer),不适用,"",""
AB-23008067,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23008068,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,2021,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23008194,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230407,"",360,mg,1,胃癌(胃癌の術後療法),未知,血中クレアチニン増加(再投与なし);食欲減退(再投与なし);腎尿細管壊死(再投与なし),""
AB-23008194,2,2,PS,カペシタビン,"",経口,20230407,20230414,1200,mg,1,胃癌(胃癌の術後療法),不适用,"",""
AB-23008194,2,3,PS,オキサリプラチン,エルプラット,静脈内点滴,20230407,"",150,mg,1,胃癌(胃癌の術後療法),未知,"",""
AB-23008194,2,4,C,ポラプレジンク,"",経口,"","","","","","",未知,"",""
AB-23008194,2,5,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
AB-23008215,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220902;20221209,20221014;,240;480,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,心筋症(再投与なし),""
AB-23008637,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221021,20221111,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫性腸炎(再投与なし),""
AB-23008637,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明;不明;不明,;;,;;,80;60;,mg;mg;,1;1;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23008637,3,3,C,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23008704,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200501,"",480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23008890,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211130,20220511,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23008890,1,2,C,オキサリプラチン,"",静脈内点滴,20211130,20220511,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23008890,1,3,C,レボホリナートカルシウム,"",静脈内点滴,20211130,20220511,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23008890,1,4,C,フルオロウラシル,"",静脈内点滴,20211130,20220511,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23008892,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221206,20230228,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,重症筋無力症(再投与なし),""
AB-23008892,1,2,C,オキサリプラチン,"",不明,20221206,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23008892,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20221206,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23008956,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200718,"",480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,帯状疱疹(再投与なし),""
AB-23008957,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,免疫介在性肝障害(再投与なし),""
AB-23008958,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190219;,20190305;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(不明),""
AB-23008958,2,2,C,ビラスチン,"",不明,"","","","","","",未知,"",""
AB-23008958,2,3,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-23008958,2,4,C,カンデサルタンシレキセチル,"",不明,"","","","","","",未知,"",""
AB-23008958,2,5,C,プレガバリン,"",不明,"","","","","","",未知,"",""
AB-23008958,2,6,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-23009285,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20230201;20230410,;,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,器質化肺炎(無),""
AB-23009285,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口,20230201;20230410,;,40;,mg/m2;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23009285,1,3,PS,オキサリプラチン,"",静脈内点滴;静脈内点滴,20230201;20230410,;,130;,mg/m2;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23009287,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220519,20221129,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,脳梗塞(再投与なし);自己免疫性脳炎(再投与なし);片麻痺(再投与なし),""
AB-23009287,1,2,PS,ボノプラザンフマル酸塩,タケキャブ,不明,20221204,20221210,10,mg,1,"",不适用,"",""
AB-23009287,1,3,PS,エルデカルシトール,"",不明,20221208,20221220,.75,ug,1,"",剂量停止,"",""
AB-23009287,1,4,PS,レムデシビル,"",不明,20221212,20221218,"","","",ＳＡＲＳ−ＣｏＶ−２検査陽性(COVID-19陽性),剂量停止,"",""
AB-23009287,1,5,PS,人免疫グロブリン,グロブリン,静脈内点滴,20221212,20221218,400,mg/kg,1,"",剂量停止,"",""
AB-23009287,1,6,C,ベニジピン塩酸塩,"",経口,20220202,"","","","","",未知,"",""
AB-23009287,1,7,C,ボグリボース,"",経口,20221020,20221129,"","","","",未知,"",""
AB-23009287,1,8,C,シロドシン,"",不明,"","","","","","",未知,"",""
AB-23009861,1,1,PS,イピリムマブ,ヤーボイ,"","","","","","",腹膜悪性中皮腫(Malignant peritoneal mesothelioma),不适用,死亡(再投与なし),""
AB-23009861,1,2,PS,ニボルマブ,オプジーボ,"","","","","","",腹膜悪性中皮腫(Malignant peritoneal mesothelioma),不适用,死亡(再投与なし),""
AB-23009862,1,1,PS,イピリムマブ,ヤーボイ,"","","","","","",腹膜悪性中皮腫(Malignant peritoneal mesothelioma),不适用,遊走性血栓静脈炎(不明);脳梗塞(不明);全身健康状態悪化(不明),""
AB-23009862,1,2,PS,ニボルマブ,オプジーボ,"","","","","","",腹膜悪性中皮腫(Malignant peritoneal mesothelioma),不适用,遊走性血栓静脈炎(不明);脳梗塞(不明);全身健康状態悪化(不明),""
AB-23009909,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221108,20230113,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺炎(再投与なし);紅斑(再投与なし),""
AB-23009909,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20221108,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23009909,2,3,C,オキサリプラチン,"",不明,20221108,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23010077,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211126,202202,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23010442,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202201;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-23010442,2,2,C,フルオロウラシル,"",不明;不明,202106;202201,202112;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23010442,2,3,C,オキサリプラチン,"",不明;不明,202106;202201,202112;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23010442,2,4,C,レボホリナートカルシウム,"",不明;不明,202106;202201,202112;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23010446,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202208,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23010487,1,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,;,;,;,120;100,mg;mg,1;1,胃癌(Gastric cancer),不适用,悪性新生物進行(再投与なし),""
AB-23010487,1,2,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"","","","","","",適応症不明の製品使用(Product used for unknown indication),不适用,悪性新生物進行(再投与なし),""
AB-23010487,1,3,PS,ニボルマブ,オプジーボ,"","","",360,mg,1,胃癌(Gastric cancer),不适用,悪性新生物進行(再投与なし),""
AB-23010487,1,4,PS,オキサリプラチン,"",;,;,;,100;130,mg/m2;mg/m2,1;1,胃癌(Gastric cancer),不适用,悪性新生物進行(再投与なし),""
AB-23010487,1,5,PS,ラムシルマブ,サイラムザ,"","","","","","",胃癌(Gastric cancer),不适用,悪性新生物進行(再投与なし),""
AB-23010488,2,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,"","","","","","",適応症不明の製品使用(product used for unknown indication),不适用,悪性新生物進行(再投与なし),""
AB-23010488,2,2,PS,ニボルマブ,オプジーボ,"","","",360,mg,1,胃癌(Gastric cancer),不适用,悪性新生物進行(再投与なし),""
AB-23010488,2,3,PS,オキサリプラチン,"",;,;,;,100;130,mg/m2;mg/m2,1;1,胃癌(gastric cancer),不适用,悪性新生物進行(再投与なし),""
AB-23010488,2,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,;,;,;,120;100,mg;mg,1;1,胃癌(gastric cancer),不适用,悪性新生物進行(再投与なし),""
AB-23010488,2,5,PS,ラムシルマブ,サイラムザ,"","","","","","",胃癌(gastric cancer),不适用,悪性新生物進行(再投与なし),""
AB-23010541,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,糖尿病性ケトアシドーシス(再投与なし);脳挫傷(再投与なし),""
AB-23010544,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-23010544,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23010544,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23010552,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220805,20221104,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫介在性肝障害(再投与なし);免疫性肝炎(再投与なし),""
AB-23010552,4,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220805,20221104,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23010552,4,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220805;20221104,20221014;20221104,140;110,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23010608,1,1,PS,デキサメタゾン,レナデックス,;,;,;,0.5;1,mg;mg,1;1,副腎機能不全(Adrenal insufficiency),剂量不变,悪液質(再投与なし);甲状腺障害(再投与なし);視床下部−下垂体障害(再投与なし);副腎機能不全(再投与なし);血中ブドウ糖増加(再投与なし);末梢性浮腫(再投与なし);食欲減退(再投与なし);腹部膨満(再投与なし);発熱(再投与なし),""
AB-23010608,1,2,PS,ニボルマブ,オプジーボ,"","","","","","",胃癌(Gastric cancer),未知,甲状腺障害(再投与なし);視床下部−下垂体障害(再投与なし),""
AB-23010608,1,3,C,インスリンデグルデク・リラグルチド（遺伝子組換え）配合剤,"","","","","","","",糖尿病(Diabetes mellitus),未知,"",""
AB-23010608,1,4,C,インスリンデグルデク・リラグルチド（遺伝子組換え）配合剤,"","","","","","","",糖尿病(Diabetes mellitus),未知,"",""
AB-23010608,1,5,C,イプラグリフロジンＬ−プロリン,"",;,;,;,50;50,mg;mg,1;1,適応症不明の製品使用(Drug use for unknown indication),剂量停止,"",""
AB-23010608,1,6,C,エルトロンボパグオラミン,"","","","","","","",適応症不明の製品使用(Drug use for unknown indication),未知,"",""
AB-23010608,1,7,C,RAMUCIRUMAB,"","","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23010608,1,8,C,パクリタキセル,"","","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23010608,1,9,C,オキサリプラチン,"","","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23010608,1,10,C,レボホリナートカルシウム,"","","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23010608,1,11,C,フルオロウラシル,"","","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23010608,1,12,C,トリフルリジン・チピラシル塩酸塩配合剤,"","","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23010608,1,13,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"","","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23010850,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,免疫性脳炎(再投与なし),""
AB-23010850,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23010850,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23010985,1,1,PS,アナモレリン塩酸塩,エドルミズ,経口,"","","","","",悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,肝障害(再投与なし),""
AB-23010985,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,肝障害(再投与なし),""
AB-23010985,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23010985,1,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23010985,1,5,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011175,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,低カリウム血症(再投与なし);慢性腎臓病(再投与なし);食欲減退(再投与なし);疲労(再投与なし),""
AB-23011175,4,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20211125,20221004,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),未知,低カリウム血症(再投与なし);慢性腎臓病(再投与なし);食欲減退(再投与なし);疲労(再投与なし),""
AB-23011175,4,3,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,不明,20220704,20220801,145,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23011175,4,4,C,レボホリナートカルシウム,"",不明,20211007,20220620,295,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011175,4,5,C,オキサリプラチン,"",静脈内点滴,20211007,20220228,125,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011175,4,6,C,フルオロウラシル,"",不明,20211007,20220620,550,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011175,4,7,C,ランソプラゾール,"",経口,20211203,20211206,30,mg,1,"",未知,"",""
AB-23011175,4,8,C,イルベサルタン,"",経口,20211206,20211207,100,mg,1,"",未知,"",""
AB-23011175,4,9,C,アムロジピンベシル酸塩,"",経口,20211206,20211207,5,mg,1,"",未知,"",""
AB-23011175,4,10,C,Ｌ−アスパラギン酸カリウム,"",経口,20211213,20220327,900,mg,1,"",未知,"",""
AB-23011175,4,11,C,酸化マグネシウム,"",経口,20220314,"",1980,mg,1,"",未知,"",""
AB-23011175,4,12,C,センノシド,"",不明,20220314,"",24,mg,1,"",未知,"",""
AB-23011175,4,13,C,プレガバリン,"",経口,20220523,"",25,mg,1,"",未知,"",""
AB-23011175,4,14,C,ラムシルマブ,"",不明,20220704,20220725,400,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011175,4,15,C,生理食塩液,"",不明,20220704,20220801,"","","","",未知,"",""
AB-23011175,4,16,C,クエン酸第一鉄ナトリウム,"",経口,20220713,"",100,mg,1,"",未知,"",""
AB-23011175,4,17,C,ゴセレリン酢酸塩,"",不明,"","",10.8,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011175,4,18,C,クエン酸第一鉄ナトリウム,"",経口,"","",100,mg,1,"",未知,"",""
AB-23011175,4,19,C,酪酸菌製剤,"",経口,"","",6,{DF},1,"",未知,"",""
AB-23011182,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,続発性副腎皮質機能不全(再投与なし),""
AB-23011182,1,2,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011182,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011182,1,4,C,パクリタキセル,"",不明,"","","","","",食道癌(食道胃接合部癌),未知,"",""
AB-23011182,1,5,C,ラムシルマブ,"",不明,"","","","","",食道癌(食道胃接合部癌),未知,"",""
AB-23011184,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,骨髄抑制(再投与なし),""
AB-23011184,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011184,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011187,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,形質細胞性骨髄腫(再投与なし),""
AB-23011187,2,2,PS,レナリドミド水和物,"",不明;不明,;,;,15;5,mg;mg,1;1,形質細胞性骨髄腫(多発性骨髄腫),剂量停止,"",""
AB-23011187,2,3,PS,デキサメタゾン,"",不明;不明,;,;,20;12,mg;mg,1;1,形質細胞性骨髄腫(多発性骨髄腫),剂量停止,"",""
AB-23011303,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肝障害(再投与なし),""
AB-23011303,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011303,1,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011303,1,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011496,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,骨髄抑制(再投与なし),""
AB-23011496,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,"","","","","","",未知,"",""
AB-23011496,3,3,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
AB-23011498,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211224,20220216,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,好中球数減少(再投与なし);白血球数減少(再投与なし),""
AB-23011498,2,2,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20211224;20220126,20211224;20220216,175;105,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011498,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20211224,20220303,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011809,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-23011809,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011809,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011810,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221012,20230208,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,器質化肺炎(再投与なし);血清反応陰性関節炎(再投与なし);Ｃ−反応性蛋白増加(再投与なし);発熱(再投与なし);リウマチ性多発筋痛(再投与なし),""
AB-23011810,2,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20230118,20230210,"","","",悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),不适用,器質化肺炎(再投与なし);血清反応陰性関節炎(再投与なし);Ｃ−反応性蛋白増加(再投与なし);発熱(再投与なし);リウマチ性多発筋痛(再投与なし),""
AB-23011810,2,3,PS,アプレピタント,イメンド,経口,20221012,20221228,"","","",悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),不适用,器質化肺炎(再投与なし);血清反応陰性関節炎(再投与なし);Ｃ−反応性蛋白増加(再投与なし);発熱(再投与なし);リウマチ性多発筋痛(再投与なし),""
AB-23011810,2,4,C,オキサリプラチン,"",不明,20221012,"",100,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011810,2,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20221012,"",100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011810,2,6,C,デキサメタゾン,"",不明,"","","","","","",未知,"",""
AB-23011810,2,7,C,オランザピン,"",不明,"","","","","","",未知,"",""
AB-23011810,2,8,C,膵臓性消化酵素配合剤（１）,"",不明,"","","","","","",未知,"",""
AB-23011810,2,9,C,カペシタビン,"",不明,"","","","","","",未知,"",""
AB-23011898,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-23011898,1,2,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23011898,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012046,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230106,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,免疫性腸炎(再投与なし),""
AB-23012046,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230106,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012046,3,3,C,オキサリプラチン,"",不明,20230106,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012123,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221226,20230417,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,末梢性ニューロパチー(再投与なし);皮膚炎(再投与なし);間質性肺疾患(再投与なし),""
AB-23012123,5,2,PS,オキサリプラチン,"",静脈内点滴,20221212,20230417,85,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23012123,5,3,C,フルオロウラシル,"",静脈内点滴;静脈内点滴,20221212;20230626,20230417;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012123,5,4,C,レボホリナートカルシウム,"",静脈内点滴;静脈内点滴,20221212;20230626,20230417;,200;,mg/m2;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012123,5,5,C,酸化マグネシウム,"",不明,20230710,"","","","",便秘(便秘),未知,"",""
AB-23012123,5,6,C,アプリンジン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-23012126,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220511,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,免疫性肺疾患(再投与なし),""
AB-23012235,3,1,PS,レナリドミド水和物,レブラミド,;,;,;,15;5,mg;mg,1;1,形質細胞性骨髄腫(Multiple myeloma),剂量停止,"",""
AB-23012235,3,2,PS,ニボルマブ,オプジーボ,"","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23012235,3,3,PS,デキサメタゾン,レナデックス,;,;,;,20;12,mg;mg,1;1,形質細胞性骨髄腫(Multiple myeloma),剂量停止,"",""
AB-23012335,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,劇症１型糖尿病(再投与なし);副腎機能不全(再投与なし),""
AB-23012335,3,2,PS,コロナウイルス（ＳＡＲＳ−ＣｏＶ−２）ＲＮＡワクチン,コミナティ（１価：起源株）,不明,2023,2023,"","","","",不适用,"",""
AB-23012335,3,3,PS,ヒドロコルチゾン,"",不明;不明,2023;202306,202306;,20;50,mg;mg,1;1,副腎機能不全(adrenocortical hypofunction (irAE)),不适用,"",""
AB-23012335,3,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","",40,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23012335,3,5,C,ラムシルマブ,"",静脈内（明記されていない場合）,202304,"",8,mg/kg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012335,3,6,C,パクリタキセル（アルブミン懸濁型）,"",静脈内（明記されていない場合）,202304,"",100,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012335,3,7,C,オキサリプラチン,"",静脈内（明記されていない場合）,"","",130,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012335,3,8,C,カペシタビン,"",経口,"","",1000,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012346,3,1,PS,デキサメタゾン,レナデックス,;,;,;,0.5;1,mg;mg,1;1,副腎機能不全(Adrenal insufficiency),剂量不变,免疫性甲状腺機能低下症(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし);副腎機能不全(再投与なし);血中ブドウ糖増加(再投与なし);悪液質(再投与なし);末梢性浮腫(再投与なし);食欲減退(再投与なし);腹部膨満(再投与なし);発熱(再投与なし),""
AB-23012346,3,2,PS,ニボルマブ,オプジーボ,"",20200422,202006,"","","",胃癌(GASTRIC CANCER),不适用,免疫性甲状腺機能低下症(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし);副腎機能不全(再投与なし);血中ブドウ糖増加(再投与なし);悪液質(再投与なし);末梢性浮腫(再投与なし);食欲減退(再投与なし);腹部膨満(再投与なし);発熱(再投与なし),""
AB-23012346,3,3,C,インスリンデグルデク・リラグルチド（遺伝子組換え）配合剤,"","","","","","","",糖尿病(Diabetes mellitus),未知,"",""
AB-23012346,3,4,C,インスリンデグルデク・インスリン　アスパルト（遺伝子組換え）配合剤,"","",202301,"","","","",糖尿病(Diabetes mellitus),未知,"",""
AB-23012346,3,5,C,イプラグリフロジンＬ−プロリン,"","",202302,"",50,mg,1,適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23012346,3,6,C,エルトロンボパグオラミン,"","","","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23012346,3,7,C,ラムシルマブ,"",;,202006;201906,;,;,;,;,胃癌(Gastric cancer),未知,"",""
AB-23012346,3,8,C,パクリタキセル,"","",202007,"","","","",胃癌(Gastric cancer),未知,"",""
AB-23012346,3,9,C,オキサリプラチン,"","",202205,"","","","",胃癌(Gastric cancer),未知,"",""
AB-23012346,3,10,C,レボホリナートカルシウム,"","",202205,"","","","",胃癌(Gastric cancer),未知,"",""
AB-23012346,3,11,C,フルオロウラシル,"","",202205,"","","","",胃癌(Gastric cancer),未知,"",""
AB-23012346,3,12,C,トリフルリジン・チピラシル塩酸塩配合剤,"","",202210,"","","","",胃癌(Gastric cancer),未知,"",""
AB-23012346,3,13,C,OTERACILPOTASSIUM,"","",202212,"","","","",胃癌(Gastric cancer),未知,"",""
AB-23012672,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;20230703,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,器質化肺炎(不明),""
AB-23012672,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012672,3,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012702,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20211224;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-23012707,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220310,20220916,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-23012707,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012707,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012710,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230403,20230403,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,紅斑(再投与なし),""
AB-23012710,1,2,C,オキサリプラチン,"",不明,20230403,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23012710,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230403,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013258,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230414,20230428,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,注入に伴う反応(再投与なし),""
AB-23013258,1,2,C,オキサリプラチン,"",不明,20230414,"",150,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013258,1,3,C,フルオロウラシル,"",静脈内急速;静脈内点滴,20230414;20230414,;,700;4200,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013258,1,4,C,レボホリナートカルシウム,"",不明,20230414,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013264,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23013264,1,2,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013264,1,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013264,1,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013266,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-23013266,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013266,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013478,1,1,PS,オキサリプラチン,エルプラット：点滴静注液,"","","","","","",胃癌(EBV関連胃癌),不适用,"",""
AB-23013478,1,2,PS,ニボルマブ,"","","","","","","",胃癌(EBV関連胃癌),未知,"",""
AB-23013478,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"","","","","","","",胃癌(EBV関連胃癌),未知,"",""
AB-23013552,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221214,20230329,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺毒性(再投与なし),""
AB-23013552,2,2,PS,スルファメトキサゾール・トリメトプリム,"",不明,"","","","","","",未知,"",""
AB-23013552,2,3,C,オキサリプラチン,"",不明,20221214,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013552,2,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20221214,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013644,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202302,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能亢進症(再投与なし),""
AB-23013644,1,2,PS,オキサリプラチン,"",不明,202302,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23013644,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202302,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013674,2,1,PS,レンバチニブメシル酸塩,レンビマ,経口,"","","","","",肝細胞癌(Unresectable hepatocellular carcinoma),不适用,"",""
AB-23013674,2,2,PS,アテゾリズマブ,テセントリク,不明;不明,202112;20220329,;,;,;,;,"",未知,"",""
AB-23013674,2,3,PS,ベバシズマブ,アバスチン,不明;不明,202112;20220329,;,;,;,;,"",未知,"",""
AB-23013755,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230220,20230330,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-23013755,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230220,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013755,1,3,C,オキサリプラチン,"",不明,20230220,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23013772,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-23013772,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","","",未知,"",""
AB-23013772,1,3,C,オキサリプラチン,"",静脈内点滴,"","","","","","",未知,"",""
AB-23013959,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202108,202204,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,原発性副腎機能不全(再投与なし),""
AB-23014147,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221011,20230501,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし);突然死(再投与なし);食欲減退(再投与なし),""
AB-23014147,2,2,C,カンデサルタンシレキセチル,"",経口,"","","","","","",未知,"",""
AB-23014147,2,3,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-23014562,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221021,20230425,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23014562,2,2,C,オキサリプラチン,"",不明,20221021,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23014562,2,3,C,フルオロウラシル,"",不明,20221021,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23014562,2,4,C,レボホリナートカルシウム,"",不明,20221021,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23014564,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220308,20220308,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,血小板減少症(再投与なし);肺炎(再投与なし),""
AB-23014564,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明;不明,20220208;20220308;202206,;;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23014564,2,3,C,オキサリプラチン,"",不明;不明;不明,20220208;20220308;202206,;;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23014566,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,下痢(再投与なし);後天性表皮水疱症(再投与なし);発熱(再投与なし);足底紅斑(再投与なし);コクサッキーウイルス検査陽性(再投与なし);手足口病(再投与なし);類天疱瘡(再投与なし);手掌・足底発赤知覚不全症候群(再投与なし);口唇びらん(再投与なし);手掌紅斑(再投与なし);口腔粘膜びらん(再投与なし);免疫介在性副作用(再投与なし),""
AB-23014566,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23014566,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23014566,1,4,C,ラムシルマブ,"",不明,"","","","","",胃癌(胃癌),未知,"",""
AB-23014566,1,5,C,パクリタキセル,"",不明,"","","","","",胃癌(胃癌),未知,"",""
AB-23014592,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23014592,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23014592,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23014593,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,末梢性ニューロパチー(再投与なし);死亡(再投与なし),""
AB-23014593,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23014593,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23014759,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能亢進症(再投与なし),""
AB-23014766,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし),""
AB-23014769,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220708;20220909,;,240;240,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,続発性副腎皮質機能不全(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-23014769,1,2,PS,オキサリプラチン,"",不明,20220708,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23014769,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220708,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23014769,1,4,C,アスピリン,"",経口,"","","","","","",未知,"",""
AB-23014769,1,5,C,ランソプラゾール,"",経口,"","","","","","",未知,"",""
AB-23014769,1,6,C,ロスバスタチンカルシウム,"",経口,"","","","","","",未知,"",""
AB-23014769,1,7,C,フロセミド,"",経口,"","","","","","",未知,"",""
AB-23014769,1,8,C,ビソプロロールフマル酸塩,"",経口,"","","","","","",未知,"",""
AB-23014769,1,9,C,ニコランジル,"",経口,"","","","","","",未知,"",""
AB-23014769,1,10,C,モサプリドクエン酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-23014769,1,11,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-23014769,1,12,C,大建中湯,"",経口,"","","","","","",未知,"",""
AB-23014992,1,1,PS,パクリタキセル,タキソール,"","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23014992,1,2,PS,ニボルマブ,オプジーボ,"","","","","","",胃癌(Gastric cancer),不适用,後天性表皮水疱症(再投与なし);手足口病(再投与なし);コクサッキーウイルス検査陽性(再投与なし);手掌・足底発赤知覚不全症候群(再投与なし);手掌紅斑(再投与なし);足底紅斑(再投与なし);類天疱瘡(再投与なし);発熱(再投与なし);下痢(再投与なし);口唇びらん(再投与なし);口腔粘膜びらん(再投与なし);好中球数減少(再投与なし),""
AB-23014992,1,3,PS,ラムシルマブ,"","","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23014992,1,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"","","","","","","",胃癌(Gastric cancer),未知,"",""
AB-23015028,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-23015029,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221202,20230330,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,筋炎(再投与なし);免疫性心筋炎(再投与なし),""
AB-23015029,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23015029,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23015036,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23015037,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20230120;;,202305;202307;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,血球減少症(再投与なし),""
AB-23015037,2,2,PS,オキサリプラチン,"",不明,"",202305,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23015037,2,3,PS,フルオロウラシル,"",不明,"",202305,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23015037,2,4,PS,レボホリナートカルシウム,レボホリナート,不明,"",202305,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23015200,2,1,PS,ホスネツピタント塩化物塩酸塩,アロカリス,;,20230208;20230301,20230208;20230301,235;235,mg;mg,1;1,悪心・嘔吐の予防(Prophylaxis of nausea and vomiting),未知,腸炎(再投与なし),""
AB-23015200,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,;,20230208;20230301,20230222;20230313,120;120,mg;mg,1;1,胃癌(Gastric cancer),未知,腸炎(再投与なし),""
AB-23015200,2,3,PS,ニボルマブ,オプジーボ,;,20230208;20230301,20230208;20230301,360;360,mg;mg,1;1,胃癌(Gastric cancer),未知,腸炎(再投与なし),""
AB-23015200,2,4,PS,オキサリプラチン,エルプラット,;,20230208;20230301,20230208;20230301,200;200,mg;mg,1;1,胃癌(Gastric cancer),未知,腸炎(再投与なし),""
AB-23015200,2,5,C,副腎ホルモン剤,"","","","","","","",悪心・嘔吐の予防(Prophylaxis of nausea and vomiting),未知,"",""
AB-23015200,2,6,C,パロノセトロン塩酸塩,"","","","","","","",悪心・嘔吐の予防(Prophylaxis of nausea and vomiting),未知,"",""
AB-23015200,2,7,C,アセトアミノフェン,"","","","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23015200,2,8,C,ロペラミド塩酸塩,"","","","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23015200,2,9,C,ラモセトロン塩酸塩,"","","","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23015200,2,10,C,オランザピン,"","","","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23015200,2,11,C,バルガンシクロビル塩酸塩,"","","","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23015200,2,12,C,スルファメトキサゾール・トリメトプリム,"","","","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23015200,2,13,C,半夏瀉心湯,"","","","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23015200,2,14,C,ロペラミド塩酸塩,"","","","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23015200,2,15,C,タンニン酸アルブミン,"","","","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23015369,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-23015369,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23015369,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23015386,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,2022;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫介在性副腎機能不全(再投与なし),""
AB-23015386,4,2,PS,オキサリプラチン,"",不明,2022,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23015386,4,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,2022,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23015386,4,4,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23015386,4,5,C,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23015443,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20220622;20221018;,202208;;20230722,360;360;360,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,関節リウマチ(再投与なし);血中ビリルビン増加(再投与なし);血中ビリルビン増加(再投与なし);静脈閉塞性肝疾患(再投与なし);胆管拡張(再投与なし),""
AB-23015443,4,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20220622;20221018;20230110;20230523,202208;;;20230725,170;75;130;130,mg;mg/m2;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23015443,4,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エヌケーエスワン,経口;経口;経口,20220622;20230110;20230523,20230109;20230508;20230807,60;50;40,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23015443,4,4,C,ボグリボース,"",経口,20220607,20230112,.3,mg,1,"",未知,"",""
AB-23015443,4,5,C,インスリンリスプロ［後続１］,"",皮下,20220622,20230824,"","","","",未知,"",""
AB-23015443,4,6,C,インスリングラルギン,"",皮下,20220622,20230824,"","","","",未知,"",""
AB-23015767,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-23015767,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23015767,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23016152,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,202303;2023,2023;,200;200,mg;mg,1;1,胃癌第４期(MSI-High 癌（結腸・直腸以外）),剂量停止,胃閉塞(無),""
AB-23016393,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし),""
AB-23016553,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202303,20230605,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23016553,3,2,C,オキサリプラチン,"",不明,202303,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23016553,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202303,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23016635,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,乳癌(再投与なし),""
AB-23016844,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-23016844,1,2,C,オキサリプラチン,"",静脈内点滴,"","",100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23016844,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23016954,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220127,20220320,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性肝炎(再投与なし),""
AB-23016954,3,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20211101,20220227,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,自己免疫性肝炎(再投与なし),""
AB-23016954,3,3,C,ラムシルマブ,"",不明,20211111,20220126,270,mg,1,胃癌(胃癌),未知,"",""
AB-23016954,3,4,C,パクリタキセル,"",不明,20211111,20220126,80,mg,1,胃癌(胃癌),未知,"",""
AB-23016954,3,5,C,デュロキセチン塩酸塩,"",不明,"",20220720,20,mg,1,"",未知,"",""
AB-23017236,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20221031;20230302,;20230323,360;240,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23017236,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,20221031,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23017236,1,3,PS,オキサリプラチン,"",不明,20221031,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23017236,1,4,PS,牛車腎気丸,"",経口,20221221,20230320,7.5,g,1,末梢性ニューロパチー(末梢神経障害),不适用,"",""
AB-23017236,1,5,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-23017236,1,6,C,ポラプレジンク,"",不明,"","","","","","",未知,"",""
AB-23017236,1,7,C,ビフィズス菌製剤（５）,"",不明,"","","","","","",未知,"",""
AB-23017236,1,8,C,センノシド,"",不明,"","","","","","",未知,"",""
AB-23017236,1,9,C,ロペラミド塩酸塩,"",不明,"","","","","","",未知,"",""
AB-23017236,1,10,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-23017236,1,11,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
AB-23017236,1,12,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-23017237,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230420,20230605,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,中毒性表皮壊死融解症(再投与なし),""
AB-23017237,3,2,PS,レボホリナートカルシウム,レボホリナート,静脈内点滴,20230420,20230605,200,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23017237,3,3,PS,オキサリプラチン,"",静脈内点滴,20230420,20230605,85,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23017237,3,4,PS,フルオロウラシル,"",静脈内急速;静脈内点滴,20230420;20230420,20230605;20230605,400;2400,mg/m2;mg/m2,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23017237,3,5,C,フェブキソスタット,"",不明,"","","","","","",未知,"",""
AB-23017237,3,6,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-23017237,3,7,C,ドンペリドン,"",不明,"","","","","","",未知,"",""
AB-23017237,3,8,C,センナ・センナ実,"",経口,"","","","","","",未知,"",""
AB-23017242,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202210;202303,;,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(無),""
AB-23017242,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23017242,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23017312,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210616,20220330,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性心筋炎(再投与なし),""
AB-23017312,3,2,PS,シタグリプチンリン酸塩水和物,グラクティブ,経口,"","","","","",２型糖尿病(2型糖尿病),未知,免疫性心筋炎(再投与なし),""
AB-23017313,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,食欲減退(再投与なし),""
AB-23017313,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23017313,1,3,PS,オキサリプラチン,"",不明,202112,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23017559,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221102,20230308,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,慢性腎臓病(再投与なし);高カリウム血症(再投与なし);多形紅斑(再投与なし);慢性腎臓病(再投与なし);肺臓炎(再投与なし),""
AB-23017559,2,2,C,オキサリプラチン,"",静脈内点滴,20221102,20230308,180,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23017559,2,3,C,フルオロウラシル,"",不明,20221102,20230308,5440,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23017559,2,4,C,レボホリナートカルシウム,"",不明,20221102,20230308,335,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23018155,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能亢進症(再投与なし),""
AB-23018155,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23018155,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23018156,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(不明),""
AB-23018156,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23018156,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23018158,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(不明),""
AB-23018158,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23018158,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23018421,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,ループス様症候群(再投与なし),""
AB-23018421,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23018421,2,3,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23018430,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",202307,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,末梢性ニューロパチー(再投与なし),""
AB-23018430,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口;経口,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23018430,3,3,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23018434,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",202306,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-23018510,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202205,20230615,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,ケトアシドーシス(再投与なし),""
AB-23018511,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,尿細管間質性腎炎(再投与なし);血小板減少症(再投与なし),""
AB-23018511,4,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23018511,4,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23018511,4,4,C,ラムシルマブ,"",不明,"","","","","","",未知,"",""
AB-23018511,4,5,C,パクリタキセル,"",不明,"","","","","","",未知,"",""
AB-23018513,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230214,20230228,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,筋炎(再投与なし);心筋炎(再投与なし),""
AB-23018513,2,2,C,コロナウイルスワクチン,"",不明,"","","","","","",未知,"",""
AB-23018827,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);甲状腺機能低下症(再投与なし),""
AB-23019565,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20211013;;,;20220523;,240;480;,mg;mg;,1;1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫介在性肝障害(再投与なし),""
AB-23019812,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230418,20230502,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,リウマチ性多発筋痛(再投与なし),""
AB-23019812,2,2,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-23019812,2,3,C,オルメサルタンメドキソミル,"",不明,"","","","","","",未知,"",""
AB-23019812,2,4,C,ラモセトロン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-23019812,2,5,C,タムスロシン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-23019812,2,6,C,コハク酸ソリフェナシン,"",不明,"","","","","","",未知,"",""
AB-23019812,2,7,C,ビラスチン,"",不明,"","","","","","",未知,"",""
AB-23019813,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-23019813,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23019813,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23019816,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,急性副腎皮質機能不全(再投与なし),""
AB-23019816,3,2,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23019816,3,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23019960,1,1,PS,パクリタキセル,タキソール,不明,"","","","","",胃癌(Gastric cancer),未知,"",""
AB-23019960,1,2,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,"","","","","",胃癌(Gastric cancer),不适用,"",""
AB-23019960,1,3,PS,ラムシルマブ,"",不明,"","","","","",胃癌(Gastric cancer),未知,"",""
AB-23019960,1,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(Gastric cancer),未知,"",""
AB-23020034,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23020037,6,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221214,20230628,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし);間質性肺疾患(再投与なし),""
AB-23020037,6,2,C,オキサリプラチン,"",不明,20221214,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020037,6,3,C,フルオロウラシル,"",不明,20221214,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020037,6,4,C,レボホリナートカルシウム,"",不明,20221214,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020037,6,5,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020037,6,6,C,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020038,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,急性腎障害(再投与なし),""
AB-23020038,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020038,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020039,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,肺静脈血栓症(再投与なし),""
AB-23020039,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020039,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020041,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,尿細管間質性腎炎(再投与なし),""
AB-23020042,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23020042,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020042,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020391,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220426;20220607,20220606;20230307,240;480,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし);副腎皮質刺激ホルモン欠損症(再投与なし),""
AB-23020391,1,2,C,ロスバスタチンカルシウム,"",経口,"","","","","","",未知,"",""
AB-23020391,1,3,C,ビソプロロールフマル酸塩,"",経口,"","","","","","",未知,"",""
AB-23020391,1,4,C,ラベプラゾールナトリウム,"",経口,"","","","","","",未知,"",""
AB-23020391,1,5,C,ニコランジル,"",経口,"","","","","","",未知,"",""
AB-23020391,1,6,C,アスピリン,"",経口,"","","","","","",未知,"",""
AB-23020391,1,7,C,アムロジピンベシル酸塩,"",経口,"","","","","","",未知,"",""
AB-23020398,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23020398,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020398,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020409,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,腸炎(再投与なし),""
AB-23020409,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020409,1,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020409,1,4,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020508,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,多発性筋炎(再投与なし),""
AB-23020704,1,1,PS,アナモレリン塩酸塩,エドルミズ,経口,20230612,20230702,100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,耐糖能障害(再投与なし),""
AB-23020704,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,耐糖能障害(再投与なし),""
AB-23020709,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23020709,1,2,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23020709,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23020709,1,4,C,オルメサルタンメドキソミル,"",経口,"","","","","","",未知,"",""
AB-23020709,1,5,C,シルニジピン,"",経口,"","","","","","",未知,"",""
AB-23020709,1,6,C,ロスバスタチンカルシウム,"",経口,"","","","","","",未知,"",""
AB-23021067,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,血中クレアチンホスホキナーゼ増加(再投与なし),""
AB-23021067,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23021067,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23021115,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202304,20230706,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肝酵素上昇(再投与なし),""
AB-23021115,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,202304,20230706,25,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23021115,3,3,C,オキサリプラチン,"",不明,202304,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23021608,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,膵炎(再投与なし),""
AB-23021611,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23021611,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23021611,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022065,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg/m2,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23022066,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,悪心(再投与なし);食欲減退(再投与なし);倦怠感(再投与なし),""
AB-23022066,1,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20230527,"",100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,悪心(再投与なし);食欲減退(再投与なし);倦怠感(再投与なし),""
AB-23022066,1,3,PS,オキシコドン塩酸塩水和物,オキシコンチン,経口,"","","","","",腫瘍疼痛(腫瘍性の疼痛),未知,"",""
AB-23022066,1,4,C,オキサリプラチン,"",静脈内点滴,"",20230707,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022066,1,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022066,1,6,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-23022066,1,7,C,レバミピド,"",不明,"","","","","","",未知,"",""
AB-23022066,1,8,C,ニフェジピン,"",不明,"","","","","","",未知,"",""
AB-23022066,1,9,C,デキストロメトルファン臭化水素酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-23022071,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,腫瘍崩壊症候群(再投与なし);腫瘍穿孔(再投与なし),""
AB-23022071,1,2,PS,オキサリプラチン,"",静脈内点滴,"","",100,mg,1,"",剂量停止,"",""
AB-23022071,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,"","","","","","",剂量停止,"",""
AB-23022190,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230427,20230427,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,吻合部潰瘍(再投与なし),""
AB-23022190,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230427,20230427,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022190,1,3,C,オキサリプラチン,"",不明,20230427,20230427,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022190,1,4,C,ロスバスタチンカルシウム,"",不明,"","","","","","",未知,"",""
AB-23022190,1,5,C,カンデサルタンシレキセチル,"",不明,"","","","","","",未知,"",""
AB-23022190,1,6,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-23022190,1,7,C,クロピドグレル硫酸塩,"",不明,"","","","","","",未知,"",""
AB-23022193,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,好酸球増加と全身症状を伴う薬物反応(再投与なし),""
AB-23022193,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022193,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022323,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-23022323,1,2,PS,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022323,1,3,PS,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022325,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-23022325,2,2,C,カペシタビン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022325,2,3,C,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022326,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23022326,1,2,C,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022326,1,3,C,フルオロウラシル,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022326,1,4,C,レボホリナートカルシウム,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022328,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性重症筋無力症(再投与なし),""
AB-23022328,1,2,C,カペシタビン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022328,1,3,C,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022720,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし);甲状腺機能亢進症(再投与なし),""
AB-23022720,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022720,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022721,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,血小板数減少(再投与なし);副腎機能不全(再投与なし),""
AB-23022721,2,2,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23022721,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023025,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫介在性肝障害(再投与なし),""
AB-23023025,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023025,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023026,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,急性副腎皮質機能不全(再投与なし),""
AB-23023027,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-23023027,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023027,1,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023027,1,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023027,1,5,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023027,1,6,C,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023319,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23023319,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023319,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023320,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220906,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,劇症１型糖尿病(再投与なし),""
AB-23023320,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220906,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023320,1,3,C,オキサリプラチン,"",不明,20220906,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023325,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230404,20230516,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,肺臓炎(再投与なし),""
AB-23023325,2,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20230412,"",100,mg,1,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量不变,肺臓炎(再投与なし),""
AB-23023325,2,3,C,パクリタキセル（アルブミン懸濁型）,"",不明,20230606,"","","","",胃癌(胃癌),未知,"",""
AB-23023325,2,4,C,牛車腎気丸,"",不明,"","","","","","",未知,"",""
AB-23023325,2,5,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-23023325,2,6,C,フロセミド,"",経口,"","","","","","",未知,"",""
AB-23023325,2,7,C,スピロノラクトン,"",経口,"","","","","","",未知,"",""
AB-23023374,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-23023374,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","",100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023374,1,3,C,オキサリプラチン,"",不明,"","",120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023377,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221018,20221018,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺膿瘍(再投与なし);細菌性肺炎(再投与なし);肺炎(再投与なし);放射線肺臓炎(再投与なし),""
AB-23023377,4,2,PS,フルオロウラシル,"",不明,19991129,"","","","",食道癌(食道癌、吻合部再発),不适用,"",""
AB-23023377,4,3,PS,シスプラチン,"",不明,19991129,"","","","",食道癌(食道癌、吻合部再発),不适用,"",""
AB-23023377,4,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20221018,20221108,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023377,4,5,C,オキサリプラチン,"",静脈内点滴,20221018,20221018,160,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023377,4,6,C,カルバゾクロムスルホン酸ナトリウム水和物,"",不明,"","","","","","",未知,"",""
AB-23023377,4,7,C,トラネキサム酸,"",不明,"","","","","","",未知,"",""
AB-23023377,4,8,C,デキストロメトルファン臭化水素酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-23023377,4,9,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
AB-23023377,4,10,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
AB-23023377,4,11,C,エドキサバントシル酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-23023624,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23023624,1,2,C,ウルソデオキシコール酸,"",経口,"","",300,mg,1,"",未知,"",""
AB-23023624,1,3,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-23023624,1,4,C,ミロガバリンベシル酸塩,"",経口,"","",30,mg,1,"",未知,"",""
AB-23023954,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,中毒性腎症(再投与なし);水腎症(再投与なし);水腎症(再投与なし);敗血症(再投与なし),""
AB-23023964,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20230314;,;,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし);末梢性ニューロパチー(再投与なし),""
AB-23023964,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023964,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023964,2,4,C,ラムシルマブ,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023964,2,5,C,パクリタキセル,"",静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,;;;20230630,;;;,;;;,;;;,;;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23023964,2,6,C,アジルサルタン,"",不明,"","",20,mg,1,血圧管理(血圧管理),未知,"",""
AB-23024018,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220922,20221124,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,大腸炎(再投与なし),""
AB-23024018,4,2,C,オキサリプラチン,"",不明;不明,20220714;20220922,20220818;20221124,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024018,4,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,20220714;20220922,20220818;20221124,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024205,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220222;20220906,20220726;20220906,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-23024205,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220222,20220920,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024205,3,3,PS,オキサリプラチン,エルプラット,静脈内点滴,20220222,20220628,191.62,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23024206,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,大腸炎(再投与なし),""
AB-23024206,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024206,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024207,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220513,20220527,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,口内炎(再投与なし),""
AB-23024207,4,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20220114;20220513,20220322;20220526,;140,;mg,;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23024207,4,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220114,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024209,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,筋炎(再投与なし);重症筋無力症(再投与なし),""
AB-23024209,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024209,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024297,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし);免疫性腸炎(再投与なし),""
AB-23024297,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,"","",120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024297,1,3,PS,オキサリプラチン,"",不明,"","",80,%,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024713,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-23024715,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,末梢性ニューロパチー(再投与なし),""
AB-23024715,3,2,PS,アプレピタント,イメンド,経口,"","","","","",悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),未知,末梢性ニューロパチー(再投与なし),""
AB-23024715,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明;不明;不明,;;;,;;;,120;100;80;80,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23024715,3,4,PS,オキサリプラチン,"",不明;不明;不明;不明,;;;,;;;,130;100;85;85,mg/m2;mg/m2;mg/m2;mg/m2,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23024721,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-23024721,1,2,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024721,1,3,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024723,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202109,202211,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性肺疾患(再投与なし);細気管支炎(再投与なし),""
AB-23024901,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230518,20230629,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,細菌性肺炎(再投与なし);肺毒性(再投与なし),""
AB-23024901,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230518,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024901,3,3,C,オキサリプラチン,"",不明,20230518,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23024901,3,4,C,酸化マグネシウム,"",不明,20230629,"",330,mg,1,便秘(便秘),未知,"",""
AB-23024901,3,5,C,ボノプラザンフマル酸塩,"",経口,"","","","","","",未知,"",""
AB-23024901,3,6,C,エスゾピクロン,"",経口,"","","","","","",未知,"",""
AB-23024901,3,7,C,トラマドール塩酸塩,"",経口,"","","","","","",未知,"",""
AB-23024901,3,8,C,ジクロフェナクナトリウム,"",経皮,"","","","","","",未知,"",""
AB-23024901,3,9,C,メトホルミン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-23024901,3,10,C,クエン酸第一鉄ナトリウム,"",経口,"","","","","","",未知,"",""
AB-23024903,7,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220617,20230127,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,呼吸困難(再投与なし);副腎機能不全(再投与なし);肝不全(再投与なし);免疫性肺疾患(再投与なし);細菌性肺炎(再投与なし),""
AB-23024903,7,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220617,20230210,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23024903,7,3,PS,オキサリプラチン,エルプラット,静脈内点滴,20220617,20230127,105.2,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23024903,7,4,C,ボノプラザンフマル酸塩,"",経口,202206,"","","","","",未知,"",""
AB-23024903,7,5,C,半夏瀉心湯,"",経口,202206,"","","","","",未知,"",""
AB-23024903,7,6,C,ヘパリン類似物質,"",局所,202206,"","","","","",未知,"",""
AB-23024903,7,7,C,ジフルプレドナート,"",局所,202206,"","","","","",未知,"",""
AB-23024903,7,8,C,アズレンスルホン酸ナトリウム水和物,"",口腔咽頭,202206,"","","","","",未知,"",""
AB-23024903,7,9,C,デキサメタゾン,"",局所,202206,"","","","","",未知,"",""
AB-23024903,7,10,C,ジメチルイソプロピルアズレン,"",局所,202206,"","","","","",未知,"",""
AB-23024905,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202206,202303,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,スティーヴンス・ジョンソン症候群(再投与なし),""
AB-23025133,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220415,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし),""
AB-23025133,1,2,C,オキサリプラチン,"",不明,20220415,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025133,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220415,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025137,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220418,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23025137,1,2,C,オキサリプラチン,"",不明,20220418,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025137,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220418,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025138,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220208,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,肺臓炎(再投与なし),""
AB-23025138,1,2,C,オキサリプラチン,"",不明,20220208,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025138,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220208,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025193,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220816,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-23025193,1,2,C,オキサリプラチン,"",不明,20220816,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025193,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220816,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025195,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220517,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,肺臓炎(再投与なし),""
AB-23025195,1,2,C,オキサリプラチン,"",不明,20220517,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025195,1,3,C,フルオロウラシル,"",不明,20220517,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025195,1,4,C,レボホリナートカルシウム,"",不明,20220517,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025197,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,１型糖尿病(再投与なし),""
AB-23025197,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025197,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025624,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230718,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,アスパラギン酸アミノトランスフェラーゼ増加(再投与なし);アラニンアミノトランスフェラーゼ増加(再投与なし),""
AB-23025624,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230718,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025624,1,3,C,オキサリプラチン,"",不明,20230718,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025625,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210928,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,腸炎(再投与なし),""
AB-23025625,1,2,C,オキサリプラチン,"",不明,20210928,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025625,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20210928,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025628,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220131,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23025628,1,2,C,オキサリプラチン,"",不明,20220131,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025628,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220131,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025629,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220412,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,肺臓炎(再投与なし),""
AB-23025629,1,2,C,オキサリプラチン,"",不明,20220412,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025629,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220412,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025637,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221027,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23025637,1,2,C,オキサリプラチン,"",不明,20221027,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025637,1,3,C,カペシタビン,"",不明,20221027,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025642,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210922,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23025642,1,2,C,オキサリプラチン,"",不明,20210922,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025642,1,3,C,フルオロウラシル,"",不明,20210922,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025642,1,4,C,レボホリナートカルシウム,"",不明,20210922,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025704,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220511,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23025704,1,2,C,オキサリプラチン,"",不明,20220511,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025704,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220511,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025865,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23025865,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23025865,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23026056,1,1,PS,ペムブロリズマブ,キイトルーダ,不明,不明,"","","","",腎細胞癌第４期(腎細胞がん),剂量不变,免疫性甲状腺機能低下症(再投与なし);自己免疫性溶血性貧血(再投与なし),""
AB-23026056,1,2,PS,アキシチニブ,"",不明,不明,"","","","",腎細胞癌第４期(腎細胞がん),剂量不变,"",""
AB-23026056,1,3,PS,デノスマブ,"",不明,不明,"","","","",骨転移(骨転移),剂量不变,"",""
AB-23026282,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220601;,20221012;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);シェーグレン症候群(再投与なし);関節リウマチ(再投与なし),""
AB-23026283,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23026293,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,急性胆管炎(再投与なし);胆管結石(再投与なし);間質性肺疾患(再投与なし);急性胆管炎(再投与なし),""
AB-23026931,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20230202;,;20230824,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,下痢(再投与なし);発疹(再投与なし),""
AB-23026931,2,2,PS,スルファメトキサゾール・トリメトプリム,ダイフェン,経口,20230610,20230701,1,{DF},1,下痢(下痢),剂量停止,"",""
AB-23026931,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23026931,2,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23027176,1,1,PS,オキサリプラチン,エルプラット：点滴静注液,"","","","","","",胃癌(胃癌),未知,"",""
AB-23027176,1,2,PS,ニボルマブ,"","","","","","","",胃癌(胃癌),未知,"",""
AB-23027176,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"","","","","","","",胃癌(胃癌),未知,"",""
AB-23027345,3,1,PS,ベプリジル塩酸塩水和物,ベプリコール,経口,20190307,20230813,100,mg,1,心房細動(発作性心房細動),不适用,間質性肺疾患(再投与なし);胃癌(再投与なし);ＣＯＶＩＤ−１９(再投与なし),""
AB-23027345,3,2,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20230511,20230803,360,mg,1,胃癌(進行胃癌),剂量停止,"",""
AB-23027345,3,3,C,カルベジロール,"",経口,不明,20230808,10,mg,1,"",未知,"",""
AB-23027345,3,4,C,カンデサルタンシレキセチル,"",経口,不明,20230808,2,mg,1,"",未知,"",""
AB-23027345,3,5,C,リバーロキサバン,"",経口,不明,20230813,15,mg,1,心房細動(発作性心房細動),未知,"",""
AB-23027345,3,6,C,フェブキソスタット,"",経口,不明,20230813,10,mg,1,"",未知,"",""
AB-23027345,3,7,C,エソメプラゾールマグネシウム水和物,"",経口,不明,20230813,10,mg,1,"",未知,"",""
AB-23027578,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴(041),20220418,20220502,130,mg,1,胃癌(Gastric cancer),未知,間質性肺疾患(再投与なし),""
AB-23027578,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴(041),20220823,20221220,360,mg,1,胃癌(Gastric cancer),剂量停止,間質性肺疾患(不明),""
AB-23027578,1,3,PS,ラムシルマブ,サイラムザ,静脈内点滴(041),20220418,20220502,400,mg,1,胃癌(Gastric cancer),未知,間質性肺疾患(再投与なし),""
AB-23027578,1,4,C,オキサリプラチン,"",その他(不明),20220823,"","","","",胃癌(Gastric cancer),未知,"",""
AB-23027578,1,5,C,ロキソプロフェンナトリウム水和物,"",経口(048),"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23027578,1,6,C,アジルサルタン,"",経口(048),"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23027578,1,7,C,ピタバスタチンカルシウム,"",経口(048),"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23027578,1,8,C,酸化マグネシウム,"",経口(048),"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23027578,1,9,C,インスリンアスパルト,"",その他(不明),"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23027578,1,10,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",その他(不明),20220823,"","","","",胃癌(Gastric cancer),未知,"",""
AB-23027578,1,11,C,アムロジピンベシル酸塩,"",経口(048),"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23027578,1,12,C,インスリングラルギン［後続１］,"",その他(不明),"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23027616,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,胃穿孔(再投与なし),""
AB-23027616,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23027616,1,3,PS,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23027796,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221020,20230418,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23027796,2,2,C,オキサリプラチン,"",不明;不明,20221020;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23027796,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,20221020;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23027796,2,4,C,アジルサルタン,"",不明,"","","","","","",未知,"",""
AB-23027796,2,5,C,ラベプラゾールナトリウム,"",不明,"","","","","","",未知,"",""
AB-23027796,2,6,C,レバミピド,"",不明,"","","","","","",未知,"",""
AB-23027796,2,7,C,セレコキシブ,"",不明,"","","","","","",未知,"",""
AB-23027796,2,8,C,エペリゾン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-23027796,2,9,C,メコバラミン,"",不明,"","","","","","",未知,"",""
AB-23027835,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220810,20230720,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺毒性(再投与なし),""
AB-23027835,3,2,PS,オキサリプラチン,エルプラット,静脈内点滴,20220721,20230720,140,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23027835,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220810,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23027835,3,4,C,ボノプラザンフマル酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-23027835,3,5,C,酸化マグネシウム,"",経口,"","",330,mg,1,"",未知,"",""
AB-23027835,3,6,C,アセトアミノフェン,"",経口,"","","","","","",未知,"",""
AB-23027838,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210215;20230710,20230508;,480;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,急性腎障害(無),""
AB-23027838,1,2,C,カルベジロール,"",経口,20201022,"",2.5,mg,1,"",未知,"",""
AB-23027838,1,3,C,ヒドロコルチゾン,"",経口,20211220,"",10,mg,1,"",未知,"",""
AB-23027838,1,4,C,ロサルタンカリウム,"",経口,20211220,"",25,mg,1,"",未知,"",""
AB-23027838,1,5,C,ダパグリフロジンプロピレングリコール水和物,"",経口,20220704,"",10,mg,1,"",未知,"",""
AB-23028023,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,大腸炎(再投与なし),""
AB-23028023,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028023,1,3,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028274,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,ＣＯＶＩＤ−１９(再投与なし),""
AB-23028274,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028274,1,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028274,1,4,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028457,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,肺毒性(再投与なし),""
AB-23028457,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028457,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028460,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220825;20230810,;20230810,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23028460,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明;不明,20220825;20230810,20230501;20230813,100;100,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23028858,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,汎血球減少症(再投与なし),""
AB-23028858,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028858,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028859,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-23028859,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","",100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028859,1,3,C,オキサリプラチン,"",不明,"","",130,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028860,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,末梢性ニューロパチー(再投与なし);薬物性肝障害(再投与なし),""
AB-23028860,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","",100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028860,1,3,C,オキサリプラチン,"",不明,"","",100,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028916,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,汎血球減少症(再投与なし),""
AB-23028916,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028916,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028917,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,重症筋無力症(再投与なし),""
AB-23028919,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);間質性肺疾患(再投与なし),""
AB-23028919,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028919,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028920,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,汎血球減少症(再投与なし),""
AB-23028920,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028920,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028921,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-23028921,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028921,1,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23028921,1,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029029,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,不明,202308,200,mg,1,胃癌(MSI-High癌（結腸・直腸以外）、胃癌),剂量停止,免疫性腎炎(再投与なし),""
AB-23029279,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-23029279,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029279,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029286,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,汎血球減少症(再投与なし),""
AB-23029286,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029286,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029363,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20230308,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);甲状腺機能低下症(再投与なし),""
AB-23029363,1,2,C,オキサリプラチン,"",不明,20220921,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029363,1,3,C,フルオロウラシル,"",不明,20220921,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029363,1,4,C,レボホリナートカルシウム,"",不明,20220921,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029365,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220512,20230809,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし),""
AB-23029365,3,2,C,オキサリプラチン,"",不明,20220512,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029365,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220512,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029536,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,不整脈(再投与なし);１型糖尿病(再投与なし);糖尿病性ケトアシドーシス(再投与なし);急性腎障害(再投与なし),""
AB-23029613,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺炎(再投与なし);死亡(再投与なし);誤嚥性肺炎(再投与なし),""
AB-23029613,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029613,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029616,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,ショック(再投与なし);下痢(再投与なし);肺炎(再投与なし),""
AB-23029616,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029616,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029806,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし);副腎機能不全(再投与なし);甲状腺機能低下症(再投与なし),""
AB-23029806,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029806,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029810,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20230209;20230817,20230601;,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-23029810,2,2,C,アスピリン,"",経口,20170811,"",100,mg,1,"",未知,"",""
AB-23029810,2,3,C,ランソプラゾール,"",経口,20170811,"",30,mg,1,"",未知,"",""
AB-23029810,2,4,C,クエン酸第一鉄ナトリウム,"",経口,20210909,"",50,mg,1,"",未知,"",""
AB-23029810,2,5,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20230209;20230316,20230209;20230921,200;150,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029810,2,6,C,カペシタビン,"",経口,20230209,"",2400,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029810,2,7,C,ジフェンヒドラミン,"",局所,20230316,"","","","","",未知,"",""
AB-23029812,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし),""
AB-23029812,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029812,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029814,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);劇症１型糖尿病(再投与なし),""
AB-23029814,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029814,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029814,1,4,C,デノスマブ,"",不明,"","","","","",骨転移(骨転移),未知,"",""
AB-23029817,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし);腸炎(再投与なし),""
AB-23029817,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029817,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029919,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,播種性血管内凝固(再投与なし),""
AB-23029919,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029919,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029920,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23029920,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23029920,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030102,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-23030102,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030102,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030103,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20230410;20230522,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,下痢(再投与なし);免疫介在性膀胱炎(再投与なし),""
AB-23030103,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,20230410;20230522,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030103,2,3,PS,オキサリプラチン,"",不明,20230410,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030112,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-23030112,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030112,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030113,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肝機能異常(再投与なし),""
AB-23030302,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,リンパ腫(再投与なし),""
AB-23030419,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,末梢性ニューロパチー(再投与なし),""
AB-23030419,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030419,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030420,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-23030420,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030420,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030421,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210219,20210625,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,視神経乳頭浮腫(再投与なし);ぶどう膜炎(再投与なし),""
AB-23030421,2,2,C,ドンペリドン,"",経口,"","",10,mg,1,"",未知,"",""
AB-23030421,2,3,C,フロセミド,"",経口,"","",40,mg,1,"",未知,"",""
AB-23030421,2,4,C,スピロノラクトン,"",経口,"","",25,mg,1,"",未知,"",""
AB-23030686,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,皮膚筋炎(再投与なし),""
AB-23030686,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030686,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030979,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23030979,2,2,PS,ラムシルマブ,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23030987,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230630,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし);糖尿病(再投与なし);心筋炎(再投与なし);甲状腺機能低下症(再投与なし),""
AB-23030990,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,2023,2023,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,骨髄抑制(再投与なし);敗血症(再投与なし),""
AB-23030990,3,2,C,オキサリプラチン,"",不明,2023,2023,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030990,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,2023,2023,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23030991,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230712,"",480,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,栄養補給障害(再投与なし);嘔吐(再投与なし);全身健康状態悪化(再投与なし),""
AB-23031285,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-23031380,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし);横紋筋融解症(再投与なし),""
AB-23031771,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,乾癬性関節症(再投与なし),""
AB-23032129,4,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20210927,"",200,mg,1,胃癌第４期(MSI-High癌（結腸・直腸以外）、胃癌);マイクロサテライト不安定性癌(MSI-High癌（結腸・直腸以外）、胃癌),不适用,間質性肺疾患(再投与なし),""
AB-23032319,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23032319,1,2,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
AB-23032319,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","","",未知,"",""
AB-23032667,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20230608,202309,200,mg,1,胃癌(MSI-High 胃がん),剂量不变,肺炎(有);発熱(再投与なし);肺炎(再投与なし),""
AB-23032942,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23032942,3,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23032942,3,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23032942,3,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23033242,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23033242,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23033242,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23033243,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23033243,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23033243,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23033556,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20230406;,20230817;,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,ケトアシドーシス(不明);高血糖(不明),""
AB-23033556,4,2,PS,オキサリプラチン,エルプラット,静脈内点滴,20230406,20230817,140,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23033556,4,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","","",未知,"",""
AB-23033556,4,4,C,パロノセトロン塩酸塩,"",静脈内点滴,"","","","","","",未知,"",""
AB-23033556,4,5,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
AB-23033556,4,6,C,酪酸菌配合剤,"",経口,"","","","","","",未知,"",""
AB-23033556,4,7,C,メトクロプラミド,"",経口,"","","","","","",未知,"",""
AB-23033556,4,8,C,バルサルタン,"",経口,"","","","","","",未知,"",""
AB-23033556,4,9,C,シロドシン,"",経口,"","","","","","",未知,"",""
AB-23033556,4,10,C,ピレノキシン,"",眼,"","","","","","",未知,"",""
AB-23033556,4,11,C,プラノプロフェン,"",眼,"","","","","","",未知,"",""
AB-23033746,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202301,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性膵炎(再投与なし),""
AB-23033746,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23033746,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23033749,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230627,20230808,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,ネフローゼ症候群(再投与なし);腎炎(再投与なし),""
AB-23033749,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23033749,1,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23034119,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230710,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし);免疫性甲状腺機能低下症(再投与なし),""
AB-23034119,2,2,C,カペシタビン,"",不明,20230710,"",2400,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23034119,2,3,C,オキサリプラチン,"",不明,20230710,"",160,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23034243,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202205;,;202307,360;480,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫介在性腎障害(再投与なし),""
AB-23034243,2,2,PS,オキサリプラチン,"",静脈内点滴,202205,202212,130,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23034243,2,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,202205,202212,40,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23034244,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230622,20230713,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性重症筋無力症(再投与なし);免疫性筋炎(再投与なし),""
AB-23034244,1,2,C,オキサリプラチン,"",不明,20230622,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23034244,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230622,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23034303,1,1,PS,オキサリプラチン,エルプラット：点滴静注液,"",20230406,"","","","",再発胃癌(進行再発胃癌),未知,"",""
AB-23034303,1,2,PS,ニボルマブ,"","","","","","","",再発胃癌(進行再発胃癌),未知,"",""
AB-23034303,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"","","","","","","",再発胃癌(進行再発胃癌),未知,"",""
AB-23035142,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230830,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,多形紅斑(再投与なし),""
AB-23035142,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,20230830;20230928,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23035142,2,3,PS,オキサリプラチン,"",不明;不明,20230830;20230928,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23035327,1,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,"","","","","",胃癌(胃癌),剂量停止,"",""
AB-23035327,1,2,PS,ニボルマブ,"",静脈内点滴,"","","","","",胃癌(胃癌),剂量停止,"",""
AB-23035327,1,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(胃癌),剂量停止,"",""
AB-23035816,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,好中球数減少(再投与なし),""
AB-23035816,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23035816,1,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23035816,1,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23035816,1,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23035817,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220125,20221206,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし);１型糖尿病(再投与なし),""
AB-23036482,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202211,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし),""
AB-23036482,2,2,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23036482,2,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23036482,2,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23036488,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,腎機能障害(再投与なし),""
AB-23036488,1,2,PS,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量减少,"",""
AB-23036488,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23036725,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230412,20230807,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,続発性副腎皮質機能不全(再投与なし),""
AB-23036725,2,2,C,オキサリプラチン,"",静脈内点滴,20230412,20230807,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23036725,2,3,C,フルオロウラシル,"",静脈内点滴,20230412,20230807,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23036725,2,4,C,レボホリナートカルシウム,"",静脈内点滴,20230412,20230807,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23036725,2,5,C,ブデソニド,"",吸入,"","","","","",肺気腫(肺気腫),未知,"",""
AB-23036948,1,1,PS,トラスツズマブデルクステカン,エンハーツ,不明,"","","","","",胃癌(Gastric cancer),未知,心不全(再投与なし);呼吸困難(再投与なし);薬物と医療機器間の不適合(再投与なし);肺炎(再投与なし);間質性肺疾患(再投与なし),""
AB-23036948,1,2,PS,ニボルマブ,オプジーボ,不明,"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23036948,1,3,C,リバーロキサバン,"",不明,"","","","","","",未知,"",""
AB-23036948,1,4,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
AB-23036950,1,1,PS,トラスツズマブデルクステカン,エンハーツ,不明,"","","","","",胃癌(Gastric Cancer),未知,足部白癬(再投与なし);末梢性ニューロパチー(再投与なし),""
AB-23036950,1,2,PS,ニボルマブ,オプジーボ,不明,"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23036950,1,3,PS,オキサリプラチン,"",不明,"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23036950,1,4,PS,アナモレリン塩酸塩,"",不明,"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23036950,1,5,PS,アプレピタント,"",不明,"","","","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23036950,1,6,C,ロペラミド塩酸塩,"",不明,"","","","","","",未知,"",""
AB-23036950,1,7,C,メトクロプラミド,"",不明,"","","","","","",未知,"",""
AB-23036950,1,8,C,プロベネシド,"",不明,"","","","","","",未知,"",""
AB-23036950,1,9,C,トラスツズマブ,"",不明,"","","","","","",未知,"",""
AB-23036950,1,10,C,デキサメタゾン,"",不明,"","","","","","",未知,"",""
AB-23036950,1,11,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-23036950,1,12,C,グラニセトロン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-23036950,1,13,C,ロスバスタチンカルシウム,"",不明,"","","","","","",未知,"",""
AB-23036950,1,14,C,乾燥硫酸鉄（２）,"",不明,"","","","","","",未知,"",""
AB-23036950,1,15,C,カペシタビン,"",不明,"","","","","","",未知,"",""
AB-23036950,1,16,C,オロパタジン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-23036950,1,17,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
AB-23037024,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,血栓性血小板減少性紫斑病(再投与なし),""
AB-23037030,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,悪性新生物進行(再投与なし),""
AB-23037030,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23037030,1,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23037072,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,240;480,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,１型糖尿病(再投与なし),""
AB-23037074,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220411;20230912,20230418;20230912,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,誤嚥(再投与なし);肺炎(再投与なし),""
AB-23037074,3,2,PS,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20220411;20221011;20230509,20220823;20230328;20230509,190;140;120,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23037074,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20220412;20220417,20220416;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23037440,3,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,"","","","","",胃癌(胃癌),未知,"",""
AB-23037440,3,2,PS,ニボルマブ,"",静脈内点滴,"","","","","",胃癌(胃癌),未知,"",""
AB-23037440,3,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(胃癌),未知,"",""
AB-23039094,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220916,20221118,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし);免疫性脳炎(再投与なし),""
AB-23039094,3,2,C,オキサリプラチン,"",不明,"","",100,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23039094,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","",120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23040274,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220902,20230317,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,皮膚筋炎(再投与なし),""
AB-23040274,5,2,PS,スルファメトキサゾール・トリメトプリム,バクタ,経口,"","","","","","",不适用,"",""
AB-23040274,5,3,PS,ゾルピデム酒石酸塩,"",経口,"","","","","",不眠症(眠剤),不适用,"",""
AB-23040274,5,4,PS,メトホルミン塩酸塩,メトグルコ,経口,"","","","","","",不适用,"",""
AB-23040274,5,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220902,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23040274,5,6,C,オキサリプラチン,"",不明,20220902,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23040274,5,7,C,クロピドグレル硫酸塩,"",経口,"","",75,mg,1,"",未知,"",""
AB-23040274,5,8,C,イプラグリフロジンＬ−プロリン,"",経口,"","",25,mg,1,"",未知,"",""
AB-23040274,5,9,C,メトホルミン塩酸塩,"",経口,"","",500,mg,1,"",未知,"",""
AB-23040274,5,10,C,アムロジピンベシル酸塩,"",経口,"","",5,mg,1,"",未知,"",""
AB-23040274,5,11,C,ロスバスタチンカルシウム,"",経口,"","",2.5,mg,1,脂質異常症(脂質異常症),未知,"",""
AB-23040274,5,12,C,ボノプラザンフマル酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-23040689,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230706,20230706,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肝障害(再投与なし),""
AB-23040689,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230706,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23040689,2,3,C,オキサリプラチン,"",不明,20230706,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23041092,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230711,20230822,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23041092,2,2,PS,オキサリプラチン,"",不明,20230711,20230822,85,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23041092,2,3,PS,フルオロウラシル,"",不明,20230711,20230822,400,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23041092,2,4,PS,レボホリナートカルシウム,レボホリナート,不明,20230711,20230822,200,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23041592,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190610;20191031,;20200817,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(再投与なし);肺臓炎(再投与なし),""
AB-23041592,3,2,C,テネリグリプチン臭化水素酸塩水和物,"",不明,"","","","","","",未知,"",""
AB-23041950,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,240;,mg;,1;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,１型糖尿病(不明),""
AB-23041981,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,低ナトリウム血症(再投与なし);抗利尿ホルモン不適合分泌(再投与なし),""
AB-23041983,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230605,"",360,mg,1,食道癌(根治切除不能な進行・再発の食道癌),未知,免疫性心筋炎(再投与なし),""
AB-23041983,2,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,20230605,"",60,mg,1,食道癌(根治切除不能な進行・再発の食道癌),未知,"",""
AB-23042041,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,202303,"",200,mg,1,腎細胞癌第４期(腎細胞癌),剂量不变,甲状腺機能低下症(再投与なし),""
AB-23042041,3,2,PS,レンバチニブメシル酸塩,レンビマ,経口;経口,202303;2023,2023;,14;,mg;,1;,腎細胞癌第４期(腎細胞癌),剂量停止,甲状腺機能低下症(不明),""
AB-23042545,4,1,PS,イピリムマブ,ヤーボイ,"",20230605,20230605,60,mg,1,食道癌(ESOPHAGEAL CANCER),剂量停止,免疫性心筋炎(再投与なし);免疫性筋炎(再投与なし);筋肉疲労(再投与なし),""
AB-23042545,4,2,PS,ニボルマブ,オプジーボ,"",20230605,20230605,360,mg,1,食道癌(ESOPHAGEAL CANCER),剂量停止,免疫性心筋炎(再投与なし);免疫性筋炎(再投与なし);筋肉疲労(再投与なし),""
AB-23043177,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20231004,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,血球減少症(再投与なし),""
AB-23043177,2,2,C,フルオロウラシル,"",不明,"",20231004,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23043177,2,3,C,レボホリナートカルシウム,"",不明,"",20231004,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23043177,2,4,C,オキサリプラチン,"",不明;不明,;,20231004;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23043447,2,1,PS,ボノプラザンフマル酸塩,タケキャブ,不明,"","","","","",慢性胃炎(慢性胃炎);胃食道逆流性疾患(逆流性食道炎),未知,腎機能障害(不明),""
AB-23043447,2,2,PS,ニボルマブ,オプジーボ,不明,"","","","","",適応症不明の製品使用(不明),未知,"",""
AB-23043537,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,心筋炎(再投与なし),""
AB-23043537,3,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23043537,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23043655,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230616,20230908,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,骨髄異形成症候群(再投与なし),""
AB-23043655,2,2,PS,オキサリプラチン,エルプラット,静脈内点滴,20230616,20230908,235,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23043655,2,3,PS,カペシタビン,ゼローダ,経口,20230616,20230922,1800,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23043655,2,4,C,酪酸菌製剤,"",経口,20230106,"",1,{DF},1,細菌叢異常(腸内菌叢の異常による諸症状の改善),未知,"",""
AB-23043655,2,5,C,ボノプラザンフマル酸塩,"",経口,20230617,"",10,mg,1,胃食道逆流性疾患(難治性逆流性食道炎),未知,"",""
AB-23043655,2,6,C,芍薬甘草湯,"",経口,20230908,"","","","",上腹部痛(胃痛),未知,"",""
AB-23043655,2,7,C,ビソプロロールフマル酸塩,"",経口;経口,;20221125,;,;2.5,;mg,;1,高血圧(高血圧症),未知,"",""
AB-23043655,2,8,C,クロピドグレル硫酸塩,"",経口;経口,;20221125,;,;75,;mg,;1,冠動脈硬化症(冠動脈硬化症),未知,"",""
AB-23043655,2,9,C,リナグリプチン,"",経口;経口,;20221125,;,;5,;mg,;1,糖尿病(糖尿病),未知,"",""
AB-23043655,2,10,C,サクビトリルバルサルタンナトリウム水和物,"",経口;経口,;20230615,;,;200,;mg,;1,高血圧(高血圧症),未知,"",""
AB-23043904,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221228,20230628,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫介在性胆管炎(再投与なし);免疫介在性胆管炎(再投与なし),""
AB-23043904,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23043904,2,3,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23044230,5,1,PS,デュルバルマブ,イミフィンジ,静脈内点滴,20230626,20230920,1500,mg,1,肝細胞癌(HIMALAYA/STRIDE),剂量停止,"",""
AB-23044230,5,2,PS,トレメリムマブ,イジュド,静脈内点滴,20230626,20230626,300,mg,1,肝細胞癌(HIMALAYA/STRIDE),不适用,"",""
AB-23044336,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221208,"",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,傍腫瘍性神経症候群(再投与なし),""
AB-23044336,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","","",未知,"",""
AB-23044336,1,3,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
AB-23044645,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺うっ血(再投与なし);免疫介在性副腎機能不全(再投与なし);免疫性肺疾患(再投与なし),""
AB-23044645,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23044645,3,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23044648,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,類天疱瘡(再投与なし),""
AB-23044648,1,2,PS,テネリグリプチン臭化水素酸塩水和物・カナグリフロジン水和物配合剤,"",経口,"","","","","","",剂量停止,"",""
AB-23044648,1,3,C,カルバマゼピン,"",経口,"","","","","","",未知,"",""
AB-23044648,1,4,C,センノシド,"",経口,"","","","","","",未知,"",""
AB-23044648,1,5,C,ゾルピデム酒石酸塩,"",経口,"","","","","","",未知,"",""
AB-23044648,1,6,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
AB-23044648,1,7,C,メトホルミン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-23044648,1,8,C,モサプリドクエン酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-23044699,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190805,20190818,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-23044707,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211008,20220203,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-23044708,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220930,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,腸炎(再投与なし),""
AB-23044708,1,2,C,オキサリプラチン,"",不明,20220930,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23044708,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220930,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045057,1,1,PS,アプレピタント,イメンド,経口,20180215,20180217,80,mg,1,悪心・嘔吐の予防(悪心予防),剂量停止,下痢(再投与なし);腹水(再投与なし);無力症(再投与なし),""
AB-23045057,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20171212,20180215,360,mg,1,胃癌(胃がん),剂量停止,下痢(再投与なし);腹水(再投与なし);無力症(再投与なし),""
AB-23045057,1,3,PS,酸化マグネシウム,マグミット,経口;経口,2017;20180207,20180217;20180217,500;500,mg;mg,1;1,便秘予防(便秘予防),剂量停止,"",""
AB-23045057,1,4,PS,ボノプラザンフマル酸塩,タケキャブ,経口,20171205,20180217,20,mg,1,潰瘍(原疾患に伴う腫瘍潰瘍),剂量停止,"",""
AB-23045057,1,5,PS,フロセミド,"",経口,20171206,20180217,20,mg,1,末梢性浮腫(下肢浮腫),剂量停止,"",""
AB-23045057,1,6,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口;経口,20171212;20180125;20180215,;2018;20180217,120;120;50,mg;mg;mg,1;1;1,胃癌(胃がん),剂量停止,"",""
AB-23045057,1,7,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴;静脈内点滴,20171212;20180125;20180215,;2018;,225.42;225.42;100,mg;mg;mg/m2,1;1;1,胃癌(胃がん),未知,"",""
AB-23045057,1,8,PS,イルベサルタン,イルベタン,経口,20180126,20180217,100,mg,1,高血圧(高血圧症),剂量停止,"",""
AB-23045057,1,9,PS,ルビプロストン,アミティーザ,経口,20180126,20180217,24,ug,1,便秘予防(便秘予防),剂量停止,"",""
AB-23045057,1,10,PS,スピロノラクトン,"",経口,20180130,20180217,25,mg,1,腹水(腹水),剂量停止,"",""
AB-23045057,1,11,PS,アムロジピンベシル酸塩,アムロジピンＯＤ,経口,20180208,20180217,5,mg,1,高血圧(高血圧症),剂量停止,"",""
AB-23045057,1,12,PS,デキサメタゾン,デカドロン,経口,20180215,20180217,8,mg,1,悪心・嘔吐の予防(悪心予防),剂量停止,"",""
AB-23045057,1,13,PS,センナ・センナ実,アローゼン,経口,20180215,20180217,1,{DF},1,便秘予防(便秘予防),剂量停止,"",""
AB-23045057,1,14,PS,レボチロキシンナトリウム水和物,チラーヂンＳ錠,経口,20180216,20180217,50,ug,1,甲状腺機能低下症(甲状腺機能低下症),剂量停止,"",""
AB-23045057,1,15,C,クロベタゾールプロピオン酸エステル,"",皮膚,20180215,"",1,{DF},1,注入部位溢出(注入部位血管外漏出),剂量不变,"",""
AB-23045179,2,1,PS,イピリムマブ,ヤーボイ,"","","","","","",肺扁平上皮癌(STAGE III PULMONARY SQUAMOUS CELL CARCINOMA OF THE RIGHT UPPER LOBE),未知,免疫性肺疾患(再投与なし),""
AB-23045179,2,2,PS,ニボルマブ,オプジーボ,"","","","","","",肺扁平上皮癌(STAGE III PULMONARY SQUAMOUS CELL CARCINOMA OF THE RIGHT UPPER LOBE),未知,免疫性肺疾患(再投与なし),""
AB-23045179,2,3,PS,カルボプラチン,"","","","","","","",肺扁平上皮癌(STAGE III PULMONARY SQUAMOUS CELL CARCINOMA OF THE RIGHT UPPER LOBE),未知,免疫性肺疾患(再投与なし),""
AB-23045179,2,4,PS,パクリタキセル,"","","","","","","",肺扁平上皮癌(STAGE III PULMONARY SQUAMOUS CELL CARCINOMA OF THE RIGHT UPPER LOBE),未知,免疫性肺疾患(再投与なし),""
AB-23045695,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202307;,;,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし),""
AB-23045695,4,2,C,オキサリプラチン,"",不明;不明,202307;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045695,4,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,202307;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045701,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,2023;2023,2023;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎皮質刺激ホルモン欠損症(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-23045701,4,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,2023;2023,2023;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045701,4,3,C,オキサリプラチン,"",不明;不明,2023;2023,2023;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045702,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20231005,20231005,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,無顆粒球症(再投与なし);肺炎(再投与なし);血小板数減少(再投与なし),""
AB-23045702,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20231005,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045702,2,3,C,オキサリプラチン,"",不明,20231005,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045708,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",202304,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,転倒(再投与なし);下痢(再投与なし),""
AB-23045708,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045708,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045708,1,4,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045708,1,5,C,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045717,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,クッシング症候群(再投与なし);免疫介在性副腎機能不全(再投与なし),""
AB-23045717,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045717,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045719,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-23045719,1,2,PS,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23045719,1,3,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23045719,1,4,PS,デキサメタゾン,"",不明,"","","","","","",未知,"",""
AB-23045719,1,5,PS,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045719,1,6,PS,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045720,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-23045720,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045720,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045721,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23045721,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045721,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045727,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220119,20220712,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,顕微鏡的大腸炎(再投与なし);顕微鏡的大腸炎(再投与なし),""
AB-23045727,4,2,PS,アプレピタント,イメンド,経口,20220209,"","","","",悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),剂量不变,顕微鏡的大腸炎(再投与なし);顕微鏡的大腸炎(再投与なし),""
AB-23045727,4,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220119,20220712,60,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23045727,4,4,PS,オキサリプラチン,"",静脈内点滴,20220119,20220531,150,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23045727,4,5,PS,ボノプラザンフマル酸塩,タケキャブ,経口,20220121,"",20,mg,1,"",剂量不变,"",""
AB-23045727,4,6,PS,ロキソプロフェンナトリウム水和物,ロキソプロフェン,経口,20220209,20230822,60,mg,1,"",剂量不变,"",""
AB-23045727,4,7,PS,ラムシルマブ,サイラムザ,不明;不明,20220720;,;20230615,550;550,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23045727,4,8,PS,パクリタキセル,"",不明;不明,20220720;,;20230615,140;140,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23045727,4,9,C,デキサメタゾン,"",経口,20220119,"",4,mg,1,予防(予防),未知,"",""
AB-23045727,4,10,C,メトクロプラミド,"",経口,20220121,"",5,mg,1,予防(予防),未知,"",""
AB-23045727,4,11,C,プレガバリン,"",経口,20220413,"",75,mg,1,予防(予防),未知,"",""
AB-23045727,4,12,C,メトホルミン塩酸塩,"",経口,"",20231003,250,mg,1,"",未知,"",""
AB-23045727,4,13,C,ロスバスタチンカルシウム,"",経口,"",20231121,2.5,mg,1,"",未知,"",""
AB-23045727,4,14,C,アムロジピンベシル酸塩,"",経口,"",20231003,2.5,mg,1,"",未知,"",""
AB-23045727,4,15,C,シロドシン,"",経口,"","",4,mg,1,"",未知,"",""
AB-23045727,4,16,C,オオウメガサソウエキス・ハコヤナギエキス配合剤,"",経口,"","",1,{DF},1,"",未知,"",""
AB-23045727,4,17,C,デュタステリド,"",経口,"","",.5,mg,1,"",未知,"",""
AB-23045733,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230801,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23045733,2,2,C,カペシタビン,"",不明,20230801,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045733,2,3,C,オキサリプラチン,"",不明,20230801,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045740,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);発熱性好中球減少症(再投与なし),""
AB-23045740,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045740,2,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045741,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,心不全(再投与なし),""
AB-23045743,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,食道癌(根治切除不能な進行・再発の食道癌),不适用,免疫性甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし),""
AB-23045743,1,2,PS,イピリムマブ,ヤーボイ,静脈内点滴;静脈内点滴,;,;,;,;,;,食道癌(根治切除不能な進行・再発の食道癌),不适用,"",""
AB-23045745,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230216,20230831,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,下垂体機能低下症(再投与なし),""
AB-23045745,1,2,C,オキサリプラチン,"",不明,20230216,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045745,1,3,C,カペシタビン,"",不明,20230216,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23045747,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,免疫性腸炎(再投与なし),""
AB-23045747,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23045747,2,3,PS,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23046074,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫介在性副腎機能不全(再投与なし),""
AB-23046074,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23046074,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23046367,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);ＣＯＶＩＤ−１９(再投与なし),""
AB-23046441,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,劇症１型糖尿病(再投与なし);血小板減少症(再投与なし);糖尿病性ケトアシドーシス(再投与なし),""
AB-23046450,1,1,PS,カルボプラチン,"",不明,"","","","","",胃癌(進行胃癌);非小細胞肺癌(非小細胞肺癌),不适用,疾患進行(再投与なし),""
AB-23046450,1,2,PS,ペムブロリズマブ,"",不明,"","","","","",胃癌(進行胃癌);非小細胞肺癌(非小細胞肺癌),不适用,"",""
AB-23046450,1,3,PS,パクリタキセル（アルブミン懸濁型）,"",不明,"","","","","",胃癌(進行胃癌);非小細胞肺癌(非小細胞肺癌),不适用,"",""
AB-23046450,1,4,PS,トラスツズマブデルクステカン,"",不明,"","","","","",胃癌(進行胃癌),不适用,"",""
AB-23046450,1,5,C,トラスツズマブ,"",不明,"","","","","",胃癌(進行胃癌),剂量停止,"",""
AB-23046450,1,6,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(進行胃癌),剂量停止,"",""
AB-23046450,1,7,C,オキサリプラチン,"",不明,"","","","","",胃癌(進行胃癌),剂量停止,"",""
AB-23046594,1,1,PS,デキサメタゾン,レナデックス,"","","","","","",適応症不明の製品使用(Product used for unknown indication),未知,免疫介在性副腎機能不全(再投与なし),""
AB-23046594,1,2,PS,ニボルマブ,オプジーボ,"","","",240,mg,1,胃癌(Gastric cancer),未知,免疫介在性副腎機能不全(再投与なし),""
AB-23046594,1,3,PS,パクリタキセル,"","","","","","","",適応症不明の製品使用(Product used for unknown indication),未知,免疫介在性副腎機能不全(再投与なし);悪性新生物進行(再投与なし),""
AB-23046594,1,4,PS,カペシタビン,"","","","","","","",適応症不明の製品使用(Product used for unknown indication),未知,免疫介在性副腎機能不全(再投与なし),""
AB-23046594,1,5,PS,オキサリプラチン,"","","","","","","",適応症不明の製品使用(Product used for unknown indication),未知,免疫介在性副腎機能不全(再投与なし),""
AB-23046594,1,6,PS,ラムシルマブ,"","","","","","","",適応症不明の製品使用(Product used for unknown indication),未知,免疫介在性副腎機能不全(再投与なし);悪性新生物進行(再投与なし),""
AB-23046687,1,1,PS,オキサリプラチン,"",静脈内（明記されていない場合）,"","","","","",胃癌(スキルス胃がんStage㈿);骨転移(多発骨転移),未知,"",""
AB-23046687,1,2,PS,フルオロウラシル,"",静脈内（明記されていない場合）,"","","","","",胃癌(スキルス胃がんStage㈿);骨転移(多発骨転移),未知,"",""
AB-23046687,1,3,PS,ホリナートカルシウム,"",静脈内（明記されていない場合）,"","","","","",胃癌(スキルス胃がんStage㈿);骨転移(多発骨転移),未知,"",""
AB-23046687,1,4,PS,ニボルマブ,"",静脈内（明記されていない場合）,"","","","","",胃癌(スキルス胃がんStage㈿);骨転移(多発骨転移),未知,"",""
AB-23046692,1,1,PS,イピリムマブ,ヤーボイ,"","","","","","",食道癌(Oesophageal carcinoma),剂量停止,発疹(不明);甲状腺機能低下症(不明);副腎機能不全(不明);状態悪化(不明),""
AB-23046692,1,2,PS,ニボルマブ,オプジーボ,"","","","","","",食道癌(Oesophageal carcinoma),剂量停止,発疹(無);甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし);状態悪化(無),""
AB-23046756,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,間質性肺疾患(再投与なし),""
AB-23046760,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺炎(再投与なし),""
AB-23046760,1,2,C,ボノプラザンフマル酸塩,"",経口,"","",10,mg,1,"",未知,"",""
AB-23046835,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし),""
AB-23046837,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,糖尿病性ケトアシドーシス(再投与なし);劇症１型糖尿病(再投与なし),""
AB-23047022,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,失神(再投与なし),""
AB-23047025,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230531,20230911,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-23047150,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,多形紅斑(再投与なし),""
AB-23047282,3,1,PS,イピリムマブ,ヤーボイ,"",20230323,20230605,40,mg,1,再発食道癌(Radically unresectable advanced/recurrent esophageal cancer),剂量停止,横紋筋融解症(再投与なし);下垂体機能低下症(再投与なし);続発性副腎皮質機能不全(再投与なし);肺炎(再投与なし),""
AB-23047282,3,2,PS,ニボルマブ,オプジーボ,"",20230323,20230605,360,mg,1,再発食道癌(Radically unresectable advanced/recurrent esophageal cancer (with IPILIMUMAB)),剂量停止,横紋筋融解症(再投与なし);下垂体機能低下症(再投与なし);続発性副腎皮質機能不全(再投与なし);肺炎(再投与なし),""
AB-23047892,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201803,201909,"","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-23047892,1,2,C,ラムシルマブ,"",不明,"","","","","",胃癌(胃癌),未知,"",""
AB-23047971,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230323,20230605,360,mg,1,食道癌(根治切除不能な進行・再発の食道癌),剂量停止,横紋筋融解症(再投与なし);下垂体機能低下症(再投与なし);発熱(再投与なし);続発性副腎皮質機能不全(再投与なし),""
AB-23047971,2,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,20230323,"",40,mg,1,食道癌(根治切除不能な進行・再発の食道癌),剂量停止,"",""
AB-23048317,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,類天疱瘡(再投与なし),""
AB-23048317,2,2,PS,コロナウイルスワクチン,"",不明,"","","","","","",未知,"",""
AB-23048319,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202310,202401,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし);食欲減退(再投与なし),""
AB-23048319,2,2,C,オキサリプラチン,"",不明;不明,202310;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23048319,2,3,C,フルオロウラシル,"",不明;不明,202310;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23048319,2,4,C,レボホリナートカルシウム,"",不明;不明,202310;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23048319,2,5,C,ラムシルマブ,"",不明,"","","","","",胃癌(胃癌),未知,"",""
AB-23048319,2,6,C,パクリタキセル,"",不明,"","","","","",胃癌(胃癌),未知,"",""
AB-23048353,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫性腸炎(再投与なし);水腎症(再投与なし);腹水(再投与なし),""
AB-23048353,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","",100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23048353,1,3,C,オキサリプラチン,"",不明,"","",100,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23048353,1,4,C,ボノプラザンフマル酸塩,"",経口,"","","","","","",未知,"",""
AB-23048353,1,5,C,レバミピド,"",経口,"","","","","","",未知,"",""
AB-23048353,1,6,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23048353,1,7,C,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23048354,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221212,20230821,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし);静脈閉塞性肝疾患(再投与なし),""
AB-23048354,2,2,PS,オキサリプラチン,"",静脈内点滴;静脈内点滴,20221212;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23048354,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20221212,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23048355,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性肝炎(再投与なし),""
AB-23048442,2,1,PS,パクリタキセル,"",静脈内（明記されていない場合）,20230905,20230919,125,mg,1,胃癌(胃癌),不适用,心筋虚血(再投与なし),""
AB-23048442,2,2,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20230113,20230609,360,mg,1,胃癌(胃癌),不适用,"",""
AB-23048442,2,3,C,ボノプラザンフマル酸塩,"",経口,20221108,"",20,mg,1,"",未知,"",""
AB-23048442,2,4,C,グラニセトロン塩酸塩,"",静脈内（明記されていない場合）,20221109,20230919,"","","",悪心・嘔吐の予防(催吐予防),未知,"",""
AB-23048442,2,5,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内（明記されていない場合）,20221109,20230919,"","","",悪心・嘔吐の予防(催吐予防);アレルギー予防(過敏症予防),未知,"",""
AB-23048442,2,6,C,Ｌ−カルボシステイン,"",経口,20230728,"",1500,mg,1,"",未知,"",""
AB-23048442,2,7,C,ファモチジン,"",静脈内（明記されていない場合）,20230905,20230919,20,mg,1,アレルギー予防(過敏症状予防),未知,"",""
AB-23048470,1,1,PS,オキサリプラチン,エルプラット：点滴静注液,"",20230330,20230801,"","","",再発胃癌(進行再発胃癌),剂量停止,"",""
AB-23048470,1,2,PS,ニボルマブ,"","","","","","","",再発胃癌(進行再発胃癌),未知,"",""
AB-23048470,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"","","","","","","",再発胃癌(進行再発胃癌),未知,"",""
AB-23048680,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23048680,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23048680,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23048730,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220616,20230111,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-23048730,2,2,C,オキサリプラチン,"",不明,20220616,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23048730,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220616,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23049009,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230802,20231011,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,食道炎(再投与なし),""
AB-23049009,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23049009,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23049011,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230914,20230914,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし),""
AB-23049011,1,2,PS,リマプロストアルファデクス,オパルモン,経口,"","",5,ug,1,腰部脊柱管狭窄症(腰部脊柱管狭窄症),未知,肺炎(再投与なし),""
AB-23049011,1,3,C,プラバスタチンナトリウム,"",経口,"","",10,mg,1,"",未知,"",""
AB-23049011,1,4,C,アロプリノール,"",経口,"","",100,mg,1,"",未知,"",""
AB-23049011,1,5,C,ラベプラゾールナトリウム,"",経口,"","",10,mg,1,"",未知,"",""
AB-23049011,1,6,C,クエン酸第一鉄ナトリウム,"",経口,"","",100,mg,1,"",未知,"",""
AB-23049011,1,7,C,シロドシン,"",経口,"","",4,mg,1,"",未知,"",""
AB-23049057,3,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴(041),20231024,20231031,176,mg/m2,1,胃癌(Gastric cancer),剂量不变,好中球数減少(再投与なし);食欲減退(再投与なし),""
AB-23049057,3,2,PS,ニボルマブ,オプジーボ,静脈内点滴(041),20231024,"",240,mg,1,胃癌(Gastric cancer),剂量不变,好中球数減少(再投与なし);食欲減退(再投与なし),""
AB-23049057,3,3,PS,ラムシルマブ,サイラムザ,静脈内点滴(041),20231024,"",520,mg,1,胃癌(Gastric cancer),未知,好中球数減少(再投与なし);食欲減退(再投与なし),""
AB-23049057,3,4,C,ボノプラザンフマル酸塩,"",経口(048),20230705,"",10,mg,1,予防(Prophylaxis),未知,"",""
AB-23049057,3,5,C,ウルソデオキシコール酸,"",経口(048),20230523,"",100,mg,1,肝機能異常(Hepatic function abnormal),未知,"",""
AB-23049057,3,6,C,クエン酸第一鉄ナトリウム,"",経口(048),20231003,"",50,mg,1,貧血(Anaemia),未知,"",""
AB-23049057,3,7,C,エスゾピクロン,"",経口(048),20231017,"",2,mg,1,不眠症(Insomnia),未知,"",""
AB-23049057,3,8,C,リナグリプチン,"",経口(048),20230920,"",5,mg,1,糖尿病(Diabetes mellitus),未知,"",""
AB-23049057,3,9,C,フェンタニルクエン酸塩,"",経皮(062),20230508,"",1,mg,1,胃癌(Gastric cancer),未知,"",""
AB-23049794,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221227,"","","","",食道癌(根治切除不能な進行・再発の食道癌),不适用,下垂体機能低下症(再投与なし);敗血症性ショック(再投与なし),""
AB-23049794,1,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,20221227,"","","","",食道癌(根治切除不能な進行・再発の食道癌),不适用,"",""
AB-23049794,1,3,C,アゾセミド,"",経口,"","","","","","",未知,"",""
AB-23049794,1,4,C,スピロノラクトン,"",経口,"","","","","","",未知,"",""
AB-23049794,1,5,C,クエン酸第一鉄ナトリウム,"",経口,"","","","","","",未知,"",""
AB-23049794,1,6,C,ランソプラゾール,"",経口,"","","","","","",未知,"",""
AB-23049796,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230928,20231019,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌);結腸癌(S状結腸癌),剂量停止,１型糖尿病(再投与なし);糖尿病性ケトアシドーシス(再投与なし),""
AB-23049796,2,2,C,オキサリプラチン,"",静脈内（明記されていない場合）,20230928,20231019,120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23049796,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230928,20231028,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23050145,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221202,20230428,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,劇症１型糖尿病(再投与なし);冠動脈狭窄(再投与なし),""
AB-23050145,1,2,C,アムロジピンベシル酸塩,"",経口,"","","","","","",未知,"",""
AB-23050145,1,3,C,アジルサルタン,"",不明,"","","","","","",未知,"",""
AB-23050145,1,4,C,ウルソデオキシコール酸,"",経口,"","","","","","",未知,"",""
AB-23050145,1,5,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
AB-23050145,1,6,C,エドキサバントシル酸塩水和物,"",経口,"","","","","","",未知,"",""
AB-23050165,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし),""
AB-23050165,1,2,C,オキサリプラチン,"",静脈内点滴,"","","","","","",未知,"",""
AB-23050165,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","","",未知,"",""
AB-23050411,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,意識レベルの低下(再投与なし);髄膜炎(再投与なし),""
AB-23050419,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,血球減少症(再投与なし),""
AB-23050419,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23050419,1,3,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23050843,1,1,PS,イピリムマブ,ヤーボイ,"","","","","","",再発食道癌(OESOPHAGEAL CARCINOMA THORACIC RECURRENT),不适用,下垂体機能低下症(再投与なし);過小食(再投与なし);敗血症(再投与なし);後腹膜血腫(再投与なし);血小板数減少(再投与なし);血中ビリルビン増加(再投与なし);意識レベルの低下(再投与なし);内分泌障害(再投与なし),""
AB-23050843,1,2,PS,ニボルマブ,オプジーボ,"","","","","","",再発食道癌(OESOPHAGEAL CARCINOMA THORACIC RECURRENT),不适用,下垂体機能低下症(再投与なし);過小食(再投与なし);敗血症(再投与なし);後腹膜血腫(再投与なし);血小板数減少(再投与なし);血中ビリルビン増加(再投与なし);意識レベルの低下(再投与なし);内分泌障害(再投与なし),""
AB-23051019,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,免疫性血小板減少症(再投与なし);間質性肺疾患(再投与なし),""
AB-23051101,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,肝不全(再投与なし),""
AB-23051171,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,202310,202311,200,mg,1,胃癌第４期(MSI-High胃癌),剂量停止,脳梗塞(再投与なし),""
AB-23051364,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230106,20230421,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,重症筋無力症(再投与なし),""
AB-23051364,2,2,C,オキサリプラチン,"",不明,20230106,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23051364,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230106,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23051379,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220520,20221028,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23051379,2,2,C,オキサリプラチン,"",不明,20220520,20221028,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23051379,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220520,20221028,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23051793,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,硬化性胆管炎(再投与なし),""
AB-23051793,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23051793,3,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23051798,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,好中球減少症(再投与なし),""
AB-23051798,1,2,PS,オキサリプラチン,"",不明,"","","","","",胃癌(切除不能胃癌),不适用,"",""
AB-23051798,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(切除不能胃癌),不适用,"",""
AB-23051798,1,4,PS,パクリタキセル,"",不明,"","","","","",胃癌(切除不能胃癌),不适用,"",""
AB-23051798,1,5,PS,ラムシルマブ,"",不明,"","","","","",胃癌(切除不能胃癌),不适用,"",""
AB-23052137,2,1,PS,カルボプラチン,"",不明,20230412,20230605,"","","",非小細胞肺癌(非小細胞肺癌),剂量停止,"",""
AB-23052137,2,2,PS,パクリタキセル,タキソール,不明,20230412,20230612,"","","",非小細胞肺癌(非小細胞肺癌),剂量停止,"",""
AB-23052137,2,3,PS,デュルバルマブ,イミフィンジ,"",20230412,"",1500,mg,1,非小細胞肺癌(非小細胞肺癌),未知,"",""
AB-23052137,2,4,PS,トレメリムマブ,イジュド,;,20230912;20230412,20230912;20230718,75;75,mg;mg,1;1,非小細胞肺癌(非小細胞肺癌),未知,"",""
AB-23052263,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,末梢性ニューロパチー(再投与なし);副腎機能不全(再投与なし),""
AB-23052263,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23052263,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23052265,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220617,20220819,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);甲状腺機能低下症(再投与なし),""
AB-23052265,2,2,C,オキサリプラチン,"",不明,20220617,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23052273,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-23052273,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23052273,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23052273,1,4,C,ラムシルマブ,"",不明;不明,;,;,;,;,;,"",未知,"",""
AB-23052273,1,5,C,パクリタキセル,"",不明;不明,;,;,;,;,;,"",未知,"",""
AB-23052274,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220906;20221213,20221129;20230502,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,貧血(再投与なし);下痢(再投与なし);免疫性膵炎(再投与なし),""
AB-23052274,1,2,PS,クエン酸第一鉄ナトリウム,クエン酸第一鉄Ｎａ,不明,20221101,20221213,"","","",貧血(貧血),不适用,"",""
AB-23052274,1,3,C,アセトアミノフェン,"",経口,20211214,"",1,{DF},1,胃癌(胃癌),未知,"",""
AB-23052274,1,4,C,フロセミド,"",経口,20220201,"",10,{DF},1,胃癌(胃癌),未知,"",""
AB-23052274,1,5,C,スピロノラクトン,"",経口,20220201,"",1,{DF},1,胃癌(胃癌),未知,"",""
AB-23052274,1,6,C,メコバラミン,"",経口,20220405,"",1,{DF},1,胃癌(胃癌),未知,"",""
AB-23052274,1,7,C,ミロガバリンベシル酸塩,"",経口,20220405,"",1,{DF},1,胃癌(胃癌),未知,"",""
AB-23052274,1,8,C,ランソプラゾール,"",経口,20220823,"",1,{DF},1,胃癌(胃癌),未知,"",""
AB-23052300,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220722,"",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,シェーグレン症候群(再投与なし),""
AB-23052300,1,2,PS,アナモレリン塩酸塩,エドルミズ,経口,"","","","","",悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),未知,シェーグレン症候群(再投与なし),""
AB-23052300,1,3,C,トラゾドン塩酸塩,"",経口,"","","","","","",未知,"",""
AB-23052300,1,4,C,レンボレキサント,"",経口,"","","","","","",未知,"",""
AB-23052300,1,5,C,ボノプラザンフマル酸塩,"",経口,"","","","","","",未知,"",""
AB-23052300,1,6,C,プレガバリン,"",経口,"","","","","","",未知,"",""
AB-23052300,1,7,C,フマル酸第一鉄,"",経口,"","","","","","",未知,"",""
AB-23052300,1,8,C,ビラスチン,"",経口,"","","","","","",未知,"",""
AB-23052300,1,9,C,リナクロチド,"",経口,"","","","","","",未知,"",""
AB-23052300,1,10,C,芍薬甘草湯,"",経口,"","","","","","",未知,"",""
AB-23052300,1,11,C,セレコキシブ,"",経口,"","","","","","",未知,"",""
AB-23052300,1,12,C,ヘパリン類似物質,"",局所,"","","","","","",未知,"",""
AB-23052300,1,13,C,プレドニゾロン吉草酸エステル酢酸エステル,"",局所,"","","","","","",未知,"",""
AB-23052302,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,240;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし);器質化肺炎(再投与なし),""
AB-23052302,1,2,C,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23052302,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23052338,14,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴(041);静脈内点滴(041);静脈内点滴(041),20231122;20240115;20240229,20240104;;,168;134;95,mg;mg;mg,1;1;1,胃癌(Gastric cancer),剂量停止,発熱性好中球減少症(再投与なし);皮膚潰瘍(再投与なし);軟部組織感染(再投与なし),""
AB-23052338,14,2,PS,ニボルマブ,オプジーボ,静脈内点滴(041);静脈内点滴(041);静脈内点滴(041),20231122;20240215;20240229,;;,240;;240,mg;;mg,1;;1,胃癌(gastric cancer),未知,発熱(再投与なし);発熱性好中球減少症(再投与なし);皮膚潰瘍(再投与なし);軟部組織感染(再投与なし),""
AB-23052338,14,3,PS,ラムシルマブ,サイラムザ,静脈内点滴(041);静脈内点滴(041);静脈内点滴(041),20231122;20240222;20240307,20231221;;,544;356;297,mg;mg;mg,1;1;1,胃癌(gastric cancer),剂量停止,発熱性好中球減少症(再投与なし);皮膚潰瘍(再投与なし);軟部組織感染(再投与なし),""
AB-23052338,14,4,C,沈降炭酸カルシウム・コレカルシフェロール・炭酸マグネシウム,"",経口(048),20220621,"",2,{DF},1,予防(Prophylaxis),未知,"",""
AB-23052338,14,5,C,ボノプラザンフマル酸塩,"",経口(048),20220624,"",20,mg,1,胃食道逆流性疾患(Reflux oesophagitis),未知,"",""
AB-23052338,14,6,C,ミロガバリンベシル酸塩,"",経口(048),20220908,"",5,mg,1,神経系障害(Nervous system disorder),未知,"",""
AB-23052338,14,7,C,ヘパリン類似物質,"",局所(061),20230502,"","","","",皮膚乾燥予防(Dry skin prophylaxis),未知,"",""
AB-23052338,14,8,C,酢酸亜鉛水和物,"",経口(048),20230502,"",50,mg,1,予防(Prophylaxis),未知,"",""
AB-23052338,14,9,C,アナモレリン塩酸塩,"",経口(048),20230611,"",100,mg,1,食欲亢進(Appetite stimulated),未知,"",""
AB-23052338,14,10,C,エドキサバントシル酸塩水和物,"",経口(048),20240105,"",30,mg,1,脾静脈閉塞(Splenic vein occlusion),未知,"",""
AB-23052338,14,11,C,アズレンスルホン酸ナトリウム水和物,"",口腔咽頭(049),20240112,"","","","",口内炎(Mucositis oral),未知,"",""
AB-23052338,14,12,C,オメプラゾール,"",静脈内（明記されていない場合）(042),20240111,"",20,mg,1,胃食道逆流性疾患(Reflux oesophagitis),未知,"",""
AB-23052338,14,13,C,アミノ酸・糖・電解質・ビタミン（２−３）,"",静脈内点滴(041),20240109,"",1500,mL,1,食欲減退(Inappetence),未知,"",""
AB-23052338,14,14,C,メロペネム水和物,"",静脈内（明記されていない場合）(042),20240111,"",1,g,1,肺炎(Bronchopneumonia),未知,"",""
AB-23052338,14,15,C,酸化マグネシウム,"",経口(048),20240126,"",1,{DF},1,便秘(Constipation),未知,"",""
AB-23052338,14,16,C,アモキシシリン水和物・クラブラン酸カリウム,"",経口(048),20240211,"",1,{DF},1,感染予防(Infection prophylaxis),未知,"",""
AB-23052338,14,17,C,アモキシシリン水和物,"",経口(048),20240211,"",1,{DF},1,感染予防(Infection prophylaxis),未知,"",""
AB-23052338,14,18,C,オランザピン,"",経口(048),20240307,"",1,{DF},1,悪心・嘔吐の予防(Nausea prophylaxis),未知,"",""
AB-23052338,14,19,C,アジルサルタン,"",経口(048),20240308,"",1,{DF},1,高血圧(Hypertension),未知,"",""
AB-23052516,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200601,20200629,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,皮膚筋炎(再投与なし),""
AB-23052558,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20231010,20231111,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,筋肉痛(再投与なし),""
AB-23052558,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23052558,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23052753,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230320,20230815,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23052753,2,2,PS,オキサリプラチン,"",静脈内点滴,20230306,20230815,91,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23052753,2,3,PS,フルオロウラシル,５−ＦＵ,静脈内点滴,20230306,20230815,2754,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23052753,2,4,C,レボホリナートカルシウム,"",静脈内点滴,20230306,20230815,300,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23052753,2,5,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内点滴,20230306,20230815,6.6,mg,1,予防(予防),未知,"",""
AB-23052753,2,6,C,パロノセトロン塩酸塩,"",静脈内点滴,20230306,20230815,.75,mg,1,予防(予防),未知,"",""
AB-23052753,2,7,C,アトルバスタチンカルシウム水和物,"",経口,"",20230909,5,mg,1,"",未知,"",""
AB-23052753,2,8,C,クロピドグレル硫酸塩,"",経口,"",20230909,75,mg,1,"",未知,"",""
AB-23052753,2,9,C,エチゾラム,"",経口,"",20230909,.5,mg,1,"",未知,"",""
AB-23053222,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,末梢性ニューロパチー(再投与なし);劇症１型糖尿病(再投与なし),""
AB-23053222,1,2,PS,デキサメタゾン,"",不明,"","","","","",悪心・嘔吐の予防(制吐),未知,"",""
AB-23053222,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23053222,1,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23053506,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202304;20231120,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-23053506,1,2,C,オキサリプラチン,"",不明,202304,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23053506,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202304,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23053703,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし),""
AB-23053703,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23053703,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23053705,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220608,20230904,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌);腹膜転移(腹膜播種),不适用,心肺停止(再投与なし),""
AB-23053705,1,2,PS,オキサリプラチン,エルプラット,静脈内（明記されていない場合）,20220608,20230904,120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌);腹膜転移(腹膜播種),不适用,"",""
AB-23053705,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20220608;20220629,20220621;20230821,100;80,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌);腹膜転移(腹膜播種),不适用,"",""
AB-23053705,1,4,PS,ジフェンヒドラミン塩酸塩,レスタミン,経口,20220608,"",50,mg,1,化学療法副作用予防投与(化学療法の前投薬),不适用,"",""
AB-23053705,1,5,C,エソメプラゾールマグネシウム水和物,"",経口,20230327,"","","","","",未知,"",""
AB-23053705,1,6,C,エロビキシバット水和物,"",経口,20230327,"","","","","",未知,"",""
AB-23053705,1,7,C,オロパタジン塩酸塩,"",経口,20230327,"","","","","",未知,"",""
AB-23053705,1,8,C,ピタバスタチンカルシウム,"",経口,20230327,"","","","","",未知,"",""
AB-23053705,1,9,C,イメグリミン塩酸塩,"",経口,20230327,"","","","","",未知,"",""
AB-23053705,1,10,C,シタグリプチンリン酸塩水和物,"",経口,20230327,"","","","","",未知,"",""
AB-23053705,1,11,C,インスリンデグルデク,"",皮下,20230327,"","","","",コントロール不良の糖尿病(血糖コントロール不良),未知,"",""
AB-23054009,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;202311,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,胆管炎(再投与なし);ショック(再投与なし),""
AB-23054009,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054009,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054014,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,発疹(再投与なし),""
AB-23054014,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054061,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;360,;mg,;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肝性脳症(再投与なし),""
AB-23054061,1,2,PS,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23054061,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23054061,1,4,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054061,1,5,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054064,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,免疫介在性副腎機能不全(再投与なし),""
AB-23054091,1,1,PS,デキサメタゾン,デカドロン,不明,"","","","","",悪心・嘔吐の予防(制吐剤),剂量不变,"",""
AB-23054091,1,2,PS,ニボルマブ,"",不明,"","","","","",胃癌(切除不能進行胃がん),剂量不变,"",""
AB-23054091,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(切除不能進行胃がん),不适用,"",""
AB-23054091,1,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(切除不能進行胃がん),剂量不变,"",""
AB-23054308,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23054367,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230906,20231129,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,心筋炎(再投与なし),""
AB-23054367,3,2,PS,メチルプレドニゾロン,"",不明,20231211,20231213,500,mg,1,心筋炎(薬剤性心筋炎),不适用,"",""
AB-23054367,3,3,PS,プレドニゾロン,プレドニン,不明;不明;不明;不明,20231214;20231219;20231223;20231229,20231218;20231222;20231228;,20;15;10;15,mg;mg;mg;mg,1;1;1;1,心筋炎(薬剤性心筋炎),剂量不变,"",""
AB-23054367,3,4,PS,コロナウイルスワクチン,"",不明,"","","","","","",不适用,"",""
AB-23054367,3,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230906,20231210,80,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054367,3,6,C,オキサリプラチン,"",不明,20230906,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054396,2,1,PS,デキサメタゾン,レナデックス,"","","","","","",悪心・嘔吐の予防(Vomiting prophylaxis),未知,"",""
AB-23054396,2,2,PS,ニボルマブ,オプジーボ,"","","","","","",胃癌(Gastric cancer),剂量停止,"",""
AB-23054396,2,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"","","","","","","",胃癌(Gastric cancer),剂量停止,"",""
AB-23054396,2,4,C,オキサリプラチン,"","","","","","","",胃癌(Gastric cancer),剂量停止,"",""
AB-23054641,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫介在性副腎機能不全(再投与なし),""
AB-23054641,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054646,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌);悪性黒色腫(根治切除不能な悪性黒色腫に対する併用療法),不适用,免疫介在性肝障害(再投与なし),""
AB-23054646,1,2,PS,イピリムマブ,ヤーボイ,静脈内点滴,"","","","","",悪性黒色腫(根治切除不能な悪性黒色腫に対する併用療法),不适用,"",""
AB-23054646,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054646,1,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054646,1,5,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054646,1,6,C,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054646,1,7,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054646,1,8,C,イリノテカン塩酸塩水和物,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054654,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,肺動脈血栓症(再投与なし),""
AB-23054654,1,2,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054654,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054765,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,劇症１型糖尿病(再投与なし),""
AB-23054765,1,2,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23054765,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054770,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,１型糖尿病(再投与なし),""
AB-23054774,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202305,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,重症筋無力症(再投与なし);免疫性筋炎(再投与なし),""
AB-23054774,2,2,C,オキサリプラチン,"",不明,202305,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054774,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202305,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054944,1,1,PS,ニボルマブ,オプジーボ,"","","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-23054951,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20230523;20230807,20230612;20230828,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫性腸炎(有);免疫性腸炎(有);免疫性腸炎(有),""
AB-23054951,3,2,PS,オキサリプラチン,"",不明;不明;不明,20230523;20230807;,20230612;;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23054951,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口;経口,20230523;20230807;,;20230911;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23054959,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230116,202305,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,溶血(再投与なし),""
AB-23054959,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23054959,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23055075,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230803,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺炎(再投与なし),""
AB-23055075,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230803,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23055075,1,3,C,オキサリプラチン,"",不明,20230803,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23055076,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,細菌性肺炎(再投与なし);間質性肺疾患(再投与なし),""
AB-23055076,1,2,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23055076,1,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23055076,1,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23055078,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌);小腸癌(十二指腸球部癌),剂量停止,横紋筋融解症(再投与なし);腎機能障害(再投与なし),""
AB-23055357,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし);中枢性甲状腺機能低下症(再投与なし),""
AB-23055357,2,2,C,トリフルリジン・チピラシル塩酸塩配合剤,"",不明,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23055358,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20231024,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,横紋筋融解症(再投与なし);血中クレアチンホスホキナーゼ増加(再投与なし),""
AB-23055358,1,2,PS,オキサリプラチン,"",不明,20231024,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23055358,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明,20231024,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23055532,2,1,PS,イピリムマブ,ヤーボイ,"","","","","","",悪性黒色腫(primary esophageal melanoma),不适用,免疫介在性肝障害(再投与なし),""
AB-23055532,2,2,PS,ニボルマブ,オプジーボ,"","","","","","","再発胃癌(unresectable, advanced or recurrent gastric cancer (anaplastic carcinoma, HER2-negative));悪性黒色腫(Malignant melanoma)",不适用,免疫介在性肝障害(再投与なし),""
AB-23055532,2,3,C,オキサリプラチン,"","","","","","","","再発胃癌(unresectable, advanced or recurrent gastric cancer (anaplastic carcinoma, HER2-negative))",不适用,"",""
AB-23055532,2,4,C,パクリタキセル,"","","","","","","","再発胃癌(unresectable, advanced or recurrent gastric cancer (anaplastic carcinoma, HER2-negative))",未知,"",""
AB-23055532,2,5,C,ラムシルマブ,"","","","","","","","再発胃癌(unresectable, advanced or recurrent gastric cancer (anaplastic carcinoma, HER2-negative))",未知,"",""
AB-23055532,2,6,C,イリノテカン塩酸塩水和物,"","","","","","","","再発胃癌(unresectable, advanced or recurrent gastric cancer (anaplastic carcinoma, HER2-negative))",未知,"",""
AB-23055556,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230217,20230623,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,甲状腺障害(再投与なし);副腎機能不全(再投与なし),""
AB-23055556,1,2,C,オキサリプラチン,"",静脈内（明記されていない場合）,20230217,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23055556,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230217,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23055560,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,皮膚炎(再投与なし);肝炎(再投与なし);大腸炎(再投与なし),""
AB-23055560,1,2,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
AB-23055560,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","","",未知,"",""
AB-23056209,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,炎症性腸疾患(再投与なし);下痢(再投与なし),""
AB-23056209,1,2,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23056209,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23056209,1,4,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23056209,1,5,C,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23056210,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,糖尿病性ケトアシドーシス(再投与なし);１型糖尿病(再投与なし),""
AB-23056393,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202210,202310,360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,細菌性肺炎(再投与なし);硬膜下血腫(再投与なし),""
AB-23056400,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221014,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-23056400,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20221014;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23056400,2,3,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20221014;20221128,20221014;,165;130,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23056400,2,4,PS,ボノプラザンフマル酸塩,タケキャブ,不明,"","","","","","",未知,"",""
AB-23056400,2,5,C,生理食塩液,"",不明,"","","","","","",未知,"",""
AB-23056400,2,6,C,3231401,"",不明,"","","","","","",未知,"",""
AB-23056400,2,7,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
AB-23056400,2,8,C,グラニセトロン塩酸塩,"",静脈内点滴,"","","","","","",未知,"",""
AB-23056400,2,9,C,ホスネツピタント塩化物塩酸塩,"",静脈内点滴,"","","","","","",未知,"",""
AB-23056572,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230529,20230801,360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-23056580,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202206,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし);副腎機能不全(再投与なし),""
AB-23056580,3,2,C,カペシタビン,"",不明,202206,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23056580,3,3,C,オキサリプラチン,"",不明,202206,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23056583,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20231205,20231205,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,イレウス(再投与なし),""
AB-23056583,2,2,C,アムロジピンベシル酸塩,"",経口,20231110,20231217,2.5,mg,1,高血圧(高血圧),未知,"",""
AB-23056583,2,3,C,酸化マグネシウム,"",経口,20231110,20231217,330,mg,1,便秘(便秘),未知,"",""
AB-23056583,2,4,C,オキサリプラチン,"",不明,20231205,"",146,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23056583,2,5,C,レボホリナートカルシウム,"",不明,20231205,"",345,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23056583,2,6,C,フルオロウラシル,"",不明;不明,20231205;20231205,;20231207,690;4140,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057096,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202205;,;,240;480,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,水疱性皮膚炎(再投与なし),""
AB-23057106,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230426,202310,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腎機能障害(再投与なし),""
AB-23057106,2,2,PS,アプレピタント,イメンド,経口,20230329,"","","","",悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),未知,腎機能障害(再投与なし),""
AB-23057106,2,3,C,ロスバスタチンカルシウム,"",不明,20210123,"","","","","",未知,"",""
AB-23057106,2,4,C,ボノプラザンフマル酸塩,"",不明,20210123,"","","","","",未知,"",""
AB-23057106,2,5,C,アスピリン,"",不明,20210123,"","","","","",未知,"",""
AB-23057106,2,6,C,テルミサルタン,"",不明,20210203,"","","","","",未知,"",""
AB-23057106,2,7,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230329,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057106,2,8,C,オキサリプラチン,"",不明,20230329,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057106,2,9,C,デキサメタゾンリン酸エステルナトリウム,"",不明,20230329,"","","","","",未知,"",""
AB-23057106,2,10,C,パロノセトロン塩酸塩,"",不明,20230329,"","","","","",未知,"",""
AB-23057106,2,11,C,アプレピタント,"",不明,20230329,"","","","","",未知,"",""
AB-23057106,2,12,C,クエン酸第一鉄ナトリウム,"",不明,20230517,"","","","","",未知,"",""
AB-23057106,2,13,C,フロセミド,"",不明,20230628,"","","","","",未知,"",""
AB-23057106,2,14,C,スピロノラクトン,"",不明,20230712,"","","","","",未知,"",""
AB-23057106,2,15,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
AB-23057106,2,16,C,クエン酸第二鉄水和物,"",不明,"","","","","","",未知,"",""
AB-23057170,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20230407;20230522,20230428;20230522,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(不明),""
AB-23057170,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230407,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057170,2,3,C,オキサリプラチン,"",静脈内点滴,20230407,20230522,130,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057170,2,4,C,生理食塩液,"",不明,"","","","","","",未知,"",""
AB-23057170,2,5,C,ブドウ糖,"",不明,"","","","","","",未知,"",""
AB-23057170,2,6,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
AB-23057170,2,7,C,グラニセトロン塩酸塩,"",静脈内点滴,"","","","","","",未知,"",""
AB-23057170,2,8,C,ホスネツピタント塩化物塩酸塩,"",静脈内点滴,"","","","","","",未知,"",""
AB-23057432,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20230427;20230606,20230427;,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,胃穿孔(無),""
AB-23057432,1,2,C,ボノプラザンフマル酸塩,"",経口;経口,20230414;,20230511;,20;20,mg;mg,1;1,予防(予防投与),未知,"",""
AB-23057432,1,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20230427;,20230427;,100;100,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057432,1,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,20230427;,20230511;,100;100,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057442,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230124,20230803,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-23057442,1,2,PS,オキサリプラチン,"",静脈内点滴,20230124,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057442,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20230124,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057442,1,4,C,スルファメトキサゾール・トリメトプリム,"",経口,"","","","","","",未知,"",""
AB-23057442,1,6,C,レンボレキサント,"",経口,"","","","","","",未知,"",""
AB-23057442,1,7,C,酢酸亜鉛水和物,"",経口,"","","","","","",未知,"",""
AB-23057442,1,8,C,ラメルテオン,"",経口,"","","","","","",未知,"",""
AB-23057445,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,細菌性肺炎(再投与なし),""
AB-23057445,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057445,3,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057447,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202206,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23057857,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230825,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,食欲減退(再投与なし);倦怠感(再投与なし),""
AB-23057857,1,2,C,オキサリプラチン,"",不明,20230825,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057857,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230825,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057872,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230424,20231115,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,脳卒中(再投与なし),""
AB-23057872,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230424,20231115,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23057872,1,3,C,オキサリプラチン,"",不明,20230424,20230719,150,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058180,2,1,PS,アテゾリズマブ,テセントリク,静脈内点滴;静脈内点滴,20230619;20231204,20231113;,1200;,mg;,1;,非小細胞肺癌(非小細胞肺癌),剂量停止,甲状腺機能低下症(不明),""
AB-23058512,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴(041),20230622,20230830,"","","",胃癌(Gastric cancer),未知,悪性新生物進行(再投与なし),""
AB-23058512,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴(041),20230317,20230410,360,mg,1,胃癌(Gastric cancer),未知,悪性新生物進行(再投与なし),""
AB-23058512,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口(048),20230317,20230529,"","","",胃癌(Gastric cancer),未知,"",""
AB-23058512,1,4,C,オキサリプラチン,"",静脈内点滴(041),20230317,20230410,170,mg,1,胃癌(Gastric cancer),未知,"",""
AB-23058512,1,5,C,ラムシルマブ,"",静脈内点滴(041),20230622,20230830,"","","",胃癌(Gastric cancer),未知,"",""
AB-23058512,1,6,C,生理食塩液,"",その他(不明),20230622,20230830,"","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23058512,1,7,C,デキサメタゾンリン酸エステルナトリウム,"",その他(不明),20230622,20230830,"","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23058704,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230516,20230919,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,アナフィラキシー反応(再投与なし),""
AB-23058704,2,2,C,レボホリナートカルシウム,"",静脈内点滴,20230420,20230919,340,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058704,2,3,C,オキサリプラチン,"",静脈内（明記されていない場合）,20230420,20230919,400,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058704,2,4,C,フルオロウラシル,"",不明;不明;不明,20230420;20230421;20230516,20230420;20230421;20230905,5000;4000;5000,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058710,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴(041),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,悪性新生物進行(再投与なし);貧血(不明);食欲減退(不明);アミラーゼ増加(不明),""
AB-23058710,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴(041),20220601,20220713,360,mg,1,胃癌(Gastric cancer),未知,悪性新生物進行(再投与なし);貧血(不明);食欲減退(不明);アミラーゼ増加(再投与なし),""
AB-23058710,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,その他(不明),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,悪性新生物進行(再投与なし);貧血(不明);食欲減退(不明);アミラーゼ増加(不明),""
AB-23058710,1,4,PS,オキサリプラチン,エルプラット,その他(不明),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,悪性新生物進行(再投与なし);貧血(不明);食欲減退(不明);アミラーゼ増加(不明),""
AB-23058710,1,5,PS,ラムシルマブ,サイラムザ,その他(不明),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,悪性新生物進行(再投与なし);貧血(不明);食欲減退(不明);アミラーゼ増加(不明),""
AB-23058710,1,6,C,生理食塩液,"",その他(不明),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23058710,1,7,C,ブドウ糖,"",その他(不明),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23058710,1,8,C,デキサメタゾンリン酸エステルナトリウム,"",その他(不明),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23058710,1,9,C,グラニセトロン塩酸塩,"",その他(不明),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23058710,1,10,C,ホスネツピタント塩化物塩酸塩,"",その他(不明),"","","","","",適応症不明の製品使用(PRODUCT USED FOR UNKNOWN INDICATION),未知,"",""
AB-23058767,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230323,20230629,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,腸炎(再投与なし);副腎機能不全(再投与なし),""
AB-23058767,2,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20230323;20230802,20230629;,440;340,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058767,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230323,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058768,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230125,20230221,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫介在性肝障害(再投与なし);アラニンアミノトランスフェラーゼ増加(再投与なし);アスパラギン酸アミノトランスフェラーゼ増加(再投与なし),""
AB-23058768,1,2,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20230125;20230405,20230221;20230418,165;160,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058768,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230130,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058877,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220309,20220629,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-23058877,1,2,PS,オキサリプラチン,"",静脈内（明記されていない場合）;静脈内（明記されていない場合）,20220309;20220421,20220329;20220608,400;200,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23058877,1,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20220309;,;20220711,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23058877,1,4,PS,パクリタキセル,"",不明,20220801,20221109,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23058877,1,5,C,ラムシルマブ,"",静脈内点滴,20220801,20221109,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058877,1,6,C,トリフルリジン・チピラシル塩酸塩配合剤,"",不明,20230329,20230403,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058882,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230705,20230705,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,溶血性貧血(再投与なし),""
AB-23058882,1,2,C,オキサリプラチン,"",不明;不明,202306;202310,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058882,1,3,C,カペシタビン,"",不明;不明,202306;202310,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058883,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202303,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,甲状腺機能低下症(再投与なし);副腎機能不全(再投与なし),""
AB-23058883,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202303,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058883,1,3,C,オキサリプラチン,"",不明,202303,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058888,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230310,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,アラニンアミノトランスフェラーゼ増加(再投与なし),""
AB-23058888,2,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20230310;20230411,20230310;,260;180,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058888,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230310,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058889,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220616,20230112,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺炎(再投与なし),""
AB-23058889,2,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20220616;20220825,20220728;20221027,160;130,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058889,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220616,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058889,2,4,C,パクリタキセル（アルブミン懸濁型）,"",不明,20230307,"","","","",胃癌(胃癌),未知,"",""
AB-23058890,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220221,20220809,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺炎(再投与なし),""
AB-23058890,1,2,C,オキサリプラチン,"",静脈内点滴,20220221,20220809,120,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058890,1,3,C,フルオロウラシル,"",不明;不明,20220221;20220308,20220221;20220809,4200;4100,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058890,1,4,C,レボホリナートカルシウム,"",静脈内点滴,20220221,20220809,300,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058890,1,5,C,パクリタキセル,"",不明,20220907,"","","","",胃癌(胃癌),未知,"",""
AB-23058890,1,6,C,ラムシルマブ,"",不明,20220907,"","","","",胃癌(胃癌),未知,"",""
AB-23058891,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220708,20221205,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,甲状腺炎(再投与なし);副腎機能不全(再投与なし),""
AB-23058891,2,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20220708;20220728,20220708;20221104,210;160,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23058891,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220708,20221220,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058892,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220922,20221118,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,下痢(再投与なし),""
AB-23058892,2,2,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220922;20221223,20221118;20230307,150;140,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058892,2,3,C,フルオロウラシル,"",不明;不明;不明,20220922;20221223;20230117,20221118;20221223;20230704,4950;4900;4200,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058892,2,4,C,レボホリナートカルシウム,"",静脈内点滴,20220922,20230704,350,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058893,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230418,20230711,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫性肺疾患(再投与なし),""
AB-23058893,1,2,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20230418;20230502;20230523;20230926,20230418;20230502;20230711;20231121,151.151;154.154;150.15;,mg;mg;mg;,1;1;1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058893,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230502,20230725,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058893,1,4,C,生理食塩液,"",不明,20230926,20231121,"","","","",未知,"",""
AB-23058893,1,5,C,ブドウ糖,"",不明,20230926,20231121,"","","","",未知,"",""
AB-23058893,1,6,C,デキサメタゾンリン酸エステルナトリウム,"",不明,20230926,20231121,"","","","",未知,"",""
AB-23058893,1,7,C,クロルフェニラミンマレイン酸塩,"",不明,20230926,20231121,"","","","",未知,"",""
AB-23058893,1,8,C,パロノセトロン塩酸塩,"",静脈内点滴,20230926,20231121,"","","","",未知,"",""
AB-23058893,1,9,C,ファモチジン,"",不明,20230926,20231121,"","","","",未知,"",""
AB-23058894,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220921,20221101,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-23058894,1,2,C,オキサリプラチン,"",静脈内点滴,20220921,20230331,190,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058894,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220921,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058897,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220404,20230126,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23058897,2,2,C,オキサリプラチン,"",不明,20220404,20230126,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058900,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202206,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,スティーヴンス・ジョンソン症候群(再投与なし),""
AB-23058900,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058900,2,3,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058900,2,4,C,シスプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058902,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220810,202306,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23058902,2,2,C,オキサリプラチン,"",不明,20220810,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058903,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230203,20230831,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,腸炎(再投与なし),""
AB-23058903,1,2,PS,ラムシルマブ,"",不明,20230929,"","","","",胃癌(胃癌),剂量不变,"",""
AB-23058903,1,3,PS,パクリタキセル（アルブミン懸濁型）,"",不明,20230929,"","","","",胃癌(胃癌),剂量不变,"",""
AB-23058903,1,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230203,20230914,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058903,1,5,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20230203;20230511,20230323;20230831,380;300,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058918,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴(041),20230622,20230830,"","","",胃癌(Gastric cancer),未知,疲労(再投与なし);悪心(再投与なし);食欲減退(再投与なし);味覚不全(再投与なし),""
AB-23058918,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴(041),20230317,20230410,360,mg,1,胃癌(Gastric cancer),剂量停止,好中球数減少(再投与なし);食欲減退(再投与なし);味覚不全(再投与なし);γ−グルタミルトランスフェラーゼ増加(再投与なし),""
AB-23058918,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口(048),20230317,20230529,"","","",胃癌(Gastric cancer),未知,"",""
AB-23058918,1,4,C,オキサリプラチン,"",静脈内点滴(041),20230317,20230410,170,mg,1,胃癌(Gastric cancer),未知,"",""
AB-23058918,1,5,C,ラムシルマブ,"",静脈内点滴(041),20230622,20230830,"","","",胃癌(Gastric cancer),未知,"",""
AB-23058918,1,6,C,SODIUMCHLORIDE,"",その他(不明),20230622,20230830,"","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23058918,1,7,C,デキサメタゾンリン酸エステルナトリウム,"",その他(不明),20230622,20230830,"","","",適応症不明の製品使用(Product used for unknown indication),未知,"",""
AB-23058931,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220722,20221223,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,甲状腺機能低下症(再投与なし),""
AB-23058931,2,2,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220722;20221028,20220930;20221223,170;130,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058931,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220722,20221223,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058933,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230612,20230926,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,腹部感染(再投与なし);好中球数減少(再投与なし),""
AB-23058933,1,2,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20230612;20230703;20230829;20230912,20230612;20230801;20230829;20230926,250;190;150;140,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058933,1,3,C,フルオロウラシル,"",不明;不明;不明;不明,20230612;20230703;20230829;20230912,20230612;20230801;20230829;20230926,4800;3600;2400;2250,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058933,1,4,C,レボホリナートカルシウム,"",静脈内点滴,20230612,20230926,600,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058934,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221012,20230202,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,水疱性皮膚炎(再投与なし),""
AB-23058934,1,2,PS,パクリタキセル（アルブミン懸濁型）,"",不明,20230217,20230419,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23058934,1,3,PS,ラムシルマブ,"",不明,20230217,20230419,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23058934,1,4,C,オキサリプラチン,"",静脈内点滴,20221012,20230202,170,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058934,1,5,C,フルオロウラシル,"",不明,20221012,20230202,5650,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058934,1,6,C,レボホリナートカルシウム,"",静脈内点滴,20221012,20230202,400,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058936,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23058936,2,2,C,オキサリプラチン,"",不明,202202,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058936,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,202202;202205,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058940,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,腸炎(再投与なし);甲状腺機能低下症(再投与なし),""
AB-23058940,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23058940,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059096,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20230324;20230725,20230602;20231121,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,低カリウム血症(不明),""
AB-23059096,2,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20230324;20230414,20230324;20231017,400;300,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059096,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230324,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059097,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230519,20230630,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,血小板数減少(再投与なし),""
AB-23059097,2,2,C,オキサリプラチン,"",静脈内（明記されていない場合）,20230519,20230630,400,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059097,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230519,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059098,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221025,20221206,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,多形紅斑(再投与なし),""
AB-23059098,1,2,C,レボホリナートカルシウム,"",静脈内点滴,20221025,"",300,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059098,1,3,C,オキサリプラチン,"",静脈内（明記されていない場合）,20221025,"",200,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059098,1,4,C,フルオロウラシル,"",不明;不明;不明;不明,20221025;20221026;20221108;20230110,;;;,5000;4000;5000;4000,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059099,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,薬物性肝障害の疑い(再投与なし);間質性肺疾患(再投与なし),""
AB-23059099,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059099,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059103,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,出血性膀胱炎(再投与なし),""
AB-23059103,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059103,1,3,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059104,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-23059104,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059104,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059106,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性ニューロパチー(再投与なし),""
AB-23059106,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059106,1,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059106,1,4,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059107,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20230316;20230331;20230424,20230316;20230331;,240;360;240,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,好中球数減少(再投与なし);食欲減退(再投与なし);悪心(再投与なし),""
AB-23059107,1,2,C,レボホリナートカルシウム,"",静脈内点滴;静脈内点滴,20230302;20230424,20230316;,292;294,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059107,1,3,C,オキサリプラチン,"",静脈内（明記されていない場合）,20230302,"",2,{DF},1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059107,1,4,C,フルオロウラシル,"",不明;不明;不明;不明;不明;不明;不明;不明,20230302;20230303;20230316;20230317;20230424;20230620;20230815;20231010,20230302;20230303;20230316;20230317;20230530;20230725;20230926;,5;4;5;4;5;4;5;4,{DF};{DF};{DF};{DF};{DF};{DF};{DF};{DF},1;1;1;1;1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059107,1,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230331,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059149,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,その他(不明),20230217,20230419,"","","",胃癌(Gastric cancer),未知,悪性新生物進行(再投与なし),""
AB-23059149,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴(041),20221012,20230202,240,mg,1,胃癌(Gastric cancer),未知,悪性新生物進行(再投与なし),""
AB-23059149,1,3,PS,ラムシルマブ,サイラムザ,その他(不明),20230217,20230419,"","","",胃癌(Gastric cancer),未知,悪性新生物進行(再投与なし),""
AB-23059149,1,4,C,オキサリプラチン,"",静脈内点滴(041),20221012,20230202,170,mg,1,胃癌(Gastric cancer),未知,"",""
AB-23059149,1,5,C,フルオロウラシル,"",その他(不明),20221012,20230202,5650,mg,1,胃癌(Gastric cancer),未知,"",""
AB-23059149,1,6,C,レボホリナートカルシウム,"",静脈内点滴(041),20221012,20230202,400,mg,1,胃癌(Gastric cancer),未知,"",""
AB-23059165,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230330,20230620,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-23059165,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230330,20230704,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059165,1,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20230330;20230512,20230330;20230620,300;220,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059286,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202304,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし);免疫性腸炎(再投与なし),""
AB-23059286,2,2,C,オキサリプラチン,"",不明,202304,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059286,2,3,C,カペシタビン,"",不明,202304,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059287,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230210,20230530,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし);体重減少(再投与なし);口腔扁平苔癬(再投与なし),""
AB-23059287,2,2,C,オキサリプラチン,"",不明,20230210,20230303,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059287,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口;経口;経口,202103;20230210;20230509;20230721,;;;,100;;80;100,mg;;mg;mg,1;;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059289,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23059289,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059289,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059290,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,大腸炎(再投与なし),""
AB-23059290,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059290,1,3,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059291,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220920,20221011,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,腸炎(再投与なし),""
AB-23059291,2,2,PS,フルオロウラシル,"",不明;不明,20220920;20221011,20220920;20221011,3350;2700,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23059291,2,3,C,オキサリプラチン,"",静脈内点滴,20220920,20221011,100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059291,2,4,C,レボホリナートカルシウム,"",静脈内点滴,20220920,20221011,225,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059292,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230317,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,下痢(再投与なし);甲状腺機能低下症(再投与なし);甲状腺機能亢進症(再投与なし),""
AB-23059292,2,2,C,カペシタビン,"",経口,20220317,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059292,2,3,C,オキサリプラチン,"",静脈内点滴,20230317,"",400,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059293,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220909;20230602,20230324;,360;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(不明),""
AB-23059293,2,2,C,カペシタビン,"",経口,20220909,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059293,2,3,C,オキサリプラチン,"",静脈内（明記されていない場合）;静脈内（明記されていない場合）,20220909;20220930,20220909;,400;200,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059320,2,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,その他(不明),20230217,20230419,"","","",胃癌(胃癌),剂量停止,水疱性皮膚炎(再投与なし);ＣＯＶＩＤ−１９(再投与なし);肺炎(再投与なし);好中球数減少(再投与なし);末梢性感覚ニューロパチー(再投与なし);低アルブミン血症(再投与なし);低カルシウム血症(再投与なし);リンパ球数減少(再投与なし);白血球数減少(再投与なし);γ−グルタミルトランスフェラーゼ増加(再投与なし),""
AB-23059320,2,2,PS,ニボルマブ,オプジーボ,静脈内点滴(041),20221012,20230202,240,mg,1,胃癌(胃癌),剂量停止,水疱性皮膚炎(再投与なし);ＣＯＶＩＤ−１９(再投与なし);肺炎(再投与なし);好中球数減少(再投与なし);末梢性感覚ニューロパチー(再投与なし);低アルブミン血症(再投与なし);低カルシウム血症(再投与なし);リンパ球数減少(再投与なし);白血球数減少(再投与なし);γ−グルタミルトランスフェラーゼ増加(再投与なし),""
AB-23059320,2,3,PS,ラムシルマブ,サイラムザ,その他(不明),20230217,20230419,"","","",胃癌(胃癌),剂量停止,水疱性皮膚炎(再投与なし);ＣＯＶＩＤ−１９(再投与なし);肺炎(再投与なし);好中球数減少(再投与なし);末梢性感覚ニューロパチー(再投与なし);低アルブミン血症(再投与なし);低カルシウム血症(再投与なし);リンパ球数減少(再投与なし);白血球数減少(再投与なし);γ−グルタミルトランスフェラーゼ増加(再投与なし),""
AB-23059320,2,4,C,オキサリプラチン,"",静脈内点滴(041),20221012,20230202,170,mg,1,胃癌(胃癌),未知,"",""
AB-23059320,2,5,C,フルオロウラシル,"",その他(不明),20221012,20230202,5650,mg,1,胃癌(胃癌),未知,"",""
AB-23059320,2,6,C,レボホリナートカルシウム,"",静脈内点滴(041),20221012,20230202,400,mg,1,胃癌(胃癌),未知,"",""
AB-23059323,1,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴(041),20230929,"","","","",胃癌(Gastric cancer),剂量不变,腸炎(再投与なし);白血球数減少(再投与なし);好中球数減少(再投与なし);血小板数減少(再投与なし);血中ビリルビン増加(再投与なし);発熱(再投与なし),""
AB-23059323,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴(041),20230203,20230831,360,mg,1,胃癌(Gastric cancer),剂量停止,腸炎(不明);白血球数減少(不明);好中球数減少(不明);血小板数減少(不明);血中ビリルビン増加(不明);発熱(不明),""
AB-23059323,1,3,PS,ラムシルマブ,サイラムザ,その他(不明),20230929,"","","","",胃癌(Gastric cancer),剂量不变,腸炎(再投与なし);白血球数減少(再投与なし);好中球数減少(再投与なし);血小板数減少(再投与なし);血中ビリルビン増加(再投与なし);発熱(再投与なし),""
AB-23059323,1,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口(048),20230203,20230914,"","","",胃癌(Gastric cancer),剂量停止,"",""
AB-23059323,1,5,C,オキサリプラチン,"",静脈内点滴(041);静脈内点滴(041),20230203;20230511,20230323;20230831,380;300,mg;mg,1;1,胃癌(Gastric cancer),剂量停止,"",""
AB-23059401,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220921,20230404,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし),""
AB-23059401,1,2,PS,パクリタキセル（アルブミン懸濁型）,"",不明,20230613,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059401,1,3,PS,ラムシルマブ,"",不明,20230613,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059401,1,4,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20220921;20221018;20230502,20220921;20230404;20230502,190;150;120,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059401,1,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220921,20230502,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059576,2,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,"","","","","",胃癌第４期(スキルス胃癌（リンパ節転移）),剂量不变,"",""
AB-23059576,2,2,PS,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌第４期(スキルス胃癌（リンパ節転移）),剂量不变,"",""
AB-23059576,2,3,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌第４期(スキルス胃癌（リンパ節転移）),剂量不变,"",""
AB-23059576,2,4,C,アプレピタント,"",経口,"","","","","",悪心・嘔吐の予防(抗癌剤の制吐),剂量停止,"",""
AB-23059576,2,5,C,ホスネツピタント塩化物塩酸塩,"",静脈内点滴,"","","","","",悪心・嘔吐の予防(抗癌剤の制吐),剂量不变,"",""
AB-23059654,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-23059654,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059654,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23059654,1,4,C,パクリタキセル,"",不明,"","","","","",胃癌(胃癌),未知,"",""
AB-23060178,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,甲状腺機能低下症(再投与なし);１型糖尿病(再投与なし);心不全(再投与なし),""
AB-23060179,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,202305;,;20231213,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫介在性肝障害(再投与なし),""
AB-23060179,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明;不明,202305;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060179,2,3,C,オキサリプラチン,"",不明,202305,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060416,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,肝障害(再投与なし),""
AB-23060417,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,末梢性ニューロパチー(再投与なし);甲状腺機能亢進症(再投与なし),""
AB-23060459,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし);１型糖尿病(再投与なし),""
AB-23060459,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060459,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060504,1,1,PS,オキサリプラチン,エルプラット：点滴静注液,"","","","","","",胃癌(胃癌),不适用,"",""
AB-23060504,1,2,PS,ニボルマブ,"","","","","","","",胃癌(胃癌),未知,"",""
AB-23060504,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"","","","","","","",胃癌(胃癌),未知,"",""
AB-23060612,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23060737,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202307,202308,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23060737,1,2,C,オキサリプラチン,"",不明,202307,202308,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060737,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202307,202308,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060740,2,1,PS,アプレピタント,イメンド,経口,20230926,20230926,125,mg,1,悪心・嘔吐の予防(抗悪性腫瘍剤投与に伴う悪心、嘔吐),不适用,肺炎(再投与なし),""
AB-23060740,2,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20230906,20231113,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺炎(再投与なし),""
AB-23060740,2,3,C,オキサリプラチン,"",不明;不明,20230906;,20230926;20231204,200;195,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060740,2,4,C,カペシタビン,"",不明;不明;不明,20230906;20230926;20231004,20230919;20231001;20231218,3000;3000;1200,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060740,2,5,C,酪酸菌製剤,"",経口,20230906,"",3,{DF},1,"",未知,"",""
AB-23060740,2,6,C,オランザピン,"",不明,20230906,"",5,mg,1,"",未知,"",""
AB-23060740,2,7,C,パロノセトロン塩酸塩,"",不明,20230926,20230926,.75,mg,1,"",未知,"",""
AB-23060740,2,8,C,デキサメタゾンリン酸エステルナトリウム,"",不明,20230926,20230926,4,mg,1,"",未知,"",""
AB-23060740,2,9,C,ファモチジン,"",不明,20230928,"",40,mg,1,"",未知,"",""
AB-23060740,2,10,C,アスピリン,"",不明,20231003,"",100,mg,1,"",未知,"",""
AB-23060740,2,11,C,クエン酸第一鉄ナトリウム,"",不明,20231225,"",100,mg,1,"",未知,"",""
AB-23060797,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20231018,20231225,200,mg,1,非小細胞肺癌(非小細胞肺癌),不适用,腸管虚血(再投与なし);劇症１型糖尿病(再投与なし),""
AB-23060797,3,2,C,大建中湯,"",経口,20231001,20240105,"","","",予防(大腸癌術後),未知,"",""
AB-23060797,3,3,C,レチノール・カルシフェロール配合剤,"",経口,20231003,20240105,1,g,1,化学療法副作用予防投与(ペメトレキセドナトリウム水和物使用),未知,"",""
AB-23060797,3,4,C,ペメトレキセドナトリウム水和物,"",静脈内点滴,20231018,20231225,"","","",非小細胞肺癌(非小細胞肺癌),未知,"",""
AB-23060797,3,5,C,カルボプラチン,"",静脈内点滴,20231018,20231225,"","","",非小細胞肺癌(非小細胞肺癌),未知,"",""
AB-23060797,3,6,C,ラベプラゾールナトリウム,"",経口,20231018,20240105,"","","",胃腸潰瘍予防(胃潰瘍予防),未知,"",""
AB-23060797,3,7,C,フェキソフェナジン塩酸塩,"",経口,20231025,20240105,"","","","",未知,"",""
AB-23060797,3,8,C,沈降炭酸カルシウム・コレカルシフェロール・炭酸マグネシウム,"",経口,20231113,20240105,"","","",化学療法副作用予防投与(デノスマブ（遺伝子組換え）使用),未知,"",""
AB-23060797,3,9,C,酸化マグネシウム,"",経口,不明,"","","","",便秘予防(便秘対策),未知,"",""
AB-23060797,3,10,C,デノスマブ,"",不明,不明,"","","","","",未知,"",""
AB-23060981,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,強膜炎(再投与なし),""
AB-23060981,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060981,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060982,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,免疫性腸炎(再投与なし),""
AB-23060982,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060982,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060982,1,4,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23060982,1,5,C,パクリタキセル（アルブミン懸濁型）,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061186,2,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20231205,20231226,200,mg,1,胃癌第４期(MSI-High 癌（結腸・直腸以外）);マイクロサテライト不安定性癌(MSI-High 癌（結腸・直腸以外）),剂量停止,気腫性胆嚢炎(再投与なし);腹水(再投与なし);腹膜炎(再投与なし);胆嚢破裂(再投与なし),""
AB-23061346,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23061349,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,血小板減少症(再投与なし),""
AB-23061349,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061349,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061353,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性脳炎(再投与なし),""
AB-23061353,1,2,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061353,1,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061353,1,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061355,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-23061355,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061355,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061355,1,4,C,ラムシルマブ,"",不明,"","","","","",胃癌(進行/再発胃癌),未知,"",""
AB-23061355,1,5,C,パクリタキセル,"",不明,"","","","","",胃癌(進行/再発胃癌),未知,"",""
AB-23061357,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,免疫性腸炎(再投与なし);末梢性ニューロパチー(再投与なし),""
AB-23061357,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,不明;不明;不明,;;,;;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,"",""
AB-23061357,1,3,C,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061359,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221122,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,発熱(再投与なし);血小板数減少(再投与なし);膿瘍(再投与なし);間質性肺疾患(再投与なし);虫垂炎(再投与なし),""
AB-23061359,2,2,C,オキサリプラチン,"",不明,20221122,20230817,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061359,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20221122,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061359,2,4,C,ピレノキシン,"",眼,20230117,"","","","","",未知,"",""
AB-23061359,2,5,C,ラムシルマブ,"",不明,20230831,"","","","",胃癌(胃癌),未知,"",""
AB-23061359,2,6,C,パクリタキセル,"",不明,20230831,"","","","",胃癌(胃癌),未知,"",""
AB-23061359,2,7,C,ドセタキセル,"",不明,20231130,"","","","",胃癌(胃癌),未知,"",""
AB-23061359,2,8,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
AB-23061359,2,9,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
AB-23061848,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,心筋炎(再投与なし),""
AB-23061848,2,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061848,2,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061848,2,4,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061850,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23061862,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし);甲状腺機能亢進症(再投与なし);発疹(再投与なし);甲状腺機能低下症(再投与なし);嘔吐(再投与なし),""
AB-23061864,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202204,202208,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性肺疾患(再投与なし),""
AB-23061864,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,202204,202302,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061864,1,3,C,オキサリプラチン,"",不明,202204,202211,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23061931,2,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,その他(不明),202307,202308,"","","",胃癌(Gastric cancer),剂量停止,間質性肺疾患(再投与なし),""
AB-23061931,2,2,PS,オキサリプラチン,"",その他(不明),202307,202308,"","","",胃癌(Gastric cancer),剂量停止,間質性肺疾患(再投与なし),""
AB-23061931,2,3,PS,ニボルマブ,オプジーボ,静脈内点滴(041),202307,202308,360,mg,1,胃癌(Gastric Cancer),剂量停止,間質性肺疾患(再投与なし),""
AB-23061931,2,4,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,その他(不明),"","","","","",胃癌(Gastric cancer),未知,間質性肺疾患(再投与なし),""
AB-23061931,2,5,PS,ラムシルマブ,サイラムザ,その他(不明),"","","","","",胃癌(Gastric cancer),未知,間質性肺疾患(再投与なし),""
AB-23061932,2,1,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,その他(不明),"","","","","",胃癌(gastric cancer),未知,間質性肺疾患(再投与なし),""
AB-23061932,2,2,PS,オキサリプラチン,"",その他(不明),202307,202308,"","","",胃癌(Gastric cancer),剂量停止,間質性肺疾患(再投与なし),""
AB-23061932,2,3,PS,ニボルマブ,オプジーボ,静脈内点滴(041),202307,202308,360,mg,1,胃癌(Gastric Cancer),剂量停止,間質性肺疾患(再投与なし),""
AB-23061932,2,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",その他(不明),202307,202308,"","","",胃癌(Gastric cancer),剂量停止,間質性肺疾患(再投与なし),""
AB-23061932,2,5,PS,ラムシルマブ,サイラムザ,その他(不明),"","","","","",胃癌(gastric cancer),未知,間質性肺疾患(再投与なし),""
AB-23062087,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230906,20230928,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腸炎(再投与なし),""
AB-23062087,2,2,C,オキサリプラチン,"",不明,20230906,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062087,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230906,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062452,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230821,20231023,360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-23062452,3,2,PS,ラムシルマブ,"",不明,202311,"","","","","",剂量停止,"",""
AB-23062452,3,3,PS,パクリタキセル,"",不明,202311,"","","","","",剂量停止,"",""
AB-23062458,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221126,20230110,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-23062458,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口;経口,20221126;;,;;20230110,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23062458,1,3,C,オキサリプラチン,"",静脈内点滴,20221126,20230110,200,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062467,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性肝炎(再投与なし),""
AB-23062467,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062467,1,3,C,カペシタビン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062480,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20231120,20240121,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-23062480,5,2,PS,アナモレリン塩酸塩,エドルミズ,経口,20231113,20240121,"","","",悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,肺臓炎(再投与なし),""
AB-23062480,5,3,PS,オキサリプラチン,"",不明,20231120,20240121,130,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23062480,5,4,PS,フルオロウラシル,５−ＦＵ,不明;不明,20231120;20231120,20240121;20240121,600;3850,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23062480,5,5,C,酸化マグネシウム,"",不明,20231113,20240121,"","","",便秘(便秘症),未知,"",""
AB-23062480,5,6,C,レボホリナートカルシウム,"",不明,20231120,20240121,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062485,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20221018;20221108,20221018;20230428,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,死亡(再投与なし),""
AB-23062485,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20221018,20221024,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23062485,1,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20221018;20221108,20221018;20230428,200;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062485,1,4,C,レボホリナートカルシウム,"",不明,20221108,20230428,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062485,1,5,C,フルオロウラシル,"",不明,20221108,20230428,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062781,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20221215;20230905,20230808;20231031,360;240,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-23062781,2,2,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20221215;20230112;20230303;20230516;20230606;20230711,20221215;20230207;20230418;20230516;20230606;20230711,140;150;143.9;123.68;120.88;87.78,mg;mg;mg;mg;mg;mg,1;1;1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062781,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20221216,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062781,2,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230207,20231031,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062784,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-23062784,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062784,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062923,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,202312,"",200,mg,1,胃癌(MSI-High 癌（結腸・直腸以外）),剂量不变,消化管穿孔(再投与なし),""
AB-23062994,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230405,20230719,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,アナフィラキシー反応(再投与なし),""
AB-23062994,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230315,20231025,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23062994,1,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20230405;20231004,20230719;20231025,170;160,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23063382,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220719,20221212,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,塞栓症(再投与なし),""
AB-23063382,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220719,20221212,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23063382,1,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20220719;20220926;20221116,20220829;20221017;20221212,159.9;121.9;91,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23063388,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",202309,240,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,自己免疫性脳炎(再投与なし),""
AB-23063408,1,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,202209,202312,200,mg,1,胃癌(胃癌(MSI-high)),剂量停止,免疫介在性肝障害(再投与なし),""
AB-23063536,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230919,20240109,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23063536,3,2,C,オキサリプラチン,"",不明,20230919,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23063536,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230919,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23063536,3,4,C,エンパグリフロジン,"",不明,"","","","","","",未知,"",""
AB-23063536,3,5,C,ゾルピデム酒石酸塩,"",不明,"","","","","","",未知,"",""
AB-23063634,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,心筋炎(再投与なし),""
AB-23063634,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23063634,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23063713,1,1,PS,ペムブロリズマブ,キイトルーダ,不明,不明,"","","","",胃癌(胃がん),未知,失明(再投与なし);ぶどう膜炎(再投与なし),""
AB-23063931,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202311,202312,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腸炎(再投与なし),""
AB-23063931,1,2,C,オキサリプラチン,"",不明,202311,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23063931,1,3,C,フルオロウラシル,"",不明,202311,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23063931,1,4,C,レボホリナートカルシウム,"",不明,202311,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23063935,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20220926;20230816,20230501;,240;240,mg;mg,1;1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23063935,2,2,PS,乾燥硫酸鉄（３）,フェロ・グラデュメット,不明,202011,"","","","",貧血(貧血),未知,"",""
AB-23063935,2,3,C,タムスロシン塩酸塩,"",不明,"","","","","","",未知,"",""
AB-23063935,2,4,C,イルベサルタン・アムロジピンベシル酸塩配合剤,"",不明,"","","","","","",未知,"",""
AB-23063935,2,5,C,オルメサルタンメドキソミル,"",不明;不明;不明,;20230903;20231125,;20231124;,10;5;10,mg;mg;mg,1;1;1,"",未知,"",""
AB-23063935,2,6,C,メコバラミン,"",不明,"","","","","","",未知,"",""
AB-23063935,2,7,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
AB-23063935,2,8,C,フロセミド,"",不明,"","","","","","",未知,"",""
AB-23063935,2,9,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
AB-23064007,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220721,20230817,360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,高血糖(再投与なし),""
AB-23064007,1,2,C,レボチロキシンナトリウム水和物,"",経口,"","",12.5,ug,1,"",未知,"",""
AB-23064007,1,3,C,ボノプラザンフマル酸塩,"",経口,"","",20,mg,1,"",未知,"",""
AB-23064007,1,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","","",未知,"",""
AB-23064007,1,5,C,酢酸亜鉛水和物,"",経口,"","",25,mg,1,"",未知,"",""
AB-23064007,1,6,C,ロキソプロフェンナトリウム水和物,"",経口,"","",60,mg,1,"",未知,"",""
AB-23064007,1,7,C,酸化マグネシウム,"",経口,"","",330,mg,1,"",未知,"",""
AB-23064007,1,8,C,ヘパリン類似物質,"",局所,"","","","","","",未知,"",""
AB-23064007,1,9,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",局所,"","","","","","",未知,"",""
AB-23064190,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,血球減少症(再投与なし),""
AB-23064190,1,2,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23064190,1,3,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23064190,1,4,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23064355,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230921,20240112,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,糖尿病性ケトアシドーシス(再投与なし);劇症１型糖尿病(再投与なし),""
AB-23064355,3,2,PS,デキサメタゾンリン酸エステルナトリウム,デキサート,静脈内（明記されていない場合）,20230921,20240112,19.8,mg,1,悪心・嘔吐の予防(支持療法（制吐）),不适用,"",""
AB-23064355,3,3,PS,デキサメタゾン,デカドロン,経口,20230922,20240115,8,mg,1,悪心・嘔吐の予防(支持療法（制吐）),不适用,"",""
AB-23064355,3,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230921,20240112,100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23064355,3,5,C,オキサリプラチン,"",静脈内点滴,20230921,20240112,230,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23064355,3,6,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,20230921,"",.75,mg,1,悪心・嘔吐の予防(支持療法（制吐）),未知,"",""
AB-23064356,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20231026,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,間質性肺疾患(再投与なし),""
AB-23064356,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"",20231026,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23064356,2,3,C,オキサリプラチン,"",不明,"",20231026,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23064590,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,悪液質(再投与なし),""
AB-23064590,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23064590,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23064592,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230118,20230118,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,食欲減退(再投与なし);低カリウム血症(再投与なし),""
AB-23064592,3,2,PS,オキサリプラチン,エルプラット,静脈内点滴,20230118,20230118,200,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23064592,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230118,20230201,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23064592,3,4,C,ブドウ糖,"",不明,20230118,20230130,"","","","",未知,"",""
AB-23064592,3,5,C,生理食塩液,"",不明,20230118,20230130,"","","","",未知,"",""
AB-23064592,3,6,C,デキサメタゾンリン酸エステルナトリウム,"",不明,20230118,20230130,"","","","",未知,"",""
AB-23064592,3,7,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,20230118,20230130,"","","","",未知,"",""
AB-23064602,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,関節リウマチ(再投与なし),""
AB-23064602,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23064602,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065060,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23065060,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065060,1,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065062,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202305,202311,360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),不适用,１型糖尿病(再投与なし),""
AB-23065066,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221122,20230509,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,末梢性感覚ニューロパチー(再投与なし),""
AB-23065066,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20221122,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065066,2,3,C,オキサリプラチン,"",静脈内点滴,20221122,20230509,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065066,2,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230418,20230529,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065066,2,5,C,ブドウ糖,"",不明,"","","","","","",未知,"",""
AB-23065066,2,6,C,生理食塩液,"",不明,"","","","","","",未知,"",""
AB-23065066,2,7,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
AB-23065066,2,8,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-23065066,2,9,C,ｄ−クロルフェニラミンマレイン酸塩,"",不明,"","","","","","",未知,"",""
AB-23065066,2,10,C,ファモチジン,"",不明,"","","","","","",未知,"",""
AB-23065067,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-23065139,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20230125,20231122,200,mg,1,胃癌(MSI-High癌（胃癌）);マイクロサテライト不安定性癌(MSI-High癌（胃癌）),不适用,死亡(再投与なし);変形性関節症(再投与なし);歩行障害(再投与なし);譫妄(再投与なし);幻覚(再投与なし);筋力低下(再投与なし);食欲減退(再投与なし),""
AB-23065139,3,2,C,酸化マグネシウム,"",経口,20201014,20240123,"","","","",未知,"",""
AB-23065139,3,3,C,エソメプラゾールマグネシウム水和物,"",経口,20201014,20240123,"","","","",未知,"",""
AB-23065139,3,4,C,アセトアミノフェン,"",経口,20201014,20240123,"","","","",未知,"",""
AB-23065139,3,5,C,デスロラタジン,"",経口,20230308,20240123,"","","","",未知,"",""
AB-23065139,3,6,C,クエン酸第一鉄ナトリウム,"",経口,20230308,20240123,"","","","",未知,"",""
AB-23065139,3,7,C,ニフェジピン,"",経口,不明,20240123,"","","","",未知,"",""
AB-23065139,3,8,C,ビソプロロールフマル酸塩,"",経口,不明,20240123,"","","","",未知,"",""
AB-23065139,3,9,C,ロスバスタチンカルシウム,"",経口,不明,20240123,"","","","",未知,"",""
AB-23065139,3,10,C,ジルチアゼム塩酸塩,"",経口,不明,20240123,"","","","",未知,"",""
AB-23065139,3,11,C,ペマフィブラート,"",経口,不明,20240123,"","","","",未知,"",""
AB-23065175,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220705,20230404,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,白血球数減少(再投与なし);血小板数減少(再投与なし);アラニンアミノトランスフェラーゼ増加(再投与なし);アスパラギン酸アミノトランスフェラーゼ増加(再投与なし),""
AB-23065175,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口;経口;経口,20220705;20230110;,202211;20230404;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065175,2,3,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20220705;20220816;20220913;20230307;,20220726;20220816;20230207;20230404;,170;140;110;100;,mg;mg;mg;mg;,1;1;1;1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065175,2,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20221213,20221213,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23065175,2,5,C,ブドウ糖,"",不明;不明,;,;,;,;,;,"",未知,"",""
AB-23065175,2,6,C,生理食塩液,"",不明;不明,;,;,;,;,;,"",未知,"",""
AB-23065175,2,7,C,デキサメタゾンリン酸エステルナトリウム,"",不明;不明,;,;,;,;,;,"",未知,"",""
AB-23065175,2,8,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-23065184,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230712,20230712,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,胃穿孔(再投与なし),""
AB-23065184,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20230712,20230713,40,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23065184,2,3,C,オキサリプラチン,"",静脈内点滴,20230712,20230712,100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065184,2,4,C,ブドウ糖,"",不明,20230712,"","","","","",未知,"",""
AB-23065184,2,5,C,生理食塩液,"",不明,20230712,"","","","","",未知,"",""
AB-23065184,2,6,C,デキサメタゾンリン酸エステルナトリウム,"",不明,20230712,"","","","","",未知,"",""
AB-23065184,2,7,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,20230712,"","","","","",未知,"",""
AB-23065185,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,大腸炎(再投与なし),""
AB-23065185,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065185,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065501,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220727,20221019,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-23065501,1,2,C,カペシタビン,"",経口,20220727,20221027,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065501,1,3,C,オキサリプラチン,"",不明,20220727,20221019,210,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065504,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230118,20230207,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,慢性腎臓病(再投与なし);血小板数減少(再投与なし),""
AB-23065504,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20230118,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23065504,2,3,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20230118;20230207,20230118;20230207,200;160,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23065504,2,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワン,経口,20230207,20230307,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23065504,2,5,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-23065504,2,6,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-23065504,2,7,C,ブドウ糖,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-23065506,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220818,20230414,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,白血球数減少(再投与なし);尿路閉塞(再投与なし);白血球数減少(再投与なし),""
AB-23065506,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220818,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065506,1,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220818;20221110,20220818;20230414,150.8;120.64,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065506,1,4,C,パクリタキセル,"",不明,20230616,20230628,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065506,1,5,C,ラムシルマブ,"",静脈内点滴,20230616,20230628,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065506,1,6,C,ブドウ糖,"",不明,"","","","","","",未知,"",""
AB-23065506,1,7,C,生理食塩液,"",不明,"","","","","","",未知,"",""
AB-23065506,1,8,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
AB-23065506,1,9,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-23065506,1,10,C,クロルフェニラミンマレイン酸塩,"",不明,"","","","","","",未知,"",""
AB-23065506,1,11,C,ファモチジン,"",不明,"","","","","","",未知,"",""
AB-23065507,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23065507,1,2,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
AB-23065507,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","","",未知,"",""
AB-23065508,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20231013,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,血中ブドウ糖増加(再投与なし),""
AB-23065508,2,2,PS,アナモレリン塩酸塩,エドルミズ,経口;経口,20231013;202402,202311;,100;,mg;,1;,悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),剂量停止,血中ブドウ糖増加(不明),""
AB-23065508,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20231013,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065508,2,4,C,オキサリプラチン,"",不明,20231013,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065509,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23065509,1,2,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
AB-23065509,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","","",未知,"",""
AB-23065511,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220207,20220802,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,細菌性肺炎(再投与なし);低カリウム血症(再投与なし),""
AB-23065511,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口,20220207,20220802,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23065511,2,3,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴,20220207;20220712,20220621;20220802,190;160,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23065511,2,4,C,ブドウ糖,"",不明,20220207,20230815,"","","","",未知,"",""
AB-23065511,2,5,C,生理食塩液,"",不明,20220207,20230815,"","","","",未知,"",""
AB-23065511,2,6,C,デキサメタゾンリン酸エステルナトリウム,"",不明,20220207,20230815,"","","","",未知,"",""
AB-23065511,2,7,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,20220207,20220802,"","","","",未知,"",""
AB-23065511,2,8,C,クロルフェニラミンマレイン酸塩,"",不明,20220920,20221206,"","","","",未知,"",""
AB-23065511,2,9,C,ラムシルマブ,"",静脈内点滴,20220920,20221206,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065511,2,10,C,パクリタキセル,"",不明,20220920,20221206,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065511,2,11,C,ファモチジン,"",不明,20220920,20221206,"","","","",未知,"",""
AB-23065511,2,12,C,イリノテカン塩酸塩水和物,"",静脈内点滴,20230131,20230815,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065511,2,13,C,グラニセトロン塩酸塩,"",静脈内（明記されていない場合）,20230131,20230815,"","","","",未知,"",""
AB-23065536,1,1,PS,アナモレリン塩酸塩,エドルミズ,経口,"","","","","",悪液質(下記の悪性腫瘍におけるがん悪液質 非小細胞肺癌、胃癌、膵癌、大腸癌),未知,腸閉塞(再投与なし),""
AB-23065536,1,2,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,腸閉塞(再投与なし),""
AB-23065536,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065536,1,4,C,レボホリナートカルシウム,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065536,1,5,C,フルオロウラシル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065647,2,1,PS,イリノテカン塩酸塩水和物,"",不明,"","","","","",胃癌,剂量停止,"",""
AB-23065647,2,2,PS,ニボルマブ,"",不明,201711,"",3,mg/kg,1,胃癌,剂量停止,"",""
AB-23065647,2,3,C,プレドニゾロン,"",不明;不明;不明,;;,;;,10;12.5;15,mg;mg;mg,1;1;1,血清反応陰性関節炎,未知,"",""
AB-23065647,2,4,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンケーケー,不明,201702,"",120,mg,1,胃癌,剂量停止,"",""
AB-23065647,2,5,PS,パクリタキセル,"",不明,"","","","","",胃癌,剂量停止,"",""
AB-23065647,2,6,C,オキサリプラチン,"",不明,201702,"",100,mg/m2,1,胃癌,剂量停止,"",""
AB-23065727,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-23065727,1,2,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
AB-23065727,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","","",未知,"",""
AB-23065738,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220912,20221205,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺炎(再投与なし);誤嚥性肺炎(再投与なし),""
AB-23065738,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220829,20221205,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065738,1,3,C,オキサリプラチン,"",不明,20220912,20221205,216.06,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065866,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肝萎縮(再投与なし),""
AB-23065866,1,2,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065866,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065868,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220427,20230622,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,発熱性好中球減少症(再投与なし),""
AB-23065868,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220427,20230622,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065868,1,3,C,オキサリプラチン,"",不明,20220427,20230622,197,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065870,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23065871,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220713,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,食欲減退(再投与なし),""
AB-23065871,2,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220713,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065871,2,3,C,オキサリプラチン,"",不明,20220713,"",200,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065873,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,肝硬変(再投与なし),""
AB-23065873,1,2,PS,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23065873,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065874,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220726,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-23065874,1,2,C,オキサリプラチン,"",不明;不明,20220726;20220929,20220908;20221208,160;140,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065874,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220726,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065874,1,4,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
AB-23065874,1,5,C,ブドウ糖,"",不明,"","","","","","",未知,"",""
AB-23065874,1,6,C,グラニセトロン塩酸塩,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
AB-23065874,1,7,C,生理食塩液,"",不明,"","","","","","",未知,"",""
AB-23065876,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230620,20230620,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,アスパラギン酸アミノトランスフェラーゼ増加(再投与なし);肺臓炎(再投与なし),""
AB-23065876,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230620,20230724,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065876,1,3,C,オキサリプラチン,"",不明,20230620,20230620,160,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065877,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221125,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,痔瘻(再投与なし);甲状腺機能低下症(再投与なし),""
AB-23065877,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20221125,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23065877,1,3,C,オキサリプラチン,"",不明,20221125,"",210,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23066029,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20231221,20240111,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腸炎(再投与なし),""
AB-23066029,3,2,PS,カペシタビン,ゼローダ,経口,20231221,20240125,3000,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23066029,3,3,C,エソメプラゾールマグネシウム水和物,"",経口,20230606,"",20,mg,1,胃腸潰瘍予防(胃潰瘍予防),未知,"",""
AB-23066029,3,4,C,パンクレリパーゼ,"",経口,20230721,20240205,300,mg,1,膵酵素補充療法(膵消化酵素の補充),未知,"",""
AB-23066029,3,5,C,酪酸菌製剤,"",経口,20230907,"",1,{DF},1,細菌叢異常(整腸),未知,"",""
AB-23066029,3,6,C,オキサリプラチン,"",静脈内点滴,20231221,20240111,190,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23066032,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201905,"","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-23066034,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20240129,20240129,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,免疫性腸炎(再投与なし);ショック(再投与なし);低酸素性虚血性脳症(再投与なし);サイトカイン放出症候群(再投与なし);脳死(再投与なし);意識消失(再投与なし);サイトカインストーム(再投与なし);心肺停止(再投与なし),""
AB-23066034,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20240129,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23066034,3,3,C,オキサリプラチン,"",不明,20240129,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23066035,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-23066035,1,2,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
AB-23066035,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","","",未知,"",""
AB-23066231,3,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,202312,"",1200,mg,1,肝細胞癌(肝細胞癌),剂量停止,黄疸(再投与なし);肝機能異常(再投与なし);免疫性肝炎(再投与なし),""
AB-23066231,3,2,PS,ベバシズマブ,アバスチン,静脈内点滴,202312,"",15,mg/kg,1,肝細胞癌(肝細胞癌),剂量停止,黄疸(再投与なし);肝機能異常(再投与なし);免疫性肝炎(再投与なし),""
AB-23066233,1,1,PS,アピキサバン,エリキュース,"","","","","","",適応症不明の製品使用(Drug use for unknown indication),未知,血腫(不明);譫妄(不明);食欲減退(不明);下痢(不明);浮動性めまい(不明);倦怠感(不明);口内炎(不明);好中球数減少(不明);流涙増加(不明),""
AB-23066233,1,2,PS,ニボルマブ,オプジーボ,"",20220420,"",360,mg,1,胃癌(Gastric cancer),不适用,血腫(再投与なし);譫妄(再投与なし);食欲減退(再投与なし);下痢(再投与なし);浮動性めまい(再投与なし);倦怠感(再投与なし);口内炎(再投与なし);好中球数減少(再投与なし);流涙増加(再投与なし),""
AB-23066233,1,3,C,OTERACILPOTASSIUM,"","",20220420,"","","","",胃癌(Gastric cancer),未知,"",""
AB-23066233,1,4,C,オキサリプラチン,"","",20220420,"",180,mg,1,胃癌(Gastric cancer),未知,"",""
AB-23066314,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし),""
AB-23066359,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,器質化肺炎(再投与なし),""
AB-23066359,1,2,PS,オキサリプラチン,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌);胃癌(胃癌術後補助化学療法),未知,"",""
AB-23066359,1,3,PS,レボホリナートカルシウム,レボホリナート,不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌);胃癌(胃癌術後補助化学療法),未知,"",""
AB-23066359,1,4,PS,フルオロウラシル,"",不明;不明,;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌);胃癌(胃癌術後補助化学療法),未知,"",""
AB-23066363,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20230322;,20230322;20230529,360;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,発熱性好中球減少症(再投与なし);好中球数減少(再投与なし),""
AB-23066363,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230322,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23066363,1,3,C,オキサリプラチン,"",不明,20230322,20230322,176.28,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23066365,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし),""
AB-23066365,1,2,C,インスリン,"",不明,"","","","","",膵性糖尿病(膵性糖尿病),未知,"",""
AB-23066732,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23066732,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","",40,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23066732,1,3,C,オキサリプラチン,"",静脈内点滴,"","",100,mg/m2,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23066734,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,間質性肺疾患(再投与なし),""
AB-23066734,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23066734,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23066917,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,202311,202312,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,ギラン・バレー症候群(再投与なし),""
AB-23066917,1,2,C,オキサリプラチン,"",不明,202311,202312,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067175,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220823,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能亢進症(再投与なし);肺臓炎(再投与なし),""
AB-23067175,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220823,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067175,1,3,C,オキサリプラチン,"",不明;不明;不明;不明,20220823;20221014;20221125;20230818,20220823;20221104;20230721;20230818,230;180;150;120,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067177,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230606,20230704,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,腎障害(再投与なし);尿細管間質性腎炎(再投与なし),""
AB-23067177,2,2,PS,オキサリプラチン,"",静脈内点滴,20230523,20230704,100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23067177,2,3,PS,レボホリナートカルシウム,レボホリナート,不明,20230523,20230704,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23067177,2,4,PS,フルオロウラシル,"",静脈内点滴,20230523,20230704,3500,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23067177,2,5,C,アムロジピンベシル酸塩,"",経口;経口,;,;,2.5;5,mg;mg,1;1,高血圧(高血圧),未知,"",""
AB-23067177,2,6,C,酪酸菌製剤,"",経口,"","",1,{DF},1,"",未知,"",""
AB-23067177,2,7,C,ラベプラゾールナトリウム,"",経口,"","",20,mg,1,"",未知,"",""
AB-23067177,2,8,C,アルファカルシドール,"",経口,"","",.5,ug,1,"",未知,"",""
AB-23067177,2,9,C,レボチロキシンナトリウム水和物,"",経口,"","",100,ug,1,"",未知,"",""
AB-23067177,2,10,C,ドンペリドン,"",経口,"","",1,{DF},1,悪心(吐き気),未知,"",""
AB-23067177,2,11,C,フロセミド,"",経口,"","",10,mg,1,"",未知,"",""
AB-23067177,2,12,C,スピロノラクトン,"",経口,"","",25,mg,1,"",未知,"",""
AB-23067484,1,1,PS,アテゾリズマブ,テセントリク,静脈内点滴,"","",1200,mg,1,肝細胞癌(肝細胞癌),剂量停止,発疹(再投与なし),""
AB-23067484,1,2,PS,ベバシズマブ,アバスチン,静脈内点滴,"","","","","",肝細胞癌(肝細胞癌),剂量停止,発疹(再投与なし),""
AB-23067556,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230216,20230420,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,副腎機能不全(再投与なし),""
AB-23067556,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230216,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067556,1,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴,20230216;20230420,20230330;,210;170,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067559,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(がん化学療法後に増悪した治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
AB-23067596,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230113,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,副腎機能不全(再投与なし),""
AB-23067596,2,2,C,フルオロウラシル,"",不明,20230113,"",4660,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067596,2,3,C,オキサリプラチン,"",静脈内点滴,20230113,20230213,140,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067596,2,4,C,レボホリナートカルシウム,"",静脈内点滴,20230113,"",300,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067600,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230411,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,低カリウム血症(再投与なし);低カリウム血症(再投与なし),""
AB-23067600,1,2,C,フルオロウラシル,"",不明;不明,20230411;20230518,20230426;,4900;3900,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067600,1,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20230411;20230518;20230907,20230426;20230816;20230921,140;120;100,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067600,1,4,C,レボホリナートカルシウム,"",静脈内点滴,20230411,"",300,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067877,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20221208;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,好中球数減少(不明),""
AB-23067877,1,2,C,オキサリプラチン,"",不明;不明,20221208;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067877,1,3,C,レボホリナートカルシウム,"",不明;不明,20221208;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067877,1,4,C,フルオロウラシル,"",不明;不明,20221208;,;,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067878,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,;20220510;,;20220510;,;360;,;mg;,;1;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺臓炎(再投与なし),""
AB-23067878,1,2,C,オキサリプラチン,"",不明;不明;不明,;20220510;,;20220517;,;200;,;mg;,;1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067878,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"",20231107,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067878,1,4,C,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067878,1,5,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067879,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20221221;20230205;20230301,20230107;20230205;20230509,360;720;360,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,白血球数減少(再投与なし);発熱性好中球減少症(再投与なし),""
AB-23067879,2,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴;静脈内点滴,20221221;20230205;20230301,20221221;20230205;20230531,162;324;110,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23067879,2,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口,20221221,20230531,"","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23067884,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221116,20230922,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,脳卒中(再投与なし),""
AB-23067884,1,2,C,カペシタビン,"",経口,20221116,20231004,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067884,1,3,C,オキサリプラチン,"",静脈内点滴;静脈内点滴;静脈内点滴,20221116;20230120;20230210,20221220;20230120;20230407,190;150;130,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067889,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220121,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量不变,肺炎(再投与なし);甲状腺機能低下症(再投与なし),""
AB-23067889,1,2,PS,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220121;20220418,20220328;,130;110,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067889,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口;経口,20220121;20220328;20220418,;;,;;,;;,;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067889,1,4,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口;経口;経口;経口,20220712;20221007;20221104;20221216;20230106,;;;;,;;;;,;;;;,;;;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067941,2,1,PS,オキサリプラチン,"","","","","","","",胃癌(HER2?negative advanced gastric cancer),剂量停止,"",""
AB-23067941,2,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"","","","","","","",胃癌(HER2?negative advanced gastric cancer),剂量停止,"",""
AB-23067941,2,3,PS,ニボルマブ,"","","","","","","",胃癌(HER2?negative advanced gastric cancer),剂量停止,"",""
AB-23067957,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230403,20230403,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,脳卒中(再投与なし),""
AB-23067957,1,2,C,オキサリプラチン,"",不明,20230403,20230403,230,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067957,1,3,C,カペシタビン,"",経口,20230404,20230719,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067962,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20231227,20240207,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,血小板数減少(再投与なし),""
AB-23067962,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20231206,20240207,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23067962,1,3,PS,オキサリプラチン,"",静脈内点滴,20231206,20240207,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23067962,1,4,C,エソメプラゾールマグネシウム水和物,"",経口,"","",20,mg,1,"",未知,"",""
AB-23067962,1,5,C,ロキソプロフェンナトリウム水和物,"",経口,"","",180,mg,1,"",未知,"",""
AB-23067962,1,6,C,スピロノラクトン,"",不明,"",20240207,"","","","",未知,"",""
AB-23067962,1,7,C,テルミサルタン,"",不明,"",20240207,"","","","",未知,"",""
AB-23067964,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20230130;20230511,20230426;20230511,240;360,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,好中球数減少(再投与なし);甲状腺機能低下症(再投与なし),""
AB-23067964,2,2,PS,レボホリナートカルシウム,レボホリナート,不明;不明,20230130;20230426,20230408;20230426,275;300,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23067964,2,3,PS,オキサリプラチン,エルプラット,不明;不明;不明,20230130;20230426;20230511,20230408;20230426;20230511,115;125;190,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23067964,2,4,PS,フルオロウラシル,５−ＦＵ,不明;不明,20230130;20230426,20230408;20230426,3740;4080,mg;mg,1;1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23067964,2,5,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20230517,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23067964,2,6,C,パクリタキセル,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067964,2,7,C,ラムシルマブ,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23067966,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220518,20220518,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,心筋梗塞(再投与なし),""
AB-23067966,3,2,PS,オキサリプラチン,エルプラット,静脈内点滴,20220518,20220518,169,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23067966,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口,20220518,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),不适用,"",""
AB-23068227,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220831,20220831,240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,肺臓炎(再投与なし);好中球数減少(再投与なし),""
AB-23068227,1,2,C,オキサリプラチン,"",不明,20220831,20220831,100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068227,1,3,C,レボホリナートカルシウム,"",不明,20220831,20220831,250,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068227,1,4,C,フルオロウラシル,"",不明,20220831,20220831,3380,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068229,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20221212;,20221212;20230706,200;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,急性腎障害(再投与なし);低カリウム血症(再投与なし),""
AB-23068229,1,2,C,オキサリプラチン,"",不明;不明,20221212;,20221212;20230706,110;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068229,1,3,C,レボホリナートカルシウム,"",不明;不明,20221212;,20221212;20230706,250;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068229,1,4,C,フルオロウラシル,"",不明;不明,20221212;,20221212;20230706,3500;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068229,1,5,C,パクリタキセル,"",不明,20230810,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068229,1,6,C,ラムシルマブ,"",不明,20230810,"","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068230,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220812,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,腸炎(再投与なし);発熱性好中球減少症(再投与なし),""
AB-23068230,1,2,C,オキサリプラチン,"",不明,20220812,"",220,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068230,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220815,20230529,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068230,1,4,C,イリノテカン塩酸塩水和物,"",不明,20230612,20230814,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068230,1,5,C,ラムシルマブ,"",不明,20230612,20230814,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068233,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230425,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),不适用,腸炎(再投与なし),""
AB-23068233,1,2,C,オキサリプラチン,"",不明;不明;不明,20230425;;,;;,150;;,mg;;,1;;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068233,1,3,C,レボホリナートカルシウム,"",不明;不明,20230425;,;,350;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068233,1,4,C,フルオロウラシル,"",不明,20230425,"",4790,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068233,1,5,C,トラスツズマブ,"",不明;不明,;,;,;,;,;,胃癌(胃癌),未知,"",""
AB-23068233,1,6,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"","","","","",胃癌(胃癌),未知,"",""
AB-23068235,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221003,20230206,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-23068235,3,2,PS,オキサリプラチン,エルプラット,静脈内点滴;静脈内点滴;静脈内点滴,20221003;20221017;20221128,20221003;20221017;20230206,180;300;150,mg;mg;mg,1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23068235,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口,20221017,20230220,"","","",胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,"",""
AB-23068238,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20231108,20231129,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,免疫介在性肝障害(再投与なし),""
AB-23068238,1,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20231018,"",50,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068238,1,3,PS,オキサリプラチン,"",静脈内点滴,20231018,"",150,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068238,1,4,C,ロキソプロフェンナトリウム水和物,"",経口,20230912,20231220,"","","","",未知,"",""
AB-23068238,1,5,C,レバミピド,"",経口,20230912,20231220,"","","","",未知,"",""
AB-23068238,1,6,C,ボノプラザンフマル酸塩,"",経口,20230912,20240110,"","","","",未知,"",""
AB-23068238,1,7,C,オキシコドン塩酸塩水和物,"",経口,20231018,20231220,"","","","",未知,"",""
AB-23068238,1,8,C,ナルデメジントシル酸塩,"",経口,20231025,20240110,"","","","",未知,"",""
AB-23068238,1,9,C,酢酸亜鉛水和物,"",経口,20231108,20231220,"","","","",未知,"",""
AB-23068238,1,10,C,酸化マグネシウム,"",経口,20231118,20231220,"","","","",未知,"",""
AB-23068238,1,11,C,アセトアミノフェン,"",経口,20231118,20231220,"","","","",未知,"",""
AB-23068238,1,12,C,プロクロルペラジンマレイン酸塩,"",経口,20231129,20231129,"","","","",未知,"",""
AB-23068238,1,13,C,ウルソデオキシコール酸,"",経口,20231129,20231220,"","","",肝酵素上昇(肝酵素軽度上昇),未知,"",""
AB-23068238,1,14,C,グリチルリチン酸一アンモニウム・グリシン・ＤＬ−メチオニン配合剤,"",経口,20231129,20231220,"","","",肝酵素上昇(肝酵素軽度上昇),未知,"",""
AB-23068271,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20221121;,20221121;20230130,240;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),不适用,水疱性皮膚炎(再投与なし);低カリウム血症(再投与なし),""
AB-23068271,1,2,PS,UNKNOWNDRUG,"",不明,"","","","","","",未知,"",""
AB-23068271,1,3,C,オキサリプラチン,"",不明;不明,20221121;,20221121;20230201,90;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068271,1,4,C,レボホリナートカルシウム,"",不明;不明,20221121;,20221121;20230201,275;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068271,1,5,C,フルオロウラシル,"",不明;不明,20221121;,20221121;20230201,3100;,mg;,1;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068272,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220914,"",360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし),""
AB-23068272,1,2,C,オキサリプラチン,"",静脈内点滴,20220914,"",160,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068272,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220914,20230315,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068441,1,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,"","","","","",胃癌(胃癌),未知,"",""
AB-23068441,1,2,PS,ニボルマブ,"",静脈内点滴,"","","","","",胃癌(胃癌),未知,"",""
AB-23068441,1,3,C,オキサリプラチン,"",静脈内点滴,"","","","","",胃癌(胃癌),未知,"",""
AB-23068461,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230601,"",240,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,副腎機能不全(再投与なし),""
AB-23068461,1,2,C,オキサリプラチン,"",不明,20230601,20230713,100,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068461,1,3,C,レボホリナートカルシウム,"",不明,20230601,"",325,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068461,1,4,C,フルオロウラシル,"",不明;不明;不明;不明,20230601;20231130;20231220;20231228,20231123;20231214;20231220;,3470;470;3200;3670,mg;mg;mg;mg,1;1;1;1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068779,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,劇症１型糖尿病(再投与なし);高血糖(再投与なし);糖尿病性ケトアシドーシス(再投与なし),""
AB-23068779,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068779,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068784,2,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220430,20220506,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,肺臓炎(再投与なし),""
AB-23068784,2,2,C,オキサリプラチン,"",静脈内点滴,20220422,20220430,234,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068784,2,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220506,20220621,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068788,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,甲状腺機能低下症(再投与なし);１型糖尿病(再投与なし),""
AB-23068788,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068788,1,3,C,オキサリプラチン,"",不明,"","","","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068789,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"",20230801,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),剂量停止,副腎機能不全(再投与なし),""
AB-23068789,1,2,C,オキサリプラチン,"",静脈内（明記されていない場合）,20221206,20230214,155,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068789,1,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,"",20230801,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068815,1,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220830,20230110,360,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,大腸炎(再投与なし),""
AB-23068815,1,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口;経口,20201006;20220830,20210810;20230110,;,;,;,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068815,1,3,C,オキサリプラチン,"",静脈内点滴,20220830,20230110,138,mg,1,胃癌(治癒切除不能な進行・再発の胃癌),未知,"",""
AB-23068820,3,1,PS,オキサリプラチン,"","",202101,"","","","","胃癌第４期(upper gastric cancer, cT4aN1M1, and cStage IV)",未知,"",""
AB-23068820,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,"","",202101,"","","","","胃癌第４期(upper gastric cancer, cT4aN1M1, and cStage IV)",剂量停止,"",""
AB-23068820,3,3,PS,ニボルマブ,"","",202101,"","","","","胃癌第４期(upper gastric cancer, cT4aN1M1, and cStage IV)",未知,"",""
CA-18500430,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20171031,20180315,156,mg,1,胃癌(胃がん),未知,心房血栓症(再投与なし);心室血栓症(再投与なし),""
CA-18500430,3,2,C,デノスマブ,"",不明,"","","","","","",未知,"",""
CA-18500430,3,3,C,沈降炭酸カルシウム・コレカルシフェロール・炭酸マグネシウム,"",不明,"","",2,{DF},1,"",未知,"",""
CA-18500430,3,4,C,イソソルビド,"",不明,"","",70,mL,1,"",未知,"",""
CA-18500430,3,5,C,ベタメタゾン,"",不明,"","",1,mg,1,"",未知,"",""
CA-18500430,3,6,C,レベチラセタム,"",不明,"","",1000,mg,1,"",未知,"",""
CA-18500430,3,7,C,UNKNOWNDRUG,"",不明,"","",150,mg,1,"",未知,"",""
CA-18500430,3,8,C,メコバラミン,"",不明,"","",1500,ug,1,"",未知,"",""
CA-18500430,3,9,C,プレガバリン,"",不明,"","",75,mg,1,"",未知,"",""
CA-18500430,3,10,C,セレコキシブ,"",不明,"","",200,mg,1,"",未知,"",""
CA-18500430,3,11,C,トピラマート,"",不明,"","",100,mg,1,"",未知,"",""
CA-18501360,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180426;20180510,20180426;20180510,255;255,mg;mg,1;1,胃癌(胃癌),未知,重症筋無力症(再投与なし);横紋筋融解症(再投与なし),""
CA-18501360,3,2,C,メコバラミン,"",不明,"","","","","","",未知,"",""
CA-18501360,3,3,C,デュロキセチン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-18501360,3,4,C,バルサルタン・アムロジピンベシル酸塩配合剤,"",不明,"","","","","","",未知,"",""
CA-18501360,3,5,C,イミダプリル塩酸塩,"",不明,"","","","","","",未知,"",""
CA-18501360,3,6,C,サキサグリプチン水和物,"",不明,"","","","","","",未知,"",""
CA-18501360,3,7,C,シロドシン,"",不明,"","","","","","",未知,"",""
CA-18501377,3,1,PS,ニボルマブ,オプジーボ,経口,20180221,"",180,mg,1,胃癌(原疾患治療),未知,筋肉痛(再投与なし),""
CA-18501377,3,2,C,塩酸メトクロプラミド,"",不明,"","","","","","",未知,"",""
CA-18501377,3,3,C,タゾバクタム・ピペラシリン水和物,"",不明,"","","","","","",未知,"",""
CA-18501377,3,4,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
CA-18501744,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20180330;20180420;20180511,20180330;20180420;20180511,158;158;158,mg;mg;mg,1;1;1,再発胃癌(再発胃癌),未知,肺障害(再投与なし),""
CA-18501744,3,2,C,デノスマブ,"",不明,"","","","","","",未知,"",""
CA-18501744,3,3,C,生理食塩液,"",不明,"","","","","","",未知,"",""
CA-18501744,3,4,C,オキシコドン塩酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-18501744,3,5,C,オキシコドン塩酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-18501744,3,6,C,プレガバリン,"",不明,"","","","","","",未知,"",""
CA-18501744,3,7,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-18501744,3,8,C,カモスタットメシル酸塩,"",不明,"","","","","","",未知,"",""
CA-18501744,3,9,C,ナルデメジントシル酸塩,"",不明,"","","","","","",未知,"",""
CA-18501744,3,10,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-18501744,3,11,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
CA-18501744,3,12,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
CA-18501744,3,13,C,沈降炭酸カルシウム・コレカルシフェロール・炭酸マグネシウム,"",不明,"","","","","","",未知,"",""
CA-18501744,3,14,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
CA-18504674,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180205;20180723,20180603;,220;160,mg;mg,1;1,胃癌(胃癌),未知,副腎機能不全(不明),""
CA-18504674,4,2,C,ゾルピデム酒石酸塩,"",不明,"","","","","","",未知,"",""
CA-18504674,4,3,C,メコバラミン,"",不明,"","","","","","",未知,"",""
CA-18504674,4,4,C,ルビプロストン,"",不明,"","","","","","",未知,"",""
CA-18504674,4,5,C,ラニチジン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-18504674,4,6,C,酪酸菌配合剤,"",不明,"","","","","","",未知,"",""
CA-18504674,4,7,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-18505629,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20180918;20181002,20180918;20181002,150;150,mg;mg,1;1,胃癌(原疾患治療のため),未知,甲状腺炎(再投与なし);肺障害(再投与なし),""
CA-18505744,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20180822,"",240,mg,1,胃癌(胃癌),未知,間質性肺疾患(再投与なし),""
CA-18505779,4,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20180208,20180816,140,mg,1,胃癌(胃癌),未知,副腎機能不全(再投与なし);劇症１型糖尿病(再投与なし),""
CA-18505779,4,2,C,アセトアミノフェン,"",不明,20180208,20180816,900,mg,1,"",未知,"",""
CA-18505779,4,3,C,メトクロプラミド,"",不明,20180208,20180816,15,mg,1,"",未知,"",""
CA-18507133,4,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20180130,"",190,mg,1,胃癌(胃癌),未知,重症筋無力症(再投与なし),""
CA-18507133,4,2,C,ランソプラゾール,"",経口,20150311,"","","","","",未知,"",""
CA-18507629,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20180704,"",200,mg,1,肺の悪性新生物(肺癌),未知,"",""
CA-18507629,3,2,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
CA-18508639,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20181024,20181217,240,mg,1,胃癌(進行胃癌),未知,肝機能異常(再投与なし),""
CA-18508639,3,2,C,ウルソデオキシコール酸,"",不明;不明,;20190116,20190115;,300;600,mg;mg,1;1,"",未知,"",""
CA-18508639,3,3,C,アムロジピンベシル酸塩,"",経口,"","","","","","",未知,"",""
CA-19100279,3,1,PS,デキサメタゾン,デカドロン,経口,20180903,20190118,2,mg,1,悪性新生物(がん症状緩和),未知,副腎機能不全(再投与なし);低血圧(再投与なし);循環虚脱(再投与なし);腹痛(再投与なし),""
CA-19100279,3,2,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20190109,20190109,240,mg,1,胃癌(胃がん),未知,"",""
CA-19100279,3,3,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
CA-19100279,3,4,C,トラマドール塩酸塩,"",不明,"","","","","","",未知,"",""
CA-19100279,3,5,C,ナプロキセン,"",不明,"","","","","","",未知,"",""
CA-19100279,3,6,C,ウルソデオキシコール酸,"",不明,"","","","","","",未知,"",""
CA-19100476,4,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20190318,20190318,240,mg,1,胃癌(胃癌),未知,１型糖尿病(再投与なし);腎障害(再投与なし),""
CA-19100476,4,2,C,エソメプラゾールマグネシウム水和物,"",不明,20180501,"","","","","",未知,"",""
CA-19100476,4,3,C,酸化マグネシウム,"",不明,20180523,"","","","","",未知,"",""
CA-19100476,4,4,C,モサプリドクエン酸塩水和物,"",不明,20181121,"","","","","",未知,"",""
CA-19100476,4,5,C,大腸菌死菌,"",不明,20180220,"","","","","",未知,"",""
CA-19100476,4,6,C,Ｌ−カルボシステイン,"",不明,20190128,"","","","","",未知,"",""
CA-19100476,4,7,C,ナプロキセン,"",不明,20190311,"","","","","",未知,"",""
CA-19100476,4,8,C,フマル酸第一鉄,"",不明,20190316,"","","","","",未知,"",""
CA-19100930,4,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20181002,20190226,240,mg,1,胃癌(原疾患治療),未知,劇症１型糖尿病(不明),""
CA-19100930,4,2,C,ラベプラゾールナトリウム,"",不明,"","","","","","",未知,"",""
CA-19100992,3,1,PS,ニボルマブ,オプジーボ,不明,20190219,"",240,mg,1,胃癌(治療のため),未知,１型糖尿病(不明),""
CA-19100992,3,2,C,ビラスチン,"",不明,"","","","","","",未知,"",""
CA-19100992,3,3,C,カンデサルタンシレキセチル,"",不明,"","","","","","",未知,"",""
CA-19100992,3,4,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-19100992,3,5,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
CA-19100992,3,6,C,プレガバリン,"",不明,"","","","","","",未知,"",""
CA-19102077,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20190104;20190118,20190104;20190118,240;240,mg;mg,1;1,胃癌(胃癌),剂量停止,間質性肺疾患(再投与なし),""
CA-19102077,3,2,C,ゾルピデム酒石酸塩,"",不明,"","","","","","",未知,"",""
CA-19102240,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190514,"",240,mg,1,胃癌(進行胃癌),未知,副腎機能不全(無),""
CA-19102240,3,2,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
CA-19102240,3,3,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
CA-19102240,3,4,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
CA-19102240,3,5,C,スボレキサント,"",不明,"","","","","","",未知,"",""
CA-19102240,3,6,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-19102240,3,7,C,ベザフィブラート,"",不明,"","","","","","",未知,"",""
CA-19102240,3,8,C,ビルダグリプチン,"",不明,"","","","","","",未知,"",""
CA-19102518,4,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20181002,"",240,mg,1,胃癌第４期(原疾患治療),剂量不变,副腎機能不全(不明);血中コルチコトロピン減少(不明),""
CA-19102518,4,2,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-19102518,4,3,C,インスリンデグルデク,"",不明,"","","","","","",未知,"",""
CA-19102518,4,4,C,インスリンアスパルト,"",不明,"","","","","","",未知,"",""
CA-19102518,4,5,C,ラベプラゾールナトリウム,"",不明,"","","","","","",未知,"",""
CA-19103159,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190307,20190530,240,mg,1,胃癌(胃癌),剂量停止,筋炎(再投与なし),""
CA-19103159,4,2,C,アンピシリンナトリウム・スルバクタムナトリウム,"",不明;不明,20190629;20190630,20190629;20190630,12;6,g;g,1;1,"",未知,"",""
CA-19103159,4,3,C,タゾバクタム・ピペラシリン水和物,"",不明;不明,20190630;20190701,20190630;20190712,9;18,g;g,1;1,"",未知,"",""
CA-19103159,4,4,C,メロペネム水和物,"",不明,20190713,20190714,3,g,1,"",未知,"",""
CA-19103159,4,5,C,レボフロキサシン水和物,"",不明,20190714,20190722,"","","","",未知,"",""
CA-19103159,4,6,C,メチルプレドニゾロンコハク酸エステルナトリウム,"",不明,20190705,20190707,"","","","",未知,"",""
CA-19103159,4,7,C,乾燥ペプシン処理人免疫グロブリン,"",不明,20190707,20190711,5,g,1,"",未知,"",""
CA-19103159,4,8,C,プレドニゾロンコハク酸エステルナトリウム,"",不明,20190708,20190722,40,mg,1,"",未知,"",""
CA-19103646,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190725,20190808,240,mg,1,胃癌(胃癌),剂量停止,心筋炎(再投与なし),""
CA-19103646,4,2,C,ドネペジル塩酸塩,"",不明,"","","","","","",未知,"",""
CA-19103646,4,3,C,フロセミド,"",不明,201907,"","","","","",未知,"",""
CA-19103646,4,4,C,スピロノラクトン,"",不明,201907,"","","","","",未知,"",""
CA-19103646,4,5,C,酸化マグネシウム,"",不明,201907,"","","","","",未知,"",""
CA-19104168,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190424,20190515,240,mg,1,胃癌(胃がん治療),未知,重症筋無力症(再投与なし),""
CA-19104168,3,2,C,エスゾピクロン,"",不明,"","",2,mg,1,"",未知,"",""
CA-19104186,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190827,20190827,240,mg,1,胃癌(胃癌),未知,スティーヴンス・ジョンソン症候群(再投与なし),""
CA-19104186,3,2,PS,バンコマイシン塩酸塩,"",静脈内点滴,20190903,20190903,1,g,1,ブドウ球菌感染(コアグラーゼ陰性ブドウ球菌),剂量停止,"",""
CA-19104186,3,3,C,乳酸リンゲル液,"",不明,"","","","","","",未知,"",""
CA-19104186,3,4,C,ダプトマイシン,"",不明,"","","","","","",未知,"",""
CA-19104383,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20190320,20190821,240,mg,1,胃癌(胃がん),未知,肺障害(再投与なし),""
CA-19104383,3,2,C,アセトアミノフェン,"",不明,201804,"",500,mg,1,"",未知,"",""
CA-19104383,3,3,C,センノシド,"",不明,201906,"",24,mg,1,"",未知,"",""
CA-19104383,3,4,C,クロピドグレル硫酸塩,"",不明,201901,"",75,mg,1,"",未知,"",""
CA-19104383,3,5,C,インスリンリスプロ,"",不明,2013,"","","","","",未知,"",""
CA-19104383,3,6,C,インスリングラルギン,"",不明,201808,"","","","","",未知,"",""
CA-19104383,3,7,C,ラタノプロスト,"",不明,"","","","","","",未知,"",""
CA-19104794,4,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20190624,20190708,240,mg,1,胃癌(胃癌),未知,重症筋無力症(再投与なし);筋炎(再投与なし),""
CA-19104794,4,2,C,アジルサルタン,"",不明,"","","","","","",未知,"",""
CA-19104794,4,3,C,ニフェジピン,"",不明,"","","","","","",未知,"",""
CA-19104991,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20190329,20190607,240,mg,1,胃癌(胃癌),剂量停止,肝機能異常(無),""
CA-19104991,3,2,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-19105463,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190111,"","","","",胃癌(原疾患治療),未知,間質性肺疾患(再投与なし),""
CA-19105463,3,2,C,ロキソプロフェンナトリウム水和物,"",経口,"","",180,mg,1,"",未知,"",""
CA-19105463,3,3,C,レバミピド,"",経口,"","",300,mg,1,"",未知,"",""
CA-19105463,3,4,C,ヒドロコルチゾン,"",経口,"","",25,mg,1,"",剂量不变,"",""
CA-19105463,3,5,C,アミノ酸・糖・電解質・ビタミン（２−４）,"",不明,"","","","","","",未知,"",""
CA-19105968,4,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20191120,20191120,240,mg,1,胃癌(胃癌治療),未知,急性腎障害(再投与なし),""
CA-19105968,4,2,PS,イオメプロール,イオメロン３００,静脈内（明記されていない場合）,20191204,20191204,100,mL,1,コンピュータ断層撮影(診断のため),不适用,"",""
CA-19105968,4,3,C,フェブキソスタット,"",不明,"","",10,mg,1,"",剂量不变,"",""
CA-19105968,4,4,C,モサプリドクエン酸塩水和物,"",不明,"","",15,mg,1,"",剂量不变,"",""
CA-19105968,4,5,C,酪酸菌配合剤,"",不明,"","",3,{DF},1,"",剂量不变,"",""
CA-19105968,4,6,C,酸化マグネシウム,"",不明,"","",1980,mg,1,"",剂量不变,"",""
CA-19105968,4,7,C,経腸成分栄養剤（９−２）,"",不明,"","","","","","",剂量不变,"",""
CA-19105968,4,8,C,センノシド,"",不明,"","",24,mg,1,"",剂量不变,"",""
CA-19105968,4,9,C,ガチフロキサシン水和物,"",不明,"","","","","","",剂量不变,"",""
CA-19105968,4,10,C,ベタメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",剂量不变,"",""
CA-19105968,4,11,C,ブロムフェナクナトリウム水和物,"",不明,"","","","","","",剂量不变,"",""
CA-19105968,4,12,C,レボフロキサシン水和物,"",不明,"","","","","","",剂量不变,"",""
CA-19105968,4,13,C,トロピカミド・フェニレフリン塩酸塩,"",不明,"","","","","","",剂量不变,"",""
CA-19105968,4,14,C,精製ヒアルロン酸ナトリウム,"",不明,"","","","","","",剂量不变,"",""
CA-19105968,4,15,C,フラビンアデニンジヌクレオチドナトリウム,"",不明,"","","","","","",剂量不变,"",""
CA-19105968,4,16,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",不明;不明,;,;,;,;,;,"",剂量不变,"",""
CA-19105968,4,17,C,ヘパリン類似物質,"",不明,"","","","","","",剂量不变,"",""
CA-19105968,4,18,C,アセトアミノフェン,"",不明,20191204,"",2,g,1,"",未知,"",""
CA-19106451,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191029,20191029,240,mg,1,胃癌(原疾患治療),未知,間質性肺疾患(再投与なし),""
CA-19106451,3,2,C,ボノプラザンフマル酸塩,"",経口,"","",10,mg,1,"",未知,"",""
CA-19106451,3,3,C,アンブロキソール塩酸塩,"",経口,"","",30,mg,1,"",未知,"",""
CA-19106451,3,4,C,フロセミド,"",経口,"","",60,mg,1,"",未知,"",""
CA-19106451,3,5,C,スピロノラクトン,"",経口,"","",75,mg,1,"",未知,"",""
CA-19106451,3,6,C,アセトアミノフェン,"",経口,"","",600,mg,1,"",未知,"",""
CA-19106451,3,7,C,フェンタニルクエン酸塩,"",その他(外用),"","",4,mg,1,"",未知,"",""
CA-19106451,3,8,C,ツロブテロール,"",その他(外用),"","",2,mg,1,"",未知,"",""
CA-19106451,3,9,C,アミノ酸・糖・電解質・ビタミン（２−６）,"",その他(注射),"","","","","","",未知,"",""
CA-19106451,3,10,C,塩化ナトリウム,"",その他(注射),"","",100,mL,1,"",未知,"",""
CA-19106451,3,11,C,ダイズ油,"",その他(注射),"","","","","","",未知,"",""
CA-19106953,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20191101,20191114,240,mg,1,胃癌(進行胃癌),未知,血小板数減少(再投与なし),""
CA-19106953,3,2,C,シタグリプチンリン酸塩水和物,"",不明,20190718,"","","","","",未知,"",""
CA-19106953,3,3,C,アセトアミノフェン,"",不明,20191101,"","","","","",未知,"",""
CA-19106953,3,4,C,ボノプラザンフマル酸塩,"",不明,20190719,"","","","","",未知,"",""
CA-19106953,3,5,C,バゼドキシフェン酢酸塩,"",不明,"","","","","","",未知,"",""
CA-19106953,3,6,C,イソロイシン・ロイシン・バリン,"",不明,20190301,"","","","","",未知,"",""
CA-19106953,3,7,C,セフォタキシムナトリウム,"",不明,20191120,20191124,"","","","",未知,"",""
CA-19106953,3,8,C,アセトアミノフェン,"",不明,20191120,20191121,"","","","",未知,"",""
CA-19106953,3,9,C,乾燥濃縮人アンチトロンビン３,"",不明,20191120,20191120,"","","","",未知,"",""
CA-19106953,3,10,C,ヘパリン類似物質,"",不明,20191114,"","","","","",未知,"",""
CA-19106953,3,11,C,ジフルコルトロン吉草酸エステル,"",不明,20191120,"","","","","",未知,"",""
CA-19107388,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）,20190718;20190802;20190816;20190913;20190927;20191108;20191122;20191206;20191220,20190718;20190802;20190816;20190913;20190927;20191108;20191122;20191206;20191220,240;240;240;240;240;240;240;240;240,mg;mg;mg;mg;mg;mg;mg;mg;mg,1;1;1;1;1;1;1;1;1,高血糖(高血糖),未知,"",""
CA-19107388,3,2,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
CA-19107388,3,3,C,酪酸菌配合剤,"",不明,"","","","","","",未知,"",""
CA-19107388,3,4,C,エルデカルシトール,"",不明,"","","","","","",未知,"",""
CA-19107388,3,5,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
CA-19107388,3,6,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-19107388,3,7,C,大建中湯,"",不明,"","","","","","",未知,"",""
CA-19107739,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190403,20190523,"","","",胃癌(胃癌),未知,下痢(無),""
CA-19107739,3,2,C,フェンタニルクエン酸塩,"",不明,"","","","","","",未知,"",""
CA-19107739,3,3,C,ロスバスタチンカルシウム,"",不明,"","","","","","",未知,"",""
CA-19107739,3,4,C,ペリンドプリルエルブミン,"",不明,"","","","","","",未知,"",""
CA-19107739,3,5,C,ビソプロロールフマル酸塩,"",不明,"","","","","","",未知,"",""
CA-19107739,3,6,C,アスピリン,"",不明,"","","","","","",未知,"",""
CA-19107739,3,7,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-19107739,3,8,C,レバミピド,"",不明,"","","","","","",未知,"",""
CA-19107739,3,9,C,アミノ酸・糖・電解質・ビタミン（２−６）,"",不明,"","","","","","",未知,"",""
CA-19107739,3,10,C,肝不全用アミノ酸製剤（１）,"",不明,"","","","","","",未知,"",""
CA-19107740,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴,20190403,20190523,"","","",胃癌(胃癌),不适用,肝機能異常(再投与なし),""
CA-19107740,3,2,C,フェンタニルクエン酸塩,"",不明,"","","","","","",未知,"",""
CA-19107740,3,3,C,ロスバスタチンカルシウム,"",不明,"","","","","","",未知,"",""
CA-19107740,3,4,C,ペリンドプリルエルブミン,"",不明,"","","","","","",未知,"",""
CA-19107740,3,5,C,ビソプロロールフマル酸塩,"",不明,"","","","","","",未知,"",""
CA-19107740,3,6,C,アスピリン,"",不明,"","","","","","",未知,"",""
CA-19107740,3,7,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-19107740,3,8,C,レバミピド,"",不明,"","","","","","",未知,"",""
CA-19107740,3,9,C,アミノ酸・糖・電解質・ビタミン（２−６）,"",不明,"","","","","","",未知,"",""
CA-19107740,3,10,C,肝不全用アミノ酸製剤（１）,"",不明,"","","","","","",未知,"",""
CA-19108594,4,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）(末梢静脈),20190320,20190410,"","","",再発胃癌(再発性胃癌),未知,肝炎(再投与なし);重症筋無力症(再投与なし),""
CA-19108594,4,2,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-19108594,4,3,C,ロペラミド塩酸塩,"",不明,"","","","","","",未知,"",""
CA-19108594,4,4,C,プレガバリン,"",不明,"","","","","","",未知,"",""
CA-19108594,4,5,C,ブロチゾラム,"",不明,"","","","","","",未知,"",""
CA-19108594,4,6,C,ケトプロフェン,"",不明,"","","","","","",未知,"",""
CA-20000360,3,1,PS,ニボルマブ,オプジーボ,その他(注射),20190813,20191210,240,mg,1,胃癌(胃癌),未知,下垂体機能低下症(再投与なし),""
CA-20000360,3,2,C,モサプリドクエン酸塩水和物,"",不明,"","",15,mg,1,"",未知,"",""
CA-20000360,3,3,C,酪酸菌製剤,"",不明,"","",3,{DF},1,"",未知,"",""
CA-20000360,3,4,C,葉酸,"",不明,"","",15,mg,1,"",未知,"",""
CA-20000360,3,5,C,メコバラミン,"",不明,"","",1500,ug,1,"",未知,"",""
CA-20000502,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190718,20191205,240,mg,1,胃癌(進行胃癌),未知,薬疹(再投与なし);肺炎(再投与なし),""
CA-20000502,3,2,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
CA-20000502,3,3,C,ジフルプレドナート,"",不明,"","","","","","",未知,"",""
CA-20000635,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20190930,20191202,240,mg,1,胃癌(胃癌),不适用,原発性甲状腺機能低下症(再投与なし);下垂体機能低下症(再投与なし),""
CA-20000635,3,2,C,茵ちん蒿湯,"",不明,"","","","","","",未知,"",""
CA-20000635,3,3,C,ブロチゾラム,"",不明,"","","","","","",未知,"",""
CA-20000790,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20190914,20191111,240,mg,1,胃癌(胃癌),未知,下痢(再投与なし),""
CA-20000790,3,2,C,レボチロキシンナトリウム水和物,"",不明,20190906,"","","","","",未知,"",""
CA-20000790,3,3,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
CA-20000790,3,4,C,半夏瀉心湯,"",不明,"","","","","","",未知,"",""
CA-20000894,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200319,20200430,240,mg,1,胃癌(切除不能進行胃がん),剂量停止,急性副腎皮質機能不全(再投与なし),""
CA-20001413,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20190909,20200413,240,mg,1,胃癌(胃癌),剂量停止,副腎機能不全(再投与なし),""
CA-20001413,3,2,C,クロピドグレル硫酸塩,"",経口,20191030,"",75,mg,1,"",未知,"",""
CA-20001413,3,3,C,レボフロキサシン水和物,"",経口,"",20200512,500,mg,1,"",未知,"",""
CA-20001413,3,4,C,経腸成分栄養剤（２−２）,"",不明,"",20200512,750,mL,1,"",未知,"",""
CA-20001413,3,5,C,アセトアミノフェン,"",経口,"",20200512,500,mg,1,"",未知,"",""
CA-20001708,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,201802,20200512,240,mg,1,胃癌(胃がん),未知,心不全(再投与なし),""
CA-20001708,3,2,C,フロセミド,"",不明,"","","","","","",未知,"",""
CA-20001708,3,3,C,フェキソフェナジン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-20001708,3,4,C,ポリスチレンスルホン酸ナトリウム,"",不明,"","","","","","",未知,"",""
CA-20001708,3,5,C,ウルソデオキシコール酸,"",不明,"","","","","","",未知,"",""
CA-20001708,3,6,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
CA-20001708,3,7,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-20002327,4,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20191211,20200205,240,mg,1,胃癌(胃癌),剂量停止,類天疱瘡(再投与なし),""
CA-20002327,4,2,C,クエン酸第一鉄ナトリウム,"",不明,20200120,"","","","","",未知,"",""
CA-20002327,4,3,C,シロドシン,"",不明,"","","","","","",未知,"",""
CA-20002327,4,4,C,デュタステリド,"",不明,"","","","","","",未知,"",""
CA-20002327,4,5,C,ロスバスタチンカルシウム,"",不明,"","","","","","",未知,"",""
CA-20002327,4,6,C,リナグリプチン,"",不明,"","","","","","",未知,"",""
CA-20002373,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20200601;20200615;20200629,;;,240;240;240,mg;mg;mg,1;1;1,腎癌(腎癌治療),剂量停止,間質性肺疾患(再投与なし),""
CA-20002373,4,2,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
CA-20002373,4,3,C,シロスタゾール,"",不明,"","","","","","",未知,"",""
CA-20002373,4,4,C,アロプリノール,"",不明,"","","","","","",未知,"",""
CA-20002373,4,5,C,アトルバスタチンカルシウム水和物,"",不明,"","","","","","",未知,"",""
CA-20003320,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200709,"",240,mg,1,胃癌(胃癌),未知,口内炎(再投与なし);皮膚障害(再投与なし),""
CA-20003320,3,2,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
CA-20003320,3,3,C,プレガバリン,"",不明,"","","","","","",未知,"",""
CA-20003320,3,4,C,フロセミド,"",不明,"","","","","","",未知,"",""
CA-20003320,3,5,C,レベチラセタム,"",不明,"","","","","","",未知,"",""
CA-20003320,3,6,C,Ｌ−カルボシステイン,"",不明,"","","","","","",未知,"",""
CA-20003320,3,7,C,チペピジンヒベンズ酸塩,"",不明,"","","","","","",未知,"",""
CA-20003320,3,8,C,アズレンスルホン酸ナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-20004616,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200821,20200821,240,mg,1,胃癌(進行胃癌),未知,間質性肺疾患(再投与なし),""
CA-20004616,3,2,C,フロセミド,"",不明,"","","","","","",未知,"",""
CA-20004616,3,3,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-20004616,3,4,C,オルメサルタンメドキソミル,"",不明,"","","","","","",未知,"",""
CA-20004616,3,5,C,ビソプロロールフマル酸塩,"",不明,"","","","","","",未知,"",""
CA-20004616,3,6,C,ピレノキシン,"",不明,"","","","","","",未知,"",""
CA-20004616,3,7,C,精製ヒアルロン酸ナトリウム,"",不明,"","","","","","",未知,"",""
CA-20004616,3,8,C,精製ヒアルロン酸ナトリウム,"",不明,"","","","","","",未知,"",""
CA-20005230,3,1,PS,ベタメタゾン,"",経口,20201022,20201205,4,mg,1,悪液質(癌性悪液質),未知,間質性肺疾患(再投与なし);ニューモシスチス・イロベチイ肺炎(再投与なし),""
CA-20005230,3,2,PS,ニボルマブ,オプジーボ,その他(注射),20201019,20201203,240,mg,1,胃癌(胃癌),未知,間質性肺疾患(再投与なし);ニューモシスチス・イロベチイ肺炎(再投与なし),""
CA-20005230,3,3,C,ヘパリンカルシウム,"",不明,"","","","","","",未知,"",""
CA-20005230,3,4,C,芍薬甘草湯,"",不明,"","","","","","",未知,"",""
CA-20005230,3,5,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
CA-20005230,3,6,C,フロセミド,"",不明,"","","","","","",未知,"",""
CA-20005230,3,7,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
CA-20005230,3,8,C,ラクツロース,"",不明,"","","","","","",未知,"",""
CA-20005230,3,9,C,ポリスチレンスルホン酸ナトリウム,"",不明,"","","","","","",未知,"",""
CA-20005230,3,10,C,球形吸着炭,"",不明,"","","","","","",未知,"",""
CA-20005230,3,11,C,ポラプレジンク,"",不明,"","","","","","",未知,"",""
CA-20005230,3,12,C,ニフェジピン,"",不明,"","","","","","",未知,"",""
CA-20005230,3,13,C,ロラタジン,"",不明,"","","","","","",未知,"",""
CA-20005230,3,14,C,カンデサルタンシレキセチル,"",不明,"","","","","","",未知,"",""
CA-20005230,3,15,C,フェブキソスタット,"",不明,"","","","","","",未知,"",""
CA-20005230,3,16,C,リナグリプチン,"",不明,"","","","","","",未知,"",""
CA-20005230,3,17,C,レボフロキサシン水和物,"",不明,"","","","","","",未知,"",""
CA-20005323,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200602,"",240,mg,1,再発胃癌(進行胃癌再発),未知,副腎機能不全(無),""
CA-20005323,3,2,C,アロプリノール,"",不明,"","","","","","",未知,"",""
CA-20005323,3,3,C,一硝酸イソソルビド,"",不明,"","","","","","",未知,"",""
CA-20005323,3,4,C,ニコランジル,"",不明,"","","","","","",未知,"",""
CA-20005323,3,5,C,ビソプロロールフマル酸塩,"",不明,"","","","","","",未知,"",""
CA-20005323,3,6,C,リバーロキサバン,"",不明,"","","","","","",未知,"",""
CA-20005323,3,7,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
CA-20005621,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200221,20200306,240,mg,1,胃癌(スキルス胃癌),未知,間質性肺疾患(有),""
CA-20005621,3,2,C,オキシコドン塩酸塩水和物,"",不明,"","",10,mg,1,"",未知,"",""
CA-20005621,3,3,C,ワクシニアウイルス接種家兎炎症皮膚抽出液,"",不明,"","",4,{DF},1,"",未知,"",""
CA-20005621,3,4,C,オキシコドン塩酸塩水和物,"",不明;不明,;,;,2.5;5,mg;mg,1;1,"",未知,"",""
CA-20005621,3,5,C,ジクロフェナクナトリウム,"",不明,"","",37.5,mg,1,"",未知,"",""
CA-20005621,3,6,C,ラベプラゾールナトリウム,"",不明,"","",10,mg,1,"",未知,"",""
CA-20005621,3,7,C,ベンフォチアミン・Ｂ６・Ｂ１２配合剤（１）,"",不明,"","",3,{DF},1,"",未知,"",""
CA-20005621,3,8,C,ジメモルファンリン酸塩,"",不明,"","",60,mg,1,"",未知,"",""
CA-20005621,3,9,C,Ｌ−カルボシステイン,"",不明,"","",1500,mg,1,"",未知,"",""
CA-20005625,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200323,20200420,240,mg,1,再発胃癌(胃癌全摘後再発),不适用,間質性肺疾患(再投与なし),""
CA-20005625,3,2,C,酪酸菌製剤,"",不明,"","",6,{DF},1,"",未知,"",""
CA-20005625,3,3,C,ロペラミド塩酸塩,"",不明,"","",2,mg,1,"",未知,"",""
CA-20005625,3,4,C,六君子湯,"",不明,"","",3,{DF},1,"",未知,"",""
CA-20005625,3,5,C,アセトアミノフェン,"",不明,"","",2700,mg,1,"",未知,"",""
CA-20005625,3,6,C,カルベジロール,"",不明,"","",5,mg,1,"",未知,"",""
CA-20005625,3,7,C,ベタヒスチンメシル酸塩,"",不明,"","",18,mg,1,"",未知,"",""
CA-20005625,3,8,C,アロプリノール,"",不明,"","",200,mg,1,"",未知,"",""
CA-20005625,3,9,C,アデノシン三リン酸二ナトリウム水和物,"",不明,"","",300,mg,1,"",未知,"",""
CA-20005625,3,10,C,ベプリジル塩酸塩水和物,"",不明,"","",150,mg,1,"",未知,"",""
CA-20005625,3,11,C,クエン酸第一鉄ナトリウム,"",不明,"","",50,mg,1,"",未知,"",""
CA-20006027,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20201013,20201203,240,mg,1,胃癌(胃がん),未知,発熱性好中球減少症(再投与なし),""
CA-20006027,3,2,PS,サラゾスルファピリジン,"",経口,20201023,20201223,1000,mg,1,関節リウマチ(関節リウマチ),剂量停止,"",""
CA-20006027,3,3,PS,プレドニゾロン,プレドニン,経口,20201102,20201222,10,mg,1,関節リウマチ(関節リウマチ),剂量停止,"",""
CA-20006027,3,4,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
CA-20006027,3,5,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-20006027,3,6,C,アルファカルシドール,"",不明,"","","","","","",未知,"",""
CA-20006027,3,7,C,フロセミド,"",不明,"","","","","","",未知,"",""
CA-20006027,3,8,C,乾燥硫酸鉄（３）,"",不明,"","","","","","",未知,"",""
CA-20006027,3,9,C,パンテチン,"",不明,"","","","","","",未知,"",""
CA-20006746,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200501,20201203,"","","",胃癌(胃原発肝様腺癌(AFP産生腫瘍、肝転移)),未知,関節炎(再投与なし),""
CA-20006746,4,2,C,ウルソデオキシコール酸,"",不明,"","","","","","",未知,"",""
CA-20006746,4,3,C,アピキサバン,"",不明,"","","","","","",未知,"",""
CA-20006746,4,4,C,牛車腎気丸,"",不明,"","","","","","",未知,"",""
CA-20006746,4,5,C,ロルメタゼパム,"",不明,"","","","","","",未知,"",""
CA-20006746,4,6,C,リスペリドン,"",不明,"","","","","","",未知,"",""
CA-20006746,4,7,C,生理食塩液,"",不明,"","","","","","",未知,"",""
CA-20007258,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20200512,20210105,240,mg,1,胃癌(胃癌),剂量停止,ショック(再投与なし);心不全(再投与なし),""
CA-20007258,3,2,C,プレガバリン,"",経口,"",20210130,"","","","",剂量停止,"",""
CA-20007258,3,3,C,ピコスルファートナトリウム水和物,"",経口,"",20210130,"","","","",剂量停止,"",""
CA-20007258,3,4,C,アスピリン,"",経口,"","","","","","",未知,"",""
CA-20007258,3,5,C,ラベプラゾールナトリウム,"",経口,"","","","","","",未知,"",""
CA-20007258,3,6,C,セレコキシブ,"",経口,"",20210130,"","","","",剂量停止,"",""
CA-20007258,3,7,C,レバミピド,"",経口,"",20210130,"","","","",剂量停止,"",""
CA-20007258,3,8,C,ニフェジピン,"",経口,"",20210130,"","","","",剂量停止,"",""
CA-20007258,3,9,C,牛車腎気丸,"",経口,"",20210130,"","","","",剂量停止,"",""
CA-20007258,3,10,C,トルバプタン,"",経口,"","","","","","",未知,"",""
CA-20007258,3,11,C,アコチアミド塩酸塩水和物,"",経口,"",20210130,"","","","",剂量停止,"",""
CA-20007258,3,12,C,ポリスチレンスルホン酸カルシウム,"",経口,"",20210130,"","","","",剂量停止,"",""
CA-20007258,3,13,C,エロビキシバット水和物,"",経口,"",20210130,"","","","",剂量停止,"",""
CA-20007258,3,14,C,センノシド,"",経口,"","","","","","",未知,"",""
CA-20007258,3,15,C,カルペリチド,"",不明,"","","","","","",未知,"",""
CA-20007258,3,16,C,開始液（１）,"",不明,"","","","","","",未知,"",""
CA-20007258,3,17,C,セフメタゾールナトリウム,"",不明,20210122,20210130,"","","","",剂量停止,"",""
CA-20007258,3,18,C,フロセミド,"",経口;経口,20200423;20210121,;20210130,;,;,;,"",剂量停止,"",""
CA-20007888,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20200827,20201105,"","","",胃癌(胃がん),未知,副腎機能不全(不明),""
CA-20007888,3,2,PS,トラスツズマブデルクステカン,エンハーツ,静脈内（明記されていない場合）,20201119,"","","","",胃癌(胃がん),未知,"",""
CA-20007888,3,3,C,ビソプロロールフマル酸塩,"",不明,20210107,"","","","","",剂量不变,"",""
CA-20008019,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20200821,20210119,240,mg,1,胃癌(胃癌),未知,間質性肺疾患(再投与なし),""
CA-20008019,3,2,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-20008019,3,3,C,メコバラミン,"",不明,"","","","","","",未知,"",""
CA-20008019,3,4,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
CA-20008019,3,5,C,デノスマブ,"",不明,"","","","","","",未知,"",""
CA-20008019,3,6,C,沈降炭酸カルシウム・コレカルシフェロール・炭酸マグネシウム,"",不明,"","","","","","",未知,"",""
CA-20008026,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20200604;20201119,20200910;,240;,mg;,1;,胃癌(胃癌),未知,続発性副腎皮質機能不全(無),""
CA-20008042,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20201008,20201008,"","","",胃癌(胃癌治療),未知,腎機能障害(再投与なし),""
CA-20008042,3,2,C,フェンタニル,"",不明,"","","","","","",未知,"",""
CA-20008042,3,3,C,オランザピン,"",不明,"","","","","","",未知,"",""
CA-20008042,3,4,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-21000752,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20200930,20210317,"","","",胃癌(胃癌),剂量停止,副腎機能不全(再投与なし),""
CA-21000752,3,2,C,インスリングラルギン［後続１］,"",不明,"","","","","","",未知,"",""
CA-21000752,3,3,C,ロペラミド塩酸塩,"",不明,202001,"",2,mg,1,"",未知,"",""
CA-21000752,3,4,C,ロキソプロフェンナトリウム水和物,"",不明,202009,"",60,mg,1,"",未知,"",""
CA-21001313,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210304,20210304,"","","",胃癌(胃癌),未知,筋炎(再投与なし),""
CA-21001313,3,2,C,オメプラゾール,"",不明,"","","","","","",未知,"",""
CA-21001313,3,3,C,ポリスチレンスルホン酸ナトリウム,"",不明,"","","","","","",未知,"",""
CA-21001313,3,4,C,グリメピリド,"",不明,"","","","","","",未知,"",""
CA-21001313,3,5,C,クロピドグレル硫酸塩,"",不明,"","","","","","",未知,"",""
CA-21001313,3,6,C,メトホルミン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-21001313,3,7,C,ビルダグリプチン,"",不明,"","","","","","",未知,"",""
CA-21001313,3,8,C,インスリングラルギン［後続１］,"",不明,"","","","","","",未知,"",""
CA-21001313,3,9,C,メコバラミン,"",不明,"","","","","","",未知,"",""
CA-21002603,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内点滴;静脈内点滴,20201029;20210310,;,200;400,mg;mg,1;1,再発胃癌(胃癌（術後再発）),未知,下垂体機能低下症(再投与なし),""
CA-21002603,3,2,C,生理食塩液,"",不明,"","","","","","",未知,"",""
CA-21002603,3,3,C,アキシチニブ,"",不明;不明,20201029;20210512,;,10;5,mg;mg,1;1,"",未知,"",""
CA-21002603,3,4,C,ニフェジピン,"",不明,"","","","","","",未知,"",""
CA-21002603,3,5,C,レボチロキシンナトリウム水和物,"",経口,20210106,"","","","","",未知,"",""
CA-21002603,3,6,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
CA-21002603,3,7,C,プレガバリン,"",不明,"","","","","","",未知,"",""
CA-21002603,3,8,C,アジルサルタン,"",不明,"","","","","","",未知,"",""
CA-21002603,3,9,C,沈降炭酸カルシウム・コレカルシフェロール・炭酸マグネシウム,"",不明,"","","","","","",未知,"",""
CA-21003656,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）,20210524;20210607;20210705;20210719,20210524;20210607;20210705;20210719,;;;,;;;,;;;,"",剂量停止,急性腎障害(再投与なし),""
CA-21003656,3,2,C,カモスタットメシル酸塩,"",経口,"","","","","","",未知,"",""
CA-21003656,3,3,C,ヘパリン類似物質,"",経皮,"","","","","","",未知,"",""
CA-21003737,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210616,20210630,240,mg,1,胃癌(胃癌),未知,心筋炎(再投与なし),""
CA-21003737,3,2,C,イトラコナゾール,"",不明,"","","","","","",未知,"",""
CA-21003737,3,3,C,アスピリン,"",不明,"","","","","","",未知,"",""
CA-21003737,3,4,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-21003737,3,5,C,タムスロシン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-21003737,3,6,C,ミグリトール,"",不明,"","","","","","",未知,"",""
CA-21004400,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","",240,mg,1,胃癌(胃がん治療のため),未知,"",""
CA-21004400,3,2,C,プレドニゾロン酢酸エステル,"",不明,"","","","","","",未知,"",""
CA-21004400,3,3,C,メサラジン,"",不明,"","","","","","",未知,"",""
CA-21004400,3,4,C,大腸菌死菌・ヒドロコルチゾン,"",不明,"","","","","","",未知,"",""
CA-21006786,4,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20201008,"",240,mg,1,治療手技(治療),未知,腎機能障害(再投与なし),""
CA-21006786,4,2,C,ヒドロモルフォン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-21006786,4,3,C,フェンタニル,"",不明,"","","","","","",未知,"",""
CA-21006786,4,4,C,オランザピン,"",不明,"","","","","","",未知,"",""
CA-21006786,4,5,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-21006786,4,6,C,エトドラク,"",不明,"","","","","","",未知,"",""
CA-21006786,4,7,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
CA-21006895,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210614;20210817,;20210928,240;,mg;,1;,胃癌(胃癌、多発肝転移),未知,無痛性甲状腺炎(無);甲状腺機能低下症(無),""
CA-21006895,3,2,C,ランソプラゾール,"",不明,"","",30,mg,1,"",未知,"",""
CA-21006895,3,3,C,フェブキソスタット,"",不明,"","",10,mg,1,"",未知,"",""
CA-21006895,3,4,C,レバミピド,"",不明,"","",300,mg,1,"",未知,"",""
CA-21007547,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）;静脈内（明記されていない場合）,20211215;20220105,;20220105,240;240,mg;mg,1;1,胃癌(胃癌),剂量停止,間質性肺疾患(再投与なし),""
CA-21007547,3,2,C,イルベサルタン・アムロジピンベシル酸塩配合剤,"",不明,"","","","","","",未知,"",""
CA-21007547,3,3,C,アトルバスタチンカルシウム水和物,"",不明,"","","","","","",未知,"",""
CA-21007547,3,4,C,アスピリン,"",不明,"","","","","","",未知,"",""
CA-21007547,3,5,C,アテノロール,"",不明,"","","","","","",未知,"",""
CA-21007547,3,6,C,ワクシニアウイルス接種家兎炎症皮膚抽出液,"",不明,"","","","","","",未知,"",""
CA-21007547,3,7,C,プレガバリン,"",不明,"","","","","","",未知,"",""
CA-21007547,3,8,C,半夏瀉心湯,"",不明,"","","","","","",未知,"",""
CA-21007547,3,9,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
CA-21007547,3,10,C,カモスタットメシル酸塩,"",不明,"","","","","","",未知,"",""
CA-21007554,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210316;20210427,20210413;20211012,;,;,;,胃癌(原疾患治療),未知,副腎機能不全(再投与なし),""
CA-21007554,3,2,C,シルニジピン,"",経口,"","",20,mg,1,"",未知,"",""
CA-21007554,3,3,C,アジルサルタン,"",経口,"","",40,mg,1,"",未知,"",""
CA-21007554,3,4,C,レボチロキシンナトリウム水和物,"",経口,"","",100,ug,1,"",未知,"",""
CA-21007830,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211203,20211217,240,mg,1,胃癌(胃癌治療のため),未知,硬化性胆管炎(再投与なし),""
CA-21007830,3,2,C,ミロガバリンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-21007830,3,3,C,ニフェジピン,"",不明,"","","","","","",未知,"",""
CA-21007830,3,4,C,ヘパリン類似物質,"",不明,"","","","","","",未知,"",""
CA-21007830,3,5,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-22000226,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20211206,20211220,"","","",胃癌(胃癌),未知,ギラン・バレー症候群(再投与なし),""
CA-22000226,3,2,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
CA-22000226,3,3,C,フロセミド,"",不明,"","","","","","",未知,"",""
CA-22000226,3,4,C,アデニン,"",不明,"","","","","","",未知,"",""
CA-22000226,3,5,C,イルベサルタン,"",不明,"","","","","","",未知,"",""
CA-22000226,3,6,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-22000226,3,7,C,ビソプロロールフマル酸塩,"",不明,"","","","","","",未知,"",""
CA-22001873,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20220118,20220510,"","","",胃癌(胃がん治療3rdLine),剂量停止,"",""
CA-22001873,3,2,C,腸癰湯,"",経口,"","","","","","",未知,"",""
CA-22001873,3,3,C,桂枝加芍薬湯,"",経口,"","","","","","",未知,"",""
CA-22001873,3,4,C,モサプリドクエン酸塩水和物,"",経口,"","","","","","",未知,"",""
CA-22001873,3,5,C,サナクターゼ配合剤,"",経口,"","","","","","",未知,"",""
CA-22001873,3,6,C,ランソプラゾール,"",経口,"","","","","","",未知,"",""
CA-22001873,3,7,C,酪酸菌製剤,"",経口,"","","","","","",未知,"",""
CA-22001873,3,8,C,センノシド,"",経口,"","","","","","",未知,"",""
CA-22002091,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20210914,20220427,240,mg,1,化学療法(癌化学療法（胃癌）),剂量停止,間質性肺疾患(再投与なし);器質化肺炎(再投与なし);咳嗽(再投与なし);労作性呼吸困難(再投与なし),""
CA-22002091,3,2,C,酪酸菌製剤,"",不明,20210824,"","","","","",未知,"",""
CA-22002091,3,3,C,コハク酸ソリフェナシン,"",不明,"","","","","","",未知,"",""
CA-22002091,3,4,C,生理食塩液,"",不明,20200403,"","","","","",未知,"",""
CA-22002139,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220222,20220315,"","","",胃癌(胃噴門部癌),未知,免疫介在性膀胱炎(再投与なし);発疹(再投与なし),""
CA-22002139,3,2,PS,オキサリプラチン,"",静脈内点滴,20220126,20220315,"","","",胃癌(胃噴門部癌),未知,"",""
CA-22002139,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220126,20220328,"","","",胃癌(胃噴門部癌),未知,"",""
CA-22002139,3,4,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
CA-22002139,3,5,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-22002139,3,6,C,フェキソフェナジン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-22002139,3,7,C,メコバラミン,"",不明,"","","","","","",未知,"",""
CA-22002237,3,1,PS,ペムブロリズマブ,キイトルーダ,静脈内（明記されていない場合）,20201126,20211118,"","","",胃癌(原疾患治療のため),不适用,肺毒性(再投与なし),""
CA-22002264,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20220204,20220506,"","","",胃癌(胃がん治療のため),未知,下痢(再投与なし),""
CA-22002264,3,2,C,オキサリプラチン,"",静脈内（明記されていない場合）,20220204,20220506,"","","","",未知,"",""
CA-22002264,3,3,C,UNKNOWNDRUG,"",経口,20220204,20220520,"","","","",未知,"",""
CA-22002264,3,4,C,牛車腎気丸,"",経口,20220107,"","","","","",未知,"",""
CA-22002264,3,5,C,メコバラミン,"",経口,"","","","","","",未知,"",""
CA-22003184,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20210525;,;20220301,240;480,mg;mg,1;1,胃癌(胃癌),未知,１型糖尿病(再投与なし),""
CA-22003184,3,2,C,膵臓性消化酵素配合剤（１）,"",不明,"","",3,g,1,"",未知,"",""
CA-22003189,3,1,PS,ニボルマブ,"",静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20220422;20220506;20220520;20220603,;;;,;;;,;;;,;;;,胃癌(胃癌),未知,副腎機能不全(再投与なし);甲状腺障害(再投与なし),""
CA-22003189,3,2,C,アセトアミノフェン,"",不明,"","",1500,mg,1,"",未知,"",""
CA-22003189,3,3,C,グリセリン,"",不明,"","","","","","",未知,"",""
CA-22003189,3,4,C,アズレンスルホン酸ナトリウム水和物・炭酸水素ナトリウム,"",不明,"","","","","","",未知,"",""
CA-22003189,3,5,C,リドカイン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-22003189,3,6,C,ヘパリン類似物質,"",不明,"","","","","","",未知,"",""
CA-22003189,3,7,C,アムホテリシンＢ,"",不明,"","",1,mL,1,"",未知,"",""
CA-22003391,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220623,20220623,360,mg,1,胃癌(幽門前庭部癌),未知,免疫性腸炎(再投与なし),""
CA-22003391,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20220623,"","","","","",未知,"",""
CA-22003391,3,3,C,メトクロプラミド,"",不明,20220629,"",15,mg,1,"",未知,"",""
CA-22003391,3,4,C,ランソプラゾール,"",不明,20220601,"",15,mg,1,"",未知,"",""
CA-22003391,3,5,C,センノシド,"",不明,"","",24,mg,1,"",未知,"",""
CA-22003391,3,6,C,オランザピン,"",不明,"","",2.5,mg,1,"",未知,"",""
CA-22003391,3,7,C,ロペラミド塩酸塩,"",不明,"","",1,mg,1,"",未知,"",""
CA-22003391,3,8,C,ロキソプロフェンナトリウム水和物,"",不明,"","",60,mg,1,"",未知,"",""
CA-22003509,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20220715,20220715,"","","",胃癌(幽門前庭部癌),未知,肝機能異常(再投与なし),""
CA-22003509,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20220715,20220728,"","","",胃癌(幽門前庭部癌),未知,"",""
CA-22003509,3,3,PS,オキサリプラチン,"",静脈内（明記されていない場合）,20220715,20220715,"","","",胃癌(幽門前庭部癌),未知,"",""
CA-22003509,3,4,C,プラバスタチンナトリウム,"",経口,20220715,"","","","","",未知,"",""
CA-22003509,3,5,C,エルデカルシトール,"",経口,20220715,"","","","","",未知,"",""
CA-22003509,3,6,C,ラベプラゾールナトリウム,"",経口,20220715,"","","","","",未知,"",""
CA-22003525,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20220620,20220712,"","","",胃癌(胃癌),未知,１型糖尿病(無),""
CA-22003525,3,2,C,オキサリプラチン,"",静脈内（明記されていない場合）,20220620,20220712,"","","","",未知,"",""
CA-22003525,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20220620,20220714,"","","","",未知,"",""
CA-22003525,3,4,C,デキサメタゾンリン酸エステルナトリウム,"",不明,20220620,20220712,"","","","",未知,"",""
CA-22003778,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220810,"","","","",胃癌(胃癌治療),未知,大腸炎(再投与なし),""
CA-22003778,3,2,C,アミノ酸・糖・電解質・ビタミン（２−６）,"",不明,"","","","","","",未知,"",""
CA-22003778,3,3,C,グラニセトロン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-22003778,3,4,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
CA-22003778,3,5,C,レボホリナートカルシウム,"",不明,"","","","","","",未知,"",""
CA-22003778,3,6,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
CA-22003778,3,7,C,フルオロウラシル,"",不明,"","","","","","",未知,"",""
CA-22003778,3,8,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
CA-22003778,3,9,C,塩酸メトクロプラミド,"",不明,"","","","","","",未知,"",""
CA-22003778,3,10,C,ヒドロモルフォン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-22003778,3,11,C,UNKNOWNDRUG,"",不明,"","","","","","",未知,"",""
CA-22003778,3,12,C,クロルプロマジンヒベンズ酸塩,"",不明,"","","","","","",未知,"",""
CA-22003778,3,13,C,グラニセトロン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-22003778,3,14,C,ナルデメジントシル酸塩,"",不明,"","","","","","",未知,"",""
CA-22003778,3,15,C,ラクツロース,"",不明,"","","","","","",未知,"",""
CA-22004252,3,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,ティーエスワンＯＤ,経口,20220913,20220923,6,{DF},1,肝転移(進行胃癌多発肝転移),剂量停止,発疹(再投与なし);そう痒症(再投与なし),""
CA-22004252,3,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20220913,20220913,360,mg,1,肝転移(進行胃癌多発肝転移),剂量停止,"",""
CA-22004252,3,3,PS,オキサリプラチン,エルプラット,静脈内点滴,20220913,20220913,200,mg,1,肝転移(進行胃癌多発肝転移),剂量停止,"",""
CA-22004252,3,4,C,パロノセトロン塩酸塩,"",不明,20220913,20220913,"","","","",未知,"",""
CA-22004252,3,5,C,デキサメタゾンリン酸エステルナトリウム,"",不明,20220913,20220913,"","","","",未知,"",""
CA-22004252,3,6,C,酸化マグネシウム,"",不明,20220905,"","","","","",未知,"",""
CA-22004252,3,7,C,ルビプロストン,"",不明,20220913,20220922,"","","","",剂量停止,"",""
CA-22004252,3,8,C,インスリンリスプロ,"",不明,20220822,"","","","","",未知,"",""
CA-22004252,3,9,C,インスリングラルギン［後続１］,"",不明,20220822,"","","","","",未知,"",""
CA-22004388,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20220106,20220421,360,mg,1,胃癌(胃癌),未知,間質性肺疾患(再投与なし),""
CA-22004388,3,2,PS,オキサリプラチン,エルプラット,静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）,20211209;20220106;20220310;20220421,;;;20220421,175;137;122;85,mg;mg;mg;mg,1;1;1;1,胃癌(胃癌),未知,間質性肺疾患(再投与なし),""
CA-22004388,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口;経口,20211209;20220106,;20220425,120;80,mg;mg,1;1,胃癌(胃癌),未知,間質性肺疾患(再投与なし),""
CA-22004388,3,4,C,オランザピン,"",経口,20220421,20220425,"","","","",未知,"",""
CA-22004388,3,5,C,アプレピタント,"",経口,20220421,20220423,"","","","",未知,"",""
CA-22004388,3,6,C,デキサメタゾン,"",経口,20220422,20220423,"","","","",未知,"",""
CA-22004388,3,7,C,生理食塩液,"",静脈内（明記されていない場合）,20220421,20220421,"","","","",未知,"",""
CA-22004388,3,8,C,ブドウ糖,"",静脈内（明記されていない場合）,20220421,20220421,"","","","",未知,"",""
CA-22004388,3,9,C,クロルフェニラミンマレイン酸塩,"",静脈内（明記されていない場合）,20220421,20220421,"","","","",未知,"",""
CA-22004388,3,10,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,20220421,20220421,"","","","",未知,"",""
CA-22004388,3,11,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内（明記されていない場合）,20220421,20220421,"","","","",未知,"",""
CA-22004455,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20211014,20220714,240,mg,1,胃癌(胃癌),未知,高血糖性高浸透圧性非ケトン性症候群(再投与なし);１型糖尿病(再投与なし),""
CA-22004455,3,2,PS,アゾセミド,ダイアート,経口,"","",30,mg,1,高血圧(高血圧),未知,"",""
CA-22004455,3,3,PS,プレガバリン,プレガバリンＯＤ,経口,"","",75,mg,1,"",未知,"",""
CA-22004455,3,4,C,ロキソプロフェンナトリウム水和物,"",経口,"","","","","","",未知,"",""
CA-22004455,3,5,C,レバミピド,"",経口,"","","","","","",未知,"",""
CA-22004455,3,6,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
CA-22004455,3,7,C,メナテトレノン,"",経口,"","","","","","",未知,"",""
CA-22004455,3,8,C,エルデカルシトール,"",経口,"","","","","","",未知,"",""
CA-22004455,3,9,C,ピラゾロン系解熱鎮痛消炎配合剤（４）,"",経口,"","","","","","",未知,"",""
CA-22004455,3,10,C,トラマドール塩酸塩,"",経口,"","","","","","",未知,"",""
CA-22004681,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220810,20220810,"","","",胃癌(胃癌治療),不适用,肝障害(再投与なし),""
CA-22004681,5,2,C,ジクロフェナクナトリウム,"",不明,"","","","","","",未知,"",""
CA-22004681,5,3,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
CA-22004681,5,4,C,メサラジン,"",不明,"","","","","","",未知,"",""
CA-22004681,5,5,C,レンボレキサント,"",不明,"","","","","","",未知,"",""
CA-22004681,5,6,C,ナルデメジントシル酸塩,"",不明,"","","","","","",未知,"",""
CA-22004681,5,7,C,ヒドロモルフォン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-22004681,5,8,C,トラゾドン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-22004681,5,9,C,プレドニゾロン,"",不明,"","","","","","",未知,"",""
CA-22004681,5,10,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
CA-22004681,5,11,C,ヒドロモルフォン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-22004681,5,12,C,フルオロウラシル,"",不明,"","","","","","",未知,"",""
CA-22004681,5,13,C,レボホリナートカルシウム,"",不明,"","","","","","",未知,"",""
CA-22004681,5,14,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
CA-22004816,4,1,PS,アテゾリズマブ,テセントリク,静脈内点滴;静脈内点滴,20220622;20220712,;20220712,1200;1200,mg;mg,1;1,肝細胞癌(肝細胞癌),剂量停止,皮膚障害(再投与なし),""
CA-22004816,4,2,PS,ベバシズマブ,アバスチン,静脈内点滴;静脈内点滴,20220622;20220712,;20220712,848;848,mg;mg,1;1,肝細胞癌(肝細胞癌),剂量停止,"",""
CA-22004816,4,3,C,イソロイシン・ロイシン・バリン,"",不明,20220624,"",3,{DF},1,"",剂量不变,"",""
CA-22004816,4,4,C,レバミピド,"",不明,20220613,20220731,"","","","",未知,"",""
CA-22004816,4,5,C,ロキソプロフェンナトリウム水和物,"",不明,20220613,20220731,"","","","",未知,"",""
CA-22004816,4,6,C,カルシポトリオール水和物・ベタメタゾンジプロピオン酸エステル,"",不明,20220531,20220731,"","","","",未知,"",""
CA-22004816,4,7,C,アプレミラスト,"",不明,20220719,20220801,"","","","",未知,"",""
CA-22004816,4,8,C,酪酸菌配合剤,"",不明,20220719,20220731,3,{DF},1,"",未知,"",""
CA-22004816,4,9,C,エピナスチン塩酸塩,"",不明,20220711,"",20,mg,1,"",剂量不变,"",""
CA-22004816,4,10,C,ベタメタゾン酪酸エステルプロピオン酸エステル,"",不明,20220711,20220731,"","","","",未知,"",""
CA-22004816,4,11,C,アムロジピンベシル酸塩,"",不明,"",20220814,2.5,mg,1,"",未知,"",""
CA-22004816,4,12,C,カンデサルタンシレキセチル,"",不明,"",20220814,2,mg,1,"",未知,"",""
CA-22004816,4,13,C,シタグリプチンリン酸塩水和物,"",不明,"","",25,mg,1,"",剂量不变,"",""
CA-22004816,4,14,C,エソメプラゾールマグネシウム水和物,"",不明,"","",20,mg,1,"",剂量不变,"",""
CA-22006286,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20220708,"","","","",胃癌(胃癌),未知,副腎機能不全(再投与なし),""
CA-22006286,3,2,C,アスピリン,"",経口,"","","","","","",未知,"",""
CA-22006286,3,3,C,ランソプラゾール,"",経口,"","","","","","",未知,"",""
CA-22006286,3,4,C,ロスバスタチンカルシウム,"",経口,"","","","","","",未知,"",""
CA-22006286,3,5,C,フロセミド,"",経口,"","","","","","",未知,"",""
CA-22006286,3,6,C,ビソプロロールフマル酸塩,"",経口,"","","","","","",未知,"",""
CA-22006286,3,7,C,ニコランジル,"",経口,"","","","","","",未知,"",""
CA-22006286,3,8,C,モサプリドクエン酸塩水和物,"",経口,"","","","","","",未知,"",""
CA-22006286,3,9,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
CA-22006286,3,10,C,大建中湯,"",経口,"","","","","","",未知,"",""
CA-22006877,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20220913,20230106,240,mg,1,胃癌(噴門癌),未知,間質性肺疾患(再投与なし),""
CA-22006877,3,2,PS,フルオロウラシル,５−ＦＵ,静脈内（明記されていない場合）,20220611,20221224,700,mg,1,胃癌(噴門癌),未知,"",""
CA-22006877,3,3,PS,シスプラチン,"",静脈内（明記されていない場合）,20220611,20221220,75,mg,1,胃癌(噴門癌),未知,"",""
CA-22006877,3,4,C,ミロガバリンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-22007057,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20220825,20221229,360,mg,1,胃癌(胃癌),未知,副腎機能不全(再投与なし),""
CA-22007057,3,2,C,オキサリプラチン,"",静脈内（明記されていない場合）,20200702,20221229,"","","","",未知,"",""
CA-22007057,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20200702,20221229,"","","","",未知,"",""
CA-22007057,3,4,C,レトロゾール,"",経口,"","","","","","",未知,"",""
CA-22007057,3,5,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
CA-22007057,3,6,C,牛車腎気丸,"",経口,"","","","","","",未知,"",""
CA-22007057,3,7,C,デキサメタゾン,"",経口,"","","","","","",未知,"",""
CA-22007470,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221215,20230105,"","","",胃癌(進行胃癌),剂量停止,薬物性肝障害(再投与なし),""
CA-22007470,3,2,PS,オキサリプラチン,"",静脈内点滴,20221215,20230105,"","","",胃癌(進行胃癌),剂量停止,薬物性肝障害(再投与なし),""
CA-22007470,3,3,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20221215,20230105,"","","",胃癌(進行胃癌),剂量停止,薬物性肝障害(再投与なし),""
CA-22007470,3,4,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
CA-22007470,3,5,C,パロノセトロン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-22007470,3,6,C,アスピリン,"",不明,"","","","","","",未知,"",""
CA-22007470,3,7,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
CA-22007470,3,8,C,ロスバスタチンカルシウム,"",不明,"","","","","","",未知,"",""
CA-22007470,3,9,C,アジルサルタン,"",不明,"","","","","","",未知,"",""
CA-22007470,3,10,C,メトホルミン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-22007470,3,11,C,ダパグリフロジンプロピレングリコール水和物,"",不明,"","","","","","",未知,"",""
CA-22007510,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20221202,20230203,240,mg,1,再発胃癌(再発胃癌),未知,劇症１型糖尿病(再投与なし),""
CA-22007510,3,2,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-22007510,3,3,C,アジルサルタン,"",不明,"","","","","","",未知,"",""
CA-22007510,3,4,C,ウルソデオキシコール酸,"",不明,"","","","","","",未知,"",""
CA-22007510,3,5,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
CA-22007510,3,6,C,エドキサバントシル酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-22007682,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）,20220819;20220907;20220928,;;,;;,;;,;;,再発胃癌(胃癌術後再発);胃手術(胃癌術後再発),未知,副腎機能不全(再投与なし);免疫介在性副作用(再投与なし),""
CA-22007682,3,2,C,オキサリプラチン,"",静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）,20220819;20220907;20220928,;;,;;,;;,;;,"",未知,"",""
CA-22007682,3,3,C,パクリタキセル,"",静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）,20221102;20221130;20221228;20230201,;;;,;;;,;;;,;;;,"",未知,"",""
CA-22007682,3,4,C,ラムシルマブ,"",静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）,20221102;20221130;20221228;20230201,;;;,;;;,;;;,;;;,"",未知,"",""
CA-22007682,3,5,C,シロドシン,"",経口,"","","","","","",未知,"",""
CA-23000004,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220519,20221130,240,mg,1,胃癌(胃がん),剂量停止,自己免疫性脳炎(再投与なし),""
CA-23000004,3,2,C,ベニジピン塩酸塩,"",不明,20220202,"","","","","",未知,"",""
CA-23000004,3,3,C,ボグリボース,"",不明,20221020,20221129,"","","","",未知,"",""
CA-23000004,3,4,C,シロドシン,"",不明,"","","","","","",未知,"",""
CA-23000565,3,1,PS,オキサリプラチン,"",静脈内点滴;静脈内点滴,20220222;20230410,20220617;20230410,;,;,;,胃癌(胃癌腹膜播種再発に対する治療),剂量停止,アナフィラキシーショック(再投与なし),""
CA-23000565,3,2,PS,ニボルマブ,オプジーボ,静脈内点滴,20230410,20230410,"","","",胃癌(胃癌腹膜播種再発に対する治療),未知,"",""
CA-23000565,3,3,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-23000565,3,4,C,アスピリン・ランソプラゾール配合剤,"",不明,"","","","","","",未知,"",""
CA-23000565,3,5,C,ピリドキサールリン酸エステル水和物,"",不明,"","","","","","",未知,"",""
CA-23000565,3,6,C,ルビプロストン,"",不明,"","","","","","",未知,"",""
CA-23000565,3,7,C,ポラプレジンク,"",不明,"","","","","","",未知,"",""
CA-23000565,3,8,C,フロセミド,"",不明,"","","","","","",未知,"",""
CA-23000565,3,9,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
CA-23000565,3,10,C,パロノセトロン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-23000565,3,11,C,ホスアプレピタントメグルミン,"",不明,"","","","","","",未知,"",""
CA-23000565,3,12,C,レボホリナートカルシウム,"",不明,"","","","","","",未知,"",""
CA-23000857,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）;静脈内（明記されていない場合）;静脈内（明記されていない場合）,20221030;20230302;20230323,;;20230323,;;,;;,;;,胃癌(胃癌),未知,間質性肺疾患(再投与なし),""
CA-23000857,3,2,PS,牛車腎気丸,ツムラ牛車腎気丸エキス顆粒（医療用）,経口,20221221,20230320,7.5,g,1,末梢性ニューロパチー(末梢神経障害),未知,"",""
CA-23000857,3,3,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-23000857,3,4,C,ポラプレジンク,"",不明,"","","","","","",未知,"",""
CA-23000857,3,5,C,ビフィズス菌製剤（５）,"",不明,"","","","","","",未知,"",""
CA-23000857,3,6,C,センノシド,"",不明,"","","","","","",未知,"",""
CA-23000857,3,7,C,ロペラミド塩酸塩,"",不明,"","","","","","",未知,"",""
CA-23000857,3,8,C,フロセミド,"",不明,"","","","","","",未知,"",""
CA-23000857,3,9,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
CA-23000857,3,10,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
CA-23000860,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴,20211110;20211222,;20230207,480;480,mg;mg,1;1,胃癌(胃癌),未知,間質性肺疾患(再投与なし),""
CA-23000860,3,2,C,レボチロキシンナトリウム水和物,"",不明;不明,20220119;20220316,;,50;12.5,ug;ug,1;1,"",剂量不变,"",""
CA-23000860,3,3,C,フェキソフェナジン塩酸塩,"",不明,20230222,20230323,120,mg,1,"",未知,"",""
CA-23000860,3,4,C,ジフルプレドナート,"",不明,20230222,"","","","","",剂量不变,"",""
CA-23000860,3,5,C,ヒドロコルチゾン酪酸エステル,"",不明,20230222,"","","","","",剂量不变,"",""
CA-23000860,3,6,C,白色ワセリン,"",不明,20230222,"","","","","",剂量不变,"",""
CA-23000860,3,7,C,尿素,"",不明,20220810,"","","","","",剂量不变,"",""
CA-23000860,3,8,C,タフルプロスト,"",眼,"","","","","","",剂量不变,"",""
CA-23000860,3,9,C,ピレノキシン,"",眼,"","","","","","",剂量不变,"",""
CA-23001196,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）;静脈内（明記されていない場合）,20220426;20220607,20220606;20230307,;,;,;,胃癌(胃癌術後再発（腹膜播種）),未知,副腎機能不全(再投与なし),""
CA-23001196,3,2,C,ロスバスタチンカルシウム,"",経口,"","","","","","",未知,"",""
CA-23001196,3,3,C,ビソプロロールフマル酸塩,"",経口,"","","","","","",未知,"",""
CA-23001196,3,4,C,ラベプラゾールナトリウム,"",経口,"","","","","","",未知,"",""
CA-23001196,3,5,C,ニコランジル,"",経口,"","","","","","",未知,"",""
CA-23001196,3,6,C,アスピリン,"",経口,"","","","","","",未知,"",""
CA-23001196,3,7,C,アムロジピンベシル酸塩,"",経口,"","","","","","",未知,"",""
CA-23001349,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220906,20230502,240,mg,1,胃癌(胃癌のため),剂量停止,免疫性膵炎(再投与なし),""
CA-23001349,3,2,C,メコバラミン,"",不明,"","","","","","",未知,"",""
CA-23001349,3,3,C,ミロガバリンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-23001349,3,4,C,フロセミド,"",不明,"","","","","","",未知,"",""
CA-23001349,3,5,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
CA-23001349,3,6,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
CA-23001349,3,7,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
CA-23001349,3,8,C,エピナスチン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-23002058,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230209,20230419,"","","",胃癌(胃体部癌),未知,肺毒性(再投与なし),""
CA-23002058,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20230209,20230502,"","","",胃癌(胃体部癌),未知,"",""
CA-23002058,3,3,C,ナプロキセン,"",不明,"","","","","","",未知,"",""
CA-23002058,3,4,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
CA-23002058,3,5,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
CA-23002058,3,6,C,プレガバリン,"",不明,"","","","","","",未知,"",""
CA-23002058,3,7,C,メコバラミン,"",不明,"","","","","","",未知,"",""
CA-23002058,3,8,C,シロスタゾール,"",不明,"","","","","","",未知,"",""
CA-23002058,3,9,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-23002058,3,10,C,クロナゼパム,"",不明,"","","","","","",未知,"",""
CA-23002058,3,11,C,イフェンプロジル酒石酸塩,"",不明,"","","","","","",未知,"",""
CA-23002180,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220615,20230303,240,mg,1,胃癌(胃癌),未知,肺障害(再投与なし),""
CA-23002180,3,2,C,デキストロメトルファン臭化水素酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-23002180,3,3,C,ロスバスタチンカルシウム,"",不明,"","","","","","",未知,"",""
CA-23002180,3,4,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
CA-23002180,3,5,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
CA-23002180,3,6,C,ブリンゾラミド,"",不明,"","","","","","",未知,"",""
CA-23002180,3,7,C,チモロールマレイン酸塩,"",不明,"","","","","","",未知,"",""
CA-23002180,3,8,C,オミデネパグイソプロピル,"",不明,"","","","","","",未知,"",""
CA-23002180,3,9,C,ジクアホソルナトリウム,"",不明,"","","","","","",未知,"",""
CA-23002502,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）;静脈内（明記されていない場合）,20230217;20230512,;,;,;,;,再発胃癌(術後胃癌再発),未知,免疫性腸炎(再投与なし),""
CA-23002502,3,2,C,オキサリプラチン,"",静脈内（明記されていない場合）,20230217,20230512,"","","","",未知,"",""
CA-23002502,3,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230217,20230512,"","","","",未知,"",""
CA-23002588,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230407,"","","","",胃癌(胃癌),未知,急性腎障害(再投与なし),""
CA-23002588,4,2,PS,カペシタビン,"",経口,20230407,20230414,"","","",胃癌(胃癌),未知,"",""
CA-23002588,4,3,PS,オキサリプラチン,エルプラット,静脈内点滴,20230407,"","","","",胃癌(胃癌),未知,"",""
CA-23002588,4,4,C,ポラプレジンク,"",不明,"","","","","","",未知,"",""
CA-23002588,4,5,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
CA-23002657,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20220823,20221220,360,mg,1,胃癌(胃癌),剂量停止,間質性肺疾患(再投与なし),""
CA-23002657,3,2,PS,パクリタキセル（アルブミン懸濁型）,アブラキサン,静脈内点滴,20230418,20230502,130,mg,1,胃癌(胃癌),未知,間質性肺疾患(再投与なし),""
CA-23002657,3,3,PS,ラムシルマブ,サイラムザ,静脈内点滴,20230418,20230502,400,mg,1,胃癌(胃癌),未知,"",""
CA-23002657,3,4,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-23002657,3,5,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-23002657,3,6,C,アジルサルタン,"",不明,"","","","","","",未知,"",""
CA-23002657,3,7,C,ピタバスタチンカルシウム,"",不明,"","","","","","",未知,"",""
CA-23002657,3,8,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
CA-23002657,3,9,C,インスリンアスパルト,"",不明,"","","","","","",未知,"",""
CA-23002657,3,10,C,インスリングラルギン［後続１］,"",不明,"","","","","","",未知,"",""
CA-23002732,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴,20221129;20230511;20230525,;;,;;,;;,;;,胃癌(胃癌),剂量停止,高血糖(再投与なし),""
CA-23002732,3,2,C,レボチロキシンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-23002732,3,3,C,トリクロルメチアジド,"",不明,"","","","","","",未知,"",""
CA-23002732,3,4,C,フロセミド,"",不明,"","","","","","",未知,"",""
CA-23002732,3,5,C,炭酸水素ナトリウム,"",不明,"","","","","","",未知,"",""
CA-23002732,3,6,C,フェブキソスタット,"",不明,"","","","","","",未知,"",""
CA-23002732,3,7,C,アログリプチン安息香酸塩,"",不明,"","","","","","",未知,"",""
CA-23002732,3,8,C,デキサメタゾン,"",不明,"","","","","","",未知,"",""
CA-23002732,3,9,C,エソメプラゾールマグネシウム水和物,"",不明,"","","","","","",未知,"",""
CA-23002732,3,10,C,アナモレリン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-23002740,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230425,20230425,480,mg,1,胃癌(胃癌),未知,副腎機能不全(再投与なし),""
CA-23002740,3,2,C,カルベジロール,"",不明,"","","","","","",未知,"",""
CA-23002740,3,3,C,アジルサルタン,"",不明,"","","","","","",未知,"",""
CA-23002740,3,4,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
CA-23002740,3,5,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-23002740,3,6,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-23002740,3,7,C,カルベジロール,"",不明,"","","","","","",未知,"",""
CA-23002740,3,8,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
CA-23002778,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230110,20230620,360,mg,1,胃癌(胃癌),未知,間質性肺疾患(再投与なし),""
CA-23002778,3,2,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","","",未知,"",""
CA-23002778,3,3,C,ロキソプロフェンナトリウム水和物,"",不明,"","","","","","",未知,"",""
CA-23002778,3,4,C,ロペラミド塩酸塩,"",不明,"","","","","","",未知,"",""
CA-23002778,3,5,C,タンニン酸アルブミン,"",不明,"","","","","","",未知,"",""
CA-23002778,3,6,C,アヘンチンキ,"",不明,"","","","","","",未知,"",""
CA-23002778,3,7,C,ポリカルボフィルカルシウム,"",不明,"","","","","","",未知,"",""
CA-23002778,3,8,C,クロピドグレル硫酸塩,"",不明,"","","","","","",未知,"",""
CA-23002778,3,9,C,アムロジピンベシル酸塩・アトルバスタチンカルシウム水和物配合剤（３）,"",不明,"","","","","","",未知,"",""
CA-23002778,3,10,C,アルプラゾラム,"",不明,"","","","","","",未知,"",""
CA-23002778,3,11,C,ブロチゾラム,"",不明,"","","","","","",未知,"",""
CA-23002778,3,12,C,ベタネコール塩化物,"",不明,"","","","","","",未知,"",""
CA-23002778,3,13,C,デュタステリド,"",不明,"","","","","","",未知,"",""
CA-23002778,3,14,C,タムスロシン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-23002778,3,15,C,八味地黄丸,"",不明,"","","","","","",未知,"",""
CA-23002778,3,16,C,エルデカルシトール,"",不明,"","","","","","",未知,"",""
CA-23002778,3,17,C,清暑益気湯,"",不明,"","","","","","",未知,"",""
CA-23003122,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,"","","","","",胃癌(胃癌),未知,肺毒性(再投与なし),""
CA-23003122,3,2,C,ルビプロストン,"",不明,"","","","","","",未知,"",""
CA-23003122,3,3,C,シロドシン,"",不明,"","","","","","",未知,"",""
CA-23003122,3,4,C,センノシド,"",不明,"","","","","","",未知,"",""
CA-23003122,3,5,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
CA-23003122,3,6,C,アルファカルシドール,"",不明,"","","","","","",未知,"",""
CA-23003122,3,7,C,デュロキセチン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-23003122,3,8,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","","",未知,"",""
CA-23003122,3,9,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
CA-23003122,3,10,C,レバミピド,"",不明,"","","","","","",未知,"",""
CA-23003122,3,11,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
CA-23003122,3,12,C,牛車腎気丸,"",不明,"","","","","","",未知,"",""
CA-23003122,3,13,C,プランルカスト水和物,"",不明,"","","","","","",未知,"",""
CA-23003122,3,14,C,アムロジピンベシル酸塩,"",不明,"","","","","","",未知,"",""
CA-23003122,3,15,C,フルチカゾンフランカルボン酸エステル・ウメクリジニウム臭化物・ビランテロールトリフェニル酢酸塩,"",不明,"","","","","","",未知,"",""
CA-23003122,3,16,C,サルブタモール硫酸塩,"",不明,"","","","","","",未知,"",""
CA-23004574,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230706,20230706,"","","",胃癌(胃癌),未知,肝炎(再投与なし),""
CA-23004574,3,2,C,ボノプラザンフマル酸塩,"",不明,"","","","","","",未知,"",""
CA-23004574,3,3,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-23004574,3,4,C,アナモレリン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-23004574,3,5,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
CA-23004574,3,6,C,フロセミド,"",不明,"","","","","","",未知,"",""
CA-23004574,3,7,C,スピロノラクトン,"",不明,"","","","","","",未知,"",""
CA-23004574,3,8,C,センノシド,"",不明,"","","","","","",未知,"",""
CA-23004574,3,9,C,トラマドール塩酸塩・アセトアミノフェン配合剤,"",不明,"","","","","","",未知,"",""
CA-23004574,3,10,C,オランザピン,"",不明,"","","","","","",未知,"",""
CA-23004574,3,11,C,クエン酸第一鉄ナトリウム,"",不明,"","","","","","",未知,"",""
CA-23005125,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20230516,"",360,mg,1,胃癌(胃体部癌),未知,１型糖尿病(無),""
CA-23005125,3,2,C,パロノセトロン塩酸塩,"",静脈内（明記されていない場合）,20230516,20230829,"","","","",未知,"",""
CA-23005125,3,3,C,デキサメタゾンリン酸エステルナトリウム,"",静脈内（明記されていない場合）,20230516,20230829,"","","","",未知,"",""
CA-23005125,3,4,C,オキサリプラチン,"",静脈内（明記されていない場合）,20230516,20230829,"","","","",未知,"",""
CA-23005125,3,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",経口,20230516,20230911,"","","","",未知,"",""
CA-23005125,3,6,C,アプレピタント,"",経口,20230829,20230831,"","","","",未知,"",""
CA-23005125,3,7,C,ルビプロストン,"",経口,20230718,"","","","","",未知,"",""
CA-23005125,3,8,C,Ｌ−アスパラギン酸カリウム,"",経口,20230829,"","","","","",未知,"",""
CA-23005125,3,9,C,ベニジピン塩酸塩,"",経口,"","","","","","",未知,"",""
CA-23005125,3,10,C,ロスバスタチンカルシウム,"",経口,"","","","","","",未知,"",""
CA-23005125,3,11,C,ドキサゾシンメシル酸塩,"",経口,"","","","","","",未知,"",""
CA-23005125,3,12,C,酸化マグネシウム,"",経口,"","","","","","",未知,"",""
CA-23005125,3,13,C,モサプリドクエン酸塩水和物,"",経口,"","","","","","",未知,"",""
CA-23005681,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）;静脈内（明記されていない場合）,20230922;20231006,;,;,;,;,胃癌(胃癌に対する化学療法、3次治療のため。),未知,心筋梗塞(再投与なし);心筋炎(再投与なし),""
CA-23005681,3,2,C,フロセミド,"",経口,20230901,"","","","","",未知,"",""
CA-23005681,3,3,C,スピロノラクトン,"",経口,20230901,"","","","","",未知,"",""
CA-23005681,3,4,C,十全大補湯,"",経口,20230602,"","","","","",未知,"",""
CA-23005760,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20230111,"",240,mg,1,胃癌(胃癌の化学療法のため),未知,劇症１型糖尿病(不明);甲状腺機能低下症(不明),""
CA-23005760,3,2,C,酪酸菌製剤,"",経口,20221124,"","","","","",未知,"",""
CA-23005760,3,3,C,ボノプラザンフマル酸塩,"",経口,20221124,"","","","","",未知,"",""
CA-23005760,3,4,C,レボチロキシンナトリウム水和物,"",経口,20230308,"","","","","",未知,"",""
CA-23005760,3,5,C,フェキソフェナジン塩酸塩,"",経口,20230322,"","","","","",未知,"",""
CA-23005775,4,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230124,20230803,"","","",胃癌(治癒切除不能な進行・再発の胃癌),未知,間質性肺疾患(再投与なし),""
CA-23005775,4,2,C,オキサリプラチン,"",不明,20230124,"","","","","",未知,"",""
CA-23005775,4,3,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,20230124,"","","","","",未知,"",""
CA-23005775,4,4,C,スルファメトキサゾール・トリメトプリム,"",不明,"","","","","","",未知,"",""
CA-23005775,4,5,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
CA-23005775,4,6,C,レンボレキサント,"",不明,"","","","","","",未知,"",""
CA-23005775,4,7,C,酢酸亜鉛水和物,"",不明,"","","","","","",未知,"",""
CA-23005775,4,8,C,ラメルテオン,"",不明,"","","","","","",未知,"",""
CA-23005875,5,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20230720,20230803,"","","",胃癌(原疾患),未知,肺炎(再投与なし),""
CA-23005875,5,2,C,フェブキソスタット,"",不明,"","","","","","",未知,"",""
CA-23005875,5,3,C,アスピリン,"",不明,"","","","","","",未知,"",""
CA-23005875,5,4,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
CA-23005875,5,5,C,ベニジピン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-23005875,5,6,C,酪酸菌配合剤,"",不明,"","","","","","",未知,"",""
CA-23005875,5,7,C,酸化マグネシウム,"",不明,"","","","","","",未知,"",""
CA-23005875,5,8,C,プレガバリン,"",不明,"","","","","","",未知,"",""
CA-23005875,5,9,C,アセトアミノフェン,"",不明,"","","","","","",未知,"",""
CA-23005875,5,10,C,メトクロプラミド,"",不明,"","","","","","",未知,"",""
CA-23005881,3,1,PS,ニボルマブ,オプジーボ,静脈内点滴,20230120,20230508,"","","",胃癌(進行胃癌),未知,尿細管間質性腎炎(再投与なし),""
CA-23005881,3,2,C,グラニセトロン塩酸塩,"",不明,"","","","","","",未知,"",""
CA-23005881,3,3,C,デキサメタゾンリン酸エステルナトリウム,"",不明,"","","","","","",未知,"",""
CA-23005881,3,4,C,オキサリプラチン,"",不明,"","","","","","",未知,"",""
CA-23005881,3,5,C,テガフール・ギメラシル・オテラシルカリウム配合剤,"",不明,"","","","","","",未知,"",""
CA-23005881,3,6,C,六君子湯,"",不明,"","","","","","",未知,"",""
CA-23005881,3,7,C,ランソプラゾール,"",不明,"","","","","","",未知,"",""
CA-23005881,3,8,C,酪酸菌製剤,"",不明,"","","","","","",未知,"",""
CA-23005881,3,9,C,モサプリドクエン酸塩水和物,"",不明,"","","","","","",未知,"",""
CA-23005881,3,10,C,タンニン酸アルブミン,"",不明,"","","","","","",未知,"",""
CA-23005992,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20230705,"","","","","",剂量停止,腸炎(再投与なし),""
CA-23005992,3,2,C,オキサリプラチン,"",静脈内（明記されていない場合）,"","","","","","",未知,"",""
CA-23005992,3,3,C,ビソプロロールフマル酸塩,"",経口,"","","","","","",未知,"",""
CA-23005992,3,4,C,スピロノラクトン,"",経口,"","","","","","",未知,"",""
CA-23005992,3,5,C,サクビトリルバルサルタンナトリウム水和物,"",経口,"","","","","","",未知,"",""
CA-23005992,3,6,C,エンパグリフロジン,"",経口,"","","","","","",未知,"",""
CA-23005992,3,7,C,シロスタゾール,"",経口,"","","","","","",未知,"",""
CA-23006251,3,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20231108,"","","","",再発胃癌(胃癌再発),未知,肝機能異常(再投与なし),""
CA-23006251,3,2,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20231018,"","","","",胃癌(胃癌),未知,"",""
CA-23006251,3,3,PS,オキサリプラチン,"",不明,20231018,"","","","",胃癌(胃癌),未知,"",""
CA-23006251,3,4,C,デキサメタゾン,"",経口,20231018,20231220,"","","","",未知,"",""
CA-23006251,3,5,C,ナルデメジントシル酸塩,"",経口,20231025,20231220,"","","","",未知,"",""
CA-23006251,3,6,C,ロキソプロフェンナトリウム水和物,"",経口,20230912,20231220,"","","","",未知,"",""
CA-23006251,3,7,C,レバミピド,"",経口,20230912,20231220,"","","","",未知,"",""
CA-23006251,3,8,C,ボノプラザンフマル酸塩,"",経口,20231010,20231220,"","","","",未知,"",""
CA-23006251,3,9,C,オキシコドン塩酸塩水和物,"",経口,20231018,20231220,"","","","",未知,"",""
CA-23006251,3,10,C,酸化マグネシウム,"",経口,20231118,20231220,"","","","",未知,"",""
CA-23006251,3,11,C,酢酸亜鉛水和物,"",経口,20231118,20231220,"","","","",未知,"",""
CA-23006415,5,1,PS,ニボルマブ,オプジーボ,静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴;静脈内点滴,20230417;20230508;20230529;20230619;20230710;20230731;20230911;20231002;20231023;20231113,;;;;;;;;;20231113,;;;;;;;;;,;;;;;;;;;,;;;;;;;;;,胃癌(胃癌),剂量停止,１型糖尿病(再投与なし),""
CA-23006415,5,2,C,カペシタビン,"",不明;不明;不明;不明,20230417;20230731;20230911;20231002,20230724;20230813;20230924;20231126,3000;2400;1800;1200,mg;mg;mg;mg,1;1;1;1,"",剂量停止,"",""
CA-23006415,5,3,C,ピリドキサールリン酸エステル水和物,"",不明,20230417,"",60,mg,1,"",剂量不变,"",""
CA-23006415,5,4,C,フェキソフェナジン塩酸塩,"",不明,20231113,"",120,mg,1,"",剂量不变,"",""
CA-23006415,5,5,C,ヘパリン類似物質,"",不明,20230417,"","","","","",剂量不变,"",""
CA-23006528,3,1,PS,テガフール・ギメラシル・オテラシルカリウム配合剤,エスワンタイホウＯＤ,経口,20230712,20230713,"","","",胃癌(胃癌),剂量停止,胃穿孔(再投与なし),""
CA-23006528,3,2,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20230712,20230712,"","","",胃癌(胃癌),未知,胃穿孔(再投与なし),""
CA-23007181,4,1,PS,ニボルマブ,オプジーボ,静脈内（明記されていない場合）,20231129,20231129,360,mg,1,胃癌(胃癌),未知,肝障害(再投与なし),""
CA-23007181,4,2,C,デキサメタゾン,"",経口,20231019,20231020,"","","","",未知,"",""
CA-23007181,4,3,C,ナルデメジントシル酸塩,"",経口,20231025,20240110,"","","","",未知,"",""
CA-23007181,4,4,C,ボノプラザンフマル酸塩,"",経口,20230912,20240110,"","","","",未知,"",""
CA-23007181,4,5,C,オキシコドン塩酸塩水和物,"",経口,20231018,20231220,"","","","",未知,"",""
CA-23007181,4,6,C,アセトアミノフェン,"",経口,20231118,20231220,"","","","",未知,"",""
CA-23007181,4,7,C,ロキソプロフェンナトリウム水和物,"",経口,20230912,20231220,"","","","",未知,"",""
CA-23007181,4,8,C,酢酸亜鉛水和物,"",経口,20231108,20231220,"","","","",未知,"",""
CA-23007181,4,9,C,プロクロルペラジンメシル酸塩,"",経口,20231129,20231129,"","","","",未知,"",""
CA-23007181,4,10,C,ウルソデオキシコール酸,"",経口,20231129,20231220,"","","","",未知,"",""
CA-23007181,4,11,C,グリチルリチン酸一アンモニウム・グリシン・ＤＬ−メチオニン配合剤,"",経口,20231129,20231220,"","","","",未知,"",""
